Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chemical synaptic transmission (GO:0007268),0.6006548191661228,2.769539616000822,0.0,0.0,0.0,109/284,15.04%,NLGN1;KCND2;DLG2;NRXN1;GRM7;GRID2;ASIC2;GRIA4;GRIK5;GRIK2;GABRB3;GRM5;ERC2;DLGAP1;HTR2C;GRIN2A;CHRM2;GRIK1;KCNQ3;CDH8;RIMS1;GABRB1;GABRG3;CACNA1E;SYN2;PTPRN2;DTNA;SHISA6;SYT1;CHRM3;RIT2;GRIN2B;GRIA3;SYN3;AMPH;UNC13C;GLRA1;HCRTR2;GABRA2;SYT10;SNPH;SNAP25;APBA2;DLGAP2;GRM1;CAMK4;CACNB2;GRID1;CPLX1;SLC1A2;SLC17A6;SYN1;SCN2B;GRIA2;PLP1;GRIK4;GRIA1;KIF1B;NRXN2;GABRA3;SLC1A6;PNOC;HRH3;NOVA1;SLC5A7;KIF5A;GABRA5;SYT5;GRM3;HOMER1;KCNIP2;GABRB2;NTSR1;RIMBP2;KCNA1;NSG1;GABRG2;CHRNA5;SLC1A1;PCDHB6;SLC6A1;GLRA2;PCDHB14;CORT;SLC6A2;CHAT;PDYN;SLC12A5;NAPB;BRSK1;DOC2A;UNC13B;HTR1B;CALM1;PCDHB11;PDLIM4;SLC18A3;PRKACB;NLGN2;PCDHB16;GLRA3;OPRK1;RIC3;HRH2;CHRNA7;CHRFAM7A;PRKAR1A;HTR7;PENK
prerank,anterograde trans-synaptic signaling (GO:0098916),0.6092389557869636,2.7421631112473555,0.0,0.0,0.0,88/224,15.04%,NLGN1;KCND2;DLG2;NRXN1;GRM7;ASIC2;GRIA4;GRIK2;GABRB3;GRM5;DLGAP1;HTR2C;GRIN2A;CHRM2;GRIK1;KCNQ3;GABRB1;GABRG3;CACNA1E;SYN2;DTNA;SYT1;CHRM3;RIT2;GRIN2B;GRIA3;AMPH;UNC13C;GLRA1;HCRTR2;GABRA2;SYT10;SNAP25;APBA2;GRM1;CAMK4;CACNB2;CPLX1;SLC1A2;SYN1;SCN2B;GRIA2;PLP1;GRIK4;GRIA1;NRXN2;GABRA3;SLC1A6;PNOC;HRH3;NOVA1;KIF5A;GABRA5;SYT5;GRM3;HOMER1;KCNIP2;GABRB2;NTSR1;KCNA1;GABRG2;CHRNA5;SLC1A1;PCDHB6;SLC6A1;GLRA2;PCDHB14;CORT;SLC6A2;PDYN;SLC12A5;DOC2A;UNC13B;HTR1B;CALM1;PCDHB11;SLC18A3;PRKACB;NLGN2;PCDHB16;GLRA3;OPRK1;HRH2;CHRNA7;CHRFAM7A;PRKAR1A;HTR7;PENK
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.597732010066605,2.5854934804913614,0.0,0.0,0.0,63/159,14.30%,NLGN1;LRRC4C;ROBO1;GRID2;LRFN5;PTPRD;TENM2;ADGRL3;IL1RAPL1;CDH18;KIRREL3;ROBO2;CDH8;CNTN6;GPC6;TENM3;CDH10;CNTN4;CDH2;PTPRT;TENM1;DSCAM;PCDHGB4;CDH20;TENM4;CDH11;UNC5D;NTNG1;CDH13;SLITRK1;CDH12;CDH22;CDH19;CDH7;ACVR1;NECTIN3;VCAM1;SDK1;DCHS1;FAT4;FLRT3;DSCAML1;CDH6;PCDHB6;PCDHB14;CDH17;ROBO3;CRB1;CDHR3;TGFB2;SLITRK3;CDH9;PKD1;CADM3;AMIGO2;CLDN5;PCDHB11;TRO;VSTM2L;PTPRS;CDH1;CDH5;PCDHB16
prerank,modulation of chemical synaptic transmission (GO:0050804),0.6173631083673105,2.5211418530436127,0.0,0.0,0.0,36/107,9.24%,NLGN1;RIMS2;LRRC4C;NRG3;GRM7;GRID2;GRIK5;GRIK2;GRM5;DLGAP1;GRIK1;RIMS1;SYT1;CDH2;GRM8;CNTNAP4;SLC8A3;SYN3;SLC12A2;DLGAP2;GRM1;GRID1;CPLX1;SNCAIP;SYN1;TMEM108;GRIK4;CLSTN2;CLSTN1;GRM3;HOMER1;BDNF;FMR1;CX3CR1;SLC8A2;CAMK2A
prerank,regulation of synapse assembly (GO:0051963),0.7126753416307097,2.4726835969576286,0.0,0.0,0.0,17/46,7.07%,NLGN1;NRXN1;GRID2;LRFN5;PTPRD;IL1RAPL1;ROBO2;GPC6;SYNDIG1;IL1RAPL2;SLITRK1;SLIT1;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF
prerank,glutamate receptor signaling pathway (GO:0007215),0.738164947479212,2.429264832873252,0.0,0.0,0.0,19/37,8.42%,GRM7;GRID2;GRIA4;GRIK2;GRM5;GRIN2A;GRIK1;PLCB1;GRIN2B;GRM8;GRIA3;GRIN3A;GRM1;GRIA2;GRIK4;GRM3;HOMER1;FMR1;TRPM1
prerank,synapse assembly (GO:0007416),0.6492085669017544,2.418655551577231,0.0,0.0,0.0,29/67,14.30%,NLGN1;NRXN1;GRID2;GABRB3;ADGRL3;DNM3;KIRREL3;CDH2;DSCAM;GPM6A;GABRA2;SLITRK1;NRCAM;LRRTM3;NRXN2;SHANK3;SDK1;GABRB2;BDNF;FLRT3;GABRG2;PCDHB6;PCDHB14;DNER;CBLN4;PCDHB11;CDH1;NLGN2;PCDHB16
prerank,neurotransmitter secretion (GO:0007269),0.7056035142386216,2.4010787470987953,0.0,0.0,0.0,15/44,5.49%,RIMS2;NRXN1;RIMS1;SYN2;PTPRN2;SYT1;SYN3;PCLO;SYT10;SNPH;SNAP25;CPLX1;SYN1;NRXN2;HRH3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7143065723989481,2.3326165075805396,0.0,0.0,0.0,22/35,14.30%,NLGN1;CDH18;CDH8;CDH10;PCDHGB4;CDH20;CDH11;CDH13;CDH12;CDH22;CDH19;CDH7;DCHS1;CDH6;PCDHB6;PCDHB14;CDH17;CDHR3;CDH9;PCDHB11;CDH5;PCDHB16
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.638947389842369,2.332191146353414,0.0,0.0,0.0,22/57,10.87%,NLGN1;DLG2;GRIA4;DLGAP1;LRRC7;GRIN2A;SHISA6;GRIN2B;DLG3;GRIA3;DLGAP2;GRIA2;GRIA1;GSG1L;SHISA9;CACNG4;NETO1;CACNG2;NEFL;CAMK2A;DLGAP3;RELN
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.8566519774617399,2.3296293939108548,0.0,0.0,0.0,10/18,3.36%,GRID2;GRIK5;GRIK2;GRIK1;CDH8;UNC13C;GRID1;SLC17A6;GRIA2;GRIK4
prerank,positive regulation of synapse assembly (GO:0051965),0.7456904040147854,2.3185024164087236,0.0,0.0,0.0,11/27,7.07%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SYNDIG1;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF
prerank,signal release from synapse (GO:0099643),0.6775758055410894,2.304093150164296,0.0,0.0,0.0,14/43,5.49%,NRXN1;RIMS1;SYN2;PTPRN2;SYT1;SYN3;PCLO;SYT10;SNPH;SNAP25;CPLX1;SYN1;NRXN2;HRH3
prerank,positive regulation of nervous system development (GO:0051962),0.6714591291975928,2.29662594830288,0.0,4.7900373057767484e-05,0.001,16/42,9.67%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SOX11;SYNDIG1;MME;CLSTN2;EPHB1;CUX2;CLSTN1;BDNF;NUMB;CX3CR1;RASSF10
prerank,synapse organization (GO:0050808),0.5557423181912647,2.2959035753519133,0.0,4.470701485391632e-05,0.001,36/125,8.97%,NLGN1;LRRC4C;NRXN1;LRFN5;PTPRD;ADGRL3;GRM5;CTNND2;DNM3;KIRREL3;ANK3;PPFIA2;GPC6;CDH2;GPHN;DSCAM;SLC8A3;UNC13C;GPM6A;CACNB2;NTNG1;PAK3;SLITRK1;SEMA3E;NRCAM;NRXN2;SHANK3;SDK1;BDNF;FLRT3;PCDHB6;SLC6A1;CX3CR1;NEDD4;SLC8A2;PCDHB14
prerank,regulation of cation channel activity (GO:2001257),0.5864712779795602,2.2906388353843363,0.0,4.191282642554655e-05,0.001,33/89,13.07%,NLGN1;DLG2;FGF14;GRIA4;LRRC7;GRIN2A;FGF12;ANK3;ANK2;DMD;SHISA6;GRIN2B;DLG3;GRIA3;CACNB2;GRIA2;PDE4D;GRIA1;GSG1L;SHISA9;HOMER1;CACNG4;NETO1;CACNG2;JPH4;NEFL;CAMK2A;PIRT;RELN;KCNG1;STAC;CALM1;CALM2
prerank,neuron cell-cell adhesion (GO:0007158),0.8751809973704585,2.2812851171169206,0.0,3.9447366047573224e-05,0.001,9/14,4.05%,NLGN1;NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1;NINJ2;NRXN2
prerank,regulation of potassium ion transport (GO:0043266),0.7172839874931256,2.2689183338109515,0.0,7.451169142319388e-05,0.002,9/31,6.77%,DPP10;KCNIP4;DPP6;ANK3;ANK2;KCNN2;KCNIP1;CASQ2;KCNIP2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.6244790077373064,-2.2577473554248453,0.0,0.0012353225673376155,0.001,38/72,21.40%,PTPRC;RUNX1;CD74;BIRC3;SYK;AXL;ELF1;VRK2;USP18;RNASEL;PIAS1;RIPK1;IRAK2;CFLAR;IFNAR2;RNF31;ABCE1;RBCK1;IRAK3;GAS6;JAK1;CBFB;PTPN6;OTULIN;IFNGR2;TRAF1;HSP90AB1;TRAF2;AGPAT1;IKBKB;CASP8;SOCS3;PTPN11;TRADD;IL7;PTPN1;STAT1;RACK1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.648143791549153,-2.2349005095465757,0.0,0.0006176612836688078,0.001,23/56,12.22%,CTSB;MAPKAPK3;SFTPA1;SFTPA2;PLCG2;TLR8;CD36;TLR7;UNC93B1;ALPK1;IRAK2;MAPKAPK2;TAB2;TLR4;IRAK4;TRAF3;MYD88;NOD1;LY96;UBC;RPS27A;HSP90B1;CTSS
prerank,B cell receptor signaling pathway (GO:0050853),-0.7209218052679143,-2.222358020380671,0.0,0.0004117741891125385,0.001,16/32,13.98%,RFTN1;PTPRC;VAV3;PRKCB;CD38;SYK;PLCG2;TEC;BLNK;BCL2;MEF2C;NCKAP1L;LCK;ITK;PIK3CD;NFAM1
prerank,innate immune response (GO:0045087),-0.5165506179192613,-2.210624571216763,0.0,0.0003088306418344039,0.001,87/217,22.02%,LYN;CYBB;CD74;FGR;SP100;MFHAS1;SYK;PLCG2;REL;TLR8;CYBA;NRROS;FES;PPARG;MALT1;KYNU;ALPK1;DHX58;TLR4;PTK2B;NLRC5;IRF5;IRAK4;CFP;CIITA;C3;PIK3CG;NUB1;RNASE7;MYD88;BST2;B2M;ATAD3A;IFITM2;OTULIN;CLEC4D;MSRB1;CHGA;RELA;LCK;NCF1;APP;CD300LB;RNASE6;IFIT1;CLEC6A;ADAM15;CAMP;CXCL16;NCF2;TRIM68;FRK;CAPZA1;FCER1G;DEFA6;PIK3CD;TRIM11;GCH1;CD40;IKBKB;RELB;ANG;TREML1;MAVS;TRIM14;ISG15;SKP2;ZAP70;POLR3A;HCK;TRIM39;ZDHHC1;DDX3X;TTC4;NOD2;HMGB1;CYBC1;AGER;CD300E;SLA;SERINC3;TRIM25;ANKHD1;IFITM1;SRPK1;RNF135;MASP1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.4789792989863124,-2.2064421660814495,0.0,0.00024706451346752313,0.001,140/428,15.44%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CD44;CTSB;ATP8B4;APAF1;CLEC12A;ADGRE5;FGR;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;SYK;TSPAN14;CD300A;CYBA;PRKCD;OSTF1;FTL;CD36;RAB7A;RAC1;ANPEP;ROCK1;ITGB2;RAP1B;PTPRJ;ACTR2;IDH1;ANO6;HPSE;RHOA;TNFRSF1B;ARL8A;RAP2B;CRACR2A;ANXA2;PLAU;C5AR1;FABP5;CDK13;RAB31;ITGAL;S100A11;RAP1A;LAMP2;GYG1;PSMB7;PLEKHO2;ATG7;TCIRG1;GNS;SYNGR1;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;DNAJC13;ITGAV;DERA;CTSA;CFP;MAPK14;STOM;CAP1;CD53;ARSA;C3;CYB5R3;MVP;CAB39;SRP14;PRCP;GRN;PLAC8;SIRPA;AP2A2;TIMP2;VAT1;CTSC;BST2;VPS35L;HMOX2;B2M;PLAUR;CPPED1;CD63;PTPN6;IGF2R;GUSB;CTSH;ADAM8;MAGT1;CLEC4D;NCKAP1L;TMC6;HK3;PSMC3;ITGAX;EEF2;RAB3D;NPC2;DGAT1;TXNDC5;XRCC6;RAB24;ACTR1B;DNASE1L1;LAMP1;CTSS;CAMP;HSP90AB1;CPNE3;EEF1A1;PKM;FRK;RAB10;FCER1G;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;KCMF1;NEU1;PDXK;ABCA13;PGRMC1;COTL1;ARPC5;CST3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.613929365243851,-2.2001705006489782,0.0,0.00020588709455626926,0.001,35/71,15.26%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;SYK;PLCG2;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;MYO1G;PLD2;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;CRK;ARPC1B;PIK3CA;ARPC1A;HSP90AB1;FCGR2B;FCER1G;MYO10;BRK1;ARPC5
prerank,neutrophil degranulation (GO:0043312),-0.47718519470410187,-2.195856739118615,0.0,0.0001764746524768022,0.001,139/425,15.44%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CD44;CTSB;ATP8B4;APAF1;CLEC12A;ADGRE5;FGR;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;TSPAN14;CD300A;CYBA;PRKCD;OSTF1;FTL;CD36;RAB7A;RAC1;ANPEP;ROCK1;ITGB2;RAP1B;PTPRJ;ACTR2;IDH1;ANO6;HPSE;RHOA;TNFRSF1B;ARL8A;RAP2B;CRACR2A;ANXA2;PLAU;C5AR1;FABP5;CDK13;RAB31;ITGAL;S100A11;RAP1A;LAMP2;GYG1;PSMB7;PLEKHO2;ATG7;TCIRG1;GNS;SYNGR1;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;DNAJC13;ITGAV;DERA;CTSA;CFP;MAPK14;STOM;CAP1;CD53;ARSA;C3;CYB5R3;MVP;CAB39;SRP14;PRCP;GRN;PLAC8;SIRPA;AP2A2;TIMP2;VAT1;CTSC;BST2;VPS35L;HMOX2;B2M;PLAUR;CPPED1;CD63;PTPN6;IGF2R;GUSB;CTSH;ADAM8;MAGT1;CLEC4D;NCKAP1L;TMC6;HK3;PSMC3;ITGAX;EEF2;RAB3D;NPC2;DGAT1;TXNDC5;XRCC6;RAB24;ACTR1B;DNASE1L1;LAMP1;CTSS;CAMP;HSP90AB1;CPNE3;EEF1A1;PKM;FRK;RAB10;FCER1G;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;KCMF1;NEU1;PDXK;ABCA13;PGRMC1;COTL1;ARPC5;CST3
prerank,neutrophil mediated immunity (GO:0002446),-0.4754663596610929,-2.188793783026415,0.0,0.0003088306418344039,0.002,140/432,15.44%,IQGAP2;DOCK2;IQGAP1;DIAPH1;PTPRC;CYBB;CD44;CTSB;ATP8B4;APAF1;CLEC12A;ADGRE5;FGR;CTSD;SDCBP;CTSZ;LILRB3;C3AR1;PSAP;TSPAN14;CD300A;CYBA;PRKCD;OSTF1;FTL;CD36;RAB7A;RAC1;ANPEP;ROCK1;ITGB2;RAP1B;PTPRJ;ACTR2;IDH1;ANO6;HPSE;RHOA;TNFRSF1B;ARL8A;RAP2B;CRACR2A;ANXA2;PLAU;C5AR1;FABP5;CDK13;RAB31;ITGAL;S100A11;RAP1A;LAMP2;GYG1;PSMB7;PLEKHO2;ATG7;TCIRG1;GNS;SYNGR1;TOM1;IMPDH2;NFKB1;DYNC1H1;GALNS;DNAJC13;ITGAV;DERA;CTSA;IRAK4;CFP;MAPK14;STOM;CAP1;CD53;ARSA;C3;CYB5R3;MVP;CAB39;SRP14;PRCP;GRN;PLAC8;SIRPA;AP2A2;TIMP2;VAT1;CTSC;BST2;VPS35L;HMOX2;B2M;PLAUR;CPPED1;CD63;PTPN6;IGF2R;GUSB;CTSH;ADAM8;MAGT1;CLEC4D;NCKAP1L;TMC6;HK3;PSMC3;ITGAX;EEF2;RAB3D;NPC2;DGAT1;TXNDC5;XRCC6;RAB24;ACTR1B;DNASE1L1;LAMP1;CTSS;CAMP;HSP90AB1;CPNE3;EEF1A1;PKM;FRK;RAB10;FCER1G;DPP7;STK11IP;GGH;GMFG;CREG1;NFAM1;KCMF1;NEU1;PDXK;ABCA13;PGRMC1;COTL1;ARPC5;CST3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.6109016935247831,-2.188062104574395,0.0,0.0002745161260750257,0.002,34/70,15.26%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;SYK;PLCG2;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;MYO1G;PLD2;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;CRK;ARPC1B;PIK3CA;ARPC1A;HSP90AB1;FCGR2B;MYO10;BRK1;ARPC5
prerank,nervous system development (GO:0007399),0.4538502347867239,2.1847996099213693,0.0,0.0005647201876284167,0.016,124/429,14.80%,LSAMP;NLGN1;RBFOX1;NRXN1;NRG1;ROBO1;ASIC2;ADGRL3;NAV3;MYT1L;NELL1;CHRM2;SPOCK1;GRIK1;FGF12;DNM3;KIRREL3;ROBO2;CNTN6;KALRN;TRPC5;CHRM3;CNTN4;EFNA5;DCLK1;ERBB4;CDH2;TENM1;DSCAM;ADAM22;LDB2;GPM6A;ST8SIA2;SERPINI1;LRCH4;APBA2;AHI1;SRRM4;DPF3;NAV2;SCN2A;SEMA6A;SH3GL2;NINJ2;IL1RAPL2;SLITRK1;SEMA5A;NRCAM;VCAN;POU6F2;SOX6;NRXN2;PAX8;PTN;POU3F2;GDNF;RBFOX2;ACVR1C;ADAM23;EPHB1;MAL;SHANK3;GPM6B;APC2;SDK1;RPS6KA6;DCHS1;FEZ1;GSS;MOG;SH3GL3;CYP51A1;FAT4;YAP1;BDNF;RBFOX3;FLRT3;DSCAML1;ADGRV1;PTS;NCKAP1;DPYSL5;GFRA2;ADGRA2;NDUFV2;PCDHB6;PTPRZ1;PCDHB14;GBX2;B3GNT5;PCDHA11;PCDHA4;NEUROD1;DNER;MBD5;CHST8;GSN;GSTP1;RELN;NBL1;SMO;PKD1;DPYSL4;RAPGEF5;HES5;ZIC2;TYRO3;DOC2A;ATXN10;VLDLR;PCDHB11;TEAD1;CDK5RAP2;PRKN;FKTN;CDH1;HES1;ZIC4;NLGN2;ARNT2;PCDHB16;INHBA;BTBD3;PAFAH1B3
prerank,cell junction assembly (GO:0034329),0.5452564669218867,2.1841306160037726,0.0,0.0006035447005278703,0.018,42/100,14.30%,NLGN1;NRXN1;ADGRL3;CDH18;CTNND2;DNM3;KIRREL3;CDH8;CDH10;CDH2;DSCAM;CDH20;TJP1;CDH11;GPM6A;SLITRK1;NRCAM;CDH12;CDH22;NRXN2;CDH19;CDH7;SHANK3;SDK1;DCHS1;BDNF;FLRT3;CDH6;TLN2;PCDHB6;PCDHB14;DNER;ARVCF;CDHR3;CDH9;FERMT2;CLDN5;PCDHB11;CDH1;CDH5;NLGN2;PCDHB16
prerank,neurotransmitter transport (GO:0006836),0.5812063866967959,2.1788829368311338,0.0,0.0006067380587317214,0.019,27/73,13.09%,NRXN1;PPFIA2;RIMS1;SYN2;PTPRN2;SYT1;SYN3;GABRA2;SNPH;SNAP25;CPLX1;SLC1A2;SLC17A6;SYN1;SLC6A16;NRXN2;SLC1A6;SLC6A15;HRH3;SLC5A7;GLUL;SLC1A1;SLC6A2;CHAT;BRSK1;UNC13B;SLC18A3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.6042407945390356,-2.1743604852619116,0.0,0.0003705967702012847,0.003,35/73,15.26%,LYN;VAV3;FGR;ABI1;GRB2;WIPF1;ARPC2;SYK;PLCG2;PRKCD;RAC1;ACTR2;WASF2;VAV1;CDC42;ACTR3;ACTB;ARPC3;MYO1G;PLD2;PIK3CB;WASL;BAIAP2;VAV2;NCKAP1L;CRK;ARPC1B;PIK3CA;ARPC1A;HSP90AB1;FCGR2B;FCER1G;MYO10;BRK1;ARPC5
prerank,presynapse assembly (GO:0099054),0.8001622641875502,2.1704450599279275,0.0,0.0006096411116443134,0.02,5/16,3.96%,NLGN1;PTPRD;IL1RAPL1;PCLO;LRRTM3
prerank,toll-like receptor signaling pathway (GO:0002224),-0.5817772187484719,-2.160948284321898,0.0,0.0003369061547284406,0.003,31/84,12.22%,RFTN1;CTSB;BIRC3;MAPKAPK3;SFTPA1;SFTPA2;PLCG2;TLR8;CD36;ITGB2;MAP3K1;PIK3AP1;TLR7;UNC93B1;RIPK1;IRAK2;MAPKAPK2;TAB2;TLR4;IRAK4;TRAF3;IRAK3;EPG5;MYD88;LY96;UBC;RPS27A;TNIP2;HSP90B1;TICAM1;CTSS
prerank,cell-cell junction organization (GO:0045216),0.5557528813074377,2.153927008378616,0.0,0.0007580754692620593,0.026,34/79,14.94%,CADM2;CDH18;CTNND2;CDH8;CDH10;CDH2;CDH20;TJP1;CDH11;CDH13;CSF1R;CDH12;CDH22;AFDN;CDH19;CDH7;NECTIN3;SDK1;DCHS1;PRKCI;CDH6;TLN2;OCLN;CDH17;ARVCF;CDHR3;TGFB2;CDH9;CADM3;CLDN5;CDH1;CDH5;NLGN2;CTNND1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.5963459656810369,-2.150154004052234,0.0,0.0004117741891125385,0.004,30/67,12.51%,CYBB;NRP1;VAV3;ABI1;MAPKAPK3;PAK2;CYBA;AXL;RAC1;ROCK1;RHOA;WASF2;VAV1;MAPKAPK2;CDC42;FLT1;PTK2B;ITGAV;MAPK14;PIK3CB;NRP2;BAIAP2;VEGFA;VAV2;NCKAP1L;NCF1;NCF4;CRK;PIK3CA;NCF2
prerank,positive regulation of synaptic transmission (GO:0050806),0.5712656337304227,2.1471971085553196,0.0,0.0008103146442272332,0.029,23/72,9.50%,NLGN1;MPP2;RIMS2;NRXN1;GRIK2;GRIN2A;RIMS1;SYT1;GRIN2B;ADCY8;SLC24A2;SLC8A3;CLSTN2;SHANK3;PRKCZ;CLSTN1;TSHZ3;CACNG4;CACNG2;FMR1;ADCY1;SLC8A2;NFATC4
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6686475038895741,2.1427238382392346,0.0,0.0008315504762828436,0.031,11/34,8.14%,MPP2;GRID2;GRIN2A;GABRG3;GRIN2B;GLRA1;GABRA2;GABRA3;GABRA5;GABRG2;INSYN1
prerank,protein targeting to ER (GO:0045047),-0.5474577621106166,-2.1304999183605946,0.0,0.0006651736901048699,0.007,51/99,24.30%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;ZFAND2A;RPL32;RPS15A;RPS28;RPS13;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;GET3;SRPRB;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;SGTA;RPLP2;RPL41;RPLP0;CHMP4B;CHMP4A;RPL7A;RPL19;RPS15;RPL39;EDEM1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.7040835218458518,2.1283264933041313,0.0,0.001212247902769654,0.046,10/26,5.48%,NLGN1;RIMS2;NRXN1;RIMS1;SLC8A3;MTMR2;TMEM108;SHANK3;PRKCZ;CUX2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.615647338750225,2.1264180445775707,0.0,0.0012418615237198979,0.049,15/46,7.48%,NLGN1;NRXN1;GRM7;GRM5;GRIK1;SYT1;CDH2;GRM8;GRM1;SHANK3;GRM3;TSHZ3;HOMER1;CACNG4;CACNG2
prerank,B cell activation (GO:0042113),-0.5900139053825462,-2.123441899236101,0.0,0.0006176612836688078,0.007,36/68,26.17%,ITGA4;PTPRC;BANK1;PRKCB;PLCG2;TPD52;PTPRJ;MALT1;LYL1;CD22;ITGB1;BLNK;HHEX;BCL2;KLF6;FCRL1;CEBPG;MEF2C;DNAJB9;HDAC5;PIK3CD;NFAM1;CD40;TCF3;CHRNB2;CASP8;ZAP70;LAT2;CD79A;LAX1;ZBTB7A;RABL3;FLT3;DCAF1;MS4A1;GPS2
prerank,positive regulation of cell communication (GO:0010647),0.6887934304717184,2.1116705042802315,0.0,0.0015328119378485595,0.061,9/28,6.74%,RIMS2;GRIK2;ANK3;RIMS1;SYT1;SOX11;CLSTN2;CLSTN1;HOMER1
prerank,axonogenesis (GO:0007409),0.46545362215670694,2.110799620771158,0.0,0.0014799563537848163,0.061,83/237,16.11%,NRXN1;ROBO1;CTNNA2;NRXN3;UNC5C;AUTS2;NCAM1;DAB1;ANK3;ROBO2;CNTN6;KIF5C;MAP1B;CNTN4;EFNA5;SLIT3;SLIT2;DCC;DSCAM;EPHA6;SEMA6D;PARD3;UNC5D;SHC3;EPHA7;TNR;DOK6;PLPPR4;EPHA5;GRB10;SEMA6A;NTNG2;NTNG1;PAK3;SLITRK1;SEMA3E;NEFH;SEMA5A;NRCAM;GAB1;DOK5;SLIT1;SPTB;SPTBN2;GDNF;EPHB1;SHANK3;SOS1;KIF5A;FEZ1;BDNF;DSCAML1;FYN;GFRA2;SPTBN4;EPHA10;SEMA3F;PLA2G10;LGR6;POU4F2;ROBO3;RELN;SLITRK3;SEMA5B;CDK5R1;BRSK1;RET;ARHGAP35;VLDLR;EPHB4;SLITRK5;VSTM2L;ENAH;HSP90AA1;KLF7;SEMA4G;ZDHHC17;EPHB3;UNC5A;EMB;NRTN;PRKCA;EPHA3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.7590346759806323,-2.1103515419768653,0.0,0.0007411935404025694,0.009,12/21,5.28%,LYN;PRKCH;FOXP1;RUNX1;PRKCB;ELF2;CD300A;LPXN;ELF1;CD22;STAP1;PTPN22
prerank,regulation of presynapse assembly (GO:1905606),0.7459121018927813,2.108259406134873,0.0,0.0014926374314130125,0.065,6/18,3.22%,LRFN5;PTPRD;IL1RAPL1;GPC6;IL1RAPL2;SLITRK1
prerank,regulation of presynapse organization (GO:0099174),0.7459121018927813,2.108259406134873,0.0,0.0014926374314130125,0.065,6/18,3.22%,LRFN5;PTPRD;IL1RAPL1;GPC6;IL1RAPL2;SLITRK1
prerank,regulation of dendrite development (GO:0050773),0.6507012119239228,2.1080002007528984,0.0,0.0014459925116813558,0.065,19/37,14.11%,ADGRB3;CSMD3;HECW1;DCC;CDKL5;HECW2;LZTS1;PTN;MARK1;KNDC1;ALK;NEDD4;BMP7;COBL;MFSD2A;TNIK;VLDLR;SDC2;PACSIN1
prerank,potassium ion transmembrane transport (GO:0071805),0.5103008185497085,2.1068658990703737,0.0,0.0014021745567819207,0.065,42/135,13.91%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;SLC12A2;NALCN;KCNT2;KCNH7;KCNH5;KCNH1;SLC24A3;SLC12A8;SLC12A1;KCNJ3;SLC9A2;KCNJ10;KCNJ6;KCNK2;KCNJ9;HCN2;KCNIP2;KCNA1;KCNH4;ATP1A3;KCNJ16;KCNF1;ATP1B1;HCN1;TMEM175;KCNG1;SLC12A5;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,potassium ion transport (GO:0006813),0.5177115500935204,2.106809358343546,0.0,0.001360934128641276,0.065,37/120,13.91%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;NALCN;KCNMB3;KCNMB2;KCNH7;KCNH5;KCNH1;SLC24A3;KCNJ3;SLC9A2;KCNJ10;KCNJ6;KCNK2;HCN2;KCNIP2;KCNA1;KCNH4;KCNJ16;KCNF1;HCN1;TMEM175;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,positive regulation of cytokine production (GO:0001819),-0.47211722873233747,-2.101508072850792,0.0,0.0008492842650446107,0.011,117/292,21.89%,RFTN1;PTPRC;FOXP1;RUNX1;CD74;FGR;PAEP;CCR2;LILRB1;SYK;PLCG2;TLR8;CYBA;RAB7B;CREBBP;CGAS;HPSE;GAPDH;LY9;ARHGEF2;TLR7;MALT1;RIPK1;BRCA1;IL6R;HTR2B;STAT3;DHX58;PIBF1;IL15;CARD11;TLR4;IL18;STAT6;DHX9;RAB1A;NFKB1;TMED10;IRF5;PTGER4;PTPN22;ANXA1;IL17RA;MAPK14;BATF;C3;PIK3CG;CYRIB;CTNNB1;POLR2H;EIF2AK2;GBP5;MDK;SULF2;LAPTM5;MYD88;POLR2F;CEBPG;CD28;NOD1;POLR3G;HIF1A;POLR2L;LPL;CLEC9A;EGR1;ARNT;SCRIB;AFAP1L2;RELA;AGT;APP;XBP1;XRCC6;TICAM1;CD46;CLEC6A;CD2;ITK;SERPINE1;FCER1G;TRAF2;PIK3CD;DHX36;SLC7A5;NFAM1;CD40;AGPAT1;POU2AF1;TXK;MAVS;POLR3B;ISG15;IL18R1;SPHK2;G3BP1;CD226;HSPA1A;RARA;LILRA5;GATA3;RPS3;POLR3A;PTPN11;MMP8;LGALS9;NOD2;HMGB1;IL7;AGER;CD274;APPL1;LRRFIP1;SLAMF6;TMEM106A;NLRP3;CEBPB
prerank,regulation of B cell proliferation (GO:0030888),-0.6356459425322357,-2.0994409411093446,0.0,0.00079932636710081,0.011,22/44,19.63%,LYN;PTPRC;VAV3;CD38;CD74;CD300A;SASH3;CD22;RC3H1;BCL2;TNFRSF21;AHR;MEF2C;NCKAP1L;IKZF3;FCGR2B;CD40;BST1;CHRNB2;IRS2;IL7;ATM
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.5345022605976962,-2.0991265335548626,0.0,0.0007549193467063205,0.011,49/112,22.97%,PTPRC;FOXP1;IGF1;CCR2;LILRB1;SYK;PLCG2;CYBA;PTPRJ;ARHGEF2;RIPK1;MAPKAPK2;STAT3;TLR4;DHX9;PTPN22;PF4;IRAK3;GAS6;SIRPA;PTPN6;LY96;SELENOS;LPL;APP;ARFGEF2;CD2;NLRC3;OAS3;NFKBIL1;MAVS;ARG2;SPN;SPHK2;RARA;LILRA5;PTPN11;MMP8;LGALS9;HSPB1;NOD2;HMGB1;AGER;OAS2;ZC3H12A;TMEM106A;NR1H4;IL6;IFNGR1
prerank,cytoplasmic translation (GO:0002181),-0.5468360222978956,-2.094766551127536,0.0,0.0007802037267395467,0.012,45/91,23.51%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;RPL36;RPS6;RPS20;RPL11;RPL10A;EIF4A2;RPL12;EIF2B3;RPS14;RPL32;RPS15A;RPS28;RPS13;RPS27A;RPL28;RPS4X;RPS23;EIF4A1;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39
prerank,positive regulation of phagocytosis (GO:0050766),-0.6277975508309404,-2.0947604288712567,0.0,0.0007411935404025694,0.012,22/47,19.96%,DOCK2;PTPRC;CYBA;PTPRJ;CAMK1D;ANO6;CD300LF;RAB31;C4B;IL15;STAP1;C3;GAS6;SIRPA;NCKAP1L;IL2RG;FCGR2B;FCER1G;APPL2;IL2RB;PLA2G5;C2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5785716627544383,2.0903514036659647,0.0,0.0018010540269720575,0.088,22/59,13.97%,ROBO1;KIRREL3;ROBO2;CNTN6;TENM3;CNTN4;CDH2;PTPRT;DSCAM;CDH13;NECTIN3;SDK1;DSCAML1;PCDHB6;CDH17;ROBO3;PKD1;CADM3;AMIGO2;TRO;VSTM2L;CDH1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6548382385521998,2.086346592115787,0.0,0.001993187745570436,0.095,9/33,3.36%,NLGN1;LRRC4C;NRG3;GRID2;GRIK5;GRIK2;GRIK1;GRID1;GRIK4
prerank,adherens junction organization (GO:0034332),0.5913652955199293,2.0838080913664436,0.0,0.002066189064870187,0.101,25/48,14.94%,CADM2;CDH18;CDH8;CDH10;CDH2;CDH20;TJP1;CDH11;CDH13;CDH12;CDH22;AFDN;CDH19;CDH7;NECTIN3;DCHS1;CDH6;CDH17;CDHR3;CDH9;CADM3;FERMT2;CDH1;CDH5;CTNND1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.552619367075803,-2.083569539372558,0.0,0.0009411981465429452,0.016,44/87,23.51%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;RPL32;RPS15A;RPS28;RPS13;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPLP2;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.5468673065409579,-2.08104118030704,0.0,0.0010107184641853218,0.018,45/91,23.51%,RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;SEC63;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SRP14;RPS14;SIL1;RPL32;RPS15A;RPS28;RPS13;RPS27A;RPL28;RPS4X;RPS23;RPL22;RPL14;RPL34;RPS11;RPL6;RPS10;RPL18A;RPL37A;RPS9;RPS27;RPS3;RPL23A;RPS16;RPL9;RPLP2;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39
prerank,regulation of cation transmembrane transport (GO:1904062),0.6728195946235307,2.079914466268843,0.0,0.0021529957153333386,0.107,8/29,6.77%,DPP10;KCNIP4;DPP6;FGF12;KCNN2;KCNIP1;HOMER1;KCNIP2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.7448826027464243,2.0748025585482575,0.0,0.002338520776974084,0.117,7/18,5.48%,NLGN1;RIMS2;NRXN1;RIMS1;SHANK3;PRKCZ;CUX2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.8548744301190144,-2.0698522301435087,0.0,0.001450161274700679,0.026,9/12,8.87%,LYN;PTPRC;RUNX1;ELF2;CD300A;ELF1;RC3H1;PTPN22;CBFB
prerank,synaptic membrane adhesion (GO:0099560),0.7958604081160994,2.0688543675833304,0.0,0.002598595238383886,0.129,6/14,3.22%,LRRC4C;LRFN5;PTPRD;GPC6;NTNG1;SLITRK1
prerank,chloride transmembrane transport (GO:1902476),0.5867397421256607,2.0655784454572634,0.0,0.0026169959914487603,0.133,18/48,8.86%,GABRB3;GABRB1;GABRG3;SLC12A2;GLRA1;GABRA2;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6377868886395354,2.0647588553992455,0.0,0.0025706533541001884,0.134,12/37,6.81%,NLGN1;GRID2;PTPRD;TENM2;IL1RAPL1;TENM3;TENM1;TENM4;NECTIN3;VCAM1;DCHS1;FAT4
prerank,regulation of cholesterol storage (GO:0010885),-0.8089598311009132,-2.0644932423431683,0.0,0.0016985685300892213,0.032,9/15,14.42%,ABCA1;MSR1;ABCG1;PPARD;PPARG;NR1H2;LPL;TTC39B;EHD1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.5701170266305045,-2.0605086520222367,0.0,0.0017788644969661664,0.035,29/68,22.61%,CD74;SYK;PLCG2;TLR8;CYBA;RAB7B;ARHGEF2;TLR7;IL6R;STAT3;TLR4;DHX9;IL17RA;MYD88;LPL;APP;XBP1;POU2AF1;MAVS;SPHK2;LILRA5;PTPN11;MMP8;LGALS9;NOD2;HMGB1;AGER;TMEM106A;IL6
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5238154238636047,-2.058958409321206,0.0,0.0017104466316982367,0.035,54/110,23.51%,DCP1A;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SMG9;RPS14;RPL32;RPS15A;RPS28;RPS13;SMG8;HELZ2;RPS27A;RPL28;RPS4X;RPS23;UPF2;EIF3E;RPL22;RPL14;RPL34;RPS11;RPL6;NCBP1;EIF4G1;RPS10;RPL18A;RPL37A;RPS9;RNPS1;RPS27;RPS3;RPL23A;RPS16;MAGOH;RPL9;RPLP2;RPL41;RPLP0;RPL7A;SMG1;RPL19;RPS15;RPL39
prerank,regulation of NMDA receptor activity (GO:2000310),0.6460086831325375,2.057757779797191,0.0,0.002760398242724368,0.148,10/32,3.60%,NLGN1;DLG2;GRIA4;LRRC7;GRIN2A;GRIN2B;DLG3;GRIA3;GRIA2;GRIA1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.723279366319089,2.0558820152252375,0.0,0.002789108085772734,0.153,10/21,13.07%,AKAP6;ANK2;CACNA1C;DMD;RYR2;PDE4D;CASQ2;CALM1;CALM3;CALM2
prerank,regulation of immune response (GO:0050776),-0.5106249093649029,-2.0540920770263673,0.0,0.0019216128825251795,0.039,78/135,33.67%,LYN;ITGA4;FOXP1;FGR;SLAMF7;BIRC3;LILRB1;SYK;CD300A;BCL6;SAMHD1;ADCY7;ITGB2;RAET1E;CD300LF;ITGAL;DHX58;IL15;CD22;ITGB1;CLEC2D;PTPN22;RSAD2;TRAF3;C3;AHR;B2M;NPDC1;ITGB7;JAML;CD300LD;CD300LB;IL4I1;CXADR;FCGR2B;CD40;ULBP1;PILRA;TREML1;SPN;APPL2;GPR108;CD226;CASP8;HCST;DENND1B;CD300E;CD300LG;APPL1;SLAMF6;IFITM1;RNF135;CD3E;CD247;TREML4;CD96;ZMPSTE24;FCRLB;CD300C;SELL;CRTAM;SPINK5;CD19;RIPK3;KIR3DL2;CD8B;TKFC;XIAP;NCR1;FCGR3A;FCGR3B;KLRD1;CD8A;KLRC1;ERAP1;IRF4;SLA2;PLSCR1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4911313899581988,-2.053230246450936,0.0,0.0018971025141256235,0.04,76/168,23.51%,CNOT4;DCP1A;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;TUT7;CNOT1;RC3H1;CNOT2;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;SMG9;PATL1;RPS14;EXOSC5;RPL32;DCP2;RPS15A;RPS28;RPS13;SMG8;HELZ2;DDX5;RPS27A;RPL28;RPS4X;RPS23;UPF2;CSDE1;EIF3E;MTPAP;RPL22;RPL14;RPL34;RPS11;RPL6;NCBP1;EIF4G1;RPS10;RPL18A;RPL37A;POLR2G;PAN3;CNOT6L;RPS9;RNPS1;RPS27;TENT4B;RPS3;RPL23A;RPS16;EXOSC10;MAGOH;RPL9;ATM;CNOT8;ZC3H12A;RPLP2;EXOSC4;PNLDC1;XRN2;RPL41;RPLP0;RPL7A;SMG1;RPL19;RPS15;RPL39
prerank,regulation of defense response (GO:0031347),-0.549970273653659,-2.037357066850637,0.0,0.0023854504748588435,0.051,35/76,23.81%,APOE;FOXP1;FGR;BIRC3;CCR2;BCL6;SAMHD1;PIK3AP1;SBNO2;BRD4;USP18;DHX58;AREL1;PTPN22;ANXA1;TRAF3;GRN;MYD88;CASP4;DAGLB;RELA;CELF1;FCGR2B;CASP1;TMSB4X;BST1;APPL2;CASP8;HCK;NOD2;APPL1;RNF135;SETD6;LRRC19;SEMA7A
prerank,positive regulation of immune response (GO:0050778),-0.5707714947723622,-2.0365631169539977,0.0,0.0023059354590302156,0.051,28/64,19.35%,PTPRC;CD74;LILRB1;TLR8;CYBA;ITGB2;SASH3;IL15;RIOK3;DHX9;RSAD2;IFI35;GRN;GBP5;POLR3G;ADAM8;XBP1;CD46;CCL5;FCGR2B;KARS1;POLR3B;SPHK2;CD226;STX4;MYB;LGALS9;NOD2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.5636269492767382,-2.034926375676987,0.0,0.00235109778944901,0.053,33/69,22.97%,PTPRC;CCR2;SYK;PLCG2;CYBA;PTPRJ;ARHGEF2;RIPK1;STAT3;TLR4;DHX9;PF4;LY96;LPL;APP;ARFGEF2;CD2;OAS3;MAVS;SPN;SPHK2;LILRA5;PTPN11;MMP8;LGALS9;HSPB1;NOD2;HMGB1;AGER;OAS2;TMEM106A;IL6;IFNGR1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.6030254962676185,-2.029436763203988,0.0,0.0025478527951338322,0.059,28/51,22.61%,P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;TMED10;AIM2;PANX1;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;LGALS9;HSPB1;NOD2;HMGB1;AGER;TMEM106A;NLRP3;IL6
prerank,axon development (GO:0061564),0.5278519523574323,2.0278930977344776,0.0,0.004142850043129579,0.218,34/78,18.79%,GRM7;CTNNA2;ANK3;MAP1B;CNTN4;DCC;PARD3;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;NEFH;PLP1;SEMA5A;NRCAM;DSCAML1;SPTBN4;SLITRK3;CDK5R1;BRSK1;ARHGAP35;RTN4RL1;SLITRK5;DHFR;KLF7;FOLR1;ZDHHC17;EPHB3;RAB3A;MAP1A;DOCK7;ADGRB1;S100B
prerank,neuronal action potential (GO:0019228),0.6864229579346977,2.025254068365499,0.0,0.004242306952985755,0.228,11/22,15.85%,ANK3;KCNMB3;KCNMB2;SCN2A;SCN1A;SCN3A;SCN9A;KCNA1;KCNA2;CACNA1G;SCN10A
prerank,regulation of innate immune response (GO:0045088),-0.5785018808319857,-2.0246937266775347,0.0,0.0027326832550195732,0.065,31/57,22.75%,FGR;BIRC3;TLR8;SAMHD1;USP18;RNASEL;DHX58;RIOK3;DHX9;IFNAR2;PTPN22;ABCE1;IFI35;IRAK3;GBP5;POLR3G;PARP9;PTPN6;ADAM8;CCL5;HSP90AB1;NLRC3;FCGR2B;POLR3B;APPL2;CASP8;PTPN11;APPL1;PTPN1;RNF135;SLC15A4
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.554118593522575,-2.0245763263810566,0.0,0.002652310218107233,0.065,34/73,22.97%,PTPRC;CCR2;SYK;PLCG2;CYBA;PTPRJ;ARHGEF2;RIPK1;STAT3;TLR4;DHX9;PF4;LY96;ADAM8;LPL;APP;ARFGEF2;CD2;OAS3;MAVS;SPN;SPHK2;LILRA5;PTPN11;MMP8;LGALS9;HSPB1;NOD2;HMGB1;AGER;OAS2;TMEM106A;IL6;IFNGR1
prerank,regulation of interferon-beta production (GO:0032648),-0.6124767667838455,-2.0243859747849164,0.0,0.002576529926161312,0.065,27/46,23.00%,LILRB1;REL;TLR8;TLR7;DHX58;RIOK3;TLR4;DHX9;IRF5;TRAF3;PPM1B;SIRPA;POLR3G;NLRC3;OAS3;YY1;RELB;RNF216;MAVS;POLR3B;ISG15;POLR3A;PTPN11;DDX3X;OAS2;RNF135;TOMM70
prerank,regulation of mast cell degranulation (GO:0043304),-0.8118281057815754,-2.023213667974069,0.0,0.0026422177134721218,0.068,7/14,3.09%,LYN;CD84;FGR;GAB2;SYK;CD300A;FES
prerank,cardiac muscle cell action potential (GO:0086001),0.6467032123671664,2.0227085733760557,0.0,0.004323263457681907,0.234,10/30,6.77%,FGF12;ANK2;CACNA1C;DMD;CACNA2D1;KCND3;SCN2B;SCN1A;HCN2;KCNIP2
prerank,regulation of B cell activation (GO:0050864),-0.6928267206156682,-2.0131253906333435,0.0,0.003138387062965834,0.082,12/25,14.64%,BANK1;THEMIS2;SH3KBP1;CD22;AHR;LAPTM5;TNIP2;IKZF3;FOXJ1;IL4I1;FCGR2B;SAMSN1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.785803005135267,-2.0124836729614466,0.0,0.003055797929729891,0.082,7/15,12.30%,OSBPL8;PLIN2;PPARG;LPL;OSBPL11;APOC4;ABHD5
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6481452867446644,2.011803274205368,0.0,0.004959684460356341,0.266,6/27,3.39%,PDE4B;ANK2;CTNNA3;CACNA1C;RYR2;PDE4D
prerank,positive regulation of defense response (GO:0031349),-0.5313497137548074,-2.0021560581033824,0.0,0.0038009925148849706,0.105,32/89,18.62%,CCR2;TLR8;CYBA;OPTN;TLR7;RIPK1;IL15;RIOK3;TLR4;IL18;DHX9;PTGER4;IL17RA;IFI35;GRN;GBP5;MDK;POLR3G;ABCC1;MEF2C;ADAM8;NFKBIZ;LPL;AGT;APP;CCL5;SERPINE1;PLA2G7;POLR3B;GPRC5B;LILRA5;TRADD
prerank,detection of calcium ion (GO:0005513),0.7775013121463838,2.001650010356058,0.0,0.005706987304311155,0.307,9/13,13.07%,RYR2;SYT1;KCNMB3;KCNMB2;CASQ2;KCNIP2;CALM1;CALM3;CALM2
prerank,regulation of interleukin-6 production (GO:0032675),-0.5265380545628953,-1.9989817328325796,0.0,0.00401479834384725,0.115,41/96,21.48%,CD74;SYK;PLCG2;TLR8;CYBA;RAB7B;ARHGEF2;TLR7;IL6R;MAPKAPK2;STAT3;TLR4;DHX9;PTPN22;IL17RA;ARRB1;IRAK3;GAS6;SIRPA;MYD88;PTPN6;SELENOS;LPL;NCKAP1L;AFAP1L2;APP;XBP1;FOXJ1;NLRC3;POU2AF1;MAVS;SPHK2;LILRA5;PTPN11;MMP8;LGALS9;NOD2;HMGB1;AGER;ZC3H12A;TMEM106A
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6228245980782283,1.994463107099091,0.0,0.006250040676577502,0.334,7/30,3.31%,FGF12;ANK2;CACNA1C;RYR2;CACNA2D1;SCN2B;SCN1A
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.6051664382667433,-1.9926602227148407,0.0,0.004429083351186085,0.129,26/45,22.61%,P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;AIM2;PANX1;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;LGALS9;HSPB1;NOD2;AGER;TMEM106A;NLRP3;IL6
prerank,heart contraction (GO:0060047),0.5924474616679893,1.989098843634646,0.0,0.006535113641881297,0.351,12/41,11.10%,SGCZ;SGCD;DMD;RYR2;SCN2B;CASQ2;TNNI1;SGCG;TNNT2;MYH7;ATP1B1;TTN
prerank,synaptic vesicle cycle (GO:0099504),0.6288029405301088,1.9880779456260484,0.0,0.006499712159530911,0.356,8/30,3.08%,NLGN1;RIMS1;PCLO;SYT10;SYNDIG1;SNAP25;CPLX1;SLC17A6
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.4876563151028122,-1.9878953040278071,0.0,0.004911877827270995,0.142,68/163,21.22%,RFTN1;PTPRC;VAV3;PRKCB;CD38;SYK;PLCG2;PAK2;PTPRJ;THEMIS2;PSME4;GRAP2;MALT1;TAB2;PSMB7;TEC;CARD11;PSME3;RC3H1;BLNK;NFKB1;FBXW11;BCL2;PTPN22;RNF31;PSMB9;FYB1;RBCK1;PIK3CB;SPG21;TNFRSF21;EIF2B3;CD28;MEF2C;PSMA8;NFKBIZ;NCKAP1L;RELA;PSMC3;LCK;PIK3CA;PSMD8;ITK;PSMC4;PSMB10;LCP2;PIK3CD;PSMA1;NFAM1;IKBKB;TXK;PSMB8;THEMIS;ZAP70;GATA3;LAT2;PSMA5;DENND1B;PRAM1;PSMD4;NFKBID;PSMB3;EIF2B1;WNK1;CD79A;PSMD3;ZC3H12A;LAX1
prerank,positive regulation of B cell activation (GO:0050871),-0.5903004634423555,-1.9852876712741503,0.0,0.005113660860141757,0.149,22/50,19.53%,PTPRC;VAV3;CD38;CD74;SYK;SASH3;SH3KBP1;BCL2;KMT5B;MEF2C;KMT5C;NCKAP1L;CD27;TNIP2;XBP1;CD40;BST1;CHRNB2;IRS2;SHLD2;NOD2;IL7
prerank,neuropeptide signaling pathway (GO:0007218),0.5443366147942095,1.9836148047231053,0.0,0.006807275657945372,0.371,20/58,16.00%,SORCS1;GLRA1;HCRTR2;SORCS3;GPR37;PNOC;OPRD1;GPR149;NTSR1;GLRA2;GALR1;PDYN;CPE;NTS;GLRA3;OPRK1;PENK;OPRL1;OPRM1;GRP
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.4956303909613415,-1.9785635819800795,0.0,0.005671253604595417,0.167,59/132,24.50%,APOE;IGF1;TFEB;MSN;DAPK1;P2RX7;ZC3HAV1;PRKCD;ROCK1;SNX9;TNFRSF1B;INSR;OPTN;ABCD2;FOXO3;CNOT1;RC3H1;PHKG2;ADAM9;PFKFB3;PIK3CB;SNX33;ATF6;PLK2;ZSWIM8;LAPTM5;HIF1A;DAGLB;ADAM8;ARNT;MOV10;ZBTB20;PFKFB4;GTPBP1;APP;FLCN;TICAM1;STK11;ABHD5;TRIM68;SH3GLB1;PIK3C2A;TRIM14;FAF1;IRS2;TMEM59;HMGB1;CNOT8;GSK3B;GRSF1;DTX3L;PTPN1;ZC3H12A;MEFV;MTDH;PIM2;GPLD1;FURIN;DCN
prerank,defense response to virus (GO:0051607),-0.518418725871658,-1.9782159478586796,0.0,0.005572677359323021,0.168,45/100,22.61%,PTPRC;LYST;LILRB1;TLR8;SAMHD1;CGAS;FLNA;IRF2;TLR7;RNASEL;ATG7;NLRC5;BCL2;IFNAR2;RSAD2;ABCE1;EXOSC5;EIF2AK2;MYD88;BST2;ATAD3A;IFITM2;RELA;MOV10;RNASE6;IFIT1;OASL;IFIT2;OAS3;CD40;MAVS;ISG15;G3BP1;BNIP3L;SKP2;MLKL;ZDHHC1;TTC4;OAS2;SERINC3;STAT1;EXOSC4;IFITM1;RNF135;IL6
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.44130689932507094,-1.9767766548136185,0.0,0.005612661229860036,0.173,127/306,23.51%,EXT1;APOE;B4GALT5;FAM111A;RBMS1;TOP3A;MEF2A;AGO2;RPS18;RPL7;RPS12;RPS21;BRCA1;RPS8;RPS24;GSPT1;POLE2;SARS1;RPL36;BLM;RPS6;RPS20;RPL11;RPL10A;RAD1;RPL12;RRBP1;MRPL42;TUFM;RPS14;EEF1B2;POLR2H;MCM6;E2F1;PCLAF;RPL32;RPS15A;RPS28;RPS13;POLR2F;THAP1;POLR2L;RPS27A;DARS1;RPL28;RPS4X;MCM9;MCM3;DBF4;RPS23;EEF2;EIF4EBP2;GTPBP1;TIMELESS;WRN;CDK1;ORC5;EXO1;RPL22;RPL14;FEN1;KAT7;EEF1A1;MRPS6;TICRR;RPL34;GCNT1;RPA3;RFC2;MRPS11;RPS11;POLR2A;RPL6;DUT;POLD2;EPC1;RHNO1;LARGE1;TOP1MT;EIF4G1;RPS10;RPL18A;NFKBIB;MRPS16;TOPBP1;MCM2;BRIP1;RPL37A;POLR2G;MRPL34;RPS9;MRPS15;RNPS1;RPS27;RAD9A;DNA2;ABCF1;DTX1;RPS3;POLR3A;RBBP8;GTPBP2;RPL23A;RPS16;RPL9;COPS5;MED20;ATM;CHEK1;MMS19;RFC3;TIPIN;NBN;POLR2I;RPLP2;XAB2;MRPL51;SET;RPL41;TOPORS;INHA;RPLP0;CDC45;RPL7A;RPL19;RPS15;RPL39
prerank,axon guidance (GO:0007411),0.44476771956227323,1.974746225692265,0.0,0.007376657450896194,0.395,61/201,12.62%,NRXN1;ROBO1;NRXN3;UNC5C;NCAM1;DAB1;ROBO2;CNTN6;KIF5C;CNTN4;EFNA5;SLIT3;SLIT2;DCC;DSCAM;EPHA6;SEMA6D;UNC5D;SHC3;EPHA7;TNR;DOK6;EPHA5;GRB10;SEMA6A;NFIB;SEMA3E;SEMA5A;GAB1;DOK5;SLIT1;SPTB;SPTBN2;GDNF;EPHB1;SHANK3;TMEFF1;SOS1;KIF5A;FEZ1;BDNF;DSCAML1;FYN;GFRA2;SPTBN4;EPHA10;PLXNA4;SEMA3F;PLA2G10;LGR6;POU4F2;ROBO3;RELN;SEMA5B;SMO;CDK5R1;PLXNA2;RET;ARHGAP35;VLDLR;EPHB4
prerank,action potential (GO:0001508),0.5701839890103761,1.973894072435666,0.0,0.007376657450896192,0.402,11/44,7.11%,KCND2;AKAP6;ANK3;DMD;KCNMB3;KCNMB2;SCN2A;SCN1A;SCN3A;SCN9A;KCNA1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.549093432233966,1.9723039430618925,0.0,0.007400607637425076,0.409,16/54,8.49%,DPP10;KCNIP4;DPP6;AKAP6;KCNN2;KCNIP1;KCNMB3;KCNMB2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;KCNIP2;GABBR1;KCNJ16;NEDD4
prerank,heart process (GO:0003015),0.7545400814004534,1.9720818581277344,0.0,0.007306067427442641,0.411,5/14,9.27%,SGCZ;SGCD;RAMP3;FYN;SGCG
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.541115024091468,1.9632285432548386,0.0,0.008347878808067479,0.462,21/57,15.71%,GRM7;CHRM2;CHRM3;ADCY2;GRM8;ADCY8;GPR37;P2RY12;ADCY5;HRH3;GNAI1;GABBR1;ADCY3;ADCY1;CORT;NPY1R;HTR1B;GNAL;OPRK1;OPRL1;OPRM1
prerank,central nervous system development (GO:0007417),0.43459340686781944,1.962389010138255,0.0,0.008308685048698177,0.465,75/250,15.04%,CNTNAP2;ASIC2;ADGRL3;GRIN2A;SPOCK1;GRIK1;ROBO2;CNTN6;CNTN4;EML1;DCLK1;GRIN2B;SOX11;CDH2;ADAM22;SLC8A3;AFF2;SERPINI1;AHI1;EPHA7;MEIS1;NFIB;SH3GL2;SYNJ2;IL1RAPL2;SMARCA1;NRCAM;VCAN;POU6F2;SOX6;PAX8;SHROOM4;ADAM23;SLC6A17;SOX12;MAL;APOD;RPS6KA6;VIT;MOG;SH3GL3;DSCAML1;PTS;NCKAP1;ADGRA2;SOX9;CX3CR1;ADGRL2;PTPRZ1;CDK5RAP3;B3GNT5;DNER;ZFHX2;CHST8;GSN;GSTP1;RELN;MFSD2A;SMO;CDK5R1;PKD1;EEF1AKMT4-ECE2;HES5;ZIC2;AMIGO2;PBX1;CDK5RAP2;ADGRG1;PAFAH1B2;PRKN;ZIC4;ARNT2;PAFAH1B3;ATP6AP2;UFC1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6643056068187471,1.9619376374740884,0.0,0.008226090733120603,0.468,5/25,1.86%,MPP2;GRID2;GRIN2A;GRIN2B;GLRA1
prerank,synaptic vesicle exocytosis (GO:0016079),0.5787595700739334,1.959728941839467,0.0,0.00831110735153133,0.478,12/40,6.51%,RIMS2;RIMS1;SYT1;PCLO;UNC13C;SYT10;SNPH;SNAP25;CPLX1;SYT2;STX2;SYT5
prerank,defense response to symbiont (GO:0140546),-0.5159825411297435,-1.9485187732271183,0.0,0.009120360231194734,0.259,42/92,22.61%,PTPRC;LYST;LILRB1;TLR8;SAMHD1;CGAS;FLNA;IRF2;TLR7;RNASEL;ATG7;NLRC5;BCL2;IFNAR2;RSAD2;ABCE1;EXOSC5;EIF2AK2;MYD88;BST2;IFITM2;RELA;MOV10;RNASE6;IFIT1;OASL;IFIT2;OAS3;CD40;MAVS;ISG15;G3BP1;BNIP3L;SKP2;MLKL;TTC4;OAS2;SERINC3;STAT1;EXOSC4;IFITM1;IL6
prerank,B cell differentiation (GO:0030183),-0.5856287920200397,-1.9458868341124964,0.0,0.00936786280231025,0.27,17/46,14.63%,ITGA4;PTPRC;PLCG2;TPD52;PTPRJ;LYL1;ITGB1;BLNK;HHEX;KLF6;FNIP1;CEBPG;DNAJB9;IRF2BP2;HDAC5;NFAM1;TCF3
prerank,excitatory postsynaptic potential (GO:0060079),0.6919218338630406,1.9452122528530356,0.0023148148148148147,0.010318667460637783,0.566,4/19,1.30%,MPP2;GRID2;GRIN2A;GRIN2B
prerank,positive regulation of type I interferon production (GO:0032481),-0.5312045517182109,-1.9448539501177742,0.0,0.009403577910549603,0.275,40/73,26.38%,TLR8;CREBBP;CGAS;GAPDH;TLR7;DHX58;RIOK3;TLR4;STAT6;DHX9;NFKB1;IRF5;PTPN22;CTNNB1;POLR2H;MYD88;POLR2F;POLR3G;POLR2L;RELA;XRCC6;OAS3;DHX36;MAVS;POLR3B;ISG15;G3BP1;POLR3A;PTPN11;DDX3X;OAS2;STAT1;LRRFIP1;RNF135;PRKDC;TOMM70;POLR3GL;POLR3D;MRE11;POLR1C
prerank,Fc receptor signaling pathway (GO:0038093),-0.4999765409629199,-1.9448394665722788,0.0,0.009215506352338611,0.275,37/110,14.72%,LYN;VAV3;GRB2;GAB2;SYK;PLCG2;PAK2;JUN;RAC1;MAP3K1;PSME4;VAV1;GRAP2;MALT1;TAB2;PSMB7;TEC;CARD11;PSME3;NFKB1;FBXW11;PSMB9;PIK3CB;NFATC3;VAV2;PSMA8;RELA;PSMC3;PIK3CA;PSMD8;ITK;FCER1G;PSMC4;PSMB10;LCP2;PSMA1;IKBKB
prerank,muscle cell differentiation (GO:0042692),0.6191626271668823,1.9426376757681054,0.0,0.010559371127401188,0.58,10/32,10.61%,SGCZ;RORA;DMD;FBXO40;MRTFA;GLMN;NEBL;MYOCD;POPDC2;TBX1
prerank,central nervous system neuron differentiation (GO:0021953),0.595463113059593,1.935501203084849,0.002304147465437788,0.011505070853812529,0.619,7/33,6.94%,MDGA2;GRID2;SPOCK1;MAP2;NTRK2;KNDC1;TOX
prerank,positive regulation of interferon-beta production (GO:0032728),-0.6221357218743555,-1.9352579985189056,0.0,0.010948349028168672,0.323,19/33,24.98%,TLR8;TLR7;DHX58;RIOK3;TLR4;DHX9;IRF5;POLR3G;OAS3;MAVS;POLR3B;ISG15;POLR3A;PTPN11;DDX3X;OAS2;RNF135;TOMM70;POLR3D
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.5004613535450547,-1.934892045174117,0.0,0.010809072464204136,0.324,37/109,14.72%,LYN;VAV3;GRB2;GAB2;SYK;PLCG2;PAK2;JUN;RAC1;MAP3K1;PSME4;VAV1;GRAP2;MALT1;TAB2;PSMB7;TEC;CARD11;PSME3;NFKB1;FBXW11;PSMB9;PIK3CB;NFATC3;VAV2;PSMA8;RELA;PSMC3;PIK3CA;PSMD8;ITK;FCER1G;PSMC4;PSMB10;LCP2;PSMA1;IKBKB
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.6534167324950731,-1.9321201552933398,0.0,0.011141211079007176,0.339,13/27,10.65%,PRKCH;ABCA1;MSR1;ABCG1;CD36;PPARG;IL18;NFKB1;ITGAV;NR1H2;PF4;LPL;AGT
prerank,regulation of interleukin-8 production (GO:0032677),-0.5339835677411252,-1.9310242764130565,0.001718213058419244,0.01116365579371771,0.346,26/69,19.37%,PTPRC;CD74;SYK;TLR8;ANXA4;TLR7;RIPK1;STAT3;TLR4;RAB1A;PTPN22;ANXA1;ARRB1;MAP2K5;MYD88;NOD1;AFAP1L2;RELA;CD2;SERPINE1;TMSB4X;MAVS;HSPA1A;LGALS9;NOD2;HMGB1
prerank,bone development (GO:0060348),-0.5922028513261022,-1.9282953669207383,0.0,0.01143234885045175,0.363,11/39,10.16%,PTPRC;AKAP13;SH3PXD2B;SLC10A7;MBTPS2;PTGER4;DYM;LRP6;SKI;SULF2;TGM2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.576463691584858,-1.9273470523328489,0.0,0.011426733747872942,0.367,18/47,14.18%,PID1;GRB2;SYK;PLCG2;XDH;CYBA;PRKCD;CD36;ITGB2;RIPK1;RNF41;TLR4;MAPK14;AGT;GADD45A;CBR1;TGFBR2;SLC5A3
prerank,plasma membrane invagination (GO:0099024),-0.6361356091865032,-1.9251396495591995,0.0,0.011573021946636609,0.376,13/29,12.80%,MSR1;ARHGAP25;MYH9;CD36;ITGB2;SNX9;RHOA;CDC42;SNX33;SH3BP1;ARHGAP12;SNX18;FCGR2B
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.6006628588721135,-1.925132955628386,0.0,0.0113734870854877,0.376,18/38,16.99%,SASH1;TLR8;CYBA;DHX58;RIOK3;DHX9;DDX60;IFI35;GRN;PUM2;GBP5;POLR3G;LY96;ADAM8;OASL;CCL5;POLR3B;ZCCHC3
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7360867865325817,1.9245837767612173,0.002386634844868735,0.013174813377334877,0.669,8/15,11.25%,GRM7;GRM5;GRM8;GRM1;GRM3;HOMER1;TRPM1;HOMER3
prerank,sensory perception of smell (GO:0007608),0.7984548426772653,1.923950920170751,0.0,0.013036159103994235,0.67,5/11,14.27%,SLC24A4;SYT10;ADCY3;UBR3;MKKS
prerank,response to alcohol (GO:0097305),0.6212239956791085,1.9230754257695957,0.005037783375314861,0.013041770228653648,0.673,6/27,1.86%,GRIN2A;GRIN2B;SLIT3;SLIT2;GRIN3A;GLRA1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.545486986528267,-1.9224693030286983,0.0,0.011494781177429676,0.381,23/62,15.14%,LYN;RUNX1;PRKCB;CDK6;CNOT4;CREBBP;FES;SPI1;CTR9;HSPA9;PTK2B;PF4;PRMT1;WDR5;KMT2C;CBFB;MEF2C;MOV10;NFE2;KMT2D;TNRC6C;SIN3A;PRMT6
prerank,regulation of cellular component size (GO:0032535),-0.6328420531747954,-1.9123060237690033,0.0,0.013423838565068756,0.435,12/30,10.78%,VAV3;MSN;RIN3;RAC1;EPS8;VAV1;RARG;PICALM;PPP1CA;VAV2;HP1BP3;MTPN
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.6972890968309492,-1.9090945924879232,0.0,0.013872064895512567,0.45,8/20,4.06%,BIRC3;SDCBP;NUPR1;OGT;PDCD6IP;RIPK1;PELI1;CFLAR
prerank,mitotic sister chromatid segregation (GO:0000070),-0.4989613359782996,-1.9088451869343352,0.0,0.013708095585939991,0.451,52/98,25.36%,RB1;PDCD6IP;EML4;CSNK2A1;NCAPG2;PIBF1;CHMP5;NIPBL;DLGAP5;KIF23;SMC4;NCAPH;KLHL22;MCPH1;CENPE;CENPK;KIFC1;KIF14;CHMP7;NAA50;CDK1;CHMP1A;KNSTRN;CHMP2A;NUSAP1;KIF2C;INO80;POGZ;SGO1;NCAPD3;KMT5A;NDC80;CEP55;KIF18B;PHF13;PRC1;SMC1A;RAB11A;VPS4A;KIF22;PDS5B;NCAPG;NUP62;SET;CHMP4B;CHMP4A;BECN1;NSL1;CCNB1;AKAP8L;CHMP2B;NUDC
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.6555033875703311,-1.9074310452365653,0.0,0.013902280956228084,0.462,10/25,11.72%,RBPJ;BCAR3;CBL;ARAP1;DGKD;HIP1;PLAUR;AFAP1L2;AGT;CCDC88A
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5467262664625681,-1.906308230904977,0.0,0.013858775052318873,0.468,22/59,14.85%,BIRC3;REL;TLR8;ROCK1;TLR7;RIPK1;IRAK2;TAB2;CARD11;TLR4;RNF31;RBCK1;LY96;UBC;RPS27A;RELA;TICAM1;NLRC3;TRAF2;NFKBIL1;IKBKB;RELB
prerank,calcium ion transport into cytosol (GO:0060402),0.6451134837135378,1.9053638079188382,0.0,0.01632134770218342,0.75,11/21,17.38%,GRIN2A;CACNA1C;RYR2;GRIN2B;CACNA2D1;TRPM1;JPH4;ADRA1A;ATP2B4;JPH3;TRPM2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5670159518503438,1.9050724166660418,0.0,0.01618199559386319,0.752,12/39,8.69%,FGF14;HECW1;FGF12;ANK3;DMD;PRKCE;HECW2;SCN2B;PTPN3;NETO1;NEDD4;FXYD6
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.4116568490261923,-1.9002813640091012,0.0,0.014671831107455985,0.483,198/532,24.60%,F13A1;CD44;MAP3K8;MSN;SP100;GRB2;BIRC3;CCR2;GAB2;SYK;VIM;PAK2;BCL6;MCL1;SAMHD1;PRKCD;CBL;CD36;ITGB2;RAP1B;PTPRJ;PITPNA;TNFRSF1B;BCL2L11;CSF2RA;CANX;ANXA2;IRF2;PSME4;VAV1;GRAP2;CD300LF;RNASEL;RIPK1;IRAK2;TRAF5;SPI1;IL10RB;IL6R;ABL2;CTR9;STAT3;FOXO3;TAB2;IL15;CCR1;PELI1;PSMB7;TEC;SLC27A1;CDC42;IL18;STAT6;PSME3;HSPA9;ITGB1;PIM1;PTK2B;NFKB1;ADIPOR1;FBXW11;BCL2;IRF5;IFNAR2;IRAK4;AIM2;ANXA1;IL17RA;PSMB9;CIITA;STX3;BATF;RSAD2;PF4;PIK3CB;TRAF3;FN1;HGF;IFI35;IRAK3;IL18RAP;STAT5B;HNRNPDL;STAT4;VEGFA;MYD88;BST2;B2M;JAK1;IFITM2;LMNB1;NOD1;HIF1A;PTPN6;PSMA8;UBC;RPS27A;LCP1;GBP2;EGR1;CD27;TNIP2;RELA;IFNGR2;TRAF1;PSMC3;LCK;ITGAX;IL2RG;IL7R;IL4R;IFNAR1;CRK;IFIT1;HSP90B1;PIK3CA;IL20RA;CSF2RB;PSMD8;OASL;CCL5;IFIT2;TRIM68;CAPZA1;FCER1G;CASP1;OAS3;TRAF2;PSMC4;PSMB10;SOCS6;PIK3CD;MT2A;CNTFR;PSMA1;CD40;TMSB4X;IKBKB;IL34;CRKL;IL31RA;APPL2;IL27RA;ISG15;PSMB8;IL2RB;IL18R1;STX4;IRS2;TNFRSF25;LIMS1;GATA3;HCK;SOCS3;CFL1;PTPN11;TRADD;IL1R2;NOD2;IL7;CSF1;PSMA5;PSMD4;OAS2;SLA;PSMB3;APPL1;MMP2;PSMD3;MMP1;STAT1;TRIM25;PLP2;IFITM1;SOCS5;RPS6KA5;RPLP0;TNFSF9;ILK;IL6;GSTO1;CNN2;IFNGR1;TYK2;MTAP;P4HB;TGFB1;HMOX1;GREM2;IL2RA;MAP3K3;CCL7;PSMB1;FLT3;ITGAM;SHC1;TNFRSF13B;MYC
prerank,regulation of necroptotic process (GO:0060544),-0.6677321139682038,-1.8990482942792999,0.0,0.014823870808051386,0.494,12/23,17.72%,BIRC3;SDCBP;OGT;PDCD6IP;ARHGEF2;RIPK1;PELI1;CFLAR;FLOT2;SLC25A4;CASP8;MLKL
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.599895306901236,-1.8979407038960272,0.0017857142857142857,0.014860746108568926,0.5,18/38,23.44%,SP100;ARHGEF2;RIPK1;BRCA1;CFLAR;SERPINE1;TRAF2;RNF34;TNFSF10;STX4;CASP8;TRADD;DDX3X;TMC8;GSK3B;SFRP1;FEM1B;HMOX1
prerank,superoxide metabolic process (GO:0006801),-0.6322178610756696,-1.8971104032338897,0.0,0.014860203824737786,0.505,10/29,14.89%,CYBB;SH3PXD2B;CYBA;NRROS;ATP7A;NCF1;NCF4;PRDX1;NCF2;PRDX2
prerank,regulation of cytokine production (GO:0001817),-0.47194104298488776,-1.8968238957018904,0.0,0.014698548228756268,0.507,34/126,14.93%,LYN;PTPRC;ATP2B1;FOXP1;FGR;CCR2;BCL6;TNFRSF1B;GAPDH;PLD3;MAPKAPK2;HTR2B;IL15;SRGN;PTGER4;ANXA1;MAPK14;BATF;TRAF3;PIK3CG;EIF2AK2;SIRPA;CD28;CLEC9A;AFAP1L2;AGT;CLEC6A;ITK;FCGR2B;PIK3CD;MAST2;NFAM1;AGPAT1;TXK
prerank,regulation of platelet activation (GO:0010543),-0.6715141907876442,-1.8958703326897657,0.0,0.014594453759831542,0.508,9/21,14.93%,LYN;APOE;SYK;PLEK;TEC;TLR4;FCER1G;PLA2G4A;TXK
prerank,cellular response to type I interferon (GO:0071357),-0.5957036289312716,-1.8955316921652439,0.0,0.014326310329540402,0.51,25/41,23.02%,SP100;SAMHD1;IRF2;RNASEL;IRF5;IFNAR2;RSAD2;IFI35;MYD88;BST2;JAK1;IFITM2;GBP2;EGR1;IFNAR1;IFIT1;OASL;IFIT2;OAS3;ISG15;PSMB8;OAS2;STAT1;IFITM1;TYK2
prerank,type I interferon signaling pathway (GO:0060337),-0.5957036289312716,-1.8955316921652439,0.0,0.014326310329540402,0.51,25/41,23.02%,SP100;SAMHD1;IRF2;RNASEL;IRF5;IFNAR2;RSAD2;IFI35;MYD88;BST2;JAK1;IFITM2;GBP2;EGR1;IFNAR1;IFIT1;OASL;IFIT2;OAS3;ISG15;PSMB8;OAS2;STAT1;IFITM1;TYK2
prerank,sodium ion transport (GO:0006814),0.4853094240107635,1.8947598169330835,0.0,0.017876419225158823,0.788,27/85,10.58%,ASIC2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;SLC4A4;SCN2A;SLC24A3;SCN2B;SCN1A;SLC9B2;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SCN9A;HCN2;SLC6A1;SLC8A2;SLC6A13;SLC5A10;SLC6A2;SLC4A11;ATP1B1;HCN1
prerank,sodium ion transmembrane transport (GO:0035725),0.48991052012377456,1.8941468155794807,0.0,0.017794651264389793,0.789,26/84,10.58%,ASIC2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;SLC4A4;SCN2A;SLC24A3;SCN2B;SCN1A;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SLC9A2;SCN9A;HCN2;ATP1A3;SLC6A1;SLC8A2;SLC6A13;SLC6A2;ATP1B1;HCN1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7125897919874858,1.8939638357056077,0.004705882352941176,0.017622015021585353,0.789,8/16,13.07%,ANK2;CACNA1C;DMD;RYR2;CASQ2;CALM1;CALM3;CALM2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5616875082312112,1.8922578086068518,0.0,0.01783074982838046,0.79,16/41,13.04%,AKAP6;ANK3;ANK2;KCNN2;KCNMB3;KCNMB2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;GABBR1;KCNJ16;PIRT;STAC;KCNMA1;KCNJ12
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.46003881056655177,-1.89216747027462,0.0,0.014874637488900876,0.531,66/158,23.87%,AKAP13;PRKCB;CD74;BIRC3;REL;LITAF;RHOA;GAPDH;FLNA;BRD4;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;TAB2;PELI1;CFLAR;CARD11;IRAK4;RNF31;TFG;RBCK1;PLK2;MYD88;WLS;BST2;NEK6;NOD1;TNIP2;RELA;PLEKHG5;TICAM1;CLEC6A;JMJD8;TRIM68;LGALS1;CASP1;TRAF2;DHX36;CD40;IKBKB;MAVS;DDX1;TRIM14;TNFSF10;GPRC5B;CASP8;TRADD;MIER1;LGALS9;SHISA5;NDFIP2;NOD2;TMED4;TICAM2;S100A4;TRIM25;NUP62;TMEM106A;ZDHHC13;TMEM9B;MTDH;HMOX1;PIM2;MAP3K3
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7484849092977651,1.8914719305754966,0.002403846153846154,0.017807287335394374,0.797,5/13,5.21%,ANK2;CACNA1C;KCNN2;CACNB2;KCNJ3
prerank,myeloid leukocyte differentiation (GO:0002573),-0.5271612751939556,-1.8900202865500202,0.0,0.015307983706062072,0.551,27/65,19.75%,FOXP1;RUNX1;SNX10;GAB2;MYH9;DEK;SBNO2;PPARG;SPI1;IL15;CDC42;MT1G;MAPK14;BATF;CBFA2T3;VEGFA;E2F1;PIK3CD;RXRA;TGFBR2;BATF3;IL31RA;CASP8;RARA;OSTM1;LGALS9;CSF1
prerank,positive regulation of cell junction assembly (GO:1901890),0.5235720680135169,1.884724422817515,0.0,0.018973657104002086,0.825,13/56,7.07%,CNTNAP2;NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;SYNDIG1;CLSTN2;EPHB1;TSC1;CUX2;CLSTN1;BDNF
prerank,response to cadmium ion (GO:0046686),-0.6349550108173426,-1.8839272252558241,0.0,0.016536851434759546,0.583,9/26,4.19%,JUN;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.667917637620761,-1.8834140768918666,0.0,0.0164330409944517,0.586,13/20,23.12%,C3AR1;P2RX7;ANO6;P2RX4;PSTPIP1;IL18;C3;APP;HSP90AB1;CASP1;TXNIP;NLRP3;MEFV
prerank,positive regulation of response to external stimulus (GO:0032103),-0.4718365475558459,-1.8832065632167174,0.0,0.01621962487764064,0.586,41/128,18.62%,SASH1;CCR2;TLR8;CYBA;OPTN;TLR7;RIPK1;DHX58;IL15;RIOK3;TLR4;IL18;DHX9;PTGER4;IL17RA;STX3;DDX60;IFI35;GRN;PUM2;GBP5;MDK;POLR3G;ABCC1;LY96;ADAM8;NFKBIZ;LPL;AGT;APP;OASL;CCL5;SERPINE1;PLA2G7;POLR3B;GPRC5B;ZCCHC3;STX4;LILRA5;PDGFRB;TRADD
prerank,regulation of interleukin-10 production (GO:0032653),-0.5639628064906819,-1.88007553588098,0.0,0.016835229347178016,0.6,21/44,23.75%,LILRB1;SYK;PLCG2;STAT3;PIBF1;TLR4;TNFRSF21;CD28;TRIB2;CD46;FCGR2B;ISG15;LILRA5;MMP8;LGALS9;NOD2;HMGB1;AGER;CD274;IL6;CD47
prerank,cellular response to cadmium ion (GO:0071276),-0.6478491141994754,-1.880003989642879,0.0,0.016637762172749655,0.6,11/24,13.43%,JUN;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;NCF1;MT2A
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5911371810172736,-1.8785034477575027,0.0,0.016939360704617053,0.612,20/36,20.02%,CD74;AXL;CD300LF;RIPK1;PARP14;NLRC5;GAS6;LAPTM5;CASP4;PARP9;HIF1A;CASP1;AGPAT1;TXK;MAVS;CXCR4;HSPA1A;IL7;CSF1;TICAM2
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.4883980206171378,-1.8728315526965154,0.0,0.018301075071668376,0.642,49/95,26.01%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;BRCA1;NIPBL;NABP1;BLM;MORF4L1;MCM6;RAD51;RFWD3;NUCKS1;MCM9;AP5Z1;MCM3;GEN1;WRN;RAD54L;FEN1;RPA3;ERCC4;RAD51AP1;YY1;INO80;RAD54B;RAD52;LIG3;SLX4;MCM2;XRCC3;RBBP8;POLN;NBN;FAN1;SMC6;GINS4;PALB2;CDC45;MMS22L;SMC5;MCM5;RAD51C;RECQL5;AP5S1;UBE2N;XRCC1;MRE11
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6821331326632601,1.87273906924474,0.0023923444976076554,0.02187408351766945,0.865,6/17,6.48%,ANK2;CACNA1C;CACNA2D1;CACNB2;SCN2B;HCN2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5931754412726713,1.8725435493005904,0.002331002331002331,0.021668386939586455,0.866,11/32,9.10%,ADGRB3;PTPRD;HECW1;IL1RAPL1;CDKL5;HECW2;LZTS1;CUX2;KNDC1;NEDD4;CAPRIN2
prerank,cell differentiation in spinal cord (GO:0021515),0.8021886476296362,1.8693895380061514,0.0,0.02220734987839728,0.874,3/10,4.35%,MDGA2;SOX6;SOX13
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.6775475500233791,-1.8640312987530425,0.0,0.020458146907859534,0.687,13/19,22.80%,ZMIZ1;SYK;AXL;GAS6;MDK;NCKAP1L;CD27;XBP1;XRCC6;ZAP70;GATA3;IL7;PRKDC
prerank,fatty acid transport (GO:0015908),-0.7193118876781734,-1.863898045650035,0.0,0.020241430019025987,0.688,7/17,10.36%,APOE;CD36;PPARD;FABP5;PPARG;SLC27A1;FABP4
prerank,negative chemotaxis (GO:0050919),0.5683390081134456,1.8636152079257315,0.0,0.023573046882783347,0.898,12/33,9.91%,ROBO1;UNC5C;SLIT3;SLIT2;SEMA6D;EPHA7;SEMA6A;SEMA3E;SLIT1;ITGB3;SEMA3F;LGR6
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.5134148522042765,-1.863196001688256,0.0,0.020206347708593853,0.691,31/66,23.12%,FOXP1;IGF1;P2RX7;TLR8;CD36;USP50;MALT1;STAT3;TLR4;NLRC4;AIM2;PANX1;SIRPA;GBP5;MYD88;LPL;EGR1;APP;CASP1;CASP8;LILRA5;TRIM16;LGALS9;HSPB1;NOD2;AGER;ZC3H12A;TMEM106A;NLRP3;IL6;MEFV
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6796573350646313,-1.8631815749696856,0.0016366612111292963,0.019968625970845692,0.691,10/19,16.92%,RUNX1;ELF1;IRAK2;DHX9;MAP2K5;CBFB;PARP9;MAPK7;MAVS;TAF9
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7475342499368839,1.862096434841183,0.0,0.023722659756859346,0.901,8/12,13.01%,RIMS2;RIMS1;SYT1;UNC13C;SYT2;SYT5;UNC13B;SYT7
prerank,receptor clustering (GO:0043113),0.6084495666657765,1.8605490339317632,0.0048543689320388345,0.023810624948122843,0.904,8/27,4.17%,NLGN1;DLG2;NRXN1;MAGI2;LRRC7;DLG3;NRXN2;PTN
prerank,negative regulation of type I interferon production (GO:0032480),-0.5741593875230329,-1.8600321884940907,0.0,0.02071319932675397,0.711,21/40,21.84%,LILRB1;REL;OTUD5;DHX58;NLRC5;PPM1B;SIRPA;UBA7;PIN1;PCBP2;NLRC3;YY1;RELB;RNF216;MAVS;NLRX1;ISG15;GPATCH3;RNF125;TRIM25;RNF135
prerank,protein localization to synapse (GO:0035418),0.7698194706009055,1.859985760700667,0.0,0.02372470428497767,0.908,4/12,4.05%,NLGN1;NRXN1;PCLO;NRXN2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6170446982800226,1.8583927068522426,0.0023584905660377358,0.023818604781206985,0.911,7/25,11.21%,AKAP6;ANK2;TRPC1;CACNB2;RAMP3;NPSR1;CAPN3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5584965037928297,1.8572533213763391,0.0024509803921568627,0.023854385782768207,0.916,8/38,5.21%,ANK2;CTNNA3;CACNA1C;CACNA2D1;KCND3;CACNB2;SCN2B;KCNJ3
prerank,response to exogenous dsRNA (GO:0043330),-0.6918189844453124,-1.8554850007384156,0.0,0.021809832912995143,0.734,9/18,17.46%,RFTN1;CGAS;DHX9;IRAK3;IFIT1;TICAM1;MAVS;ZCCHC3;RALB
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.5410717735358145,-1.8542009546735725,0.001694915254237288,0.02198312659603075,0.739,19/49,19.37%,CD74;SYK;TLR8;TLR7;RIPK1;STAT3;TLR4;RAB1A;MYD88;NOD1;AFAP1L2;RELA;CD2;SERPINE1;MAVS;HSPA1A;LGALS9;NOD2;HMGB1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5674544265465239,-1.8521629679384428,0.0,0.02229132632746304,0.752,20/42,21.39%,ARID2;PPP4C;PPP4R2;ACTR2;CGAS;SPIDR;ERCC6;RTEL1;FUS;WDR48;RAD51;TIMELESS;RADX;RAD51AP1;UBQLN4;WRAP53;SHLD2;CHEK1;MMS19;KDM1A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6558361409351359,1.8501368880706541,0.002386634844868735,0.02554611425240842,0.932,9/20,13.07%,ANK2;CACNA1C;DMD;RYR2;CASQ2;ATP1B1;CALM1;CALM3;CALM2
prerank,inorganic anion transmembrane transport (GO:0098661),0.49656896956291097,1.8496971755544571,0.0,0.025397223380093974,0.932,21/63,13.02%,GABRB3;GABRB1;GABRG3;SLC12A2;GLRA1;GABRA2;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2;SLC25A11;SLC12A5;CLCN3
prerank,lymphocyte differentiation (GO:0030098),-0.5122978418665685,-1.840693718742766,0.0,0.025722161013229904,0.795,32/68,26.17%,ITGA4;PTPRC;PLCG2;TPD52;AXL;PTPRJ;IKZF1;LYL1;ITGB1;BLNK;HHEX;PTPN22;KLF6;CEBPG;DNAJB9;LCK;KAT7;HDAC5;PIK3CD;NFAM1;TCF3;RELB;ZAP70;GATA3;CD79A;ZBTB7A;CHD7;RABL3;FLT3;DCAF1;MS4A1;GPS2
prerank,response to muramyl dipeptide (GO:0032495),-0.7669509367255389,-1.8406708500755684,0.0,0.025439499903194406,0.795,7/12,8.97%,VIM;ARHGEF2;CHMP5;IRF5;PTPN22;ERBIN;NOD1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5103647060508487,-1.839632844156483,0.0016722408026755853,0.025592661014624946,0.804,29/70,20.83%,CYBB;CYBA;CD36;PSME4;PSMB7;PSME3;ITGAV;LNPEP;PSMB9;TAPBP;B2M;PSMA8;ITGB5;PSMC3;NCF1;TAP2;NCF4;PSMD8;NCF2;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3
prerank,lysosome localization (GO:0032418),-0.5769154577640317,-1.8374276990931633,0.0016778523489932886,0.02636683114156093,0.818,16/37,17.80%,TFEB;PLEKHM1;PLEKHM2;MYH9;ARL8B;MILR1;PIK3CG;BORCS6;PIP4P1;CHGA;KXD1;FLCN;PIK3CD;SPAG9;RAB34;VPS33A
prerank,positive regulation of B cell proliferation (GO:0030890),-0.6140160030908077,-1.8374142449439426,0.0,0.02609947466736707,0.819,13/29,19.53%,PTPRC;VAV3;CD38;CD74;SASH3;BCL2;MEF2C;NCKAP1L;CD40;BST1;CHRNB2;IRS2;IL7
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.6642374617139082,-1.836389689861319,0.0,0.02621484521844877,0.826,8/21,13.54%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;RXRA
prerank,phospholipid transport (GO:0015914),-0.5338301629394635,-1.8360418078844274,0.0016638935108153079,0.02609618923500713,0.828,14/52,11.01%,OSBPL8;APOE;ABCA1;ATP8B4;ABCG1;PLTP;PITPNC1;PITPNA;PITPNM1;ATP11C;OSBPL5;ABCC1;PRELID2;NPC2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6915667973217359,1.8350184873914217,0.0022522522522522522,0.029144348821147865,0.953,11/15,20.37%,SCN1A;COL11A1;TMC1;KCNA1;ADGRV1;WHRN;PDZD7;MKKS;TMC2;TMEM120A;KIT
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6244548457405644,1.8349471406824533,0.0,0.028820783552984917,0.953,9/24,15.15%,AKAP6;DMD;PDE4D;CASQ2;JPH4;CALM1;CALM3;CALM2;JPH3
prerank,regulation of inflammatory response (GO:0050727),-0.43386659986051246,-1.8334115026129834,0.0,0.026833243808044905,0.844,50/190,13.02%,APOE;FOXP1;AOAH;BIRC3;CCR2;MFHAS1;BCL6;PRKCD;RB1;TNFRSF1B;PPARD;METRNL;PIK3AP1;SBNO2;BRD4;TLR7;PPARG;USP18;RIPK1;IL15;AREL1;TLR4;IL18;DHX9;SNX6;TNFAIP8L2;PTGER4;ANXA1;IL17RA;IFI35;GRN;SIRPA;MDK;MYD88;CASP4;ABCC1;DAGLB;MAPK7;OTULIN;SELENOS;NFKBIZ;LPL;RELA;AGT;APP;CELF1;CCL5;NLRC3;SERPINE1;CASP1
prerank,positive regulation of chemokine production (GO:0032722),-0.551888946887249,-1.830423218718743,0.0,0.027769547100456805,0.859,21/44,23.44%,CD74;SYK;TLR7;IL6R;TLR4;IL18;IL17RA;EIF2AK2;HIF1A;LPL;EGR1;APP;OAS3;MAVS;LGALS9;DDX3X;HMGB1;IL7;AGER;IL6;HMOX1
prerank,positive regulation of immune effector process (GO:0002699),-0.6245152658473365,-1.8299900920581162,0.0017605633802816902,0.02768869471638554,0.86,12/27,19.28%,PTPRC;CCR2;LILRB1;PTPRJ;DHX58;DDX60;XBP1;CD46;APPL2;MYB;LGALS9;PLA2G5
prerank,recombinational repair (GO:0000725),-0.4986332210257262,-1.8274429769179916,0.0,0.02823947388933789,0.866,42/77,26.01%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;BRCA1;NABP1;BLM;MORF4L1;RAD51;RFWD3;NUCKS1;MCM9;AP5Z1;GEN1;WRN;FEN1;RPA3;ERCC4;RHNO1;RAD51AP1;YY1;INO80;RAD54B;RAD52;LIG3;SLX4;XRCC3;RBBP8;POLN;NBN;FAN1;SMC6;PALB2;MMS22L;SMC5;RAD51C;RECQL5;AP5S1;UBE2N;XRCC1;MRE11
prerank,ventricular septum morphogenesis (GO:0060412),0.59937752997145,1.826933694823556,0.002512562814070352,0.03125472431697386,0.966,7/27,5.01%,ROBO1;ROBO2;SOX11;SLIT3;SLIT2;ZFPM2;ACVR1
prerank,neuron projection fasciculation (GO:0106030),0.7696200897865354,1.8267967429744598,0.0044943820224719105,0.030929803109767777,0.966,6/10,15.52%,CNTN4;SEMA5A;NRCAM;CDK5R1;ARHGAP35;EPHB3
prerank,DNA replication (GO:0006260),-0.4671359352464821,-1.8265233987121905,0.0,0.028180031635107582,0.867,49/105,26.01%,FAM111A;RBMS1;TOP3A;BRCA1;POLE2;RFC1;BLM;RAD1;MCM6;PCLAF;MCM9;MCM3;DBF4;TIMELESS;WRN;CDK1;ORC5;EXO1;FEN1;KAT7;BAZ1A;TICRR;RPA3;RFC2;DUT;POLD2;RHNO1;MCMBP;TOP1MT;TOPBP1;MCM2;BRIP1;RAD9A;DNA2;RBBP8;ATM;CHEK1;RFC3;TIPIN;NBN;SET;POLG2;POLB;CDC45;MCM5;POLD4;CDK2AP1;RECQL5;MRE11
prerank,regulation of establishment of cell polarity (GO:2000114),-0.695209360446031,-1.826086556918485,0.0,0.02809753290414969,0.869,8/16,6.62%,ROCK1;RAP1B;PTK2B;ARFGEF1;RUFY3;KIF20B;RIPOR2;CYRIB
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5769835052539584,-1.8246665449153854,0.0,0.028280491395942693,0.873,19/37,23.12%,ADCY7;PLD3;ABCD2;STAT3;TLR4;IL17RA;MAPK14;SIRPA;GBP5;MYD88;HIF1A;TICAM1;NLRC3;APPL2;NOD2;APPL1;ZC3H12A;IL6;MEFV
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.5877033331692422,-1.824524338386216,0.0,0.028056076000494687,0.875,14/35,13.27%,LYN;CDK6;SPI1;STAT3;FOXO3;HSPA9;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.7664402392884945,1.8237623462189896,0.009950248756218905,0.031474229743034605,0.97,6/10,7.52%,GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.6390076765603929,-1.822631243974565,0.0,0.028353594164606217,0.881,13/23,22.97%,PPARG;PIAS1;PARP14;NLRC5;NR1H2;JAK1;PARP9;IFNGR2;HSP90AB1;TXK;SOCS3;STAT1;IFNGR1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5739027295199235,1.8212239983317513,0.004739336492890996,0.03215260475879753,0.973,12/31,15.39%,NLGN1;PPFIA2;TANC2;SRCIN1;SHANK3;CUX2;ABI2;CAPRIN2;RELN;CDK5R1;ARC;SIPA1L1
prerank,long-term synaptic potentiation (GO:0060291),0.6309135550212516,1.821124032241975,0.004739336492890996,0.03181408863475464,0.973,9/21,9.50%,MPP2;GRIN2A;GRIN2B;SLC24A2;SLC8A3;PRKCZ;TSHZ3;SLC8A2;NFATC4
prerank,polarized epithelial cell differentiation (GO:0030859),-0.737287677608733,-1.8206766973256925,0.0017793594306049821,0.028831962562200573,0.887,8/13,12.98%,MSN;RHOA;RAP2A;CDC42;ZDHHC7;SH3BP1;SCRIB;RAB10
prerank,regulation of RNA metabolic process (GO:0051252),-0.5185823314866582,-1.8205135262511276,0.0,0.028597140180329658,0.887,23/59,15.03%,MBNL1;AHNAK;MITF;PTBP3;TNFRSF1B;MBNL2;SON;TRA2B;RC3H1;AHNAK2;FUS;HNRNPH1;MBNL3;USP36;HNRNPL;METTL4;PCBP2;CELF1;HNRNPLL;OASL;OAS3;ZNF326;RASA1
prerank,mesonephric tubule development (GO:0072164),0.6924352413189607,1.8205094767064167,0.002325581395348837,0.03171820021923063,0.975,6/15,11.28%,ROBO2;SLIT2;WT1;BMP7;SALL1;PKD1
prerank,regulation of neuron projection development (GO:0010975),0.41953904403770886,1.8197924977723026,0.0,0.03155374048373778,0.975,43/163,12.47%,LRRC4C;CSMD3;MAGI2;CTNNA2;IL1RAPL1;LRRC7;SPOCK1;PPFIA2;TENM3;RIT2;CDH2;DCC;NTRK3;SERPINI1;NTRK2;FUT9;CDKL5;TANC2;NCS1;NTNG2;NTNG1;PAK3;PTN;MARK1;SRCIN1;SHANK3;KNDC1;ABI2;PRKCI;TOX;PRKD1;BDNF;KANK1;TSKU;LTK;RELN;MFSD2A;CDK5R1;DPYSL3;BRSK1;RET;ARHGAP35;RTN4RL1
prerank,natural killer cell mediated immunity (GO:0002228),-0.7213481853148436,-1.8194468336593947,0.005076142131979695,0.028709811518679764,0.888,7/15,14.18%,LYST;SLAMF7;PLEKHM2;ARL8B;RAET1E;CEBPG;ULBP1
prerank,positive regulation of inflammatory response (GO:0050729),-0.48389994466805886,-1.8168293578886288,0.0,0.029466409863099084,0.898,27/86,18.62%,CCR2;NUPR1;TLR7;RIPK1;IL15;TLR4;IL18;DHX9;PTGER4;IL17RA;IFI35;GRN;MDK;ABCC1;ADAM8;NFKBIZ;LPL;AGT;APP;SERPINE1;PLA2G7;KARS1;GPRC5B;LILRA5;SNX4;MMP8;TRADD
prerank,T cell activation (GO:0042110),-0.5079318992565531,-1.8145483497307504,0.001718213058419244,0.030108180027564973,0.907,38/69,33.42%,PTPRC;CD44;MSN;CD74;KIF13B;DPP4;PTPN22;PIK3CG;MDK;CD28;JAML;LCP1;SCRIB;LCK;RAB29;CD2;ITK;CXADR;NLRC3;PIK3CD;CASP8;ZAP70;GATA3;CD3E;CHD7;DDOST;NCK1;CRTAM;IL2;LAT;CD8B;NCK2;ADA;CD4;CCL19;CD8A;IRF4;SLA2
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.6338899000144096,-1.8134419607639132,0.005272407732864675,0.030348870640807903,0.91,10/22,11.99%,SASH1;MFHAS1;XDH;RELL1;MINK1;SPI1;VEGFA;PRMT1;NCF1;GADD45A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6549157775026018,-1.8116915843756194,0.0,0.030783797191422185,0.916,13/21,18.15%,PTPRC;PRKCH;FOXP1;PRKCB;CARD11;STAP1;RELA;LCK;RAB29;NFAM1;CD226;TESPA1;RPS3
prerank,negative regulation of lipid storage (GO:0010888),-0.6722935903452775,-1.811687109714512,0.0,0.030511374207427302,0.916,9/19,12.50%,OSBPL8;ABCA1;ABCG1;PPARD;PPARG;ITGAV;NR1H2;ABHD5;TTC39B
prerank,negative regulation of programmed cell death (GO:0043069),-0.40418710576049316,-1.8099913005189818,0.0,0.030926408834925916,0.92,152/355,29.30%,DAB2;CD44;IGF1;NOTCH2;CD38;CD74;ARHGAP10;BIRC3;TNFAIP8;PAK2;MCL1;AXL;CBL;RAB7A;NIBAN2;BFAR;BIRC6;NUPR1;ANXA4;FLNA;IGF1R;SON;MALT1;RIPK1;HTR2B;AREL1;CFLAR;HSPA9;PIM1;PTK2B;NFKB1;ANXA5;BCL2;ANXA1;HGF;CTNNB1;GAS6;GRK5;HIGD2A;WFS1;PLK2;BABAM2;VEGFA;LAPTM5;MYD88;DNAJA1;PLAUR;CD28;ATAD3A;ZFAND6;CTSH;SERPINB9;UBC;RPS27A;MGMT;PRDX5;NCKAP1L;CD27;TPT1;SPRY2;RELA;KIF14;XBP1;TXNDC5;CDK1;WDR73;OSR1;HSP90B1;HTATIP2;TMBIM6;CIB1;PLK3;AVEN;GREM1;GPX4;IKBKB;PRDX2;RASA1;AATF;BAG3;IL31RA;ANKLE2;CLN3;BID;BNIP2;IL2RB;STIL;TAF9;DNAJC3;VHL;BNIP3L;HSPA1A;ATF5;HCK;API5;CFL1;THOC6;HSPB1;CASP2;DDX3X;COPS5;IL7;NAA16;GSK3B;CAT;SFRP1;PPT1;KDR;NUP62;HAX1;HNRNPK;HYPK;BCL2L2;MAP4K4;UFM1;TOPORS;NR1H4;IL6;TCIM;CRYAB;PRKDC;MTDH;PIM2;FANK1;LRP2;SHC1;MYC;PKHD1;VDAC1;PSEN2;TMEM14A;MT3;MRE11;SIAH2;VIP;RPS6KA3;HIPK3;PDPN;HIGD1A;NAA38;APIP;FFAR4;BCL2L1;CITED2;AQP1;GHRL;LEF1;PRELID1;RIPK3;BNIP3;RIPK2;IL2
prerank,regulation of exocytosis (GO:0017157),0.5238647688913555,1.8094755895856143,0.0,0.03503912289175692,0.981,11/46,5.14%,RIMS2;CADPS;IL1RAPL1;STXBP5L;SYT1;RAB3C;CPLX1;CADPS2;RAB15;CLASP2;RAB27B
prerank,reverse cholesterol transport (GO:0043691),-0.7276688153332043,-1.808523094915067,0.0034662045060658577,0.031355709339639125,0.923,3/13,0.54%,APOE;ABCA1;ABCG1
prerank,DNA metabolic process (GO:0006259),-0.4091300677950379,-1.8075524374701528,0.0,0.03157527079444853,0.927,111/270,26.18%,SP100;SAMHD1;TOP3A;DDB2;BACH1;RAD51B;PSME4;BRCA1;UVRAG;POLE2;RFC1;NOC3L;TOP2A;NABP1;PARP4;BLM;RAD1;PRIMPOL;RTEL1;UHRF2;REXO4;PWWP3A;KMT5B;ALKBH1;MCM6;USP3;CNBP;NEIL3;RAD51;KMT5C;UBC;RPS27A;MGMT;MCM3;DBF4;GEN1;TIMELESS;LIG1;XRCC6;WRN;CDK1;DNASE1L1;PCNA;RAD54L;GADD45A;ORC5;EXO1;ASF1A;FEN1;HMGB2;TICRR;UHRF1;RPA3;RFC2;ENDOG;POLD2;ERCC4;RAD51AP1;DOT1L;INO80;TOP1MT;RAD52;UBE2T;NSMCE3;CDC34;LIG3;SLX4;TOPBP1;MCM2;USP7;PRIM1;XRCC3;LRWD1;RAD9A;DNA2;RBBP8;ADPRS;HMGB1;PRIM2;HMGB3;ATM;CHEK1;SMC1A;MMS19;RFC3;PDS5B;DMC1;NBN;ALKBH3;FAN1;POLB;CDC45;PRKDC;ZRANB3;UBE2V2;NUDT15;DNTT;EID3;MCM5;POLD4;RAD51C;DNASE2;DDB1;TRIM28;TSN;MPG;RECQL5;UBE2N;XRCC1;MRE11;DCLRE1B
prerank,phagosome maturation (GO:0090382),-0.5702461986020022,-1.8062545061601432,0.0,0.03180163737453759,0.928,13/35,17.67%,ATP6V0D2;ATP6V1E1;RAB7A;RAB31;ATP6V1A;RAB20;TCIRG1;RAB32;ATP6V1G1;ATP6V0B;ATP6V0E1;RAB39A;RAB34
prerank,neutrophil activation (GO:0042119),-0.7394399366215805,-1.8044853007731452,0.0051635111876075735,0.03218119976267653,0.931,5/12,13.01%,SYK;PRKCD;IL15;CCL5;FCER1G
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.5970227244931338,-1.8040287407958986,0.001692047377326565,0.0321495293365092,0.934,9/27,10.70%,CD44;CCR2;ITGB2;RHOA;CYRIB;SIRPA;MDK;RELA;LCK
prerank,neuron migration (GO:0001764),0.5046589557237035,1.8026601874798944,0.0,0.03718056585840649,0.985,18/48,11.20%,ADGRL3;ASTN2;AUTS2;SPOCK1;MAP1B;GPM6A;NTRK2;CDKL5;ASTN1;NRCAM;MARK1;TUBB2A;DCDC2;PEX13;DNAAF4;DNER;RELN;CDK5R1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.39560697144144397,-1.8026225137447562,0.0,0.03240662868315678,0.938,158/416,24.81%,PID1;F13A1;GRB2;CCR2;GAB2;DAPK1;SYK;VIM;BCL6;MCL1;AXL;CBL;CD36;ITGB2;PTPRJ;RHOA;TNFRSF1B;BCL2L11;GAPDH;CSF2RA;NFE2L2;ARHGEF2;SBNO2;VAV1;GRAP2;RIPK1;IRAK2;IL10RB;BRCA1;IL6R;ABL2;LRCH1;STAT3;FOXO3;CCR1;TEC;TLR4;MT1X;IL18;STAT6;DHX9;ITGB1;PTPN12;PIM1;RC3H1;DOCK8;NFKB1;BCL2;IRF5;IFNAR2;IRAK4;AIM2;DAPK3;ANXA1;RIPOR2;STX3;BATF;PF4;PIK3CB;FN1;HGF;TNFRSF21;IRAK3;GAS6;STAT5B;STAT4;VEGFA;SIRPA;GBP5;ERBIN;JAK1;IFITM2;GSDME;HIF1A;ZFAND6;PTPN6;UBC;RPS27A;GBP2;EGR1;RELA;IFNGR2;LCK;ITGAX;IL2RG;XBP1;IL4R;IFNAR1;TPR;CRK;IFIT1;HSP90B1;PIK3CA;IL20RA;CSF2RB;CCL5;TCF7;CIB1;CASP1;SOCS6;PIK3CD;MT2A;CNTFR;CD40;IKBKB;IL34;CDC34;CRKL;IL31RA;CXCR4;HCLS1;IL27RA;IL2RB;IL18R1;STX4;GATA3;RPS3;HCK;SOCS3;PTPN13;PTPN11;TRADD;IL1R2;LGALS9;GBP3;IL7;GBP7;CSF1;GBP6;SLA;WNK1;GSK3B;MMP2;SFRP1;MMP1;ZC3H12A;STAT1;ASAH1;PLP2;HAX1;SOCS5;SHMT1;PTPN7;IL6;IFNGR1;TYK2;TGFB1;HMOX1;CD47;GREM2;IL2RA;CCL7;FLT3;ITGAM;SHC1;MYC;GBP4;STAT2
prerank,T cell receptor signaling pathway (GO:0050852),-0.45148180033307794,-1.800972981932116,0.0,0.032873873279562996,0.94,55/138,20.90%,RFTN1;PTPRC;PLCG2;PAK2;PTPRJ;THEMIS2;PSME4;GRAP2;MALT1;TAB2;PSMB7;TEC;CARD11;PSME3;RC3H1;NFKB1;FBXW11;PTPN22;RNF31;PSMB9;FYB1;RBCK1;PIK3CB;TNFRSF21;EIF2B3;CD28;PSMA8;NFKBIZ;RELA;PSMC3;LCK;PIK3CA;PSMD8;ITK;PSMC4;PSMB10;LCP2;PIK3CD;PSMA1;IKBKB;TXK;PSMB8;THEMIS;ZAP70;GATA3;PSMA5;DENND1B;PRAM1;PSMD4;NFKBID;PSMB3;EIF2B1;WNK1;PSMD3;ZC3H12A
prerank,regulation of apoptotic process (GO:0042981),-0.3808693133839917,-1.8009013748599076,0.0,0.03262466649149014,0.94,227/676,22.80%,DAB2;CD44;CTSB;VAV3;MAP3K5;AKAP13;APAF1;IGF1;NOTCH2;CD38;CD74;ABR;CTSD;ARHGAP10;BIRC3;ITSN1;LILRB1;TNFAIP8;DAPK1;PAK2;BCL6;MCL1;CRADD;AXL;CBL;JUN;ARHGEF3;DNM2;NIBAN2;BFAR;BIRC6;CREBBP;NUPR1;ANO6;BCL2L11;ANXA4;MAP3K20;CTNNBL1;FLNA;IGF1R;ARHGEF2;SON;CALHM2;VAV1;MALT1;RIPK1;HTR2B;SGK1;FOXO3;ANP32A;AREL1;CFLAR;FGD4;ATG7;NLRC4;HSPA9;ITGB1;RYBP;PIM1;PTK2B;NFKB1;ANXA5;TOP2A;RARG;PRMT2;BCL2;ANP32B;IRF5;STEAP3;DAPK3;ANXA1;RPS6;FGD3;STK3;HGF;CTNNB1;GAS6;ARHGEF18;USP36;GRK5;HIGD2A;ATF6;WFS1;PLK2;HIP1;BABAM2;NF2;VEGFA;NME1;E2F1;MYD88;DNAJA1;PLAUR;CD28;ATAD3A;VAV2;ZFAND6;PTPN6;MEF2C;SOS2;CTSH;SERPINB9;UBC;RPS27A;MGMT;PRDX5;NCKAP1L;SUDS3;TGM2;CD27;TPT1;SCRIB;SPRY2;RELA;PLEKHG5;KIF14;AGT;IKZF3;GNA13;XBP1;DUSP6;TXNDC5;FLCN;OSGIN1;WRN;PSENEN;CDK1;WDR73;OSR1;ARHGEF11;HSP90B1;GADD45A;MLLT11;TRIM24;IGFBP3;HTATIP2;EEF1E1;STK17B;TMBIM6;USP42;FBXO10;CIB1;IFIT2;PLK3;LGALS1;CASP1;TRAF2;AVEN;DFFA;TFAP4;GREM1;TRIO;IKBKB;PRDX2;RASA1;MAP3K10;AATF;BAG3;IL31RA;SHQ1;ANKLE2;QRICH1;LATS2;ARHGEF5;CLN3;FAF1;BID;KLF11;RABGGTA;BNIP2;TNFSF10;IL2RB;STIL;TAF9;SPHK2;DNAJC3;VHL;BNIP3L;SKP2;CASP8;HSPA1A;RNPS1;PHLDA1;TNFRSF25;ATF5;RPS3;HCK;API5;CFL1;THOC6;IFT57;TRADD;PDCD5;HSPB1;CASP2;DDX3X;RABGGTB;HMGB1;COPS5;IL7;ATM;NAA16;C1QBP;GSK3B;CAT;SFRP1;STAT1;PPT1;KDR;CDK5;RACK1;NUP62;HAX1;HNRNPK;ZBTB7A;HYPK;BCL2L2;MAP4K4;UFM1;TOPORS;TNFSF9;CD3E;NR1H4;IL6;TCIM;CRYAB;PRKDC
prerank,positive regulation of potassium ion transport (GO:0043268),0.5456735668477333,1.8007542755264598,0.0,0.03748546337292147,0.987,11/38,7.72%,AKAP6;ANK2;KCNN2;KCNMB3;KCNMB2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;GABBR1;KCNJ16
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.5311375372849073,-1.7999304601335353,0.0,0.03272098312508903,0.942,22/48,20.11%,ZMIZ1;DEK;ARID1B;ATAD2;SMARCA5;ERCC6;ACTB;POLR2H;ARID1A;POLR2F;WBP2;ATAD2B;POLR2L;ASF1A;ELOF1;ZMIZ2;SPHK2;TAF1A;POLR1F;SERTAD1;CHEK1;SF3B1
prerank,cellular response to zinc ion (GO:0071294),-0.6840823326233056,-1.7999002228415946,0.0,0.03245710422891897,0.942,9/15,4.19%,P2RX4;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,cellular response to copper ion (GO:0071280),-0.6857019971976065,-1.7994746855854729,0.0,0.032385216425322924,0.942,8/16,4.19%,MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,protein transport (GO:0015031),-0.4019705691360244,-1.798839828800495,0.0,0.032481140203091424,0.943,142/332,24.99%,APOE;ABCA1;RAB8B;PRKCB;ABCG1;ATP6V0D2;CD74;LRP1;MYH9;ATP6V1E1;CD36;RAB7A;DNM2;SNX9;SNX27;SLC10A7;SNX8;CANX;OPTN;STX7;ARHGEF2;TBC1D15;GOLGA4;PPARG;UNC93B1;RAB31;SGSM2;TLK1;ATP6V1A;KIF3B;TBC1D2B;RAB20;TBC1D9;GGA3;LAMP2;TCIRG1;RAB1A;COG7;SNX6;TOM1;TMED10;CENPF;STX8;CTSA;STEAP3;TBC1D5;MACF1;TBC1D1;ARL11;STX3;TBC1D22A;PREB;RAB32;SNX33;GOLPH3L;TBC1D16;TBC1D22B;SIL1;LAPTM5;WLS;TBC1D8B;SYS1;RAB5A;RCN3;TMED3;TBC1D8;RAB21;ATP6V1G1;TBC1D17;VPS26B;SEL1L;RAB3D;SNX13;RAB24;CHMP1A;RAB11B;SAR1A;HSP90B1;RAB29;ARRDC4;VPS26A;STX5;TBC1D10B;RAB10;ARL5A;MIA2;SEC31A;ATP6V0B;MIA3;COPA;ARRDC1;EHD1;CHMP2A;TBC1D30;STX16;VAMP4;RAB13;LMAN2L;ARFIP1;ATP6V0E1;AP3B1;STX4;AP3D1;TBC1D9B;TMED2;RAB34;VPS33A;ARL1;RILP;PDIA4;SNX1;SNX4;TBC1D25;RAB12;ARFIP2;SLU7;TMED4;TICAM2;TXNIP;ATP6V0D1;GOLGA7;PPT1;BLZF1;NEURL1B;TBC1D10C;TBC1D4;TVP23A;TMED5;SCFD2;RABL3;VMP1;TANGO6;MON1A;RAB26;LRP2;ARRDC2;ARCN1;FAM91A1;RAB19;COPB2;RAB1B;CHMP2B
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.6784924165882554,-1.7973459888220311,0.003676470588235294,0.03301326609089659,0.948,11/18,23.35%,BIRC3;DHX58;DDX60;PUM2;OASL;SEC14L1;ZCCHC3;GPATCH3;C1QBP;RNF125;PUM1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4690437331880014,1.7950790270956671,0.002421307506053269,0.039301530330670076,0.99,32/75,18.79%,CTNNA2;MAP2;ANK3;MAP1B;CNTN4;DCC;PARD3;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;NEFH;NRCAM;DCDC2;DSCAML1;SPTBN4;CDHR1;MFSD2A;SLITRK3;BRSK1;SLITRK5;SDC2;BTBD3;KLF7;ZDHHC17;RAB3A;MAP1A;DOCK7;ADGRB1;CELSR2;S100B
prerank,negative regulation of apoptotic process (GO:0043066),-0.3924870245680393,-1.7939888639297543,0.0,0.03399067251689908,0.954,182/444,28.72%,DAB2;APOE;PRKCH;CD44;IGF1;NOTCH2;CD38;CD74;ARHGAP10;BIRC3;RNF213;TNFAIP8;PAK2;MCL1;PRKCD;RB1;AXL;CBL;ITGA5;NIBAN2;BFAR;BIRC6;NUPR1;ANXA4;FLNA;IGF1R;CSNK2A1;SON;MALT1;RIPK1;HTR2B;AREL1;CFLAR;HSPA9;ITGB1;SNX6;PIM1;PTK2B;NFKB1;ANXA5;BCL2;ANXA1;HGF;CTNNB1;GAS6;GRN;GRK5;HIGD2A;WFS1;PLK2;BABAM2;VEGFA;MAP2K5;MDK;MYD88;DNAJA1;FNIP1;PLAUR;CD28;ATAD3A;YWHAE;ZFAND6;MEF2C;CTSH;SERPINB9;ADAM8;UBC;RPS27A;MGMT;PRDX5;NCKAP1L;CD27;TPT1;SPRY2;RELA;KIF14;XBP1;TXNDC5;CDK1;WDR73;OSR1;HSP90B1;PIK3CA;MAEA;HTATIP2;TMBIM6;CIB1;PLK3;RETREG1;AVEN;DFFA;GREM1;IKBKB;PRDX2;RASA1;AATF;BAG3;IL31RA;ANKLE2;HCLS1;CLN3;BID;BNIP2;IL2RB;STIL;TAF9;DNAJC3;VHL;BNIP3L;HSPA1A;ATF5;HCK;API5;CFL1;THOC6;HSPB1;CASP2;DDX3X;BEX3;COPS5;IL7;NAA16;NDNF;GSK3B;CAT;DNAJB6;MAZ;SFRP1;ZC3H12A;CPEB4;PPT1;KDR;NUP62;HAX1;APOH;HNRNPK;SFN;SNAI2;HYPK;BCL2L2;MAP4K4;SET;UFM1;MAPK1;TOPORS;NR1H4;IL6;TCIM;CRYAB;PRKDC;MTDH;PIM2;FANK1;LRP2;SHC1;MYC;PKHD1;VDAC1;PSEN2;TMEM14A;MT3;MRE11;SIAH2;VIP;RPS6KA3;HIPK3;PDPN;HIGD1A;KDM2B;CARD16;NAA38;POU3F4;FGF20;APIP;FFAR4;BCL2L1;CITED2;AQP1;GHRL;LEF1;SLC30A10;PRELID1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.689347954779287,-1.7936838040245155,0.0016474464579901153,0.03380378808295956,0.955,8/15,10.65%,PRKCH;MSR1;CD36;IL18;NFKB1;PF4;LPL;AGT
prerank,double-strand break repair (GO:0006302),-0.440570473693834,-1.792904695231347,0.0,0.033838335863763454,0.955,76/158,27.75%,NSMCE2;ZFYVE26;SAMHD1;SPIDR;RAD51B;SMARCA5;BRCA1;DCLRE1C;NABP1;BLM;ABRAXAS1;MORF4L1;BABAM2;KDM2A;RAD51;PARP9;RFWD3;NUCKS1;RNF8;MCM9;AP5Z1;APTX;GEN1;DCLRE1A;XRCC6;WRN;BABAM1;FEN1;CIB1;HMGB2;RPA3;XRCC4;ERCC4;APLF;RAD51AP1;YY1;INO80;RAD54B;RAD52;LIG3;SLX4;DDX1;BRIP1;XRCC3;EYA1;DNA2;EYA3;RBBP8;BRCC3;UBXN1;HMGB1;POLN;ATM;BAP1;DTX3L;NBN;FAN1;SMC6;POLB;PALB2;PRKDC;UBE2V2;MMS22L;DNTT;SMC5;RAD51C;RECQL5;BAZ1B;AP5S1;UBE2N;XRCC1;MRE11;DCLRE1B;VCP;UIMC1;RAD51AP2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.6226689835422378,-1.7924155523235965,0.0016638935108153079,0.033740336991862505,0.955,13/23,22.48%,LILRB1;AXL;TLR4;GAS6;LAPTM5;RARA;LGALS9;HMGB1;C1QBP;CD274;ZC3H12A;INHA;NR1H4
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.7238270256160076,-1.7903124528564924,0.003418803418803419,0.034411220303791,0.963,8/13,10.46%,PIK3AP1;TLR7;UNC93B1;IRAK2;IRAK4;EPG5;MYD88;TNIP2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.587131166076545,-1.7898930206501147,0.0,0.03430109955772792,0.963,14/30,22.61%,SYK;PLCG2;STAT3;PIBF1;TLR4;CD28;CD46;ISG15;LILRA5;LGALS9;NOD2;HMGB1;CD274;IL6
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.7049596452364724,-1.7894908809643413,0.005253940455341506,0.034275591831054136,0.965,10/15,22.61%,STAT3;TLR4;IL17RA;GBP5;MYD88;HIF1A;TICAM1;NOD2;APPL1;IL6
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6727968788584155,-1.7891183014519674,0.0017421602787456446,0.034195558771412365,0.966,8/18,6.62%,ROCK1;RAP1B;PTK2B;ARFGEF1;RUFY3;KIF20B;RIPOR2;CYRIB
prerank,translation (GO:0006412),-0.4179360465038005,-1.788242353396814,0.0,0.03428928449779043,0.967,81/208,26.20%,RARS1;AGO2;RPS18;FARS2;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;NOA1;SARS1;RPL36;RPS6;RPS20;RPL11;ABCE1;RPL10A;RPL12;RRBP1;MRPL42;TUFM;RPS14;EEF1B2;RPL32;RPS15A;RPS28;RPS13;RPS27A;DARS1;RPL28;RPS4X;FASTKD2;RPS23;EEF2;EIF4EBP2;GTPBP1;RPL22;EEF1E1;RPL14;EEF1A1;MRPS6;RPL34;MRPS11;RPS11;RPL6;EIF4G1;RPS10;RPL18A;KARS1;MRPS16;RPL37A;MRPL34;RPS9;MRPS15;RPS27;ABCF1;RPS3;GTPBP2;RPL23A;RPS16;RPL9;AARS1;COPS5;DARS2;RPLP2;MRPL51;MRPL47;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39;IARS1;MRPL18;MRPS7;EEFSEC;EEF1D;RPL5;RPL13
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.632179512830494,-1.787805130951483,0.0,0.03426442157578787,0.967,7/24,4.47%,ITGA4;MSN;SYK;ROCK1;ITGB2;ITGAL;ITGB1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7217613551034607,-1.7876508008043894,0.0,0.034123548019499926,0.967,9/13,13.01%,ABCA1;SYK;CD36;ITGB2;PPARG;CD9;ITGB1;LPL;FCER1G
prerank,regulation of phagocytosis (GO:0050764),-0.5223345281045464,-1.7873956078648598,0.0017035775127768314,0.03401136305900039,0.967,15/53,13.01%,DOCK2;PTPRC;FGR;SYK;CYBA;SNX3;CAMK1D;IL15;ITGAV;GAS6;SIRPA;TGM2;IL2RG;FCGR2B;FCER1G
prerank,response to interferon-gamma (GO:0034341),-0.4990073603156262,-1.7866445142761256,0.0,0.03413019778901354,0.969,30/67,25.96%,CD74;SP100;DAPK1;GAPDH;KYNU;TLR4;DAPK3;CIITA;NUB1;SIRPA;GBP5;BST2;IFITM2;GBP2;CXCL16;CCL5;CASP1;GCH1;CD40;LGALS9;GBP3;GBP7;GBP6;STAT1;IFITM1;MEFV;CD47;CCL7;GBP4;IL12RB1
prerank,positive regulation of signaling (GO:0023056),0.5472250169087145,1.7864247226210401,0.0022675736961451248,0.04268402243177661,0.992,9/37,6.74%,RIMS2;GRIK2;RIMS1;SYT1;SOX11;CLSTN2;RAMP3;CLSTN1;HOMER1
prerank,negative regulation of B cell activation (GO:0050869),-0.6456554919094146,-1.785948381339253,0.00505902192242833,0.03415097423746117,0.97,15/21,25.73%,LYN;BANK1;CD300A;RC3H1;TNFRSF21;LAPTM5;FOXJ1;FCGR2B;ID2;SAMSN1;ATM;SFRP1;INHA;TNFRSF13B;BLK
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.7229348881487155,1.7855041593695427,0.004555808656036446,0.04270626527827571,0.994,3/11,9.60%,RTP4;PKD1L3;RTP2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.4983778367543191,-1.781359625943155,0.005084745762711864,0.03605923972967899,0.971,27/67,20.83%,CYBB;CYBA;CD36;PSME4;PSMB7;PSME3;ITGAV;PSMB9;TAPBP;B2M;PSMA8;ITGB5;PSMC3;NCF1;TAP2;NCF4;PSMD8;NCF2;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3
prerank,regulation of chemokine production (GO:0032642),-0.5638140190371317,-1.7813116471485002,0.0,0.03581571583343884,0.971,17/36,23.44%,FOXP1;CD74;TLR7;IL6R;TLR4;IL18;EIF2AK2;HIF1A;LPL;EGR1;APP;LGALS9;IL7;AGER;SNAI2;IL6;HMOX1
prerank,chloride transport (GO:0006821),0.46952044829696915,1.78098572235617,0.0,0.04437171224251195,0.994,19/74,8.86%,GABRB3;GABRB1;GABRG3;SLC12A2;GLRA1;GABRA2;SLC4A10;ANO4;GABRA3;SLC12A8;SLC12A1;GABRA5;GABRB2;ANO3;GABRG2;ANO5;SLC1A1;SLC6A1;GLRA2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5997586276859773,-1.7807656697773357,0.0,0.03577288267915178,0.971,9/26,4.19%,SLC30A5;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.738979542041796,-1.7794461216973874,0.0017452006980802793,0.0360543800342951,0.971,3/11,6.32%,NRP1;RAC1;HGF
prerank,response to copper ion (GO:0046688),-0.6394932011052165,-1.7788953947742618,0.0017301038062283738,0.036103571197463054,0.971,8/20,4.19%,MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,regulation of myoblast fusion (GO:1901739),-0.745573622737024,-1.7782340337683924,0.005405405405405406,0.03621091797726384,0.971,5/11,14.42%,CFLAR;RIPOR2;MAPK14;CD53;EHD1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5898530715239934,-1.7780043792987916,0.001736111111111111,0.036049717353588924,0.972,8/28,6.22%,FOXP1;FGR;BIRC3;SAMHD1;CD36;DHX58;PTPN22;TRAF3
prerank,superoxide anion generation (GO:0042554),-0.7192722326515141,-1.7779251956285573,0.0070052539404553416,0.03583264520827634,0.972,5/13,12.51%,CYBB;CYBA;NCF1;NCF4;NCF2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.7666102545396161,-1.7773050502166807,0.0035149384885764497,0.03593141574196011,0.973,3/11,4.81%,APOE;ATG7;ATG10
prerank,mononuclear cell differentiation (GO:1903131),-0.6193636693531636,-1.7768519377691954,0.0,0.03594706861510916,0.973,12/24,15.67%,LYN;LILRB1;MYH9;AXL;PPARG;IKZF1;MT1G;GAS6;VEGFA;BATF3;RELB;IL31RA
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.46926927973270494,-1.7764756582645913,0.0,0.03586499006355854,0.973,22/86,11.34%,LYN;DENND1A;AKAP13;IGF1;NOTCH2;GRB2;STARD8;DENND4C;MYO9B;EPS8;OGT;ARHGAP17;ARHGEF2;VAV1;RASGRP4;ARHGEF18;ERBIN;SH3BP1;SPRY2;KIF14;RASAL3;FLCN
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.7719921671166226,1.7759149111090273,0.0044943820224719105,0.04633035694667017,0.995,7/10,19.75%,GNB5;FMR1;CALM1;CALM3;CBARP;CRHR1;GPR35
prerank,neuromuscular synaptic transmission (GO:0007274),0.6309537945385711,1.775492702301957,0.009925558312655087,0.04614924595809795,0.995,6/18,10.75%,ERC2;DTNA;KIF1B;SLC5A7;RIMBP2;CHAT
prerank,microvillus organization (GO:0032528),-0.7156879717023503,-1.774238959581439,0.005385996409335727,0.03655908879022695,0.975,6/13,3.69%,RAP1B;RAP2B;RAP2A;FXYD5;MINK1;RAP1A
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.4709995442479147,-1.7727732357871822,0.0,0.0370035259943404,0.978,28/86,16.21%,PTPRC;NRP1;CD44;BANK1;IGF1;CD74;PLCG2;PAK2;PRKCD;ITGB2;ITGA5;PTPRJ;RAP2B;ARHGEF2;IL6R;IL15;TEC;PTK2B;HGF;VEGFA;PTPN6;AGT;APP;CLEC6A;SAMSN1;CSPG4;BST1;HCLS1
prerank,inorganic cation transmembrane transport (GO:0098662),0.389570567841617,1.772685146182361,0.0,0.046942365596612134,0.995,74/268,17.46%,KCND2;ASIC2;KCNB2;KCNQ3;TRPM3;CACNA1C;RYR3;KCNN2;TRPC5;KCNQ5;KCNC2;KCNK10;KCND3;SLC24A4;SLC24A2;SLC8A3;SLC12A2;NALCN;TRPC1;KCNH7;KCNH5;SLC4A4;SCN2A;KCNH1;SLC24A3;SCN2B;SCN1A;SLC6A16;SCN3A;SLC6A15;SLC12A1;SLC6A17;SLC9A2;KCNJ10;KCNK2;SCN9A;HCN2;KCNA1;KCNH4;ATP1A3;KCNJ16;SLC6A1;TRPM1;SLC8A2;SLC6A13;SLC6A2;SLC4A11;KCNF1;ATP1B1;HCN1;TMEM175;KCNG1;COX15;PKD1;SCARA5;KCNJ12;KCNV1;KCNH8;ATP2B4;KCNA2;KCNS3;ATP2A1;TRPV3;SLC39A6;CACNA1G;KCNK12;SCN10A;SLC39A13;UCP3;SLC6A5;KCND1;TRPM2;TRPC7;SLC6A11
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5889607003047445,-1.7719568958707095,0.0,0.03709952613520387,0.979,14/30,20.02%,BIRC3;CD300LF;RIPK1;TLR4;TRAF3;LY96;UBC;RPS27A;TICAM1;CD40;IKBKB;TNIP3;CASP8;TICAM2
prerank,positive regulation of dendrite development (GO:1900006),0.7605414904858188,1.7698717974844245,0.009433962264150943,0.047916641108994656,0.995,6/10,14.11%,PTN;ALK;BMP7;COBL;VLDLR;PACSIN1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.45864922386848006,-1.7686479809273634,0.0,0.03839002440033821,0.981,44/101,23.38%,LYN;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;CTR9;TLR4;IL18;CHMP5;STAP1;NFKB1;PTPN22;ADAM9;MAPK14;PF4;SIRPA;MYD88;MEF2C;LY96;SELENOS;TNIP2;RELA;XBP1;TICAM1;CCL5;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;NFKBIB;TNIP3;HCK;NOD2;HMGB1;TICAM2;CD274;ZC3H12A;NLRP3;IL6;MTDH;TGFB1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.7050406714450576,-1.76798093181873,0.008849557522123894,0.03843662892639651,0.982,9/14,20.32%,ARID2;ACTR2;ERCC6;FUS;WDR48;TIMELESS;RAD51AP1;WRAP53;MMS19
prerank,DNA repair (GO:0006281),-0.4000213775438581,-1.7673012534834769,0.0,0.03847482502448358,0.982,120/284,26.18%,FAM111A;DDB2;BACH1;RAD51B;PSME4;SMARCA5;BRCA1;UVRAG;ERCC6;POLE2;DCLRE1C;NABP1;PARP4;BLM;ABRAXAS1;RAD1;PRIMPOL;WDR48;TEX264;REXO4;PWWP3A;KMT5B;ALKBH1;BABAM2;USP3;ATXN3;NEIL3;RAD51;PARP9;RFWD3;KMT5C;UBC;RPS27A;MGMT;NUCKS1;RNF8;APTX;FTO;TIMELESS;DCLRE1A;LIG1;WRN;CDK1;PCNA;CUL4B;RAD54L;GADD45A;BABAM1;EXO1;ASF1A;MLH3;FEN1;CIB1;TICRR;WDR33;RPA3;RFC2;XRCC4;POLD2;ERCC4;APLF;RHNO1;RAD51AP1;DOT1L;INO80;RAD52;PRMT6;UBE2T;NSMCE3;LIG3;SLX4;DDX1;TOPBP1;BRIP1;NEIL2;XRCC3;EYA1;RAD9A;DNA2;EYA3;RBBP8;HUWE1;ADPRS;BRCC3;UBXN1;POLN;ATM;FAAP24;CHEK1;SMC1A;MMS19;RFC3;BAP1;DTX3L;PDS5B;NBN;EXO5;ALKBH3;CETN2;FAN1;FANCD2;POLB;PRKDC;ZRANB3;UBE2V2;MLH1;EID3;ASCC3;POLD4;RAD51C;DDB1;TRIM28;MPG;RECQL5;BAZ1B;UBE2N;XRCC1;ASCC2;MRE11;DCLRE1B
prerank,positive regulation of T cell activation (GO:0050870),-0.5057430332992211,-1.7667004722269108,0.0,0.03854361796579817,0.982,33/62,32.12%,PTPRC;ZMIZ1;CCR2;IL15;DOCK8;ANXA1;CYRIB;SIRPA;MDK;CD28;NCKAP1L;LCK;XBP1;CD46;CCL5;FLOT2;ZAP70;GATA3;LGALS9;NOD2;IL7;CD274;CD3E;IL6;CD47;NCK1;TNFRSF13C;PNP;ZBTB1;NCK2;SLC7A1;CCL19;CD80
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.6913163585596706,-1.7640567454420333,0.005076142131979695,0.039406789898069935,0.985,6/16,8.66%,LYST;SLAMF7;PLEKHM2;ARL8B;RAET1E;CEBPG
prerank,regulation of fibroblast proliferation (GO:0048145),-0.5341329617156538,-1.7638978643299559,0.0034129692832764505,0.0392234097157136,0.985,15/45,14.06%,IGF1;CD74;CD300A;CDK6;DHX9;FN1;CTNNB1;GAS6;SKI;E2F1;MORC3;AGT;B4GALT7;NLRC3;S100A6
prerank,response to lipopolysaccharide (GO:0032496),-0.4357312388474309,-1.7637031020791847,0.0,0.0390499189341724,0.985,40/138,14.06%,FOXP1;MAPKAPK3;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;OTUD5;MAPKAPK2;CTR9;TAB2;PELI1;TLR4;CHMP5;STAP1;NFKB1;PTPN22;ADAM9;MAPK14;PF4;IRAK3;SIRPA;ERBIN;MYD88;TRIB1;MEF2C;LY96;SELENOS;TNIP2;RELA;XBP1;IFNAR1;TICAM1;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;GCH1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.5816034905337994,-1.7627239916659407,0.0,0.03924233284462683,0.985,10/28,12.64%,MITF;RAC1;TNFRSF1B;MFSD12;PRKAG2;ADIPOR1;C3;SIRPA;CTNS;CCL5
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4893816747677246,-1.7607157832583815,0.0,0.03991447734342698,0.985,30/67,23.31%,NEDD9;NRP1;RREB1;RSU1;CDK6;CD36;RAC1;FLNA;CDC42;PTK2B;TRIOBP;FN1;DOCK5;MYADM;UTRN;MDK;CRK;CIB1;PLEKHA2;CRKL;LIMS1;CSF1;C1QBP;NDNF;GSK3B;SFRP1;JUP;CD3E;ILK;P4HB
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5815890352045338,-1.759817430634966,0.0,0.04013675323331489,0.988,14/30,21.99%,SDCBP;OGT;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;UBXN1;SGTA;BAG6;EIF3H
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5502167856326512,-1.7568863416983398,0.0035026269702276708,0.04145028132572601,0.988,17/37,26.75%,SDCBP;OGT;CSNK2A1;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;UBXN1;SGTA;BAG6;EIF3H;RPL5;PML
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.6006691988999109,-1.7566263654525656,0.00338409475465313,0.04131303316515319,0.988,7/26,5.20%,PLCG2;CYBA;CD36;ABCB7;ABCD2;TLR4;COA8
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.4361759944528797,-1.7525711022872479,0.0,0.04303040276226027,0.989,39/140,11.55%,ARHGAP15;VAV3;AKAP13;ABR;ARHGAP10;ARHGAP25;ITSN1;STARD8;ARHGAP22;MYO9B;RAC1;ARHGEF3;ARHGAP30;ARHGAP24;ARHGAP19;RHOA;ARHGAP17;ARHGEF2;VAV1;CDC42;FGD4;ITGAV;ARAP1;ARHGAP18;FGD3;RHOQ;CYRIB;ARHGEF18;SH3BP1;VAV2;SOS2;ARHGAP12;TGM2;PLEKHG5;GNA13;TRIP10;FLCN;ARHGEF11;FAM13B
prerank,phagosome acidification (GO:0090383),-0.5903327171887842,-1.7524309421016004,0.0,0.042834261802357554,0.989,10/26,16.62%,ATP6V0D2;ATP6V1E1;RAB7A;ATP6V1A;RAB20;TCIRG1;ATP6V1G1;ATP6V0B;ATP6V0E1;RAB39A
prerank,inhibitory synapse assembly (GO:1904862),0.7193805153044699,1.7518469688506757,0.004796163069544364,0.05650632419480041,0.998,8/11,21.59%,GABRB3;GABRA2;GABRB2;GABRG2;CBLN4;PLXNB1;WNT5A;LGI2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6886446084691322,-1.7517682838037925,0.003316749585406302,0.04295289232666262,0.989,9/15,16.47%,IQGAP2;ARPC2;ACTR2;ACTR3;ARPC3;ARPC1B;ARPC1A;ARPC5;ARPC5L
prerank,tryptophan metabolic process (GO:0006568),-0.7390451534125693,-1.7516474349046638,0.0017605633802816902,0.04277394690763755,0.989,5/11,12.50%,KYNU;ATP7A;KMO;KYAT1;IL4I1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.525254337244845,-1.7516189466895584,0.0016722408026755853,0.04252526116980245,0.989,14/44,11.64%,LYN;APOE;CD300A;PRKCD;PTPRJ;PTPN22;PIK3CB;IRAK3;STK38;DNAJA1;SPRY2;AGT;PAQR3;AIDA
prerank,brain development (GO:0007420),0.4192942085430082,1.751275679011682,0.0,0.056324629408315965,0.998,41/136,15.04%,CNTNAP2;CTNNA2;ADGRL3;GRIN2A;ROBO2;CNTN4;EML1;GRIN2B;CDH2;AFF2;EPHA7;MEIS1;NFIB;SYNJ2;SMARCA1;SOX6;SHROOM4;SLC6A17;SHANK3;APOD;DSCAML1;CX3CR1;ADGRL2;CDK5RAP3;B3GNT5;ZFHX2;RELN;MFSD2A;CDK5R1;EEF1AKMT4-ECE2;HES5;ZIC2;AMIGO2;PBX1;CDK5RAP2;ADGRG1;PAFAH1B2;ARNT2;MKKS;PAFAH1B3;UFC1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.6168002584230586,-1.7510526715431476,0.0017152658662092624,0.04228494948886689,0.99,9/23,12.65%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;TGFB1I1;FLCN;STK11;HSP90AB1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.6168002584230586,-1.7510526715431476,0.0017152658662092624,0.04228494948886689,0.99,9/23,12.65%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;TGFB1I1;FLCN;STK11;HSP90AB1
prerank,inflammatory response (GO:0006954),-0.41336605878060734,-1.7504334982885021,0.0,0.04238215253882882,0.99,48/195,14.85%,CYBB;CD44;ADGRE5;CCR2;MFHAS1;C3AR1;REL;CYBA;RAC1;ITGB2;NRROS;SIGLEC1;CDO1;NFX1;C5AR1;IL10RB;ITGAL;MAPKAPK2;STAT3;CCR1;TLR4;IL18;NLRC4;BLNK;NFKB1;PTGER4;TPST1;ANXA1;PARP4;CIITA;PF4;PIK3CG;NFATC3;HRH1;NOD1;ADAM8;PRDX5;AFAP1L2;RELA;CCL5;CCRL2;FCGR2B;HDAC5;PIK3CD;NFAM1;CD40;IKBKB;RELB
prerank,myoblast fusion (GO:0007520),0.6938936825994189,1.7501392104488287,0.025,0.0564292761798331,0.998,3/12,2.80%,ADGRB3;ADAM12;KCNH1
prerank,response to lipid (GO:0033993),-0.4518726192230321,-1.7496405827132444,0.0,0.04249930764334808,0.991,30/105,14.81%,FOXP1;ABCG1;MAPKAPK3;CD36;PPARD;OTUD5;PPARG;MAPKAPK2;STAT3;FOXO3;TAB2;PELI1;TLR4;RARG;PTPN22;ANXA1;IRAK3;CTNNB1;STAT5B;ERBIN;TRIB1;CTSH;LY96;ASXL1;IFNAR1;HMGB2;RXRA;GCH1;TMEM161A;SPP1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.7173977612987523,-1.7494352479904114,0.0033222591362126247,0.04234992846669294,0.992,8/13,17.10%,FGR;GAB2;SYK;ITGB2;AP1G1;LAMP1;SPHK2;STX4
prerank,lipoprotein catabolic process (GO:0042159),-0.7422277614065287,-1.7485905774076775,0.005545286506469501,0.04264638863084071,0.992,3/11,3.48%,APOE;CTSD;ABHD17C
prerank,adipose tissue development (GO:0060612),-0.7409661880304703,-1.7485747594488603,0.0,0.04241504189305578,0.992,4/11,2.25%,SH3PXD2B;NAMPT;SPTLC2;ARID5B
prerank,negative regulation of cytokine production (GO:0001818),-0.4244350899272739,-1.745994054198515,0.0,0.04342158824191718,0.992,64/163,23.12%,PTPRC;CD84;ATP2B1;LILRB1;TLR8;AXL;RAC1;ADCY7;ANXA4;ABCD2;OTUD5;DHX58;PIBF1;TLR4;SRGN;NLRC5;PTGER4;SARS1;PTPN22;ANXA1;FN1;TNFRSF21;ARRB1;IRAK3;GAS6;SIRPA;MAP2K5;LAPTM5;UBA7;PTPN6;SELENOS;NCKAP1L;TRIB2;PIN1;PCBP2;FOXJ1;NLRC3;FCGR2B;VSIG4;TMSB4X;RNF216;MAVS;NLRX1;APPL2;ISG15;GPATCH3;RARA;LILRA5;CMKLR1;MMP8;LGALS9;HMGB1;C1QBP;AGER;CD274;ZC3H12A;RNF125;TRIM25;RNF135;RPS6KA5;INHA;NR1H4;IL6;MEFV
prerank,response to interferon-alpha (GO:0035455),-0.671233639641862,-1.7457256852691379,0.0017605633802816902,0.04333866465521469,0.992,10/16,21.76%,AXL;IFNAR2;GAS6;EIF2AK2;BST2;IFITM2;IFNAR1;TPR;GATA3;IFITM1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.6519420332447807,-1.7456969197743732,0.0033222591362126247,0.04310054012414207,0.992,5/17,4.75%,PPARD;PANK2;PRKAG2;PPARG;ADIPOR1
prerank,regulation of type I interferon production (GO:0032479),-0.46882501802594573,-1.7447658502495824,0.0,0.04337129778767311,0.992,43/84,27.84%,CREBBP;CGAS;GAPDH;OTUD5;DHX58;STAT6;DHX9;NFKB1;NLRC5;IRF5;PTPN22;TRAF3;CTNNB1;POLR2H;MYD88;POLR2F;UBA7;POLR3G;POLR2L;RELA;PIN1;XRCC6;PCBP2;DHX36;RNF216;MAVS;POLR3B;NLRX1;ISG15;G3BP1;GPATCH3;POLR3A;RNF125;TRIM25;LRRFIP1;RNF135;PRKDC;POLR3GL;POLR3D;MRE11;POLR1C;EP300;RNF26
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5661560891855868,-1.7445003232791365,0.0,0.04327657211444712,0.992,12/29,15.67%,CCR2;PIAS1;CTR9;STAT3;IL15;STAT6;IFNAR2;STAT5B;STAT4;IFNAR1;SOCS6;IL31RA
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.6768650564719797,-1.744074936801617,0.010676156583629894,0.04322293501825073,0.992,3/14,4.21%,CD84;PAEP;IL18
prerank,sensory perception of sound (GO:0007605),0.44385929165179083,1.7439789850525202,0.0,0.05945220120755344,0.998,31/88,18.66%,GRM7;PCDH15;LHFPL3;PAX3;COL11A1;TMC1;DCDC2;ADGRV1;COL4A3;SPTBN4;TSPEAR;TFAP2A;ESPNL;OTOS;WHRN;TBX1;EML2;NDUFB9;TMIE;CLRN1;TIMM10;PDZD7;USH2A;MKKS;ATP2B2;TMC2;USP53;EPS8L2;ROR1;COL1A1;ALDH7A1
prerank,axonal fasciculation (GO:0007413),0.7053171084093052,1.7426050452676933,0.016587677725118485,0.05978657013437242,0.998,7/12,16.11%,CNTN4;SEMA5A;NRCAM;CDK5R1;ARHGAP35;EPHB3;EPHA3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5252389771133724,-1.7424174635263994,0.005190311418685121,0.043900441774739986,0.992,20/42,22.33%,NRP1;CDK6;CD36;RAC1;ROCK1;PTPRJ;RIN2;PTK2B;UTRN;VEGFA;CIB1;PLEKHA2;LIMS1;CSF1;GSK3B;SFRP1;JUP;KDR;MAP4K4;CD3E
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.4753758119191363,-1.7422117683015694,0.0,0.04379780011469728,0.992,29/74,20.83%,RBPJ;CREBBP;BACH1;NFE2L2;PSME4;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;PSMA8;UBC;RPS27A;ARNT;PSMC3;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;PSMB8;VHL;ELOC;PSMA5;PSMD4;PSMB3;SIRT2;PSMD3
prerank,response to zinc ion (GO:0010043),-0.5937113384042656,-1.7414315845350257,0.0017699115044247787,0.04397879757016308,0.992,11/25,6.66%,SLC30A5;P2RX4;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;CRIP1
prerank,T cell activation involved in immune response (GO:0002286),-0.7239957595622541,-1.741227591345812,0.0034602076124567475,0.04388336358256482,0.992,6/12,13.01%,CD74;LILRB1;ITGAL;MDK;LCP1;FCER1G
prerank,postsynaptic membrane organization (GO:0001941),0.636679221263678,1.7400248517403456,0.007042253521126761,0.06067181002429474,0.999,5/17,5.24%,NLGN1;NRXN1;GPHN;NRXN2;SHANK3
prerank,positive regulation of programmed cell death (GO:0043068),-0.4026803568066015,-1.73998406016572,0.0,0.04430906998108342,0.993,87/272,19.87%,VAV3;MAP3K5;AKAP13;APAF1;ABR;CTSD;ITSN1;LILRB1;TNFAIP8;DAPK1;SYK;BCL6;CRADD;JUN;ARHGEF3;DNM2;ANO6;BCL2L11;MAP3K20;CTNNBL1;ARHGEF2;CALHM2;VAV1;RIPK1;FOXO3;FGD4;ATG7;NLRC4;ITGB1;RYBP;TOP2A;RARG;PRMT2;IRF5;DAPK3;RPS6;FGD3;STK3;CTNNB1;ARHGEF18;ATF6;E2F1;LAPTM5;DNAJA1;VAV2;SOS2;UBC;RPS27A;SUDS3;TGM2;SCRIB;PLEKHG5;GNA13;DUSP6;FLCN;PSENEN;ARHGEF11;GADD45A;MLLT11;IGFBP3;HTATIP2;EEF1E1;STK17B;IFIT2;TFAP4;TRIO;MAP3K10;SHQ1;QRICH1;LATS2;ARHGEF5;FAF1;BID;KLF11;TNFSF10;SPHK2;BNIP3L;CASP8;RNPS1;PHLDA1;TRADD;PDCD5;CASP2;DDX3X;HMGB1;ATM;C1QBP
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5806225169320621,-1.739805954919066,0.0017421602787456446,0.044148229553123364,0.993,13/29,20.02%,BIRC3;CD300LF;RIPK1;TLR4;TRAF3;LY96;UBC;RPS27A;TICAM1;CD40;IKBKB;CASP8;TICAM2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.4084747787695623,-1.7397546970087217,0.0,0.043924724829239065,0.993,82/208,23.87%,AKAP13;PRKCB;CD74;BIRC3;PLCG2;REL;LITAF;RHOA;GAPDH;FLNA;OPTN;BRD4;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;TAB2;PELI1;RIOK3;CFLAR;CARD11;IRAK4;RNF31;TFG;RBCK1;TRAF3;PPM1B;PLK2;MYD88;WLS;BST2;NEK6;NOD1;ZFAND6;TNIP2;RELA;PLEKHG5;TRAF1;TICAM1;CLEC6A;JMJD8;TRIM68;NLRC3;LGALS1;CASP1;TRAF2;DHX36;CD40;IKBKB;MAVS;DDX1;TRIM14;NLRX1;TNIP3;TNFSF10;GPRC5B;SPHK2;CASP8;TRIM39;TRADD;MIER1;LGALS9;SHISA5;HSPB1;NDFIP2;NOD2;TMED4;TICAM2;S100A4;ZC3H12A;STAT1;TRIM25;NUP62;TMEM106A;ZDHHC13;NR1H4;TMEM9B;MTDH;HMOX1;PIM2;MAP3K3
prerank,androgen receptor signaling pathway (GO:0030521),-0.7632897751565197,-1.7395534587866475,0.0036496350364963502,0.04384435018788946,0.993,5/11,9.07%,ZMIZ1;KDM3A;PMEPA1;ARID1A;DDX5
prerank,negative regulation of interferon-beta production (GO:0032688),-0.7479243523720001,-1.7365916874691976,0.0034782608695652175,0.045152950128819744,0.993,7/10,14.85%,LILRB1;REL;PPM1B;SIRPA;NLRC3;YY1;RELB
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.4612524192153319,-1.7363004737406607,0.0,0.045003751376238056,0.993,34/86,20.83%,CREBBP;BACH1;NFE2L2;PSME4;ATF3;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;MAPK7;PSMA8;UBC;RPS27A;ARNT;PSMC3;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;KLF2;INO80;BAG3;PSMB8;VHL;HSPA1A;ELOC;PSMA5;PSMD4;CHEK1;PSMB3;PSMD3
prerank,gene expression (GO:0010467),-0.38563747391021114,-1.7350816793403177,0.0,0.045328775021898624,0.993,142/348,26.81%,APOBEC1;RBM39;RBMS1;TSPAN14;MEF2A;AGO2;RPS18;NUP50;RPL7;RPS12;SRRM1;RNASEL;RPS21;RPS8;RPS24;GSPT1;RBPMS;MPHOSPH10;HHEX;NUP42;SARS1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;RRBP1;CHTOP;NUP88;MRPL42;HNRNPH1;RPS14;RAE1;POLR2H;HNRNPL;E2F1;RPL32;CDC40;RPS15A;RPS28;RPS13;POLR2F;THAP1;AGFG1;POLR2L;RPS27A;DARS1;RPL28;ANGPT2;RPS4X;FASTKD2;NUP205;DUSP11;RPS23;UPF2;EIF4EBP2;ALYREF;HNRNPUL1;TPR;TSPAN17;RPL22;RPL14;EEF1A1;MRPS6;NUP188;RPL34;WDR33;MRPS11;RPS11;YTHDC1;POLR2A;RPL6;EPC1;RBMS2;NCBP1;EIF4G1;RPS10;THOC2;RPL18A;NFKBIB;MRPS16;NUFIP1;RPL37A;POLR2G;MRPL34;ATXN1;RPS9;TFIP11;MRPS15;RNPS1;RPS27;ABCF1;DTX1;RPS3;POLR3A;NUP153;THOC6;RPL23A;RPS16;NUP35;MAGOH;RPL9;SLU7;COPS5;MED20;CPSF3;RBM3;MMS19;NUP107;POLR2I;RPLP2;NOL9;DDX54;NUP62;XAB2;HNRNPK;XRN2;MRPL51;RPL41;TOPORS;RPLP0;RPL7A;SRSF11;SMG1;RPL19;RPS15;RPL39;DDX39B;DHX38;MRPL18;RANBP2;MRPS7;RBM15B;CPSF1;DEDD2;RPL5;RPL13;NUP37;U2AF2;LMF1;NKX2-8
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5958766189320776,1.7330836655136577,0.009708737864077669,0.06424754108077407,0.999,9/22,14.48%,AKAP6;ANK2;RYR2;ATP1B1;STAC;CALM1;CALM3;CALM2;ATP2A1
prerank,macrophage activation (GO:0042116),-0.5523069389189644,-1.7294616103312381,0.0,0.04822774550961219,0.994,16/34,24.40%,FOXP1;SYK;PLCG2;ITGB2;C1QA;SBNO2;C5AR1;TLR4;IFI35;APP;CRTC3;AGER;CD93;TMEM106A;IFNGR1;ITGAM
prerank,histone methylation (GO:0016571),-0.5821338459250291,-1.7287961968479497,0.003418803418803419,0.04838970622358862,0.994,10/26,15.15%,CREBBP;NSD3;PRMT2;SMYD2;SMYD3;EZH2;PRMT1;SMYD1;PRMT6;NSD1
prerank,cardiac muscle cell contraction (GO:0086003),0.6050265114054364,1.7287457325234683,0.009111617312072893,0.06620755949747739,0.999,5/19,3.31%,FGF12;CACNA1C;CACNA2D1;SCN2B;SCN1A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6576672470208433,-1.7277550895483358,0.005199306759098787,0.048649361609170313,0.995,7/17,12.13%,BACH2;STAT3;TLR4;IL18;MYO1G;JAG1;CD46
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.45081066806569786,-1.7268652137481024,0.001607717041800643,0.04891259705373289,0.995,39/95,21.62%,LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;CTR9;TLR4;CHMP5;STAP1;NFKB1;ADAM9;MAPK14;PF4;CYRIB;SIRPA;MYD88;MEF2C;LY96;SELENOS;TNIP2;RELA;XBP1;TICAM1;HMGB2;SERPINE1;FCGR2B;CASP1;DEFA6;NFKBIL1;NFKBIB;TNIP3;NOD2;HMGB1;TICAM2;CD274;SIRT2;ZC3H12A;NLRP3
prerank,regulation of RNA splicing (GO:0043484),-0.4748514312370394,-1.7268379010269854,0.0,0.04866925079973422,0.995,37/69,26.35%,MBNL1;AHNAK;PTBP3;RBM39;ERN1;MBNL2;SON;TRA2B;AHNAK2;FUS;HNRNPH1;MBNL3;HNRNPL;RPS13;CWC22;METTL4;DYRK1A;CELF1;HNRNPLL;TMBIM6;YTHDC1;POLR2A;ZNF326;SRSF10;HSPA1A;SNRNP70;SLC38A2;GRSF1;HNRNPH2;HNRNPK;RBM38;SRPK1;RBM22;ESRP1;CLK4;LARP7;U2AF2
prerank,regulation of protein metabolic process (GO:0051246),-0.5154274682082304,-1.7264916730243873,0.0,0.04862400857871971,0.995,18/44,19.56%,APOE;GSAP;TRAF3;WFS1;MAP2K5;PLAUR;MAPK7;NEDD4L;ZDHHC2;MTPN;APP;LTBP4;HSP90AB1;KLF2;SSH1;FAF1;FAM83D;LDLR
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.6367621567139601,-1.724857176822207,0.0017452006980802793,0.04930945203515615,0.995,6/17,5.26%,RBPJ;CREBBP;PLXND1;MAML1;MAML2;DLGAP5
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.5840992825049249,-1.722713163922447,0.0050335570469798654,0.05032122811066464,0.995,9/27,14.06%,IGF1;CD74;CDK6;DHX9;FN1;GAS6;E2F1;AGT;S100A6
prerank,spinal cord development (GO:0021510),0.671651063205624,1.7220520745325438,0.01411764705882353,0.06975460587163657,0.999,5/12,11.28%,SOX11;SOX12;VIT;RELN;PKD1
prerank,negative regulation of T cell activation (GO:0050868),-0.5551578406225615,-1.721894771996416,0.0016863406408094434,0.050527705985980026,0.996,16/35,21.89%,LILRB1;TNFAIP8L2;PTPN22;RIPOR2;DUSP3;TNFRSF21;LAPTM5;NCKAP1L;SDC4;IL4I1;FCGR2B;VSIG4;SPN;CD274;LAX1;CEBPB
prerank,integrin-mediated signaling pathway (GO:0007229),-0.47850624897340865,-1.7217808638752896,0.0,0.0503423929747538,0.996,23/73,12.32%,DAB2;NEDD9;NRP1;FGR;SYK;PLEK;MYH9;ITGB2;ITGA5;TEC;CDC42;ITGB1;PTK2B;ITGAV;ADAM9;FYB1;FN1;ERBIN;ITGB7;ITGB1BP1;ITGB5;ZYX;ADAM15
prerank,response to ethanol (GO:0045471),0.6585875472099121,1.7214825624499228,0.00954653937947494,0.06946545135577481,0.999,4/14,1.86%,GRIN2A;GRIN2B;GRIN3A;GLRA1
prerank,protein modification by small protein conjugation (GO:0032446),-0.38421084041397274,-1.7211044941860854,0.0,0.05048709623031993,0.996,126/361,23.30%,NSMCE2;RNF213;WWP1;CBL;ZNRF3;CNOT4;PEX14;KLHL24;BIRC6;FBXW8;NFE2L2;RNF111;NFX1;NUP50;MKRN2;PIAS1;BRCA1;ARRB2;MYLIP;WWP2;FBXL17;RNF41;CTR9;AMFR;AREL1;TNFAIP1;ATG7;RNF20;FBXO32;ATG10;NUP42;FBXW11;UBE2R2;KLHL25;UHRF2;ARRB1;NUP88;MGRN1;NUB1;UBR2;USP9X;RAE1;DET1;KCTD10;ZSWIM8;CBLL1;RNF38;TRIM47;UBA7;HIF1A;RFWD3;SPSB2;OTULIN;SELENOS;UBC;RPS27A;UBE2L3;RNF8;NUP205;EIPR1;DERL1;NEDD4L;KLHL18;DCUN1D4;TPR;PCNA;CUL4B;TSPAN17;ARRDC4;ASB5;TRIM24;FBXO10;TRIM68;UHRF1;UBE2H;NUP188;MOCS3;CUL2;TRIM11;WAC;ARIH1;ARRDC1;RNF25;RNF34;RNF43;UBE2G1;UBE2T;CDC34;HLTF;BRAP;TRIM14;USP7;UBE2C;ISG15;MIB1;UBA2;UBE2I;VHL;EYA1;ANAPC7;FBXO7;DTX1;NUP153;HUWE1;TRIM39;UBE2M;NUP35;ELOC;DTX3;RTF1;VPS18;NUP107;DTX3L;RACK1;NUP62;SMURF2;RNF135;EGR2;CCNF;UFM1;TOPORS;SUMO3;PRKDC;UBE2V2;MEFV;TRIM72
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.5142914941454293,-1.7208036721379836,0.0033003300330033004,0.05043441943187996,0.996,17/43,22.48%,IGF1;LILRB1;TLR4;PTPN22;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NLRC3;NFKBIL1;ARG2;RARA;LGALS9;CD274;ZC3H12A;NR1H4
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.6397362483706425,-1.7201382789715518,0.005136986301369863,0.050612761455081354,0.996,13/18,28.75%,CCR2;NCKAP1L;IKZF3;XRCC6;CD2;IL4I1;PRKDC;ZFP36L1;METTL3;TBX21;CRTAM;PRELID1;SPINK5
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6933622069384704,-1.7201120987257545,0.0034482758620689655,0.05037763079371114,0.996,7/14,18.85%,CCR2;SYK;IL18;PTPN22;RASAL3;TGFBR2;LGALS9
prerank,Rap protein signal transduction (GO:0032486),-0.7413463489064718,-1.7200730388295695,0.0035842293906810036,0.05016229268696061,0.996,5/10,7.62%,RAP1B;RAP2B;RAP2A;RAP1A;PLK2
prerank,regulation of synapse maturation (GO:0090128),0.7465557511889078,1.7196146575245308,0.00980392156862745,0.07009830662351238,0.999,4/10,10.87%,NRXN1;ANAPC2;ARHGEF15;RELN
prerank,lymphocyte proliferation (GO:0046651),-0.605982250217829,-1.7187823930238038,0.003389830508474576,0.050706495193263826,0.996,7/22,14.15%,PTPRC;ELF4;MSN;BCL2;PIK3CG;MEF2C;CD40
prerank,defense response to bacterium (GO:0042742),-0.44352466758793374,-1.7187819940726132,0.001597444089456869,0.050468436530384644,0.996,38/105,24.79%,LYST;FGR;STAB1;SYK;PRKCD;OPTN;IL6R;TLR4;NLRC4;RAB1A;LYZL4;CFP;RNASE7;MYD88;NOD1;GBP2;CHGA;RNASE6;CAMP;HMGB2;SERPINE1;FCER1G;OAS3;DEFA6;ANG;MAVS;SPN;ISG15;PLA2G6;NOD2;GBP7;GBP6;OAS2;CEBPB;IL6;RPL39;SHC1;GBP4
prerank,regulation of nervous system process (GO:0031644),0.6193743039173852,1.7187780206955008,0.00997506234413965,0.06998163316666851,1.0,7/18,10.68%,DLGAP1;HTR2C;SLC8A3;DLGAP2;TMEM108;SLC8A2;DLGAP3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5642837413905273,1.7184197534536574,0.0075,0.06963587174998032,1.0,7/27,6.74%,CTNNA2;IL1RAPL1;NCS1;NTNG2;NTNG1;MARK1;HOMER1
prerank,receptor internalization (GO:0031623),-0.5173305198509625,-1.718365613933783,0.005076142131979695,0.05039423370494104,0.996,15/44,8.68%,GRB2;LILRB1;SYK;LRP1;CD36;ITGB2;DNM2;RAB31;CD9;ARRB2;GRK3;ITGB1;ARRB1;PICALM;RAB5A
prerank,regulation of acrosome reaction (GO:0060046),0.7279189258405975,1.7178319059208251,0.011337868480725623,0.06935734516899443,1.0,3/10,9.63%,PLCB1;GLRA1;PLA2G10
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5800390220511645,-1.7174703203587185,0.01001669449081803,0.050636733888122815,0.996,11/27,9.70%,CD36;MAP3K1;IRAK2;TAB2;TLR4;IRAK4;IRAK3;MYD88;LY96;UBC;RPS27A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.5614431722107857,1.7164906450615596,0.011111111111111112,0.06958776179823636,1.0,4/25,1.17%,ANK2;CTNNA3;CACNA1C;RYR2
prerank,negative regulation of chemotaxis (GO:0050922),0.534440667090735,1.715021599358222,0.009708737864077669,0.0698638719827799,1.0,7/31,3.44%,ROBO1;ROBO2;SLIT2;SEMA6D;SEMA6A;SEMA3E;SEMA5A
prerank,regulation of T cell cytokine production (GO:0002724),-0.667511424995367,-1.7140868465382002,0.006896551724137931,0.05250692819780855,0.997,6/15,17.79%,CCR2;TNFRSF1B;MALT1;B2M;TRAF2;SMAD7
prerank,regulation of regulated secretory pathway (GO:1903305),0.5184906887123517,1.7140394582242653,0.009592326139088728,0.06985198467175316,1.0,12/34,13.01%,RIMS2;RIMS1;SYT1;SYT10;SYN1;SYT2;RAB15;SYT5;SYT11;SYT12;DOC2A;SYT7
prerank,DNA recombination (GO:0006310),-0.5362798202780145,-1.7128666323911022,0.008445945945945946,0.05302209397319148,0.997,21/37,26.01%,RAD51B;BLM;RTEL1;RAD51;HDAC10;GEN1;WRN;RAD54L;EXO1;ENDOG;RHNO1;RAD54B;RAD52;XRCC3;HMGB1;HMGB3;DMC1;RAD51C;TSN;RECQL5;MRE11
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.5186399801316179,-1.7126971837291378,0.005042016806722689,0.052875205852418755,0.997,16/41,22.48%,IGF1;LILRB1;TLR4;PTPN22;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NLRC3;NFKBIL1;ARG2;RARA;LGALS9;ZC3H12A;NR1H4
prerank,response to ionizing radiation (GO:0010212),-0.46898685105996696,-1.710709866697965,0.0016207455429497568,0.05383524466972695,0.998,35/70,27.50%,GRB2;SPIDR;BRCA1;NABP1;ANXA1;BLM;ABRAXAS1;MAPK14;RAD1;BABAM2;RAD51;RFWD3;RNF8;GADD45A;BABAM1;STK11;TICRR;XRCC4;RHNO1;RAD51AP1;INO80;TOPBP1;EYA1;RAD9A;EYA3;BRCC3;ATM;FANCD2;MYC;ECT2;EEF1D;CLOCK;USP28;COP1;UIMC1
prerank,mitotic chromosome condensation (GO:0007076),-0.5763406669763199,-1.7104788171331502,0.0034542314335060447,0.05374776188434389,0.998,16/26,24.73%,RB1;CSNK2A1;NCAPG2;SMC4;NCAPH;MCPH1;CDK1;CHMP1A;NUSAP1;NCAPD3;KMT5A;PHF13;NCAPG;SET;CCNB1;AKAP8L
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.6289783091686629,-1.7100043588692753,0.005084745762711864,0.05382876164462098,0.998,9/19,20.94%,TLR8;TLR7;TLR4;DHX9;IRF5;DHX36;MAVS;DDX3X;STAT1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5647443532302091,-1.7099911047884546,0.0017761989342806395,0.05358628974532089,0.998,15/30,28.51%,ARHGEF2;RIPK1;BRCA1;CFLAR;SERPINE1;TRAF2;RNF34;TNFSF10;CASP8;TRADD;DDX3X;GSK3B;HMOX1;SCRT2;BCL2L1
prerank,protein deubiquitination (GO:0016579),-0.39618998066868494,-1.709928998043568,0.0,0.053373690297300116,0.998,103/242,27.93%,BIRC3;USP12;SNX3;DDB2;USP50;RHOA;OGT;ATXN7;PSME4;OTUD5;UCHL5;USP18;RIPK1;BRCA1;ARRB2;PSMB7;PSME3;ACTB;USP8;MINDY2;PSMB9;ABRAXAS1;TRAF3;WDR48;USP36;USP9X;BABAM2;USP3;ATXN3;TGFBR1;RNF123;HIF1A;PSMA8;OTULIN;UBC;RPS27A;ASXL1;SUDS3;TNIP2;PSMC3;WDR20;CDC25A;CDK1;STAM2;BABAM1;PSMD8;USP42;RNF128;TRAF2;PSMC4;USP35;PSMB10;USP40;PSMA1;JOSD1;YY1;INO80;USP30;OTUD4;USP11;INO80E;USP7;TNIP3;PSMB8;STAMBPL1;MINDY1;SKP2;SMAD7;INO80C;GATA3;ADRB2;MDM4;BRCC3;COPS5;MBD6;PSMA5;PSMD4;PSMB3;BAP1;PSMD3;ZC3H12A;USP9Y;NLRP3;SMURF2;ZRANB1;POLB;BECN1;PSMB1;MYC;RCE1;TADA3;USP34;USP16;SIAH2;SMAD4;ENY2;VCP;STAMBP;ESR1;USP28;UIMC1;EP300;JOSD2
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.36858078185354787,-1.7094823377717914,0.0,0.05333394887822357,0.998,186/509,24.50%,IQGAP1;LYN;SASH1;PTPRC;OSBPL8;AKAP13;PRKCB;IGF1;BCAR3;CD74;FGR;GRB2;BIRC3;GAB2;MFHAS1;PLCG2;REL;LITAF;AXL;CBL;RAC1;ROCK1;PTPRJ;CGAS;NUPR1;HPSE;RHOA;BCL2L11;PIK3R5;GAPDH;INSR;FLNA;IGF1R;P2RX4;PIK3AP1;BRD4;TLR7;VAV1;MALT1;RIPK1;ALPK1;TRAF5;HTR2B;DHX58;TAB2;PELI1;CFLAR;CARD11;TLR4;IL18;FLT1;ITGB1;ITGAV;BCL2;IRAK4;RNF31;RPS20;TFG;DDX60;RBCK1;PIK3CB;FN1;HGF;PIK3CG;GCNT2;IFI35;GAS6;PLK2;HIP1;VEGFA;EIF2AK2;PUM2;LAPTM5;MYD88;WLS;FRS2;BST2;FNIP1;TGFBR1;NEK6;CD28;GSDME;NOD1;ITGB1BP1;PTPN6;ADAM8;FIS1;TGM2;CD27;SPRY2;TNIP2;RELA;PLEKHG5;AGT;STYXL1;LCK;NCF1;APP;STRN;RRAGD;FLCN;PIK3CA;F7;TICAM1;OASL;CLEC6A;JMJD8;CCL5;HSP90AB1;TRIM68;LGALS1;CASP1;TRAF2;KSR1;PIK3CD;DHX36;BBC3;CD40;IKBKB;MAVS;DDX1;TRIM14;HCLS1;BID;TNFSF10;GPRC5B;SPHK2;ZCCHC3;CASP8;IRS2;LILRA5;LIMS1;GATA3;RPS3;RYK;HCST;PTPN11;MMP8;PDGFRB;TRADD;MIER1;RHEB;ADRB2;LGALS9;SHISA5;DDX3X;NDFIP2;NOD2;HMGB1;F10;TMED4;C1QBP;AGER;TICAM2;S100A4;MAZ;KDR;TRIM25;PDGFA;RACK1;NUP62;HAX1;TMEM106A;ZDHHC13;HTR6;FGF18;ILK;BECN1;IL6;TCIM;TMEM9B;WDR24;MTDH;KITLG;PUM1;TGFB1;HMOX1;RPS15;PIM2;LRRC19;MAP3K3;LRP2;FGF9;FLT3;SHC1;DCN
prerank,fatty acid transmembrane transport (GO:1902001),-0.6392353838495556,-1.7088740641294582,0.014209591474245116,0.053547115552194505,0.998,6/19,4.13%,CD36;ABCD2;PRKAG2;CPT1A;SLC27A1;SLC2A1
prerank,positive regulation of transport (GO:0051050),-0.46256547796622804,-1.7068800540119395,0.0016611295681063123,0.05460563029956982,0.998,23/85,17.14%,DOCK2;DAB2;APOE;LRP1;CYBA;CAMK1D;ANXA2;SGK1;IL15;DYNC1H1;ACTB;ANXA1;GAS6;CBLL1;SIRPA;NEDD4L;IL2RG;FCGR2B;FCER1G;RXRA;BID;IL2RB;KMT2A
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5466001579540594,-1.7046782253802917,0.0018484288354898336,0.055578631630921,0.998,17/34,23.31%,NEDD9;NRP1;RREB1;RAC1;FLNA;CDC42;TRIOBP;DOCK5;MYADM;MDK;CRK;CIB1;CRKL;LIMS1;C1QBP;ILK;P4HB
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.707819795342337,-1.703813330065105,0.01015228426395939,0.05590376425346279,0.999,5/11,3.98%,BIRC3;NUPR1;ARHGEF2;RIPK1;PELI1
prerank,microvillus assembly (GO:0030033),-0.6743441352616042,-1.7035262727937301,0.008960573476702509,0.05585923661476424,0.999,6/14,3.69%,RAP1B;RAP2B;RAP2A;FXYD5;MINK1;RAP1A
prerank,mitotic nuclear division (GO:0140014),-0.4691098454030099,-1.7021825678733604,0.0,0.056405902618172334,0.999,33/71,22.85%,RHOA;EPS8;STAG1;FLNA;NCAPG2;KIF3B;KIF11;PIBF1;SMC4;ABRAXAS1;STAG2;ARHGEF10;KLHL22;CENPK;TPX2;KIFC1;PPP2R2D;CHMP7;KNSTRN;CHMP2A;NUSAP1;INO80;SGO1;UBE2C;NDC80;KIF18B;SMC1A;RAB11A;CEP192;LSM14A;NUP62;CHMP4B;NSL1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4556487929129979,1.701936009683598,0.0024096385542168677,0.07716286547609008,1.0,25/75,17.38%,CACNA2D1;SLC24A2;SLC8A3;SLC12A2;SLC12A8;SLC39A10;SLC12A1;KCNJ3;SLC9A2;KCNJ10;KCNJ6;KCNJ9;HCN2;ATP1A3;KCNJ16;SLC6A1;SLC8A2;ATP1B1;SLC12A5;KCNJ12;ATP2B4;TRPV3;SLC39A6;ATP1B2;TRPM2
prerank,negative regulation of viral genome replication (GO:0045071),-0.525658610485596,-1.7015944769562132,0.008517887563884156,0.056477236509318435,0.999,19/40,21.84%,FAM111A;ZC3HAV1;RNASEL;RSAD2;EIF2AK2;BST2;IFITM2;RESF1;IFIT1;OASL;CCL5;OAS3;SETDB1;MAVS;ISG15;PARP10;OAS2;IFITM1;SRPK1
prerank,cytosolic transport (GO:0016482),-0.44254293847290604,-1.7011992215409808,0.0,0.05645211146083362,0.999,47/108,22.66%,VPS13C;RAB7A;SNX2;VTI1A;VPS54;VPS13A;SNX6;KIF16B;STX8;SNX5;ANKFY1;TBC1D5;AP1G1;EPS15;EEA1;LAPTM5;SYS1;RAB5A;CORO7;TBC1D17;VPS26B;DCTN1;LAMP1;RAB29;VPS26A;WDR91;STX5;TBC1D10B;TBC1D23;TMEM87B;STX16;SNX16;BAIAP3;CLN3;SPAG9;ARL1;RILP;TMEM87A;SNX1;DOP1B;VPS51;TBC1D10C;SNX32;VPS50;PHETA1;BECN1;BET1L
prerank,positive regulation of organelle assembly (GO:1902117),-0.5140752609643229,-1.7009377625508437,0.0,0.056379485755657516,0.999,16/44,17.46%,SDCBP;ASAP1;PDCD6IP;PIP4K2A;CNOT1;CNOT2;DYNC1H1;RAB3GAP1;CAPG;LCP1;SDC4;CCDC88A;SH3GLB1;G3BP1;CNOT6L;RALB
prerank,phagosome-lysosome fusion (GO:0090385),-0.7436833258251881,-1.700821968442185,0.008547008547008548,0.05617550187623747,0.999,8/10,19.28%,RAB7B;RAB7A;ARL8B;RAB20;CLN3;RAB39A;RAB34;PLA2G5
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.6192514874160524,-1.7003440164206167,0.004966887417218543,0.05623608861862898,0.999,12/18,28.83%,LYN;C3AR1;C5AR1;SPG21;FCER1G;CMKLR1;LAX1;BAG6;GPLD1;BLK;FPR2;CD19
prerank,protein sumoylation (GO:0016925),-0.5112234793964795,-1.7000243754962492,0.0,0.05617053589025404,0.999,26/49,30.34%,NSMCE2;NUP50;PIAS1;NUP42;NUP88;RAE1;NUP205;TPR;NUP188;UBA2;UBE2I;EYA1;NUP153;NUP35;NUP107;NUP62;EGR2;TOPORS;SUMO3;SAE1;RANBP2;TRIM28;NUP37;PIAS2;AAAS;NUP133
prerank,myeloid cell development (GO:0061515),-0.6305309857570349,-1.6988001705434965,0.005291005291005291,0.05673101613039075,0.999,5/18,11.05%,FOXP1;NRROS;ANXA2;NCKAP1L;APP
prerank,generation of neurons (GO:0048699),0.39058078851741335,1.6987065181712113,0.0,0.07878270157557134,1.0,40/190,11.93%,PTPRD;ADGRL3;IL1RAPL1;ASTN2;AUTS2;MYT1L;SPOCK1;TAFA1;MAP1B;EML1;SOX11;GPM6A;NTRK2;SNPH;FUT9;CDKL5;ASTN1;SMARCA1;NRCAM;WNT9A;POU3F2;MARK1;TUBB2A;DCDC2;YAP1;FZD8;OLIG1;CX3CR1;PEX13;DNAAF4;EN1;POU4F2;NEUROD1;DNER;RELN;TGFB2;CDK5R1;PER2;BRSK1;HES5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.7488020592027438,-1.6976492252221835,0.0017064846416382253,0.05721412041917032,0.999,7/10,16.42%,CD300A;ANO6;RAB31;STAP1;C3;NCKAP1L;APPL2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6729492074141991,1.6974526713149003,0.007317073170731708,0.07900368196327784,1.0,3/12,1.17%,CTNNA3;CACNA1C;RYR2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.5325659029266607,-1.6968607414243368,0.003389830508474576,0.05753295187043932,0.999,11/35,11.99%,SASH1;MFHAS1;XDH;RELL1;MINK1;SPI1;PTPN22;VEGFA;PRMT1;NCF1;GADD45A
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.4528256830472498,-1.6959060620988933,0.0016778523489932886,0.057823390506128225,0.999,23/91,11.05%,FTL;IREB2;SLC30A5;ABCB7;FRRS1;ATP6V1A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;ATP7A;TMEM199;HMOX2;FLVCR1;SLC31A1;ATP6V1G1;CP;LCK;APP
prerank,regulation of immunoglobulin production (GO:0002637),-0.6027471900794483,-1.6958395247782494,0.008849557522123894,0.0576244659834418,0.999,11/23,29.86%,PTPRC;SASH3;CD22;DNAJB9;XBP1;FCGR2B;STX4;IL6;RBP4;IL2;VAMP3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4642361730378181,-1.6956356160209058,0.0017241379310344827,0.05754969679406727,0.999,27/74,20.29%,IGF1;MCL1;BIRC6;ARHGEF2;RIPK1;BRCA1;CFLAR;PSME3;ITGAV;BCL2;EYA4;PF4;MAP2K5;TGFBR1;MAPK7;RELA;SERPINE1;TRAF2;RNF34;TNFSF10;CASP8;EYA1;HSPA1A;EYA3;TRADD;DDX3X;GSK3B
prerank,zinc ion homeostasis (GO:0055069),-0.5611295201309192,-1.6956141978273875,0.0017985611510791368,0.05731795039807248,0.999,9/28,4.19%,SLC30A5;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6638867400878916,-1.69444689888993,0.014010507880910683,0.05773614163081216,0.999,6/15,9.64%,APOE;SNX9;TNFRSF1B;ADAM9;SNX33;ADAM8
prerank,endosome organization (GO:0007032),-0.5258683435013978,-1.6940358030919636,0.0036231884057971015,0.05783830681603995,0.999,13/41,7.90%,TMCC1;SNX10;CORO1C;SNX3;PI4K2A;USP50;DNAJC13;USP8;PI4K2B;WASHC4;SNX33;ALS2;EEA1
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.5884726443690994,-1.6940334283455787,0.009983361064891847,0.05760319174768206,0.999,13/22,29.30%,RFTN1;LY9;IL15;IL18;MYD88;SLC7A5;NOD2;SLAMF6;NR1H4;IL6;TGFB1;ZBTB7B;IL2
prerank,natural killer cell activation (GO:0030101),-0.5929999210154322,-1.6937338626054477,0.0035398230088495575,0.0575450261529822,0.999,11/23,17.31%,PTPRC;ELF4;SLAMF7;AXL;SNX27;PRDX1;CD2;KAT7;PIK3CD;ULBP1;CASP8
prerank,regulation of interferon-alpha production (GO:0032647),-0.597028704656996,-1.6935681566205418,0.004966887417218543,0.05746740507812125,0.999,10/23,20.94%,TLR8;TLR7;TLR4;DHX9;IRF5;NLRC3;DHX36;MAVS;DDX3X;STAT1
prerank,lipoprotein localization (GO:0044872),-0.7113552173133562,-1.691803737755072,0.0088339222614841,0.05826852832682849,0.999,4/11,3.16%,PRKCB;LRP1;CD36;PPARG
prerank,secretory granule organization (GO:0033363),-0.7230281540444048,-1.6903230583528261,0.0035587188612099642,0.05896441678415906,0.999,3/10,4.49%,ABCA1;LYST;SRGN
prerank,synaptic vesicle endocytosis (GO:0048488),0.5216722104408701,1.6900573174297666,0.006711409395973154,0.08373588679764625,1.0,11/33,6.51%,NLGN1;DNAJC6;DNM3;SYT1;AMPH;SNAP91;SYNJ2;SYT2;DNM1;STON1;SYT5
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.563246367024429,-1.6896542548383642,0.006791171477079796,0.05916752153200324,0.999,13/28,23.75%,CCR2;SH3KBP1;CYRIB;SIRPA;NCKAP1L;TNIP2;LCK;XRCC6;TICAM1;NOD2;IL6;PRKDC;CD47
prerank,membrane assembly (GO:0071709),0.5160350689193416,1.6891435804234103,0.007263922518159807,0.08364752333878453,1.0,7/34,4.49%,NLGN1;NRXN1;PTPRD;IL1RAPL1;ANK3;NRXN2;STX2
prerank,organophosphate ester transport (GO:0015748),-0.5850907443128469,-1.6886929499942707,0.010273972602739725,0.05953078276884128,0.999,9/24,11.01%,OSBPL8;PLTP;PITPNC1;PITPNA;PITPNM1;EPG5;OSBPL5;PRELID2;NPC2
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.3760313873554556,-1.6886340620063234,0.0,0.05932477941957324,0.999,136/336,27.53%,LYN;FNIP2;VAV3;FOXP1;TAOK3;FAM111A;SUSD6;GRB2;BCL6;MCL1;SAMHD1;DDB2;CGAS;TNFRSF1B;BCL2L11;BACH1;SPIDR;RAD51B;PSME4;BRCA1;MAPKAPK2;UVRAG;DYRK2;POLE2;NIPBL;TOP2A;RNF169;BCL2;NABP1;PARP4;BLM;MAPK14;BATF;RAD1;RTEL1;CRIP1;MACROD1;WDR48;REXO4;PWWP3A;KMT5B;ALKBH1;BABAM2;USP3;E2F1;PCLAF;UBA7;RAD51;MASTL;RFWD3;KMT5C;MGMT;RNF8;MCM9;APTX;TAOK1;TIMELESS;LIG1;WRN;CDK1;CUL4B;RAD54L;GADD45A;STK11;EXO1;ASF1A;FEN1;CIB1;TICRR;PLK3;WDR76;RFC2;WAC;ERCC4;APLF;RAD51AP1;DOT1L;YY1;INO80;RAD52;UBE2T;NSMCE3;SLX4;AATF;UBQLN4;TOPBP1;BID;TAF9;XRCC3;RAD9A;RPS3;NCOA6;RBBP8;TAOK2;CASP2;ADPRS;ATM;TRIP12;FBXO31;CHEK1;SMC1A;MMS19;RFC3;DTX3L;PDS5B;ZC3H12A;NBN;ALKBH3;FAN1;CCNK;SFN;SMC6;BCL2L2;TOPORS;POLB;PRKDC;ZRANB3;MTREX;EID3;SMC5;MYC;RAD51C;DDB1;TRIM28;RECQL5;BAZ1B;BLK;USP16;MRE11;RBBP5;PML;VCP;ASH2L;USP28;METTL3;BOD1L1
prerank,positive regulation of nervous system process (GO:0031646),0.6037287898695146,1.6884920099808545,0.007009345794392523,0.08343576609364615,1.0,4/18,1.83%,RIMS2;RIMS1;TENM4;PARD3
prerank,positive regulation of apoptotic process (GO:0043065),-0.38597829138382067,-1.6875198507230544,0.0,0.059806148073034096,0.999,97/293,21.40%,VAV3;MAP3K5;AKAP13;APAF1;ABR;CTSD;ITSN1;LILRB1;TNFAIP8;DAPK1;BCL6;CRADD;JUN;ARHGEF3;DNM2;NUPR1;ANO6;BCL2L11;MAP3K20;CTNNBL1;ARHGEF2;CALHM2;VAV1;RIPK1;FOXO3;FGD4;ATG7;NLRC4;ITGB1;RYBP;TOP2A;RARG;PRMT2;IRF5;DAPK3;RPS6;FGD3;STK3;CTNNB1;ARHGEF18;GRN;ATF6;E2F1;DNAJA1;TGFBR1;VAV2;SOS2;UBC;RPS27A;SIK1;SUDS3;TGM2;SCRIB;PLEKHG5;GNA13;DUSP6;FLCN;PSENEN;ARHGEF11;FAP;GADD45A;MLLT11;IGFBP3;EEF1E1;STK17B;IFIT2;TFAP4;TRIO;BTG1;MAP3K10;SHQ1;QRICH1;LATS2;ARHGEF5;FAF1;BID;KLF11;TNFSF10;SPHK2;BNIP3L;CASP8;RNPS1;PHLDA1;RPS3;TRIM39;TRADD;PDCD5;CASP2;DDX3X;HMGB1;ATM;C1QBP;SIRT2;SFRP1;ZC3H12A;CDK5;RACK1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.733055121370688,-1.6874843170103109,0.010327022375215147,0.059581302963471895,0.999,4/10,9.54%,PTPRC;IRAK3;MAP2K5;MAPK7
prerank,kinetochore organization (GO:0051383),-0.6806330050618242,-1.6873286753438914,0.00539568345323741,0.059454724031901406,0.999,8/13,17.75%,CENPF;DLGAP5;CENPA;CENPE;POGZ;NUF2;NDC80;CENPH
prerank,regulation of neuron differentiation (GO:0045664),0.4399533378526354,1.6869398300482716,0.0,0.08379986034252354,1.0,24/76,13.98%,NLGN1;BRINP3;BRINP1;CNTN4;SOX11;NRCAM;ZEB1;VWC2;MOSMO;ALK;BDNF;HOXD3;BMP7;CDK5RAP3;ADRA2C;NEUROD1;ZFHX2;LTK;NBL1;CDK5R1;HES5;REST;CDK5RAP2;HES1
prerank,B cell mediated immunity (GO:0019724),-0.7364196502328024,-1.686895295128246,0.012195121951219513,0.05960311219839078,0.999,5/10,13.01%,CD74;TLR8;CD27;FCGR2B;FCER1G
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.5609696769388453,-1.6865441995535322,0.00686106346483705,0.05963543634182171,0.999,11/29,19.94%,CCR2;ANO6;CCR1;GAS6;CCL5;SERPINE1;PLA2G7;LGALS9;HMGB1;C1QBP;AGER
prerank,regulation of AMPA receptor activity (GO:2000311),0.559449245867469,1.6859002306908661,0.007481296758104738,0.08393827357553425,1.0,10/25,14.13%,NLGN1;SHISA6;GSG1L;SHANK3;SHISA9;CACNG4;CACNG2;RELN;ARC;NLGN2
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.438500431068943,-1.6846933343433534,0.0,0.060549884140351465,0.999,34/98,15.13%,PID1;APOE;GRB2;XDH;PPARD;INSR;ANXA2;PPARG;RIPK1;IL10RB;ARRB2;RNF41;RAB1A;TBC1D5;NR1H2;MAPK14;ARRB1;VEGFA;CD63;SCRIB;AGT;CDK1;IFNAR1;RAB29;GADD45A;CCL5;CBR1;UHRF1;TGFBR2;GREM1;AGPAT1;ACACB;GHITM;EIF4G1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5934567829378576,-1.6839789509762377,0.008278145695364239,0.060782621553654284,0.999,9/22,20.25%,CD44;MYADM;GCNT2;MAP2K5;MAPK7;LCK;FLOT2;AGER;WNK1
prerank,long-chain fatty acid transport (GO:0015909),-0.5606895831399173,-1.682701122101365,0.006779661016949152,0.06134962114111177,0.999,8/30,4.06%,APOE;CD36;FABP5;ABCD2;PRKAG2;PPARG;CPT1A;SLC27A1
prerank,regulation of autophagy (GO:0010506),-0.39767447449683896,-1.6826609904517318,0.0,0.06114375211158091,0.999,74/216,23.49%,ATP6V0D2;TFEB;DAPK1;PSAP;MCL1;GPR137B;ATP6V1E1;ROCK1;NUPR1;ITPR1;ERN1;GAPDH;OPTN;PIP4K2A;PRKAG2;ABL2;HTR2B;ATP6V1A;STAT3;FOXO3;TAB2;MTMR3;SNX6;BCL2;CTSA;SNX5;PTPN22;DAPK3;EIF4G3;PIK3CB;HGF;KLHL22;EXOC4;USP36;ATF6;PLK2;ATP6V1G1;VPS26B;RRAGD;FLCN;TICAM1;STK11;VPS26A;TRIM68;EEF1A1;SH3GLB1;RB1CC1;ATP6V0B;CAPNS1;PIK3C2A;EIF4G1;TRIM14;ATP6V0E1;RMC1;TMEM59;RHEB;HSPB1;DCAF12;HMGB1;ATM;GSK3B;ATP6V0D1;SIRT2;ZC3H12A;CDK5;HAX1;PRKAG1;SNX32;GFAP;MEFV;WDR24;TPCN2;MTDH;PIM2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.7443201100222165,-1.682117811297054,0.008849557522123894,0.06126824170475991,0.999,5/10,8.31%,MSN;RHOA;RAP2A;CDC42;SH3BP1
prerank,response to laminar fluid shear stress (GO:0034616),-0.7471796774297192,-1.680918059123088,0.005076142131979695,0.061887788922754934,0.999,7/10,17.79%,ABCA1;NFE2L2;MAP2K5;MAPK7;KLF2;ASS1;SMAD7
prerank,regulation of mast cell activation (GO:0033003),-0.7314030752921993,-1.6791657039090442,0.010221465076660987,0.06292220382612504,1.0,4/10,5.83%,LYN;CD84;CD300LF;MILR1
prerank,lipoprotein transport (GO:0042953),-0.7246457807868016,-1.6789504743929935,0.010434782608695653,0.06286677290995978,1.0,4/10,3.16%,PRKCB;LRP1;CD36;PPARG
prerank,regulation of integrin activation (GO:0033623),-0.6697843322959806,-1.6789156243171888,0.005253940455341506,0.06266370356562047,1.0,6/15,10.62%,FBLIM1;PLEK;RAP1B;PIEZO1;PTGER4;KIF14
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.45664292629255165,-1.678670165487939,0.0,0.06257277556570198,1.0,19/72,12.02%,APOE;NRP1;ABCA1;AKAP13;STARD8;MYO9B;RAC1;ARHGEF3;EPS8;ARHGEF2;ABL2;TNFAIP1;RIPOR2;ARRB1;ARHGEF18;KCTD10;CCDC125;FLCN;ITGA3
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.6771744804495948,-1.6783031197957283,0.008445945945945946,0.06252844638241253,1.0,8/13,19.93%,ZMIZ1;ARID1B;SPI1;ARID1A;ELOF1;ZMIZ2;SERTAD1;CHEK1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.4678425333931236,-1.6781986954116712,0.0016778523489932886,0.06240209072562125,1.0,31/63,27.60%,CRADD;CNOT4;CNOT1;CNOT2;PLK2;E2F1;PRMT1;RFWD3;CDK1;PCNA;GADD45A;PLK3;E2F8;WAC;CNOT6L;AURKA;CASP2;MDM4;ATM;FBXO31;CNOT8;CDC25C;SFN;PRKDC;GTSE1;CCNB1;PCBP4;RBL2;CNOT3;PML;EP300
prerank,membrane depolarization during action potential (GO:0086010),0.5476693324073866,1.677168747901691,0.01694915254237288,0.08955627930054963,1.0,7/26,6.48%,CACNA1C;SCN2A;SCN2B;SCN1A;SCN3A;SCN9A;HCN2
prerank,regulation of interleukin-12 production (GO:0032655),-0.4957990790875063,-1.6759994196592274,0.010471204188481676,0.06373535105724921,1.0,20/47,19.94%,FOXP1;LILRB1;SYK;PLCG2;TLR8;PIBF1;TLR4;IRF5;MAPK14;IRAK3;MDK;LAPTM5;MAST2;CD40;LILRA5;CMKLR1;LGALS9;HMGB1;C1QBP;AGER
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.41106932284216985,-1.6732286719996223,0.001639344262295082,0.06549480420432262,1.0,56/149,22.61%,PRKCH;PRKCB;CD36;RAB7B;ARHGEF2;MALT1;RIPK1;IRAK2;TRAF5;STAT3;TAB2;CFLAR;CARD11;TLR4;IL18;NLRC4;DHX9;NFKB1;AIM2;RNF31;RBCK1;IRAK3;IL18RAP;EIF2AK2;MYD88;NOD1;ADAM8;UBC;RPS27A;RELA;TRAF1;AGT;MTPN;APP;TICAM1;CIB1;TRIM68;TRAF2;CD40;RNF25;FLOT2;IKBKB;NFKBIB;TRIM14;IL18R1;HSPA1A;RPS3;TRADD;LGALS9;NOD2;AGER;TRIM25;NLRP3;ZBTB7A;RPS6KA5;IL6
prerank,regulation of interleukin-17 production (GO:0032660),-0.5438211733793684,-1.6731780426936105,0.008445945945945946,0.06528204644314937,1.0,13/31,23.38%,RFTN1;LY9;IL15;TLR4;IL18;MYD88;NCKAP1L;SLC7A5;NOD2;SLAMF6;NR1H4;IL6;TGFB1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6828239993425167,-1.672044089871793,0.01692047377326565,0.06578318094898959,1.0,6/12,18.51%,PLCG2;CYBA;CD36;TLR4;SLC5A3;MMP8
prerank,DNA-dependent DNA replication (GO:0006261),-0.4184204811642824,-1.6717117833883304,0.0,0.06574162099267637,1.0,53/128,25.43%,PSME4;PSMB7;POLE2;RFC1;PSME3;NOC3L;BLM;PSMB9;PRIMPOL;GINS3;MCM6;RAD51;PSMA8;UBC;RPS27A;SSBP1;MCM3;PSMC3;DBF4;WRN;PSMD8;ORC5;BAZ1A;PSMC4;PSMB10;RPA3;RFC2;PSMA1;POLD2;MCMBP;CDC34;TOPBP1;MCM2;PSMB8;PRIM1;LRWD1;DNA2;PRIM2;PSMA5;PSMD4;PSMB3;RFC3;PSMD3;GINS4;POLG2;POLB;CDC45;TWNK;PSMB1;MCM5;POLD4;CDK2AP1;RECQL5
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.43275080650820014,-1.6699023367607055,0.0,0.06669846702342444,1.0,35/105,20.83%,LYN;SYK;PLCG2;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;RELA;PSMC3;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;RELB;PSMB8;KRAS;NRAS;PSMA5;PSMD4;PSMB3;PSMD3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.469513826154495,-1.6692804841728726,0.0,0.06681890984266965,1.0,23/65,11.72%,BCAR3;GRB2;CBL;PTPRJ;SH3KBP1;CDC42;PTPN12;ARAP1;TSG101;DUSP3;MVP;DGKD;RHBDF1;EPS15;HIP1;RHBDF2;PLAUR;MVB12B;AFAP1L2;SPRY2;AGT;STAM2;CCDC88A
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.6627019344162951,-1.668683915671561,0.015901060070671377,0.06703624550667363,1.0,7/14,12.26%,MSN;RHOA;RAP2A;CDC42;SH3BP1;SCRIB;FOXJ1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.43276390088212824,-1.6685446884078725,0.0,0.06664565250786436,1.0,35/104,20.83%,LYN;SYK;PLCG2;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;RELA;PSMC3;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;RELB;PSMB8;KRAS;NRAS;PSMA5;PSMD4;PSMB3;PSMD3
prerank,cellular response to lectin (GO:1990858),-0.43276390088212824,-1.6685446884078725,0.0,0.06664565250786436,1.0,35/104,20.83%,LYN;SYK;PLCG2;PAK2;PRKCD;CREBBP;PSME4;MALT1;TAB2;PSMB7;CARD11;PSME3;NFKB1;FBXW11;CLEC10A;PSMB9;PSMA8;CLEC4D;RELA;PSMC3;PSMD8;CLEC6A;FCER1G;PSMC4;PSMB10;PSMA1;IKBKB;RELB;PSMB8;KRAS;NRAS;PSMA5;PSMD4;PSMB3;PSMD3
prerank,ventricular septum development (GO:0003281),0.5094701977418036,1.6682873812718753,0.002680965147453083,0.09579570397100257,1.0,8/37,5.02%,ROBO1;ROBO2;SOX11;SLIT3;SLIT2;ZFPM2;ACVR1;MATR3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.4813506890774108,-1.6671980303257634,0.0033444816053511705,0.06733167416848014,1.0,24/55,26.05%,PID1;GRB2;XDH;RAC1;RIPK1;BRCA1;RNF41;MAPK14;AGT;BCO2;GADD45A;CBR1;TGFBR2;MPV17;AATF;BST1;SPHK2;PDGFRB;SIRT2;ZC3H12A;CYP1B1;DHRS4;MT3;EIF6
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.6215093694348612,1.6670990009604776,0.0234192037470726,0.096036673326118,1.0,3/15,1.72%,NLGN1;CNTNAP4;SYN3
prerank,protein modification by small protein removal (GO:0070646),-0.3836267844921087,-1.6664952754400817,0.0,0.06759667566165511,1.0,90/252,22.50%,BIRC3;USP12;SNX3;DDB2;USP50;RHOA;OGT;ATXN7;PSME4;OTUD5;UCHL5;USP18;RIPK1;BRCA1;ARRB2;PSMB7;PSME3;ACTB;USP8;PSMB9;ABRAXAS1;TRAF3;WDR48;USP36;USP9X;GPS1;BABAM2;USP3;ATXN3;SENP3;TGFBR1;RNF123;HIF1A;PSMA8;UBC;RPS27A;ASXL1;SUDS3;TNIP2;PSMC3;WDR20;CDC25A;CDK1;STAM2;BABAM1;PSMD8;COPS6;USP42;RNF128;TRAF2;PSMC4;USP35;PSMB10;USP40;PSMA1;JOSD1;YY1;INO80;USPL1;USP30;OTUD4;USP11;INO80E;USP7;TNIP3;PSMB8;STAMBPL1;SKP2;SMAD7;INO80C;GATA3;ADRB2;MDM4;BRCC3;COPS5;MBD6;PSMA5;PSMD4;PSMB3;BAP1;COPS4;PSMD3;COPS8;ZC3H12A;USP9Y;NLRP3;SMURF2;ZRANB1;POLB;BECN1
prerank,activation of GTPase activity (GO:0090630),-0.44061131645974466,-1.665579634984288,0.0,0.06803877334661276,1.0,32/89,18.32%,ABR;CORO1C;ARHGAP25;ARHGAP22;ARHGAP24;SIPA1;TBC1D15;SGSM2;TBC1D2B;TBC1D9;TBC1D5;TBC1D1;SIPA1L2;ARHGEF10;TBC1D22A;SIPA1L3;TBC1D16;TBC1D22B;TBC1D8B;TBC1D8;SCRIB;TBC1D17;CCDC125;FOXJ1;TBC1D10B;RALGAPA2;TBC1D30;ARHGEF5;TBC1D7;TBC1D9B;GPR65;TBC1D25
prerank,nucleotide catabolic process (GO:0009166),-0.6385763986839732,-1.6646124311352122,0.0035087719298245615,0.06848210739494162,1.0,5/16,9.96%,GDA;XDH;SAMHD1;DERA;NT5C2
prerank,regulation of leukocyte activation (GO:0002694),-0.6571542560839456,-1.6644844355527773,0.012411347517730497,0.06835018092753284,1.0,4/14,1.45%,LYN;CD74;MFHAS1;GPR137B
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5683053863362441,1.6632860710779263,0.01348314606741573,0.09842000947784933,1.0,9/23,13.32%,KIF5C;KIF1B;DYNC1I1;KIF5A;HOOK3;HOOK1;MAP6D1;F8A1;DYNC1I2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5552854419006509,1.6627996091456188,0.008791208791208791,0.09801191186595161,1.0,8/24,13.93%,AGBL4;TTLL11;TTLL7;TTLL10;TTLL5;NAA10;GGCX;TTLL9
prerank,neuron projection morphogenesis (GO:0048812),0.39750862294054595,1.6625581728585876,0.0,0.09750208345348459,1.0,32/137,8.93%,CNTNAP2;NLGN1;CTNNA2;MAP2;CTNND2;ANK3;MAP1B;CNTN4;DCLK1;NYAP2;DCC;MYO16;PARD3;GPM6A;PLPPR4;NTNG2;NTNG1;PAK3;SLITRK1;NEFH;NRCAM;EPB41L3;EPHB1;SHANK3;DCDC2;BDNF;FLRT3;DSCAML1;NCKAP1;SPTBN4;BMP7;SRGAP2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.479271210774267,-1.6621763323182397,0.0,0.06992098503517943,1.0,29/55,32.12%,PTPRC;IGF1;CCR2;SYK;IL15;IL18;ANXA1;CD28;NCKAP1L;CD46;CCL5;IL27RA;RPS3;HMGB1;AGER;CD274;TNFSF9;CD3E;IL6;NCK1;IL12RB1;TNFRSF13C;PNP;IL2;IGFBP2;NCK2;SLC7A1;CCL19;CD80
prerank,B cell homeostasis (GO:0001782),-0.7250050916662616,-1.662088407086771,0.010362694300518135,0.06973761754705243,1.0,5/10,9.89%,LYN;DOCK10;DOCK11;MEF2C;NCKAP1L
prerank,dendrite morphogenesis (GO:0048813),0.5008274983470729,1.6610115127745988,0.00702576112412178,0.09808330302298336,1.0,15/35,15.52%,CTNNA2;MAP2;CTNND2;PAK3;PTN;EPHB1;PHACTR1;SHANK3;DCDC2;SDC2;ARC;BTBD3;KLF7;CHRNA7;EPHB3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.45526393464032544,-1.6609963170074935,0.001658374792703151,0.07028899621861634,1.0,23/75,16.15%,LYN;APOE;CD300A;PRKCD;RB1;PTPRJ;IPO5;HHEX;PIK3CB;LRP6;IRAK3;PKIB;STK38;SLC8A1;INCA1;SPRY2;AGT;PAQR3;CDK5RAP1;GADD45A;TFAP4;RGS14;LATS2
prerank,receptor signaling pathway via STAT (GO:0097696),-0.5652816180817506,-1.6609513927503967,0.0033500837520938024,0.07007997747923947,1.0,11/25,15.67%,CCR2;PIAS1;CTR9;STAT3;STAT6;IFNAR2;STAT5B;STAT4;IFNAR1;SOCS6;IL31RA
prerank,myeloid cell differentiation (GO:0030099),-0.4919688323826252,-1.6605347358778768,0.0034423407917383822,0.07008112716496018,1.0,10/47,9.00%,LYN;RUNX1;MFHAS1;SPI1;RASGRP4;IKZF1;HSPA9;RPS14;ACIN1;FLVCR1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6704378128078012,1.6598312001128217,0.013605442176870748,0.09827502437851893,1.0,8/12,16.29%,DPYD;DPYS;CDA;DPYSL5;DPYSL4;DPYSL3;CTPS1;DPYSL2
prerank,protein localization to Golgi apparatus (GO:0034067),-0.5518863836322204,-1.659708795780169,0.010416666666666666,0.07044734709610903,1.0,10/27,13.08%,VPS13C;OPTN;VPS13A;IFT20;COG7;TMED10;GBP5;SYS1;PAQR3;ARL5A
prerank,V(D)J recombination (GO:0033151),-0.7155769247016266,-1.6595327514700777,0.01658374792703151,0.07031608353328256,1.0,8/11,25.05%,LIG1;HMGB2;XRCC4;TCF3;LIG3;HMGB1;PRKDC;DCAF1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5851627655875695,-1.6589174620752407,0.010309278350515464,0.07060732776519811,1.0,9/22,12.80%,CD300A;PTPRJ;DGKZ;LPXN;CD22;PTPN22;DUSP3;LAPTM5;FCGR2B
prerank,histone H3-K4 trimethylation (GO:0080182),-0.7134004836626122,-1.6588963715721907,0.0017921146953405018,0.07037557034128476,1.0,6/11,17.14%,TET3;OGT;CTR9;KMT2D;TET2;KMT2A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5360604742753498,-1.658787141207319,0.00510204081632653,0.07021657223429538,1.0,14/34,29.86%,PTPRC;SASH3;PTPN22;LAPTM5;DNAJB9;XBP1;SLC7A5;SPHK2;STX4;NOD2;IL6;RBP4;IL2;VAMP3
prerank,positive regulation of lipid storage (GO:0010884),-0.592923285225222,-1.6567769955485712,0.010948905109489052,0.07145673310119814,1.0,8/21,14.42%,MSR1;PLIN2;NFKB1;C3;LPL;OSBPL11;APOC4;EHD1
prerank,positive regulation of behavior (GO:0048520),0.688813096078623,1.6556615914301196,0.026128266033254157,0.10088776573426989,1.0,2/10,0.93%,NLGN1;SGIP1
prerank,negative regulation of bone mineralization (GO:0030502),-0.6661790571266358,-1.6548873729147586,0.0142602495543672,0.07268438338122839,1.0,6/13,19.32%,CCR1;SRGN;PTK2B;GREM1;RFLNB;ENPP1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5483727913530149,-1.6545205894784794,0.007042253521126761,0.07270578022998134,1.0,14/29,20.80%,SAMHD1;YTHDF3;USP18;RNASEL;NLRC5;IFNAR2;ABCE1;PTPN6;HSP90AB1;OAS3;MAVS;ISG15;PTPN11;PTPN1
prerank,positive regulation of innate immune response (GO:0045089),-0.539503253525932,-1.6539001744148192,0.005235602094240838,0.07286337390490363,1.0,13/30,19.28%,TLR8;SPI1;RIOK3;DHX9;NLRC5;IFI35;GBP5;POLR3G;ADAM8;CCL5;MAVS;POLR3B;PLA2G5
prerank,positive regulation of cell projection organization (GO:0031346),0.4071372567588517,1.65356363426599,0.0,0.10182736042790941,1.0,32/115,12.27%,ROBO1;MAGI2;PTPRD;IL1RAPL1;LRRC7;ROBO2;GRIP1;TENM3;RIT2;SLIT2;NTRK3;SERPINI1;NTRK2;FUT9;CDKL5;SLITRK1;CARMIL1;PTN;CARMIL2;CUX2;PRKCI;TOX;PRKD1;BDNF;PLXNA4;CAPRIN2;LTK;RELN;DPYSL3;PLXNA2;RET;ARHGAP35
prerank,cellular response to interferon-gamma (GO:0071346),-0.44188632758309754,-1.6534632478609392,0.0,0.07300344598776194,1.0,37/88,26.75%,CD44;SP100;DAPK1;PRKCD;GAPDH;IRF2;TLR4;IRF5;DAPK3;CIITA;SIRPA;GBP5;B2M;JAK1;GBP2;IFNGR2;OASL;CCL5;TRIM68;CASP1;OAS3;MT2A;HCK;LGALS9;GBP3;GBP7;GBP6;OAS2;STAT1;TRIM25;IFNGR1;CD47;CCL7;GBP4;MID1;IL12RB1;PML
prerank,regulation of actin filament-based movement (GO:1903115),0.7181577057135449,1.653303787781251,0.025404157043879907,0.1013227820800114,1.0,3/10,3.39%,PDE4B;ANK2;PDE4D
prerank,positive regulation of proteolysis (GO:0045862),-0.4832164897375554,-1.6529690745303434,0.0017271157167530224,0.07314669142079176,1.0,15/55,11.31%,APOE;SNX9;TNFRSF1B;OGT;NLRC4;FBXW11;ADAM9;ASPH;SNX33;WDR48;CTSC;RCN3;CTSH;ADAM8;CLN6
prerank,transferrin transport (GO:0033572),-0.530164724098501,-1.6509390664436494,0.007054673721340388,0.07430342528373438,1.0,10/33,16.52%,ATP6V0D2;ATP6V1E1;DNM2;ATP6V1A;TCIRG1;STEAP3;ATP6V1G1;RAB11B;ATP6V0B;ATP6V0E1
prerank,actin nucleation (GO:0045010),-0.5911226003461947,-1.6506763400719535,0.011784511784511785,0.07427427898269531,1.0,9/21,16.47%,IQGAP2;ARPC2;ACTR2;ACTR3;ARPC3;ARPC1B;ARPC1A;ARPC5;ARPC5L
prerank,receptor metabolic process (GO:0043112),-0.47584369109299623,-1.6499783510438126,0.005119453924914676,0.07458260000300855,1.0,20/53,13.45%,GRB2;LILRB1;SYK;LRP1;CD36;ITGB2;DNM2;RAB31;CD9;ARRB2;UVRAG;GRK3;ITGB1;KIF16B;PICALM;SNX25;ARFGEF2;RAB11B;FCER1G;SH3GLB1
prerank,sister chromatid segregation (GO:0000819),-0.538958457126787,-1.649840265139059,0.00676818950930626,0.0744312223605356,1.0,15/31,22.85%,RB1;NCAPG2;TOP2A;SMC4;KLHL22;CENPK;KIFC1;KNSTRN;NUSAP1;INO80;SGO1;NDC80;KIF18B;SMC1A;NSL1
prerank,regulation of cholesterol efflux (GO:0010874),-0.5439023848665854,-1.6481950862374757,0.008849557522123894,0.07550808267804825,1.0,9/30,13.54%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;TTC39B;RXRA
prerank,regulation of dendrite extension (GO:1903859),0.5909219774138458,1.6453379148741363,0.02696078431372549,0.10708111648681734,1.0,4/18,3.66%,RIMS2;RIMS1;SYT1;SYT2
prerank,inorganic ion transmembrane transport (GO:0098660),0.6809429212823915,1.6446448781096463,0.024630541871921183,0.10692893417299716,1.0,1/12,0.21%,ASIC2
prerank,regulation of T cell activation (GO:0050863),-0.5004582251282519,-1.644618231135143,0.004942339373970346,0.0779057987824872,1.0,23/42,31.27%,CCR2;TNFRSF1B;TNFAIP8L2;PTPN22;DUSP3;CYRIB;SIRPA;LAPTM5;LCK;CD2;IL4I1;CCL5;LAX1;TNFSF9;CD47;METTL3;TBX21;CRTAM;PRELID1;SPINK5;IL27;LAT;CD4
prerank,establishment of epithelial cell polarity (GO:0090162),-0.6073123145389818,-1.6441683279043373,0.02127659574468085,0.077993774819634,1.0,7/19,8.31%,MSN;RHOA;CYTH1;RAP2A;CDC42;SIPA1L3;SH3BP1
prerank,response to calcium ion (GO:0051592),0.41014839799358854,1.6441001722873396,0.0024937655860349127,0.10667710392625179,1.0,34/102,13.07%,NLGN1;RYR3;RYR2;SYT1;ADCY8;SYT10;KCNMB3;KCNMB2;TRPC1;KCNH1;SYT2;CPNE4;PDCD6;AHCYL1;CASQ2;SYT5;HOMER1;KCNIP2;ADGRV1;NEDD4;ADCY1;SYT11;SYT12;TNNT2;RYR1;TTN;CAPN3;CPNE8;CALM1;KCNMA1;PPIF;CALM3;SYT7;CALM2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.5662528363797357,-1.6434601579640824,0.006756756756756757,0.07830905646928549,1.0,9/25,19.35%,PLCG2;MALT1;LAPTM5;B2M;TRAF2;SLC7A5;SPHK2;CD226;NOD2
prerank,positive regulation of autophagy (GO:0010508),-0.4423882907354561,-1.6425681835578392,0.0016666666666666668,0.07876177594654184,1.0,31/81,24.50%,TFEB;DAPK1;ROCK1;GNAI3;OPTN;FOXO3;PIK3CB;CAMKK2;ATF6;PLK2;FLCN;SESN1;TICAM1;STK11;TRIM68;PLK3;SH3GLB1;WAC;PIK3C2A;TRIM14;BNIP3L;FBXO7;TMEM59;HMGB1;GSK3B;ZC3H12A;KDR;MEFV;MTDH;PIM2;DCN
prerank,nucleosome assembly (GO:0006334),-0.5345607617388598,-1.641797454729864,0.0068846815834767644,0.07911228158734177,1.0,13/31,18.84%,SMARCA5;ANP32B;UBN1;ASF1B;ASF1A;HMGB2;SPTY2D1;PADI4;SART3;CHAF1A;RBBP4;BRD2;RSF1
prerank,tryptophan catabolic process (GO:0006569),-0.6977012544907424,-1.6417392484494384,0.012544802867383513,0.0789101883558932,1.0,4/11,12.50%,KYNU;KMO;KYAT1;IL4I1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4253855619999684,-1.6413390966719095,0.0017035775127768314,0.07898565667772428,1.0,25/93,13.07%,SASH1;MAP3K5;TAOK3;SDCBP;MFHAS1;XDH;RELL1;MINK1;RIPK1;TRAF5;SPI1;PTK2B;AXIN1;TRAF3;VEGFA;EIF2AK2;PRMT1;CD27;TAOK1;TRAF1;NCF1;APP;GADD45A;FCGR2B;TRAF2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5893246954434619,1.6412875062899468,0.017114914425427872,0.10823843887320597,1.0,9/20,20.63%,B3GALT1;FUT9;B3GALT5;FUT8;ST3GAL6;B4GALNT2;B3GALT4;ST6GALNAC5;MPDU1
prerank,oligosaccharide metabolic process (GO:0009311),0.4747697953126342,1.641128826612351,0.004819277108433735,0.10763898117124036,1.0,18/46,17.48%,B3GALT1;ST8SIA2;FUT9;B3GALT5;ST8SIA3;GAL3ST3;ST6GAL2;FUT8;AMY1B;AMY1C;AMY1A;ST6GALNAC3;ST3GAL6;B4GALNT2;IDUA;ST8SIA1;ST8SIA5;B3GALT4
prerank,regulation of interleukin-1 production (GO:0032652),-0.6429775815424026,-1.6411162109575221,0.017391304347826087,0.07888754178424798,1.0,6/15,7.96%,FOXP1;TLR4;TMED10;ANXA1;GAS6;SIRPA
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.538345620561358,-1.6405764881829048,0.010362694300518135,0.07906456596855133,1.0,11/32,11.05%,PID1;IGF1;P2RX7;NUPR1;INSR;PFKFB3;HIF1A;ARNT;ZBTB20;PFKFB4;APP
prerank,regulation of muscle contraction (GO:0006937),0.5471959932106999,1.640456323374743,0.011876484560570071,0.107514329235175,1.0,7/26,7.70%,KCNB2;CHRM2;TNNI1;PLCE1;ENO1;KCNA1;PPP1R12B
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.7002734561665013,-1.6403216832304899,0.017094017094017096,0.07902155182329924,1.0,7/11,19.93%,ZMIZ1;ARID1B;ARID1A;ELOF1;ZMIZ2;SERTAD1;CHEK1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.667373009481015,-1.6402648904286026,0.01415929203539823,0.07882293239601877,1.0,7/12,20.50%,DHRS3;CNOT1;EZH2;ASXL1;KLF2;TRIM16;CYP26C1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.5325658484129158,-1.6401607534717724,0.008680555555555556,0.07864887012049485,1.0,13/34,16.86%,LYN;MFHAS1;CD300A;RAB7B;CD300LF;TLR4;IRAK3;GRAMD4;LY96;TICAM1;NFKBIL1;OTUD4;GPR108
prerank,calcium ion transport (GO:0006816),0.39263020982591573,1.640093055135298,0.0,0.10710330528308523,1.0,16/113,3.14%,ANK2;TRPM3;CACNA1C;RYR3;CACNA1E;TRPC5;RYR2;CACNA2D1;GRIN3A;SLC24A4;SLC24A2;SLC8A3;NALCN;TRPC1;CACNB2;SLC24A3
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6738864908878004,-1.6397600476253378,0.021505376344086023,0.0787005032476563,1.0,6/13,8.82%,AKAP13;RAC1;ROCK1;CDC42;PTGER4;SLC9A1
prerank,neuron differentiation (GO:0030182),0.38350548281980884,1.6391964025414343,0.0,0.10707777127661497,1.0,29/165,12.13%,PTPRD;TENM2;IL1RAPL1;MYT1L;SPOCK1;PHOX2A;TENM3;SOX11;TENM1;TENM4;NTRK2;SNPH;FUT9;ATP8A2;RORB;EPHA5;SMARCA1;WNT9A;POU3F2;ALK;FZD8;OLIG1;EN1;POU4F2;NEUROD1;TGFB2;CDK5R1;BRSK1;PBX1
prerank,cell-cell junction assembly (GO:0007043),0.4455738923522205,1.6389813498068586,0.0,0.10655517291953784,1.0,25/63,16.74%,CDH18;CTNND2;CDH8;CDH10;CDH2;CDH20;TJP1;CDH11;CDH12;EPB41L3;CDH22;CDH19;CDH7;DCHS1;CDH6;TLN2;ARVCF;CDHR3;CDH9;CLDN5;PATJ;CDH5;CTNND1;PRKCA;RAMP2
prerank,negative regulation of protein binding (GO:0032091),-0.4478156419389919,-1.6375409285024634,0.0,0.08036545377135776,1.0,27/71,21.40%,DAB2;ITGA4;CTSZ;PRKCD;ROCK1;PEX14;ARRB2;ACTB;PPP1CA;B2M;ITGB1BP1;ATP2A3;NES;PIN1;IFIT1;ADAM15;TMBIM6;IFIT2;TFIP11;AURKA;RALB;ADRB2;TMC8;GSK3B;DISC1;KDM1A;RACK1
prerank,regulation of cell size (GO:0008361),-0.5770840606148648,-1.6371068397655053,0.01060070671378092,0.08044990115324877,1.0,9/23,10.78%,VAV3;MSN;PLEK;RAC1;RHOA;VAV1;RARG;VAV2;MTPN
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.6625003631278459,-1.6366227505530229,0.01386481802426343,0.08056451526114883,1.0,3/13,17.36%,NAMPT;PARP9;PARP10
prerank,stress-activated MAPK cascade (GO:0051403),-0.46301205815145746,-1.6365537446906984,0.003305785123966942,0.08038010649453457,1.0,24/61,19.35%,MAP3K8;MAP3K5;MAP4K3;MAP3K20;MINK1;IRAK2;TAB2;NFKB1;FBXW11;PTGER4;MAPK14;GPS1;TRIB1;NOD1;UBC;RPS27A;TNIP2;IKBKB;MAP3K10;CRKL;MAP2K3;TAOK2;LGALS9;NOD2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.6094617591372019,-1.6365029394860504,0.007017543859649123,0.08015489608993423,1.0,7/18,15.58%,DOCK2;SYK;PLCG2;SBNO2;IFI35;FCER1G;KARS1
prerank,regulation of organelle assembly (GO:1902115),-0.45211092506030215,-1.6362457053205657,0.003289473684210526,0.08010211625868587,1.0,28/73,18.25%,MSN;PDCD6IP;TBC1D15;CENPJ;IFT20;ATG5;TBC1D2B;CEP295;MTMR3;TBC1D5;TBC1D1;TSG101;TBC1D22A;SDCCAG8;TBC1D16;PLK2;TBC1D22B;RNF4;RAB5A;TBC1D8;CEP295NL;TBC1D17;TBC1D10B;TBC1D24;DYNLT2B;STIL;TBC1D9B;HCK
prerank,regulation of dopamine secretion (GO:0014059),0.5476832180950796,1.6358585332907516,0.016355140186915886,0.10857627982449479,1.0,11/25,16.07%,SYT1;SYT10;SYT2;GDNF;SYT5;SYT11;SYT12;SYT7;PRKN;KCNA2;SNCA
prerank,endocytic recycling (GO:0032456),-0.48745356547367313,-1.6353169208678973,0.006600660066006601,0.08057258818803595,1.0,27/50,35.53%,DENND1A;RAB7A;SNX3;SNX27;EHD4;EPS15;VPS35L;EIPR1;RAB11B;VPS26A;EHD1;ACAP2;RAB13;SNX4;DENND1B;VPS51;VPS50;MICALL1;RAB35;SNX31;MICALL2;DENND1C;RAB14;STX6;ARL4C;VPS53;TRARG1
prerank,mesenchymal cell development (GO:0014031),0.5933651747331623,1.6349399079817821,0.028503562945368172,0.10858983264762519,1.0,4/18,4.88%,NRG1;SOX11;CDH2;PDCD6
prerank,phagolysosome assembly (GO:0001845),-0.685506410995785,-1.634606340362771,0.01011804384485666,0.08091173928818668,1.0,8/12,19.28%,RAB7B;RAB7A;ARL8B;RAB20;CLN3;RAB39A;RAB34;PLA2G5
prerank,ureteric bud development (GO:0001657),0.5989595742949806,1.6336259220219922,0.018140589569160998,0.10887754796030549,1.0,5/17,9.17%,ROBO2;SLIT2;WT1;BMP7;SALL1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5619197852952432,1.6319812369438547,0.011876484560570071,0.10954660800978978,1.0,7/22,7.07%,MAGI2;NTRK3;NTRK2;SH3GL2;TMEM108;WASF1;BDNF
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.7096794626769859,-1.6319446459076865,0.014084507042253521,0.08280427428501468,1.0,5/10,18.41%,KYNU;ATP7A;KYAT1;IL4I1;QDPR
prerank,calcium ion import across plasma membrane (GO:0098703),0.6386689196719564,1.6310313358563693,0.028846153846153848,0.10963965517780151,1.0,8/14,19.02%,CACNA2D1;SLC24A2;SLC8A3;SLC8A2;ATP2B4;TRPV3;TRPM2;SLC24A1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.3880531926582083,-1.6308098144665484,0.0,0.08348752974088718,1.0,66/193,21.63%,RNF213;CBL;ZNRF3;CNOT4;RNF150;BFAR;BIRC6;RNF149;RNF19A;RNF111;MYLIP;AMFR;AREL1;RNF166;ANAPC1;RC3H1;RNF20;UBE2R2;KLHL25;ARRB1;UBE3B;NUB1;KCTD10;ATXN3;SPSB2;UBC;RPS27A;UBE2L3;RNF8;UBE4B;NEDD4L;XBP1;WDR91;RNF128;FBXO10;UHRF1;BUB1B;UBE2H;RNF185;PCYOX1;ARIH1;ARRDC1;RNF34;RNF43;UBE2G1;CDC34;UBQLN4;UBE2C;ISG15;MIB1;UBE2I;AURKA;ANAPC7;FBXO7;NDFIP2;TRIP12;ELOC;UBE3C;FBXO22;FBXW4;DTX3L;PSMD3;RNF125;TRIM25;BAG6;SMURF2
prerank,pinocytosis (GO:0006907),-0.7056813363908155,-1.6307772528614535,0.016666666666666666,0.08325325423511687,1.0,5/10,6.98%,DOCK2;MAPKAPK3;MAPKAPK2;SNX5;SNX33
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.4995294119030928,-1.6306356538279945,0.00686106346483705,0.08314728543116234,1.0,24/41,30.34%,OGT;NUP50;PRKAG2;NUP42;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;NUP62;PRKAG1;ZBTB7A;RANBP2;EIF6;NUP37;EP300;PGAM1;AAAS;NUP133
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.6845597336333393,-1.6300327701467496,0.015463917525773196,0.0833805524441826,1.0,5/11,17.79%,PTPRC;LILRB1;AHR;IL4I1;SMAD7
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.6623576609644986,-1.6284437626045618,0.016722408026755852,0.08450645070255519,1.0,8/13,19.53%,CD74;AXL;DHX9;GAS6;AGPAT1;MAVS;TAF9;IL7
prerank,positive regulation of viral transcription (GO:0050434),-0.5589682176982845,-1.626773747213865,0.007532956685499058,0.08575875559538111,1.0,13/25,26.70%,MDFIC;NELFB;DHX9;POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;RSF1;POLR2I;GTF2F2;GTF2F1;NELFE
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.45337530273751103,-1.6262856592987274,0.001610305958132045,0.08597476315664627,1.0,22/63,22.61%,PTPRC;VAV3;CD38;CD74;SASH3;IL15;IL18;BCL2;ANXA1;CD28;MEF2C;NCKAP1L;CD46;CCL5;CD40;BST1;CHRNB2;IRS2;IL7;CD274;CD3E;IL6
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5819404041485212,-1.6238543279834123,0.01694915254237288,0.08779246305194917,1.0,8/22,9.64%,APOE;ROCK1;SNX9;TNFRSF1B;ADAM9;SNX33;TIMP2;ADAM8
prerank,regulation of T cell differentiation (GO:0045580),-0.5255459427602099,-1.6232510270538956,0.008503401360544218,0.08802681344820623,1.0,19/33,29.30%,ZMIZ1;RUNX1;CCR2;MDK;CBFB;XBP1;CD2;TCF7;ZAP70;GATA3;IL7;IL2RA;METTL3;TBX21;CRTAM;PRELID1;SPINK5;ZBTB1;IL2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5303069071621895,-1.6230522031361974,0.0053285968028419185,0.08793084511117069,1.0,18/32,21.01%,TAOK3;BRCA1;BLM;ABRAXAS1;BABAM2;RINT1;FOXN3;TAOK1;CDK1;BABAM1;TICRR;TOPBP1;TRIM39;TAOK2;BRCC3;ATM;CHEK1;NBN
prerank,dendrite self-avoidance (GO:0070593),0.5980183312815257,1.6224996263428666,0.017369727047146403,0.11659988135180328,1.0,7/16,15.94%,CNTN6;CNTN4;DSCAM;DSCAML1;ROBO3;VSTM2L;EMB
prerank,cellular response to interleukin-12 (GO:0071349),-0.4800052984331522,-1.620436701529347,0.0034662045060658577,0.09010202300881971,1.0,26/48,28.03%,MSN;PAK2;RAP1B;PITPNA;ANXA2;CDC42;HSPA9;HNRNPDL;STAT4;SIRPA;JAK1;LMNB1;LCP1;CAPZA1;CFL1;RPLP0;GSTO1;CNN2;TYK2;MTAP;P4HB;CD47;IL12RB1;TALDO1;HNRNPF;SERPINB2
prerank,positive regulation of dendrite extension (GO:1903861),0.5909242648602625,1.6199010501427387,0.02702702702702703,0.11814111630937602,1.0,4/17,3.66%,RIMS2;RIMS1;SYT1;SYT2
prerank,negative regulation of protein transport (GO:0051224),-0.5526550928567564,-1.618344267309836,0.021660649819494584,0.0916900009098002,1.0,7/25,8.22%,APOE;SNX3;WWP2;PKDCC;RSAD2;RHBDF1;RHBDF2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.47226889976856923,1.6181534963331854,0.00468384074941452,0.11890800658268516,1.0,17/44,15.28%,AKAP6;ANK2;KCNN2;KCNMB3;KCNMB2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;KCNIP2;GABBR1;KCNJ16;ATP1B1;KCNMA1;KCNJ12;WNK4;WNK3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6751603940376162,1.6177903777456302,0.0387243735763098,0.11849594287030521,1.0,4/10,8.49%,HECW1;PRKCE;HECW2;NEDD4
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6779553643502536,1.6177145647804794,0.0234192037470726,0.11781409147295246,1.0,4/10,8.49%,HECW1;PRKCE;HECW2;NEDD4
prerank,regulation of programmed cell death (GO:0043067),-0.3929508632343539,-1.6174563930242252,0.0,0.09219636169719155,1.0,60/161,23.12%,CTSB;APAF1;BIRC3;DAPK1;BCL6;CRADD;CREBBP;ACER3;BCL2L11;MALT1;RIPK1;SGK1;ANP32A;NLRC4;RARG;ANP32B;STEAP3;DAPK3;USP36;WFS1;HIP1;NF2;NME1;PTPN6;TGM2;TPT1;AGT;IKZF3;OSGIN1;WRN;TRIM24;IGFBP3;HTATIP2;USP42;FBXO10;LGALS1;CASP1;TRAF2;DFFA;PRDX2;BID;RABGGTA;BNIP3L;SKP2;TNFRSF25;RPS3;IFT57;CASP2;RABGGTB;ATM;STAT1;ASAH1;CDK5;NUP62;HAX1;ZBTB7A;TNFSF9;CD3E;TOMM70;TARDBP
prerank,potassium ion import across plasma membrane (GO:1990573),0.48043240725755676,1.61673658420262,0.018779342723004695,0.11791889121561669,1.0,13/41,13.04%,SLC12A2;SLC12A8;SLC12A1;KCNJ3;KCNJ10;KCNJ6;KCNJ9;HCN2;ATP1A3;KCNJ16;ATP1B1;SLC12A5;KCNJ12
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6970282007199704,-1.616559721940295,0.015437392795883362,0.0927286577447113,1.0,3/10,4.21%,ROCK1;IL15;IL18
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4452640061915097,-1.6162340055303035,0.0033613445378151263,0.09273923063831951,1.0,31/73,24.19%,RUNX1;PSME4;SPI1;PSMB7;PSME3;PSMB9;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;PSMD8;METTL14;PSMC4;PSMB10;DHX36;PSMA1;TCF3;PSMB8;KMT2A;GATA3;MYB;TCF12;LMO2;PSMA5;PSMD4;PSMB3;PSMD3;PRKDC;KITLG;PSMB1
prerank,regulation of intracellular signal transduction (GO:1902531),-0.3536433927316483,-1.6160946400129388,0.0,0.09259532674069888,1.0,126/420,19.99%,ARHGAP15;LYN;VAV3;AKAP13;TAOK3;ABR;SGMS1;ARHGAP10;BIRC3;ARHGAP25;ITSN1;STARD8;PLCG2;PAK2;ARHGAP22;MYO9B;RAC1;ARHGEF3;TOP3A;ARHGAP30;ARHGAP24;ARHGAP19;RHOA;ARHGAP17;BRD7;PHF20;OPTN;CSNK2A1;ARHGEF2;PIP4K2A;MOB3B;VAV1;PRKAG2;VRK2;MINK1;GNA12;TRAF5;BRCA1;SGK1;RNF41;DYRK2;CDC42;FGD4;CHD3;ITGAV;ARAP1;PTPN22;BLM;ARHGAP18;FGD3;STK3;MAPK14;RPL11;SMYD2;RAD1;TRAF3;RHOQ;TAF6;ARHGEF18;NF2;VEGFA;RCN3;VAV2;PIP4P1;ZFAND6;SOS2;ARHGAP12;SPRED1;TPX2;TAOK1;RELA;PLEKHG5;PIN1;TRAF1;STYXL1;GNA13;TRIP10;FLCN;WRN;CDK1;ARHGEF11;FAM13B;CRK;STK11;EXO1;CLEC6A;PLK3;TRAF2;RPA3;RFC2;TRIO;ARHGAP36;RHNO1;RNF34;TMSB4X;RACGAP1;TAF4B;PAK1IP1;TOPBP1;BST1;ARHGEF5;BRIP1;USP7;KMT5A;ARHGAP31;TAF9;RBBP4;SPHK2;AURKA;TAF3;RAD9A;DNA2;CMKLR1;RBBP8;PTPN13;FAM83D;TAF4;TAOK2;HSPB1;PAK6;MDM4;AKAP7;ATM;CHEK1;AGER;PIP5K1A
prerank,immunoglobulin mediated immune response (GO:0016064),-0.7103163298915175,-1.6145943459796535,0.013628620102214651,0.09358732157247321,1.0,5/10,13.01%,CD74;TLR8;CD27;FCGR2B;FCER1G
prerank,defense response to protozoan (GO:0042832),-0.6632927785861599,-1.6144320410654511,0.008818342151675485,0.09341680628436043,1.0,9/12,24.79%,LYST;BATF;PF4;MYD88;GBP2;CD40;GBP7;GBP6;GBP4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5798245536174818,1.6138809564532495,0.01935483870967742,0.11974623076730875,1.0,2/17,0.67%,AKAP6;ANK3
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.47818557020337205,-1.6130463114322309,0.006546644844517185,0.09433307604989088,1.0,19/49,18.88%,RUNX1;CNOT4;RAB7B;PF4;PRMT1;WDR5;KMT2C;CBFB;MEF2C;MOV10;NFE2;KMT2D;CIB1;HMGB2;TNRC6C;SIN3A;PRMT6;KMT2A;PITHD1
prerank,osteoclast differentiation (GO:0030316),-0.5737322854803582,-1.6129330100175245,0.011686143572621035,0.09416139776206202,1.0,6/22,5.75%,FOXP1;SNX10;GAB2;ANXA2;SBNO2;MAPK14
prerank,peptide biosynthetic process (GO:0043043),-0.3925458220837734,-1.6127762403955606,0.0016181229773462784,0.09400840133501355,1.0,64/153,26.20%,AGO2;RPS18;RPL7;RPS12;RPS21;RPS8;RPS24;GSPT1;SARS1;RPL36;RPS6;RPS20;RPL11;RPL10A;RPL12;RRBP1;MRPL42;RPS14;RPL32;RPS15A;RPS28;RPS13;RPS27A;DARS1;RPL28;RPS4X;RPS23;EIF4EBP2;RPL22;RPL14;EEF1A1;MRPS6;RPL34;MRPS11;RPS11;RPL6;EIF4G1;RPS10;RPL18A;MRPS16;RPL37A;MRPL34;RPS9;MRPS15;RPS27;ABCF1;RPS3;RPL23A;RPS16;RPL9;COPS5;RPLP2;MRPL51;RPL41;RPLP0;RPL7A;RPL19;RPS15;RPL39;FURIN;MRPL18;MRPS7;RPL5;RPL13
prerank,protein ubiquitination (GO:0016567),-0.3492631876802758,-1.612508286247677,0.0,0.09395157548559996,1.0,151/471,22.24%,SASH1;RNF213;WWP1;CBL;ZNRF3;CNOT4;PEX14;KLHL24;BFAR;BIRC6;DDB2;RNF19A;FBXW8;NFE2L2;RNF111;NFX1;PSME4;MKRN2;BRCA1;ARRB2;MYLIP;WWP2;FBXL17;RNF41;CTR9;AMFR;AREL1;RNF166;PELI1;PSMB7;TNFAIP1;PSME3;RC3H1;RNF20;FBXO32;FBXW11;BCL2;UBE2R2;RNF31;LNPEP;PSMB9;KLHL25;FBXL20;RBCK1;UHRF2;ARRB1;KLHL22;UBE3B;MGRN1;NUB1;HERC6;UBR2;CTNNB1;USP9X;DET1;KCTD10;TPP2;ZSWIM8;CBLL1;RNF4;RNF38;TRIM47;CBFB;HIF1A;RFWD3;HECTD2;SPSB2;PSMA8;OTULIN;SELENOS;UBC;RPS27A;UBE2L3;RNF8;EIPR1;DERL1;PSMC3;UBE4B;NEDD4L;KLHL18;PCNA;CUL4B;TSPAN17;ARRDC4;PSMD8;ASB5;TRIM24;UBE3A;FBXO10;TRIM68;UHRF1;TRAF2;UBE2H;PSMC4;PSMB10;TNKS2;FBXW2;RNF185;CUL2;TRIM11;PSMA1;WAC;ARIH1;ARRDC1;RNF25;RNF34;RNF43;KLHL42;UBE2G1;UBE2T;CDC34;HLTF;BRAP;TRIM14;USP7;UBE2C;ISG15;MIB1;ASB4;PSMB8;FBXL8;VHL;SKP2;ANAPC7;FBXO7;DTX1;HUWE1;TRIM39;TRIP12;ELOC;DTX3;FBXO31;PSMA5;PSMD4;RTF1;UBE3C;PSMB3;FBXO22;VPS18;FBXW4;DTX3L;PSMD3;RNF125;TRIM25;RACK1;SMURF2;RUSC1;RNF135;CCNF;RNF115;TOPORS
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.6023354097557351,-1.6123439971259863,0.02030456852791878,0.09384228186749338,1.0,9/17,21.89%,SYK;CD28;FCER1G;SLC7A5;RARA;GATA3;LGALS9;NLRP3;CEBPB
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.49739355291281095,-1.6108992617336433,0.008665511265164644,0.09485662975161481,1.0,24/41,30.34%,OGT;NUP50;PRKAG2;NUP42;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;NUP62;PRKAG1;ZBTB7A;RANBP2;EIF6;NUP37;EP300;PGAM1;AAAS;NUP133
prerank,ether lipid metabolic process (GO:0046485),-0.636209656433788,-1.6101402697102913,0.02434782608695652,0.09518282863743853,1.0,9/14,24.15%,NCEH1;TMEM86B;AGMO;PLA2G7;PLAAT3;PEX7;PLA2G6;PAFAH1B1;LIPE
prerank,response to molecule of bacterial origin (GO:0002237),-0.4511719662932173,-1.6097045159716632,0.0017271157167530224,0.09534317283841336,1.0,19/69,14.06%,FOXP1;MAPKAPK3;OTUD5;C4B;MAPKAPK2;TAB2;PELI1;TLR4;IRF5;PTPN22;CYRIB;IRAK3;ERBIN;TRIB1;LY96;IFNAR1;HMGB2;FCGR2B;GCH1
prerank,carbohydrate biosynthetic process (GO:0016051),0.5648747209572333,1.6090972261659966,0.03317535545023697,0.12340771722175561,1.0,9/21,20.63%,B3GALT1;FUT9;B3GALT5;FUT8;ST3GAL6;B4GALNT2;B3GALT4;ST6GALNAC5;MPDU1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.4366336540831439,-1.60874109606439,0.00333889816360601,0.0959410662086349,1.0,33/80,22.66%,RAB7B;RAB7A;SNX3;SNX2;VTI1A;VPS54;SNX8;SGSM2;SNX6;SNX5;ANKFY1;TBC1D5;TBC1D17;VPS26B;DCTN1;RAB29;VPS26A;STX5;TBC1D10B;TBC1D23;TMEM87B;STX16;BAIAP3;SPAG9;ARL1;TMEM87A;SNX1;VPS51;TBC1D10C;SNX32;VPS50;PHETA1;BET1L
prerank,phosphorylation (GO:0016310),-0.3522482065403099,-1.6070558984365375,0.0,0.09722613206245126,1.0,131/385,23.02%,LYN;PRKCH;FNIP2;MAP3K5;TAOK3;PRKCB;FGR;FAM20C;DAPK1;SYK;PAK2;CDK6;PRKCD;ROCK1;MAP4K3;BIRC6;RUNX3;MAP3K1;ERN1;MAP3K20;INSR;DGKZ;PEAK1;CSNK2A1;PANK2;PRKAG2;VRK2;CDK13;RNASEL;MINK1;MAML1;TLK1;MAPKAPK2;NADK;HTR2B;SGK1;GRK3;STAT3;DYRK2;TEC;PIM1;PTK2B;DAPK3;STK3;PIK3CB;PIK3CG;CDK18;IRAK3;GAS6;DGKD;CAMKK2;GRK5;PLK2;EIF2AK2;COQ8A;STK38;TGFBR1;TRIB1;JAK1;CDK14;NEK6;FGGY;RSKR;MORC3;SIK1;TRIB2;POMK;TAOK1;LCK;APP;GNPTAB;CDK1;DYRK1A;MAP2K1;PPP4R1;PIK3CA;STK11;IGFBP3;STK17B;FRK;STK24;MKNK1;ACVR2A;PIK3CD;GMFG;TGFBR2;MAST2;MARK2;IKBKB;GMFB;TXK;CCNE1;MKNK2;DGKG;LATS2;STRADA;SPHK2;CDKL4;AURKA;ZAP70;RARA;PGK1;BRD2;PKN3;RYK;HCK;HCST;STK10;TAOK2;IP6K3;MAK;PAK6;ATM;CHEK1;BMPR2;CDC42BPG;CDK16;WNK1;GSK3B;COPS8;CDK5;PRKAG1;GRK6;SRPK1;MAP4K4;MAPK1;RPS6KA5;ILK;NEK3;PRKDC;TYK2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.42223519614801774,-1.6062277053905756,0.004966887417218543,0.09764930770383055,1.0,43/94,29.09%,FNIP2;MAP3K5;APAF1;MCL1;PRKCD;ITPR1;ERN1;TNFRSF1B;BCL2L11;BRCA1;BCL2;CRIP1;E2F1;CASP4;DDX5;ATP2A3;MLLT11;STK11;STK24;TRAF2;CUL2;BBC3;QRICH1;CASP2;DDX3X;ATM;C1QBP;BAG6;SFN;BCL2L2;CEBPB;TOPORS;PRKDC;RRP8;ERO1A;CYP1B1;ERN2;DIABLO;PML;CUL3;MYBBP1A;BCL2L1;BNIP3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.41144765745299583,1.606117919611149,0.0025575447570332483,0.12546414077639972,1.0,28/85,18.66%,GRM7;PCDH15;LHFPL3;PAX3;COL11A1;DCDC2;ADGRV1;COL4A3;SPTBN4;TSPEAR;TFAP2A;ESPNL;OTOS;WHRN;TBX1;EML2;NDUFB9;TMIE;CLRN1;TIMM10;PDZD7;USH2A;ATP2B2;USP53;EPS8L2;ROR1;COL1A1;ALDH7A1
prerank,regulation of cellular component movement (GO:0051270),-0.47305728081569065,-1.6056612179311822,0.0032733224222585926,0.09798040307137316,1.0,15/49,8.63%,DIAPH1;LYN;SP100;CDK6;ROCK1;RHOA;FES;CD9;ABL2;ARAP1;DAPK3;ARHGAP18;ZSWIM8;VEGFA;TGFBR1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.40820941185996323,-1.605415333089827,0.001584786053882726,0.09791393775373773,1.0,38/121,18.46%,LYN;PTPRC;NEDD9;NRP1;CD44;BANK1;IGF1;CD74;PLCG2;PAK2;ITGA5;PTPRJ;ARHGEF2;IL6R;STAT3;PIBF1;IL15;TEC;IL18;PARP14;PTK2B;HGF;GAS6;VEGFA;PARP9;AGT;CLEC6A;CCL5;GREM1;CD40;IL34;CSPG4;IL31RA;HCLS1;GPRC5B;LILRA5;SOCS3;PTPN11
prerank,indolalkylamine catabolic process (GO:0046218),-0.7031648354064901,-1.6049038905054585,0.0125,0.09809490620133449,1.0,4/10,12.50%,KYNU;KMO;KYAT1;IL4I1
prerank,centromere complex assembly (GO:0034508),-0.4987817608409496,-1.6045358261873168,0.008605851979345954,0.09815510393770682,1.0,17/36,25.87%,SMARCA5;KNL1;MIS18BP1;CENPF;DLGAP5;CENPA;CENPE;CENPK;CENPN;CENPL;POGZ;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.46563667493831085,-1.6042600895615007,0.0015923566878980893,0.0981433067310216,1.0,30/58,27.50%,NSMCE2;BRCA1;UVRAG;ERCC6;DCLRE1C;ABRAXAS1;BABAM2;KDM2A;RNF8;DCLRE1A;XRCC6;BABAM1;HMGB2;XRCC4;ERCC4;LIG3;BRCC3;HMGB1;ATM;NBN;ZBTB7A;POLB;PRKDC;UBE2V2;DNTT;SMC5;UBE2N;MRE11;DCLRE1B;UIMC1
prerank,endothelial tube morphogenesis (GO:0061154),-0.688780947763185,-1.6042390998147875,0.022530329289428077,0.09789335804968002,1.0,3/10,7.15%,RBPJ;RHOA;CTNNB1
prerank,actin filament organization (GO:0007015),-0.3913750270779852,-1.603963152108465,0.0032520325203252032,0.09785858854170368,1.0,34/151,11.84%,MYO5A;NEDD9;ABI1;CORO1C;ARHGAP25;RAC1;MYO1F;RHOA;EPS8;ARHGAP17;FLNA;ARHGEF2;GAS2L3;SVIL;CDC42;RUFY3;MYO1G;TRIOBP;WASL;TPM3;TPM4;CAPG;NRAP;HIP1;BAIAP2;MARCKSL1;SH3BP1;CORO7;LCP1;MYO1E;ARHGAP12;CDC42EP2;MYO7A;BAIAP2L2
prerank,macrophage activation involved in immune response (GO:0002281),-0.653082944084546,-1.6033679590057233,0.01507537688442211,0.09814553186362605,1.0,5/13,7.30%,SYK;PLCG2;SBNO2;IFI35;GRN
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5556179438423742,-1.6026911993797115,0.012237762237762238,0.09854566393048185,1.0,8/24,9.54%,RBPJ;NFE2L2;ATF3;MBTPS2;ATF6;VEGFA;HIF1A;MAPK7
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.4643582020937352,-1.6020805465211232,0.008710801393728223,0.09879214537155045,1.0,27/54,27.60%,CRADD;CNOT4;CNOT1;CNOT2;PLK2;E2F1;PRMT1;CDK1;PCNA;GADD45A;PLK3;E2F8;CNOT6L;AURKA;CASP2;MDM4;ATM;CNOT8;CDC25C;SFN;GTSE1;CCNB1;PCBP4;RBL2;CNOT3;PML;EP300
prerank,cellular response to ionizing radiation (GO:0071479),-0.4779818909966372,-1.601429368278504,0.011608623548922056,0.09915142030285638,1.0,23/47,25.98%,GRB2;MAP3K20;SPIDR;NIPBL;BLM;MAPK14;RAD1;RAD51;NUCKS1;XRCC6;WRN;GADD45A;RHNO1;RAD51AP1;INO80;TMEM109;RAD9A;ATM;KDM1A;CRYAB;ECT2;EEF1D;CLOCK
prerank,cholesterol transport (GO:0030301),-0.4815410868685952,-1.6009674530508315,0.015384615384615385,0.09933801230517363,1.0,9/45,11.01%,APOE;ABCA1;MSR1;ABCG1;CD36;OSBPL5;LIMA1;STARD5;NPC2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.5963335325980497,-1.600704112879064,0.019538188277087035,0.09931993441394428,1.0,7/18,9.89%,CD74;RAC1;CAMK1D;RIPOR2;MDK;ADAM8;NCKAP1L
prerank,positive regulation of endocytosis (GO:0045807),-0.4741987574315484,-1.6006636124807236,0.012861736334405145,0.09908552280008831,1.0,21/45,16.42%,DAB2;APOE;LRP1;AXL;CBL;ANO6;RAB31;CDC42;STAP1;ANKFY1;C3;HIP1;CBLL1;B2M;RAB21;NCKAP1L;NEDD4L;SERPINE1;ABCA13;CLN3;APPL2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.5321957737573831,-1.6003906193977189,0.01073345259391771,0.09907154159664092,1.0,9/30,10.16%,LYN;IGF1;NOTCH2;GRB2;VAV1;RASGRP4;ITGAV;ERBIN;TGM2
prerank,response to tumor necrosis factor (GO:0034612),-0.418820412444038,-1.6002484869445308,0.006980802792321117,0.09894834408671833,1.0,30/91,21.34%,PID1;MAP4K3;NFE2L2;ARHGEF2;RIPK1;BRCA1;DHX9;ADAM9;TNFRSF21;YTHDC2;NUB1;ERBIN;GSDME;ZFAND6;GBP2;RELA;CXCL16;CCL5;CIB1;GCH1;CD40;IKBKB;CASP8;GATA3;RPS3;TRADD;GBP3;SFRP1;ZC3H12A;ASAH1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.4118323605638237,-1.600146835874376,0.0016474464579901153,0.09879277537183978,1.0,39/107,23.54%,MAP3K5;NIBAN1;JUN;ITPR1;ERN1;BCL2L11;ATF3;MBTPS2;ATG10;BCL2;PPP1R15B;ATF6;WFS1;CREB3L2;RCN3;CASP4;DNAJB9;ATP2A3;SELENOS;DERL1;SEL1L;HSP90B1;UBXN6;TRAF2;RNF185;BBC3;TMEM259;QRICH1;HYOU1;PDIA4;ERP44;ERLEC1;GSK3B;BAG6;CEBPB;UFM1;P4HB;ERO1A;PDIA3
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6271668542798907,-1.5997819828935471,0.01592920353982301,0.09885215893511243,1.0,3/15,1.14%,APOE;ABCG1;PLTP
prerank,positive regulation of cell killing (GO:0031343),-0.6517816788454027,-1.5996026857829833,0.025044722719141325,0.09874695501037066,1.0,3/13,1.55%,SYK;CYBA;RAC1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6705555429079446,1.5987657131279627,0.034324942791762014,0.13165273256695292,1.0,3/10,3.75%,UPP2;DPYD;DPYS
prerank,regulation of glycolytic process (GO:0006110),-0.44784763655317295,-1.598626267954208,0.005110732538330494,0.0993533569343338,1.0,21/68,13.15%,IGF1;P2RX7;NUPR1;OGT;INSR;NUP50;PRKAG2;NUP42;PFKFB3;CBFA2T3;NUP88;RAE1;HIF1A;ARNT;NUP205;ZBTB20;PFKFB4;APP;TPR;JMJD8;NUP188
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.5991619488572981,-1.5983209536523504,0.025179856115107913,0.09934869324619977,1.0,4/18,4.11%,LILRB1;LILRB3;GPR137B;TLR4
prerank,neuromuscular process controlling balance (GO:0050885),0.6322975863070848,1.5982097840210703,0.044444444444444446,0.13147877967187976,1.0,2/12,0.23%,NRXN1;PCDH15
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5575128922676645,-1.5967772676343557,0.01867572156196944,0.10043922140503594,1.0,8/24,12.16%,APOE;UCHL5;PSME3;PTK2B;NUB1;RHBDF1;CTSC;UBE3A
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6254469834640506,1.596686467729481,0.03990610328638498,0.13218107945290936,1.0,3/13,3.44%,B3GALT1;B3GALT5;GAL3ST3
prerank,positive regulation of neurogenesis (GO:0050769),0.42356595311212286,1.5959984963681468,0.0025974025974025974,0.13207748426739094,1.0,17/68,9.67%,ROBO1;PTPRD;IL1RAPL1;ROBO2;SOX11;SLIT2;NTRK2;CDKL5;SLITRK1;MME;SHANK3;CUX2;NUMB;CX3CR1;PLXNA4;CAPRIN2;RASSF10
prerank,regulation of ion transport (GO:0043269),0.42500386335569734,1.595629862688069,0.0024752475247524753,0.1316398052373566,1.0,20/76,8.73%,NKAIN2;ANK3;SYT1;NKAIN3;SYT10;SYT2;GDNF;KCNJ3;KCNJ10;KCNJ6;CA2;ITGB3;KCNJ9;SYT5;KCNJ16;TOR1A;SPTBN4;NEDD4;SYT11;SYT12
prerank,regulation of DNA repair (GO:0006282),-0.4830746403351945,-1.5951849059777596,0.0051813471502590676,0.10157277267490473,1.0,26/44,27.50%,DEK;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;RNF8;PCNA;BABAM1;KAT7;RADX;TMEM161A;RAD52;EYA1;EYA3;RPS3;WRAP53;BRCC3;TRIP12;UBE2V2;TRIM28;UBE2N;PML;UIMC1
prerank,regulation of monocyte differentiation (GO:0045655),-0.6389808122368109,-1.5941617697991655,0.017271157167530225,0.10223672229209892,1.0,9/14,26.84%,FOXP1;CD74;CDK6;FES;ACIN1;IL34;CSF1;MYC;ZFP36L1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.6965780236018428,-1.593650977242676,0.02097902097902098,0.10240241994060977,1.0,4/10,7.18%,LYN;LILRB1;AXL;GAS6
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.7008722666229009,-1.5919121767435156,0.01549053356282272,0.1037316164181333,1.0,3/10,0.99%,LYN;FGR;LILRB1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.6088153586142002,-1.5918687630073487,0.02268760907504363,0.10350330281645947,1.0,7/17,19.37%,CCR2;ANO6;CCR1;CCL5;SERPINE1;PLA2G7;HMGB1
prerank,regulation of response to external stimulus (GO:0032101),-0.3989042255172538,-1.5916535950320663,0.0,0.10346869306217167,1.0,44/121,25.51%,FOXP1;FGR;BIRC3;CCR2;BCL6;SAMHD1;CD36;P2RX4;PIK3AP1;SBNO2;BRD4;USP18;DHX58;AREL1;PTPN22;ANXA1;TRAF3;CYRIB;GRN;MYD88;CASP4;DAGLB;RELA;CELF1;FCGR2B;CASP1;STK24;TMSB4X;CXCR4;BST1;APPL2;CASP8;HCK;PPEF1;NOD2;APPL1;RNF135;NMT1;SETD6;LRRC19;SEMA7A;GUCY2F;GUCY2D;ZMPSTE24
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6553049059073357,-1.5911845182983961,0.024054982817869417,0.10364228327261314,1.0,7/13,20.02%,NUPR1;MBTPS2;NR1H2;WFS1;FCGR2B;MANF;LPCAT3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.5548293173972212,-1.591099996449661,0.021164021164021163,0.10347981133837421,1.0,13/25,22.80%,STAT3;FOXO3;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A;HSPA1A;STAT1;PRKDC
prerank,cellular response to fluid shear stress (GO:0071498),-0.6680785083175305,-1.5908805835478321,0.03166666666666667,0.10342961062507675,1.0,7/12,16.40%,MTSS1;NFE2L2;MAP2K5;MEF2C;MAPK7;KLF2;ASS1
prerank,response to estrogen (GO:0043627),-0.5146717183902835,-1.590142851711143,0.012280701754385965,0.10396080947797305,1.0,16/31,28.55%,BRCA1;WBP2;SERPINB9;KMT2D;TRIM24;RARA;GATA3;ARID5A;SFRP1;TRIM25;RBBP5;ASH2L;ESR1;EP300;CITED2;GHRL
prerank,mitotic recombination (GO:0006312),-0.6203618445357884,-1.5899594365981609,0.026041666666666668,0.10385578548170701,1.0,10/15,24.23%,NSMCE2;TEP1;RAD51;GEN1;RAD54B;RAD52;XRCC3;DMC1;SMC6;SMC5
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.48925033203889035,-1.5892573040135995,0.012259194395796848,0.1042504827479266,1.0,14/40,20.26%,SLC16A7;SLC38A6;SLC38A10;SLC27A1;SLC7A7;SLC38A7;SLC36A4;ABCC1;SLC7A5;SLC23A1;SLC23A2;SLC38A2;SLC25A10;SLC16A1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.44405776549016795,-1.5892110706842386,0.008756567425569177,0.10402865630199495,1.0,18/67,12.66%,LYN;FGR;ABI1;SYK;INSR;IGF1R;FES;ABL2;PIBF1;IL15;TEC;FLT1;PTK2B;PKDCC;PTPN6;LCK;DYRK1A;ITK
prerank,regulation of viral genome replication (GO:0045069),-0.46020297148039946,-1.5891275234439923,0.011864406779661017,0.10385825177456018,1.0,20/56,21.84%,FAM111A;ZC3HAV1;RNASEL;RSAD2;EIF2AK2;BST2;CD28;IFITM2;IFIT1;OASL;CCL5;OAS3;MAVS;VAPB;ISG15;PARP10;DDX3X;OAS2;IFITM1;SRPK1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.647231850905059,-1.5881937116187093,0.013961605584642234,0.10443178698700836,1.0,5/13,7.14%,NRP1;PLXNC1;PLXNA1;PLXND1;NRP2
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.6164868548139766,-1.5875741923546791,0.02531645569620253,0.10468029613651814,1.0,3/16,1.57%,APOE;LRP1;ROCK1
prerank,presynaptic endocytosis (GO:0140238),0.5314495000381754,1.5874211254223554,0.017857142857142856,0.13891724448862083,1.0,7/24,6.51%,NLGN1;SYT1;AMPH;SYNJ2;SYT2;STON1;SYT5
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.42784561705393986,-1.5873304137222242,0.005016722408026756,0.10460624154174814,1.0,30/79,15.33%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;ACTR1B;SEC24D;CTSS;FCGR2B;CAPZA1;FCER1G;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.4461974154855683,-1.5871181808552268,0.010273972602739725,0.10453256001798453,1.0,35/61,27.50%,BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;HGF;RTEL1;USP9X;BABAM2;CEBPG;RAD51;RNF8;WRN;PCNA;BABAM1;DHX36;APLF;TMEM161A;OTUD4;USP7;EYA1;EYA3;RPS3;PDGFRB;WRAP53;BRCC3;HMGB1;NBN;MYC;FGFR4;TRIM28;UBE2N;MRE11;PML;UIMC1
prerank,snRNA transcription (GO:0009301),-0.4433607499432636,-1.586655805065061,0.006993006993006993,0.1046765165413595,1.0,29/70,22.59%,GTF2A1;INTS8;NABP1;INTS11;SRRT;TAF6;POLR2H;POLR2F;POLR2L;SNAPC2;INTS6;INTS14;RPRD2;GTF2E2;POLR2A;NCBP1;USPL1;TAF8;INTS1;POLR2G;TAF9;SNAPC3;PHAX;INTS5;POLR2I;CCNK;GTF2F2;GTF2A2;ELL2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5322771636960244,-1.5864414843401473,0.0070052539404553416,0.1046185084533969,1.0,8/30,9.22%,PTPRC;CD300A;PRKCD;PIBF1;PARP14;MVP;NF2;PTPN6
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4913751087733272,-1.5861360660420594,0.012152777777777778,0.10462564484065935,1.0,13/36,20.64%,SGMS1;CRADD;RB1;CSNK2A1;BCL2;TGFBR1;TRAF1;STYXL1;TMBIM6;DEPTOR;RPS3;TRIM39;MAZ
prerank,regulation of B cell apoptotic process (GO:0002902),-0.6476965620379913,-1.586122698399941,0.01950354609929078,0.104364733008139,1.0,4/12,8.48%,LYN;FOXP1;BCL6;FNIP1
prerank,negative regulation of viral process (GO:0048525),-0.4569165337141794,-1.5855734902551955,0.012345679012345678,0.10461215462655335,1.0,24/57,26.75%,FAM111A;ZC3HAV1;UBP1;RNASEL;RSAD2;EIF2AK2;BST2;IFITM2;IFIT1;OASL;CCL5;OAS3;TRIM11;MAVS;TRIM14;ISG15;PARP10;OAS2;STAT1;IFITM1;SRPK1;TRIM28;LARP7;PML
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.42898946211757427,-1.5840555223022426,0.003367003367003367,0.10558032902871417,1.0,30/78,15.33%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;ACTR1B;SEC24D;CTSS;FCGR2B;CAPZA1;FCER1G;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.42898946211757427,-1.5840555223022426,0.003367003367003367,0.10558032902871417,1.0,30/78,15.33%,CD74;CTSD;RAB7A;KLC1;DNM2;CANX;CAPZB;KIF3B;KIF11;DYNC1H1;KIF23;KIF15;AP1G1;KIF4A;AP2A2;CENPE;AP1S3;SEC24A;DCTN1;ACTR1B;SEC24D;CTSS;FCGR2B;CAPZA1;FCER1G;SEC31A;RACGAP1;KIF2C;CTSE;DYNC1LI2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5637363581112007,1.5840475759813486,0.029213483146067417,0.14135734277996423,1.0,8/19,13.39%,DLG2;LRRC7;DLG3;PARD3;PRKCI;MTCL1;CRB1;PATJ
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.5133363434146755,-1.5840162899270707,0.006756756756756757,0.10535318882923762,1.0,14/33,18.15%,CD300A;PTPRJ;DGKZ;CARD11;RC3H1;PTPN22;DUSP3;LAPTM5;RELA;LCK;RAB29;CD226;TESPA1;RPS3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6169583474144853,-1.583970418428071,0.024390243902439025,0.10513325287984392,1.0,7/15,21.23%,IGF1R;TEC;PTK2B;DYRK1A;ITK;TXK;KDR
prerank,calcium ion import into cytosol (GO:1902656),0.6012723722816136,1.583775609917246,0.03278688524590164,0.14085810743597785,1.0,8/15,19.02%,CACNA2D1;SLC24A2;SLC8A3;SLC8A2;ATP2B4;TRPV3;TRPM2;SLC24A1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.39413558233005397,-1.583738991664578,0.0016638935108153079,0.10511775546585661,1.0,47/136,21.77%,SP100;RB1;PEX14;NUPR1;ANXA4;FLNA;IRAK2;SPI1;ARRB2;WWP2;PIM1;NLRC5;PRMT2;AIM2;MDFI;RBCK1;TRAF3;ARRB1;IRAK3;GAS6;WFS1;BHLHE40;MAP2K5;ERBIN;EGLN1;CEBPG;TRIB1;OTULIN;SIK1;FOXJ1;NLRC3;NFKBIL1;ID2;TMSB4X;MAP3K10;USP7;PARP10;TAF3;SMAD7;CMKLR1;ID1;SUFU;ZC3H12A;KDM1A;NLRP3;ID3;HEYL
prerank,receptor-mediated endocytosis (GO:0006898),-0.39309277697935524,-1.5828583421289086,0.0033003300330033004,0.10567760678378627,1.0,29/132,7.99%,DAB2;MRC1;APOE;MSR1;GRB2;CD163;LILRB1;STAB1;SYK;LRP1;CD36;ITGB2;DNM2;SNX9;CANX;INSR;RAB31;CD9;ARRB2;GRK3;ITGB1;DNAJC13;AP1G1;FCHO2;LRP6;PICALM;PI4KB;EPS15;AP2A2
prerank,regulation of humoral immune response (GO:0002920),-0.4877907967041426,-1.5826620085408918,0.01192504258943782,0.10558232515017364,1.0,13/44,19.96%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;FCGR2B;C1QC;C1QBP;C2
prerank,histone H4-K8 acetylation (GO:0043982),-0.6269469740843174,-1.582426795457464,0.010452961672473868,0.10526992116406969,1.0,6/15,12.61%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7
prerank,histone H4-K5 acetylation (GO:0043981),-0.6269469740843174,-1.582426795457464,0.010452961672473868,0.10526992116406969,1.0,6/15,12.61%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7
prerank,regulation of striated muscle contraction (GO:0006942),0.5284281189602315,1.5824263738100959,0.022935779816513763,0.1414052047405336,1.0,9/27,15.85%,ANK2;DMD;RYR2;SLC8A3;TNNI1;CALM1;CALM3;CALM2;SCN10A
prerank,cellular response to dsRNA (GO:0071359),-0.6154598138548271,-1.582291645138541,0.025996533795493933,0.1051403425880117,1.0,7/15,17.46%,CGAS;RIOK3;DHX9;IFIT1;MAVS;ZCCHC3;RALB
prerank,nucleic acid metabolic process (GO:0090304),-0.43855546166522047,-1.5821895756350073,0.006872852233676976,0.10495156959501757,1.0,34/69,27.43%,HNRNPA3;HNRNPH1;POLR2H;HNRNPL;POLR2F;POLR2L;DUSP11;PCBP2;WRN;DNASE1L1;FEN1;METTL14;POLR2A;NCBP1;DDX1;WTAP;TOPBP1;POLR2G;DNA2;HNRNPA1;ENPP1;MMS19;POLR2I;HNRNPH2;DDX54;HNRNPK;XRN2;GTF2F2;DNTT;DNASE2;GTF2F1;RECQL5;HNRNPF;METTL3
prerank,iron ion transport (GO:0006826),-0.47442913823030863,-1.5816173290785365,0.005357142857142857,0.10525903112415874,1.0,15/47,20.46%,ATP6V0D2;ATP6V1E1;IREB2;DNM2;ABCB7;ATP6V1A;TCIRG1;STEAP3;ATP6V1G1;CP;RAB11B;ATP6V0B;ATP6V0E1;SLC11A2;ATP6V0D1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.6906949421332806,-1.581553069676698,0.015517241379310345,0.10504706843697457,1.0,4/10,12.65%,RB1;C5AR1;EGR1;HSP90AB1
prerank,nucleosome organization (GO:0034728),-0.4518068625063617,-1.5813480675159066,0.010084033613445379,0.10498757059668605,1.0,18/55,18.84%,ARID2;BPTF;SMARCA5;SMARCD3;ANP32B;SMARCC2;ARID1A;RNF8;NFE2;ASF1A;HMGB2;SPTY2D1;PADI4;SART3;INO80;CHAF1A;BRD2;RSF1
prerank,regulation of axonogenesis (GO:0050770),0.44107565550797306,1.5806381303481711,0.0,0.14261282269742998,1.0,9/51,3.22%,LRRC4C;ROBO1;ROBO2;CDH2;SLIT2;NTRK2;LINGO1;PAK3;SLITRK1
prerank,regulation of endocytosis (GO:0030100),-0.4437177190338435,-1.5804610873259934,0.006896551724137931,0.10560971109253237,1.0,15/61,10.66%,DAB2;APOE;MCTP1;LILRB1;LRP1;ROCK1;ABL2;CD22;PICALM;SNX33;HIP1;CBLL1;RAB5A;PACSIN2;NEDD4L
prerank,positive regulation of cholesterol transport (GO:0032376),-0.5391800083517588,-1.5799821725631116,0.01763668430335097,0.10578853258473035,1.0,9/27,15.21%,APOE;PLTP;LRP1;EEPD1;PPARG;NR1H2;ZDHHC8;RXRA;ABCA13
prerank,positive regulation of immune system process (GO:0002684),-0.6102482568035941,-1.5795864826757595,0.022375215146299483,0.10593701787488115,1.0,9/16,18.85%,IL15;ANXA1;RSAD2;PIK3CB;VEGFA;NCKAP1L;PIK3CD;MIA3;LGALS9
prerank,regulation of actin filament depolymerization (GO:0030834),-0.6657168379958268,-1.5795573078460743,0.01565217391304348,0.1057083168336045,1.0,6/12,11.79%,PLEK;SH3BP1;LIMA1;WDR1;MTPN;PIK3CA
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6631311806115265,-1.5794568529818749,0.010291595197255575,0.10558046702599069,1.0,5/12,15.91%,RHOA;DOCK8;APP;CCL5;SPN
prerank,cardiac muscle contraction (GO:0060048),0.48864143775243585,1.578336131054207,0.009615384615384616,0.14402771262596906,1.0,10/34,11.10%,DMD;RYR2;SCN2B;CASQ2;TNNI1;TNNT2;MYH7;ATP1B1;GSN;TTN
prerank,membrane raft organization (GO:0031579),-0.6109485318383271,-1.5783197234737436,0.01697792869269949,0.10644557942203249,1.0,7/15,21.12%,RFTN1;ANXA2;MYADM;FLOT2;NPC1;CLN3;PPT1
prerank,positive regulation of viral process (GO:0048524),-0.44998331275097225,-1.5783157798391765,0.0068143100511073255,0.10619393502623573,1.0,30/60,35.10%,MDFIC;AXL;RAB7A;NELFB;DHX9;POLR2H;POLR2F;CD28;POLR2L;IFIT1;CCL5;POLR2A;VAPB;POLR2G;RSF1;DDX3X;VPS4A;POLR2I;SRPK1;GTF2F2;DDB1;GTF2F1;NELFE;HACD3;PPID;POLR2D;NELFA;ADARB1;RAD23A;POLR2B
prerank,chromosome condensation (GO:0030261),-0.49424992642994814,-1.5779573879793396,0.023972602739726026,0.10628727023359329,1.0,20/36,26.18%,RB1;CSNK2A1;NCAPG2;TOP2A;INCENP;SMC4;NCAPH;MCPH1;ACIN1;CDK1;CHMP1A;NUSAP1;NCAPD3;KMT5A;PHF13;NCAPG;SET;CCNB1;AKAP8L;ERN2
prerank,regulation of hemopoiesis (GO:1903706),-0.6902163665841754,-1.5776631655088273,0.021314387211367674,0.10631040682440773,1.0,4/10,8.87%,RUNX1;PRKCB;CREBBP;CBFB
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.5745373855136592,-1.5774618310518438,0.017452006980802792,0.10623194115456855,1.0,6/19,9.89%,CD74;RAC1;CAMK1D;RIPOR2;MDK;NCKAP1L
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.38657230246465035,-1.5773948819569676,0.001564945226917058,0.10608730338236619,1.0,50/148,21.66%,TOP3A;BRD7;PHF20;CSNK2A1;PIP4K2A;PRKAG2;BRCA1;SGK1;DYRK2;CHD3;BLM;MAPK14;RPS20;RPL11;SMYD2;RAD1;TAF6;PIP4P1;TPX2;PIN1;WRN;CDK1;STK11;EXO1;PLK3;RPA3;RFC2;RHNO1;RNF34;TAF4B;PAK1IP1;TOPBP1;BRIP1;USP7;KMT5A;TAF9;RBBP4;AURKA;TAF3;RAD9A;DNA2;RBBP8;TAF4;MDM4;ATM;CHEK1;RFC3;NBN;CDK5;PRKAG1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4671632416235446,1.5772057165185511,0.02493765586034913,0.1442710524256169,1.0,14/41,10.87%,GRM5;DLG3;NTRK2;DOCK3;TGFA;CSF1R;EGF;SRCIN1;PRNP;BDNF;FYN;AREG;FBXW7;RELN
prerank,response to X-ray (GO:0010165),-0.6260889762152975,-1.5767871609285884,0.021996615905245348,0.10642534819028014,1.0,8/14,19.63%,NIPBL;ANXA1;BLM;NUCKS1;XRCC6;XRCC4;BRCC3;ATM
prerank,intracellular cholesterol transport (GO:0032367),-0.616870364089571,-1.5763104620292425,0.036458333333333336,0.10668118991777152,1.0,7/15,20.48%,ABCA1;ABCG1;LRP6;NPC2;NPC1;LDLR;VPS4A
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.6773379527932496,-1.5757693897648481,0.02460456942003515,0.10689849472240158,1.0,3/11,1.27%,LYN;MFHAS1;CYBA
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.5396139361385084,-1.5753723681775393,0.01694915254237288,0.10699727786840028,1.0,13/24,25.96%,LILRB1;CGAS;PTPN22;AIM2;PARP9;SIN3A;MAVS;ZDHHC1;DTX3L;ZC3H12A;STAT1;TOMM70;IL12RB1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.5356173063873555,-1.5747303718036405,0.02671118530884808,0.1073987152408939,1.0,12/26,25.05%,SPTLC2;ACER3;CYB5R3;CYB5B;GCH1;ARG2;SPHK2;SPTLC3;ASAH1;CYP1B1;NQO1;ABCA2
prerank,regulation of lymphocyte migration (GO:2000401),-0.6833217900891776,-1.574647577588,0.01877133105802048,0.10721344591350483,1.0,7/10,23.67%,MSN;WASL;MIA3;SPN;STK10;SLC8B1;ADTRP
prerank,regulation of interferon-gamma production (GO:0032649),-0.42894059434827714,-1.5745926924384641,0.009693053311793215,0.10704895491935573,1.0,29/71,22.48%,CCR2;LILRB1;TLR8;AXL;TLR7;TLR4;IL18;PTPN22;CYRIB;GAS6;SIRPA;LAPTM5;CEBPG;SCRIB;CD2;SLC7A5;TXK;ISG15;IL18R1;CD226;RARA;LGALS9;HMGB1;C1QBP;CD274;ZC3H12A;SLAMF6;INHA;NR1H4
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6696707021332103,-1.5744857870467135,0.0341726618705036,0.1068823803836456,1.0,6/11,9.23%,PARP11;PARP14;PARP4;TIPARP;PARP9;PARP8
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.5291738201714117,-1.5739542378482834,0.018581081081081082,0.10716706602517881,1.0,10/27,14.72%,MAP3K8;MAP3K5;MAP3K20;NFKB1;FBXW11;UBC;RPS27A;TNIP2;KAT7;IKBKB
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4755705467135602,-1.5736365291714836,0.006756756756756757,0.1072723587764939,1.0,30/44,39.64%,CD44;CSNK2A1;HGF;GAS6;VEGFA;MAP2K5;FNIP1;CAST;YWHAE;CST7;DDX3X;BEX3;DNAJB6;SFN;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;XIAP;TNF;KLF4;LTF;NGF;LAMP3;USP47;RAF1;TRIAP1
prerank,regulation of translational initiation (GO:0006446),-0.4449560124851719,-1.5735665408976174,0.008460236886632826,0.10709513362315967,1.0,38/63,33.45%,YTHDF3;AGO2;ATF3;PPP1R15B;KLHL25;EIF4G3;EIF4A2;EIF5;ALKBH1;EIF4EBP1;CSDE1;EIF4EBP2;EIF3E;TPR;CCL5;BOLL;NCBP1;EIF4G1;DDX1;POLR2G;DNAJC3;HSPB1;DDX3X;EIF5B;CEBPB;EIF3H;EIF1;MIF4GD;NCK1;EIF1B;EIF2B2;EIF2AK3;NCK2;POLR2D;ATF4;CTIF;RPS6KB1;EIF4H
prerank,mitochondrion distribution (GO:0048311),-0.644953622504646,-1.5734386052306475,0.030100334448160536,0.10695529717980735,1.0,3/12,2.65%,TRAK1;MEF2A;MTM1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6325353919183063,-1.57272094691255,0.025878003696857672,0.10740568212742686,1.0,4/13,8.64%,APOE;PLEK;NFKB1;ERLIN1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.46500958810594983,-1.5722023232929403,0.011844331641285956,0.10768875460028865,1.0,26/49,33.28%,SGMS1;MCL1;NUPR1;BCL2L11;BCL2;PLAUR;GSDME;FIS1;STYXL1;LCK;BBC3;BID;DDX3X;RACK1;BCL2L2;BECN1;P4HB;URI1;RTKN2;NOC2L;EIF2AK3;BCL2L1;PTPMT1;CAV1;NDUFS3;MMP9
prerank,embryonic appendage morphogenesis (GO:0035113),-0.6451144878007569,-1.5721408553171865,0.02608695652173913,0.10749542213787186,1.0,5/12,21.71%,MBNL1;LRP6;SKI;FBXW4;MEGF8
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5307883487548576,-1.5717008068630438,0.010238907849829351,0.10761527882323535,1.0,12/27,23.38%,AGO2;RIPK1;STAT3;DHX9;PUM2;DDX5;MAP2K1;EIF4G1;DDX6;IL6;PUM1;TGFB1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6128446014654859,1.5712674251848686,0.02040816326530612,0.14961277869764536,1.0,8/14,18.59%,ANK3;DMD;TESC;ATP1B1;GLRX;WNK4;WNK3;WNK2
prerank,DNA replication initiation (GO:0006270),-0.495736859150427,-1.5701155976422636,0.015957446808510637,0.108855845601541,1.0,20/37,34.40%,POLE2;NOC3L;MCM6;MCM3;DBF4;ORC5;RPA3;CDC34;TOPBP1;MCM2;PRIM1;LRWD1;PRIM2;CDC45;MCM5;ORC3;ORC6;MCM7;POLE;POLA2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.4679695650945495,-1.5700196115479235,0.005136986301369863,0.10870560991994087,1.0,24/46,28.03%,MSN;PAK2;RAP1B;PITPNA;ANXA2;CDC42;HSPA9;HNRNPDL;STAT4;JAK1;LMNB1;LCP1;CAPZA1;CFL1;RPLP0;GSTO1;CNN2;TYK2;MTAP;P4HB;IL12RB1;TALDO1;HNRNPF;SERPINB2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.4384748604248308,-1.569388647661874,0.010327022375215147,0.10911000424917194,1.0,20/63,20.24%,IGF1;SP100;PAK2;BIRC6;RIPK1;CFLAR;PSME3;ITGAV;TGFBR1;RELA;TRAF1;AGT;TRAF2;BID;TNFSF10;STX4;DEPTOR;CASP8;TRADD;TMC8
prerank,platelet degranulation (GO:0002576),-0.4017096227440828,-1.569233483667833,0.003257328990228013,0.1090427797302915,1.0,41/118,22.07%,F13A1;LYN;IGF1;PSAP;PLEK;PHACTR2;CD36;FLNA;TAGLN2;CD9;CYB5R1;LAMP2;LHFPL2;SRGN;ANXA5;TLN1;PF4;FN1;HGF;CYRIB;PROS1;TEX264;GAS6;VEGFA;CD63;WDR1;APP;SERPINE1;ABCC4;MANF;TMSB4X;LGALS3BP;APLP2;ENDOD1;FAM3C;GTPBP2;F5;FERMT3;PDGFA;APOH;TUBA4A
prerank,intracellular pH reduction (GO:0051452),-0.5007386340303259,-1.5686554038898515,0.0176678445229682,0.10938671037116787,1.0,10/33,16.62%,ATP6V0D2;ATP6V1E1;RAB7A;ATP6V1A;RAB20;TCIRG1;ATP6V1G1;ATP6V0B;ATP6V0E1;RAB39A
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.656448492758649,-1.5686135738107831,0.03859649122807018,0.10919261036190485,1.0,5/12,5.73%,ABCA1;ABCG1;PPARG;ITGAV;NR1H2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.3517286384444145,-1.5678296936269678,0.0,0.10969664397958026,1.0,114/341,22.27%,RNF213;WWP1;CBL;ZNRF3;CNOT4;RNF150;BFAR;BIRC6;RNF149;RNF19A;NFE2L2;RNF111;PSME4;ARRB2;MYLIP;WWP2;FBXL17;AMFR;AREL1;RNF166;PELI1;PSMB7;ANAPC1;TNFAIP1;PSME3;RC3H1;RNF20;FBXW11;UBE2R2;PSMB9;KLHL25;TSG101;RBCK1;ARRB1;UBAP1;KLHL22;UBE3B;NUB1;CTNNB1;TBL1XR1;USP9X;ZFAND2A;KCTD10;ZSWIM8;ATXN3;RNF4;MVB12B;TGFB1I1;ATE1;SPSB2;PSMA8;UBE2L3;RNF8;PSMC3;KIF14;UBE4B;NEDD4L;SPSB3;XBP1;PCBP2;PSMD8;MAEA;WDR91;RNF128;FBXO10;UHRF1;BUB1B;UBE2H;PSMC4;PSMB10;RNF185;PSMA1;ARIH1;ARRDC1;RNF34;RNF43;KLHL42;UBE2G1;RNF216;CDC34;UBQLN4;FAF1;UBE2C;MIB1;UBE2I;PSMB8;SKP2;AURKA;ANAPC7;FBXO7;HUWE1;NDFIP2;UBXN1;TRIP12;ELOC;PSMA5;PSMD4;UBE3C;PSMB3;FBXO22;VPS4A;FBXW4;SIRT2;DTX3L;PSMD3;RNF125;TRIM25;BAG6;SMURF2;ZRANB1;HECTD3;RNF115;TOPORS;FEM1B
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.6531464908081794,-1.567738059569515,0.02613240418118467,0.1095547599241743,1.0,6/12,17.46%,CGAS;DHX9;IFIT1;MAVS;ZCCHC3;RALB
prerank,positive regulation of DNA recombination (GO:0045911),-0.5269778278941926,-1.567552302419299,0.015625,0.10949002808114947,1.0,12/27,20.32%,ARID2;ACTR2;ERCC6;FUS;WDR48;KMT5B;KMT5C;TIMELESS;RAD51AP1;WRAP53;SHLD2;MMS19
prerank,small GTPase mediated signal transduction (GO:0007264),-0.4051351216366468,-1.5671555652395588,0.0016863406408094434,0.1095892009130171,1.0,34/103,18.69%,IGF1;ABR;GRB2;RREB1;GNB1;RB1;JUN;RAC1;ARHGAP30;USP50;GRAP2;RGS19;RIN2;RGL2;USP8;ARHGAP18;MAPK14;PLD2;ARHGEF18;PLK2;CCDC88A;KSR1;ARL3;SETDB1;CRKL;GRAP;BRAP;ARHGAP31;G3BP1;RALB;KRAS;NRAS;ARFIP2;RHEB
prerank,Golgi to endosome transport (GO:0006895),-0.6122375487556572,-1.5670848557792958,0.02867383512544803,0.109396792554645,1.0,6/16,9.73%,VPS13C;VPS13A;KIF16B;EPS15;SYS1;CORO7
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.36016967115972426,-1.5663174967049693,0.0015503875968992248,0.10994099349839428,1.0,82/234,23.82%,PRKCH;PRKCB;PLCG2;CD36;RAB7B;CAMK1D;ARID5B;ARHGEF2;PPARG;MALT1;RIPK1;IRAK2;TRAF5;STAT3;MBTPS2;TAB2;CFLAR;CARD11;TLR4;IL18;NLRC4;DHX9;NFKB1;AIM2;RNF31;STK3;RBCK1;LRP6;IRAK3;CTNNB1;IL18RAP;VEGFA;EIF2AK2;MYD88;CEBPG;NOD1;ADAM8;UBC;RPS27A;RELA;TRAF1;AGT;MTPN;APP;TICAM1;CIB1;TRIM68;TRAF2;HDAC5;NFAM1;CRTC3;CD40;RNF25;TCF3;FLOT2;IKBKB;MAVS;NFKBIB;TRIM14;ARHGEF5;HCLS1;IL18R1;HSPA1A;PPARGC1B;RPS3;TRADD;LGALS9;NOD2;COPS5;AGER;JUP;TRIM25;KDM1A;NLRP3;ZBTB7A;RPS6KA5;IL6;PLPP3;ESR2;MTDH;FANK1;DVL2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6800176739536942,-1.566181663771644,0.015517241379310345,0.10985701919007672,1.0,6/10,20.93%,DHX58;RIOK3;SEC14L1;GPATCH3;C1QBP;RNF125
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5715230284318804,-1.5659824282754224,0.024263431542461005,0.10956879618549335,1.0,9/20,11.05%,IGF1;P2RX7;INSR;PFKFB3;HIF1A;ARNT;ZBTB20;PFKFB4;APP
prerank,positive regulation of glycolytic process (GO:0045821),-0.5715230284318804,-1.5659824282754224,0.024263431542461005,0.10956879618549335,1.0,9/20,11.05%,IGF1;P2RX7;INSR;PFKFB3;HIF1A;ARNT;ZBTB20;PFKFB4;APP
prerank,regulation of immune effector process (GO:0002697),-0.4865116635463731,-1.5658105643636204,0.013201320132013201,0.10947003360883989,1.0,13/41,19.96%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;FCGR2B;C1QC;C1QBP;C2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.41020574042604896,-1.5651990750691203,0.0017241379310344827,0.10982823268784014,1.0,34/100,21.99%,DAB2;SDCBP;HECTD1;RNF19A;OGT;UCHL5;GNA12;PIAS1;RYBP;CBFA2T3;RPL11;NUB1;DET1;TRIB1;TRIB2;RNF180;HSP90AB1;WAC;ARIH1;GABARAP;UBQLN4;USP7;TAF9;HSPA1A;SMAD7;TRIM39;UBXN1;FBXO22;GSK3B;SIRT2;RACK1;BAG6;SOCS5;EIF3H
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.6665507605605444,-1.5651402134245465,0.02464788732394366,0.10965162571682262,1.0,6/11,19.35%,LILRB1;AXL;GAS6;SELENOS;HCLS1;NOD2
prerank,negative regulation of MAPK cascade (GO:0043409),-0.4211338771928956,-1.5645513492027872,0.005376344086021506,0.1099838163686107,1.0,22/87,11.47%,LYN;PTPRC;APOE;P2RX7;CD300A;PRKCD;PTPRJ;TLR4;DUSP3;PIK3CB;IRAK3;SIRPA;STK38;ITGB1BP1;SPRED1;SPRY2;PIN1;AGT;PAQR3;DUSP6;FLCN;SPRED2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.654915496452063,-1.5645427295345884,0.028764805414551606,0.1097596107454316,1.0,6/12,14.83%,NOTCH2;DOCK10;DOCK11;PTK2B;FCGR2B;POU2AF1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.6652511154222246,-1.5621376812009133,0.029850746268656716,0.11178338067845789,1.0,6/11,17.31%,RFTN1;UNC93B1;RIPK1;TNIP2;TICAM1;CASP8
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.5429694032585176,-1.5614503483958917,0.029513888888888888,0.11221510805234597,1.0,13/24,25.67%,RFC1;UBC;RPS27A;LIG1;PCNA;RPA3;RFC2;POLD2;LIG3;RFC3;POLB;POLD4;XRCC1
prerank,negative regulation of binding (GO:0051100),-0.4176380329595501,-1.5611303562979992,0.0,0.11236663730537949,1.0,29/81,21.40%,DAB2;SP100;CTSZ;PRKCD;JUN;ROCK1;PEX14;ACTB;MDFI;PPP1CA;E2F1;ITGB1BP1;NES;PIN1;IFIT1;TMBIM6;IFIT2;TFAP4;BTAF1;TFIP11;AURKA;RALB;RSF1;PLN;TMC8;GSK3B;DISC1;KDM1A;RACK1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.3944900258292101,-1.5610014629138746,0.005067567567567568,0.1122265422738023,1.0,43/121,24.21%,VIM;ZC3HAV1;PRKCD;YTHDF3;DCP1A;PSME4;MAPKAPK2;ANP32A;PSMB7;CNOT1;PSME3;RC3H1;PSMB9;EXOSC5;PUM2;DCP2;PSMA8;UBC;RPS27A;ZC3H14;PSMC3;MOV10;GTPBP1;PSMD8;PSMC4;PSMB10;DHX36;PSMA1;EIF4G1;PSMB8;HSPA1A;HSPB1;PSMA5;PSMD4;CNOT8;PSMB3;PSMD3;ZC3H12A;EXOSC4;SET;PUM1;PSMB1;PCBP4
prerank,regulation of protein kinase activity (GO:0045859),-0.4000073097579128,-1.5608379082925832,0.003289473684210526,0.11213191876724199,1.0,28/106,13.36%,IQGAP1;PTPRC;FGR;PAK2;RB1;SNX9;RAP2B;C5AR1;PRKAG2;CEP85;UVRAG;RAP1A;TAB2;PTK2B;LRP6;GAS6;CAMKK2;ALS2;CENPE;SMG8;TRIB1;ITGB1BP1;TRIB2;SPRED1;XRCC6;CAMKK1;CACUL1;LCP2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.46379751693881727,1.5601472537241217,0.01272264631043257,0.16085159352677908,1.0,8/41,1.66%,HTR2C;GRIN2A;RYR3;RYR2;GRIN2B;CACNA2D1;SLC24A2;SLC8A3
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.552018340881596,-1.5598414209234241,0.03015075376884422,0.11287529488419228,1.0,8/22,23.84%,CCR2;LILRB1;TNFRSF1B;LAPTM5;SLC7A5;SPHK2;NOD2;TRIL
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.436376636842443,-1.5597883150522363,0.012152777777777778,0.11269558663773391,1.0,28/69,22.59%,GTF2A1;INTS8;NABP1;INTS11;SRRT;TAF6;POLR2H;POLR2F;POLR2L;SNAPC2;INTS6;INTS14;RPRD2;GTF2E2;POLR2A;NCBP1;TAF8;INTS1;POLR2G;TAF9;SNAPC3;PHAX;INTS5;POLR2I;CCNK;GTF2F2;GTF2A2;ELL2
prerank,erythrocyte differentiation (GO:0030218),-0.46528057045519683,-1.5593710114390358,0.013513513513513514,0.11289694248630076,1.0,10/44,9.89%,LYN;MFHAS1;IKZF1;HSPA9;RPS14;VEGFA;ACIN1;CEBPG;FLVCR1;NCKAP1L
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.4080148650653064,-1.559328318192885,0.008156606851549755,0.11270486380775367,1.0,44/95,28.61%,DAB2;ZEB2;SDCBP;CREBBP;RNF111;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRED1;SPRY2;PIN1;FLCN;SPRED2;LTBP4;ITGA3;STK11;HTRA3;HSP90AB1;TGFBR2;LDLRAD4;LATS2;VASN;HSPA1A;SMAD7;IL17RD;SMURF2;ZBTB7A;EID2;TGFB1;SKIL;SMAD4;SMURF1;ENG;BCL9;NREP;EP300;WFIKKN1;CITED2;DKK3
prerank,positive regulation of GTPase activity (GO:0043547),-0.37045666181094306,-1.5588277279473979,0.0,0.11294974712942324,1.0,66/188,22.58%,BCAR3;ABR;CORO1C;ARHGAP25;RSU1;ARHGAP22;ARHGAP24;SNX9;DOCK10;SIPA1;TBC1D15;DOCK11;SGSM2;RGS1;TBC1D2B;RAP1A;TBC1D9;ITGB1;DOCK8;ARAP1;RAB3GAP1;TBC1D5;TBC1D1;SIPA1L2;ARHGEF10;TBC1D22A;PICALM;EZH2;SIPA1L3;TBC1D16;ALS2;TBC1D22B;SH3BP1;TBC1D8B;TBC1D8;TGM2;SCRIB;TBC1D17;PIN1;SNX13;CCDC125;FLCN;FOXJ1;SNX18;TBC1D10B;CCL5;CD40;RALGAPA2;TBC1D30;ARHGEF5;TBC1D7;AGRN;TBC1D9B;LIMS1;GPR65;TBC1D25;MMUT;PIP5K1A;GSK3B;SFRP1;RACK1;TBC1D10C;MAP4K4;RAP1GDS1;TBC1D4;RAP1GAP2
prerank,regulation of dendritic spine development (GO:0060998),0.5662722898032345,1.5581776372915939,0.02891566265060241,0.16220450105915074,1.0,9/19,13.71%,NLGN1;PPFIA2;GRIN3A;TANC2;SHANK3;FMR1;CPEB3;ARF6;PTPRS
prerank,negative regulation of RNA splicing (GO:0033119),-0.572119105728357,-1.5580928234202807,0.023972602739726026,0.11342554594022723,1.0,9/19,28.39%,PTBP3;RPS13;TMBIM6;SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5785777515018221,1.5557571481537917,0.03547671840354767,0.16395741947489162,1.0,5/16,9.62%,PAX8;GDNF;WT1;SALL1;CITED1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.39931610504795717,-1.555744334353682,0.006644518272425249,0.1155195644601464,1.0,37/108,19.37%,MAP3K5;APAF1;CTSD;DAPK1;SYK;XDH;CRADD;PPARG;MALT1;RIPK1;CFLAR;NLRC4;ANP32B;HIP1;LAPTM5;CASP4;NOD1;GRAMD4;ATP2A3;FIS1;LCK;HSPE1;CASP1;TRAF2;BBC3;BID;TNFSF10;CASP8;RPS3;IFT57;TRADD;LGALS9;PDCD5;CASP2;DDX3X;BEX3;HMGB1
prerank,chromatin disassembly (GO:0031498),-0.6153847475248604,-1.5554043738343344,0.036231884057971016,0.11540554349203107,1.0,5/14,11.99%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,nucleosome disassembly (GO:0006337),-0.6153847475248604,-1.5554043738343344,0.036231884057971016,0.11540554349203107,1.0,5/14,11.99%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.5280075997348671,-1.555061490194655,0.030141843971631204,0.11549749133239617,1.0,17/25,33.35%,HSPA9;DNAJB14;HSPE1;ST13;DNAJB13;HSPA1A;SDF2L1;HSPA2;DNAJC7;HSPA13;ERO1A;HSPA8;SDF2;GAK;HSPA1B;DNAJC18;DNAJB12
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.4135830320358579,-1.5549046296598452,0.0017064846416382253,0.11543689652734657,1.0,23/87,11.79%,IQGAP2;IQGAP1;NOTCH2;LRP1;PRKCD;RAC1;ROCK1;RHOA;EPS8;ARHGAP17;ABL2;PTK2B;DAPK3;ARHGAP18;RHOQ;BAIAP2;MDK;SH3BP1;BST2;TAOK1;CRK;CCDC88A;PIK3CA
prerank,striated muscle tissue development (GO:0014706),0.5048496433816219,1.5546589296275097,0.016786570743405275,0.16438671104609529,1.0,8/29,11.24%,SGCZ;SGCD;NDUFV2;BMP7;ZBTB18;SGCG;POPDC2;PGM5
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.6895673831007352,-1.5542693683142843,0.04448398576512456,0.11586296246154053,1.0,8/10,29.55%,NPL;ST3GAL1;GNPDA1;ST6GAL1;GNPDA2;AMDHD2;RENBP;GNE
prerank,regulation of cell adhesion (GO:0030155),-0.39079949019667193,-1.5540722777051796,0.0014947683109118087,0.11584038336749093,1.0,39/129,15.96%,LYN;PLXNC1;RSU1;ROCK1;PTPRJ;PLXNA1;SIPA1;PLAU;PLXND1;CYTH1;LPXN;FES;MINK1;CYTIP;ABL2;IL18;PTK2B;ITGAV;TGFBI;RIPOR2;STX3;PIK3CG;MYADM;VEGFA;CBLL1;ATXN3;MDK;ITGB1BP1;ADAM8;TGM2;KIF14;ZDHHC2;FLCN;CCL5;MIA3;PPP1R12A;RASA1;SPN;CXCR4
prerank,regulation of hydrolase activity (GO:0051336),-0.42622199653197473,-1.553768247800007,0.008460236886632826,0.11589222234945981,1.0,20/71,12.63%,ARHGAP15;VAV3;PLXNC1;FGD6;GPR137B;PLXNA1;PLXND1;TBC1D15;VAV1;FGD4;FBXW11;RAB3GAP1;FGD3;ITGB1BP1;VAV2;ARHGAP12;ADAP1;WRN;CRK;TBC1D10B
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.5043834969760246,-1.553053722726684,0.022887323943661973,0.11637096648832608,1.0,17/30,33.35%,HSPA9;DNAJB14;HSPE1;ST13;DNAJB13;HSPA1A;SDF2L1;HSPA2;DNAJC7;HSPA13;ERO1A;HSPA8;SDF2;GAK;HSPA1B;DNAJC18;DNAJB12
prerank,cation transport (GO:0006812),0.35835063337792883,1.5511341438266264,0.002564102564102564,0.16746441572205917,1.0,38/167,13.91%,KCNB2;TRPM3;KCNN2;KCND3;SLC8A3;SLC12A2;KCNMB3;KCNMB2;SLC4A4;SCN2A;KCNH1;SCN1A;SLC9B2;SCN3A;SLC47A1;SLC6A17;KCNJ3;KCNJ10;KCNJ6;SCN9A;KCNIP2;KCNA1;KCNH4;KCNJ16;SLC1A1;PKD1L3;TRPM1;SLC8A2;SLC5A10;SLC4A11;KCNF1;ATP1B1;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNA2;KCNS3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.48778677523856306,-1.5511333491673167,0.01384083044982699,0.11807284563554842,1.0,11/35,8.06%,IQGAP2;NRP1;NOTCH2;FES;ABL2;CDC42;PTK2B;STAP1;DAPK3;BAIAP2;MDK
prerank,cellular response to estrogen stimulus (GO:0071391),-0.6197909333029674,-1.5511041530545011,0.046125461254612546,0.11786505526504776,1.0,6/14,20.83%,WBP2;SERPINB9;TRIM24;RARA;ARID5A;SFRP1
prerank,glial cell differentiation (GO:0010001),0.4903844018538788,1.5509525804629203,0.019704433497536946,0.1668021153928686,1.0,11/28,16.92%,SOX11;CDH2;SLC8A3;NFIB;FGF10;SOX9;PTPRZ1;RELN;HES5;ERBB3;GPR157
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.41945639989566935,-1.5509054496250922,0.0016339869281045752,0.1178309634857404,1.0,30/76,23.68%,SASH1;RHOA;TLR7;SPI1;TLR4;ADIPOR1;PTPN22;IFI35;PPM1B;EIF2AK2;LAPTM5;NOD1;CD27;RELA;APP;NLRC3;TMSB4X;LIMS1;RPS3;MMP8;TRADD;LGALS9;DDX3X;NOD2;AGER;ZC3H12A;NLRP3;ILK;TCIM;LRRC19
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.68673158783556,-1.550687437150908,0.02737226277372263,0.11781984108356788,1.0,7/10,23.67%,TNFRSF1B;DPP4;FAP;CHADL;CST3;TGFB1;ADTRP
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5820896727983187,-1.5504663337808282,0.020066889632107024,0.11780370146760372,1.0,10/18,23.67%,TNFAIP8L2;PTPN22;DUSP3;LAPTM5;IL4I1;MIA3;ASS1;WNK1;LAX1;ADTRP
prerank,regulation of T cell proliferation (GO:0042129),-0.43996169752457426,-1.5500494256933848,0.008417508417508417,0.11803014517617193,1.0,28/61,32.12%,PTPRC;LILRB1;TNFRSF1B;IL15;ANXA1;TNFRSF21;CD28;NCKAP1L;SDC4;CD46;IL4I1;CCL5;VSIG4;SPN;CD274;CEBPB;TNFSF9;CD3E;IL6;NCK1;TNFRSF13C;PNP;RIPK3;IL27;NCK2;SLC7A1;CCL19;CD80
prerank,neural crest cell development (GO:0014032),0.4538717319882875,1.5493725376102108,0.02112676056338028,0.16772380356411146,1.0,17/44,16.05%,NRG1;ERBB4;SOX11;CDH2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;PDCD6;SEMA3F;TBX1;SEMA5B;TAPT1;SEMA4G;RADIL;NRTN
prerank,DNA geometric change (GO:0032392),-0.5345067927536671,-1.5483441810764458,0.015306122448979591,0.1195565349201056,1.0,17/24,26.01%,DHX9;ANXA1;BLM;RTEL1;MCM9;WRN;HMGB2;DHX36;DDX1;DNA2;HMGB1;HMGB3;NBN;ZRANB3;ASCC3;RECQL5;MRE11
prerank,cellular protein metabolic process (GO:0044267),-0.3389994206294419,-1.5481642342652906,0.0,0.11953192499839128,1.0,133/396,23.54%,APOE;IGF1;FAM20C;SFTPA1;SFTPA2;ST3GAL1;PPP4R2;ST8SIA4;AGO2;CSF2RA;RPS18;RPL7;RPS12;RPS21;RIPK1;ABL2;WWP2;RPS8;RPS24;GSPT1;CCDC59;SARS1;MSRA;RPL36;PARP4;RPS6;RPS20;RPL11;RPL10A;FN1;RPL12;C3;RRBP1;MRPL42;GAS6;RPS14;WFS1;RPL32;STK38;RPS15A;RPS28;RPS13;UBA7;CTSH;RPS27A;DARS1;RPL28;UBE2L3;RPS4X;MSRB1;CP;KLK3;UBL5;ZDHHC2;RPS23;SEPHS1;EIF4EBP2;APP;B4GALT7;PSENEN;HSP90B1;CSF2RB;SERP1;RPL22;IGFBP3;RPL14;EEF1A1;MRPS6;LGALS1;RPL34;MRPS11;RPS11;PADI4;RPL6;FBXW2;MIA3;DENND3;SPP1;MFGE8;UBE2G1;FDXR;EIF4G1;RPS10;PIGH;CDC34;CST3;RPL18A;MRPS16;HM13;RPL37A;APLP2;RABGGTA;MRPL34;UBE2I;DNAJC3;RPS9;TTF1;MRPS15;RPS27;MAN2B1;GNMT;ABCF1;RPS3;RAB12;RPL23A;RPS16;UBE2M;SHISA5;RABGGTB;RPL9;COPS5;IGFALS;CSF1;FBXO22;F5;BAP1;MMP2;MMP1;RPLP2;CSNK1G3;MRPL51;MANBA;RPL41;RPLP0;D2HGDH;IL6;PRKDC;RPL7A;RPL19;P4HB;RPS15;RPL39;ERO1A
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5817744576248306,-1.5480656072529728,0.033216783216783216,0.1193843850239206,1.0,6/17,14.65%,ANXA4;PTPN22;ANXA1;ARRB1;MAP2K5;TMSB4X
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.45225648097452664,-1.5477540042034803,0.010582010582010581,0.11949803901892674,1.0,18/55,18.47%,PAK2;CRADD;NUPR1;BCL2L11;RIPK1;BCL2;TGFBR1;GSDME;FIS1;AGT;STYXL1;LCK;TRAF2;BBC3;BID;TNFSF10;RPS3;TRIM39
prerank,regulation of ATP metabolic process (GO:1903578),-0.45154381832571827,-1.5473777603868881,0.011986301369863013,0.11965624462976701,1.0,28/54,30.34%,OGT;NUP50;PRKAG2;ATP7A;NUP42;NUP88;RAE1;HIF1A;FIS1;NUP205;TPR;JMJD8;NUP188;SPHK2;NUP153;COX7A2;NUP35;NUP107;NUP62;PRKAG1;ZBTB7A;RANBP2;EIF6;NUP37;EP300;PGAM1;AAAS;NUP133
prerank,regulation of defense response to virus by host (GO:0050691),-0.5121236104424358,-1.5471782405823717,0.011945392491467578,0.1195742333159889,1.0,14/30,23.00%,LILRB1;CGAS;DHX9;PTPN22;AIM2;PARP9;SIN3A;RNF216;MAVS;ZDHHC1;DTX3L;ZC3H12A;STAT1;TOMM70
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5049486338771257,1.5446912441925214,0.0297029702970297,0.172107585569883,1.0,8/27,8.73%,RIMS2;RIMS1;SYT1;SYT10;SYT2;SYT5;SYT11;SYT12
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.5556453181218816,-1.5445370533937013,0.021885521885521887,0.12220727365750428,1.0,10/21,14.64%,BANK1;PIBF1;TNFAIP8L2;PTPN22;DUSP3;LAPTM5;FOXJ1;IL4I1;FCGR2B;SAMSN1
prerank,calcium ion transmembrane transport (GO:0070588),0.3982421939328417,1.5440682806333377,0.010101010101010102,0.17189727673857952,1.0,13/86,3.14%,GRIN2A;TRPM3;CACNA1C;RYR3;TRPC5;GRIN2B;CACNA2D1;SLC24A4;SLC24A2;SLC8A3;NALCN;TRPC1;SLC24A3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.6797189442779092,-1.5436703776178504,0.034782608695652174,0.12285369926719582,1.0,4/10,9.89%,RUNX1;RUNX3;CBFB;NCKAP1L
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.44768774337479006,-1.5431102592168973,0.020100502512562814,0.12322962751043787,1.0,22/50,23.68%,SASH1;RHOA;TLR7;TLR4;IFI35;EIF2AK2;LAPTM5;NOD1;CD27;RELA;APP;LIMS1;RPS3;MMP8;TRADD;LGALS9;DDX3X;NOD2;AGER;ILK;TCIM;LRRC19
prerank,cAMP-mediated signaling (GO:0019933),0.5238527757671544,1.5419903867420182,0.01951219512195122,0.17343349222438287,1.0,7/24,8.71%,RIMS2;AKAP6;ADCY2;EPHA5;PDE4D;SOX9;ADCY1
prerank,vesicle organization (GO:0016050),-0.46433620752237714,-1.541987644937382,0.020477815699658702,0.12413877783395737,1.0,14/46,11.59%,SNX10;PI4K2A;USP50;SRGN;DNAJC13;USP8;PI4K2B;WASL;WASHC4;SNX33;EPS15;ALS2;ARFGEF2;SAR1A
prerank,protein ADP-ribosylation (GO:0006471),-0.5151377779471187,-1.541749682524384,0.03130434782608696,0.12412768221121827,1.0,11/28,20.66%,ZC3HAV1;PARP11;PARP14;PARP4;TIPARP;PARP9;PARP8;SIRT3;TNKS2;PARP10;SIRT2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.673896520913395,-1.54135451691125,0.03986135181975736,0.12432375083379224,1.0,7/10,27.63%,MALT1;RC3H1;NFKBIZ;SMAD7;NFKBID;ZC3H12A;TBX21
prerank,negative regulation of B cell proliferation (GO:0030889),-0.6650149759376658,-1.540608941384712,0.027491408934707903,0.12482171694349245,1.0,8/11,25.73%,LYN;CD300A;RC3H1;TNFRSF21;FCGR2B;ATM;TNFRSF13B;BLK
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6596099317838471,-1.5405374339079871,0.04060913705583756,0.12467179882371114,1.0,4/10,7.44%,LYN;STAT3;STAT6;STAT5B
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6404095624286593,-1.5401024729203434,0.033112582781456956,0.12483620833261792,1.0,5/11,23.38%,RIPK1;DDX5;MAP2K1;IL6;TGFB1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.47338205360805724,-1.539883330743891,0.024305555555555556,0.12478470258421077,1.0,15/38,19.93%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;EPC1;RHNO1;PHC3;RBBP4;UXT;RBBP8;MAX;CHEK1
prerank,B cell proliferation (GO:0042100),-0.5784298825621358,-1.539305151579538,0.029565217391304348,0.12518504997108876,1.0,8/17,28.83%,PTPRC;BCL2;MEF2C;CD40;CD79A;MS4A1;GAPT;CD19
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.36998552177598154,-1.5388919766957334,0.0017152658662092624,0.12529387057239094,1.0,54/175,22.43%,PID1;BIRC3;TNFRSF1B;NFE2L2;ARHGEF2;PSME4;RIPK1;TRAF5;BRCA1;FOXO3;PSMB7;PSME3;DHX9;PTK2B;AIM2;PSMB9;TRAF3;TNFRSF21;ERBIN;GSDME;ZFAND6;PSMA8;GBP2;CD27;RELA;TRAF1;PSMC3;PSMD8;CCL5;CIB1;TRAF2;PSMC4;PSMB10;PSMA1;CD40;TMSB4X;IKBKB;PSMB8;TNFRSF25;LIMS1;GATA3;RPS3;TRADD;GBP3;PSMA5;PSMD4;PSMB3;PSMD3;SFRP1;ZC3H12A;STAT1;ASAH1;TNFSF9;ILK
prerank,mitotic spindle organization (GO:0007052),-0.37442543873448814,-1.5388510883395203,0.0,0.1250837051549454,1.0,63/153,23.98%,RHOA;STAG1;FLNA;EML4;KIF3B;KIF11;PIBF1;DYNC1H1;KNL1;INCENP;CENPF;DLGAP5;KIF23;CENPA;ABRAXAS1;EFHC2;STAG2;ARHGEF10;KIF4A;PLK2;SUN2;ZWILCH;CENPE;CENPK;CKAP5;CENPN;NEK6;CENPL;TPX2;BUB1;KIFC1;TAOK1;TBCE;BUB1B;MAP4;SPC25;KIF2C;DYNC1LI2;TTK;SGO1;MAD1L1;STIL;PCNT;NUF2;AURKA;RPS27;NDC80;CENPH;RCC1;ERCC6L;PAFAH1B1;PRC1;SMC1A;RAB11A;NUP107;CEP192;LSM14A;NSL1;PPP1CC;CENPP;CCNB1;CENPO;SPC24
prerank,positive regulation of catalytic activity (GO:0043085),-0.4819387880121808,-1.5387801613113796,0.022146507666098807,0.12492533169182007,1.0,16/37,25.75%,ABL2;ATP7A;MAPK14;CHTOP;SSBP1;WRN;PSENEN;CIB1;XRCC4;SLC5A3;STX4;NOD2;PHACTR4;FGFR4;PSEN2;MT3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5643053256247776,1.5387138211411864,0.04157043879907621,0.1764223962354307,1.0,2/17,1.49%,ANK2;CACNA2D1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5106998750339351,-1.5385217094227848,0.020168067226890758,0.1249613553900933,1.0,11/29,20.83%,ADIPOR1;SDHAF2;SPRED1;SPRY2;SPRED2;LDLRAD4;VASN;SMAD7;GATA3;IL17RD;SFRP1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4496140058378199,-1.5384003898512018,0.024390243902439025,0.12484252059187699,1.0,32/54,36.01%,APOE;P2RX4;PPARG;MAPK14;PRCP;VEGFA;SH3BP1;HIF1A;MEF2C;ANGPT2;GADD45A;CD40;TMSB4X;MAP2K3;HSPB1;HMGB1;JUP;KDR;FGF18;TGFB1;ATP5F1B;NUS1;ETS1;AGTR2;ATP5F1A;CSNK2B;FGF2;PLCG1;TNF;GATA2;HRG;PDGFB
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.44290985629302226,1.5383818430484346,0.02517162471395881,0.1758891614392157,1.0,14/48,16.07%,AKAP6;ANK2;DMD;TRPC1;PDE4D;CASQ2;JPH4;NPSR1;CAPN3;CALM1;CALM3;CALM2;JPH3;SNCA
prerank,DNA conformation change (GO:0071103),-0.5893278200051532,-1.5382369833786176,0.030927835051546393,0.12478446847682449,1.0,8/17,20.42%,TOP3A;HHEX;TOP2A;HMGB2;TOP1MT;HMGB1;HMGB3;PRM1
prerank,response to cytokine (GO:0034097),-0.38184695946379693,-1.538106886791018,0.0032626427406199023,0.1246977462514836,1.0,45/141,18.85%,PID1;CD74;SP100;MAPKAPK3;REL;MCL1;MAP4K3;RHOA;KYNU;RIPK1;IRAK2;IL6R;MAPKAPK2;STAT3;PTPN12;BCL2;IFNAR2;ANXA1;ADAM9;CIITA;YTHDC2;NUB1;IRAK3;EIF2AK2;MYD88;TIMP2;BST2;IFITM2;PTPN6;RELA;APP;CXCL16;CASP1;GCH1;CD40;RELB;CXCR4;HCLS1;ISG15;IL18R1;TAF9;CASP8;PTPN13;PTPN11;LGALS9
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6258397198938825,1.5374539636519975,0.037527593818984545,0.17607775876365733,1.0,4/10,8.01%,BMPR1B;SOX5;SOX6;SOX9
prerank,positive regulation of T cell differentiation (GO:0045582),-0.483576536475942,-1.537094420039616,0.028862478777589132,0.12547416458280589,1.0,19/36,29.46%,ZMIZ1;BCL6;MDK;ADAM8;NCKAP1L;SART1;XBP1;CD46;IL4I1;TESPA1;ZAP70;GATA3;IL7;TNFSF9;IL12RB1;PNP;LEF1;ZBTB1;NKAP
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.31861963125820425,-1.5363769376747778,0.0,0.12594533343811426,1.0,237/834,22.18%,PID1;RBPJ;DAB2;MITF;ZMIZ1;ZEB2;ELF4;RUNX1;IGF1;TFEB;NAMPT;TCF4;RREB1;LILRB1;REL;LITAF;TET3;JUN;MEF2A;CREBBP;ACTR2;PPARD;OGT;AGO2;BPTF;TOX2;NFE2L2;RNF111;IRF2;ARHGEF2;SBNO2;NFIC;BRD4;PLXND1;ATF3;PAXBP1;ATAD2;ELF1;UBP1;PPARG;CDK13;ELK3;RNASEL;SMARCA5;RIPK1;MAML1;SPI1;BRCA1;ETV1;STAT3;FOXO3;MAML2;EAPP;E2F2;TLR4;ACTR3;IL18;STAT6;DHX9;USF2;NFKB1;HHEX;NLRC5;RUNX2;SMARCD3;RARG;NFATC2IP;MLXIP;IRF5;CRLF3;DLGAP5;MEF2B;KLF6;TCF20;NR1H2;CIITA;JAG1;SS18;PF4;NRF1;WASL;HGF;RHOQ;LRP6;NFATC3;ARRB1;TAF6;MED24;AHR;CTNNB1;TBL1XR1;DPF2;STAT5B;ATF6;PLAC8;NR2F1;SKI;VEGFA;MAP2K5;E2F1;FIZ1;CNBP;ATMIN;RNF4;HELZ2;WBP2;CEBPG;E2F3;KMT2C;SLC9A1;ITGB1BP1;MEF2D;HIF1A;MEF2C;ATAD2B;TFEC;MAPK7;MRTFB;UBC;RPS27A;ASXL1;EGR1;ARNT;TNIP2;RELA;PIN1;PSMC3;APP;XBP1;XRCC6;FLCN;OSR1;MLLT10;KLF10;MED4;PRDM2;KMT2D;MICAL2;IER2;FOXJ1;HTATIP2;CHD8;RBM14;IL4I1;FOSL2;MLLT6;KAT7;HMGB2;SERPINE1;UHRF1;ZBED4;ACVR2A;HDAC5;DHX36;RXRA;FOXJ3;CALCOCO1;TET2;E2F8;GREM1;SIN3A;CRTC3;EPC1;PPP1R12A;CD40;DR1;KLF2;CKAP2;TCF3;IKBKB;DOT1L;YY1;POU2AF1;INO80;TXK;ZMIZ2;POGZ;TFCP2;MAVS;AATF;NUFIP1;HCLS1;NR4A1;NRIP1;TNIP3;FOXJ2;AGRN;TAF9;KMT2A;RARA;NFATC1;CSRNP1;ATF5;MED6;SMAD7;NR3C1;TFE3;GATA3;MYB;PPARGC1B;TCF12;NCOA6;PLAG1;SSBP4;CASZ1;RSF1;DDX3X;MEIS3;HOXD8;LMO2;NOD2;HMGB1;COPS5;ATM;MAX;CHP2;EHF;BMPR2;GLMP;MAML3;RLF;SIRT2;ZC3H12A;STAT1;JUP;ZSCAN21;KDM1A;HOXB2;HAX1;CCNK;NLRP3;HEYL;CEBPB;EGR2;ZNF296;BARX2;RPS6KA5
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6122650045383261,1.5358308487571821,0.06234413965087282,0.17702231514383132,1.0,5/12,9.55%,NFIB;MYCBP2;EPHB1;SPTBN4;TSKU
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.47324829471216645,-1.5347359629453663,0.01559792027729636,0.12749678032196135,1.0,16/38,25.87%,SMARCA5;KNL1;MIS18BP1;UBN1;CENPA;ASF1B;CENPK;CENPN;CENPL;ASF1A;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,negative regulation of bone remodeling (GO:0046851),-0.6455840672130869,-1.5343860718274929,0.035650623885918005,0.1276372551296726,1.0,7/11,22.61%,P2RX7;GPR137B;GREM1;CALCA;UBASH3B;SFRP1;IL6
prerank,positive regulation of heart rate (GO:0010460),0.564774042324338,1.5342612128638717,0.060324825986078884,0.17797445656728866,1.0,8/17,17.04%,RYR2;PDE4D;ADRA1B;EDN1;ADRA1D;ADRA1A;ADRB1;TPM1
prerank,regulation of coagulation (GO:0050818),0.6363132573970406,1.5340971145933908,0.06728538283062645,0.1772506392266186,1.0,1/11,0.53%,HS3ST5
prerank,telomere maintenance (GO:0000723),-0.4461828548220953,-1.5338772167413621,0.03633217993079585,0.127905966364065,1.0,23/50,26.18%,NSMCE2;SP100;TEP1;BLM;RTEL1;RAD51;XRCC6;WRN;PCNA;RPA3;POLD2;ERCC4;TEN1;XRCC3;DNA2;ATM;NBN;SMC6;PRKDC;SMC5;POLD4;MRE11;DCLRE1B
prerank,regulation of postsynapse organization (GO:0099175),0.49572671725900624,1.5336449638265974,0.03926096997690531,0.17688846277123385,1.0,8/28,6.74%,IL1RAPL1;PPFIA2;CDKL5;TANC2;SRCIN1;SHANK3;ABI2;HOMER1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.3142488535161484,-1.5335917527939718,0.0,0.127945143130378,1.0,309/1082,22.19%,PID1;RBPJ;MDFIC;DAB2;APOE;MITF;ZMIZ1;ZEB2;MAP3K5;FLI1;ELF4;RUNX1;IGF1;TFEB;NAMPT;CD38;CD74;SP100;TCF4;RREB1;ELF2;LILRB1;REL;LITAF;TET3;JUN;DNM2;NIBAN2;MEF2A;CREBBP;ACTR2;RUNX3;PPARD;OGT;AGO2;BPTF;TOX2;NFE2L2;BRD7;RNF111;IRF2;ARHGEF2;SBNO2;NFIC;BRD4;NFYA;ARID1B;ATF3;PAXBP1;ATAD2;ELF1;NSD3;UBP1;PPARG;KDM3A;ELK3;RNASEL;SMARCA5;RIPK1;MAML1;SPI1;BRCA1;ETV1;STAT3;ERCC6;FOXO3;MAML2;E2F2;LYL1;TLR4;ACTR3;IL18;STAT6;DHX9;USF2;RYBP;RNF20;NFKB1;HHEX;NLRC5;RUNX2;SMARCD3;FBXW11;RARG;PRMT2;NFATC2IP;MLXIP;IRF5;CRLF3;SNX5;MEF2B;KLF6;SMARCC2;BLM;TCF20;NR1H2;CIITA;JAG1;AXIN1;SS18;PF4;NRF1;WASL;HGF;RHOQ;LRP6;NFATC3;ARRB1;TAF6;PICALM;MED24;AHR;CTNNB1;TBL1XR1;CAMKK2;DPF2;STAT5B;ATF6;EDF1;PLAC8;NR2F1;CREB3L2;SKI;VEGFA;MAP2K5;E2F1;FIZ1;CNBP;ARID1A;ATMIN;RNF4;HELZ2;TGFBR1;WBP2;CEBPG;E2F3;KMT2C;SLC9A1;ITGB1BP1;MEF2D;PARP9;TGFB1I1;HIF1A;MEF2C;ATAD2B;TFEC;MAPK7;MRTFB;UBC;RPS27A;ASXL1;EGR1;ARNT;AFAP1L2;TNIP2;RELA;PIN1;PSMC3;AGT;NCF1;APP;XBP1;XRCC6;FLCN;ALYREF;OSR1;ARHGEF11;DYRK1A;MAP2K1;MLLT10;KLF10;MED4;PRDM2;NFE2;KMT2D;MLLT11;ASF1A;IER2;SPIN1;FOXJ1;HTATIP2;CHD8;RBM14;IL4I1;FOSL2;MLLT6;KAT7;HMGB2;SERPINE1;UHRF1;ZBED4;ACVR2A;HDAC5;DHX36;RXRA;FOXJ3;ELOF1;CALCOCO1;TET2;E2F8;TFAP4;GREM1;WAC;SIN3A;CRTC3;EPC1;PPP1R12A;CD40;DR1;KLF2;ID2;CKAP2;TFAM;TCF3;IKBKB;DOT1L;YY1;SPP1;POU2AF1;INO80;TXK;ZMIZ2;NSD1;POGZ;TFCP2;MAVS;AATF;KARS1;IL31RA;DNAJC2;HMGN1;QRICH1;NUFIP1;HCLS1;NR4A1;NRIP1;TNIP3;SOX10;FOXJ2;AGRN;TAF9;VHL;KMT2A;MAP2K3;GPATCH3;RARA;NFATC1;CSRNP1;ATF5;MED6;SMAD7;NR3C1;TFE3;GATA3;MYB;SERTAD1;PPARGC1B;TCF12;NCOA6;PLAG1;CXXC1;SSBP4;TRIM16;HAS3;CASZ1;RSF1;PITHD1;DDX3X;MEIS3;HOXD8;LMO2;NOD2;HMGB1;COPS5;ATM;NAA16;MAX;CHP2;RASL11A;CHEK1;EHF;BMPR2;MMS19;GLMP;MAML3;RLF;MAZ;SIRT2;DTX3L;SFRP1;ZC3H12A;STAT1;JUP;RAI1;POU3F1;ZSCAN21;KDM1A;HOXB2;NUP62;HAX1;CCNK;NLRP3;HEYL;CEBPB;EGR2;ZNF296;BARX2;RPS6KA5;MYRFL
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5112348036139389,1.5333569600462624,0.034912718204488775,0.1762904801286764,1.0,12/25,18.59%,ANK3;ANK2;DMD;TCAF1;PIRT;ATP1B1;STAC;GLRX;WNK4;WNK3;ATP1B2;WNK2
prerank,regulation of complement activation (GO:0030449),-0.48068703046382677,-1.5316208785573873,0.01870748299319728,0.1299250510197337,1.0,16/40,28.83%,C3AR1;C1QA;C1QB;C5AR1;C4B;CFP;C3;PROS1;CD46;C1QC;C1QBP;C2;C6;C7;C8G;CD19
prerank,rRNA processing (GO:0006364),-0.3651504663256858,-1.5313374071117698,0.004830917874396135,0.13000525214418707,1.0,70/172,28.41%,RPL7;RPS24;RIOK3;ESF1;MPHOSPH10;RPL36;RPS6;RPL11;RPL10A;DDX49;RPL12;RPS14;EXOSC5;NOP14;RPL32;SENP3;WDR36;NVL;RPS28;NOL6;RPL28;SART1;DHX37;KRR1;RPL22;RPL14;RPL34;RPL6;NOLC1;EMG1;RPL18A;RPL37A;UTP6;RPS9;LSM6;RPS27;RPL23A;RPS16;EXOSC10;RPL9;THUMPD1;C1D;RPLP2;NOL9;DDX54;EXOSC4;XRN2;RPL41;RPLP0;SNU13;PRKDC;RPL7A;MTREX;RPL19;WDR12;RPS15;RPL39;NHP2;RCL1;MRM2;RPL5;PDCD11;EIF6;RPL13;IMP4;EXOSC8;RPL18;WDR3;RPL27A;PIH1D2
prerank,positive regulation of protein kinase activity (GO:0045860),-0.3743797243952712,-1.5310064742961138,0.001597444089456869,0.13012301027789042,1.0,54/148,19.18%,IQGAP1;PTPRC;NEDD9;TAOK3;PAK2;PRKCD;SNX9;RHOA;INSR;PRKAG2;MINK1;IL6R;RAP1A;TAB2;SLC27A1;PTK2B;INCENP;STK3;AXIN1;CAB39;GAS6;EZH2;ALS2;VEGFA;CENPE;EGR1;TPX2;TAOK1;KIF14;AGT;XRCC6;MAP2K1;CCDC88A;CAMKK1;STK11;CCL5;HSP90AB1;CACUL1;CIB1;LCP2;TGFBR2;MARK2;CALCA;IL34;STRADA;GPRC5B;MAP2K3;RALB;LILRA5;TAOK2;ADRB2;DDX3X;PAK6;JTB
prerank,positive regulation of cation channel activity (GO:2001259),0.46199941944394474,1.5309224580666343,0.027906976744186046,0.17832311978089388,1.0,12/40,14.03%,AKAP6;ANK3;ANK2;SHANK3;KCNIP2;PIRT;RELN;STAC;CALM1;CALM3;CALM2;ARC
prerank,positive regulation of peptidase activity (GO:0010952),-0.5572679877068603,-1.5303918963649872,0.03484320557491289,0.13059225511573502,1.0,5/20,11.38%,PSME3;GRN;RCN3;CTSH;PSENEN
prerank,cell part morphogenesis (GO:0032990),-0.6297432000049781,-1.529875697083978,0.03304347826086956,0.13085696516261264,1.0,4/13,10.11%,PID1;MTM1;FIS1;PACSIN2
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.5480834624893375,-1.5293070182269675,0.028268551236749116,0.13125714052151277,1.0,11/20,39.23%,CYP46A1;FDXR;TSPOAP1;FDX1;HSD17B10;HSD3B2;FDX2;STARD3;AKR1C1;AKR1D1;TSPO
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6128573446207173,-1.529124760529921,0.037102473498233215,0.1312001810348211,1.0,5/13,8.17%,CD74;LILRB1;PLCG2;IRAK3;LAPTM5
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5645758708424048,-1.5290473628176295,0.0353356890459364,0.13104264289267942,1.0,7/20,11.08%,RBPJ;NFE2L2;RUNX2;VEGFA;HIF1A;RELA;XBP1
prerank,amino sugar biosynthetic process (GO:0046349),-0.6324449983369614,-1.528604610200891,0.05226480836236934,0.1312202680145786,1.0,8/12,30.31%,GNPDA1;UAP1L1;UAP1;GNPDA2;GFPT1;AMDHD2;RENBP;GNPNAT1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.515205259494175,-1.5275431699435085,0.034545454545454546,0.13208143616480694,1.0,12/26,25.98%,DAB2;FOXP1;BRCA1;CNOT1;CNOT2;VPS18;SFRP1;ZBTB7A;HEYL;NCOR1;VPS11;CLOCK
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5609133191800175,1.5274878610179996,0.03990610328638498,0.18158837889338816,1.0,7/18,10.87%,NLGN1;NRXN1;SHANK3;TSHZ3;CACNG4;CACNG2;RELN
prerank,regulation of DNA binding (GO:0051101),-0.46215821334553403,-1.5270605436920415,0.01232394366197183,0.13231003935374921,1.0,22/44,23.38%,IGF1;SP100;JUN;PPARG;MDFI;EDF1;SKI;NME1;E2F1;PLAUR;CEBPG;HMGB2;TFAP4;DOT1L;MMP8;RSF1;HMGB1;SIRT2;KDM1A;ZBTB7A;SUMO3;TGFB1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.6131465640714711,-1.5267365963349597,0.03247863247863248,0.1324144818977823,1.0,8/14,22.61%,CD74;IL18;RSAD2;RARA;NOD2;DENND1B;NLRP3;IL6
prerank,regulation of amyloid-beta formation (GO:1902003),-0.483780243593341,-1.5264639164691745,0.029462738301559793,0.13247905720735523,1.0,10/34,10.58%,APOE;IGF1;ABCG1;GSAP;ROCK1;GGA3;TMED10;PICALM;RELA;PIN1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6637196074298782,1.5260786218209674,0.06222222222222222,0.18234059296964006,1.0,5/10,12.92%,PDE4B;CACNA2D1;CACNB2;CALM1;CALM3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6424911745820093,-1.5257540932357934,0.0528169014084507,0.13302546730752304,1.0,8/11,30.31%,GNPDA1;UAP1L1;UAP1;GNPDA2;GFPT1;AMDHD2;RENBP;GNPNAT1
prerank,regulation of viral transcription (GO:0046782),-0.47107695583790726,-1.5256921406479247,0.011406844106463879,0.13282493604648665,1.0,17/39,26.70%,MDFIC;NELFB;UBP1;DHX9;POLR2H;POLR2F;POLR2L;POLR2A;TRIM11;TRIM14;POLR2G;RSF1;POLR2I;GTF2F2;GTF2F1;LARP7;NELFE
prerank,histone modification (GO:0016570),-0.392770004315453,-1.525598381601692,0.004746835443037975,0.1326736437320599,1.0,34/109,18.64%,RCOR1;MIDEAS;PRKCD;CREBBP;ATXN7;PHF20;NSD3;PRMT2;INCENP;EYA4;MORF4L1;TAF6;TBL1XR1;EZH2;USP36;USP3;PRMT1;SUDS3;HDAC10;NAA50;RBM14;UHRF1;MTA3;HDAC5;PADI4;SIN3A;PRMT6;NSD1;MRGBP;PHF20L1;EYA1;EYA3;HUWE1;MIER1
prerank,kidney development (GO:0001822),0.4087361925947246,1.5252698629314987,0.011904761904761904,0.1823207949511275,1.0,20/65,11.28%,ROBO2;PCSK5;MME;PAX8;GREB1L;GDNF;HNF1B;WT1;TRAF3IP1;FGF10;BMP7;SALL1;TFAP2A;CITED1;AGTR1;HAS2;CEP290;TGFB2;PYGO2;PKD1
prerank,histone H3-K9 demethylation (GO:0033169),-0.6549622410468287,-1.525210847536486,0.033210332103321034,0.13283174658302885,1.0,6/11,21.39%,KDM3A;JMJD1C;KDM7A;KDM3B;HR;KDM1A
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.565040486041248,-1.524924503490541,0.03372681281618887,0.13280292702495444,1.0,6/18,11.58%,DAB2;MSN;SNX3;DNAJC13;RAB21;MAP2K1
prerank,regulation of cellular metabolic process (GO:0031323),-0.45689219909849027,-1.5247023973753202,0.022033898305084745,0.13276962232558168,1.0,19/45,27.28%,PID1;ABCG1;PANK2;RNF41;KIF16B;TBC1D16;BCO2;NPC2;AGPAT1;MPV17;RNF34;ACACB;SSH1;RSPO1;CYP1B1;ABCA2;LAMTOR1;EIF6;MKLN1
prerank,rRNA metabolic process (GO:0016072),-0.3651242144915488,-1.5246630946548065,0.006420545746388443,0.13253933964588926,1.0,66/160,28.41%,RPL7;RPS24;ESF1;MPHOSPH10;RPL36;RPS6;RPL11;RPL10A;DDX49;RPL12;RPS14;EXOSC5;NOP14;RPL32;SENP3;WDR36;NVL;RPS28;NOL6;RPL28;DHX37;KRR1;RPL22;RPL14;RPL34;NIFK;RPL6;NOLC1;EMG1;RPL18A;RPL37A;UTP6;RPS9;RPS27;RPL23A;RPS16;EXOSC10;RPL9;C1D;RPLP2;NOL9;DDX54;EXOSC4;XRN2;RPL41;RPLP0;SNU13;RPL7A;MTREX;RPL19;WDR12;RPS15;RPL39;RCL1;MRM2;DEDD2;RPL5;PDCD11;ERN2;RPL13;IMP4;EXOSC8;RPL18;WDR3;RPL27A;PIH1D2
prerank,actin filament-based transport (GO:0099515),-0.5457231438828598,-1.5243364091932257,0.02072538860103627,0.13268736953836366,1.0,7/21,11.64%,MYO5A;MYO1F;MYO1G;WASL;SUN2;MYO1E;MYO7A
prerank,anterior/posterior axis specification (GO:0009948),-0.6079612504744524,-1.5241419728750376,0.049403747870528106,0.1326430460936083,1.0,4/15,19.11%,SKI;WLS;RIPPLY2;HOXD8
prerank,cellular response to interleukin-6 (GO:0071354),-0.517809329127333,-1.5237735274191828,0.02702702702702703,0.13281085114636568,1.0,10/26,10.48%,PID1;CBL;SBNO2;SPI1;IL6R;CTR9;STAT3;NFKB1;JAK1;RELA
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4103182381272158,-1.5228350288192882,0.01658374792703151,0.1336218618647787,1.0,38/80,31.13%,CD44;MAP3K5;CTSD;DAPK1;SYK;CSNK2A1;MALT1;HGF;GAS6;VEGFA;MAP2K5;FNIP1;NOD1;YWHAE;GRAMD4;FIS1;CASP1;TNFSF10;PDCD5;DDX3X;BEX3;HMGB1;DNAJB6;NLRP3;SFN;SOX7;CYCS;MYC;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;F2R;XIAP;BCL10
prerank,regulation of establishment of protein localization (GO:0070201),-0.6280589204591147,-1.522558735820898,0.029654036243822075,0.1336646267621815,1.0,5/14,8.47%,CTSD;SPIDR;CENPJ;CEP295;DNAJA1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.5989481645196607,-1.5223311646820257,0.023529411764705882,0.13367776831431782,1.0,11/15,30.08%,CD36;USP50;TLR4;EIF2AK2;GBP5;MYD88;NLRC3;DDX3X;MEFV;CPTP;PYDC1
prerank,negative regulation of ossification (GO:0030279),-0.5279924832321006,-1.5217674114456348,0.027210884353741496,0.13412073588236967,1.0,9/23,20.83%,RBPJ;CCR1;SRGN;PTK2B;MDK;MEF2C;GREM1;ENPP1;SFRP1
prerank,epithelial cell migration (GO:0010631),-0.47791766640551386,-1.5217661956390318,0.017035775127768313,0.13387780094029467,1.0,10/37,11.83%,NRP1;ZEB2;ROCK1;RHOA;PLXND1;LPXN;DPP4;PLEKHG5;PIK3CA;FAP
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.5745497621648298,-1.5217126016922005,0.03398926654740608,0.13369436281689653,1.0,6/17,9.89%,CD74;RAC1;CAMK1D;RIPOR2;MDK;NCKAP1L
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.5424021644988999,-1.521562273031151,0.045454545454545456,0.13361959930092826,1.0,9/22,20.56%,LYN;MFHAS1;RAB7B;PTPN22;IFI35;APPL2;WDFY1;TICAM2;APPL1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5344193999092248,-1.5211571202276715,0.04285714285714286,0.13380564841194748,1.0,10/23,11.05%,IGF1;P2RX7;INSR;NFKB1;PFKFB3;HIF1A;ARNT;ZBTB20;PFKFB4;APP
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.4304337309923179,-1.5207067680071245,0.006872852233676976,0.13411208830411764,1.0,14/62,8.11%,LYN;AKAP13;IGF1;NOTCH2;GRB2;RAC1;ARHGEF3;VAV1;RASGRP4;PIK3CB;PIK3CG;ARRB1;ALS2;ERBIN
prerank,positive regulation of vacuole organization (GO:0044090),-0.6530534252326412,-1.520462585303025,0.02847571189279732,0.13411753887779584,1.0,6/10,17.46%,ANXA2;PIP4K2A;RAB3GAP1;GRN;SH3GLB1;RALB
prerank,potassium ion export across plasma membrane (GO:0097623),0.6078971510554517,1.5201707123853796,0.0481651376146789,0.18750922752386606,1.0,3/13,6.77%,KCND3;KCNT2;KCNIP2
prerank,regulation of response to interferon-gamma (GO:0060330),-0.6123767366541766,-1.5198974951810564,0.029411764705882353,0.13453176545269538,1.0,8/14,22.97%,PIAS1;JAK1;PARP9;IFNGR2;HSP90AB1;SOCS3;STAT1;IFNGR1
prerank,proteasomal protein catabolic process (GO:0010498),-0.3583228002438379,-1.5193568353861098,0.0,0.1348887510215783,1.0,85/201,27.63%,WWP1;BFAR;NFE2L2;PSME4;ARRB2;WWP2;FBXL17;RNF41;AREL1;PELI1;PSMB7;TNFAIP1;PSME3;FBXW11;PSMB9;RBCK1;DDI2;ARRB1;KLHL22;CTNNB1;TBL1XR1;ZFAND2A;KCTD10;ZSWIM8;ATXN3;RNF4;RCN3;ATE1;SPSB2;PSMA8;DERL1;PSMC3;KIF14;UBE4B;NEDD4L;SEL1L;SPSB3;PCBP2;CUL4B;PSMD8;UBXN6;MAEA;PSMC4;PSMB10;SOCS6;RNF185;PSMA1;RNF34;KLHL42;UBE2G1;RNF216;CDC34;FAF1;PSMB8;SKP2;HUWE1;UBXN1;ERLEC1;PSMA5;PSMD4;PSMB3;SIRT2;PSMD3;BAG6;SMURF2;HECTD3;TOPORS;FEM1B;TRIM72;ZNRF1;KCTD2;PSMB1;RNF187;DDB1;SPOP;CLOCK;SIAH2;FBXL19;SMURF1;PML;VCP;CUL3;DCAF11;COP1;TBX21
prerank,negative regulation of endocytosis (GO:0045806),-0.5266550309651143,-1.519015095818755,0.028716216216216218,0.135035224351781,1.0,7/24,6.98%,MCTP1;LILRB1;CD300A;RAC1;NR1H2;PICALM;SNX33
prerank,phospholipid homeostasis (GO:0055091),-0.6474446716737154,-1.5188980408305535,0.02867383512544803,0.13492344163077585,1.0,4/11,9.94%,ABCA1;ABCG1;RCN3;TLCD2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.4520225238614944,-1.5185245745402172,0.015100671140939598,0.13507819800047544,1.0,21/48,28.51%,FNIP2;MCL1;TNFRSF1B;BCL2L11;BRCA1;DYRK2;BCL2;CRIP1;E2F1;TMEM109;CASP2;ATM;BAG6;SFN;BCL2L2;TOPORS;PRKDC;PML;USP28;EP300;BCL2L1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.6214669924343301,-1.51815222878934,0.0387858347386172,0.13526339344401608,1.0,6/13,11.84%,AXL;IL18;AP1G1;GAS6;LAMP1;TICAM1
prerank,response to unfolded protein (GO:0006986),-0.4527071783021537,-1.5178307114426268,0.020202020202020204,0.13539709906656236,1.0,19/48,21.32%,ERN1;OPTN;HSPA9;DNAJA1;DERL1;HSPE1;DNAJC4;TMBIM6;HSP90AB1;HSPA4;HSPH1;BAG3;HSPA1A;HSPB1;ERP44;HSPA2;STT3B;PTPN1;HSPA13
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.43790157872824054,-1.5177473982712832,0.011647254575707155,0.13524796772506525,1.0,23/56,20.48%,ROCK1;SNX9;RHOA;PDCD6IP;SON;INCENP;USP8;KIF23;CENPA;EFHC2;SNX33;KIF4A;SNX18;ARL3;BIN3;CKAP2;RACGAP1;NUSAP1;RASA1;KIF20A;CEP55;JTB;VPS4A
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.3491850113825724,-1.5176454964559773,0.0,0.13512799405925155,1.0,103/264,27.44%,CTNNBL1;TRA2B;DDX46;SRRM1;CDK13;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;SRRT;FUS;SNRPG;HNRNPH1;GCFC2;COIL;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;SPEN;CWC22;RBM19;DDX5;RALY;SF3B3;POLR2L;PRPF8;SART1;SF3B5;UBL5;PCBP2;ALYREF;HNRNPUL1;NUDT21;SNRPA;RBM14;CWC15;SMN1;METTL14;RBM10;WDR33;YTHDC1;POLR2A;NCBP1;PSPC1;SART3;ZRSR2;GEMIN7;SNUPN;PDCD7;SF3A1;DDX1;SRSF10;POLR2G;RBM4B;TFIP11;LSM6;RNPS1;WBP11;SNRNP70;TXNL4A;HNRNPA1;SCNM1;PAPOLA;MAGOH;SLU7;WDR77;BUD13;TGS1;CPSF3;SF3B1;LSM5;POLR2I;HNRNPH2;GEMIN6;PPIL1;XAB2;HNRNPK;SRPK1;GTF2F2;SNU13;SYF2;SRSF11;NONO;MTREX;RBM22;PRPF6;DHX35;DDX39B;DHX38;GTF2F1;RBM15B;CPSF1;U2AF2;ISY1;HSPA8;WDR83;HNRNPF;METTL3;BUD31
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.6197861169590606,-1.5171279131105324,0.04938271604938271,0.13501155739939352,1.0,3/12,5.26%,NSMCE2;RB1;DLGAP5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.6197861169590606,-1.5171279131105324,0.04938271604938271,0.13501155739939352,1.0,3/12,5.26%,NSMCE2;RB1;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.6197861169590606,-1.5171279131105324,0.04938271604938271,0.13501155739939352,1.0,3/12,5.26%,NSMCE2;RB1;DLGAP5
prerank,protein mannosylation (GO:0035268),0.5155131206289498,1.5169414443480604,0.037037037037037035,0.19062119449730355,1.0,7/22,5.39%,TMTC2;TMTC1;CRPPA;DPY19L1;TMTC3;DPY19L2;POMT2
prerank,protein autophosphorylation (GO:0046777),-0.3700211235294835,-1.5165854736237394,0.004754358161648178,0.13536948926396658,1.0,48/157,20.29%,LYN;TAOK3;FGR;MAPKAPK3;DAPK1;PAK2;ERN1;INSR;IGF1R;PEAK1;FES;VRK2;MINK1;RIPK1;MAPKAPK2;TEC;FLT1;PIM1;PTK2B;DAPK3;ULK2;CAMKK2;GRK5;EIF2AK1;EIF2AK2;NEK6;SIK1;TAOK1;DYRK1A;STK11;HTATIP2;STK17B;ITK;STK24;MKNK1;MARK2;TXK;MAP3K10;MKNK2;AURKA;HCK;STK10;PDGFRB;TAOK2;MAK;ATM;STK16;GSK3B
prerank,negative regulation of anoikis (GO:2000811),-0.6012577993850929,-1.5163620852596973,0.04852686308492201,0.13540095659450704,1.0,5/14,11.79%,MCL1;ITGA5;ITGB1;BCL2;PIK3CA
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.49163647179742603,-1.5160549576982398,0.037800687285223365,0.13547370821802515,1.0,21/33,32.47%,RAB7B;FES;STAT3;FOXO3;MAPK14;STAT5B;PRMT1;HIF1A;NCKAP1L;ARNT;HMGB2;ACVR2A;HSPA1A;PITHD1;STAT1;PRKDC;HOXA5;ETS1;ANKRD54;MTURN;HSPA1B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.597483249262584,-1.515715208894664,0.04553734061930783,0.1355723020379535,1.0,5/15,14.42%,RIPOR2;ADAM9;MAPK14;CD53;EHD1
prerank,mitotic cytokinesis (GO:0000281),-0.4580708801678151,-1.5139095004605911,0.02054794520547945,0.13726409370812082,1.0,26/47,27.29%,ROCK1;SNX9;PDCD6IP;SON;INCENP;USP8;KIF23;CENPA;EFHC2;SNX33;KIF4A;SNX18;ARL3;CKAP2;RACGAP1;NUSAP1;RASA1;KIF20A;CEP55;JTB;CHMP4B;KLHDC8B;RAB35;ECT2;MITD1;STAMBP
prerank,platelet aggregation (GO:0070527),-0.4843557128659883,-1.5135051662095174,0.022298456260720412,0.1375282446984393,1.0,9/33,6.59%,PLEK;MYH9;RAP2B;FLNA;ACTB;TLN1;PIK3CB;FN1;PIK3CG
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.5554777206561465,-1.512850119804272,0.034482758620689655,0.1380489194777815,1.0,13/19,32.15%,GNPDA1;MPI;UAP1L1;NANS;PMM2;UAP1;GNPDA2;GFPT1;AMDHD2;RENBP;PMM1;GNPNAT1;UGP2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.4508573854850566,-1.5115065005270067,0.02023608768971332,0.13932797221891421,1.0,25/48,30.34%,OGT;NUP50;PRKAG2;NOA1;NUP42;NUP88;RAE1;HIF1A;NUP205;TPR;JMJD8;NUP188;NUP153;NUP35;NUP107;NUP62;PRKAG1;ZBTB7A;RANBP2;EIF6;NUP37;EP300;PGAM1;AAAS;NUP133
prerank,purine nucleotide catabolic process (GO:0006195),-0.6124252791627536,-1.5108845999438067,0.034050179211469536,0.13981350634725837,1.0,3/13,9.96%,GDA;XDH;NT5C2
prerank,positive regulation of protein import (GO:1904591),-0.4925031677562444,-1.5104342899425864,0.03826086956521739,0.14008859211795716,1.0,16/30,25.22%,PRKCD;IPO5;FLNA;TPR;MAVS;BAG3;ARHGEF5;HCLS1;PDCD5;CHP2;ZC3H12A;JUP;TGFB1;RBM22;TRIM28;ECT2
prerank,mitotic metaphase plate congression (GO:0007080),-0.4397587472584929,-1.5094449425764358,0.024179620034542316,0.1409986436423786,1.0,25/51,25.36%,PDCD6IP;EML4;PIBF1;CHMP5;CENPE;KIFC1;KIF14;CHMP7;CHMP1A;CHMP2A;KIF2C;MAD1L1;NUF2;NDC80;CEP55;RAB11A;VPS4A;KIF22;NUP62;CHMP4B;CHMP4A;BECN1;CCNB1;CHMP2B;NUDC
prerank,methylguanosine-cap decapping (GO:0110156),-0.6549380197428869,-1.5091485622658816,0.050434782608695654,0.141056251000629,1.0,3/10,8.37%,DCP1A;PATL1;DCP2
prerank,regulation of interleukin-4 production (GO:0032673),-0.5394843958544752,-1.5090841179469716,0.04948805460750853,0.14086530960233232,1.0,9/21,21.89%,SYK;CD28;FCER1G;SLC7A5;RARA;GATA3;LGALS9;NLRP3;CEBPB
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.4429568855048051,-1.5089546590825478,0.01697792869269949,0.14073914598918566,1.0,26/52,26.32%,ERN1;TATDN2;TLN1;PREB;WFS1;DNAJB9;XBP1;DCTN1;SERP1;SEC31A;VAPB;TPP1;SRPRB;DNAJC3;HYOU1;CXXC1;ATP6V0D1;GFPT1;ACADVL;LMNA;EDEM1;PPP2R5B;SHC1;KLHDC3;ERN2;PDIA5
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.39999481822220856,-1.5089014196370518,0.005119453924914676,0.14056861372890983,1.0,41/87,32.21%,CD44;GRB2;CBL;KIF16B;GALNT3;HNRNPH1;CEP57;POLR2H;FRS2;POLR2F;ITGB1BP1;POLR2L;SPRED1;SPRED2;CCL5;SHCBP1;POLR2A;NCBP1;NR4A1;POLR2G;PTPN11;HNRNPA1;NDNF;SFRP1;POLR2I;GTF2F2;MAPK1;FGF18;FGF9;FGFR4;ESRP1;GTF2F1;ZFP36L1;HNRNPF;FGF22;FGF20;FIBP;FGF16;RAB14;FGF2;POLR2D
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.6041749647734812,-1.5086502973915965,0.03860294117647059,0.1406137860269472,1.0,8/13,20.90%,ZC3HAV1;CNOT1;RC3H1;MOV10;GTPBP1;NUDT21;CNOT8;ZC3H12A
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.6262195192471148,-1.5082604168960985,0.030357142857142857,0.14077149146004964,1.0,7/12,32.31%,NELFB;EAPP;RNF8;RECQL5;LARP7;NELFE;NELFA
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6229131136238324,-1.5079807509997076,0.03666666666666667,0.14086285598171966,1.0,6/12,13.07%,FOXP1;CD74;TLR4;MAP2K5;LPL;OAS3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5098342142906954,-1.5077757363362,0.037996545768566495,0.14085431846272384,1.0,12/27,21.80%,CD44;CD74;SMYD2;DDX5;SPRED1;DYRK1A;SPRED2;EEF1E1;KMT5A;ATM;KDM1A;SNAI2
prerank,aminoglycan biosynthetic process (GO:0006023),0.42390573912966534,1.5076083007251577,0.020361990950226245,0.20175967479332063,1.0,9/49,3.81%,B3GALT1;HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;B3GALT5;PXYLP1;HS3ST1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.41840577361658454,-1.5070023233387309,0.01733102253032929,0.14152904509490613,1.0,25/70,20.83%,RUNX1;PSME4;PSMB7;PSME3;PSMB9;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;TCF3;PSMB8;KMT2A;GATA3;MYB;TCF12;LMO2;PSMA5;PSMD4;PSMB3;PSMD3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.4401994339320619,-1.5064992970822788,0.024390243902439025,0.14185726398052365,1.0,20/46,25.22%,PRKCD;IPO5;FLNA;DHX9;ANP32B;GAS6;YWHAE;TPR;MAVS;BAG3;HCLS1;CHP2;GSK3B;ZC3H12A;JUP;GTSE1;TGFB1;RBM22;TRIM28;ECT2
prerank,protein polyubiquitination (GO:0000209),-0.34181261371962607,-1.5062490016142092,0.0,0.14188291022979216,1.0,96/297,22.24%,SASH1;RNF213;WWP1;HECTD1;BFAR;DDB2;RNF19A;FBXW8;PSME4;TRAF5;BRCA1;MYLIP;WWP2;FBXL17;RNF41;AMFR;AREL1;RNF166;PELI1;PSMB7;ANAPC1;PSME3;RC3H1;RNF20;FBXO32;FBXW11;BCL2;UBE2R2;RNF31;LNPEP;PSMB9;FBXL20;RBCK1;TRAF3;UBE3B;HERC6;UBR2;CTNNB1;TPP2;RNF4;FBXO38;CBFB;ANKRD39;HECTD2;PSMA8;UBC;RPS27A;UBE2L3;RNF8;TRAF1;PSMC3;UBE4B;NEDD4L;PSMD8;UBE3A;FBXO10;TRIM68;TRAF2;UBE2H;PSMC4;PSMB10;TNKS2;FBXW2;PSMA1;ARIH1;RNF34;KLHL42;UBE2G1;UBE2T;RNF216;CDC34;TRIM14;UBE2C;PSMB8;FBXL8;SKP2;ANAPC7;FBXO7;HUWE1;TRIP12;FBXO31;PSMA5;PSMD4;UBE3C;PSMB3;FBXO22;FBXW4;DTX3L;PSMD3;RNF125;SMURF2;RUSC1;RNF135;CCNF;RNF115;TOPORS
prerank,mitotic spindle assembly (GO:0090307),-0.4564826732295266,-1.5061714330737923,0.022968197879858657,0.14173169380758727,1.0,19/42,21.20%,RHOA;STAG1;FLNA;KIF3B;KIF11;PIBF1;KIF23;ABRAXAS1;STAG2;ARHGEF10;KIF4A;TPX2;KIFC1;RACGAP1;PRC1;SMC1A;RAB11A;CEP192;LSM14A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.6251072635668984,-1.5061248813226227,0.04280821917808219,0.14131125402293127,1.0,9/11,29.30%,SYK;PTK2B;STAT5B;JAK1;IL2RG;IL2RB;IL2RA;SHC1;IL2
prerank,cellular response to interleukin-2 (GO:0071352),-0.6251072635668984,-1.5061248813226227,0.04280821917808219,0.14131125402293127,1.0,9/11,29.30%,SYK;PTK2B;STAT5B;JAK1;IL2RG;IL2RB;IL2RA;SHC1;IL2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5369226186447354,-1.5060055006057267,0.037102473498233215,0.14121621335025902,1.0,8/21,21.54%,CNOT4;TUT7;CNOT1;CNOT2;PAN3;CNOT6L;CNOT8;PNLDC1
prerank,cellular response to chemokine (GO:1990869),-0.4485719255117627,-1.5058533352124264,0.017123287671232876,0.14113612587440014,1.0,8/46,6.05%,CCR2;RHOA;LRCH1;CCR1;DOCK8;PTK2B;RIPOR2;PF4
prerank,retrograde axonal transport (GO:0008090),0.5573819075084087,1.5057112252911438,0.05647058823529412,0.20322954259659326,1.0,5/16,8.86%,DLG2;TMEM108;DST;KIF5A;NEFL
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.6166283715972721,-1.504976250166732,0.036395147313691506,0.14188472629412358,1.0,5/13,13.58%,RUNX1;RUNX3;CBFB;NCKAP1L;TGFBR2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.5712313028849699,-1.5043961406961972,0.03345070422535211,0.14228707810600533,1.0,4/16,6.62%,PTPRC;LILRB1;STX7;CYRIB
prerank,cellular response to mechanical stimulus (GO:0071260),-0.45384932618226154,-1.5041397749097123,0.028428093645484948,0.14235116904325326,1.0,16/46,19.93%,TLR8;CRADD;MAP3K1;PIEZO1;TLR7;TLR4;NFKB1;PTGER4;MYD88;SLC9A1;GADD45A;CASP1;CD40;CASP8;CASP2;CHEK1
prerank,cholesterol efflux (GO:0033344),-0.5389592684835472,-1.5029426183540546,0.0341726618705036,0.14341991198170612,1.0,3/20,0.54%,APOE;ABCA1;ABCG1
prerank,DNA double-strand break processing (GO:0000729),-0.5617154538747755,-1.5027652490831955,0.048027444253859346,0.14337410729940414,1.0,11/18,26.01%,BRCA1;BLM;RAD52;SLX4;DNA2;RBBP8;ATM;NBN;UBE2V2;UBE2N;MRE11
prerank,regulation of mRNA stability (GO:0043488),-0.370797329443396,-1.5023952858726508,0.00322061191626409,0.14356641602515652,1.0,53/145,27.43%,VIM;PRKCD;ROCK1;YTHDF3;DCP1A;PSME4;MAPKAPK2;ANP32A;PSMB7;PSME3;RC3H1;PSMB9;FUS;EXOSC5;PUM2;E2F1;DCP2;PSMA8;UBC;RPS27A;ZC3H14;TENT5A;PSMC3;FTO;CELF1;PSMD8;METTL14;PSMC4;PSMB10;DHX36;PSMA1;FASTKD3;EIF4G1;PSMB8;HSPA1A;TENT5C;HSPB1;PSMA5;PSMD4;PSMB3;PSMD3;EXOSC4;SET;PUM1;PSMB1;PCBP4;TENT5D;VIP;ZFP36L1;HSPA8;EXOSC8;TBRG4;METTL3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5962935340952883,-1.5014561266501503,0.03511705685618729,0.14436128256397088,1.0,6/13,26.42%,DAB2;RBPMS;TGFBR1;TGFB1;SH2B1;SMAD4
prerank,neuromuscular junction development (GO:0007528),0.5065165450102682,1.5004949589737322,0.05411764705882353,0.20892133248733313,1.0,4/24,2.57%,ANK3;GPHN;UNC13C;CACNB2
prerank,positive regulation of T cell migration (GO:2000406),-0.5474736057404901,-1.5002947006072465,0.046232876712328765,0.14539684748319961,1.0,7/20,20.25%,CCR2;RHOA;DOCK8;APP;CCL5;SPN;WNK1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.44940344598050286,-1.5002701608800164,0.019400352733686066,0.14518334359729884,1.0,18/48,20.66%,APOE;CD84;ROCK1;SNX3;FLNA;NFKB1;ITGAV;IRAK3;AZIN1;EIF2AK1;SF3B3;PIN1;HSP90AB1;FLOT2;RILP;MDM4;LDLR;SIRT2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.541726244928903,1.5002144831042192,0.04066985645933014,0.20828151825498203,1.0,6/19,10.87%,PTPRD;IL1RAPL1;CDKL5;CUX2;CAPRIN2;RELN
prerank,negative regulation of microtubule polymerization (GO:0031115),0.6200006997596951,1.5001879477748636,0.04914004914004914,0.2073109633718705,1.0,6/12,16.07%,MAP2;ARHGEF7;TUBB4A;EML2;CDH5;SNCA
prerank,sterol transport (GO:0015918),-0.5544312679070609,-1.499928979177122,0.0374331550802139,0.14535902935033085,1.0,13/19,36.99%,MSR1;CD36;OSBPL5;NPC2;NPC1;LDLR;LCAT;LDLRAP1;CAV1;ARV1;STARD3;ABCG8;APOA2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.41147841267758367,-1.4998904485566866,0.01507537688442211,0.1451688699397546,1.0,31/72,27.60%,SP100;CRADD;CNOT4;CNOT1;CNOT2;BATF;PLK2;E2F1;PRMT1;CDK1;PCNA;GADD45A;PLK3;E2F8;TFAP4;CNOT6L;AURKA;CASP2;MDM4;ATM;CNOT8;NBN;CDC25C;SFN;GTSE1;CCNB1;PCBP4;RBL2;CNOT3;PML;EP300
prerank,pyroptosis (GO:0070269),-0.5872752003326976,-1.4996056596521465,0.03993055555555555,0.14522722520491468,1.0,7/15,17.31%,NLRC4;DHX9;AIM2;CASP4;GSDME;CASP1;CASP8
prerank,triglyceride catabolic process (GO:0019433),-0.5423340051723513,-1.4987121147891618,0.047186932849364795,0.1458887318721183,1.0,3/19,10.36%,FABP5;LPL;FABP4
prerank,RNA metabolic process (GO:0016070),-0.3766876710519948,-1.4985518689609314,0.010221465076660987,0.14581502562195228,1.0,53/127,27.43%,APOBEC1;RBM39;RBMS1;AGO2;RNASEL;HNRNPA3;DHX9;RBPMS;MPHOSPH10;RNASE4;HNRNPH1;ALKBH1;POLR2H;HNRNPL;POLR2F;POLR2L;FASTKD2;DUSP11;FTO;PCBP2;HNRNPUL1;RNASE6;METTL14;DHX36;POLR2A;RBMS2;NCBP1;WTAP;NUFIP1;POLR2G;ATXN1;TFIP11;HNRNPA1;PAPOLA;DDX3X;RBM3;ZC3H12A;POLR2I;NOL9;HNRNPH2;DDX54;HNRNPK;XRN2;GTF2F2;MTREX;DDX39B;SND1;GTF2F1;DEDD2;RNASEH2B;TBRG4;HNRNPF;METTL3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4483132148007122,-1.4978742866523294,0.01658374792703151,0.14633068510522013,1.0,19/45,22.97%,CD44;SP100;PRKCD;IRF2;IRF5;CIITA;B2M;JAK1;GBP2;IFNGR2;OASL;TRIM68;OAS3;MT2A;HCK;OAS2;STAT1;TRIM25;IFNGR1
prerank,actin filament polymerization (GO:0030041),-0.49343129739482355,-1.4975465050792296,0.03664921465968586,0.1464864630550152,1.0,9/29,10.01%,DIAPH1;GAS7;RAC1;PSTPIP2;PSTPIP1;WASL;CORO7;MSRB1;DIAPH3
prerank,regulation of cell cycle (GO:0051726),-0.3400165693108854,-1.4973962648596382,0.0,0.14646496367050443,1.0,100/271,28.92%,IQGAP1;PTPRC;NOTCH2;BIRC3;SDCBP;LILRB1;CDK6;RB1;JUN;NUPR1;RUNX3;ERN1;MAP3K20;SIPA1;APBB2;CSNK2A1;SON;BRCA1;FBXL17;STAT3;RNF20;CENPF;CRLF3;KIF20B;DLGAP5;DAPK3;UHRF2;LRP6;TAF6;GRK5;NF2;PCLAF;RPS15A;TGFBR1;THAP1;NEK6;MASTL;SIK1;AFAP1L2;CDKN3;CDC25A;CHMP1A;MAP2K1;FAP;GADD45A;STK11;MAEA;HSP90AB1;TFAP4;PRR11;LIN37;ID2;GADD45GIP1;PPP1R9B;NR4A1;RBBP4;FBXL8;SKP2;RARA;CDKN2C;DYNLT3;GATA3;FBXL6;ATM;LIN9;CHEK1;BAP1;SIRT2;SFRP1;NBN;GAS2L1;CDK5;RACK1;INHA;PHACTR4;RRP8;TARDBP;WDR12;CCNB1;PUM1;TGFB1;PIM2;MYC;NUDT6;CKS2;CCNB2;SND1;RNF40;BMP2;PML;TBRG4;TSC2;METTL3;EP300;MYBBP1A;FBXL3;CITED2;ZBTB17;USP51;RNF167
prerank,neuron development (GO:0048666),0.35507160878598354,1.4972907049621937,0.0,0.21016703201554637,1.0,22/141,5.31%,CNTNAP2;NLGN1;TENM2;MYT1L;MAP2;TENM3;CNTN4;TENM1;TENM4;GPM6A;RASGRF1;NTRK2;ATP8A2;SRRM4;EPHA5;SH3GL2;PLP1;TMEM108;BICDL1;POU3F2;GDNF;GPM6B
prerank,metal ion transport (GO:0030001),0.3807232769773065,1.4970989932840235,0.012953367875647668,0.20937642683809488,1.0,30/86,20.35%,CACNA1C;RYR3;CACNA1E;TRPC5;RYR2;CACNA2D1;GRIN3A;SLC8A3;TRPC1;NIPA1;RAMP3;FYN;SLC8A2;CAMK2A;RYR1;MMGT1;ATP2B2;ATP2A1;CHRNA7;SELENOK;NDFIP1;RAMP2;NIPAL4;TRPM2;TUSC3;NIPAL2;CCR5;SLC24A1;MRS2;CACNB3
prerank,transition metal ion homeostasis (GO:0055076),-0.5051384842434313,-1.4970670002901676,0.03773584905660377,0.1466159526554398,1.0,7/28,10.18%,FTL;IREB2;ABCB7;PICALM;HMOX2;B2M;CP
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6372198571700534,1.495948671522091,0.058695652173913045,0.2099249816047679,1.0,5/10,15.81%,TGFA;EGF;AREG;FBXW7;ADAM17
prerank,secondary alcohol metabolic process (GO:1902652),-0.4592151856726411,-1.4958332383730257,0.026936026936026935,0.14776280512424445,1.0,12/42,13.54%,APOE;ABCA1;ABCG1;IDH1;PPARD;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;RXRA
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.481372366160717,-1.4953020659525018,0.03264604810996564,0.14812548702687897,1.0,19/33,34.29%,APOE;RHOA;PPARG;MAP2K5;ITGB1BP1;MEF2C;ANGPT2;GADD45A;HDAC5;HMGB1;JUP;TGFB1;CARD10;TBXA2R;AGTR2;CSNK2B;FGF2;TNF;KLF4
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5139273350363375,-1.4951623478466267,0.02992957746478873,0.14802474698224952,1.0,8/25,18.51%,CD36;INSR;P2RX4;TLR4;HSP90AB1;KLF2;ASS1;MMP8
prerank,cellular response to insulin stimulus (GO:0032869),-0.37088206596148415,-1.4948817327319728,0.0017301038062283738,0.14810368913759114,1.0,36/124,20.56%,MYO5A;RAB8B;ATP6V0D2;NAMPT;BCAR3;GRB2;DENND4C;ATP6V1E1;INSR;IGF1R;PPARG;RAB31;ATP6V1A;SLC27A1;TCIRG1;AP3S1;RHOQ;ZDHHC7;BAIAP2;SELENOS;ATP6V1G1;XBP1;ZNF106;PKM;RAB10;HDAC5;ATP6V0B;PIK3C2A;RAB13;ATP6V0E1;IRS2;RAB12;ENPP1;GSK3B;ATP6V0D1;APPL1
prerank,ERBB2 signaling pathway (GO:0038128),0.47200844111399437,1.4940346763281716,0.04866180048661801,0.21153621999859923,1.0,7/31,7.63%,NRG1;ERBB4;PTPRR;EGF;GAB1;SOS1;NRG2
prerank,cytoplasmic translational initiation (GO:0002183),-0.5666388015148053,-1.493444719651613,0.05423728813559322,0.14954645998404714,1.0,6/17,15.13%,EIF4A2;EIF2B3;EIF3A;EIF5;EIF4A1;EIF4G1
prerank,regulation of platelet aggregation (GO:0090330),-0.5580171187012317,-1.4927288888487031,0.040492957746478875,0.15005453182177111,1.0,4/17,3.36%,LYN;SYK;PRKCD;CD9
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.4307608631496147,-1.492708534911549,0.018612521150592216,0.14985305007192098,1.0,22/53,19.63%,PRKCD;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;DDX5;RNF8;SPRED1;SPRED2;PCNA;BABAM1;EEF1E1;TMEM161A;EYA1;EYA3;RPS3;WRAP53;BRCC3;ATM
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6053483007772769,1.4923005573641153,0.06222222222222222,0.21294879056360708,1.0,6/13,13.07%,ANK3;PDE4D;CASQ2;CALM1;CALM3;CALM2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.45990039478336603,1.4922878609841264,0.03258145363408521,0.21195847612747945,1.0,8/35,3.86%,RIMS2;HTR2C;AKAP6;ADCY2;EPHA5;GUCY1B1;PDE4D;PDE9A
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.34749126494438914,-1.4922321636440814,0.0014947683109118087,0.15009269300329287,1.0,94/241,27.44%,CTNNBL1;TRA2B;DDX46;SRRM1;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;SRRT;FUS;SNRPG;HNRNPH1;GCFC2;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;SPEN;CWC22;RBM19;DDX5;RALY;SF3B3;POLR2L;PRPF8;SART1;SF3B5;UBL5;PCBP2;ALYREF;HNRNPUL1;NUDT21;SNRPA;RBM14;CWC15;METTL14;RBM10;WDR33;YTHDC1;POLR2A;NCBP1;PSPC1;SART3;ZRSR2;GEMIN7;PDCD7;SF3A1;SRSF10;POLR2G;RBM4B;TFIP11;LSM6;RNPS1;WBP11;SNRNP70;TXNL4A;HNRNPA1;PAPOLA;MAGOH;SLU7;BUD13;CPSF3;SF3B1;LSM5;POLR2I;HNRNPH2;GEMIN6;PPIL1;XAB2;HNRNPK;GTF2F2;SNU13;SYF2;SRSF11;NONO;MTREX;RBM22;PRPF6;DHX35;DDX39B;DHX38;GTF2F1;RBM15B;CPSF1;U2AF2;ISY1;HSPA8;WDR83;HNRNPF;METTL3;BUD31
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6343318623531448,-1.4918370976055322,0.04355400696864112,0.15025560204563307,1.0,2/11,1.90%,RUNX1;ETV6
prerank,intermediate filament organization (GO:0045109),-0.5535012456630919,-1.4918213544868537,0.04528985507246377,0.15002882818213234,1.0,7/17,24.88%,VIM;KLHL24;MTM1;DNAJB6;BFSP2;GFAP;DSP
prerank,sulfation (GO:0051923),0.614461342351906,1.491268970009269,0.06521739130434782,0.21246277619828458,1.0,4/11,18.29%,HS3ST5;CHST5;SULT4A1;SULT2B1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6152245662916699,-1.4910974869661495,0.034722222222222224,0.15057187376817893,1.0,7/13,25.90%,BFAR;PPP1R15B;WFS1;DNAJB9;PTPN1;RACK1;NCK1
prerank,protein autoubiquitination (GO:0051865),-0.42169850381988633,-1.491080783888178,0.015332197614991482,0.1503532779502077,1.0,20/61,16.71%,RNF213;CNOT4;KLHL24;BFAR;DDB2;NFX1;BRCA1;WWP2;RNF41;AMFR;UHRF2;RNF4;RNF8;UBE3A;TRIM68;UHRF1;TRAF2;RNF185;UBE2T;ASB4
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3856105757963549,-1.4910396527143586,0.0047694753577106515,0.15017311994640908,1.0,37/113,21.40%,ABCA1;FNIP2;ASAP1;SYK;PLEK;CD36;RAP1B;DDB2;USP50;BCL2L11;SPIDR;PIEZO1;TLR4;CAPG;VEGFA;GBP5;MYD88;FNIP1;LCP1;CDC42EP2;PSMC3;CUL4B;PSMC4;RPA3;SH3GLB1;ERCC4;BRK1;EIF4G1;FAF1;BID;ISG15;RPS3;DDX3X;ATM;GSK3B;MMP1;RACK1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5483996384212864,-1.4909324450498969,0.042735042735042736,0.15005500899814025,1.0,6/18,17.07%,TLR4;CLEC4D;TNIP2;CD2;KARS1;CD226
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5281301919365048,-1.4903876371384885,0.03231292517006803,0.15041438035856522,1.0,13/23,33.07%,LILRB1;RAET1E;ARRB2;AP1G1;LAMP1;CD226;LGALS9;SLAMF6;CRTAM;KLRC2;NCR1;KLRD1;KLRC1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4662696487810466,1.4901913916273877,0.04484304932735426,0.21294990872940203,1.0,9/32,17.62%,AKAP6;TRPC1;NPSR1;CAPN3;CALM1;CALM3;CALM2;SNCA;HAP1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5498884832162196,-1.4900682866009276,0.041884816753926704,0.15052553721716927,1.0,10/17,21.47%,NRP1;FES;CDC42;STAP1;BAIAP2;BAIAP2L2;HCLS1;HCK;CDK5;HAX1
prerank,negative regulation of axon extension (GO:0030517),0.4831465156176163,1.4889512491842916,0.045112781954887216,0.2137212635783851,1.0,10/30,14.89%,MAP2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;TRIM46;SEMA3F;SEMA5B;PTPRS;SEMA4G
prerank,peptidyl-tyrosine modification (GO:0018212),-0.42968674739482043,-1.4888360508342655,0.02608695652173913,0.15175720670281892,1.0,15/56,11.45%,LYN;FGR;ABI1;SYK;INSR;FES;ABL2;TEC;FLT1;PTK2B;TPST1;PKDCC;PTPN6;LCK;DYRK1A
prerank,vesicle transport along actin filament (GO:0030050),-0.5460845670111582,-1.4883464102698107,0.04203152364273205,0.15209244163986374,1.0,6/19,11.64%,MYO5A;MYO1F;MYO1G;WASL;MYO1E;MYO7A
prerank,ncRNA processing (GO:0034470),-0.3493986931279196,-1.488241830649816,0.001610305958132045,0.15196631359819662,1.0,78/200,28.64%,AGO2;FARS2;RPL7;ADAT1;RPS24;TUT7;ESF1;MPHOSPH10;INTS8;SARS1;RPL36;RPS6;RPL11;RPL10A;DDX49;RPL12;INTS11;SRRT;RPS14;EXOSC5;NOP14;RPL32;SENP3;WDR36;NVL;RPS28;NOL6;RPL28;DHX37;INTS6;KRR1;RPL22;RPL14;RPL34;RPL6;NOLC1;EMG1;RPL18A;KARS1;RPL37A;INTS1;UTP6;RPS9;RPS27;RPL23A;RPS16;EXOSC10;RPL9;AARS1;INTS5;C1D;RPLP2;NOL9;DDX54;EXOSC4;XRN2;RPL41;RPLP0;SNU13;RPL7A;MTREX;RPL19;WDR12;RPS15;RPL39;RCL1;MRM2;RPL5;PDCD11;RPL13;IMP4;EXOSC8;METTL3;RPL18;WDR3;RPL27A;PIH1D2;THG1L
prerank,positive regulation of lipid transport (GO:0032370),-0.6184175496398071,-1.4881419965485922,0.03527336860670194,0.15183862265273937,1.0,2/12,1.17%,APOE;LRP1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5877128528694199,-1.487412322243449,0.03678929765886288,0.15244664812734962,1.0,9/14,21.86%,MALT1;IL18;ANXA1;NFKBIZ;RARA;MYB;NFKBID;NLRP3;SOCS5
prerank,actin filament capping (GO:0051693),-0.5649867659661809,-1.48695143832182,0.0528169014084507,0.152531063077149,1.0,9/18,21.95%,EPS8;CAPZB;SVIL;TRIOBP;CAPG;CAPZA1;ADD3;TWF2;FLII
prerank,barbed-end actin filament capping (GO:0051016),-0.5649867659661809,-1.48695143832182,0.0528169014084507,0.152531063077149,1.0,9/18,21.95%,EPS8;CAPZB;SVIL;TRIOBP;CAPG;CAPZA1;ADD3;TWF2;FLII
prerank,substrate-dependent cell migration (GO:0006929),-0.5882314839885843,-1.4867733240553378,0.04529616724738676,0.15251452442338387,1.0,3/14,0.91%,PTPRC;NRP1;SDCBP
prerank,cAMP metabolic process (GO:0046058),0.5942560899160229,1.4866866839129744,0.05502392344497608,0.21578654510526918,1.0,6/13,8.71%,ADCY2;ADCY8;PDE4D;ADCY5;ADCY3;ADCY1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.44279765016749495,-1.4861631591782503,0.027210884353741496,0.15302217322690795,1.0,18/45,26.35%,ERN1;RIPK1;NFKB1;DIMT1;DDX5;RELA;DYRK1A;MAP2K1;HNRNPLL;POLR2A;HSPA1A;SLC38A2;GRSF1;IL6;TGFB1;RBM22;BUD23;U2AF2
prerank,"transcription, DNA-templated (GO:0006351)",-0.34830968642993004,-1.4856532621477172,0.0,0.1533473018786691,1.0,78/207,27.09%,RREB1;AFF4;MEF2A;DEK;NELFB;NFIC;NFX1;NFYA;SMARCA5;ARRB2;GTF2A1;CTR9;KLF13;ERCC6;FOXO3;NFKB1;MAF;TAF6;POLR2H;E2F1;POLR2F;THAP1;CBFB;POLR3G;DDX5;POLR2L;SNAPC2;XBP1;MED4;TRIM24;SMN1;GTF2E2;POLR2A;EPC1;NCBP1;TFAM;TAF4B;NFKBIB;POLR2G;TAF9;TTF1;TAF3;RNPS1;TAF1A;SNAPC3;DTX1;POLR3A;NCOA6;GMEB2;TAF4;GTF3A;RSF1;MED20;ELOC;RTF1;GTF3C5;MMS19;PKNOX1;POLR2I;XAB2;CCNK;GTF2F2;GTF2A2;TOPORS;TWNK;DEAF1;TRIP11;DRAP1;POLR3GL;GTF2F1;BRF1;SSRP1;POLR1C;UBTF;NELFE;NKX2-8;HIPK3;ZBTB7B
prerank,fibrinolysis (GO:0042730),-0.6068142202348941,-1.4855114714658495,0.04006968641114982,0.15326351858633525,1.0,3/13,12.79%,PLAU;PLAUR;SERPINE1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.6030495904912372,-1.4849878398078185,0.05765765765765766,0.15357755113841096,1.0,5/13,11.30%,P2RX7;ANO6;C3;AZIN1;ACSL5
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.31759528236313833,-1.4849774636535242,0.0,0.1533542601540342,1.0,135/572,18.15%,RBPJ;DAB2;MITF;FNIP2;ZEB2;FOXP1;RUNX1;TRPS1;SP100;RREB1;SDCBP;BCL6;RB1;JUN;ZNF568;MEF2A;CREBBP;ETV6;RUNX3;PPARD;ARID5B;BPTF;BACH1;DNMT3A;IRF2;ZNF148;NFIC;NFX1;ATF3;PPARG;GATAD2A;SPI1;WWP2;PHF21A;ZNF3;CTR9;STAT3;FOXO3;CNOT1;NIPBL;CHD3;NFKB1;CNOT2;HHEX;ZBTB21;RARG;SAP30;SARS1;NR1H2;CIITA;CUX1;MDFI;SMYD2;NFATC3;ZBTB2;TBL1XR1;MCPH1;EZH2;RPS14;DPF2;USP9X;WFS1;NR2F1;SKI;VEGFA;BHLHE40;MAP2K5;EED;E2F1;CNBP;FNIP1;SPEN;THAP1;CBFB;PARP9;DDX5;MEF2C;SAP130;TFEC;UBC;RPS27A;SUDS3;HDAC10;RELA;NEDD4L;FLCN;TCF25;OSR1;TPR;KLF10;PRDM2;GADD45A;FOXJ1;ZFP57;CHD8;UHRF1;FRK;PLK3;MTA3;IRF2BP2;HDAC5;TGIF1;SP2;RXRA;E2F8;BATF3;SIN3A;LIN37;EPC1;DR1;KLF2;ID2;TCF3;YY1;NSD1;BAG3;KLF8;ZNF177;KMT5A;NRIP1;KLF11;SOX10;UBE2I;ATXN1;VHL;UXT;HSPA1A;TAF3;RARA;SMAD7;NR3C1;GATA3;MYB;RIPPLY2;ARID5A
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5261168782996123,1.4847859939722199,0.04666666666666667,0.2173806819954255,1.0,6/21,8.71%,ADCY2;ADCY8;GUCY1B1;ADCY5;ADCY3;ADCY1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.44256192740006917,-1.4847676859276602,0.019963702359346643,0.15336558671678827,1.0,14/47,12.70%,NEDD9;NRP1;CORO1C;RREB1;RAC1;FLNA;CDC42;TRIOBP;DOCK5;MYADM;MDK;ITGB1BP1;CRK;CIB1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6492814808543775,-1.4837942576666288,0.042444821731748725,0.15432460191616307,1.0,3/10,9.66%,APOE;ABCA1;ZDHHC8
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.528103020473625,-1.4830189619804923,0.03697183098591549,0.15494336831728076,1.0,5/21,13.46%,MITF;JUN;MED24;MED4;DHX36
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.4884136963282062,-1.482803311639609,0.023931623931623933,0.154992574453341,1.0,12/31,29.86%,PTPRC;SASH3;KMT5B;KMT5C;DNAJB9;XBP1;STX4;SHLD2;IL6;RBP4;IL2;VAMP3
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.4498595635696448,-1.4805406761775077,0.029668411867364748,0.1574142921887634,1.0,17/44,20.90%,ZC3HAV1;ROCK1;YTHDF3;AGO2;CNOT1;RC3H1;MOV10;FTO;GTPBP1;CELF1;METTL14;TNRC6C;DHX36;POLR2G;TOB1;CNOT8;ZC3H12A
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.45214035302039846,-1.4803824142181539,0.031088082901554404,0.1573309890885578,1.0,19/43,21.01%,TAOK3;BRCA1;NABP1;BLM;ABRAXAS1;BABAM2;RINT1;FOXN3;TAOK1;CDK1;BABAM1;TICRR;TOPBP1;TRIM39;TAOK2;BRCC3;ATM;CHEK1;NBN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4817289421232823,-1.479935359381592,0.03231597845601436,0.15755438089839008,1.0,13/32,22.64%,RB1;BACH1;BRD4;CDK18;E2F1;CDK14;PCNA;ID2;CCNE1;KLF11;CDK16;CDK5;CDC45
prerank,regulation of protein import into nucleus (GO:0042306),-0.4726108678102323,-1.4797942269497715,0.031078610603290677,0.15747876790307636,1.0,17/36,25.22%,MDFIC;PRKCD;IPO5;FLNA;TPR;MAVS;BAG3;HCLS1;CHP2;SUFU;ZC3H12A;JUP;UFM1;TGFB1;RBM22;TRIM28;ECT2
prerank,interstrand cross-link repair (GO:0036297),-0.43084314779269206,-1.4795630882060529,0.01877133105802048,0.157510309915122,1.0,22/53,22.31%,DCLRE1C;WDR48;NEIL3;RAD51;RFWD3;UBC;RPS27A;NUCKS1;RNF8;MCM9;DCLRE1A;RPA3;ERCC4;RAD51AP1;UBE2T;SLX4;XRCC3;POLN;FAAP24;EXO5;FAN1;FANCD2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4470808402126445,-1.4792480354602984,0.03430531732418525,0.15763707267461022,1.0,20/43,25.09%,FOXP1;IGF1;JUN;ERN1;IL6R;IL18;MEF2D;CCL5;ID2;FOXJ2;PDGFRB;RBPMS2;ADAMTS1;MMP2;STAT1;IL6;P2RY6;HMOX1;FGF9;CCN4
prerank,metanephros development (GO:0001656),0.49013567261821384,1.478785651407052,0.06338028169014084,0.22494671357421553,1.0,8/26,11.28%,ROBO2;PAX8;GDNF;WT1;FGF10;BMP7;CITED1;PKD1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.3776832028284889,-1.4784151931256346,0.013223140495867768,0.15851720093663577,1.0,35/108,21.30%,IQGAP2;IQGAP1;DIAPH1;CLIC4;P2RX7;LRP1;PAK2;PRKCD;RAC1;ROCK1;RHOA;ARHGAP17;ARHGAP18;RHOQ;BAIAP2;SH3BP1;BST2;KATNBL1;TAOK1;CRK;CCDC88A;SPEF1;MARK2;BST1;RND2;ARHGEF5;CLN3;TWF2;CDK2AP2;PDGFRB;TAOK2;RHOBTB1;GSK3B;RHOF;PDGFA
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.5512709648951117,-1.4780529916234586,0.0539568345323741,0.15875985536171544,1.0,6/17,19.35%,LYN;TAOK3;EIF2AK2;TAOK1;TAOK2;NOD2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.40217493497523976,-1.477953581591081,0.013675213675213675,0.15862983923065332,1.0,29/77,28.72%,IGF1;MCL1;RB1;BIRC6;CSNK2A1;RIPK1;CFLAR;PSME3;ITGAV;BCL2;SLC35F6;HGF;PLAUR;TGFBR1;RELA;TMBIM6;GHITM;HSPA1A;ACAA2;DDX3X;MAZ;BCL2L2;URI1;TMEM14A;SIAH2;RTKN2;NOC2L;BCL2L1;PRELID1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.46145125117367664,-1.4774219174366499,0.040421792618629174,0.1590458858782037,1.0,14/36,19.93%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;EPC1;PHC3;RBBP4;UXT;RBBP8;MAX;CHEK1
prerank,regulation of DNA recombination (GO:0000018),-0.4856855197579045,-1.4772971779950541,0.04475043029259897,0.1589404228790267,1.0,13/32,22.94%,PPP4C;PPP4R2;SPIDR;BLM;RTEL1;RAD51;IL7R;ALYREF;RAD51AP1;SHLD2;CHEK1;KDM1A;ZRANB3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6117945781449838,-1.4771487028204031,0.05381944444444445,0.15887872646249057,1.0,7/12,28.82%,DAB2;FOXP1;SFRP1;ZBTB7A;HEYL;NCOR1;PIAS2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5841088243063326,-1.4766101994080207,0.036458333333333336,0.15923402192414485,1.0,4/14,7.44%,LYN;STAT3;STAT6;STAT5B
prerank,Golgi to lysosome transport (GO:0090160),-0.631150929832776,-1.4756922616036325,0.04903677758318739,0.16005712947168899,1.0,5/11,16.22%,ANKFY1;AP1G1;LAPTM5;LAMP1;CLN3
prerank,engulfment of apoptotic cell (GO:0043652),0.5637068154300602,1.4754976922427627,0.056074766355140186,0.22849044043873046,1.0,4/15,6.42%,XKR4;XKR6;RHOBTB2;XKR8
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5446222051735995,-1.4746314617127227,0.051926298157453935,0.16107703759311848,1.0,10/18,25.05%,STX7;ACTB;STX8;ZDHHC7;ZDHHC2;CLN3;VPS4A;APPL1;CDK5;ABCA2
prerank,actin polymerization or depolymerization (GO:0008154),-0.42918387808678937,-1.4742215714171767,0.039603960396039604,0.16128093585451755,1.0,15/50,12.08%,DIAPH1;GAS7;ABI1;RAC1;PSTPIP2;SVIL;PSTPIP1;WASL;CAPG;CORO7;WDR1;MSRB1;DIAPH3;MICAL1;MICAL2
prerank,regulation of B cell differentiation (GO:0045577),-0.5578365329652539,-1.474046053641472,0.0456140350877193,0.1612742667045894,1.0,9/17,22.25%,SYK;NCKAP1L;CD27;IKZF3;XBP1;IL4I1;ID2;SFRP1;INHA
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3920131287870924,-1.4740171995136373,0.020338983050847456,0.16105798726793102,1.0,33/94,20.83%,MAP3K8;PSME4;IRAK2;TAB2;PELI1;PSMB7;PSME3;NFKB1;FBXW11;IRAK4;PSMB9;IRAK3;MYD88;NOD1;PSMA8;UBC;RPS27A;EGR1;TNIP2;RELA;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;IKBKB;PSMB8;IL1R2;NOD2;PSMA5;PSMD4;PSMB3;PSMD3
prerank,histone mRNA metabolic process (GO:0008334),-0.4924493233244165,-1.4735143650424287,0.036585365853658534,0.16141984282700736,1.0,11/27,21.33%,TUT7;SNRPG;SNRPF;DCP2;MTPAP;NCBP1;TENT4B;EXOSC10;ATM;CPSF3;EXOSC4
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3921358418805499,-1.47344759923134,0.01929260450160772,0.16125438014574026,1.0,21/84,12.93%,APOE;MSN;WWP1;RAB7A;SNX9;TNFRSF1B;CSNK2A1;WWP2;RNF41;AREL1;ATG7;TIPARP;ADAM9;AXIN1;SNX33;PLK2;ADAM8;NEDD4L;ASB5;STX5;PLK3
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.3904282325570577,-1.473250296708906,0.015100671140939598,0.16127387652861938,1.0,31/84,24.12%,SASH1;NRP1;FOXP1;RAC1;P2RX4;RIN2;PTK2B;MAPK14;PIK3CB;PIK3CG;NRP2;GRN;VEGFA;ITGB1BP1;HIF1A;AGT;PIK3CD;CD40;TMSB4X;MAP2K3;GATA3;HSPB1;HMGB1;BMPR2;ZC3H12A;KDR;FGF18;PLPP3;TGFB1;GPLD1;ATP5F1B
prerank,cardiac muscle tissue development (GO:0048738),0.4228184182654599,1.4724869355503576,0.023809523809523808,0.23172596581453667,1.0,10/50,11.10%,SGCZ;NRG1;SGCD;CBY1;MSX1;NDUFV2;BMP7;SGCG;MYOCD;TTN
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.47343371711075855,-1.472148485945313,0.04599659284497445,0.1624039882427256,1.0,8/33,10.48%,MAP3K5;PRKCD;NFE2L2;RIPK1;ANXA1;SIRPA;MAPK7;RELA
prerank,regulation of protein export from nucleus (GO:0046825),-0.512705522919759,-1.4721425835714121,0.03270223752151463,0.16216534460281476,1.0,9/23,23.55%,SP100;ANP32B;GAS6;YWHAE;TPR;BAG3;GSK3B;GTSE1;RBM22
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.49190628424064287,-1.472106030809861,0.04778156996587031,0.1619719337390239,1.0,13/28,26.18%,MAP3K5;ITPR1;ERN1;BCL2;CASP4;ATP2A3;TRAF2;BBC3;QRICH1;BAG6;CEBPB;ERO1A;ERN2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5920771984634883,-1.4706791739847793,0.05178571428571429,0.16347188366724832,1.0,5/14,20.80%,BFAR;BCL2L11;DNAJB9;COPS5;PTPN1
prerank,positive regulation of vasoconstriction (GO:0045907),0.5718794547624763,1.4705109462015393,0.0763888888888889,0.23335853456045563,1.0,5/13,12.77%,SMTNL2;ADRA1B;OXTR;ADRA1D;ADRA1A
prerank,spindle assembly (GO:0051225),-0.41465338433867727,-1.4701990660686255,0.02276707530647986,0.16381153942714569,1.0,26/67,21.20%,GOLGA8B;RHOA;STAG1;FLNA;KIF3B;KIF11;PIBF1;HAUS5;ABRAXAS1;STAG2;ARHGEF10;HAUS6;STARD9;TUBGCP4;NEK6;TPX2;KIFC1;HAUS4;HAUS7;INO80;RPS3;RCC1;SMC1A;RAB11A;CEP192;LSM14A
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.6003774233371874,-1.4701966750254631,0.041970802919708027,0.1635685256500757,1.0,7/13,32.31%,NELFB;EAPP;RNF8;RECQL5;LARP7;NELFE;NELFA
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.43341724605770066,-1.4701661271933117,0.02555366269165247,0.16335758129270556,1.0,31/50,39.64%,CD44;PAK2;CSNK2A1;HGF;GAS6;VEGFA;MAP2K5;FNIP1;PLAUR;YWHAE;RNF34;DDX3X;BEX3;DNAJB6;SFN;MT3;SIAH2;RPS6KA3;CARD16;AQP1;PAX2;NGFR;XIAP;MMP9;TNF;KLF4;NGF;LAMP3;USP47;RAF1;TRIAP1
prerank,synaptic vesicle localization (GO:0097479),0.5790350421090117,1.4701316927463082,0.07857142857142857,0.23291653059285072,1.0,5/13,8.20%,NLGN1;KIF5C;SYNDIG1;KIF5A;TOR1A
prerank,regulation of GTPase activity (GO:0043087),-0.3542861774908014,-1.4693767002015927,0.006535947712418301,0.16408618447342324,1.0,41/177,12.64%,ARHGAP15;VAV3;PLXNC1;BCAR3;RSU1;FGD6;GPR137B;SNX9;PLXNA1;DOCK10;PLXND1;TBC1D15;DOCK11;VAV1;SGSM2;RGS1;LRCH1;RAP1A;FGD4;ITGB1;DOCK8;ARFGEF1;ARAP1;RAB3GAP1;FGD3;PICALM;EZH2;ALS2;SH3BP1;ITGB1BP1;VAV2;ARHGAP12;TGM2;ADAP1;PIN1;SNX13;FLCN;CRK;SNX18;TBC1D10B;CCL5
prerank,replication fork processing (GO:0031297),-0.45804127352213564,-1.4692213520885304,0.02276707530647986,0.16406076364163716,1.0,12/38,11.65%,FAM111A;SAMHD1;BLM;PRIMPOL;RTEL1;RAD51;RFWD3;NUCKS1;GEN1;ALYREF;WRN;PCNA
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.42693142526216754,-1.468926124942834,0.023931623931623933,0.1641822620476677,1.0,25/57,22.80%,TAOK3;BRCA1;BLM;ABRAXAS1;BABAM2;RINT1;RFWD3;FOXN3;TAOK1;CDK1;BABAM1;TICRR;WAC;TOPBP1;RAD9A;TRIM39;TAOK2;BRCC3;ATM;FBXO31;CHEK1;TIPIN;NBN;FANCD2;PRKDC
prerank,regulation of organelle organization (GO:0033043),-0.39586256495295524,-1.4687369006334328,0.020100502512562814,0.16416410539148796,1.0,19/80,16.22%,DIAPH1;MYO5A;ZEB2;MSN;CLIC4;PAK2;MTM1;PREB;ARMH3;FIS1;TAOK1;SAR1A;STX5;SPEF1;MARK2;PRMT6;MAVS;ARHGEF5;CLN3
prerank,histone H4-K16 acetylation (GO:0043984),-0.5472216094267033,-1.4686554094364057,0.04475043029259897,0.164025215437335,1.0,7/19,17.14%,OGT;PHF20;KANSL2;WDR5;JADE2;KAT7;KMT2A
prerank,lymphocyte migration (GO:0072676),-0.479478993889074,-1.4684997041564476,0.030508474576271188,0.16396165981035535,1.0,14/32,31.92%,MSN;CKLF;MYO1G;ADAM8;CCL5;ZAP70;GATA3;CCL7;TBX21;CRTAM;CCL24;CCL4;CCL25;CCL19
prerank,protein-DNA complex disassembly (GO:0032986),-0.5623323092619261,-1.4682308520612366,0.038869257950530034,0.16399135169030063,1.0,5/16,11.99%,ARID2;SMARCD3;SMARCC2;ARID1A;NFE2
prerank,intracellular sterol transport (GO:0032366),-0.5910918238049967,-1.4678706322591442,0.06540447504302926,0.16420133494252692,1.0,5/13,20.48%,ABCA1;ABCG1;NPC2;NPC1;VPS4A
prerank,regulation of sodium ion transport (GO:0002028),0.46069713468462714,1.4678551602174361,0.06053268765133172,0.2350291679545684,1.0,15/34,19.95%,NKAIN2;FGF12;ANK3;NKAIN3;AHCYL1;SPTBN4;NEDD4;ATP2B4;WNK4;CNKSR3;WNK3;NKAIN4;WNK2;NKAIN1;PER1
prerank,negative regulation of viral life cycle (GO:1903901),-0.5675302460839603,-1.4664991123497353,0.053082191780821915,0.16563510629683534,1.0,5/15,13.91%,SNX3;CIITA;BST2;IFITM2;TRIM11
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.470417428649957,1.4663663512258542,0.0332541567695962,0.23604111655805043,1.0,11/31,15.66%,SYT1;SYT10;SYT2;SYT5;SYT11;SYT12;DOC2A;REST;SYT7;CBARP;CACNA1G
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5718248351085451,-1.466086532727542,0.05789473684210526,0.16590018749177313,1.0,6/15,10.78%,IGF1;ROCK1;MEF2A;SLC9A1;AGT;MTPN
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.4297643730399436,-1.465826141214728,0.02901023890784983,0.1660103016079832,1.0,17/54,18.62%,BIRC3;SYK;RIPK1;CFLAR;RNF31;RBCK1;GAS6;LAPTM5;CASP4;OTULIN;TRAF1;CASP1;TRAF2;IKBKB;CASP8;HSPA1A;TRADD
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.556973302940025,1.4650956238628736,0.07852193995381063,0.2369105822755442,1.0,5/15,10.56%,KCNN2;KCND3;KCNJ3;KCNIP2;ATP1B1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5238134794784133,1.4649611066154047,0.07345971563981042,0.23607667209291813,1.0,4/18,3.20%,NLGN1;RIMS2;RIMS1;SYN1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.5019039766730771,-1.4640675694968426,0.04712041884816754,0.16794771813212764,1.0,6/26,9.13%,APOE;POR;HTR2B;ATP7A;PIK3CB;HIF1A
prerank,protein-DNA complex assembly (GO:0065004),-0.3709721544564103,-1.4638912292283042,0.00667779632721202,0.1679369483160541,1.0,38/116,21.28%,TCF4;DDB2;PSME4;SMARCA5;PSMB7;PSME3;ANP32B;PSMB9;MCM6;RAD51;PSMA8;UBC;RPS27A;MCM3;PSMC3;CUL4B;PSMD8;ORC5;ASF1A;HMGB2;SPTY2D1;PSMC4;PSMB10;RPA3;PADI4;PSMA1;SART3;CHAF1A;MCM2;PSMB8;BRD2;RSF1;PSMA5;PSMD4;PSMB3;PSMD3;DMC1;CETN2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.39687856164945445,-1.4638223328581954,0.02422145328719723,0.16778895192763327,1.0,29/72,22.50%,LYN;IGF1;FGR;CBL;PIK3R5;INSR;IGF1R;PIK3AP1;IL18;FLT1;PIK3CB;FN1;HGF;PIK3CG;PTPN6;AGT;NCF1;PIK3CA;CCL5;PIK3CD;HCLS1;IRS2;HCST;PDGFRB;MAZ;KDR;PDGFA;HAX1;BECN1
prerank,response to hydrogen peroxide (GO:0042542),-0.4466380248194429,-1.4637162926769614,0.03231292517006803,0.1676846690200781,1.0,22/45,30.94%,MAP3K5;PRKCD;NFE2L2;RIPK1;ANXA1;ADAM9;SIRPA;MAPK7;APTX;RELA;STK24;RPS3;CAT;HP;IL6;HMOX1;CYP1B1;ECT2;AQP1;RIPK3;PAX2;RHOB
prerank,purine nucleotide metabolic process (GO:0006163),-0.499275219554253,-1.4637015218799079,0.046875,0.16746003910640556,1.0,5/24,9.96%,GDA;XDH;GUK1;HPRT1;NT5C2
prerank,regulation of extracellular matrix organization (GO:1903053),-0.5702283150840901,-1.4636279882197918,0.055062166962699825,0.16730798875972117,1.0,5/15,11.83%,RUNX1;LRP1;RB1;AGT;FAP
prerank,carboxylic acid metabolic process (GO:0019752),-0.47367315626523937,-1.4634093050414896,0.05338078291814947,0.16735388838847354,1.0,19/33,32.65%,TBXAS1;ST3GAL1;SLC2A1;CYB5R3;ST6GAL1;AGXT;PLA2G4A;SLC23A1;SLC23A2;GNMT;CARNMT1;ACOT4;GSTO1;CYB5A;PON3;CYP2S1;GNE;SLC2A3;DAO
prerank,regulation of anoikis (GO:2000209),-0.5363835456464658,-1.4625454714256099,0.04639175257731959,0.1681616462057034,1.0,6/19,11.79%,MCL1;ITGA5;ITGB1;BCL2;SIK1;PIK3CA
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.6399726270006025,-1.4624703776277215,0.06093189964157706,0.168000288512793,1.0,5/10,13.88%,CD36;TLR4;MYD88;TICAM1;MIA3
prerank,entry into host (GO:0044409),-0.6083854278418636,-1.4623714379366366,0.0415944540727903,0.16787515247940876,1.0,5/13,7.85%,GRB2;CBL;ITGAV;CTNNB1;CBLL1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6126875376977466,-1.4619890180358668,0.054770318021201414,0.16815917705294225,1.0,3/12,3.68%,INSR;IGF1R;UVRAG
prerank,cellular response to purine-containing compound (GO:0071415),0.6074468550077585,1.4617713779599477,0.09237875288683603,0.23969136588751333,1.0,4/10,9.78%,RYR3;RYR2;CASQ2;RYR1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5825268137532906,-1.4610458196993863,0.0539568345323741,0.16909836851772134,1.0,7/14,23.35%,DHX58;DDX60;PUM2;OASL;ZCCHC3;ZDHHC5;PUM1
prerank,positive regulation of JNK cascade (GO:0046330),-0.39737047867832526,-1.4608759428013767,0.018998272884283247,0.16903983131092795,1.0,24/70,19.94%,MAP3K5;TAOK3;SDCBP;MFHAS1;MINK1;RIPK1;TRAF5;PTK2B;AXIN1;TRAF3;CD27;TAOK1;TRAF1;NCF1;APP;GADD45A;FCGR2B;TRAF2;MAP3K10;MMP8;TAOK2;NOD2;HMGB1;AGER
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5302590890400356,-1.4605699593089432,0.055944055944055944,0.16919831054676587,1.0,9/20,12.79%,NRP1;IGF1;LRP1;PLAU;S100A11;TRIB1;IGFBP3;CCL5;SERPINE1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.547942017992588,-1.4604207471880248,0.05619834710743802,0.16913624817797518,1.0,13/16,38.49%,ITGB2;RHOA;MDK;RELA;IL6;FUT4;ST3GAL4;ETS1;TRAF6;TNF;SELE;SELP;FUT7
prerank,peripheral nervous system development (GO:0007422),0.4940672453369662,1.4600236125844095,0.058673469387755105,0.24116310879462255,1.0,12/23,25.16%,ASIC2;SERPINI1;GDNF;BDNF;ADGRB2;ERBB3;ADGRB1;GPC1;NF1;GFRA3;SCN8A;ALDH3A2
prerank,t-circle formation (GO:0090656),-0.636360530804628,-1.459946941365863,0.05555555555555555,0.16901828282551482,1.0,7/10,21.01%,BLM;WRN;EXO1;SLX4;XRCC3;DNA2;NBN
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.636360530804628,-1.459946941365863,0.05555555555555555,0.16901828282551482,1.0,7/10,21.01%,BLM;WRN;EXO1;SLX4;XRCC3;DNA2;NBN
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.636360530804628,-1.459946941365863,0.05555555555555555,0.16901828282551482,1.0,7/10,21.01%,BLM;WRN;EXO1;SLX4;XRCC3;DNA2;NBN
prerank,cellular defense response (GO:0006968),-0.4484953893914149,-1.4599193671677009,0.026981450252951095,0.16880859357320993,1.0,26/40,36.25%,ZNF148;C5AR1;TCIRG1;ITGB1;PTK2B;LY96;RELA;NCF1;NCF2;ITK;CD5L;LGALS3BP;SPN;LSP1;BECN1;PRF1;CD300C;ADORA2A;KLRC2;KIR3DL2;TRAT1;CXCR2;NCR1;ADORA2B;FOSL1;CXCL9
prerank,regulation of cell cycle process (GO:0010564),-0.3838323297794394,-1.4595541598967514,0.008025682182985553,0.16901186417719832,1.0,35/104,21.28%,ZFYVE26;BIRC6;CSNK2A1;CDK13;CEP85;UVRAG;KIF11;CDC42;DYNC1H1;KIF20B;DAPK3;CTNNB1;PLK2;BUB1;PIN1;DBF4;FLCN;PLK3;MKI67;SH3GLB1;KNSTRN;RACGAP1;KIF20A;MAD1L1;AURKA;ATF5;RCC1;HORMAD1;CHEK1;PRC1;RAB11A;SFRP1;TIPIN;CDC25C;CETN2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.5355625424330093,-1.4575310884607395,0.04794520547945205,0.17132621817092628,1.0,7/19,20.43%,CYBA;PRDX5;PRDX1;PRDX2;ACOX1;CAT;PXDNL
prerank,cellular response to glucagon stimulus (GO:0071377),0.5355130091889247,1.4571487881523546,0.06636155606407322,0.2442635788957626,1.0,7/17,14.85%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,prostaglandin biosynthetic process (GO:0001516),-0.536805414076944,-1.4570357133228276,0.06379310344827586,0.17167820697911482,1.0,5/18,14.49%,TBXAS1;CD74;DAGLB;CBR1;PLA2G4A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6338315003881986,-1.4569350585320735,0.060955518945634266,0.17133661174383932,1.0,5/10,21.40%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6338315003881986,-1.4569350585320735,0.060955518945634266,0.17133661174383932,1.0,5/10,21.40%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.4498086616096224,-1.456634824970997,0.04195804195804196,0.17143687606601257,1.0,13/40,11.65%,FAM111A;BLM;PRIMPOL;RTEL1;RAD51;RFWD3;NUCKS1;MCM9;GEN1;TIMELESS;ALYREF;WRN;PCNA
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.542710975402107,-1.45647222141229,0.08216783216783216,0.17136038210254873,1.0,10/17,25.09%,NRP1;IGF1;S100A11;DOCK5;MDK;CCL5;PDGFRB;ADAMTS1;FGF9;CCN4
prerank,positive regulation of biosynthetic process (GO:0009891),-0.44073932032594954,-1.4564258848963287,0.026595744680851064,0.17116894703524682,1.0,11/40,14.18%,APOE;RUNX1;VIM;PLCG2;CYBA;CD36;TLR4;MTPN;ZBTB20;CCL5;SLC5A3
prerank,error-prone translesion synthesis (GO:0042276),-0.5292844163031132,-1.456198635501115,0.05,0.17122198027480226,1.0,8/21,13.37%,POLE2;RFC1;PRIMPOL;UBC;RPS27A;PCNA;RPA3;RFC2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.4005751369726102,-1.4555967300212047,0.01384083044982699,0.1717463745696667,1.0,23/70,21.85%,P2RX7;MCL1;CRADD;TNFRSF1B;RIPK1;IL6R;RNF41;ITGAV;BCL2;CD27;MLLT11;CIB1;TRAF2;GABARAP;BAG3;BID;CASP8;TRADD;CASP2;DDX3X;GSK3B;APPL1;BCL2L2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.6412043667094898,-1.4555778747974626,0.0759493670886076,0.17152219292564944,1.0,7/10,28.52%,JUN;BAG3;VHL;HSPA1A;SIRT2;NCK1;CITED2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.4937740849287138,-1.455293270698417,0.05752961082910321,0.1716109416543973,1.0,11/27,12.76%,TLR4;PTPN22;ARRB1;IRAK3;GAS6;SIRPA;PTPN6;SELENOS;NCKAP1L;FOXJ1;NLRC3
prerank,positive regulation of bone resorption (GO:0045780),-0.621362323010234,-1.455220436102746,0.05128205128205128,0.17144995132682808,1.0,4/11,14.81%,PLEKHM1;SYK;ADAM8;SPP1
prerank,intracellular protein transport (GO:0006886),-0.3287800974439251,-1.4537225015998576,0.0,0.17298149244395258,1.0,104/304,22.37%,CD74;SYK;TRAK1;RAB7A;SNX9;SNX27;IPO5;KIF13B;SNX8;STX7;ARHGEF2;TBC1D15;NUP50;UNC93B1;RAB31;SGSM2;TLK1;TBC1D2B;RAB20;TBC1D9;STAT3;GGA3;LAMP2;RAB1A;COG7;SNX6;NUP42;TMED10;STX8;CTSA;TBC1D5;TBC1D1;XPO6;ARL11;STX3;FUT10;RPL11;TBC1D22A;PREB;RAB32;NUP88;TBC1D16;TBC1D22B;SIL1;LAPTM5;WLS;BCS1L;TBC1D8B;E2F3;RAB5A;TMED3;AP1S3;TBC1D8;RAB21;XPO5;TBC1D17;VPS26B;SNX13;RAB24;TPR;SAR1A;RAB29;VPS26A;STX5;TBC1D10B;ARL5A;NUP188;SEC31A;COPA;EHD1;GABARAP;BAG3;TBC1D30;STX16;ARFIP1;APPL2;STRADA;CCHCR1;AP3B1;MAIP1;STX4;AP3D1;TBC1D9B;TMED2;VPS33A;ARL1;SNX1;TBC1D25;NUP153;ARFIP2;SLU7;TMED4;TICAM2;FAM53A;TNPO3;APPL1;NUP107;NXT2;NUP62;TBC1D10C;EGR2;TBC1D4;HPS4;SPRN
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.31517599375527683,-1.4537167389191856,0.0,0.17274819890604032,1.0,121/476,18.88%,MDFIC;APOE;MITF;ZMIZ1;MAP3K5;FLI1;ELF4;RUNX1;IGF1;TFEB;CD38;CD74;SP100;TCF4;RREB1;ELF2;JUN;DNM2;NIBAN2;CREBBP;RUNX3;PPARD;BRD7;RNF111;BRD4;NFYA;ARID1B;ATAD2;ELF1;NSD3;PPARG;KDM3A;BRCA1;STAT3;FOXO3;LYL1;RYBP;RNF20;NFKB1;HHEX;RUNX2;SMARCD3;FBXW11;PRMT2;CRLF3;SNX5;KLF6;SMARCC2;BLM;NR1H2;CIITA;AXIN1;LRP6;PICALM;MED24;AHR;CTNNB1;TBL1XR1;CAMKK2;EDF1;CREB3L2;E2F1;CNBP;ARID1A;ATMIN;RNF4;TGFBR1;WBP2;PARP9;TGFB1I1;HIF1A;MEF2C;EGR1;AFAP1L2;RELA;AGT;NCF1;XRCC6;ARHGEF11;DYRK1A;MAP2K1;MED4;NFE2;MLLT11;SPIN1;CHD8;HMGB2;RXRA;CALCOCO1;TFAP4;WAC;EPC1;KLF2;ID2;TFAM;TCF3;IKBKB;SPP1;NSD1;KARS1;IL31RA;DNAJC2;QRICH1;SOX10;VHL;KMT2A;MAP2K3;GPATCH3;RARA;NFATC1;ATF5;TFE3;GATA3;MYB;NCOA6;CXXC1;TRIM16;HAS3;CASZ1;RSF1;PITHD1
prerank,cellular response to starvation (GO:0009267),-0.3553669150630394,-1.4530211562421964,0.0033003300330033004,0.17331955188133358,1.0,44/147,23.57%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;PRKAG2;ATG5;ATP6V1A;FOXO3;LAMP2;ATG7;TCIRG1;MTMR3;EIF2AK2;FNIP1;SIK1;ATP6V1G1;XBP1;RRAGD;FLCN;WRN;KLF10;SESN1;STK24;XPR1;SH3GLB1;ATP6V0B;GABARAP;ATP6V0E1;RALB;RHEB;HNRNPA1;BMPR2;ATP6V0D1;SFRP1;ZC3H12A;CPEB4;GAS2L1;PRKAG1;CEBPB;MAPK1;BECN1;RRP8;WDR24;KPTN
prerank,positive regulation of viral life cycle (GO:1903902),-0.5152129853047489,-1.4519224885131392,0.07360861759425494,0.17446476124650154,1.0,11/22,24.99%,CD74;AXL;TSG101;LGALS1;TRIM11;CHMP2A;LGALS9;VPS4A;P4HB;DDB1;CHMP2B
prerank,regulation of endothelial cell migration (GO:0010594),-0.3833601506088735,-1.4513860749777396,0.02577319587628866,0.17488416852669442,1.0,16/85,8.99%,SASH1;APOE;NRP1;FOXP1;SP100;RAC1;RIN2;PTK2B;PIK3CB;PIK3CG;PRCP;NRP2;GRN;VEGFA;SH3BP1;ITGB1BP1
prerank,negative regulation of translation (GO:0017148),-0.3888379659136322,-1.4512636059949637,0.02249134948096886,0.17479041177402638,1.0,29/87,22.06%,DAPK1;ROCK1;YTHDF3;AGO2;GAPDH;CNOT1;DAPK3;PUS7;EIF2AK2;PCIF1;EIF4EBP1;FTO;EIF4EBP2;EIF3E;TPR;CELF1;METTL14;UNK;DHX36;NCL;TOB1;RPS3;DDX3X;CNOT8;DDX6;CPEB4;LSM14A;RACK1;SHMT1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.41644881534472084,-1.4510774160933928,0.019867549668874173,0.17475010295620944,1.0,22/54,24.74%,BFAR;AMFR;PELI1;UBE2R2;RNF4;FBXO38;RNF8;NEDD4L;UBE3A;UBE2H;RNF34;UBE2G1;UBE2T;RNF216;CDC34;UBE2C;SKP2;DTX3L;RNF115;TOPORS;ZNRF1;RNF187
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5801289385593046,1.4507636247228708,0.08767772511848342,0.25279784762850865,1.0,5/13,8.85%,GRIK2;SHISA6;SLC4A10;SHISA9;SLC8A2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.48308900098375196,1.4506566023182599,0.05324074074074074,0.2518931962777813,1.0,4/24,1.32%,NRG1;CTNNA2;OLFM2;CDH2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4970317012250656,-1.4505370323204978,0.047957371225577264,0.17516394267928032,1.0,9/26,21.48%,CD36;INSR;P2RX4;TLR4;HSP90AB1;KLF2;ASS1;MMP8;TMEM106A
prerank,negative regulation of immune effector process (GO:0002698),-0.5883160034300562,-1.4504645562799217,0.07179487179487179,0.1750188588062318,1.0,4/13,7.30%,LILRB1;CD300A;RC3H1;GRN
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.5168268181596928,-1.4504008997255136,0.05679862306368331,0.1748656332387288,1.0,11/20,33.12%,MBTPS2;NFKB1;ADAM9;RELA;PSENEN;HM13;TGFB1;PSEN2;NGFR;TRAF6;RHBDD1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.5179042704389224,1.4498107077421778,0.0794392523364486,0.25217634511612275,1.0,6/17,16.91%,SLIT2;TWSG1;DOK5;PCSK6;ZDHHC17;TMEM204
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.49360637020863674,1.4492725759216212,0.05555555555555555,0.2519412237075315,1.0,7/23,14.38%,METAP2;GRK4;FNTB;CAMKMT;FNTA;CALM1;METAP1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.5050619323283688,-1.4490315305321884,0.05263157894736842,0.17641395884632333,1.0,8/23,9.89%,CD74;MPP1;RAC1;CAMK1D;DPP4;RIPOR2;MDK;NCKAP1L
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5394747793269019,1.4483970969510374,0.0661764705882353,0.25218180744704,1.0,8/17,19.00%,CACNA1C;RYR2;GJC3;ATP1A3;ATP1B1;ATP1B2;GJD3;GJC1
prerank,detection of visible light (GO:0009584),-0.556092684033892,-1.4482085546064494,0.0859106529209622,0.17723045081603045,1.0,8/16,41.84%,GNA11;ABCA4;RP1;REEP6;GNAQ;CNGB1;CACNA2D4;PDE6B
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3980572003028143,-1.4473952799172318,0.017035775127768313,0.17804129040409283,1.0,34/72,32.21%,GRB2;CBL;KIF16B;GALNT3;HNRNPH1;CEP57;POLR2H;FRS2;POLR2F;POLR2L;SPRED1;SPRED2;SHCBP1;POLR2A;NCBP1;POLR2G;PTPN11;HNRNPA1;POLR2I;GTF2F2;MAPK1;FGF18;FGF9;FGFR4;ESRP1;GTF2F1;HNRNPF;FGF22;FGF20;FIBP;FGF16;RAB14;FGF2;POLR2D
prerank,positive regulation of protein metabolic process (GO:0051247),-0.3691436692196687,-1.4466062425833868,0.013975155279503106,0.17874964620859396,1.0,43/110,26.84%,APOE;PAEP;WWP1;RAB7A;CSNK2A1;WWP2;RNF41;AREL1;IL18;ATG7;RAB1A;TIPARP;NR1H2;AXIN1;WFS1;PLK2;MAP2K5;PRMT1;MAPK7;AGT;NEDD4L;MTPN;APP;ASB5;STX5;UHRF1;KLF2;EIF4G1;SLC6A9;RILP;HUWE1;CSF1;GSK3B;SMURF2;OAZ3;TGFB1;RAB1B;DDB1;ABCA2;RANBP9;VIP;SMURF1;VCP
prerank,regulation of neurotransmitter secretion (GO:0046928),0.439432480484315,1.4457081595733001,0.0430622009569378,0.25503741763878507,1.0,8/32,9.24%,RIMS2;RIMS1;CPLX1;SNCAIP;SYN1;FMR1;SYT11;CAMK2A
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4933282725149174,-1.4454899421074763,0.05227655986509275,0.17992269568673355,1.0,11/26,26.84%,IQGAP1;PTPN12;DUSP3;STAT5B;EEF1A1;KNSTRN;PTPN11;SNAI2;INPP5K;PDE8A;ZFP36L1
prerank,regulation of cell junction assembly (GO:1901888),-0.4860092801616337,-1.4449946581803015,0.05226480836236934,0.1803147312315889,1.0,7/27,9.25%,PRKCH;RUNX1;ROCK1;RAP1B;RAP1A;CBFB;MEF2C
prerank,lipid transport (GO:0006869),-0.3781898118547205,-1.4445420702422365,0.013008130081300813,0.18066000269369384,1.0,24/97,16.74%,OSBPL8;APOE;ABCA1;ABCG1;PLTP;PITPNC1;CD36;PITPNA;PPARD;FABP5;ABCD2;SLC27A1;PITPNM1;GLTP;OSBPL5;PRELID2;STARD5;NPC2;ABCC4;RXRA;ABCA9;ABCA13;CLN3;ABCD3
prerank,mitochondrion morphogenesis (GO:0070584),-0.6206684003634467,-1.4444784603273693,0.06445993031358885,0.1805125663445546,1.0,3/11,10.02%,PID1;MTM1;FIS1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.44056670028341693,-1.4444749433739574,0.037037037037037035,0.18027271487450652,1.0,12/42,16.92%,ARID1B;SMARCA5;ERCC6;CHD3;ACTB;SMARCC2;ARID1A;RNF8;CHD8;SPTY2D1;INO80;RBBP4
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5838451747990288,-1.4439919580857383,0.05913978494623656,0.1806604482584689,1.0,8/14,23.12%,LILRB1;TLR8;PIBF1;IRAK3;LILRA5;CMKLR1;C1QBP;MEFV
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5308597155736062,-1.443515369479619,0.058098591549295774,0.18100505012887358,1.0,9/18,27.33%,PTBP3;RPS13;TMBIM6;SHQ1;ZC3H12A;TGFB1;NCOR1;NUDT16;ESR1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5097915977618924,-1.4434964574500844,0.059964726631393295,0.18079407968504393,1.0,10/22,20.21%,NFE2L2;PSME4;PSMB7;PSMB9;PSMA8;PSMB10;PSMA1;PSMB8;PSMA5;PSMB3
prerank,mitotic DNA replication (GO:1902969),-0.6252800961885034,-1.4433603295217714,0.06206896551724138,0.18072634885957214,1.0,6/10,22.64%,GINS3;MCM6;MCM3;LIG1;MCM2;CDC45
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.49945882589010737,-1.4433027151873388,0.059336823734729496,0.18055152823402074,1.0,14/24,30.66%,PID1;DAB2;RHOQ;PICALM;ITGB1BP1;PPFIA1;TMEM59;TGFB1;PPP2R5A;LZTFL1;GDI1;INPP5K;BCL2L1;ABI3
prerank,negative regulation of autophagy (GO:0010507),-0.42000312168173193,-1.4429078252849825,0.03898305084745763,0.1808107159908427,1.0,13/54,7.32%,MCL1;NUPR1;HTR2B;STAT3;TAB2;ATG7;BCL2;CTSA;PTPN22;EIF4G3;HGF;KLHL22;USP36
prerank,regulation of actin filament-based process (GO:0032970),-0.3989416556331212,-1.4427657679296824,0.0156794425087108,0.18072652147186238,1.0,25/70,21.30%,IQGAP2;IQGAP1;LRP1;PRKCD;RAC1;ROCK1;RHOA;ARHGAP17;ARHGAP18;RHOQ;BAIAP2;SH3BP1;BST2;TAOK1;CRK;CCDC88A;BST1;RND2;ARHGEF5;TWF2;PDGFRB;TAOK2;RHOBTB1;RHOF;PDGFA
prerank,aortic valve morphogenesis (GO:0003180),0.4495651640938527,1.4427505912551342,0.060240963855421686,0.25856783065605865,1.0,7/30,10.02%,ROBO1;ROBO2;SLIT3;SLIT2;TIE1;SOX9;SNAI1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.44015096653527724,-1.4423606332176493,0.043697478991596636,0.1810231674047617,1.0,9/40,9.10%,DAB2;SDCBP;JAG1;GCNT2;CTNNB1;EZH2;MDK;TGFBR1;TGFB1I1
prerank,manganese ion transport (GO:0006828),0.5447976490432911,1.4419784051715,0.07077625570776255,0.25873245623702934,1.0,2/14,2.25%,TRPC5;TRPC1
prerank,negative regulation of phagocytosis (GO:0050765),-0.5446684807551327,-1.4419212384369504,0.057432432432432436,0.18138402965110287,1.0,10/17,25.27%,CD300A;SNX3;CD300LF;SIRPA;FCGR2B;HMGB1;APPL1;RACK1;CD47;PRTN3
prerank,homotypic cell-cell adhesion (GO:0034109),-0.44075441211623395,-1.441192115810578,0.034782608695652174,0.18209520367266716,1.0,16/39,22.74%,PLEK;MYH9;RAP2B;FLNA;ACTB;TLN1;PIK3CB;FN1;PIK3CG;TJP2;CLIC1;HSPB1;UBASH3B;FERMT3;ILK;PLPP3
prerank,positive regulation of exosomal secretion (GO:1903543),-0.5660298679862956,-1.44058302290667,0.07457627118644068,0.18262490099797893,1.0,6/15,14.44%,SDCBP;RAB7A;PDCD6IP;TSG101;SDC4;CHMP2A
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5415697284514629,-1.4398405699054144,0.06844741235392321,0.1833673633992799,1.0,9/18,22.88%,MDFIC;MFHAS1;FLCN;SIN3A;LATS2;SUFU;GSK3B;UFM1;CTNNA1
prerank,T cell proliferation (GO:0042098),-0.5859610443691782,-1.4395176887110053,0.06440677966101695,0.18348602595151478,1.0,4/13,6.59%,MSN;LILRB1;DOCK8;PIK3CG
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.4091635612883206,-1.439054625898709,0.03119584055459272,0.1838560714864988,1.0,25/62,23.38%,AGO2;NUP50;PPARG;STAT3;DHX9;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;PUM1;TGFB1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.5109140024222769,-1.438605746425448,0.07465277777777778,0.184215204000768,1.0,14/21,26.84%,IGF1;HTR2B;ITGAV;PTGER4;CTSH;CDK1;MAP2K1;KARS1;LGALS9;KDR;MAPK1;MYC;MT3;ZFP36L1
prerank,CENP-A containing chromatin organization (GO:0061641),-0.472260139566143,-1.4384898753708133,0.05545927209705372,0.18386844562683496,1.0,13/29,25.87%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.472260139566143,-1.4384898753708133,0.05545927209705372,0.18386844562683496,1.0,13/29,25.87%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5858464676000869,1.4378922866680584,0.09200968523002422,0.2640893873253517,1.0,8/12,18.59%,ANK3;DMD;ATP1B1;GLRX;WNK4;WNK3;ATP1B2;WNK2
prerank,Golgi organization (GO:0007030),-0.364960003234299,-1.4378141453659465,0.014925373134328358,0.18442048252945437,1.0,38/112,24.20%,ATP8B4;PLEKHM2;VTI1A;GOLGA5;GOLGA8B;PI4K2A;FBXW8;OPTN;CDC42;RAB1A;COG7;ARFGEF1;TMED10;PI4K2B;TRAPPC11;DYM;GOLPH3L;TJAP1;TMED3;CDK1;RAB29;STX5;PLK3;COG2;STX16;VAMP4;LMAN2L;TMED2;ARL1;HUWE1;TMED4;TICAM2;VPS51;BLZF1;TMED5;VMP1;COG4;TRIP11
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4861435865699069,-1.4374284210167674,0.05922165820642978,0.18469470549716308,1.0,8/25,8.89%,PTPRC;RUNX1;CCR2;PLCG2;MALT1;CARD11;ANXA1;CD28
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.576268575075815,1.437166073495648,0.0936768149882904,0.2640284529735163,1.0,2/12,3.01%,B3GALT1;B3GALT5
prerank,regulation of neurotransmitter transport (GO:0051588),0.5302725637846143,1.436805061633724,0.0728643216080402,0.26347550511241336,1.0,6/16,9.24%,RIMS1;CPLX1;SNCAIP;SYN1;FMR1;CAMK2A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.48323869387903073,-1.436756304447645,0.04482758620689655,0.1853443811536815,1.0,11/26,23.64%,MFHAS1;CYBA;PTPN22;RSAD2;IFI35;WDFY1;DDX3X;HMGB1;TICAM2;SLC15A4;TREML4
prerank,negative regulation of receptor binding (GO:1900121),-0.6259314558334268,-1.4366586742361078,0.08,0.1852015935581816,1.0,3/10,12.32%,B2M;ATP2A3;ADAM15
prerank,cardiolipin metabolic process (GO:0032048),-0.5837005571310154,-1.4365411419029057,0.07833333333333334,0.1851247190633243,1.0,9/13,34.89%,SLC27A1;TAMM41;PLA2G4A;PLA2G6;PLA2G5;PNPLA8;LCLAT1;PTPMT1;PGS1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.6071375572155249,-1.4360604514678743,0.07979626485568761,0.1855225429704771,1.0,8/11,26.67%,LYN;ANXA1;PIK3CB;MEF2C;PIK3CD;LGALS9;BLK;RAPGEF2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4733062477053007,-1.4360580464798436,0.05892857142857143,0.18527877680592267,1.0,9/29,18.70%,RPS21;RPS8;RPS14;NOP14;DHX37;MRPS11;NGDN;UTP6;RPS16
prerank,dendritic cell differentiation (GO:0097028),-0.5155236572736817,-1.435904850993008,0.05695142378559464,0.1852429016564026,1.0,11/22,25.73%,LYN;LILRB1;AXL;BATF;GAS6;TGFBR2;BATF3;LGALS9;FLT3;PRTN3;BLK
prerank,adenine nucleotide transport (GO:0051503),-0.5445772474765858,-1.4353787902083441,0.070298769771529,0.18571559166691995,1.0,6/17,15.51%,LRRC8D;SLC25A24;LRRC8C;SLC25A42;ABCC4;SLC25A4
prerank,transcription by RNA polymerase II (GO:0006366),-0.32242381962494093,-1.4342665634410678,0.004531722054380665,0.18689502731218147,1.0,92/305,22.62%,RBPJ;NOTCH2;RREB1;AFF4;CREBBP;DEK;PPARD;NELFB;NFIC;NFX1;NFYA;C5AR1;PPARG;CDK13;MAML1;ARRB2;GTF2A1;CTR9;KLF13;ERCC6;MAML2;E2F2;NFKB1;INTS8;RARG;NABP1;MAF;NR1H2;INTS11;SRRT;TAF6;SNRPG;TBL1XR1;NR2F1;SNRPF;POLR2H;SSU72;POLR2F;E2F3;CBFB;DDX5;POLR2L;NRBF2;SNAPC2;INTS6;HDAC10;INTS14;XBP1;RPRD2;NUDT21;MED4;TRIM24;WDR33;HDAC5;GTF2E2;RXRA;ELOF1;POLR2A;NCBP1;TAF4B;TFCP2;TAF8;NR4A1;INTS1;POLR2G;TAF9;ELP4;TAF3;RARA;TAF1A;SNAPC3;NR3C1;DTX1;PHAX;GMEB2;TAF4;PAPOLA;MED20;ELOC;CPSF3;RTF1;INTS5;MAML3;MAZ;PKNOX1;POLR2I;CCNK;GTF2F2;GTF2A2;NR1H4;ELL2;MED18
prerank,monocyte chemotaxis (GO:0002548),-0.46085417610126533,-1.4341989258103482,0.04878048780487805,0.18674501284397194,1.0,17/32,39.74%,IL6R;FLT1;ANXA1;CCL5;CALCA;PTPRO;IL6;CCL7;CCL24;CCL4;CCL25;CCL19;PDGFB;CCL8;MSMP;TNFRSF11A;CCL14
prerank,endomembrane system organization (GO:0010256),-0.3426724159987463,-1.4338040849662932,0.014634146341463415,0.1869979681860595,1.0,78/178,30.77%,MYOF;ATP8B4;TMCC1;SNX10;PLEKHM2;GOLGA5;GOLGA8B;PI4K2A;USP50;FBXW8;OPTN;CDC42;SYNGR1;RAB1A;COG7;SRGN;DNAJC13;ARFGEF1;TMED10;USP8;PI4K2B;TRAPPC11;WASHC4;DYM;SNX33;GOLPH3L;SUN2;ALS2;TJAP1;TMED3;TLCD2;ARFGEF2;RAB29;SERP1;COG2;SEC31A;MIA3;LEMD2;LMAN2L;VAPB;AP3D1;TMED2;LAPTM4B;ARL1;HUWE1;DOP1B;TMED4;TICAM2;VPS51;VPS18;VPS4A;REEP3;BLZF1;PHETA1;TMED5;TLCD1;VMP1;COG4;TRIP11;CHMP2B;LAMTOR1;VPS11;OTOF;RAB22A;VAPA;RNF26;EIF2AK3;TRAPPC8;HACE1;SYNGR2;ATP8B2;RAB2A;MAPK15;REEP6;SQSTM1;GAK;ANXA8;ANXA8L1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.6226460093547641,-1.4335282924875572,0.07964601769911504,0.18712218810360137,1.0,4/10,8.66%,ZEB2;MFSD12;ATP7A;CTNS
prerank,positive regulation of macroautophagy (GO:0016239),-0.4293403086595553,-1.432991937402363,0.04020100502512563,0.1875099848738837,1.0,21/48,29.09%,SPTLC2;GNAI3;OPTN;PIP4K2A;UVRAG;RAB3GAP1;SESN1;SH3GLB1;WAC;SLC25A4;BAG3;BNIP3L;RALB;ADRB2;KDR;DCN;VDAC1;LRSAM1;VPS13D;TSC2;BNIP3
prerank,positive regulation of binding (GO:0051099),-0.385719570696581,-1.432882125153985,0.022887323943661973,0.18740684141976308,1.0,28/84,20.74%,APOE;IGF1;LRP1;PPARG;AMFR;DHX9;STK3;RPL11;EDF1;SKI;NME1;NVL;B2M;PLAUR;CEBPG;PARP9;PIN1;DERL1;APP;HMGB2;NCBP1;RALB;RARA;MMP8;HMGB1;GSK3B;SIRT2;DTX3L
prerank,nuclear export (GO:0051168),-0.3912424523936712,-1.4319787213378068,0.029850746268656716,0.1883455141000751,1.0,41/80,32.74%,SRRM1;MALT1;NUP42;XPO6;WASHC4;CHTOP;RAE1;CDC40;XPO5;ALYREF;TPR;NUP188;NCBP1;THOC2;STRADA;CCHCR1;ATXN1;RNPS1;NUP153;PHAX;THOC6;HNRNPA1;MAGOH;SLU7;NUP62;EGR2;SRSF11;TGFB1;DDX39B;DHX38;U2AF2;SMURF1;SRSF7;EIF4A3;CSE1L;EIF4E;SRSF5;XPO7;SARNP;U2AF1L4;ANKLE1
prerank,protein O-linked mannosylation (GO:0035269),0.5057901997216362,1.4315612153792527,0.08447488584474885,0.2707582442570117,1.0,8/18,16.49%,TMTC2;TMTC1;CRPPA;TMTC3;POMT2;POMGNT2;FKTN;DPM2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.36749501513538874,-1.431309419441556,0.021702838063439065,0.1889962893394219,1.0,38/100,24.50%,LYN;IGF1;FGR;CBL;PIK3R5;INSR;IGF1R;PIK3AP1;PIP4K2A;IL18;FLT1;PIK3CB;FN1;HGF;PIK3CG;PTPN6;AGT;NCF1;PIK3CA;CCL5;NLRC3;PIK3CD;HCLS1;IRS2;HCST;PTPN13;PDGFRB;PIP5K1A;MAZ;KDR;PDGFA;HAX1;MAPK1;BECN1;PIP5K1C;FLT3;PPP2R5B;DCN
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5344948094695011,-1.4312443091858373,0.05516014234875445,0.18880302904657018,1.0,9/19,21.91%,NRP1;RAC1;ROCK1;PTPRJ;VEGFA;LIMS1;SFRP1;KDR;MAP4K4
prerank,vacuolar acidification (GO:0007035),-0.5065970443832353,-1.4311441868626256,0.05516014234875445,0.18867622024570613,1.0,9/21,21.12%,ATP6V0D2;TCIRG1;TMEM199;GRN;CLN6;CLN3;ATP6V0E1;ATP6V0D1;PPT1
prerank,regulation of catecholamine secretion (GO:0050433),0.46344790408822567,1.4307112197812906,0.06398104265402843,0.2710210992443555,1.0,11/29,16.07%,SYT1;SYT10;SYT2;HRH3;SYT5;SYT11;SYT12;SYT7;PRKN;KCNA2;SNCA
prerank,nucleocytoplasmic transport (GO:0006913),-0.4404538237021619,-1.4302010336176232,0.04679376083188908,0.1896677965221746,1.0,17/40,21.28%,BACH2;MALT1;ANP32A;SNRPG;SNRPF;NUP205;HTATIP2;SMN1;NCBP1;GEMIN7;RGS14;SNUPN;ATXN1;PHAX;HNRNPA1;GEMIN6;NXT2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.41895160387096597,-1.4301741817294622,0.05958132045088567,0.18945195669393725,1.0,17/48,18.85%,CCR2;LILRB1;TLR8;TLR7;TLR4;IL18;PTPN22;CYRIB;CEBPG;SCRIB;CD2;SLC7A5;TXK;ISG15;IL18R1;CD226;LGALS9
prerank,regulation of membrane repolarization (GO:0060306),0.5668147389185252,1.4299978816866536,0.09360730593607305,0.2711059032307385,1.0,3/13,5.77%,AKAP6;CACNA2D1;CASQ2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.39514270763447706,-1.4299169024087968,0.023728813559322035,0.1895651347722637,1.0,23/72,20.89%,BIRC3;REL;PSME4;MALT1;PSMB7;PSME3;FBXW11;PSMB9;PSMA8;RELA;PSMC3;PSMD8;TRAF2;PSMC4;PSMB10;PSMA1;RELB;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;COPS8
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.5511635322485181,-1.429453744515475,0.06968641114982578,0.18994044568075424,1.0,8/15,23.55%,ANP32B;GAS6;YWHAE;TPR;BAG3;GSK3B;GTSE1;RBM22
prerank,protein phosphorylation (GO:0006468),-0.3086233837902529,-1.4291324774568979,0.0,0.19013100533819594,1.0,146/479,23.06%,LYN;PRKCH;FNIP2;MAP3K5;TAOK3;PRKCB;FGR;ABI1;MAPKAPK3;FAM20C;DAPK1;SYK;PAK2;CDK6;PRKCD;ROCK1;MAP4K3;BIRC6;CAMK1D;RUNX3;MAP3K1;ERN1;MAP3K20;INSR;IGF1R;PEAK1;CSNK2A1;TLR7;FES;PRKAG2;VRK2;CDK13;RNASEL;MINK1;RIPK1;MAML1;TLK1;ABL2;MAPKAPK2;SGK1;GRK3;DYRK2;TEC;TLR4;FLT1;PIM1;PTK2B;INCENP;DAPK3;PKDCC;STK3;MAPK14;ULK2;CAB39;CDK18;IRAK3;GAS6;CAMKK2;GRK5;PLK2;VRK3;EIF2AK1;EIF2AK2;COQ8A;STK38;TGFBR1;TRIB1;JAK1;CDK14;NEK6;PTPN6;MASTL;RSKR;MORC3;SIK1;TRIB2;TAOK1;LCK;APP;CDK1;DYRK1A;MAP2K1;PPP4R1;STK11;IGFBP3;HTATIP2;STK17B;FRK;STK24;MKNK1;ACVR2A;PIK3CD;GMFG;TGFBR2;MAST2;MARK2;IKBKB;GMFB;TXK;CCNE1;MAP3K10;TTK;MKNK2;LATS2;STRADA;PNCK;CDKL4;AURKA;ZAP70;RARA;SMAD7;BRD2;PKN3;RYK;HCK;HCST;STK10;PDGFRB;TAOK2;IP6K3;MAK;PAK6;ATM;STK16;CHEK1;BMPR2;CDC42BPG;CDK16;WNK1;GSK3B;COPS8;KDR;CDK5;CSNK1G3;PRKAG1;GRK6;SRPK1;MAP4K4;MAST3;MAPK1;RPS6KA5;ILK;NEK3;PRKDC;TYK2;SMG1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6308574319481243,-1.4290512349970095,0.06260869565217392,0.19001463598757082,1.0,3/10,3.50%,PTPRC;LILRB1;ARRB2
prerank,"phototransduction, visible light (GO:0007603)",-0.5738456140621683,-1.4290347013013853,0.06902356902356903,0.18979017735194217,1.0,7/14,34.78%,GNB1;GNA11;ABCA4;RP1;GNAQ;CNGB1;SAG
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3988531951105521,-1.428787975091053,0.021848739495798318,0.1898767197703111,1.0,23/67,17.60%,RAC1;P2RX4;CAPZB;TBC1D15;IFT20;ATG5;TBC1D2B;CDC42;TBC1D5;TBC1D1;TBC1D22A;SDCCAG8;TBC1D16;TBC1D22B;RAB5A;TBC1D8;TBC1D17;TBC1D10B;MYO10;TBC1D24;DYNLT2B;TBC1D9B;TWF2
prerank,protein-containing complex subunit organization (GO:0043933),-0.36496531740044424,-1.428240303141134,0.016286644951140065,0.19037322375565088,1.0,29/109,14.74%,MITF;SKAP2;CD74;WIPF1;PEX14;SNX9;CREBBP;LPXN;SLC2A1;PTK2B;TAPBP;WASL;CAPG;PICALM;DET1;TUBGCP4;REPS2;DARS1;NCKAP1L;NUP205;TRAF1;TPR;CAPZA1;TRAF2;KPNA3;TFAP4;NIFK;CD40;ST13
prerank,response to glucagon (GO:0033762),0.5150404106340726,1.4278966599888576,0.0831353919239905,0.2733359516526696,1.0,10/19,22.52%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A;PRKAR2B;CRY1;PRKAR1B
prerank,positive regulation of stem cell differentiation (GO:2000738),0.511059683839419,1.4275062488196681,0.09048723897911833,0.2728300102210065,1.0,5/16,10.93%,SOX5;SOX6;PTN;SOX9;TGFB2
prerank,histone exchange (GO:0043486),-0.44602454627590016,-1.4274838614207765,0.04070796460176991,0.191108211930833,1.0,15/37,25.87%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RNF8;SPTY2D1;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.34606755134854955,1.4256856980195993,0.013368983957219251,0.2746739262604774,1.0,36/118,16.13%,ADGRB3;LRRC4C;HECW1;PPFIA2;EFNA5;CDH2;TANC2;HECW2;LZTS1;PAK3;CLASP2;GDNF;WARS1;SRCIN1;SHANK3;KNDC1;ABI2;ADGRA2;TSPAN12;NEDD4;TBX1;EMP2;CDK5R1;SH3D19;BRSK1;FERMT2;TNIK;ARHGAP35;WTIP;SDC2;ARC;SIPA1L1;EPHB3;BMPER;SPARC;PDZD8
prerank,phospholipid translocation (GO:0045332),-0.48246233475761935,-1.4253485891221005,0.04317789291882556,0.19374742058045594,1.0,6/28,9.21%,ABCA1;ATP8B4;P2RX7;ANO6;ATP11C;ABCC1
prerank,regulation of neutrophil migration (GO:1902622),-0.6199962649221369,-1.4250953178407266,0.0777027027027027,0.19380944084022225,1.0,4/10,16.07%,MPP1;RAC1;NCKAP1L;BST1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.4988384201744373,-1.424966878672501,0.06610169491525424,0.19373685615921618,1.0,6/22,12.50%,RUNX1;BCL6;MDK;CBFB;CD46;IL4I1
prerank,protein polyglutamylation (GO:0018095),0.5896071397607588,1.4248539451043567,0.11830357142857142,0.27485620353878093,1.0,3/11,5.31%,TTLL11;TTLL7;TTLL5
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4734849860997586,-1.4247341349052232,0.041811846689895474,0.19383506432556877,1.0,11/28,26.60%,CRADD;SPI1;BCL2;GABARAP;BAG3;BID;CASP8;TRADD;DDX3X;DEDD2;DIABLO
prerank,presynapse organization (GO:0099172),0.601036037144153,1.4239223963159895,0.1,0.2752416994611683,1.0,2/10,3.96%,NLGN1;LRRTM3
prerank,regulation of leukocyte migration (GO:0002685),-0.5449403844736239,-1.4234225361918662,0.07973421926910298,0.19526616029915966,1.0,8/16,23.67%,RAC1;ANXA1;VEGFA;NCKAP1L;MIA3;BST1;HMOX1;ADTRP
prerank,regulation of JUN kinase activity (GO:0043506),-0.4551833652510268,-1.423327679231767,0.0547945205479452,0.19512896864352416,1.0,10/33,18.15%,SASH1;MAP3K5;TAOK3;PTPN22;DNAJA1;AIDA;TRAF2;MAP3K10;ARHGEF5;RPS3
prerank,postreplication repair (GO:0006301),-0.4301786859612238,-1.42295448020834,0.041736227045075125,0.19536351012063136,1.0,20/45,26.84%,BRCA1;RFC1;PRIMPOL;PCLAF;UBC;RPS27A;PCNA;WDR33;RPA3;RFC2;POLD2;ISG15;PARP10;POLN;RFC3;TRIM25;UBE2V2;POLD4;UBE2N;VCP
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5317744692979856,-1.4228256558297936,0.061837455830388695,0.19528783832964725,1.0,4/17,8.64%,APOE;ABCG1;MBTPS2;ERLIN1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.31231824235365635,-1.4227305154171221,0.0,0.19515271175597337,1.0,94/390,15.26%,LYN;NEDD9;CYBB;NRP1;VAV3;MTSS1;IGF1;ATP6V0D2;NAMPT;BCAR3;FGR;ABI1;GRB2;MAPKAPK3;SDCBP;ARPC2;ITSN1;SYK;PAK2;CYBA;AXL;CBL;ATP6V1E1;RAC1;ROCK1;PTPRJ;ACTR2;RHOA;INSR;IGF1R;WASF2;VAV1;FES;MAPKAPK2;ATP6V1A;RASGRP4;STAT3;CDC42;ACTR3;FLT1;TCIRG1;BLNK;PTK2B;STAP1;ACTB;KIF16B;ITGAV;ARPC3;AP3S1;MAPK14;PIK3CB;WASL;HGF;RHOQ;MVP;GALNT3;HNRNPH1;NRP2;CEP57;BAIAP2;POLR2H;VEGFA;AP2A2;SULF2;FRS2;POLR2F;VAV2;POLR2L;ANGPT2;NCKAP1L;ATP6V1G1;SPRED1;LCK;NCF1;NCF4;PSENEN;SPRED2;CRK;ARPC1B;ZNF106;PIK3CA;ARPC1A;NCF2;SHCBP1;FRK;LCP2;ATP6V0B;POLR2A;NCBP1;RGS14;PIK3C2A;RASA1;BRK1;ARPC5
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3603008674755834,-1.421759278767885,0.009819967266775777,0.19622032967759812,1.0,41/122,22.80%,IGF1;NAMPT;BCAR3;VIM;NIBAN1;YTHDF3;INSR;DYRK2;TLR4;DHX9;NFKB1;NLRC5;CIITA;HGF;LARP4B;PRMT1;PCIF1;CD28;LARP4;RPS4X;MTPN;EEF2;XBP1;EIF3E;PCNA;KAT7;PPP1R3E;METTL14;HSPH1;FAF1;SLC6A9;IRS2;DNA2;PDGFRB;DDX3X;NOD2;RBM3;KDR;TMEM106A;IL6;PRKDC
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.49869931954297236,-1.4215596525333922,0.055267702936096716,0.19622840644738995,1.0,11/23,24.96%,DDB2;GPS1;UBC;RPS27A;CUL4B;COPS6;COPS5;COPS4;COPS8;CETN2;DDB1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5441935834933147,-1.4215506186923246,0.08041958041958042,0.19599096195564816,1.0,7/16,20.56%,LILRB1;TNFRSF21;TRIB2;FCGR2B;MMP8;AGER;CD274
prerank,telomere maintenance via recombination (GO:0000722),-0.6104995365901229,-1.4215026037786702,0.06884681583476764,0.1958025312294828,1.0,7/11,24.23%,NSMCE2;TEP1;RAD51;ERCC4;XRCC3;SMC6;SMC5
prerank,regulation of cellular response to stress (GO:0080135),-0.3610706442440657,-1.4200838351931022,0.022690437601296597,0.19750499420668297,1.0,39/115,23.06%,MCL1;CREBBP;NUPR1;ATF3;NUP50;MAPKAPK2;AMFR;MBTPS2;NUP42;ARMT1;NUP88;RAE1;NEK6;YWHAE;NUP205;TPR;HSP90AB1;NUP188;RPA3;MANF;HSPH1;EIF4G1;BAG3;DNAJC2;CLN3;HSPA1A;NUP153;NUP35;SLC38A2;ATM;GSK3B;DNAJB6;NUP107;DNAJC7;NUP62;CEBPB;MAPK1;CRYAB;SMG1
prerank,pulmonary valve morphogenesis (GO:0003184),0.5243489822296055,1.420051002432544,0.0924170616113744,0.2802056862984059,1.0,3/17,1.35%,ROBO1;ROBO2;SLIT2
prerank,cellular response to superoxide (GO:0071451),-0.6158832541565337,-1.4197171678096252,0.08854166666666667,0.19770769099145122,1.0,5/10,25.75%,ATP7A;PRDX1;PRDX2;ADPRS;MT3
prerank,regulation of Golgi organization (GO:1903358),-0.5434467541775805,-1.4193732220133746,0.06598984771573604,0.19793321453307153,1.0,6/17,22.16%,MYO5A;ARMH3;MAP2K1;STX5;CAMSAP2;MAPK1
prerank,regulation of heart contraction (GO:0008016),0.37164810994824843,1.418455919373602,0.02,0.28157671329496586,1.0,30/90,17.68%,ANK2;RYR3;RYR2;SLC8A3;TRPC1;PDE4D;ADORA3;CORIN;AHCYL1;CASQ2;KCNIP2;APLN;ATP1A3;FXYD6;SLC8A2;TNNT2;RYR1;ATP1B1;TGFB2;CALM1;CALM3;KCNJ12;CALM2;ATP2B4;ATP2B2;ATP2A1;SCN10A;TPM1;ATP1B2;CELF2
prerank,regulation of neuron migration (GO:2001222),0.47478558975591334,1.4181032338580593,0.052132701421800945,0.2809835883568641,1.0,8/26,9.24%,CTNNA2;SEMA6A;NTNG2;NTNG1;PHACTR1;SRGAP2;NEXMIF;CAMK2A
prerank,mitotic cell cycle phase transition (GO:0044772),-0.33888615475733047,-1.4179184058089545,0.006359300476947536,0.1996296807466232,1.0,73/204,23.49%,CDK6;RB1;DNM2;EPS8;OPTN;CENPJ;FBXL17;GSPT1;CNTRL;ANAPC1;GPR132;CCND3;DYNC1H1;FBXW11;CRLF3;CCNY;HAUS5;SDCCAG8;HAUS6;CEP57;PLK2;E2F1;CKAP5;E2F3;CDK14;YWHAE;MASTL;NES;EIF4EBP1;DBF4;PPP2R2D;CDKN3;CEP70;CHMP7;HAUS4;CDC25A;DCTN1;CDK1;CUL4B;HAUS7;CACUL1;PLK3;CUL2;PPP1R12A;CHMP2A;CCNE1;CDC34;ODF2;LATS2;NINL;UBE2C;PCNT;FBXL8;SKP2;AURKA;WEE1;PHLDA1;ANAPC7;CDKN2C;RCC1;FBXL6;MAX;PAFAH1B1;CEP192;CDC25C;CETN2;TUBA4A;CCNF;CHMP4B;CEP41;CCNB1;PPP1CB;PIM2
prerank,epithelial cell differentiation (GO:0030855),-0.37592117294349986,-1.417913642929061,0.018302828618968387,0.199383545428728,1.0,22/88,17.97%,DAB2;CTSB;ANXA4;TAGLN2;PPARG;CPT1A;MAF;ANXA1;JAG1;EDF1;ZDHHC7;VEGFA;SCRIB;CDK1;PCNA;CBR1;RAB10;E2F8;TPP1;TDRD7;PGK1;GATA3
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5810044855727442,-1.417085166038347,0.08159722222222222,0.20025710291416218,1.0,3/13,1.62%,SYK;PRKCD;ITGB2
prerank,pentose-phosphate shunt (GO:0006098),-0.5987897771436883,-1.4169680311720139,0.08703071672354949,0.20015166835077317,1.0,7/11,29.43%,PGD;DERA;RPE;TKT;PGLS;TALDO1;PGM2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5761624362727955,-1.4167294685623424,0.06896551724137931,0.20021038280023093,1.0,2/12,4.21%,PAEP;IL18
prerank,stem cell development (GO:0048864),0.5203817209532201,1.416522989700113,0.09133489461358314,0.2824705825465704,1.0,4/16,4.88%,NRG1;SOX11;CDH2;PDCD6
prerank,midbody abscission (GO:0061952),-0.5317516582001406,-1.4162766065329937,0.09693877551020408,0.2005808694118178,1.0,12/17,26.94%,PDCD6IP;CHMP5;CHMP7;CHMP1A;CHMP2A;KIF20A;CEP55;VPS4A;CHMP4B;CHMP4A;CHMP2B;MITD1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.47153641491187603,-1.415550809890781,0.06371681415929203,0.20128200943008934,1.0,14/28,25.22%,PRKCD;IPO5;FLNA;TPR;MAVS;BAG3;HCLS1;CHP2;ZC3H12A;JUP;TGFB1;RBM22;TRIM28;ECT2
prerank,RNA biosynthetic process (GO:0032774),-0.45845749175985856,-1.4150560281226927,0.06785714285714285,0.20173957348438512,1.0,10/31,19.39%,SMARCA5;TAF6;SMN1;POLR2A;PRIM1;TTF1;NCOA6;TAF4;RSF1;PRIM2
prerank,focal adhesion assembly (GO:0048041),0.49936880803945155,1.4148534721727,0.08726415094339622,0.2839881109692906,1.0,7/21,11.91%,SORBS1;ARHGEF7;DLC1;PTPRK;THSD1;TESK2;FERMT2
prerank,metal ion homeostasis (GO:0055065),0.42351882872307234,1.414544336275992,0.052132701421800945,0.28333728119770263,1.0,11/40,16.07%,ANK3;TMTC2;SLC12A2;SLC12A8;SLC12A1;KCNA1;LETM1;SLC12A5;FAM20A;COX11;SNCA
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.41991553050843516,-1.4141311179369538,0.04208754208754209,0.2028051980723759,1.0,14/49,16.21%,LYN;IGF1;IL6R;STAT3;PIBF1;IL15;IL18;PARP14;VEGFA;PARP9;CCL5;CD40;IL31RA;HCLS1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5056042843521013,-1.4137063453811747,0.08673469387755102,0.2031245199591635,1.0,5/23,6.74%,PTPRC;CBL;SNX6;TSG101;MVP
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5151469859144926,-1.4135554241780424,0.07588532883642496,0.20304866601541774,1.0,5/20,6.87%,PID1;DAB2;PKDCC;RHOQ;PICALM
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4919138315584015,-1.4128895521768663,0.08838821490467938,0.2037577213301885,1.0,7/23,18.15%,SASH1;MAP3K5;TAOK3;TRAF2;MAP3K10;ARHGEF5;RPS3
prerank,NAD biosynthetic process (GO:0009435),-0.5112479519115138,-1.41285543283059,0.07337883959044368,0.20354962546045194,1.0,8/20,35.32%,NAMPT;KYNU;PARP9;PARP10;NMNAT3;NADSYN1;NUDT12;HAAO
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4076144743844255,-1.4120159245917718,0.03754266211604096,0.2045192703934251,1.0,15/57,16.21%,LYN;IGF1;IL6R;STAT3;PIBF1;IL15;IL18;PARP14;NF2;VEGFA;PARP9;CCL5;CD40;IL31RA;HCLS1
prerank,purine ribonucleotide transport (GO:0015868),-0.5467148501658666,-1.4115718809715911,0.08050089445438283,0.2048986329057667,1.0,6/16,15.51%,LRRC8D;SLC25A24;LRRC8C;SLC25A42;ABCC4;SLC25A4
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.6013675504516781,-1.4111328596097132,0.08506944444444445,0.20526790818301113,1.0,4/11,16.92%,UBN1;ASF1B;ASF1A;RBBP4
prerank,cell-substrate junction assembly (GO:0007044),0.44186979746295374,1.4108237276076685,0.07441860465116279,0.2882345073284836,1.0,9/33,11.91%,SORBS1;ARHGEF7;DST;DLC1;PTPRK;THSD1;CD151;TESK2;FERMT2
prerank,histone mRNA catabolic process (GO:0071044),-0.5468636196717978,-1.4103771563095677,0.07352941176470588,0.20605363208281538,1.0,7/15,21.33%,TUT7;DCP2;MTPAP;TENT4B;EXOSC10;ATM;EXOSC4
prerank,regulation of adaptive immune response (GO:0002819),-0.5248794308282895,-1.4103663144134995,0.07908611599297012,0.2058181274507036,1.0,6/18,14.64%,ADCY7;SASH3;AHR;IL4I1;FCGR2B;SAMSN1
prerank,mRNA destabilization (GO:0061157),-0.4380287481624045,-1.4103586576407652,0.04655172413793104,0.20557560485601808,1.0,16/38,27.43%,ROCK1;YTHDF3;TUT7;CNOT1;RC3H1;MOV10;FTO;CELF1;METTL14;DHX36;ZC3H12A;TARDBP;PUM1;ZC3H12D;ZFP36L1;METTL3
prerank,mitochondrial genome maintenance (GO:0000002),-0.5883704730486466,-1.410289048815783,0.0989010989010989,0.2054004523327726,1.0,4/11,15.51%,TOP3A;MEF2A;MPV17;SLC25A4
prerank,embryonic limb morphogenesis (GO:0030326),-0.4450666892470241,-1.4098127707200145,0.06451612903225806,0.20583657011588735,1.0,9/34,11.44%,MBNL1;CREBBP;MAP3K20;NIPBL;RARG;LRP6;CTNNB1;SKI;OSR1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.4708663873044981,-1.4086918900116885,0.06070826306913996,0.20710122286387314,1.0,17/29,36.85%,STX7;RAET1E;SPI1;STAP1;AP1G1;CYRIB;LAMP1;CD226;SLAMF6;ITGAM;IL12RB1;CRTAM;KLRC2;KLRD1;IL12A;NOS2;IL12B
prerank,regulation of MAP kinase activity (GO:0043405),-0.3703436607878019,-1.4085441157066731,0.026936026936026935,0.20704580797214403,1.0,25/92,14.89%,LYN;APOE;CD300A;PRKCD;PTPRJ;PIK3R5;HTR2B;FLT1;TSG101;PIK3CB;PIK3CG;IRAK3;EZH2;VEGFA;STK38;TRIB1;ADAM8;TRIB2;SPRY2;AGT;PAQR3;KSR1;CD40;IL34;RGS14
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5266060687933537,1.408426182751577,0.0966183574879227,0.2910348386224644,1.0,3/17,3.78%,NLGN1;SYT10;RAB15
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.6135851383382349,-1.4082840771389604,0.09407665505226481,0.20718836140083635,1.0,6/10,22.33%,PIEZO1;DPP4;CCL5;WNK1;FERMT3;CD3E
prerank,cell differentiation in hindbrain (GO:0021533),0.5845332745319711,1.4081935475932548,0.07441860465116279,0.2902420992237042,1.0,2/11,5.54%,GRID2;KNDC1
prerank,iron ion homeostasis (GO:0055072),-0.4097670080169019,-1.408099954571859,0.035,0.20722498358829422,1.0,12/58,10.18%,FTL;IREB2;ABCB7;FRRS1;ATP6V1A;TMEM199;PICALM;HMOX2;B2M;FLVCR1;ATP6V1G1;CP
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.6123342621612498,-1.406752177812542,0.07288135593220339,0.2087921112440937,1.0,1/10,1.12%,GNB1
prerank,positive regulation of neuron projection development (GO:0010976),0.3666203193905116,1.4059190929744951,0.033734939759036145,0.2930104658083954,1.0,24/85,12.33%,MAGI2;LRRC7;TENM3;RIT2;NTRK3;SERPINI1;NTRK2;FUT9;PTN;CUX2;PRKCI;ALK;TOX;PRKD1;BDNF;BMP7;COBL;CAPRIN2;LTK;RELN;DPYSL3;RET;ARHGAP35;VLDLR
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.5711750183709265,-1.4054977061612466,0.08710801393728224,0.21027116055752712,1.0,8/13,23.02%,CANX;STAT3;JAK1;OASL;IL27RA;OAS2;STAT1;TYK2
prerank,protein localization to membrane (GO:0072657),0.32068719779750576,1.4046186767172208,0.007894736842105263,0.29391079365193107,1.0,22/187,4.30%,NLGN1;DLG2;DPP10;KCNIP4;NRXN1;DPP6;MAGI2;LRRC7;KCNB2;ANK3;ANK2;DLG3;RAB3C;MAP7;CACNB2;FRMPD1;TESC;RAB15;EPB41L3;NRXN2;PTN;CLASP2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3734944793483498,-1.4044555789565651,0.031825795644891124,0.21151968455916628,1.0,45/96,32.70%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;NUP205;UPF2;ALYREF;TPR;NUP188;WDR33;YTHDC1;NCBP1;THOC2;RNPS1;NUP153;THOC6;NUP35;MAGOH;SLU7;CPSF3;NUP107;NUP62;SRSF11;SMG1;DDX39B;DHX38;RANBP2;RBM15B;CPSF1;NUP37;U2AF2;SRSF7;AAAS;NUP133;EIF4A3;EIF4E;SRSF5;SARNP;ALKBH5;U2AF1L4
prerank,regulation of lamellipodium organization (GO:1902743),-0.5737051180749696,-1.4038649543302277,0.07692307692307693,0.21202818373873256,1.0,4/14,4.09%,CD44;RAC1;CAPZB;CDC42
prerank,organelle organization (GO:0006996),-0.30673819174381983,-1.403116942995864,0.004784688995215311,0.2128337850937127,1.0,121/388,24.60%,DIAPH1;APOE;NEDD9;ATP8B4;TMCC1;VPS13C;ARHGAP10;PLEKHM2;FGD6;RAB7A;YTHDF3;PEX14;GOLGA5;GOLGA8B;PI4K2A;FBXW8;PDCD6IP;ATXN7;OPTN;STX7;CAPZB;SIPA1;ABCD2;RAB31;SH3KBP1;CDC42;FGD4;PYROXD2;CHMP5;RAB1A;COG7;ATP7A;ARFGEF1;TMED10;RAB3GAP1;FGD3;PI4K2B;PLD2;TRAPPC11;NRF1;WASL;DYM;RAB32;GOLPH3L;SIPA1L3;KIF4A;EPS15;MDK;TJAP1;BCS1L;ATAD3A;TMED3;LARP4;SIRT3;DIAPH3;PACSIN2;SSBP1;CHGA;CHMP7;SYNE3;WDR73;SPRYD3;CHMP1A;TMEM11;SAR1A;MICAL1;FMNL2;RAB29;MICAL2;CXADR;COG2;SEC31A;MAST2;MIA3;CHMP2A;AFG1L;ZMYM6;TFAM;PLAAT3;PEX7;ODF2;NIPSNAP2;LMAN2L;VAPB;ABCD3;STX4;TMED2;RAB34;CEP55;ARL1;HUWE1;CFL1;DOP1B;PAK6;TTC17;TMED4;TICAM2;VPS51;VPS18;VPS4A;CYP26C1;MTX1;BLZF1;FAF2;HAX1;ZRANB1;MAST3;POLG2;CHMP4B;CHMP4A;CNN2;TWNK;TMED5;VMP1;COG4;ATP5F1B;CCL7;TRIP11;CYCS;PTCD2;MYC
prerank,renal system development (GO:0072001),0.39279919848685063,1.4030691409389586,0.041666666666666664,0.2953129574281452,1.0,16/52,11.28%,PCSK5;MME;PAX8;GREB1L;HNF1B;WT1;TRAF3IP1;SALL1;TFAP2A;AGTR1;MYOCD;HAS2;CEP290;TGFB2;PYGO2;PKD1
prerank,ureteric bud morphogenesis (GO:0060675),0.5134735036661162,1.4030644132130996,0.10222222222222223,0.29419604698334784,1.0,5/16,9.62%,PAX8;GDNF;WT1;SALL1;CITED1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.46475838652949003,-1.4027299190862368,0.08034188034188035,0.21307442585714267,1.0,4/26,4.11%,LILRB3;CDK6;GPR137B;TLR4
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.49611901361061045,1.4021431577101036,0.10256410256410256,0.29461497817106763,1.0,7/18,10.87%,ADCY8;EPHA5;OPRD1;PRKD1;CD200;ADCY1;RELN
prerank,Notch signaling involved in heart development (GO:0061314),-0.6080326036596362,-1.4019952231484492,0.08727272727272728,0.21389924318510303,1.0,3/11,5.78%,RBPJ;NOTCH2;JAG1
prerank,striated muscle contraction (GO:0006941),0.3914218241724254,1.4019245552285602,0.05970149253731343,0.2939003594098279,1.0,11/53,11.89%,DMD;DTNA;RYR2;SCN2B;CASQ2;TNNI1;TNNT2;MYH7;ATP1B1;TTN;STAC
prerank,Ras protein signal transduction (GO:0007265),-0.3516720602809242,-1.4015555763972036,0.01740506329113924,0.21424108167226705,1.0,39/137,18.37%,IGF1;GRB2;RREB1;GNB1;RB1;MYO9B;JUN;RAC1;ROCK1;ARHGEF3;RAP1B;USP50;RHOA;EPS8;RAP2B;RAP2A;GRAP2;GNA12;RAP1A;RGL2;USP8;MAPK14;PLK2;CDC42EP2;PLEKHG5;GNA13;ARHGEF11;KSR1;SETDB1;BRK1;CRKL;GRAP;BRAP;CDC42EP3;G3BP1;RALB;KRAS;NRAS;CFL1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.4899265998519392,-1.401442633472451,0.06690140845070422,0.21413152995132678,1.0,6/24,7.83%,NRP1;RAC1;ROCK1;PTPRJ;DUSP3;VEGFA
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5288467591917109,-1.4012705513304289,0.08644067796610169,0.21410867040450898,1.0,10/18,22.61%,CBL;SPI1;IL6R;CTR9;STAT3;JAK1;SOCS3;PTPN11;STAT1;IL6
prerank,cellular response to chemical stress (GO:0062197),-0.36619700511114633,-1.4006347324808186,0.028716216216216218,0.21476454918275087,1.0,29/96,20.90%,CYBB;LRRC8D;CYBA;NFE2L2;VRK2;FOXO3;SLC25A24;ATG7;NUDT2;MSRA;GSR;SELENOS;PRDX5;NCF1;NCF4;PRDX1;PIK3CA;NCF2;TMEM161A;PRDX2;RAD52;STX4;HSPA1A;DDX3X;ATM;CAT;RBM11;SIRT2;ZC3H12A
prerank,mitotic cytokinetic process (GO:1902410),-0.5010354968735868,-1.4003863823380736,0.08166666666666667,0.2148822050917204,1.0,14/20,26.94%,RHOA;PDCD6IP;CHMP5;CHMP7;CHMP1A;CHMP2A;KIF20A;CEP55;VPS4A;CHMP4B;CHMP4A;KLHDC8B;CHMP2B;MITD1
prerank,cell projection organization (GO:0030030),-0.46021847283492523,-1.4003611391413893,0.08768971332209106,0.21466105227812873,1.0,9/30,10.11%,PLEK;RAC1;PARVB;CDC42;ITGB1;RHOQ;CAPG;NCKAP1L;PACSIN2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.2935990442729013,-1.4000250235712208,0.0,0.21486159684118897,1.0,219/807,23.02%,RBPJ;MDFIC;DAB2;MITF;FNIP2;ZEB2;FOXP1;RUNX1;TRPS1;CD38;SP100;RCOR1;RREB1;SDCBP;BCL6;WWP1;MIDEAS;RB1;JUN;PEX14;NIBAN2;ZNF568;MEF2A;CREBBP;ETV6;RUNX3;PPARD;ARID5B;BPTF;BACH1;DNMT3A;BRD7;FLNA;IRF2;ZNF148;SBNO2;NFIC;NFX1;ATF3;PPARG;ELK3;GATAD2A;SPI1;BRCA1;WWP2;PHF21A;ZNF3;CTR9;STAT3;FOXO3;CNOT1;IKZF1;NIPBL;CHD3;SNX6;NFKB1;CNOT2;HHEX;ZBTB21;RUNX2;FBXW11;RARG;PRMT2;SAP30;CENPF;SARS1;SMARCC2;NR1H2;CIITA;CUX1;MDFI;CBFA2T3;SMYD2;ZBTB2;AHR;CTNNB1;TBL1XR1;GAS6;GCFC2;MCPH1;EZH2;RPS14;PBXIP1;JARID2;DPF2;USP9X;WFS1;NR2F1;KDM2A;SKI;VEGFA;BHLHE40;MAP2K5;EED;E2F1;CNBP;FNIP1;SPEN;THAP1;CBFB;PARP9;DDX5;MEF2C;SAP130;TFEC;FOXN3;UBC;RPS27A;PRDX5;SUDS3;HDAC10;CIART;RELA;NEDD4L;TIMELESS;MAF1;XRCC6;FLCN;TCF25;OSR1;CHMP1A;TPR;KLF10;PRDM2;GADD45A;FOXJ1;ZFP57;CHD8;KAT7;CCDC85B;HMGB2;UHRF1;FRK;PLK3;MTA3;IRF2BP2;HDAC5;TGIF1;SP2;RXRA;E2F8;TFAP4;BATF3;SIN3A;CALCA;LIN37;EPC1;DR1;PSPC1;KLF2;ID2;TCF3;YY1;PRMT6;NSD1;MAP3K10;KLF8;ZNF177;BTAF1;PHC3;KMT5A;NRIP1;KLF11;IKZF4;SOX10;UBE2I;ATXN1;VHL;UXT;TAF3;RARA;ATF5;LIMS1;SMAD7;NR3C1;GATA3;MYB;RIPPLY2;SAMD1;ARID5A;MIER1;ID1;RSF1;MDM4;HMGB1;MAX;C1QBP;SUFU;RTF1;CIC;BAP1;CBFA2T2;MAZ;SIRT2;SFRP1;STAT1;GTF2IRD1;LRRFIP1;CDK5;KDM1A;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SNAI2;CEBPB;SET;RPS6KA5;SCMH1;NR1H4;GATAD2B;EID2;HOXD9;CRYAB;NONO;ESR2;SOX7;HDAC8
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.6094483363423866,-1.3994852973170955,0.0962566844919786,0.21533272046983276,1.0,5/10,25.54%,OGT;SELENOS;USP7;GNMT;ZNF692
prerank,sensory perception (GO:0007600),0.40392593514633784,1.399341978603006,0.05432098765432099,0.29711860307621707,1.0,20/45,17.27%,PCDH15;TMEM150C;MME;PNOC;TTC8;SCN9A;ADGRV1;WHRN;PDYN;CLRN1;KCNA2;USH2A;GNAL;OPRK1;CHRNA7;PENK;OPRL1;OPRM1;SCN10A;NIPSNAP1
prerank,actin crosslink formation (GO:0051764),-0.5756651648786907,-1.399172740187252,0.09481216457960644,0.21553345972181462,1.0,6/12,11.84%,EPS8;FLNA;GAS2L3;BAIAP2;LCP1;BAIAP2L2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.33955571950455243,-1.3983671067035899,0.012718600953895072,0.21645924909587635,1.0,46/166,20.56%,ZEB2;IGF1;BCAR3;VIM;NIBAN1;CD36;YTHDF3;INSR;P2RX4;DYRK2;SLC27A1;TLR4;DHX9;ATP7A;NR1H2;HGF;PAOX;LARP4B;PRMT1;PCIF1;CD28;HIF1A;LARP4;RPS4X;EGR1;ARNT;EEF2;EIF3E;PCNA;KAT7;CCL5;HSP90AB1;PPP1R3E;METTL14;KLF2;FAF1;ASS1;SLC6A9;IRS2;DNA2;MMP8;PDGFRB;DDX3X;LDLR;RBM3;APPL1
prerank,negative regulation of developmental growth (GO:0048640),0.4451765480824469,1.3982790010761585,0.07334963325183375,0.2978092246614714,1.0,7/30,15.44%,MAP2;DCC;TRIM46;WWC1;DUSP10;PTPRS;GDF15
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5393802685232387,-1.3978559600591716,0.0763765541740675,0.21688840210338345,1.0,6/16,18.32%,INSR;IGF1R;GSPT1;IRAK3;CLN3;TBC1D25
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3791768025806866,-1.397748240794991,0.04462809917355372,0.21675046421366784,1.0,16/76,12.13%,RBPJ;ZMIZ1;TSPAN14;NIBAN2;CREBBP;MAML1;WWP2;STAT3;MAML2;JAG1;ARRB1;POFUT1;ITGB1BP1;ENHO;RFNG;CD46
prerank,retinoic acid metabolic process (GO:0042573),-0.5556685027012744,-1.3974472757716574,0.09124087591240876,0.2169249986243753,1.0,8/14,31.69%,BCO2;CYP26C1;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1;SCPEP1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.49805765887729075,-1.3973466180404284,0.08916083916083917,0.21680646367827136,1.0,13/21,36.77%,ROCK1;CCR1;SRGN;PTK2B;GAS6;GREM1;ENPP1;TGFB1;HEY2;ASPN;ROCK2;HEY1;FGF23
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5937829141990224,-1.397126823564544,0.10600706713780919,0.21688944628462575,1.0,6/11,20.94%,CANX;STAT3;STAT4;JAK1;IL27RA;STAT1
prerank,O-glycan processing (GO:0016266),-0.4048547155255088,-1.3970381289066878,0.03672787979966611,0.21674922818379727,1.0,15/54,13.17%,B4GALT5;ST3GAL1;GALNT7;GALNT10;GALNT3;POFUT1;GALNT1;XXYLT1;ST6GAL1;C1GALT1;B3GNT2;GXYLT1;GALNT12;POMGNT1;GCNT1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.5184995102900564,-1.3956496093824398,0.07958477508650519,0.21853046716716956,1.0,8/18,22.22%,GINS3;MCM3;LIG1;PCNA;POLD2;LIG3;RFC3;GINS4
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5837288287228379,-1.3956354619726428,0.08644067796610169,0.21828618133601577,1.0,4/12,11.08%,ERN1;BCL2L11;ATF6;XBP1
prerank,mRNA export from nucleus (GO:0006406),-0.36808713959083716,-1.3955997801814446,0.026755852842809364,0.21806147865875275,1.0,47/102,32.70%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;NUP205;UPF2;ALYREF;TPR;NUP188;WDR33;YTHDC1;NCBP1;THOC2;RNPS1;NUP153;THOC6;NUP35;MAGOH;SLU7;CPSF3;NUP107;NUP62;SRSF11;SMG1;DDX39B;DHX38;RANBP2;RBM15B;CPSF1;NUP37;U2AF2;ENY2;SRSF7;AAAS;NUP133;EIF4A3;EIF4E;SRSF5;POLR2D;SARNP;ALKBH5;U2AF1L4
prerank,synaptic vesicle recycling (GO:0036465),0.4415114172348422,1.3951943896503065,0.07126436781609195,0.3019230480668135,1.0,12/31,16.98%,NLGN1;SYT1;AMPH;SYNJ2;SYT2;STON1;SYT5;SYT7;PACSIN1;NLGN2;SNCA;RAB3A
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.46202754430180215,-1.3950584123320118,0.06156405990016639,0.21853381885380008,1.0,15/31,25.73%,LYN;LILRB1;CD300A;RC3H1;TNFRSF21;SDC4;IL4I1;FCGR2B;VSIG4;SPN;ATM;CD274;CEBPB;TNFRSF13B;BLK
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4531109250478761,-1.3949660680034326,0.057391304347826085,0.2183881116741439,1.0,15/34,18.91%,NRP1;ERN1;MAPKAPK2;MT1G;FLT1;ANXA1;MAPK14;VEGFA;ITGB1BP1;SPRY2;RELA;PIK3CA;NR4A1;MAP2K3;HSPB1
prerank,alcohol catabolic process (GO:0046164),-0.6223044635118856,-1.3947479774949743,0.09023941068139964,0.21842047143738216,1.0,3/10,14.91%,APOE;CYP27A1;CYP46A1
prerank,cell chemotaxis (GO:0060326),-0.3934772773069973,-1.3946331650416899,0.057724957555178265,0.21833053224280788,1.0,16/60,19.99%,NRP1;CCR2;PRKCD;ARRB2;CCR1;HGF;VEGFA;ABCC1;PLEKHG5;CCRL2;HMGB2;CXCR4;RAB13;NR4A1;PDGFRB;PIP5K1A
prerank,carboxylic acid catabolic process (GO:0046395),-0.5762575130820682,-1.3944729111034413,0.09106830122591944,0.21828731093122647,1.0,8/12,26.01%,NPL;GNPDA1;IL4I1;ACOT4;GNPDA2;AMDHD2;RENBP;PON3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5456290910129218,-1.394098670345876,0.09358752166377816,0.2185809653872661,1.0,5/16,14.06%,APOE;HTR2B;PIK3CB;HIF1A;GCH1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5355807576263375,-1.3940805926976099,0.0931899641577061,0.2183519632316231,1.0,6/15,16.54%,SAMHD1;YTHDF3;USP18;NLRC5;OAS3;ISG15
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.5332808686343384,-1.394052971942207,0.09090909090909091,0.2181365318935854,1.0,7/18,14.77%,ERN1;BCL2L11;ATXN3;XBP1;FCGR2B;RNF185;TMEM259
prerank,positive regulation of cellular respiration (GO:1901857),-0.5958950354275738,-1.393577410251262,0.09271523178807947,0.21854215938934615,1.0,3/11,11.52%,NUPR1;IL10RB;IFNAR1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3823448600699961,-1.393543759359197,0.03885135135135135,0.21832845435433265,1.0,30/74,31.23%,DAB2;SDCBP;ADIPOR1;GCNT2;CTNNB1;EZH2;SDHAF2;MDK;TGFBR1;TGFB1I1;SPRED1;SPRY2;SPRED2;TGFBR2;GREM1;LDLRAD4;VASN;SMAD7;GATA3;IL17RD;SFRP1;IL6;TGFB1;SMAD4;BMP2;PDPN;LEF1;DAG1;SMAD2;GLIPR2
prerank,regulation of T cell mediated immunity (GO:0002709),-0.6063217741644814,-1.3929680503476576,0.10657193605683836,0.2189075291084995,1.0,6/10,29.03%,CCR2;TNFRSF1B;HMGB1;AGER;RIPK3;ZBTB1
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.3406416828114855,-1.392952091473086,0.009538950715421303,0.21867227471740758,1.0,34/150,13.40%,OSBPL8;GRB2;GAB2;MFHAS1;AXL;RAC1;PTPRJ;HPSE;PIK3R5;INSR;IGF1R;P2RX4;PIK3AP1;VAV1;IL18;ITGB1;PIK3CB;HGF;PIK3CG;GCNT2;GAS6;HIP1;FRS2;TGFBR1;CD28;ITGB1BP1;ADAM8;SPRY2;LCK;STRN;PIK3CA;F7;HSP90AB1;PIK3CD
prerank,regulation of protein binding (GO:0043393),-0.3539123009133683,-1.3928884404633437,0.02086677367576244,0.21851387650912574,1.0,33/114,21.40%,DAB2;CTSZ;LRP1;PRKCD;ROCK1;PEX14;AMFR;ACTB;STK3;RPL11;PPP1CA;NVL;B2M;ITGB1BP1;NES;PIN1;DERL1;APP;CRK;IFIT1;TMBIM6;IFIT2;HDAC5;MARK2;TFIP11;AURKA;RALB;TMC8;GSK3B;DTX3L;DISC1;KDM1A;RACK1
prerank,positive regulation of DNA binding (GO:0043388),-0.4538861779854116,-1.3928144143678003,0.058098591549295774,0.21836159947277167,1.0,14/31,20.66%,IGF1;RB1;NIBAN2;PPARG;EDF1;SKI;NME1;PLAUR;CEBPG;HMGB2;GATA3;MMP8;HMGB1;SIRT2
prerank,regulation of phosphorylation (GO:0042325),-0.35541032739458017,-1.3926699519440766,0.03156146179401993,0.21831740818830483,1.0,48/120,26.75%,LYN;NRP1;FNIP2;CORO1C;SDCBP;ROCK1;OGT;NUP50;PRKAG2;STAP1;NLRC5;NUP42;FN1;NUP88;RAE1;FNIP1;HIF1A;NCKAP1L;NUP205;PIN1;APP;FLCN;TPR;CCDC88A;JMJD8;CCL5;NUP188;IKBKB;ANG;ANKLE2;CDKN2C;NUP153;HSPB1;NUP35;SIRT2;NUP107;NUP62;PRKAG1;ZBTB7A;INHA;ILK;STAT2;RANBP2;EIF6;CCDC88C;NUP37;FZD7;PML
prerank,sterol metabolic process (GO:0016125),-0.39677094035402616,-1.392545867051657,0.04013377926421405,0.21822740745019586,1.0,15/60,15.10%,APOE;ABCA1;LIPA;ABCG1;PPARD;PRKAG2;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;RXRA;CYP46A1;FDXR
prerank,defense response to fungus (GO:0050832),-0.5371946357907417,-1.3920706150180078,0.09491525423728814,0.21860336939870054,1.0,5/17,12.30%,PLCG2;GAPDH;RNASE7;CLEC4D;CLEC6A
prerank,mammary gland development (GO:0030879),0.48477573383858247,1.3914959884178149,0.09930715935334873,0.3069495226743504,1.0,6/21,14.32%,NRG1;ERBB4;APLN;OXTR;ARHGAP35;JAK2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3818607462007886,-1.3914431667794593,0.03924914675767918,0.2192103514306486,1.0,25/73,19.29%,APAF1;XDH;CRADD;PPARG;RIPK1;CFLAR;NLRC4;ANP32B;HIP1;LAPTM5;CASP4;NOD1;ATP2A3;LCK;HSPE1;CASP1;TRAF2;BBC3;BID;TNFSF10;CASP8;IFT57;TRADD;CASP2;BEX3
prerank,plasma membrane tubulation (GO:0097320),-0.5587045107112217,-1.3911496284409803,0.09386281588447654,0.21940272445099435,1.0,9/13,32.16%,SNX9;SNX33;PACSIN2;BIN3;CHMP4A;MICALL1;PACSIN3;WHAMM;CAVIN2
prerank,lymphocyte mediated immunity (GO:0002449),-0.5823661712408887,-1.3910845378078274,0.07563025210084033,0.21924904798308986,1.0,8/12,33.42%,MYO1G;JAG1;CD46;GNL1;KLRC2;KLRD1;CD8A;SLA2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.35680773195524984,-1.390783972103555,0.022298456260720412,0.2194052703027698,1.0,36/114,22.43%,BIRC3;TNFRSF1B;PSME4;RIPK1;TRAF5;FOXO3;PSMB7;PSME3;PTK2B;AIM2;PSMB9;TRAF3;PSMA8;CD27;RELA;TRAF1;PSMC3;PSMD8;TRAF2;PSMC4;PSMB10;PSMA1;CD40;TMSB4X;IKBKB;PSMB8;TNFRSF25;LIMS1;TRADD;PSMA5;PSMD4;PSMB3;PSMD3;STAT1;TNFSF9;ILK
prerank,chromatin remodeling at centromere (GO:0031055),-0.45160819008264913,-1.3907276404690347,0.07017543859649122,0.21925621987268085,1.0,13/31,25.87%,SMARCA5;KNL1;MIS18BP1;CENPA;CENPK;CENPN;CENPL;RBBP4;CENPH;RSF1;CENPP;CENPO;HJURP
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5197696955610873,-1.3899910156146618,0.09075342465753425,0.22002831207154072,1.0,5/17,8.17%,PTPRJ;DGKZ;PTPN22;DUSP3;LAPTM5
prerank,regulation of MAPK cascade (GO:0043408),-0.3400936369695189,-1.3898738580245142,0.011570247933884297,0.21995565114401525,1.0,27/157,10.46%,IQGAP1;LYN;PTPRC;TAOK3;IGF1;BCAR3;CD74;P2RX7;SYK;PLCG2;PAK2;ROCK1;PTPRJ;INSR;IGF1R;VRK2;MINK1;RNF41;FLT1;STK3;DUSP3;FN1;LAPTM5;GSDME;PTPN6;SPRED1;TAOK1
prerank,regulation of histone deacetylation (GO:0031063),-0.5663000648290805,-1.3897330831604238,0.10431654676258993,0.21992007493902516,1.0,9/13,35.15%,AKAP8;NIPBL;PRMT6;SPHK2;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,regulation of ion transmembrane transport (GO:0034765),0.43796247816246314,1.3896170535241816,0.07729468599033816,0.30900690921037,1.0,10/33,8.49%,AKAP6;CHRM3;KCNJ3;KCNJ10;AHCYL1;KCNJ6;CASQ2;KCNJ9;KCNJ16;NEDD4
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.4842728754961055,-1.3894645709594933,0.07192982456140351,0.22006895692710501,1.0,3/24,1.57%,PRKCH;RUNX1;ROCK1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.34298791506603366,-1.3892891068896056,0.02106969205834684,0.2200715820477399,1.0,48/146,22.45%,RAD51B;BRD4;PSME4;CENPJ;PSMB7;CNTRL;PSME3;GPR132;DYNC1H1;CENPF;HAUS5;PSMB9;SDCCAG8;HAUS6;CEP57;CKAP5;YWHAE;PSMA8;TPX2;PSMC3;KIF14;CEP70;HAUS4;CDC25A;DCTN1;CDK1;PSMD8;HAUS7;PSMC4;PSMB10;AVEN;PSMA1;ODF2;NINL;PSMB8;PCNT;AURKA;PSMA5;PSMD4;PAFAH1B1;PSMB3;RAB11A;PSMD3;CEP192;CDC25C;CETN2;TUBA4A;CEP41
prerank,insulin secretion (GO:0030073),0.47961052733434417,1.3889206825194158,0.1021377672209026,0.3090496587929337,1.0,4/19,10.49%,RIMS2;PTPRN2;MAFA;NEUROD1
prerank,ribosome biogenesis (GO:0042254),-0.32729114903097034,-1.3878984235215335,0.013071895424836602,0.22175667370024557,1.0,74/187,28.41%,RPL7;RPS24;ESF1;MPHOSPH10;RPL36;RPS6;RPL11;ABCE1;RPL10A;DDX49;RPL12;RPS14;EXOSC5;NOP14;RPL32;SENP3;WDR36;NVL;RPS28;NOL6;RPL28;DHX37;KRR1;CUL4B;RPL22;RPL14;RPL34;RPL6;NOLC1;EMG1;DDX31;PAK1IP1;RPL18A;EIF2A;RPL37A;UTP6;RPS9;RPS27;SURF6;MRPL22;RPL23A;RPS16;GTF3A;EXOSC10;RPL9;C1D;RPLP2;NOL9;DDX54;EXOSC4;XRN2;NIP7;RPL41;RPLP0;SNU13;RPL7A;MTREX;RPL19;WDR12;RPS15;RPL39;RCL1;MRM2;RPL5;PDCD11;EIF6;RPL13;IMP4;EXOSC8;NOC2L;RPL18;WDR3;RPL27A;PIH1D2
prerank,cAMP biosynthetic process (GO:0006171),0.6006647283081579,1.3878890042431262,0.10585585585585586,0.30978002000935617,1.0,5/10,8.71%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1
prerank,protein import (GO:0017038),-0.37044608923548467,-1.3875686185990275,0.03125,0.22194251883152905,1.0,28/84,22.37%,APOE;RAB8B;SYK;PEX14;IPO5;NUP50;ABCD2;STAT3;LAMP2;PEX26;NUP88;SNX33;E2F3;FIS1;TPR;NUP188;HSPA4;APPL2;ABCD3;NUP153;TOMM22;FAM53A;TNPO3;APPL1;NUP107;NXT2;NUP62;SPRN
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5254658051846421,-1.3867069364826365,0.09911504424778761,0.22301172423354484,1.0,5/17,13.47%,SASH1;CD36;TRIB1;LY96;NFKBIL1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.4384801982639178,-1.3865225690513103,0.06129597197898424,0.22303354101318487,1.0,13/36,21.99%,SDCBP;OGT;UCHL5;RYBP;RPL11;HSP90AB1;WAC;USP7;TAF9;TRIM39;UBXN1;BAG6;EIF3H
prerank,dendritic cell migration (GO:0036336),-0.525570352723457,-1.3862007744513118,0.10391822827938671,0.2232116601547578,1.0,7/16,19.37%,CCR2;EPS8;CCR1;PIK3CG;CCL5;CXCR4;HMGB1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.40201615353805636,-1.3859046578699934,0.055944055944055944,0.22339922237114646,1.0,17/52,21.54%,CNOT4;DCP1A;TUT7;CNOT1;RC3H1;CNOT2;PATL1;EXOSC5;DCP2;PAN3;CNOT6L;LSM6;CNOT8;DDX6;LSM5;EXOSC4;PNLDC1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3726372452936991,-1.3855383136379513,0.02422145328719723,0.22369738226488084,1.0,23/76,17.95%,ANXA4;IRAK2;SPI1;ARRB2;NLRC5;PRMT2;AIM2;RBCK1;TRAF3;ARRB1;IRAK3;MAP2K5;ERBIN;OTULIN;FOXJ1;NLRC3;NFKBIL1;TMSB4X;NFKBIB;FAF1;USP7;PARP10;CMKLR1
prerank,heart development (GO:0007507),0.3267755716621536,1.3855037067604676,0.007772020725388601,0.31273132164402656,1.0,47/150,19.08%,SGCZ;FGF12;CACNA1C;SGCD;PCSK5;ERBB4;NTRK3;ZFPM2;PRICKLE4;SCUBE1;DLC1;ACVR1;WT1;PLCE1;APLN;FLRT3;CACYBP;NDUFV2;SOX9;BMP7;SALL1;SGCG;DNAAF4;MYH7;POU4F2;MYOCD;POPDC2;TBX1;TGFB2;PKD1;EEF1AKMT4-ECE2;ALPK2;EPHB4;PDLIM4;FLRT2;MKKS;ECE1;ERBB3;RAMP2;TGFBR3;PDLIM7;KAT2A;ZDHHC16;RBM20;TEK;FOXC2;PTK2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5049482689089939,1.3853203899794329,0.10047846889952153,0.31190757791708124,1.0,2/17,1.17%,ANK2;RYR2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5245891795424639,1.3846083709137296,0.10426540284360189,0.31198072392939236,1.0,7/16,16.29%,UPP2;DPYD;DPYS;DPYSL5;DPYSL4;DPYSL3;DPYSL2
prerank,amyloid fibril formation (GO:1990000),-0.4080069933430637,-1.383706803889035,0.056666666666666664,0.22608649023309887,1.0,14/51,15.44%,TSPAN14;CD36;RIPK1;GGA3;TGFBI;USP9X;B2M;UBC;RPS27A;APP;PSENEN;CALCA;MFGE8;CST3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5687750481042455,-1.3836548356660285,0.0773286467486819,0.22590978977464843,1.0,6/13,22.14%,MDFIC;SP100;TPR;NUP153;SUFU;UFM1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5388036103455087,-1.3830567913881373,0.09515260323159784,0.22649681289909582,1.0,2/14,1.96%,ITGA4;ANO6
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.565076394864833,-1.3825643267367396,0.09294320137693632,0.22697897994627036,1.0,4/12,6.87%,APOE;ROCK1;TMED10;PICALM
prerank,regulation of cell-cell adhesion (GO:0022407),0.41312776696645326,1.3822553904333599,0.0625,0.314867441342055,1.0,7/39,4.11%,PTPRG;TENM3;EFNA5;PTPRR;FUT9;EPHA7;AFDN
prerank,regulation of JNK cascade (GO:0046328),-0.3521382445957806,-1.3820144982314337,0.028862478777589132,0.22750617110048998,1.0,30/101,19.94%,MAP3K5;TAOK3;SDCBP;MFHAS1;IGF1R;RAP2A;MINK1;RIPK1;TRAF5;PTK2B;DUSP3;AXIN1;TRAF3;SIRPA;CD27;TAOK1;TRAF1;NCF1;APP;AIDA;GADD45A;FCGR2B;TRAF2;MAP3K10;MMP8;TAOK2;NOD2;HMGB1;COPS5;AGER
prerank,protein deacetylation (GO:0006476),-0.43014132031974733,-1.3818989793416045,0.06495726495726496,0.22740404074328546,1.0,12/41,14.02%,RCOR1;MIDEAS;FLNA;MORF4L1;TBL1XR1;SIRT3;SUDS3;HDAC10;RBM14;MTA3;HDAC5;SIN3A
prerank,mRNA processing (GO:0006397),-0.3161186656084928,-1.38171714339784,0.004418262150220913,0.22738161427665954,1.0,106/287,27.44%,ERN1;CTNNBL1;SON;TRA2B;DDX46;SRRM1;HNRNPA3;DHX9;SF3B6;SMU1;SNRNP35;CRNKL1;CHTOP;SRRT;FUS;SNRPG;HNRNPH1;GCFC2;SNRPF;POLR2H;HNRNPL;CDC40;POLR2F;SPEN;CWC22;RBM19;DDX5;RALY;SF3B3;POLR2L;PRPF8;SART1;CMTR2;SF3B5;UBL5;PCBP2;ALYREF;HNRNPUL1;RPRD2;NUDT21;SNRPA;CELF1;RBM14;CWC15;METTL14;RBM10;WDR33;YTHDC1;POLR2A;NCBP1;PSPC1;SART3;ZRSR2;GEMIN7;PDCD7;THOC2;SF3A1;SRSF10;PRPF18;POLR2G;RBM4B;TFIP11;LSM6;RNPS1;WBP11;SNRNP70;TXNL4A;THOC6;HNRNPA1;PAPOLA;MAGOH;SLU7;BUD13;CPSF3;SF3B1;LSM5;POLR2I;HNRNPH2;GEMIN6;PPIL1;XAB2;HNRNPK;GTF2F2;SNU13;SYF2;SRSF11;NONO;MTREX;RBM22;PRPF6;DHX35;DDX39B;DHX38;AKAP8L;GTF2F1;RBM15B;CPSF1;U2AF2;RAMAC;ISY1;HSPA8;TBRG4;WDR83;HNRNPF;METTL3;BUD31
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.42905599726843624,-1.3816139716424638,0.06932409012131716,0.22728960350853009,1.0,17/40,13.83%,DAB2;CBL;INSR;ANXA2;ARRB2;TBC1D5;WASL;C3;ARRB1;DGKD;HIP1;VEGFA;B2M;CD63;RAB21;SERPINE1;GREM1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6131640078450131,-1.3800652194790493,0.10252100840336134,0.2289515442152781,1.0,4/10,20.25%,MYADM;MAP2K5;MAPK7;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6131640078450131,-1.3800652194790493,0.10252100840336134,0.2289515442152781,1.0,4/10,20.25%,MYADM;MAP2K5;MAPK7;WNK1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.3460756390213789,-1.3800555114531268,0.02258064516129032,0.22870956332092462,1.0,51/125,25.36%,EML4;KIF3B;KIF11;DYNC1H1;KNL1;INCENP;CENPF;DLGAP5;CENPA;EFHC2;KIF4A;PLK2;SUN2;ZWILCH;CENPE;CENPK;CKAP5;CENPN;NEK6;CENPL;BUB1;TAOK1;TBCE;BUB1B;MAP4;SPC25;NUSAP1;KIF2C;DYNC1LI2;TTK;SGO1;MAD1L1;STIL;PCNT;NUF2;AURKA;RPS27;NDC80;CENPH;RCC1;ERCC6L;PAFAH1B1;NUP107;NSL1;PPP1CC;CENPP;CCNB1;CENPO;SPC24;RANBP2;NUDC
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.3407219038737673,-1.3799227127906544,0.012658227848101266,0.22865390923444096,1.0,50/153,23.06%,PRKCH;PRKCB;MAPKAPK3;PAK2;PRKCD;ROCK1;CAMK1D;ERN1;CSNK2A1;VRK2;RIPK1;TLK1;MAPKAPK2;SGK1;DYRK2;MAPK14;ULK2;CAB39;GAS6;PLK2;VRK3;STK38;TGFBR1;NEK6;MASTL;MORC3;CDK1;DYRK1A;MKNK1;TGFBR2;MAST2;MARK2;IKBKB;MAP3K10;TTK;MKNK2;LATS2;PNCK;AURKA;PKN3;ATM;WNK1;GSK3B;CDK5;CSNK1G3;MAST3;MAPK1;RPS6KA5;PRKDC;SMG1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4710686603459336,1.3798154497164865,0.08315098468271334,0.31814143499604575,1.0,10/22,20.35%,PDE4B;DMD;CACNB2;GNB5;FMR1;STAC;CBARP;CRHR1;GPR35;CACNB3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.27734387936566207,-1.379587253856919,0.0,0.22886704874239275,1.0,424/1667,22.11%,PID1;RBPJ;DAB2;APOE;MITF;FNIP2;ZMIZ1;ZEB2;FLI1;ELF4;FOXP1;RUNX1;PRKCB;TRPS1;IGF1;BACH2;TFEB;NAMPT;SP100;TCF4;RCOR1;RREB1;SDCBP;ELF2;LILRB1;REL;LITAF;TRAK1;BCL6;TET3;MIDEAS;RB1;JUN;ZNF568;MEF2A;CREBBP;ACTR2;ETV6;DEK;RUNX3;PPARD;OGT;AGO2;ARID5B;ANXA4;BPTF;ZBTB34;BACH1;TOX2;DNMT3A;NFE2L2;BRD7;PHF20;CCNL1;RNF111;IRF2;ZNF148;ARHGEF2;SBNO2;NFIC;BRD4;NFX1;NFYA;ARID1B;ZSCAN12;ATF3;PAXBP1;ATAD2;ELF1;UBP1;PPARG;CDK13;KDM3A;ELK3;GATAD2A;RNASEL;PIAS1;SMARCA5;RIPK1;MAML1;SPI1;BRCA1;WWP2;JMJD1C;PHF21A;ZNF3;ETV1;CTR9;STAT3;KLF13;FOXO3;MAML2;E2F2;CNOT1;IKZF1;LYL1;TLR4;ZSCAN26;ACTR3;IL18;STAT6;DHX9;USF2;NIPBL;CHD3;NFKB1;CNOT2;HHEX;NLRC5;ZBTB21;RUNX2;SMARCD3;RARG;NFATC2IP;SAP30;MLXIP;IRF5;CRLF3;SARS1;MAF;MEF2B;KLF6;SMARCC2;TCF20;NR1H2;MAPK14;CIITA;JAG1;CUX1;BATF;MDFI;SS18;PF4;SMYD2;NRF1;WASL;HGF;TEF;KDM7A;RHOQ;ETV3;LRP6;NFATC3;ARRB1;KDM3B;TAF6;FUS;ZBTB2;MYNN;MED24;AHR;CTNNB1;TBL1XR1;KLF3;MCPH1;EZH2;RPS14;DPF2;USP9X;STAT5B;STAT4;ATF6;PLAC8;WFS1;NR2F1;CREB3L2;KDM2A;SKI;VEGFA;BHLHE40;MAP2K5;EED;E2F1;SSU72;FIZ1;CNBP;ARID1A;ATMIN;RNF4;FNIP1;HELZ2;SPEN;THAP1;WBP2;CEBPG;E2F3;KMT2C;SP110;SLC9A1;CBFB;ITGB1BP1;MEF2D;PARP9;DDX5;HIF1A;MEF2C;SAP130;ATAD2B;TFEC;MAPK7;OLIG2;MRTFB;UBC;RPS27A;ASXL1;SP140;NUCKS1;EGR1;SUDS3;ARNT;HDAC10;BAZ2B;PROX2;TNIP2;RELA;PIN1;PSMC3;NEDD4L;ZNF569;IKZF3;MOV10;ZBTB20;APP;XBP1;CCNL2;XRCC6;FLCN;TCF25;CDK1;ZNF319;OSR1;TPR;CRK;MLLT10;KLF10;MED4;PRDM2;NFE2;GADD45A;KMT2D;IER2;SALL3;FOXJ1;HTATIP2;ZFP57;ARID3B;CHD8;RBM14;IL4I1;FOSL2;MLLT6;KAT7;BAZ1A;TCF7;HMGB2;ZFP41;SERPINE1;ZFX;UHRF1;FRK;ZBED4;PLK3;MED31;MTA3;ACVR2A;TNRC6C;IRF2BP2;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;TET2;CREG1;E2F8;TFAP4;GREM1;BATF3;SIN3A;CRTC3;LIN37;EPC1;PPP1R12A;CD40;DR1;KLF2;ID2;CKAP2;ZBTB46;PPIL4;TCF3;IKBKB;DOT1L;YY1;POU2AF1;INO80;RELB;TXK;ZMIZ2;NSD1;POGZ;TFCP2;MAVS;AATF;MED13L;KLF8;ZNF177;HR;MRGBP;NUFIP1;HCLS1;NR4A1;BRIP1;ZBTB12;KMT5A;NRIP1;KLF11;IRX5;IKZF4;TNIP3;SOX10;PHF20L1;UBE2I;FOXJ2;AGRN;TAF9;ATXN1;ELP4;VHL;KMT2A;UXT;ZBTB25;TAF3;RARA;NFATC1;CSRNP1;ZBTB24;ATF5;MED6;REPIN1;SMAD7;NR3C1;TFE3;BRD2;GATA3;MYB;RIPPLY2;PPARGC1B;ARID5A;TCF12;NCOA6;RBBP8;HTATSF1;PLAG1;GMEB2;SSBP4;MIER1;CASZ1;ID1;RSF1;DDX3X;MEIS3;HOXD8;LMO2;MDM4;NOD2;HMGB1;HMGB3;COPS5;MED20;WDR77;LCORL;ATM;ELOC;DBX2;MAX;CHP2;SP9;KDM5B;C1QBP;LIN9;SUFU;EHF;BMPR2;RTF1;BRD9;CIC;ZFP28;GLMP;MAML3;RLF;MAZ;SIRT2;PKNOX1;ATF7;ZC3H12A;STAT1;JUP;RAI1;ZFP2;POU3F1;GTF2IRD1;LRRFIP1;ZSCAN21;KDM1A;HOXB2;ZKSCAN1;HAX1;HNRNPK;CCNK;NLRP3;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SNAI2;CEBPB;EGR2;BBX;ZNF296;BARX2
prerank,regulation of autophagosome maturation (GO:1901096),-0.5607962887376867,-1.3793193165994815,0.10638297872340426,0.22900501053740824,1.0,5/13,18.81%,UVRAG;UBQLN4;CLN3;TBC1D25;ADRB2
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.35421185075099176,-1.3789849820005946,0.017973856209150325,0.22923109841823983,1.0,38/109,19.99%,INPP4A;PLCG2;PLEK;PI4K2A;PIK3R5;PLBD1;MTM1;PIP4K2A;MTMR10;SLC27A1;SYNJ1;MTMR3;MTMR14;PITPNM1;PI4K2B;PIK3CB;PIK3CG;PI4KB;RAB5A;IMPA1;PIP4P1;MTMR6;PIK3CA;PLCB3;PIK3CD;PLCD1;PLA2G4A;PLAAT3;PIK3C2A;PLEKHA2;PGAP3;PTPN13;PLEKHA4;PDGFRB;IP6K3;PLA2G5;PLA2G12A;PIP5K1A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.37068860826704664,1.3788394522545346,0.051643192488262914,0.3185737951963997,1.0,9/65,5.80%,KCND2;RORA;SLC8A3;SCN2A;TIGAR;FMN2;SUV39H1;TSC1;OPRD1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.5489948365369427,-1.3784536629061892,0.10283687943262411,0.22977137777347506,1.0,7/14,27.24%,ABCG1;PSENEN;DYRK1A;CLN3;ADAM19;PSEN2;BACE1
prerank,mitochondrial protein processing (GO:0034982),0.5625723871641525,1.3783487025583636,0.12751677852348994,0.31834691316292396,1.0,4/11,11.39%,OMA1;ATP23;IMMP1L;PMPCB
prerank,regulation of secretion (GO:0051046),0.5466814958288791,1.3781940631324474,0.11724137931034483,0.31747268472768686,1.0,8/13,20.54%,NRG1;EGF;MYO6;FGF10;OPRK1;ERBB3;ACSL3;POFUT2
prerank,electron transport chain (GO:0022900),-0.5274493283425622,-1.377700764543265,0.09556313993174062,0.23064961337073553,1.0,2/15,1.82%,ENOX2;POR
prerank,hyaluronan catabolic process (GO:0030214),-0.5057468180543838,-1.377685808842716,0.10720887245841035,0.2304158908180867,1.0,5/18,9.43%,CD44;HEXA;LYVE1;SLC9A1;GUSB
prerank,regulation of chromosome segregation (GO:0051983),-0.5274645309135724,-1.3771931722651818,0.09693877551020408,0.23090764982233347,1.0,9/16,24.23%,CSNK2A1;PUM2;BUB1;MKI67;KIF2C;HORMAD1;SMC6;PUM1;SMC5
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.3898474494388061,-1.3771647303033543,0.05326460481099656,0.23067965663444887,1.0,23/61,24.84%,PANK2;PSME4;PRKAG2;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;NR1H4;OAZ3;NQO1;PSMB1;FGFR4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.5681145672908655,-1.3764196105540418,0.10535405872193437,0.23150219428032986,1.0,3/12,10.70%,CD44;GCNT2;LCK
prerank,positive regulation of hemostasis (GO:1900048),-0.5999503663744196,-1.376332740854804,0.10701754385964912,0.23111625260649593,1.0,6/10,32.21%,HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12
prerank,positive regulation of coagulation (GO:0050820),-0.5999503663744196,-1.376332740854804,0.10701754385964912,0.23111625260649593,1.0,6/10,32.21%,HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5423288329594398,1.3754804271712076,0.11848341232227488,0.32100195502797596,1.0,9/13,25.63%,SAR1B;INSIG1;TMEM30A;GCC2;TM9SF4;CD81;SORL1;SEC16A;BRSK2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5280750949938599,-1.3753714793056808,0.07952622673434856,0.2323473482632949,1.0,4/15,7.23%,DAB2;PIK3CB;WASL;DGKD
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4211636637064291,-1.3752616814951173,0.053726169844020795,0.23225020821032502,1.0,16/39,25.15%,RPS24;RIOK3;RPS6;ERAL1;RPS14;NOP14;RPS28;MRPS11;EMG1;LSM6;RPS27;SURF6;RPS16;SNU13;RPS15;MRPS7
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5811120044382817,-1.3751450735351167,0.11785714285714285,0.23218877276161667,1.0,3/11,0.83%,CD44;CORO1C;RREB1
prerank,response to muscle stretch (GO:0035994),0.5329766990226712,1.3747932048647198,0.11778290993071594,0.3210122766208181,1.0,5/15,11.10%,DMD;RYR2;CDH2;GSN;TTN
prerank,negative regulation of inflammatory response (GO:0050728),-0.32902756915334647,-1.3747524761471186,0.01631321370309951,0.23246016466095223,1.0,31/182,9.62%,LYN;APOE;AOAH;IGF1;FGR;CD163;MFHAS1;SYK;PLCG2;GNB1;PRKCD;MYH9;RB1;ADCY7;TNFRSF1B;PPARD;METRNL;PPARG;TNFAIP8L2;PTGER4;MAPK14;GNG2;GRN;PLK2;SIRPA;MDK;CYSLTR1;RHBDF2;MAPK7;OTULIN;SELENOS
prerank,membrane protein proteolysis (GO:0033619),-0.4248629949998786,-1.374685666171167,0.07960199004975124,0.232314189978806,1.0,18/37,33.37%,MYH9;MBTPS2;NFKB1;ADAM9;CTSH;RELA;PSENEN;HM13;ADAM19;TGFB1;PSEN2;PRTN3;BACE1;NGFR;DAG1;TRAF6;RHBDD1;ERAP1
prerank,regulation of catabolic process (GO:0009894),-0.5115926291582039,-1.3739972491363286,0.1003584229390681,0.23306917949152967,1.0,12/18,34.65%,ITGB1;ZDHHC7;NEDD4L;ZDHHC2;FAP;FAF1;FAM83D;FURIN;CENATAC;RARRES2;TMEM9;HGS
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.4871206308617215,-1.3738332542654759,0.08848080133555926,0.23306283204697364,1.0,6/22,13.07%,STX7;MALT1;CYRIB;B2M;FBXO38;TRAF2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5894414156145833,-1.3737342133441544,0.11804384485666104,0.23296418873462663,1.0,3/11,5.20%,ABCB7;ABCD2;COA8
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5833130825430832,-1.3732478493298548,0.11185308848080133,0.2333742646861394,1.0,6/11,27.63%,RC3H1;ANXA1;SMAD7;ZC3H12A;SOCS5;TBX21
prerank,positive regulation of integrin activation (GO:0033625),-0.5849421987667847,-1.3731980725318298,0.11072664359861592,0.2331874523903588,1.0,3/11,2.79%,PLEK;RAP1B;PIEZO1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5938480320805544,-1.373044217080154,0.09764918625678119,0.2331701789176984,1.0,5/11,29.20%,DHX9;NCBP1;SRPK1;PTCD2;SAFB
prerank,innate immune response in mucosa (GO:0002227),-0.6066160316364321,-1.3727391895531387,0.09982174688057041,0.23331242690006113,1.0,6/10,39.36%,CAMP;DEFA6;RPL39;LTF;NOS2;RNASE3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4823483919957692,-1.3724386649573923,0.11826086956521739,0.23348136554404358,1.0,9/22,24.20%,BRD4;CDK13;ERCC6;EAPP;ALYREF;KAT7;HMGN1;CCNK;DDX39B
prerank,myoblast differentiation (GO:0045445),-0.5566686535578184,-1.3723380269021839,0.10247349823321555,0.23338426005805502,1.0,6/14,9.07%,MBNL1;PLEKHM3;IGF1;RB1;JAG1;DDX5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5746254277640935,-1.3717867002153432,0.11392405063291139,0.23392994963814276,1.0,3/11,5.01%,CD44;CD74;BCL2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.5269958413278937,-1.3717640768050068,0.11591695501730104,0.2337114570016286,1.0,4/16,5.77%,ABCB7;ABCD2;COA8;CIITA
prerank,RNA export from nucleus (GO:0006405),-0.36023702462063617,-1.3706842236960637,0.03672787979966611,0.23503927332889163,1.0,47/100,32.70%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;NUP205;XPO5;UPF2;ALYREF;TPR;NUP188;WDR33;YTHDC1;NCBP1;THOC2;RNPS1;NUP153;THOC6;HNRNPA1;NUP35;MAGOH;SLU7;CPSF3;NUP107;NUP62;SRSF11;SMG1;DDX39B;DHX38;RANBP2;RBM15B;CPSF1;NUP37;U2AF2;SRSF7;AAAS;NUP133;EIF4A3;EIF4E;SRSF5;SARNP;ALKBH5;U2AF1L4
prerank,protein polymerization (GO:0051258),-0.3940627396374648,-1.3704760693618596,0.04929577464788732,0.23514096520887307,1.0,20/56,22.39%,DIAPH1;GAS7;RAC1;PSTPIP2;CENPJ;PSTPIP1;WASL;CKAP5;CORO7;MSRB1;DIAPH3;PIN1;GPX4;CHMP2A;ANG;UBE2C;TTC17;RNF135;CHMP4B;CHMP4A
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.3720032678906368,-1.3703435899011611,0.04470198675496689,0.23505197393106741,1.0,29/83,20.14%,CDK6;RB1;BACH1;BRD4;GSPT1;GPR132;CRLF3;CDK18;PLK2;E2F1;E2F3;CDK14;EIF4EBP1;DBF4;CDKN3;CDC25A;PCNA;CUL4B;CACUL1;PLK3;CUL2;CCNE1;CDC34;LATS2;KLF11;CDKN2C;RCC1;MAX;CDK16
prerank,cellular response to interleukin-1 (GO:0071347),-0.3390820988811732,-1.3702796727082045,0.026446280991735537,0.2348827859379856,1.0,47/143,24.19%,MAP3K8;PSME4;IRAK2;TAB2;PELI1;PSMB7;PSME3;RC3H1;NFKB1;FBXW11;IRAK4;PSMB9;IRAK3;SIRPA;MYD88;NOD1;HIF1A;PSMA8;UBC;RPS27A;GBP2;EGR1;TNIP2;RELA;PSMC3;PSMD8;CCL5;PSMC4;PSMB10;PSMA1;CD40;IKBKB;PSMB8;IL1R2;GBP3;NOD2;PSMA5;PSMD4;PSMB3;PSMD3;SFRP1;ZC3H12A;RPS6KA5;CD47;MAP3K3;CCL7;PSMB1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.42311044717000756,-1.3696455109228565,0.06833333333333333,0.2356106775723169,1.0,7/37,4.91%,APOE;SDCBP;RIN3;OPTN;BRCA1;NFKB1;ITGAV
prerank,prostanoid biosynthetic process (GO:0046457),-0.5326853679574921,-1.3695925619840226,0.10265486725663717,0.2354492727045045,1.0,4/15,14.49%,TBXAS1;CD74;DAGLB;PLA2G4A
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3581538903977015,-1.369318856693506,0.04251700680272109,0.2356100684296261,1.0,19/92,10.65%,SASH1;NRP1;FOXP1;RREB1;PLCG2;RAC1;RIN2;PTK2B;ADAM9;PIK3CB;DOCK5;PIK3CG;NRP2;GRN;VEGFA;ITGB1BP1;HIF1A;CTSH;AGT
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5109564308425867,1.36895928876201,0.12224938875305623,0.3301470364999421,1.0,10/16,26.01%,ANK2;RYR2;BCAP29;BCAP31;TAPT1;GABARAPL2;HSPA5;SEC16A;LRRK2;GBF1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5047436257214654,-1.3688367912386195,0.11284722222222222,0.23610002515116474,1.0,9/20,22.61%,MALT1;IL18;RSAD2;B2M;TRAF2;IL18R1;DENND1B;NLRP3;IL6
prerank,cellular response to growth factor stimulus (GO:0071363),-0.33809874039915727,-1.368645390836471,0.027156549520766772,0.23614117033433388,1.0,64/151,26.84%,IQGAP1;NRP1;CD44;ERN1;MAPKAPK2;RAP1A;MT1G;FLT1;PTPN12;RUNX2;ANXA1;MAPK14;DUSP3;HGF;CTNNB1;STAT5B;VEGFA;MAP2K5;TGFBR1;ITGB1BP1;MEF2C;MAPK7;SPRY2;RELA;CCL5;CIB1;CPNE3;EEF1A1;ACVR2A;TGFBR2;KNSTRN;EHD1;STMN2;CRKL;ACAP2;NR4A1;APPL2;MAP2K3;TWF2;LIMS1;SMAD7;NR3C1;PTPN11;PDCD5;HSPB1;BMPR2;NDNF;APPL1;SIRT2;SFRP1;KDR;RACK1;SNAI2;TGFB1;URI1;LRP2;SHC1;RAB35;INPP5K;SMAD4;BMP2;PDE8A;RAPGEF2;ZFP36L1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.370658856232563,-1.368492859615656,0.03414634146341464,0.23610901268175952,1.0,32/72,27.60%,ERCC6;RFC1;GPS1;POLR2H;POLR2F;POLR2L;UBC;RPS27A;LIG1;PCNA;CUL4B;COPS6;RPA3;RFC2;POLR2A;POLD2;ERCC4;LIG3;HMGN1;USP7;POLR2G;COPS5;RFC3;COPS4;COPS8;POLR2I;XAB2;POLD4;DDB1;XRCC1;ISY1;EP300
prerank,embryonic organ morphogenesis (GO:0048562),0.4009380474795706,1.3678769470470233,0.0625,0.3308571859697816,1.0,12/42,17.23%,RYR2;HOXC4;SOX11;ACVR1;DSCAML1;HOXD3;NEUROD1;TBX1;HOXC9;HES1;FUZ;ALDH1A3
prerank,translesion synthesis (GO:0019985),-0.4225761812551757,-1.3677952997878782,0.06844741235392321,0.23688407258965785,1.0,18/42,26.84%,POLE2;RFC1;PRIMPOL;PCLAF;UBC;RPS27A;PCNA;RPA3;RFC2;POLD2;ISG15;PARP10;POLN;RFC3;TRIM25;POLD4;POLDIP2;VCP
prerank,Golgi to plasma membrane transport (GO:0006893),-0.40806553980356247,-1.3669183904942397,0.07092198581560284,0.23800282469937553,1.0,20/47,21.24%,OPTN;GOLGA4;RAB31;GGA3;MACF1;EXOC4;GOLPH3L;OSBPL5;VPS35L;SYS1;RABEP1;ARFGEF2;RAB10;ARL3;VAMP4;EXOC2;RAB34;EXOC6;GOLGA7;BLZF1
prerank,mesenchymal to epithelial transition (GO:0060231),0.5717324093628257,1.3667796816013005,0.12529002320185614,0.3315339989550669,1.0,4/10,9.62%,PAX8;WT1;SALL1;CITED1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.4642444296402174,-1.3667779575962458,0.09183673469387756,0.23796479040973428,1.0,5/25,10.13%,NELFB;BRD4;CDK13;EAPP;RNF8
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.596048933655971,-1.3666933414232976,0.11091549295774648,0.23782080146686588,1.0,4/10,21.23%,NAMPT;TLR4;NOD2;KDR
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5336155116038838,-1.3664653615290732,0.12612612612612611,0.23789293852224158,1.0,7/14,44.74%,ADAM8;IL6;PTGER3;TNF;IL1B;IL6ST;OSM
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.44822766840364464,-1.3662392011957496,0.07570422535211267,0.23796756633888486,1.0,8/29,12.00%,RUNX1;BRCA1;CNOT1;CNOT2;AXIN1;WBP2;CBFB;KMT2D
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5204315572890668,-1.366109052880418,0.11552346570397112,0.23789406005587566,1.0,8/16,20.76%,RB1;NIPBL;NAA50;MAU2;POGZ;SGO1;SMC1A;PDS5B
prerank,protein localization to vacuole (GO:0072665),-0.5462244700466733,-1.3654216468329605,0.11655405405405406,0.23869573098943783,1.0,8/13,34.24%,MFSD1;RNF128;SH3GLB1;LMBRD1;GLMP;KPTN;ATP13A2;SH3BP4
prerank,JNK cascade (GO:0007254),-0.42334509037917556,-1.3652197003426978,0.08739495798319327,0.23875607929531215,1.0,11/40,9.70%,MAP3K5;MAP4K3;MINK1;IRAK2;TAB2;PTGER4;GPS1;TRIB1;NOD1;UBC;RPS27A
prerank,regulation of blood coagulation (GO:0030193),-0.4621038188765534,-1.3648815935335965,0.07446808510638298,0.23903359980481012,1.0,13/27,36.81%,APOE;HPSE;TFPI;FAP;SERPINE1;APOH;ADTRP;ST3GAL4;F2R;F12;CAV1;HRG;FOXA2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5700081768229399,-1.3644811799462073,0.1038961038961039,0.23939867257308614,1.0,3/11,7.48%,ATF3;MBTPS2;ATF6
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.45921790886231395,-1.363968328444036,0.0905982905982906,0.23990752761462877,1.0,5/27,4.70%,PID1;PRKCB;PRKCD;PIP4K2A;PTPRE
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.38603454737520315,-1.3639237593056495,0.055248618784530384,0.23970902744755215,1.0,28/64,22.33%,CORO1C;CDK6;CD36;ROCK1;RHOA;PEAK1;PLAU;MINK1;PTK2B;DAPK3;MACF1;JAG1;DUSP3;PIK3CB;UTRN;NF2;SLC9A1;ADAM15;CIB1;RASA1;PLEKHA2;BST1;CSF1;GSK3B;SFRP1;JUP;MAP4K4;CD3E
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5968594375546221,-1.3632716910972484,0.12477396021699819,0.24040137762395364,1.0,3/10,4.50%,LRP1;PTPRJ;PTPN12
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.5074238769789884,-1.3628739053208203,0.0976027397260274,0.2407726213244451,1.0,9/19,22.16%,MPP1;CAMK1D;MDK;CCL5;IL34;BST1;CMKLR1;CSF1;MAPK1
prerank,I-kappaB phosphorylation (GO:0007252),-0.5853682172947302,-1.3627409599282931,0.12203389830508475,0.24070731322162678,1.0,2/10,4.11%,TLR7;TLR4
prerank,regulation of centrosome duplication (GO:0010824),-0.44884013698225217,-1.3624847851583013,0.0859504132231405,0.24082384686808417,1.0,16/30,26.34%,PDCD6IP;CENPJ;CEP295;CHMP5;PLK2;CEP295NL;GEN1;CHMP1A;CHMP2A;STIL;XRCC3;CCNF;CHMP4B;PKHD1;CHMP2B;ALMS1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.4473640532331919,-1.3620712585016115,0.0823327615780446,0.24118171413786563,1.0,13/33,21.47%,RUNX1;CD74;FES;RIPK1;CCR1;PF4;ACIN1;ID2;IL34;HCLS1;CASP8;CSF1;HAX1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4184338099134826,-1.3617093344254745,0.04513888888888889,0.24147360267173745,1.0,13/43,11.63%,GRB2;CBL;RAB7A;PTPRJ;SH3KBP1;CDC42;SNX6;TSG101;DUSP3;MVP;EPS15;SPRY2;STAM2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3233869557378608,-1.361477562247317,0.011041009463722398,0.24160199004739727,1.0,42/182,14.80%,APOBEC1;APOE;FOXP1;RUNX1;MSR1;IGF1;NOTCH2;SDCBP;RIN3;REL;XDH;RB1;AGO2;OPTN;ZNF148;SPI1;WWP2;CCR1;PARP14;NFKB1;PTPN22;TIPARP;PICALM;MYADM;VEGFA;CD28;PARP9;HIF1A;MEF2C;MOV10;APP;FLCN;MAP2K1;CELF1;CD46;HSP90AB1;TNRC6C;SLC7A5;SETDB1;ID2;FLOT2;YY1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5826141624851086,1.3608967268988215,0.14553990610328638,0.3408768702564212,1.0,5/10,20.86%,ADGRV1;TSKU;WHRN;PDZD7;PLS1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5015888871018505,-1.3608864893498906,0.09107142857142857,0.2421765932985529,1.0,7/19,14.66%,APOE;IGF1;ROCK1;GGA3;PICALM;PIN1;FLOT2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.5294952097915512,-1.3607383950920084,0.10947712418300654,0.2421479296495194,1.0,11/15,40.70%,PRKCD;SIRT3;SPHK2;PLA2G6;RACK1;SAMD8;ORMDL2;ORMDL3;TNF;SPHK1;ORMDL1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.3639595130709009,-1.3604809114598502,0.034653465346534656,0.2422726050017939,1.0,36/88,28.30%,RAC1;RHOA;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;AP2A2;VANGL1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;SPEF1;PSMA1;VANGL2;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;SMURF2;DVL2;PSMB1;PKHD1;AP2S1;PFN1;FZD1;FZD7;SMURF1;AP2A1;DAAM1;CELSR1;PSMA7
prerank,negative regulation of defense response (GO:0031348),-0.36984621164906695,-1.3602649459798914,0.04786324786324787,0.24235419737567904,1.0,17/77,9.62%,APOE;AOAH;MFHAS1;PRKCD;RB1;PPARD;METRNL;PPARG;DHX58;TNFAIP8L2;PTGER4;IRAK3;PPM1B;SIRPA;MAPK7;OTULIN;SELENOS
prerank,positive regulation of neuron differentiation (GO:0045666),0.4002139482320509,1.359730580167084,0.08083140877598152,0.34193363088025747,1.0,11/40,12.75%,BRINP3;BRINP1;SOX11;NRCAM;ZEB1;VWC2;HOXD3;ADRA2C;NEUROD1;NBL1;REST
prerank,negative regulation of innate immune response (GO:0045824),-0.42526328462702234,-1.3596021020545908,0.08404802744425385,0.24312781395335273,1.0,10/34,13.11%,SAMHD1;YTHDF3;USP18;DHX58;NLRC5;IRAK3;GRN;NLRC3;OAS3;VSIG4
prerank,insulin receptor signaling pathway (GO:0008286),-0.369502459392712,-1.3592066051118725,0.06097560975609756,0.24346731630603052,1.0,22/69,20.56%,ATP6V0D2;NAMPT;BCAR3;GRB2;ATP6V1E1;INSR;IGF1R;ATP6V1A;TCIRG1;AP3S1;RHOQ;BAIAP2;ATP6V1G1;ZNF106;PIK3CA;ATP6V0B;PIK3C2A;ATP6V0E1;IRS2;GSK3B;ATP6V0D1;APPL1
prerank,inner ear morphogenesis (GO:0042472),0.46575980469574296,1.3589528463679013,0.091324200913242,0.3421068009821392,1.0,6/22,12.82%,PAX8;MYO6;SOX9;TFAP2A;TBX1;TMIE
prerank,melanocyte differentiation (GO:0030318),-0.5756485331348764,-1.358704804647605,0.10616438356164383,0.24398590853531,1.0,4/11,11.94%,MITF;LRMDA;MEF2C;SLC24A5
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.38069349256532103,-1.358562837487691,0.0587248322147651,0.24392710426930583,1.0,24/65,23.38%,NRROS;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRED1;SPRY2;PIN1;SPRED2;HTRA3;TGFBR2;LDLRAD4;VASN;HSPA1A;SMAD7;IL17RD;SMURF2;ZBTB7A;EID2;TGFB1
prerank,intestinal lipid absorption (GO:0098856),-0.583410178739626,-1.3584957182934552,0.10956521739130434,0.24375483001647436,1.0,3/11,19.56%,CD36;LIMA1;LDLR
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.46945528556843863,-1.3583674281252311,0.0981067125645439,0.24368865283987187,1.0,10/24,21.40%,NR1H2;TXNDC12;WFS1;SELENOS;XBP1;TMBIM6;HSPA1A;UBXN1;LPCAT3;RACK1
prerank,positive regulation of cell migration (GO:0030335),-0.31009587789284704,-1.357640791570244,0.007776049766718507,0.24456939374600803,1.0,76/253,21.91%,DAB2;PTPRC;NEDD9;NRP1;IGF1;FGR;RREB1;CCR2;SDCBP;PLCG2;MGAT5;AGO2;INSR;IGF1R;ARHGEF2;PLAU;S100A11;STAT3;CCR1;FLT1;NIPBL;ITGB1;PTK2B;RUFY3;KIF20B;ADAM9;ELP5;SEMA4A;FN1;DOCK5;HGF;MYADM;GCNT2;GRN;SUN2;VEGFA;CBLL1;MDK;TGFBR1;HIF1A;CTSH;NCKAP1L;SPRY2;ITGAX;XBP1;ARHGEF39;F7;CXCL16;CCL5;CIB1;CPNE3;SEMA4B;PIK3CD;MIA3;SEMA3D;CRKL;STX4;CLDN1;SPAG9;PDGFRB;TRADD;F10;ATM;CSF1;C1QBP;BMPR2;RAB11A;MAZ;FERMT3;KDR;PDGFA;RACK1;SEMA3B;SMURF2;SNAI2;MAP4K4
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.46724731541407405,-1.3572930901740896,0.08673469387755102,0.24484350643499736,1.0,11/25,27.13%,TRA2B;SRRM1;MPHOSPH10;SF3B3;PRPF8;SRSF10;TXNL4A;SLU7;SF3B1;PRPF6;WDR83
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.483756986681269,-1.3572721577668527,0.10387323943661972,0.24461572107337307,1.0,7/22,10.78%,IGF1;ROCK1;MEF2A;P2RX4;SLC9A1;AGT;MTPN
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.47204688513148124,1.3561409087252885,0.11538461538461539,0.34624185910144006,1.0,5/20,8.49%,HECW1;PRKCE;HECW2;CASQ2;NEDD4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.4192547429205041,1.3557811683625978,0.0525,0.3456795891081811,1.0,10/39,8.69%,FGF12;ANK2;CHRM3;SCN2B;TCAF1;AHCYL1;PTPN3;HOMER1;NEDD4;FXYD6
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.4128302595791332,-1.3550305867121506,0.06239168110918544,0.24761540055836284,1.0,21/42,43.28%,CCR2;CCR1;PTK2B;PF4;CCL5;CIB1;WNK1;CCL7;CCL24;CCL4;CCL25;CCL19;ACKR3;CCL8;CXCL9;CXCL1;SH2B3;CCL14;RBM15;CXCL10;OXSR1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.5043628449386988,-1.354728947250716,0.11672473867595819,0.24782905370649838,1.0,8/18,28.79%,APOE;MSN;CTSC;RNF128;FAF1;ABCA2;VPS11;PTTG1IP
prerank,regulation of interleukin-13 production (GO:0032656),-0.5482764264872527,-1.353501690270567,0.13937282229965156,0.249478774584602,1.0,7/13,18.85%,IL18;TNFRSF21;SPHK2;RARA;LILRA5;GATA3;LGALS9
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.4746611270496365,-1.3529743193316557,0.09385665529010238,0.25001264597796713,1.0,8/24,14.13%,LYN;CCR2;ANO6;CCR1;CCL5;SERPINE1;GREM1;PLA2G7
prerank,plasma membrane repair (GO:0001778),-0.54725723704949,-1.3527220534511386,0.10877192982456141,0.250133637858424,1.0,4/13,6.20%,MYOF;MYH9;ARL8B;AHNAK2
prerank,positive regulation of developmental growth (GO:0048639),0.3853012783677009,1.3522546720523796,0.07042253521126761,0.35102946009513886,1.0,9/49,10.14%,RIMS2;RIMS1;PLCB1;SYT1;CDKL5;SYT2;BDNF;POU4F2;GHRH
prerank,regulation of protein kinase A signaling (GO:0010738),0.47337344585989516,1.3522417507934854,0.12322274881516587,0.3498485226290075,1.0,9/20,24.60%,AKAP6;RAMP3;ADGRV1;PJA2;PRKAR1A;IAPP;PRKAR2B;PRKAR1B;LRRK2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.42428316551887985,-1.3518354501172456,0.06993006993006994,0.2512572008160257,1.0,12/39,11.63%,GRB2;CBL;PTPRJ;SH3KBP1;CDC42;PTPN12;TSG101;DUSP3;MVP;EPS15;SPRY2;STAM2
prerank,regulation of developmental growth (GO:0048638),-0.4527780567928691,-1.3516637762832109,0.09262435677530018,0.25122479401454856,1.0,9/29,16.15%,APOE;IGF1;DNM2;INSR;NIPBL;STAT5B;APP;SIN3A;LATS2
prerank,T-helper cell differentiation (GO:0042093),-0.5431363213977793,-1.3515789423319493,0.12216404886561955,0.25109174152760516,1.0,4/14,5.95%,FOXP1;ATP7A;PTGER4;BATF
prerank,outflow tract septum morphogenesis (GO:0003148),0.45689933703981106,1.3515414419577696,0.08374384236453201,0.34999851147544486,1.0,6/24,10.93%,ROBO1;ROBO2;ZFPM2;ACVR1;TBX1;TGFB2
prerank,sphingosine metabolic process (GO:0006670),-0.5106176146871488,-1.3508956559849685,0.11379310344827587,0.2519434008442967,1.0,12/17,40.34%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;PLPP3;ABCA2;ACER2;SPHK1;PLPP2;PLPP1;SGPP1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.44071481784416816,-1.350813894401401,0.0800711743772242,0.25181369899159245,1.0,10/33,11.72%,BCAR3;CBL;ARAP1;DGKD;HIP1;PLAUR;AFAP1L2;AGT;NCF1;CCDC88A
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.433767850528751,-1.350746631429669,0.08375209380234507,0.25140020367046034,1.0,17/32,30.34%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;RANBP2;NUP37;AAAS;NUP133
prerank,tRNA export from nucleus (GO:0006409),-0.433767850528751,-1.350746631429669,0.08375209380234507,0.25140020367046034,1.0,17/32,30.34%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;RANBP2;NUP37;AAAS;NUP133
prerank,positive regulation of dendritic spine development (GO:0060999),0.4769008201572444,1.350516419425657,0.10311750599520383,0.35065100261309406,1.0,7/20,10.87%,NLGN1;SHANK3;CUX2;FMR1;CAPRIN2;CPEB3;RELN
prerank,cellular protein catabolic process (GO:0044257),-0.3853831090846595,-1.3502513081640015,0.05565217391304348,0.2519335107324195,1.0,19/59,18.40%,CTSB;CTSZ;RAB7A;MALT1;RIPK1;MYLIP;TCIRG1;AP2A2;CTSC;RNF123;CTSH;FAP;CTSS;AFG1L;DENND3;UBE2G1;BNIP3L;CASP8;RAB12
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.5797965312560056,-1.3489223293706336,0.11169284467713787,0.25379987220389927,1.0,5/11,20.43%,PRDX5;PRDX1;PRDX2;CAT;PXDNL
prerank,cellular protein modification process (GO:0006464),-0.27777877676625945,-1.3487466600305051,0.0,0.2538208166073265,1.0,278/983,22.68%,F13A1;LYN;PTPRC;APOE;PRKCH;FNIP2;PPM1H;MAP3K5;B4GALT5;TAOK3;PRKCB;FGR;FAM20C;DAPK1;SYK;ZC3HAV1;PAK2;CDK6;PRKCD;ROCK1;MAP4K3;PTPRJ;BIRC6;ST3GAL1;DDB2;PPP4R2;RUNX3;MAP3K1;ST8SIA4;ERN1;FBXW8;DAPP1;MAP3K20;INSR;MAN2A1;MTM1;PEAK1;CSNK2A1;PSME4;PRKAG2;VRK2;CDK13;RNASEL;MINK1;MAML1;TLK1;ATG5;ABL2;MAPKAPK2;WWP2;SGK1;GRK3;DYRK2;PSMB7;TEC;ALG5;PSME3;ATG7;MTMR3;RAB1A;COG7;PARP14;PTPN12;PIM1;PTK2B;FBXO32;PTPRE;ATG10;FBXW11;UBXN7;PTPN22;MSRA;DAPK3;ANXA1;PARP4;TIPARP;PSMB9;STK3;KLHL25;FUT10;FBXL20;TRIOBP;DCAF10;FN1;C3;MACROD1;KLHL22;GCNT2;CDK18;NUB1;IRAK3;LRRC41;GAS6;CAMKK2;GRK5;DCAF8;PPM1B;WFS1;PLK2;GPS1;PPP1CA;EIF2AK2;SDHAF2;COQ8A;STK38;WDR5;TGFBR1;RAB5A;TRIB1;JAK1;CDK14;NEK6;UBA7;MPI;PARP9;HIF1A;PTPN6;PARP8;RSKR;MORC3;SIRT3;ATE1;SPSB2;PSMA8;MTMR6;UBE2L3;SUMF2;SIK1;TRIB2;PTP4A2;TGM2;CP;B3GNT2;TAOK1;UBL5;PSMC3;DUSP11;LCK;SEPHS1;APP;SPSB3;B4GALT7;DUSP6;CDK1;DYRK1A;RAB11B;MAP2K1;PPP4R1;CUL4B;HSP90B1;PSMD8;ASB5;SERP1;STK11;COPS6;IGFBP3;STK17B;FBXO10;FRK;LGALS1;STK24;PSMC4;MKNK1;PSMB10;ACVR2A;SOCS6;PIK3CD;GMFG;TNKS2;TGFBR2;PADI4;MAST2;FBXW2;MIA3;CUL2;MARK2;PSMA1;METAP1D;PPP1R12A;LARGE1;IKBKB;SPP1;GMFB;TXK;CCNE1;KLHL42;MFGE8;NPC1;PIGH;CDC34;CST3;SSH1;MKNK2;RAB13;LATS2;APLP2;STRADA;ISG15;RABGGTA;ASB4;UBE2I;PSMB8;DNAJC3;FBXL8;VHL;CDKL4;SKP2;WSB2;AURKA;PARP10;ZAP70;MAN2B1;RARA;GNMT;FBXO7;PTPRO;BRD2;PKN3;RYK;HCK;HCST;SOCS3;PTPN13;STK10;PMM2;TAOK2;DUSP5;IP6K3;UBE2M;SHISA5;MAK;PPEF1;PAK6;RABGGTB;COPS5;ATM;ELOC;FBXO31;CSF1;PSMA5;PSMD4;CHEK1;BMPR2;CDC42BPG;CDK16;STT3B;PSMB3;FBXO22;F5;WNK1;GSK3B;RAB11A;BAP1;COPS4;FBXW4;SIRT2;PTPN1;PSMD3;COPS8;CDK5;CSNK1G3;ILKAP;PRKAG1;GRK6;SRPK1;SOCS5;MAP4K4;MANBA;CCNF;MAPK1;RPS6KA5;FEM1B;ILK;NEK3;PTPN7;IL6;CD247;FUT4
prerank,RNA modification (GO:0009451),-0.3872475764783859,-1.3485565384707667,0.06587837837837837,0.25386953502065623,1.0,25/54,35.14%,NSUN3;METTL1;ELP5;PUS7;ALKBH1;NSUN4;ANKRD16;QTRT1;TRMT6;ADAT2;TYW5;AARS1;THUMPD1;BCDIN3D;RBM15B;MRM2;METTL3;THG1L;CTU2;FTSJ1;CTU1;TRMT61A;ADARB1;PUS7L;CDKAL1
prerank,mesenchymal cell differentiation (GO:0048762),-0.394303606773201,-1.3484665663300215,0.06440677966101695,0.2537375289309634,1.0,23/51,29.33%,RBPJ;ROCK1;HTR2B;FBXL17;HGF;LRP6;CTNNB1;TGFBR1;DDX5;HIF1A;MEF2C;LIMS1;FAM83D;GSK3B;S100A4;HEYL;SNAI2;TGFB1;TRIM28;BMP2;ENG;LEF1;DDX17
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5799698130677855,-1.347390205572504,0.1267123287671233,0.2552057812963916,1.0,5/10,26.27%,LRP6;CTNNB1;RYK;WNT3;FZD1
prerank,regulation of cell killing (GO:0031341),-0.5215698006622131,-1.3472522713876602,0.11552346570397112,0.25515713681681645,1.0,2/16,1.55%,CYBA;RAC1
prerank,granulocyte differentiation (GO:0030851),-0.5091710760860071,-1.3471340767245834,0.09930313588850175,0.2550871842896515,1.0,9/18,28.56%,DEK;SPI1;CBFA2T3;E2F1;RXRA;RARA;PML;EP300;LEF1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.3961048006781173,-1.3470675470894462,0.07931034482758621,0.2549318325470847,1.0,19/51,22.61%,CCR2;ANO6;IL6R;CCR1;GAS6;VEGFA;MDK;F7;CCL5;SERPINE1;PLA2G7;IL34;CMKLR1;LGALS9;HMGB1;CSF1;C1QBP;MAPK1;IL6
prerank,nucleotide-excision repair (GO:0006289),-0.34649252884417836,-1.347039682443582,0.03333333333333333,0.2547240160595096,1.0,36/101,22.36%,DDB2;RNF111;ERCC6;RFC1;GPS1;POLR2H;ATXN3;POLR2F;POLR2L;UBC;RPS27A;LIG1;PCNA;CUL4B;COPS6;RPA3;RFC2;POLR2A;POLD2;ERCC4;LIG3;SLX4;HMGN1;BRIP1;USP7;POLR2G;COPS5;MMS19;RFC3;COPS4;COPS8;POLR2I;CETN2;FAN1;XAB2;POLB
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5136799467059199,1.3462287275165543,0.13551401869158877,0.35749873189128367,1.0,3/15,5.01%,MAGI2;IGSF1;ACVR1
prerank,nucleoside catabolic process (GO:0009164),0.5524537419631859,1.3461018517511087,0.12761020881670534,0.3565187420636064,1.0,3/11,3.75%,UPP2;DPYD;DPYS
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.5238910778751859,-1.3458476392102443,0.11206896551724138,0.25629679208561335,1.0,10/15,36.48%,KYNU;KMO;KYAT1;IL4I1;QDPR;IDO2;HGD;FAH;HAAO;TAT
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.39775216753857434,-1.3457649393458837,0.07118055555555555,0.25615949748613465,1.0,20/46,26.48%,FOXP1;IGF1;PPARG;IL6R;IL18;CTNNB1;TRIB1;XRCC6;IGFBP3;CCL5;ID2;ANG;PDGFRB;RBPMS2;STAT1;IL6;PRKDC;HMOX1;CCN4;VIP
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4972538030522689,-1.3454862579392433,0.12062937062937062,0.25631940982140033,1.0,5/18,9.25%,ITGA4;PPARG;FLT1;MDK;MEF2C
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5099888540158024,-1.344986511715597,0.113345521023766,0.2568594824766256,1.0,4/17,3.81%,APOE;IGF1;ROCK1;GGA3
prerank,regulation of superoxide anion generation (GO:0032928),-0.5394456183850365,-1.3447168347122171,0.12758620689655173,0.25699585673914527,1.0,8/14,28.39%,SYK;PRKCD;ITGB2;AATF;TGFB1;ITGAM;CD177;FPR2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.3994385427207046,-1.3441703860440923,0.06228373702422145,0.25739380661138245,1.0,23/50,26.25%,AGO2;NUP50;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;PUM1;RANBP2;NUP37
prerank,regulation of gene silencing by RNA (GO:0060966),-0.3994385427207046,-1.3441703860440923,0.06228373702422145,0.25739380661138245,1.0,23/50,26.25%,AGO2;NUP50;NUP42;NUP88;RAE1;POLR2H;PUM2;POLR2F;POLR2L;NUP205;TPR;NUP188;POLR2A;EIF4G1;POLR2G;NUP153;NUP35;NUP107;POLR2I;NUP62;PUM1;RANBP2;NUP37
prerank,tRNA modification (GO:0006400),-0.3796905633836253,-1.343642575263495,0.058419243986254296,0.2579667649043897,1.0,21/62,24.41%,OSGEP;METTL1;ELP5;PUS7;ALKBH1;ANKRD16;PUS1;TRMT44;QTRT1;MOCS3;METTL6;TRMT6;ADAT2;TYW5;AARS1;THUMPD1;BCDIN3D;METTL2B;METTL2A;TYW1;THADA
prerank,negative regulation of gene expression (GO:0010629),-0.302943833068731,-1.3430438197444952,0.007716049382716049,0.25864317196662107,1.0,86/302,22.34%,APOE;PTBP3;ATP2B1;FOXP1;RUNX1;MSR1;IGF1;NOTCH2;DAPK1;REL;XDH;RB1;ERN1;AGO2;GAPDH;DNMT3A;ZNF148;SPI1;WWP2;CCR1;CNOT1;PARP14;SRGN;NFKB1;PTGER4;PTPN22;DAPK3;TIPARP;PUS7;PICALM;MYADM;EZH2;JARID2;VEGFA;EIF2AK2;EED;DCP2;RPS13;PCIF1;CD28;PARP9;HIF1A;MEF2C;MOV10;APP;FLCN;MAP2K1;CELF1;CD46;TMBIM6;FCGR2B;TNRC6C;DHX36;SLC7A5;SETDB1;EPC1;ID2;FLOT2;YY1;CRKL;NCL;SHQ1;RBBP4;VHL;AURKA;PARP10;HSPA1A;LSM6;TOB1;RPS3;MMP8;LGALS9;DDX3X;NDFIP2;CNOT8;DDX6;LSM5;SFRP1;ZC3H12A;LSM14A;KDR;RACK1;SHMT1;RPS6KA5;CD3E;ANXA7
prerank,negative regulation of translational initiation (GO:0045947),-0.5495056339332984,-1.3429171865556546,0.12141652613827993,0.2585805064240632,1.0,6/13,11.56%,AGO2;EIF2AK1;EIF4EBP1;EIF4EBP2;EIF3E;TPR
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.499719269928532,-1.3428064406869626,0.13908450704225353,0.25850429639744543,1.0,9/18,24.60%,CD300A;SKI;MORC3;B4GALT7;NLRC3;PARP10;SFRP1;FTH1;MYC
prerank,RNA processing (GO:0006396),-0.3235620419328871,-1.3423130997288548,0.030063291139240507,0.25905521231711776,1.0,57/176,24.73%,APOBEC1;MBNL1;RBM39;RBMS1;SON;SRRM1;RNASEL;TUT7;RBPMS;MPHOSPH10;SMU1;SNRNP35;FUS;SNRPG;HNRNPH1;SNRPF;HNRNPL;SF3B3;TSEN54;PRPF8;FASTKD2;DUSP11;HNRNPUL1;MTPAP;NUDT21;CELF1;RBMS2;NCBP1;ZRSR2;PDCD7;PPIG;SF3A1;PPP1R9B;NUFIP1;PRPF18;ATXN1;TFIP11;LSM6;RNPS1;TENT4B;SCNM1;MAGOH;SLU7;SF3B1;RBM3;LSM5;NOL9;DDX54;HNRNPK;XRN2;SRPK1;SRSF11;NONO;TARDBP;PRPF6;DDX39B;AKAP8L
prerank,cellular glucose homeostasis (GO:0001678),-0.4113244250333212,-1.3413914335882025,0.09106239460370995,0.26026609319316724,1.0,10/41,11.08%,LRRC8D;ERN1;IGF1R;TRA2B;GAS6;HIF1A;NUCKS1;HK3;ZBTB20;XBP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.553231892195514,-1.341264222099079,0.11538461538461539,0.2602454176514123,1.0,3/12,5.01%,CD44;CD74;BCL2
prerank,modulation by symbiont of host process (GO:0044003),-0.5817229159097255,-1.3411861361942725,0.12935323383084577,0.26010224152540595,1.0,4/10,9.70%,MRC1;B2M;UBC;RPS27A
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.36925606230066194,-1.3410971016711721,0.06518010291595197,0.2599840832208198,1.0,24/72,21.68%,DDB2;DCP1A;RFC1;RNASE4;REXO4;UBC;RPS27A;DNASE1L1;RNASE6;PCNA;CUL4B;FEN1;RPA3;RFC2;POLD2;ERCC4;DDX1;DNA2;ENPP1;HORMAD1;RFC3;ZC3H12A;FAN1;XRN2
prerank,diol biosynthetic process (GO:0034312),-0.5297048890922752,-1.340817519314281,0.1256544502617801,0.26020587493886066,1.0,8/15,25.05%,SPTLC2;ACER3;GCH1;SPHK2;QDPR;SPTLC3;ASAH1;ABCA2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5047548384999848,-1.340778788822529,0.11631944444444445,0.2600199743185823,1.0,7/18,15.91%,ITGA4;ROCK1;ITGB1;ITGB7;PODXL2;GCNT1;SPN
prerank,regulation of focal adhesion assembly (GO:0051893),-0.38702104648290214,-1.3405584535632242,0.06631762652705062,0.26013649468656574,1.0,13/54,8.99%,NRP1;CORO1C;RAC1;ROCK1;PTPRJ;RHOA;PEAK1;DAPK3;MACF1;DUSP3;VEGFA;SLC9A1;ITGB1BP1
prerank,negative regulation of cell junction assembly (GO:1901889),0.4577615832104209,1.3405024303762145,0.11510791366906475,0.3658559290895033,1.0,6/25,5.44%,ROBO2;ARHGAP6;SLIT1;CLASP2;DLC1;APOD
prerank,actin filament network formation (GO:0051639),0.5633663365475678,1.3394074681033563,0.13176470588235295,0.3667668665553484,1.0,6/11,15.56%,CARMIL1;CARMIL2;SPIRE1;COBL;FHOD3;PLS3
prerank,regulation of macroautophagy (GO:0016241),-0.346852263996118,-1.33891456706214,0.04926108374384237,0.26248079719171546,1.0,37/105,25.56%,ATP6V0D2;ATP6V1E1;ERN1;GNAI3;GAPDH;PRKAG2;ATP6V1A;SNX6;SNX5;EXOC4;USP36;ATP6V1G1;VPS26B;RRAGD;SESN1;PIK3CA;VPS26A;SH3GLB1;RB1CC1;ATP6V0B;WAC;CAPNS1;CLN3;ATP6V0E1;BNIP3L;TBC1D25;RHEB;ATP6V0D1;KDR;CDK5;PRKAG1;SNX32;SMG1;DCN;QSOX1;LAMTOR1;LAMTOR3
prerank,neuron projection development (GO:0031175),0.31168480883852856,1.3385909523647441,0.03888888888888889,0.36711360277895094,1.0,37/168,12.42%,CNTNAP2;NLGN1;GRM7;MAP2;CTNND2;CNTN4;DCLK1;NYAP2;MYO16;GPM6A;RASGRF1;PAK3;SH3GL2;NEFH;PLP1;TMEM108;EPB41L3;BICDL1;GDNF;EPHB1;SHANK3;GPM6B;BDNF;FLRT3;ADGRV1;NCKAP1;TOR1A;NEDD4;BMP7;SRGAP2;TSKU;WHRN;NBL1;CDK5R1;TNIK;ATXN10;FRY
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5317150005945994,-1.3384351142084934,0.11964285714285715,0.26298098033114803,1.0,7/14,16.82%,CD74;LILRB1;PLCG2;LAPTM5;TICAM1;MAVS;GPRC5B
prerank,positive regulation of ruffle assembly (GO:1900029),0.521747608935425,1.3378135786219068,0.13513513513513514,0.3673122359526212,1.0,4/13,5.46%,NLGN1;FAM98A;P2RY12;CARMIL2
prerank,regulation of cellular response to heat (GO:1900034),-0.3639773539794232,-1.337706700359073,0.05638474295190713,0.26386490038331467,1.0,30/77,27.60%,CREBBP;NUP50;MAPKAPK2;NUP42;NUP88;RAE1;YWHAE;NUP205;TPR;HSP90AB1;NUP188;RPA3;HSPH1;BAG3;DNAJC2;HSPA1A;NUP153;NUP35;ATM;GSK3B;DNAJB6;NUP107;DNAJC7;NUP62;MAPK1;CRYAB;RANBP2;NUP37;HSPA8;EP300
prerank,regulation of secretion by cell (GO:1903530),0.3745266745137797,1.3376633011896681,0.09113300492610837,0.3663717513771015,1.0,9/54,3.78%,RIMS2;RIMS1;STXBP5L;SYT1;RAB3C;CPLX1;SNCAIP;SYN1;RAB15
prerank,regulation of autophagosome assembly (GO:2000785),-0.4250115765156163,-1.3370464436411083,0.0779436152570481,0.26454322263599583,1.0,13/33,25.71%,NUPR1;MTM1;PIP4K2A;IFT20;MTMR3;RAB3GAP1;RAB5A;SH3GLB1;RALB;CHMP4B;CHMP4A;RAB1B;LRSAM1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.40763537020419877,-1.3367411042118462,0.07986688851913477,0.2647699857757493,1.0,15/42,21.27%,RFC1;PRIMPOL;PCLAF;UBC;RPS27A;WRN;PCNA;RPA3;RFC2;POLD2;ISG15;PARP10;POLN;RFC3;TRIM25
prerank,cellular response to peptide (GO:1901653),-0.38653019160955415,-1.3355712174413008,0.0711864406779661,0.26643260657685214,1.0,17/56,11.08%,ITGA4;IGF1;VIM;LRP1;CD36;IGF1R;ARHGEF2;TLR4;CHMP5;SNX6;PTPN22;CASP4;NOD1;ABCC1;APP;TIMELESS;XBP1
prerank,tRNA processing (GO:0008033),-0.376280025499976,-1.3355089328846055,0.06802721088435375,0.26626527047798476,1.0,30/61,35.14%,FARS2;ADAT1;METTL1;SARS1;ELP5;TSEN54;ANKRD16;QTRT1;TRMT6;ADAT2;KARS1;DDX1;TYW5;AARS1;THUMPD1;ELAC2;RPP40;CPSF1;ZBTB8OS;THG1L;CTU2;POP1;FTSJ1;CTU1;TRMT61A;TRNT1;RTCB;TRMT10B;PTCD1;CDKAL1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5880961543615313,-1.3354639130733448,0.12244897959183673,0.265800850013077,1.0,6/10,36.08%,CDC42;CDC42EP2;CDC42EP3;CDC42EP5;APC;CCR7
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5880961543615313,-1.3354639130733448,0.12244897959183673,0.265800850013077,1.0,6/10,36.08%,CDC42;CDC42EP2;CDC42EP3;CDC42EP5;APC;CCR7
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.35474660637609434,-1.3347410889716798,0.05116279069767442,0.2667515513786111,1.0,28/88,21.40%,FNIP2;SDCBP;SYK;PLEK;RAB7A;BCL2L11;PDCD6IP;SPIDR;TSG101;VEGFA;FNIP1;CDC42EP2;SDC4;CHGA;TPR;SH3GLB1;CHMP2A;BRK1;SLX4;FAF1;BID;RPS3;HAS3;SYNPO;GSK3B;VPS4A;MMP1;RACK1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4372941269523203,1.333979625680988,0.12530712530712532,0.37211237715602047,1.0,8/28,17.35%,MAP2;MAP1B;MAPRE3;CLASP2;GAS2L2;ARL2;PRUNE1;MAP1A
prerank,neural tube development (GO:0021915),0.5083671294299057,1.333844942182095,0.15217391304347827,0.3711178155059692,1.0,4/15,11.93%,SOX11;ARL13B;PKD1;HES5
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.43055875229020857,-1.3337720891037628,0.10157618213660245,0.26806377764279826,1.0,12/30,28.79%,CD44;CD74;RTEL1;TPT1;DYRK1A;TMEM161A;RPS3;KDM1A;SNAI2;DDX39B;BCL2L1;PTTG1IP
prerank,positive regulation of cellular component organization (GO:0051130),-0.34534192254220364,-1.3336767232258326,0.05396825396825397,0.2679602261647369,1.0,14/107,2.64%,DAB2;APOE;FNIP2;RUNX1;PLEKHM2;ASAP1;SYK;LRP1;RB1;BCL2L11;SPIDR;INSR;ABCB7;IGF1R
prerank,positive regulation of blood coagulation (GO:0030194),-0.5057159257120055,-1.3334806898272247,0.1289198606271777,0.2680236168489232,1.0,11/17,43.77%,ANO6;HPSE;SERPINE1;APOH;ST3GAL4;F2R;F12;HRG;F3;THBD;ENPP4
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.29610085910284706,-1.3334122192894815,0.011976047904191617,0.2678765374686235,1.0,94/348,22.78%,IQGAP1;LYN;DAB2;PTPRC;NRP1;FNIP2;CD44;BANK1;IGF1;BCAR3;CD74;SDCBP;PLCG2;PAK2;NIBAN1;RAC1;ITGA5;PTPRJ;SNX9;INSR;ARHGEF2;RAP2A;PRKAG2;RIPK1;IL6R;RAP1A;TAB2;IL15;TEC;RBPMS;CCND3;PTK2B;AXIN1;HGF;C3;ARRB1;CAB39;GAS6;CAMKK2;ALS2;VEGFA;CENPE;FNIP1;PLAUR;TGFBR1;SPRY2;PIN1;AGT;APP;XRCC6;FLCN;WDFY2;CAMKK1;CLEC6A;HSP90AB1;CACUL1;CIB1;ACVR2A;LCP2;RB1CC1;CD40;IL34;EIF4G1;CRKL;TTK;MAVS;CSPG4;HCLS1;MAP2K3;RALB;KRAS;PTPN11;TAOK2;DDX3X;RSPO1;JTB;CSF1;GDF3;AGER;BMPR2;NBN;KDR;PDGFA;RACK1;HAX1;PRKAG1;MAPK1;RPS6KA5;INHA;FGF18;ILK;S1PR2;IL6;APLNR
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.41516103857151204,-1.3329450709606891,0.0919931856899489,0.26833829856521335,1.0,14/39,26.43%,FXYD5;JAG1;MYADM;NF2;VEGFA;MAP2K5;MAPK7;MIA3;ASS1;WNK1;TGFB1;ADTRP;SPINT2;BMP2
prerank,homologous chromosome segregation (GO:0045143),0.4736830038593771,1.3325834707792803,0.12406947890818859,0.37238508832899453,1.0,6/20,14.25%,ZCWPW1;FMN2;PTTG1;IHO1;MEIKIN;MEIOB
prerank,positive regulation of DNA repair (GO:0045739),-0.3921999719441831,-1.3325289121974848,0.06608695652173913,0.2687372649927194,1.0,21/46,19.37%,SPIDR;BRCA1;ERCC6;DHX9;ABRAXAS1;EYA4;BABAM2;CEBPG;MGMT;RNF8;HDAC10;TIMELESS;PCNA;BABAM1;TMEM161A;EYA1;EYA3;RPS3;WRAP53;BRCC3;HMGB1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.3616052305622442,-1.3322838333991254,0.05892857142857143,0.268863895612631,1.0,29/73,28.38%,DEK;DNMT3A;SMARCA5;SPI1;ERCC6;ACTB;EZH2;JARID2;POLR2H;EED;POLR2F;WBP2;POLR2L;ZFP57;HDAC5;EPC1;RBBP4;SPHK2;TAF1A;POLR1F;SF3B1;SMYD5;BAZ1B;POLR1C;EP300;POLR1E;MYBBP1A;CREBZF;CGGBP1
prerank,cellular iron ion homeostasis (GO:0006879),-0.3927453109008356,-1.3322028150199383,0.06960950764006792,0.2687189914126178,1.0,31/55,42.07%,FTL;IREB2;ABCB7;FRRS1;ATP6V1A;TMEM199;HMOX2;FLVCR1;ATP6V1G1;CP;SLC11A2;ATP6V0D1;CYB561A3;HMOX1;FTH1;MYC;SMAD4;LCN2;ATP13A2;ATP6AP1;SLC11A1;ABCB6;TFR2;HAMP;GLRX3;CCDC115;NEDD8;CUL1;ACO1;NUBP1;HFE
prerank,cellular response to oxidative stress (GO:0034599),-0.33775865332730515,-1.3320083279792276,0.056105610561056105,0.26877279701617296,1.0,36/118,23.54%,CYBB;DAPK1;CYBA;PRKCD;JUN;NFE2L2;VRK2;FOXO3;SLC25A24;NUDT2;MSRA;GSR;CAMKK2;HIF1A;SELENOS;PRDX5;ARNT;NCF1;NCF4;PRDX1;NCF2;MPV17;TMEM161A;PRDX2;RAD52;STX4;HSPA1A;RPS3;CAT;RBM11;SIRT2;ZC3H12A;MAPK1;SRXN1;HMOX1;ERO1A
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4772306627933323,-1.331604705400212,0.12897526501766785,0.26913593233208755,1.0,4/19,4.21%,IGF1;NUPR1;TNFRSF1B;IL18
prerank,cyclooxygenase pathway (GO:0019371),-0.5878271494978877,-1.3311642422141754,0.1310592459605027,0.2695816785830114,1.0,2/10,12.84%,TBXAS1;CBR1
prerank,regulation of exosomal secretion (GO:1903541),-0.4911042233435634,-1.3310447095824467,0.13559322033898305,0.2694969579398307,1.0,6/19,14.44%,SDCBP;RAB7A;PDCD6IP;TSG101;SDC4;CHMP2A
prerank,regulation of protein modification process (GO:0031399),-0.3928695265109198,-1.330929878257211,0.09122203098106713,0.2694003506777358,1.0,13/50,11.72%,LYN;FNIP2;CORO1C;ATG7;ATG10;FN1;PUM3;FNIP1;SPRED1;PIN1;FLCN;SPRED2;CCDC88A
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.3925245673736424,-1.330763424227241,0.07678883071553229,0.26937737683779667,1.0,21/47,27.09%,RREB1;PPARD;METRNL;PPARG;PIM1;MEDAG;LPL;XBP1;WDFY2;ID2;TFE3;CMKLR1;GDF3;SFRP1;ZC3H12A;CEBPB;ADIG;ZBTB16;BMP2;ZFP36L1;ZBTB7B
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.29910285623442834,-1.3306406457274529,0.01694915254237288,0.2693231737485188,1.0,115/314,27.66%,WWP1;RB1;BFAR;NFE2L2;PSME4;ARRB2;WWP2;FBXL17;AMFR;AREL1;PELI1;PSMB7;ANAPC1;TNFAIP1;PSME3;RHBDD2;FBXW11;PSMB9;FBXL20;RBCK1;ARRB1;KLHL22;UBR2;CTNNB1;TBL1XR1;ZFAND2A;WFS1;KCTD10;ZSWIM8;ATXN3;RNF4;ERLIN1;FBXO38;DNAJB9;SPSB2;PSMA8;SELENOS;UBC;RPS27A;DNAJB14;DERL1;PSMC3;KIF14;UBE4B;NEDD4L;SEL1L;SPSB3;PCBP2;CDK1;CUL4B;HSP90B1;PSMD8;MAEA;BUB1B;PSMC4;PSMB10;RNF185;CUL2;PSMA1;RNF34;KLHL42;UBE2G1;RNF216;CDC34;FAF1;UBE2C;PSMB8;FBXL8;SKP2;AURKA;ANAPC7;RNF121;HUWE1;DCAF12;UBXN1;FBXL6;FBXO31;PSMA5;PSMD4;STT3B;PSMB3;FBXW4;FOXRED2;SIRT2;PSMD3;SGTA;TRIM25;FAF2;BAG6;SMURF2;CCNF;MAN1B1;HECTD3;TOPORS;FEM1B;CCNB1;TRIM72;ZNRF1;KCTD2;PSMB1;EDEM1;RNF187;DDB1;SPOP;CLOCK;SIAH2;FBXL19;SMURF1;PML;VCP;CUL3;DCAF11;COP1;TBX21;UBE4A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4967031321027161,-1.3297573038563437,0.12086092715231789,0.2701778909106243,1.0,7/17,19.53%,STAT3;STAT5B;JAK1;IL2RG;IL7R;IRS2;IL7
prerank,cellular response to interleukin-7 (GO:0098761),-0.4967031321027161,-1.3297573038563437,0.12086092715231789,0.2701778909106243,1.0,7/17,19.53%,STAT3;STAT5B;JAK1;IL2RG;IL7R;IRS2;IL7
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5476400471426844,1.329472174899136,0.17903930131004367,0.37718234875642503,1.0,1/10,0.67%,ANK3
prerank,tRNA transport (GO:0051031),-0.42197215362065116,-1.3293757900169854,0.08983050847457627,0.2705056586894781,1.0,18/35,30.34%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;NUP35;NUP107;NUP62;TOMM20L;RANBP2;NUP37;AAAS;NUP133
prerank,protein deacylation (GO:0035601),-0.46275964614179543,-1.3290178040657574,0.11993243243243243,0.27080762888397525,1.0,8/23,22.00%,ABHD17C;SIRT3;HDAC10;HDAC5;SIN3A;SIRT2;PPT1;LYPLA1
prerank,glucose import (GO:0046323),-0.5369263059629105,-1.3282498525095743,0.13780918727915195,0.2717697677962838,1.0,3/13,7.63%,SLC27A1;SLC2A1;ZDHHC7
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3903924425977725,-1.328238389355858,0.09262435677530018,0.27152222609790927,1.0,17/47,27.39%,TAOK3;IGF1R;RAP2A;EIF2AK2;TAOK1;MAP2K1;GREM1;TAOK2;LGALS9;NOD2;COPS5;AGER;MAP4K4;MAPK1;MYC;MID1;MAPK8IP3
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.45259283765576247,-1.3281580460136349,0.11657559198542805,0.27139941228193304,1.0,6/26,8.82%,PLEK;RAC1;ROCK1;CDC42;PTGER4;SLC9A1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.47077043334471225,-1.3280324877864442,0.122040072859745,0.271349642238169,1.0,8/21,8.82%,CORO1C;ROCK1;RHOA;PEAK1;DAPK3;MACF1;DUSP3;SLC9A1
prerank,ncRNA transcription (GO:0098781),-0.5454365477629047,-1.3279270223015447,0.1234991423670669,0.2712403484605445,1.0,7/13,18.73%,SNAPC2;SPIN1;NIFK;USPL1;ANG;SNAPC3;GTF3A
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5756435580261436,-1.3279216906642333,0.13513513513513514,0.27098593340455945,1.0,4/10,18.28%,PIBF1;PARP14;NF2;SOCS3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4721281332827302,-1.3276780946800963,0.12545454545454546,0.27109974908404577,1.0,7/20,12.70%,CDK6;CTR9;HSPA9;PTK2B;PF4;PRMT1;CIB1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4399594614869089,1.3276467354739019,0.10930232558139535,0.3793822622465682,1.0,6/27,5.24%,TMEFF2;TJP1;ARHGAP6;CLASP2;DLC1;SHANK3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.45054746141689433,-1.3269195899751414,0.12629757785467127,0.2720444240928968,1.0,9/26,20.56%,BIRC3;CD36;IRAK3;NFKBIL1;FLOT2;OTUD4;APPL2;GPR108;APPL1
prerank,mRNA modification (GO:0016556),-0.4733079282924107,-1.3268395263584263,0.11643835616438356,0.27190993860310086,1.0,8/22,15.81%,PUS7;CBLL1;PCIF1;PUS1;METTL14;VIRMA;TRMT6;WTAP
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3137463705168625,1.326789360032165,0.026737967914438502,0.3797444522976356,1.0,40/152,17.09%,ADGRB3;ADGRL3;CHRM2;ADCY2;GRM8;ADCY8;GNAO1;LGR5;GPR37;P2RY12;ADCY5;RAMP3;GNAI1;ADRA1B;GABBR1;ADCY3;PTH1R;ADGRL2;ADCY1;CORT;GPR3;GHRH;CALCB;LPAR2;LGR4;NPY1R;GNAZ;HTR1B;ADRA1D;ADGRG1;GPR26;PRKACB;GNAL;OPRK1;ADGRB2;OPRL1;IAPP;RAMP2;ADGRL4;CRHR1
prerank,regulation of synapse organization (GO:0050807),0.43432772405821257,1.3263522029312547,0.12331838565022421,0.37931790534442517,1.0,3/26,2.26%,CTNNA2;IL1RAPL1;CDKL5
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5540249695711602,-1.3261046570342487,0.1433389544688027,0.2727915002685601,1.0,6/13,24.86%,KPNA4;IPO5;KPNA3;CBLB;NUP35;RANBP2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5858934306079272,-1.3261039960264023,0.145985401459854,0.2725320752636331,1.0,9/10,38.87%,CDC42;KNSTRN;RACGAP1;SIRT2;CCNB1;ECT2;RCC2;APC;NEK2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.4609206644478899,-1.3261037394445294,0.11072664359861592,0.2722707789306862,1.0,17/25,33.62%,LYST;CHMP5;TMEM50A;CHMP7;CHMP1A;UBXN6;CHMP2A;LEPROTL1;LAPTM4B;RILP;CHMP4B;CHMP4A;CHMP2B;VCP;MVB12A;VPS4B;VTA1
prerank,AMP metabolic process (GO:0046033),-0.5404642011405653,-1.326020032624428,0.15703971119133575,0.2721484244876286,1.0,3/13,8.98%,XDH;NUDT2;ADSS1
prerank,pre-replicative complex assembly (GO:0036388),-0.3770178637361821,-1.3252230381340095,0.07093425605536333,0.2731977919327218,1.0,21/64,20.83%,PSME4;PSMB7;PSME3;PSMB9;MCM6;PSMA8;UBC;RPS27A;MCM3;PSMC3;PSMD8;ORC5;PSMC4;PSMB10;PSMA1;MCM2;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3
prerank,histone ubiquitination (GO:0016574),-0.4715850202218837,-1.3251760287942789,0.12886597938144329,0.27300864937504965,1.0,13/21,31.77%,CTR9;RNF20;UBR2;RNF8;UHRF1;WAC;HUWE1;DTX3L;UBE2N;RNF40;UBE2E1;UBE2U;UBE2A
prerank,leukocyte tethering or rolling (GO:0050901),-0.5052082377493224,-1.325127266620889,0.12758620689655173,0.27282222785868593,1.0,7/17,15.91%,ITGA4;ROCK1;ITGB1;ITGB7;PODXL2;GCNT1;SPN
prerank,lipid catabolic process (GO:0016042),-0.48469656500015895,-1.3250079518165643,0.11392405063291139,0.27275875137098243,1.0,8/18,29.61%,LPL;PLAAT3;SIRT2;PPT1;LIPE;MT3;LIPH;HSD17B14
prerank,response to histamine (GO:0034776),0.5663705055501,1.3248308959308404,0.16279069767441862,0.3811519775793937,1.0,4/10,7.52%,GABRB3;GABRB1;GABRB2;GABRG2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.38759373105407735,-1.324748831766274,0.09540636042402827,0.27288617022063266,1.0,19/55,20.83%,PSME4;PSMB7;PSME3;GPR132;PSMB9;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;AVEN;PSMA1;PSMB8;AURKA;ATF5;PSMA5;PSMD4;PSMB3;PSMD3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.551294258629095,1.324561296067584,0.14831460674157304,0.3804415047027513,1.0,2/11,2.57%,CACNA2D1;CACNB2
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3820496638048158,-1.324311156183307,0.08166666666666667,0.2733215887607049,1.0,12/59,10.98%,MAP3K5;PRKCD;JUN;NFE2L2;RIPK1;ANXA1;CAMKK2;SIRPA;MAPK7;PRDX5;RELA;NCF1
prerank,regulation of glucose import (GO:0046324),-0.4303570625489841,-1.3242859628777321,0.1035653650254669,0.27309679150881094,1.0,12/30,20.56%,PID1;OSBPL8;IGF1;INSR;PRKAG2;RHOQ;SELENOS;APPL2;IRS2;PTPN11;ENPP1;APPL1
prerank,regulation of sensory perception of pain (GO:0051930),0.553221710281688,1.3242447111581332,0.15384615384615385,0.37980051280171395,1.0,4/11,10.55%,CCN3;SPX;TMEM100;ZFHX2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.5005018910430173,1.3231865603534962,0.1396508728179551,0.3804768217511351,1.0,5/15,12.03%,NTRK3;CDH13;VEGFD;PGF;SCG2
prerank,protein localization to cell junction (GO:1902414),0.4577431197770744,1.3231248145210197,0.13963963963963963,0.37937341104690603,1.0,3/22,1.75%,NLGN1;TJP1;PCLO
prerank,chromosome organization (GO:0051276),-0.3430332667829385,-1.3228606183631142,0.06010016694490818,0.2751176086516444,1.0,32/99,24.96%,DDB2;HHEX;TOP2A;EZH2;PWWP3A;RAE1;GPS1;RFWD3;UBC;RPS27A;NUCKS1;HDAC10;CUL4B;COPS6;HMGB2;HDAC5;PADI4;DOT1L;HMGN1;NUF2;LRWD1;NDC80;CENPH;COPS5;COPS4;COPS8;MTHFR;CETN2;ZBTB7A;HDAC8;MYC;DDB1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5555750389045938,-1.3228076354245704,0.14388489208633093,0.2749349391391658,1.0,4/11,9.97%,ATP6V1A;ATG7;TMEM199;ATP6V1G1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5642762448156146,-1.322599018772492,0.12367491166077739,0.274979990610642,1.0,7/11,32.83%,MAP3K5;PRKCD;STK24;CYP1B1;DIABLO;GSKIP;STK25
prerank,maturation of SSU-rRNA (GO:0030490),-0.42469365600534686,-1.3224448522501386,0.10124333925399645,0.2749347956928974,1.0,11/34,18.70%,RPS8;RIOK3;RPS14;NOP14;RPS28;DHX37;MRPS11;NGDN;UTP6;LSM6;RPS16
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4790016720514384,-1.3223520688407617,0.13582342954159593,0.27480312020683134,1.0,11/20,30.66%,PID1;DAB2;RHOQ;PICALM;PPFIA1;TMEM59;TGFB1;PPP2R5A;LZTFL1;BCL2L1;ABI3
prerank,regulation of vacuole organization (GO:0044088),-0.4819658495023328,-1.3219045000994858,0.12647554806070826,0.275206961359188,1.0,5/20,8.68%,ANXA2;MTM1;IFT20;MTMR3;RAB5A
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4420523646170865,-1.3216714049394123,0.1174496644295302,0.2753099654774137,1.0,8/26,10.11%,CCR2;HPSE;BRCA1;SARS1;C3;SULF2;HIF1A;ARNT
prerank,regulation of smooth muscle contraction (GO:0006940),0.4714232344724349,1.3215603353645045,0.14617169373549885,0.3812979881559958,1.0,7/20,15.27%,KCNB2;CHRM2;CHRM3;PLCE1;MYOCD;ZDHHC21;SETD3
prerank,regulation of protein kinase B signaling (GO:0051896),-0.3156420555209059,-1.321450970104298,0.02694136291600634,0.2754221070576812,1.0,40/193,12.70%,OSBPL8;BANK1;GRB2;GAB2;MFHAS1;XDH;AXL;RAC1;PTPRJ;HPSE;PIK3R5;INSR;IGF1R;P2RX4;PIK3AP1;VAV1;ARRB2;RNF41;IL18;ITGB1;PIK3CB;HGF;PIK3CG;GCNT2;GAS6;HIP1;FRS2;TGFBR1;RCN3;CD28;ITGB1BP1;ADAM8;SPRY2;LCK;STRN;FLCN;PIK3CA;F7;HSP90AB1;CIB1
prerank,monocyte differentiation (GO:0030224),-0.5738582472169078,-1.3207404584956037,0.1310344827586207,0.2762962077661358,1.0,5/10,15.67%,MYH9;PPARG;MT1G;VEGFA;IL31RA
prerank,regulation of double-strand break repair (GO:2000779),-0.41591505194919676,-1.320554764387992,0.10608695652173913,0.2763396790029962,1.0,16/39,21.39%,PPP4C;PPP4R2;ACTR2;DEK;SPIDR;RNF169;RTEL1;RAD51;MGMT;TIMELESS;RAD51AP1;WRAP53;SHLD2;TRIP12;CHEK1;KDM1A
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4489446548356899,1.3200327617051462,0.135632183908046,0.3830116880678264,1.0,5/25,3.38%,B3GALT1;FUT9;NDST4;B3GALT5;NDST3
prerank,regulation of peptide hormone secretion (GO:0090276),0.3488827906423161,1.319582420505457,0.06,0.382621793269039,1.0,16/67,16.07%,HTR2C;CACNA1C;CACNA1E;KCNC2;SNAP25;PAX8;ADRA2C;NEUROD1;RAPGEF4;FFAR1;PER2;SYT7;KCNS3;RFX3;GRP;PRKCA
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.44261047046528534,-1.319471392137616,0.12413793103448276,0.27778472910159696,1.0,5/28,4.70%,PID1;PRKCB;PRKCD;PIP4K2A;PTPRE
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2892944726326716,-1.3194357091570703,0.004431314623338257,0.27757221623116096,1.0,124/423,24.84%,PID1;RBPJ;LYN;PTPRC;PRKCH;FOXP1;IGF1;NAMPT;CD74;GAB2;SDCBP;CDK6;ACER3;HPSE;INSR;IGF1R;CSNK2A1;C5AR1;CDK13;IL6R;HTR2B;IL15;EAPP;IL18;FLT1;TCIRG1;DHX9;DPP4;PIM1;PTK2B;ITGAV;BCL2;KIF20B;RPS6;STX3;FN1;SLC35F6;CHTOP;GCNT2;GAS6;EZH2;GRN;GRK5;VEGFA;NME1;E2F1;MDK;CNBP;RPS15A;BST2;PRMT1;TGFBR1;ITGB1BP1;PTPN6;MEF2C;TBC1D8;CTSH;NES;RPS4X;RELA;KIF14;AGT;ITGAX;IL7R;XBP1;OSR1;KMT2D;CCL5;CACUL1;CIB1;GLP2R;TGFBR2;GREM1;S100A6;ID2;CAPNS1;DOT1L;IL34;CRKL;TTK;IL31RA;BST1;HCLS1;CNOT6L;STX4;RPS9;IRS2;RARA;KRAS;SERTAD1;HCK;PDGFRB;MEIS3;NOD2;RBPMS2;IL7;WDR77;CSF1;CHP2;CNOT8;PRC1;MAZ;SFRP1;TIPIN;STAT1;KDR;PDGFA;KDM1A;TBX2;FGF18;S1PR2;IL6;KITLG;TGFB1;HMOX1;CD47;MAP3K3;FGF9;FLT3;SHC1;MYC;PKHD1;RNF187;FGFR4
prerank,multivesicular body assembly (GO:0036258),-0.42867648122975555,-1.3194199748231008,0.12413793103448276,0.27733688247199767,1.0,17/30,34.65%,PDCD6IP;CHMP5;TSG101;CHMP7;CHMP1A;STAM2;CHMP2A;RAB11A;VPS4A;CHMP4B;CHMP4A;CHMP2B;MVB12A;VPS4B;IST1;VTA1;HGS
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3017144304079678,-1.3191482721475671,0.02050473186119874,0.27748940637011993,1.0,38/245,10.46%,IQGAP1;PTPRC;APOE;NRP1;CD44;TAOK3;IGF1;NOTCH2;BCAR3;CD74;MFHAS1;PLCG2;CD36;ROCK1;PTPRJ;PIK3R5;INSR;IGF1R;C5AR1;ARRB2;HTR2B;RAP1A;CCR1;FLT1;PTK2B;PTPN22;PIK3CG;ARRB1;GCNT2;GAS6;EZH2;VEGFA;EIF2AK2;LAPTM5;GSDME;ADAM8;SPRY2;TAOK1
prerank,regulation of macrophage differentiation (GO:0045649),-0.5109313193366312,-1.3191335640056263,0.14380165289256197,0.27725459182050577,1.0,8/15,22.25%,RIPK1;PF4;ID2;IL34;C1QC;CASP8;CSF1;INHA
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.549657375650673,1.3188973315583732,0.15789473684210525,0.382677899360013,1.0,2/11,6.77%,AKAP6;KCNIP2
prerank,connective tissue development (GO:0061448),-0.4160555708006587,-1.3168314028160104,0.08947368421052632,0.2806949257786975,1.0,9/35,11.08%,CD44;SH3PXD2B;NAMPT;SPTLC2;ARID5B;ATP7A;CREB3L2;SULF2;XBP1
prerank,sensory perception of chemical stimulus (GO:0007606),0.4925019344511437,1.3168260509456866,0.1509433962264151,0.3855260770028027,1.0,6/15,14.29%,SLC24A4;SYT10;ADCY3;UBR3;MKKS;GNAL
prerank,regulation of cytokinesis (GO:0032465),-0.35747822212122715,-1.3164761177831545,0.057724957555178265,0.28102547404767264,1.0,25/78,22.50%,ZFYVE26;BIRC6;RHOA;SVIL;UVRAG;CDC42;KIF20B;KIF23;PLK2;PIN1;KIF14;FLCN;PLK3;SH3GLB1;E2F8;RACGAP1;KIF20A;AURKA;PRC1;CSPP1;RAB11A;VPS4A;CETN2;ZFYVE19;BECN1
prerank,regulation of protein ubiquitination (GO:0031396),-0.3390594670085283,-1.3155726157648493,0.043689320388349516,0.28216200365945765,1.0,27/108,19.34%,SASH1;BIRC3;OGT;MALT1;BRCA1;ARRB2;AXIN1;ARRB1;WFS1;LAPTM5;DNAJA1;TGFBR1;UBE2L3;SPRY2;PRMT3;DERL1;UBE3A;HSP90AB1;NSMCE3;ISG15;TBC1D7;HSPA1A;SMAD7;RPS3;HUWE1;NDFIP2;UBXN1
prerank,regulation of gene expression (GO:0010468),-0.27339701196934446,-1.3154686915820144,0.0,0.2820610863494905,1.0,250/903,23.12%,PID1;RBPJ;LYN;PTPRC;MBNL1;APOE;AHNAK;MITF;PTBP3;FOXP1;RUNX1;MSR1;IGF1;NOTCH2;TFEB;MSN;CD74;RREB1;LILRB1;P2RX7;PLCG2;REL;XDH;BCL6;AFF4;CDK6;RB1;CD36;ROCK1;DNM2;CREBBP;RUNX3;AGO2;BACH1;NFE2L2;MBNL2;INSR;IRF2;ZNF148;APBB2;SBNO2;SON;NFX1;TRA2B;NFYA;NSD3;SPI1;BRCA1;FOXN2;AFF1;WWP2;JMJD1C;CTR9;STAT3;CCR1;LYL1;TLR4;ZSCAN26;PARP14;RYBP;CHD3;RC3H1;RNF20;STAP1;NFKB1;SAP30;PTPN22;DAPK3;TIPARP;GPBP1L1;MAPK14;CIAO3;TAPBP;PF4;RPL11;PIK3CB;ZC3H7B;AHNAK2;TRAF3;FN1;GON4L;CRIP1;SRRT;FUS;PICALM;MYADM;GCNT2;AHR;HNRNPH1;GAS6;MBNL3;GCFC2;EZH2;USP36;REXO4;POFUT1;HNRNPDL;EDF1;VEGFA;HNRNPL;PUM2;BHLHE40;SIRPA;E2F1;MYD88;CNBP;TGFBR1;THAP1;CD28;PARP9;METTL4;HIF1A;LARP4;MEF2C;SLC8A1;CTSH;SERPINB9;FOXN3;NFKBIZ;UBE2L3;EGR1;HDAC10;HP1BP3;SPRY2;RELA;PIN1;ITGAX;MOV10;APP;MYOM1;PCBP2;FLCN;OSR1;MAP2K1;NUDT21;TICAM1;CELF1;PRDM2;KMT2D;CD46;HNRNPLL;SPIN1;MLLT6;KAT7;TCF7;TRIM68;SPTY2D1;TNRC6C;HDAC5;PIK3CD;DHX36;YTHDC1;CALCOCO1;POLR2A;ZNF326;SLC7A5;RPL6;TRIM11;SETDB1;PSPC1;BTG1;ANKRA2;ID2;SART3;TCF3;FLOT2;ZNF628;YY1;TXK;NSD1;POGZ;DTNBP1;CRKL;NKAPL;TRIM14;SRSF10;HCLS1;ATXN1;ADAM19;VHL;CASP8;AURKA;PARP10;HSPA1A;TOB1;TDRD7;KRAS;ATF5;LIMS1;SNRNP70;NR3C1;GATA3;TOB2;MYB;MARF1;PPARGC1B;RPS3;PLAG1;TRIM39;CXXC1;MMP8;CASZ1;LGALS9;PDCD5;NUP35;DDX3X;PAK6;SLC38A2;NDFIP2;ATM;CSF1;NFKBID;WNT3;SUFU;GSK3B;UBAP2;GRSF1;MAZ;C1D;NUP107;ATF7;SFRP1;ZFPL1;ZC3H12A;POU3F1;GTF2IRD1;KDR;HNRNPH2;ZSCAN21;RACK1;HNRNPK;PRKAG1;MEGF8;RBM38;SNAI2;CEBPB;MAPK1;RPS6KA5;CD3E;ANXA7;FGF18;IL6;APLNR;CHD7;NONO;ESR2;IFNGR1;SOX7;MEFV;TARDBP
prerank,regulation of cardiac muscle contraction (GO:0055117),0.40992148761634023,1.3151275024546791,0.10681818181818181,0.3877004981060356,1.0,9/34,13.07%,PDE4B;ANK2;RYR2;PDE4D;ATP1B1;CALM1;ADRA1A;CALM3;CALM2
prerank,aorta morphogenesis (GO:0035909),-0.48717599369220466,-1.3143632945567023,0.15539305301645337,0.2836212953995477,1.0,3/17,5.78%,RBPJ;LRP1;JAG1
prerank,negative regulation of neuron differentiation (GO:0045665),0.448340302412958,1.3143535480612758,0.12866817155756208,0.38804707861525456,1.0,8/22,17.30%,CNTN4;SOX9;BMP7;POU4F2;HES5;REST;HES1;HES3
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.43254761713438683,-1.313979837384357,0.10050251256281408,0.28399973634840486,1.0,17/31,33.35%,ERN1;OPTN;HSPA9;ATXN3;DNAJB14;TMBIM6;BAG3;HSPA1A;HSPA2;PTPN1;HSPA13;HSPA8;HSPA1B;STUB1;DNAJC18;RHBDD1;DNAJB12
prerank,cellular response to oxygen levels (GO:0071453),-0.5680334235372365,-1.3137473551540133,0.13568773234200743,0.28413915711707877,1.0,9/10,41.67%,ATP6V1A;TMEM199;ATP6V1G1;ATP6V0D1;CPEB4;ATP6AP1;PICK1;CCDC115;NDUFS2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4116725239639518,-1.3134498796908394,0.10851419031719532,0.2843473306906902,1.0,12/37,22.50%,NUPR1;BCL2L11;BCL2;GSDME;FIS1;STYXL1;LCK;BBC3;BID;RPS3;RACK1;BECN1
prerank,positive regulation of cell cycle process (GO:0090068),-0.3466352738787515,-1.3124139204745775,0.07586206896551724,0.285818018826494,1.0,29/91,22.13%,IGF1;RHOA;MAP3K20;INSR;SVIL;CDC42;CEP295;DYNC1H1;KIF20B;KIF23;CD28;KIF14;DBF4;GEN1;TPR;FEN1;E2F8;RHNO1;RACGAP1;NUSAP1;INO80;AURKA;XRCC3;NDC80;PDGFRB;CSPP1;SIRT2;NUP62;RANBP1
prerank,nuclear pore complex assembly (GO:0051292),-0.5714425056869594,-1.3122922904312795,0.15532286212914484,0.2857429682013561,1.0,4/10,20.68%,NUP205;TPR;NUP153;NUP107
prerank,regulation of cell division (GO:0051302),-0.36292150953635777,-1.3121977565294012,0.0800711743772242,0.28563594085325134,1.0,26/72,24.85%,ZFYVE26;BIRC6;HTR2B;UVRAG;BLM;PLK2;PIN1;FLCN;CIB1;PLK3;SH3GLB1;KIF20A;AURKA;KIF18B;CDK2AP2;PRC1;TXNIP;CSPP1;RAB11A;SIRT2;CETN2;RACK1;SFN;BECN1;MYC;SMYD5
prerank,regulation of protein catabolic process (GO:0042176),-0.33742486734438676,-1.3119726983712987,0.04595879556259905,0.2857388189638841,1.0,39/99,26.84%,WWP1;RAB7A;SNX3;FLNA;CSNK2A1;WWP2;RNF41;AREL1;ATG7;CTSA;TIPARP;AXIN1;IRAK3;PLK2;AZIN1;SF3B3;PIN1;NEDD4L;ZDHHC2;ASB5;WDR91;STX5;EEF1A1;FAF1;RILP;HUWE1;FAM83D;MDM4;GSK3B;SIRT2;SMURF2;GFAP;OAZ3;FURIN;RAB26;DDB1;VIP;SMURF1;VCP
prerank,actin cytoskeleton reorganization (GO:0031532),-0.37013134003145515,-1.3118342847687998,0.08585858585858586,0.2857132801294167,1.0,11/63,5.43%,NEDD9;NRP1;GRB2;PLEK;MYH9;RHOA;FLNA;RAP2A;MINK1;PARVB;ANXA1
prerank,hemopoiesis (GO:0030097),-0.3468313475324079,-1.3115475536098857,0.07011686143572621,0.2859371407369387,1.0,32/87,27.07%,PTPRC;RUNX1;NOTCH2;PLEK;ETV6;RUNX3;CDK13;RASGRP4;LYL1;FLT1;RUNX2;JAG1;FUT10;MFAP5;LCK;FLCN;TGFBR2;TET2;MKNK2;KMT2A;NCOA6;ARMC6;SFRP1;KDR;PRRC2C;KITLG;TGFB1;FLT3;TNFRSF13B;ZBTB16;ASH2L;RTKN2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4769250687791635,-1.3113729744493237,0.10583941605839416,0.285989173309016,1.0,3/20,1.73%,IGF1;RB1;NIBAN2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5585110149000274,-1.310720246713755,0.14482758620689656,0.28677750809069463,1.0,6/11,20.56%,RUNX1;RUNX3;CBFB;LGALS9;HMGB1;CD274
prerank,ribosome assembly (GO:0042255),-0.3875535678612842,-1.3106100516169379,0.10507880910683012,0.2866769623304046,1.0,20/47,26.05%,RPL11;ERAL1;RPS14;RPS28;DHX37;EFL1;MRPS11;RPL6;EIF2A;RPS27;MRPL22;RPL23A;DDX3X;C1QBP;RPLP0;BRIX1;RPS15;MRPS7;RPL5;EIF6
prerank,negative regulation of platelet activation (GO:0010544),-0.5000399731515164,-1.3106042607259574,0.14629629629629629,0.28641705857389077,1.0,3/16,3.36%,APOE;PRKCD;CD9
prerank,regulation of cardiac conduction (GO:1903779),0.36718766803540887,1.3105688103252366,0.0948905109489051,0.3942844363917228,1.0,16/54,14.48%,ANK2;RYR3;RYR2;SLC8A3;TRPC1;CORIN;AHCYL1;CASQ2;ATP1A3;FXYD6;SLC8A2;RYR1;ATP1B1;ATP2B4;ATP2B2;ATP2A1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5413781661359347,1.3104189626006961,0.17090069284064666,0.39337159200621624,1.0,4/11,10.56%,KCND3;KCNJ3;KCNIP2;ATP1B1
prerank,protein catabolic process (GO:0030163),-0.37496937266783303,-1.309950355103263,0.08532423208191127,0.28722672873280825,1.0,25/59,26.97%,APOE;CTSD;RIPK1;RNF41;LAMP2;DDI2;ATE1;PSMA8;CLN6;CUL4B;TRIM24;SOCS6;DENND3;UBE2G1;TPP1;RAB12;STT3B;PPT1;BAG6;MANBA;DDB1;LRSAM1;SIAH2;VCP;HSPA8
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.4084703387853584,-1.309820070702933,0.09195402298850575,0.28717609697767627,1.0,20/39,26.23%,PI4K2A;ITPKB;PIP4K2A;PI4K2B;PIK3CB;TMEM150A;PIK3CG;PI4KB;TTC7A;PIK3CA;SOCS6;PIK3CD;PIK3C2A;SOCS3;IP6K3;SOCS5;SMG1;ITPKC;PIK3C2G;IP6K1
prerank,histone H3-K4 methylation (GO:0051568),-0.4431670385179067,-1.3096915307898367,0.10215053763440861,0.28713010418646295,1.0,13/26,28.47%,TET3;OGT;CTR9;WDR5;KMT2C;KMT2D;TET2;KMT2A;CXXC1;RBBP5;ASH2L;KDM6A;WDR5B
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.513494201677809,1.3092938523667432,0.1276595744680851,0.39446373738054635,1.0,6/13,14.82%,ADCY8;SHANK3;ADCY1;RELN;LGMN;CHRNA7
prerank,oligodendrocyte differentiation (GO:0048709),0.45277616849034935,1.3086727733497117,0.13285024154589373,0.3944944222473362,1.0,6/19,11.93%,SLC8A3;SOX6;SOX13;SOX9;PTPRZ1;HES5
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.42755375556878417,1.3086572725423984,0.12903225806451613,0.39330168410050403,1.0,8/27,15.15%,ANK2;DMD;CACNB2;PDE4D;JPH4;CALM1;CALM2;JPH3
prerank,protein localization to lysosome (GO:0061462),-0.43214090984670916,-1.3084674113245325,0.11467116357504216,0.2888701907923126,1.0,11/28,23.57%,RAB7A;GGA3;MFSD1;LAPTM5;AP3M1;RNF128;SNX16;LMBRD1;VPS4A;GLMP;KPTN
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.457643224136544,-1.3083974023271179,0.13356164383561644,0.2887217684173296,1.0,10/23,21.62%,SPI1;ADIPOR1;IFI35;PPM1B;RELA;NLRC3;TMSB4X;DDX3X;ZC3H12A;NLRP3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3675874137064493,-1.3081591748900234,0.0986159169550173,0.28882861615464095,1.0,21/57,23.47%,RPL7;RPS24;RPS6;RPL11;NOP14;NVL;RPS28;DHX37;CUL4B;RPL14;EMG1;DDX31;PAK1IP1;SHQ1;SURF6;RPS16;GTF3A;TGS1;NIP7;WDR12;RPS15
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.3117388896532454,-1.3077927840845383,0.03354632587859425,0.28918097379262847,1.0,57/185,21.28%,PSME4;CENPJ;PSMB7;CNTRL;ANAPC1;PSME3;DYNC1H1;CENPF;HAUS5;PSMB9;SDCCAG8;HAUS6;CEP57;E2F1;CENPE;CKAP5;NEK6;YWHAE;PTPN6;PSMA8;UBC;RPS27A;TPX2;PSMC3;KIF14;KLHL18;CEP70;HAUS4;DCTN1;CDK1;PSMD8;HAUS7;BUB1B;PSMC4;PSMB10;TFAP4;PSMA1;ID2;INO80;PPP1R9B;ODF2;NINL;APPL2;UBE2C;PSMB8;PCNT;AURKA;ANAPC7;PSMA5;PSMD4;PAFAH1B1;PSMB3;APPL1;SIRT2;PSMD3;CEP192;CETN2
prerank,neutrophil migration (GO:1990266),-0.3747283615963871,-1.3076706915372374,0.0903010033444816,0.28911525565898266,1.0,27/58,36.42%,SYK;ITGB2;CKLF;IRAK4;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD;PPIB;PIP5K1C;CCL7;PRTN3;PECAM1;CCL24;CD177;CXCR2;CCL4;CCL25;CCL19;EDN3;CCL8;CXCL9;EDN2
prerank,import into nucleus (GO:0051170),-0.35800532427449844,-1.3067644232006905,0.07653910149750416,0.29030645438823416,1.0,26/73,22.37%,BACH2;SYK;IPO5;NUP50;STAT3;NUP88;SNRPG;SNRPF;E2F3;TPR;HTATIP2;SMN1;NUP188;GEMIN7;SNUPN;APPL2;NUP153;HNRNPA1;FAM53A;TNPO3;APPL1;NUP107;GEMIN6;NXT2;NUP62;SPRN
prerank,protein targeting to lysosome (GO:0006622),-0.47372220118787095,-1.306656231439449,0.1166077738515901,0.29021950238754957,1.0,8/20,20.48%,RAB7A;GGA3;LAMP2;LAPTM5;AP3M1;GNPTAB;SNX16;VPS4A
prerank,microglial cell activation (GO:0001774),-0.46565167858643786,-1.306475994976874,0.11594202898550725,0.29023875515885694,1.0,8/21,24.40%,ITGB2;C1QA;C5AR1;GRN;APP;AGER;IFNGR1;ITGAM
prerank,regulation of myotube differentiation (GO:0010830),-0.45195005309619396,-1.3057009321910735,0.11864406779661017,0.2912430749176738,1.0,7/24,13.52%,PIEZO1;MAML1;MAPK14;SIK1;XBP1;HDAC5;SMYD1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.33682323175011214,-1.3056718378986245,0.03918495297805643,0.2910203759045846,1.0,38/110,23.64%,APOE;ABCA1;FNIP2;SYK;FBLIM1;RB1;CD36;BCL2L11;SPIDR;RIOK3;CDC42;PREB;VEGFA;EIF2AK2;FNIP1;CDC42EP2;SAR1A;AIDA;TRAF2;SH3GLB1;ANKRA2;BRK1;FAF1;BID;TFIP11;RALB;RPS3;HCK;PTPN11;DDX3X;TMC8;GSK3B;MMP1;RACK1;GFAP;CRYAB;TGFB1;BIK
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3397678548212161,1.3052461503376729,0.08142493638676845,0.39894614214995067,1.0,20/76,15.71%,GRM5;HTR2C;CHRM2;GRM1;P2RY12;OPRD1;PLCE1;ADRA1B;HOMER1;TRHR;PTH1R;CX3CR1;CCKBR;AGTR1;F2RL2;ADRA1D;ADRA1A;OPRK1;OPRL1;OPRM1
prerank,telomere capping (GO:0016233),-0.5085070267987144,-1.305137765491429,0.14789915966386555,0.29170038554088606,1.0,8/16,26.18%,DCLRE1C;DCLRE1A;TEN1;TFIP11;NBN;PRKDC;MRE11;DCLRE1B
prerank,nuclear pore organization (GO:0006999),-0.5164530666864728,-1.304917011901919,0.15575221238938053,0.2918025239339512,1.0,5/14,20.68%,NUP205;TPR;NUP153;NUP35;NUP107
prerank,regulation of translation (GO:0006417),-0.31280848090306057,-1.3047173869554787,0.03821656050955414,0.2918359723693856,1.0,52/173,22.80%,DAPK1;VIM;NIBAN1;YTHDF3;GAPDH;GSPT1;NSUN3;FOXO3;CNOT1;DHX9;DAPK3;KLHL25;EIF4G3;PUS7;EIF4A2;PUM3;EIF5;ALKBH1;EIF2AK2;LARP4B;PCIF1;CD28;LARP4;RPS4X;MTPN;EEF2;CSDE1;APP;EIF3E;METTL14;DHX36;NOLC1;NCBP1;EIF4G1;NCL;DDX1;EIF2A;RBM4B;TOB1;RPS3;HSPB1;DDX3X;EIF5B;CNOT8;DDX6;RBM3;LSM14A;RACK1;EIF3H;SHMT1;IL6;PRKDC
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4398269504247606,1.3045624790195918,0.12183908045977011,0.3990944474918632,1.0,5/24,4.86%,TMEFF2;TJP1;ARHGAP6;CLASP2;DLC1
prerank,negative regulation of cell motility (GO:2000146),0.32696488147004094,1.3044282982047233,0.06601466992665037,0.39812417039611636,1.0,16/108,5.36%,ROBO1;MAGI2;NAV3;TMEFF2;SLIT2;PTPRT;SPOCK3;FRMD5;LIMCH1;IGFBP5;TCAF1;ADORA3;AFDN;DLC1;PTPRK;PODN
prerank,negative regulation of cation channel activity (GO:2001258),0.4261341369588074,1.3043323046577864,0.1310344827586207,0.3970984737805746,1.0,11/26,20.78%,GNB5;CASQ2;FMR1;CALM1;CALM3;CALM2;CBARP;CRHR1;GPR35;UBQLN1;KCNAB1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4949521677417079,-1.303986631703902,0.15502555366269166,0.2928017424729278,1.0,6/16,18.28%,PIBF1;PARP14;ADIPOR1;NF2;VHL;SOCS3
prerank,granulocyte chemotaxis (GO:0071621),-0.3786454470146032,-1.3037724003697013,0.08191126279863481,0.2928880306250794,1.0,12/55,13.40%,SYK;ITGB2;CKLF;ANXA1;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD
prerank,positive regulation of filopodium assembly (GO:0051491),0.4379472349181185,1.3035570347736694,0.12718204488778054,0.39746710406461894,1.0,4/24,1.83%,NLGN1;TENM2;TENM1;GPM6A
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2628571976738655,-1.3028437422499992,0.0,0.29409524834531864,1.0,429/1645,23.03%,RBPJ;MDFIC;APOE;MITF;ZMIZ1;ZEB2;MAP3K5;FLI1;ELF4;FOXP1;RUNX1;PRKCB;TRPS1;IGF1;BACH2;TFEB;CD38;CD74;SP100;TCF4;RCOR1;RREB1;ELF2;REL;LITAF;TRAK1;BCL6;WWP1;MIDEAS;RB1;JUN;PEX14;DNM2;NIBAN2;ZNF568;MEF2A;CREBBP;ETV6;DEK;RUNX3;PPARD;OGT;ARID5B;ANXA4;BPTF;ZBTB34;BACH1;TOX2;NFE2L2;BRD7;INSR;PHF20;CCNL1;RNF111;IRF2;ZNF148;APBB2;SBNO2;NFIC;BRD4;NFX1;NFYA;ARID1B;ZSCAN12;ATF3;ATAD2;ELF1;NSD3;UBP1;PPARG;KDM3A;ELK3;GATAD2A;PIAS1;SMARCA5;SPI1;BRCA1;FOXN2;WWP2;JMJD1C;ZNF3;ETV1;CTR9;STAT3;KLF13;ERCC6;FOXO3;E2F2;IKZF1;LYL1;ZSCAN26;STAT6;DHX9;USF2;NIPBL;RYBP;CHD3;SNX6;RNF20;NFKB1;CNOT2;HHEX;ZBTB21;RUNX2;SMARCD3;FBXW11;PRMT2;SAP30;CENPF;MLXIP;IRF5;CRLF3;SNX5;MAF;MEF2B;DAPK3;KLF6;SMARCC2;BLM;GPBP1L1;TCF20;NR1H2;MAPK14;CIITA;AXIN1;CUX1;BATF;CBFA2T3;NRF1;TEF;KDM7A;ETV3;GON4L;LRP6;NFATC3;ARRB1;KDM3B;SRRT;FUS;PICALM;ZBTB2;CDK18;MYNN;MED24;AHR;CTNNB1;TBL1XR1;GAS6;GCFC2;KLF3;CAMKK2;EZH2;PBXIP1;JARID2;DPF2;REXO4;STAT5B;POFUT1;STAT4;ATF6;EDF1;NR2F1;CREB3L2;KDM2A;VEGFA;BHLHE40;EED;E2F1;CNBP;ARID1A;ATMIN;RNF4;SPEN;TGFBR1;THAP1;WBP2;CEBPG;E2F3;SP110;CDK14;CBFB;POLR3G;MEF2D;PARP9;DDX5;TGFB1I1;METTL4;HIF1A;MEF2C;POLR2L;TFEC;OLIG2;FOXN3;UBE2L3;SP140;NUCKS1;EGR1;SUDS3;ARNT;HDAC10;BAZ2B;AFAP1L2;HP1BP3;PROX2;CIART;RELA;AGT;ZNF569;IKZF3;ZBTB20;NCF1;TIMELESS;CCNL2;XRCC6;ZNF319;OSR1;ARHGEF11;DYRK1A;CHMP1A;CRK;MAP2K1;PCNA;KLF10;MED4;PRDM2;NFE2;KMT2D;MLLT11;SALL3;SPIN1;FOXJ1;HTATIP2;ZFP57;ARID3B;CHD8;FOSL2;MLLT6;KAT7;BAZ1A;CCDC85B;TCF7;HMGB2;ZFP41;ZFX;SPTY2D1;MED31;MTA3;IRF2BP2;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;CREG1;E2F8;TFAP4;POLR2A;ZNF326;RPL6;BATF3;WAC;SIN3A;CALCA;EPC1;PSPC1;BTG1;KLF2;ID2;ZBTB46;TFAM;TCF3;IKBKB;ZNF628;YY1;SPP1;RELB;RGS14;CCNE1;ZMIZ2;PRMT6;NSD1;MAP3K10;TFCP2;AATF;KARS1;MED13L;IL31RA;KLF8;DNAJC2;ZNF177;BTAF1;HR;SRSF10;MRGBP;PHC3;QRICH1;HCLS1;NR4A1;BRIP1;ZBTB12;KMT5A;KLF11;IRX5;IKZF4;SOX10;PHF20L1;UBE2I;FOXJ2;ATXN1;ELP4;VHL;KMT2A;UXT;ZBTB25;MAP2K3;GPATCH3;RARA;NFATC1;CSRNP1;ZBTB24;ATF5;LIMS1;MED6;REPIN1;SMAD7;NR3C1;TFE3;BRD2;GATA3;MYB;SAMD1;PPARGC1B;ARID5A;TCF12;NCOA6;RBBP8;HTATSF1;PLAG1;GMEB2;CXXC1;TRIM16;HAS3;CASZ1;ID1;RSF1;PITHD1;NUP35;MEIS3;HOXD8;PAK6;MDM4;HMGB1;HMGB3;MED20;WDR77;LCORL;ELOC;NAA16;DBX2;MAX;SP9;KDM5B;LIN9;SUFU;EHF;BRD9;CDK16;MMS19;CIC;BAP1;ZFP28;CBFA2T2;RLF;MAZ;SIRT2;NUP107;PKNOX1;DTX3L;ATF7;SFRP1;ZFPL1;STAT1;RAI1;ZFP2;POU3F1;GTF2IRD1;LRRFIP1;ZSCAN21;CDK5;KDM1A;HOXB2;ZKSCAN1;NUP62;HNRNPK;CCNK;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SNAI2;CEBPB;EGR2;BBX;SET;ZNF296;BARX2;RPS6KA5;MYRFL;MTF1;TADA1;ILK;SCMH1;NR1H4;IL6;MED18;EID2;CDC45;TCIM;HOXD9;CRYAB;HES7;CHD7;NONO;ESR2;SOX7;E2F5
prerank,antibacterial humoral response (GO:0019731),-0.5036781496782582,-1.3025892715444607,0.13427561837455831,0.29422832344332067,1.0,7/16,23.51%,RNASE7;RNASE6;CAMP;DEFA6;ANG;PLA2G6;RPL39
prerank,regulation of store-operated calcium entry (GO:2001256),-0.564008154077769,-1.301925721674483,0.1480836236933798,0.2950520439679459,1.0,2/10,1.63%,CD84;SARAF
prerank,membrane depolarization (GO:0051899),0.40205008131190073,1.3017605383845297,0.11556603773584906,0.39995301915721304,1.0,7/32,7.48%,CACNA1E;SCN2A;SCN1A;SCN3A;SCN9A;CACNG4;CACNG2
prerank,ion homeostasis (GO:0050801),0.41453464032233905,1.301045711393894,0.1201923076923077,0.40007173034084603,1.0,10/30,21.50%,UNC80;SLC4A10;SLC4A4;SLC4A11;SLC12A5;WNK4;WNK3;WNK2;SLC30A3;P2RY2
prerank,embryonic skeletal system development (GO:0048706),0.40157818848855514,1.3004919835051705,0.12315270935960591,0.39993925938593816,1.0,14/35,20.96%,PCSK5;HOXC4;SOX11;WNT9A;KIAA1217;DSCAML1;HOXD3;HOXC9;FUZ;UCMA;COL1A1;WNT5A;SULF1;DYNC2I1
prerank,acetyl-CoA metabolic process (GO:0006084),0.4824724254537974,1.300416565218741,0.15270935960591134,0.3989053884373111,1.0,8/15,22.79%,HMGCS1;NUDT7;ACACA;MVK;ACAT1;MLYCD;ACSS1;MVD
prerank,early endosome to late endosome transport (GO:0045022),-0.4730477678077476,-1.3004099247003396,0.13859649122807016,0.29727266902535354,1.0,8/20,18.08%,RAB7A;KIF16B;STX8;EEA1;RAB5A;WDR91;SNX16;RILP
prerank,nitric oxide metabolic process (GO:0046209),-0.5216219016635844,-1.3002223708586804,0.1559792027729636,0.29732886251954493,1.0,6/14,24.02%,CYB5R3;CYB5B;GCH1;ARG2;CYP1B1;NQO1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.38491547022918515,-1.300067911089732,0.10380622837370242,0.29731805985757337,1.0,19/50,24.19%,PSME4;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;OAZ3;NQO1;PSMB1
prerank,regulation of vasoconstriction (GO:0019229),0.4294145086612355,1.2991598680891814,0.12740384615384615,0.40015455361012825,1.0,11/27,14.70%,CHRM3;KCNMB2;SMTNL2;ADRA1B;OXTR;AGTR1;PER2;ADRA1D;ADRA1A;ZDHHC21;ECE1
prerank,amino acid transmembrane transport (GO:0003333),-0.39211098959296703,-1.2989572896411676,0.11208406304728546,0.2988745434512987,1.0,11/45,14.82%,LRRC8D;SLC38A6;SLC6A6;MFSD12;SLC38A10;SLC7A7;SLC38A7;SLC36A4;SFXN2;SLC7A5;SFXN1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.4810032135450136,-1.2979784788881414,0.13660245183887915,0.30017002902447476,1.0,8/18,27.33%,RIPK1;DDX5;MAP2K1;ZC3H12A;IL6;TGFB1;NCOR1;ESR1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.5005200379437255,-1.2977136811569614,0.14659685863874344,0.30033349056564235,1.0,3/15,5.01%,CD44;CD74;BCL2
prerank,axonemal dynein complex assembly (GO:0070286),0.41758208785683654,1.2968231702822193,0.12993039443155452,0.4037463820702046,1.0,6/28,10.14%,DNAAF3;DNAI4;ODAD3;DNAH17;DNAAF4;CFAP73
prerank,DNA methylation (GO:0006306),-0.4570739469879268,-1.2967516372094832,0.1292517006802721,0.3016942100245326,1.0,4/23,12.31%,DNMT3A;GATAD2A;METTL4;ZFP57
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.39238614324807247,-1.2966537796982873,0.10696095076400679,0.30158519195158273,1.0,10/42,13.36%,OPTN;IL6R;TLR4;RNASE7;CHGA;RNASE6;CAMP;HMGB2;SERPINE1;DEFA6
prerank,post-translational protein modification (GO:0043687),-0.29165212732993084,-1.29654058465704,0.016793893129770993,0.30150852790969085,1.0,87/332,20.89%,APOE;FAM20C;DDB2;FBXW8;PSME4;ATG5;PSMB7;PSME3;RAB1A;FBXO32;FBXW11;UBXN7;PSMB9;KLHL25;FBXL20;DCAF10;FN1;C3;KLHL22;NUB1;LRRC41;GAS6;DCAF8;WFS1;GPS1;WDR5;RAB5A;HIF1A;SPSB2;PSMA8;SUMF2;PTP4A2;CP;PSMC3;APP;SPSB3;RAB11B;CUL4B;HSP90B1;PSMD8;ASB5;COPS6;IGFBP3;FBXO10;LGALS1;PSMC4;PSMB10;SOCS6;FBXW2;MIA3;CUL2;PSMA1;SPP1;KLHL42;MFGE8;CST3;RAB13;APLP2;RABGGTA;ASB4;PSMB8;DNAJC3;FBXL8;VHL;SKP2;WSB2;FBXO7;SOCS3;UBE2M;SHISA5;RABGGTB;COPS5;ELOC;FBXO31;CSF1;PSMA5;PSMD4;STT3B;PSMB3;FBXO22;ESCO2;F5;RAB11A;COPS4;FBXW4;PSMD3;COPS8
prerank,response to amino acid starvation (GO:1990928),-0.3508341939614427,-1.2963824253623686,0.08955223880597014,0.3015073394396939,1.0,23/72,25.86%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;ATP6V1A;TCIRG1;EIF2AK2;ATP6V1G1;RRAGD;FLCN;SESN1;SH3GLB1;ATP6V0B;ATP6V0E1;RHEB;ATP6V0D1;CEBPB;MAPK1;WDR24;KPTN;LAMTOR1;LAMTOR3;MIOS
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5624823735067332,-1.2961615730466278,0.16610169491525423,0.30160577588725995,1.0,6/10,27.85%,SMARCD3;CTNNB1;VEGFA;DISC1;KDM1A;DCT
prerank,regulation of protein sumoylation (GO:0033233),-0.4881598979847389,-1.2959532058419523,0.14310344827586208,0.3017007182966907,1.0,5/17,16.61%,ZMIZ1;PIAS1;CTNNB1;EGR1;UBA2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.42783472476402523,1.2958784054703636,0.13064133016627077,0.4044547833087694,1.0,4/26,4.23%,EFNA5;ADCY8;EPHA5;ADCY5
prerank,endothelial cell development (GO:0001885),-0.44379965422168555,-1.295621816968476,0.1445993031358885,0.30197449109171165,1.0,13/25,32.83%,MSN;RAP1B;RAP1A;MYADM;COL22A1;COL18A1;PECAM1;MARVELD2;RAPGEF2;MET;TNMD;CNMD;EZR
prerank,cellular response to metal ion (GO:0071248),0.3122982410606085,1.2954945672920422,0.05555555555555555,0.40394711516108,1.0,32/123,14.45%,NLGN1;DLG2;ANK3;RYR3;SYT1;ADCY8;SLC12A2;GLRA1;SYT10;KCNH1;SYT2;TIGAR;CPNE4;PRNP;SYT5;KCNA1;ADGRV1;ADCY1;SYT11;SYT12;GLRA2;SLC13A5;TFAP2A;RYR1;CAPN3;CPNE8;HSF1;PPIF;SYT7;PRKN;CDH1;LGMN
prerank,regulation of cellular catabolic process (GO:0031329),-0.3654603458776353,-1.295445273880039,0.10238907849829351,0.30201152878843024,1.0,10/62,5.42%,DAPK1;PSAP;GPR137B;ROCK1;NUPR1;ITPR1;PIP4K2A;ABL2;MTMR3;DAPK3
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3819629855233289,-1.294543186926586,0.09268292682926829,0.3033091911450359,1.0,17/49,21.01%,GRB2;MAP3K20;ERCC6;MAPK14;BATF;RAD1;E2F1;GADD45A;RHNO1;DOT1L;BID;BRIP1;RAD9A;MDM4;ATM;CHEK1;NBN
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.3130304413579456,-1.2944922669892749,0.054817275747508304,0.3031124537863085,1.0,52/150,23.42%,PID1;LYN;PTPRC;CORO1C;XDH;PAK2;NIBAN1;PRKCD;RB1;IBTK;PRKAG2;CEP85;PMEPA1;PPP1R15B;LRP6;MVP;MYADM;SIRPA;TRIB1;ITGB1BP1;PTPN6;SNX25;TRIB2;SPRED1;SPRY2;PAQR3;SPRED2;IGFBP3;CIB1;GREM1;SAMSN1;LDLRAD4;EIF4G1;DTNBP1;CRKL;DNAJC3;DEPTOR;SMAD7;PTPN13;HSPB1;ENPP1;UBASH3B;SIRT2;SFRP1;ZC3H12A;RACK1;SFN;PLPP3;PRKDC;TARDBP;TGFB1;GPD1L
prerank,negative regulation of hemostasis (GO:1900047),-0.5373487721379703,-1.2942674608540614,0.1675485008818342,0.3032661852788564,1.0,5/12,23.67%,APOE;TFPI;SERPINE1;APOH;ADTRP
prerank,sphingosine biosynthetic process (GO:0046512),-0.5554321491691625,-1.294245734003028,0.17173524150268335,0.30276283409928734,1.0,6/11,25.05%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),-0.5554321491691625,-1.294245734003028,0.17173524150268335,0.30276283409928734,1.0,6/11,25.05%,SPTLC2;ACER3;SPHK2;SPTLC3;ASAH1;ABCA2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.41853020090711995,-1.294087709416643,0.12310286677908938,0.3027297954485125,1.0,13/33,22.66%,PLCG2;PSME3;EZH2;E2F1;PTPN6;KIF14;ID2;INO80;APPL2;FAM83D;TRIM39;APPL1;TCIM
prerank,DNA alkylation (GO:0006305),-0.4729656781443922,-1.2934552163249464,0.14431239388794567,0.3032744305710194,1.0,2/19,3.22%,DNMT3A;GATAD2A
prerank,DNA methylation or demethylation (GO:0044728),-0.4729656781443922,-1.2934552163249464,0.14431239388794567,0.3032744305710194,1.0,2/19,3.22%,DNMT3A;GATAD2A
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.5200458674403696,-1.2932473289816704,0.15306122448979592,0.30332097176678374,1.0,7/14,18.15%,CARD11;RELA;LCK;RAB29;CD226;TESPA1;RPS3
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5695366229345694,-1.2928118817859302,0.16129032258064516,0.30377993415430604,1.0,3/10,8.47%,SNX3;WWP2;DNAJA1
prerank,error-free translesion synthesis (GO:0070987),-0.4558417434028169,-1.2927889173268527,0.1414141414141414,0.30354171211689995,1.0,9/22,26.84%,RFC1;UBC;RPS27A;PCNA;RPA3;RFC2;RFC3;POLDIP2;VCP
prerank,lipid homeostasis (GO:0055088),-0.3751390576099926,-1.2927239344862476,0.09777015437392796,0.3033836448022972,1.0,19/57,26.47%,APOE;ABCA1;ABCG1;PPARG;USF2;RCN3;TLCD2;ZBTB20;XBP1;ABHD5;ACOX1;IRS2;DDX3X;TLCD1;ACOXL;THADA;ABCA2;PNPLA8;ORMDL2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5003785416364466,1.2923283820713163,0.16587677725118483,0.40895807972257314,1.0,6/14,20.36%,UPP2;DPYD;DPYS;DHODH;CAD;NT5M
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.48260683040404534,-1.2923069008003403,0.13989637305699482,0.30383697039612034,1.0,9/17,33.12%,SELENOS;DERL1;SEL1L;HSP90B1;HM13;FAF2;VCP;AUP1;RHBDD1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5532764818002633,-1.2918140342075208,0.16607142857142856,0.3043930753303756,1.0,5/12,14.50%,CBL;PTPRJ;IFT20;F7;CBLB
prerank,calcium ion homeostasis (GO:0055074),0.32573272506690626,1.2918022467422066,0.05970149253731343,0.4088377380930729,1.0,22/95,16.07%,HTR2C;ANK2;TMTC2;RYR2;SLC24A4;SLC24A2;SLC8A3;SLC24A3;TMEM203;PTH1R;SLC8A2;EDN1;CALCB;ATP1B1;ATP2B4;CDH5;FAM20A;ATP2B2;ATP2A1;CHRNA7;ATP13A5;SNCA
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.5392262564262588,-1.2917315840559984,0.1695501730103806,0.3042782494103264,1.0,7/11,37.67%,LRP6;CTNNB1;RYK;FZD1;LMX1A;NR4A2;WNT2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.5375809801738497,-1.2916440756847074,0.1552901023890785,0.30415491870728284,1.0,6/12,17.50%,NABP1;PLK2;ZWILCH;BUB1;BUB1B;WEE1
prerank,myeloid dendritic cell activation (GO:0001773),-0.5367562142731949,-1.2916165313457098,0.15734265734265734,0.303927411679364,1.0,5/12,19.37%,DOCK2;BATF;TGFBR2;BATF3;HMGB1
prerank,macrophage migration (GO:1905517),-0.5198254911579918,-1.2911595075685263,0.15706806282722513,0.3044358487078598,1.0,4/13,12.64%,CCR2;P2RX4;CKLF;CCL5
prerank,cellular response to amino acid starvation (GO:0034198),-0.35114357516292877,-1.2909715310152299,0.09547738693467336,0.30445599337537876,1.0,23/71,25.86%,MAP3K5;ATP6V0D2;TFEB;ATP6V1E1;ATP6V1A;TCIRG1;EIF2AK2;ATP6V1G1;RRAGD;FLCN;SESN1;SH3GLB1;ATP6V0B;ATP6V0E1;RHEB;ATP6V0D1;CEBPB;MAPK1;WDR24;KPTN;LAMTOR1;LAMTOR3;MIOS
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4797136294077384,-1.2905684113517688,0.14181818181818182,0.30482641802526383,1.0,10/18,31.85%,RAD51B;BRD4;CDC25A;CDK1;RAB11A;CDC25C;CCNB1;RAD51C;RCC2;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),-0.5714642600942151,-1.2903528890302356,0.1713810316139767,0.30466562350263543,1.0,9/10,33.62%,CHMP5;CHMP7;CHMP1A;CHMP2A;VPS4A;CHMP2B;VPS4B;IST1;VTA1
prerank,ESCRT complex disassembly (GO:1904896),-0.5714642600942151,-1.2903528890302356,0.1713810316139767,0.30466562350263543,1.0,9/10,33.62%,CHMP5;CHMP7;CHMP1A;CHMP2A;VPS4A;CHMP2B;VPS4B;IST1;VTA1
prerank,positive regulation of organelle organization (GO:0010638),-0.4179781292351318,-1.2902292184325366,0.1472,0.30461842985786036,1.0,11/32,20.29%,P2RX7;ANXA2;UVRAG;SYNJ1;RAB3GAP1;ANXA1;KATNBL1;SHCBP1L;ADRB2;PLA2G5;GSK3B
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.4533920106247784,1.2900707942215668,0.1496437054631829,0.4109606871153154,1.0,3/20,1.22%,CHRM2;PLCB1;CHRM3
prerank,keratinocyte differentiation (GO:0030216),-0.4253947336700742,-1.2897943361649828,0.13989637305699482,0.305058747031247,1.0,9/29,25.78%,CLIC4;ANXA1;ADAM9;JAG1;PIP5K1A;TXNIP;ASAH1;DSP;CERS3
prerank,regulation of receptor recycling (GO:0001919),-0.49718975375285734,-1.2896963447035374,0.18673647469458987,0.3049519017453508,1.0,6/16,11.92%,ANXA2;OPTN;KIF16B;TBC1D16;SCRIB;RAB29
prerank,protein-containing complex disassembly (GO:0032984),-0.3770036085846679,-1.2896120393249728,0.09547738693467336,0.30483984866708347,1.0,25/54,32.34%,TECPR1;UVRAG;LAMP2;TSG101;AXIN1;LRP6;CTNNB1;PPP1CA;EPG5;LIX1;GABARAP;CLN3;VPS33A;GSK3B;VPS4A;VPS16;DVL2;MYC;FZD1;VCP;HSPA8;FRAT1;STX17;GABARAPL1;CAV1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4076555098214687,-1.288894814414685,0.12166666666666667,0.3057735957602595,1.0,6/36,9.13%,APOE;DNM2;HTR2B;PIK3CB;WASL;HIF1A
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.3632720039049605,-1.2886622035606718,0.0907563025210084,0.3058548822410701,1.0,24/62,28.79%,MCL1;NFE2L2;ARHGEF2;BCL2;TXNDC12;DNAJA1;PLAUR;MAPK7;SELENOS;TPT1;XBP1;TMBIM6;TMEM161A;HSPA1A;HYOU1;HSPB1;DDX3X;SNAI2;BCL2L2;URI1;RTKN2;NOC2L;BCL2L1;PTTG1IP
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.49257553091883344,1.2884338751810391,0.18850574712643678,0.41308298432903123,1.0,6/15,13.86%,CELF4;RAI2;STOX2;TGFB2;UBR3;NR5A2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5383753945186238,-1.2875234250416419,0.1413427561837456,0.3074651154076169,1.0,5/12,21.76%,SNX3;CIITA;IFITM2;TRIM11;IFITM1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.44627580286516605,1.2871465193103975,0.14489311163895488,0.41452030439113635,1.0,5/21,3.38%,HS3ST5;HS6ST3;HS3ST4;HS6ST2;NDST3
prerank,regulation of protein localization to nucleus (GO:1900180),-0.40021157004177677,-1.286711592389089,0.12582781456953643,0.3086113156344588,1.0,21/43,31.44%,MFHAS1;NVL;PARP9;PIN1;FLCN;CDK1;TPR;KAT7;SIN3A;LATS2;GSK3B;DTX3L;SUMO3;CTNNA1;GTSE1;TGFB1;CARD10;EIF2AK3;ATP13A2;NGFR;ORMDL3
prerank,ion transport (GO:0006811),0.32330960991445207,1.2859888172280136,0.06753246753246753,0.4157811034932248,1.0,18/111,8.85%,TRPM3;GABRB1;KCNN2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;GLRA1;SLC1A2;SLC17A6;SLC24A3;SLC1A6;SLC12A1;SLC9A2;SLC26A3;SLC1A1;PKD1L3;SLC8A2
prerank,positive regulation of neuron death (GO:1901216),-0.3827148238711549,-1.2859715651068813,0.10983606557377049,0.3095761321489537,1.0,10/46,10.03%,MAP3K5;ITGB2;C1QA;NUPR1;FOXO3;TLR4;PICALM;CTNNB1;GRN;EGR1
prerank,response to prostaglandin E (GO:0034695),-0.5790358409326712,-1.2856790453456917,0.15555555555555556,0.30975364566403923,1.0,3/10,6.74%,GNB1;PTGER4;GNG2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4739312234967329,-1.285611867495,0.1646655231560892,0.30960379076760736,1.0,6/18,11.81%,LYN;CAMK1D;IL6R;PTK2B;MDK;F7
prerank,glycolipid metabolic process (GO:0006664),-0.38455282495362386,-1.2852273731759574,0.12736660929432014,0.3099931092980303,1.0,19/47,29.05%,HEXA;PSAP;CTSA;GLTP;ARSA;ESYT1;ESYT2;SUMF2;GBGT1;NEU1;PGAP3;ASAH1;PGAP1;ABCA2;B4GALNT1;CPTP;ST3GAL4;B3GALNT1;CERK
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.40783724923536724,-1.28490749706976,0.12844036697247707,0.3102436624486895,1.0,10/34,18.61%,IGF1;NSMCE2;RB1;INSR;DLGAP5;CD28;NUSAP1;AURKA;ANAPC7;PDGFRB
prerank,icosanoid secretion (GO:0032309),-0.5362139889973676,-1.2845554061302717,0.14642857142857144,0.3104820167642474,1.0,7/12,39.07%,ANXA1;ABCC4;PLA2G5;PNPLA8;ACE;NOS2;NMUR2
prerank,negative regulation of immune response (GO:0050777),-0.31560322231321414,-1.2844984305926614,0.04991680532445923,0.31030747210089227,1.0,22/154,8.22%,LYN;FGR;CCR2;CD163;LILRB1;SYK;PLCG2;GNB1;CD300A;MYH9;ADCY7;SPI1;DHX58;RC3H1;PTGER4;MAPK14;GNG2;IRAK3;PPM1B;PLK2;CYSLTR1;RHBDF2
prerank,basement membrane organization (GO:0071711),0.49408412170049815,1.2841670034480677,0.17494089834515367,0.4181126092523162,1.0,7/14,22.01%,NTNG2;NTNG1;FLRT2;NID2;RAMP2;NID1;NTN4
prerank,negative regulation of response to stimulus (GO:0048585),-0.3704262408171127,-1.2840551492522652,0.11204013377926421,0.31075889814953933,1.0,22/60,28.75%,LYN;VPS13C;MCTP1;CDK6;NR1H2;WFS1;MAP2K5;MAPK7;IGFBP3;FCGR2B;BRAP;APPL2;LPCAT3;UBASH3B;PTPN1;SOCS5;MAP3K3;KIF26A;FCRLB;CASK;SLC30A10;SPINK5
prerank,translational elongation (GO:0006414),-0.33086705473914896,-1.283865331999881,0.09015025041736227,0.31080843806915687,1.0,43/101,33.59%,MRPS10;ERAL1;MRPL42;TUFM;EEF1B2;CHCHD1;EEF2;GTPBP1;EEF1A1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;GTPBP2;MRPL17;MRPL15;RACK1;MRPL51;MRPL47;MRPL18;MRPS7;EEFSEC;EEF1D;MRPL54;MRPS25;MRPL39;MRPL53;MRPL11;MRPL33;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPL1;MRPS28;MRPS35
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3899368961514361,-1.283852719380843,0.09726962457337884,0.3105701124382822,1.0,11/43,10.48%,JUN;PPARD;PPARG;SPI1;STAT3;FOXO3;NFATC3;DDX5;HIF1A;EGR1;RELA
prerank,activation of protein kinase A activity (GO:0034199),0.4782206154170931,1.2836513005936967,0.1750599520383693,0.41801447645062656,1.0,7/16,14.85%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.4218444134912265,-1.283509003662104,0.1195840554592721,0.31091258633366686,1.0,8/30,19.98%,NIBAN2;DCP2;ERCC4;TEN1;TENT4B;HNRNPA1;EXOSC10;BMPR2
prerank,neural crest cell differentiation (GO:0014033),0.4682532235224132,1.283291532200632,0.1559633027522936,0.4176029280983832,1.0,4/18,4.88%,NRG1;SOX11;CDH2;PDCD6
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.38619844673784937,-1.2831730482778614,0.12887438825448613,0.3112236138016238,1.0,7/43,5.22%,PID1;PRKCB;PRKCD;OGT;PIP4K2A;PTPRE;SNX5
prerank,neuromuscular process (GO:0050905),0.47983594518266365,1.2826996859515674,0.15211970074812967,0.41768655965542134,1.0,4/16,9.57%,NRXN1;MYCBP2;KCNA1;PRRT2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.334668193330912,1.2825447562256898,0.07598039215686274,0.4167946351611511,1.0,18/75,12.43%,METAP2;KCTD8;PLCB1;RGS6;FRMPD1;GIT2;RAMP3;RGS20;PLCE1;GNG7;GRK4;FNTB;CAMKMT;CAMK2A;EDN1;MRAP;FNTA;CALM1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3985717126727676,-1.2825289744039146,0.11979166666666667,0.3120816026011151,1.0,11/38,20.90%,CD36;RAC1;INSR;P2RX4;TLR4;SIRPA;HSP90AB1;KLF2;ASS1;MMP8;ZC3H12A
prerank,positive regulation of cartilage development (GO:0061036),0.46082501991644614,1.282523675702689,0.1592920353982301,0.41562728226131784,1.0,6/17,12.14%,BMPR1B;SOX5;SOX6;SOX9;BMP1;TAPT1
prerank,pulmonary valve development (GO:0003177),0.4678116383163424,1.2824248946966281,0.16820276497695852,0.4146122170835792,1.0,3/18,1.35%,ROBO1;ROBO2;SLIT2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.4485721499680229,-1.2824059855551961,0.14513274336283186,0.31202463578107986,1.0,8/24,18.95%,DCP2;TNKS2;ERCC4;TEN1;SLX4;TENT4B;HNRNPA1;EXOSC10
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.37790422256918066,-1.282367066533567,0.11980033277870217,0.31181812725283636,1.0,11/48,7.18%,PTPRC;SAMHD1;YTHDF3;PPARG;USP18;PARP14;STAP1;NLRC5;NR1H2;IRAK3;GAS6
prerank,motor neuron axon guidance (GO:0008045),0.4774181886165303,1.2822833732821761,0.16,0.4137118374558564,1.0,3/15,5.27%,SLIT2;SLIT1;TMEFF1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.4202953877283471,-1.282218653369861,0.11979166666666667,0.31178693309426414,1.0,13/30,28.82%,DAB2;FOXP1;PRMT2;DDX5;KLK3;TRIM68;SFRP1;KDM1A;ZBTB7A;HEYL;NCOR1;EP300;PIAS2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5168336460546017,-1.28219371284223,0.1637323943661972,0.31155661521841727,1.0,8/13,30.31%,GNPDA1;UAP1L1;UAP1;GNPDA2;GFPT1;AMDHD2;RENBP;GNPNAT1
prerank,activation of adenylate cyclase activity (GO:0007190),0.40406965933675054,1.2820749202130823,0.13488372093023257,0.41296707877091016,1.0,9/35,13.09%,ADCY2;ADCY8;LGR5;ADORA3;ADCY5;ADCY3;ADCY1;LGR4;ADRB1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4066433323111816,-1.2817054869125315,0.14874551971326164,0.31214388916582353,1.0,10/35,12.02%,ARHGAP24;ABL2;TNFAIP1;RIPOR2;KCTD10;SPRY2;RASAL3;CCDC125;FLCN;ITGA3
prerank,aortic valve development (GO:0003176),0.39259108804936216,1.2816105797418145,0.1435523114355231,0.4127489658469902,1.0,7/34,10.02%,ROBO1;ROBO2;SLIT3;SLIT2;TIE1;SOX9;SNAI1
prerank,histone lysine demethylation (GO:0070076),-0.43111233534495297,-1.2812235924876545,0.14948453608247422,0.31271958111531173,1.0,11/25,30.88%,KDM3A;JMJD1C;KDM7A;KDM3B;KDM2A;HR;KDM5B;KDM1A;KDM2B;KDM6A;RIOX2
prerank,positive regulation of neuron migration (GO:2001224),-0.5450767402196425,-1.2801122130993607,0.17770034843205576,0.3143985756302139,1.0,4/11,8.06%,ARHGEF2;NIPBL;KIF20B;MDK
prerank,regulation of cholesterol esterification (GO:0010872),-0.5679510917706985,-1.2800384489792354,0.1601423487544484,0.3142502236618774,1.0,2/10,0.54%,APOE;ABCG1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.36072854900071566,1.2799043667061378,0.10377358490566038,0.4149928653814782,1.0,10/53,15.71%,HTR2C;CHRM2;CHRM3;HRH3;OPRD1;NPY1R;HTR1B;HRH2;HTR7;OPRM1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4854771943202385,-1.2799014562927948,0.1636060100166945,0.3142023433825535,1.0,5/17,11.34%,PID1;NUPR1;CBFA2T3;FIS1;FLCN
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.41489681191808986,-1.2797276849811003,0.14157706093189965,0.31423254299277015,1.0,11/31,19.94%,SYK;PLCG2;TLR4;IRF5;MAPK14;MDK;LAPTM5;CD40;LGALS9;HMGB1;AGER
prerank,protein import into peroxisome membrane (GO:0045046),-0.45567680363227997,-1.2787895941154686,0.16554054054054054,0.3156401863530782,1.0,5/22,10.02%,RAB8B;PEX14;ABCD2;PEX26;FIS1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.4601420023300325,1.2786916861210933,0.16241299303944315,0.41627960883012577,1.0,4/18,5.49%,CHRM2;PLCB1;CHRM3;HRH3
prerank,epithelial cell morphogenesis (GO:0003382),-0.48775143480264016,-1.2785107901855375,0.18629173989455183,0.3158479895359154,1.0,12/17,35.77%,SIPA1L3;COL22A1;COL18A1;RILPL1;PKHD1;CCDC88C;RILPL2;GRHL2;MET;TNMD;CNMD;POF1B
prerank,calcium ion import (GO:0070509),0.40641197849384436,1.2772118803500498,0.13316582914572864,0.41816191459450797,1.0,7/28,15.66%,CACNA1C;CACNA1E;CACNB2;SLC25A23;MICU3;ATP2A1;CACNA1G
prerank,cellular response to calcium ion (GO:0071277),0.3432126948555681,1.2771723598525009,0.0948905109489051,0.4170713658829849,1.0,18/67,13.01%,NLGN1;RYR3;SYT1;ADCY8;SYT10;KCNH1;SYT2;CPNE4;SYT5;ADGRV1;ADCY1;SYT11;SYT12;RYR1;CAPN3;CPNE8;PPIF;SYT7
prerank,positive regulation of histone modification (GO:0031058),-0.4037301895638838,-1.2771083874298346,0.13644214162348878,0.31795625875737454,1.0,13/33,27.09%,BRD7;BRCA1;AKAP8;NIPBL;CHTOP;ARRB1;SART3;KDM1A;RPS6KA5;APLNR;AKAP8L;UBE2N;ZBTB7B
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4664339513536283,1.2771041784521207,0.1575178997613365,0.41606183758022,1.0,6/19,7.14%,HS3ST5;HS6ST3;HS6ST2;NDST4;NDST3;GLCE
prerank,regulated exocytosis (GO:0045055),-0.3069164925279325,-1.2765299309982066,0.045813586097946286,0.3186659523769057,1.0,39/173,13.02%,F13A1;LYN;IGF1;PSAP;PLEK;PHACTR2;MYH9;CD36;ARHGAP17;FLNA;TAGLN2;RAB31;CD9;CYB5R1;RAB11FIP5;LAMP2;LHFPL2;SYNGR1;SRGN;ANXA5;TMED10;TLN1;PF4;FN1;HGF;CYRIB;PROS1;TEX264;GAS6;RIMS3;VEGFA;SYT4;CD63;WDR1;APP;RAB11B;SERPINE1;RAB10;ABCC4
prerank,hyaluronan metabolic process (GO:0030212),-0.441658515480306,-1.2762968889291044,0.1524822695035461,0.3187856414530932,1.0,5/23,9.43%,CD44;HEXA;LYVE1;SLC9A1;GUSB
prerank,metal ion export (GO:0070839),0.4025294317174027,1.2761568597266089,0.14782608695652175,0.4168437233432229,1.0,9/31,17.14%,KCND3;KCNT2;SLC4A4;KCNIP2;ATP1A3;ATP1B1;ATP2B4;KCNE4;ATP1B2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5407563864058884,1.2760992482418971,0.16784869976359337,0.41579386606427754,1.0,3/10,10.68%,DLGAP1;DLGAP2;DLGAP3
prerank,cellular response to sterol (GO:0036315),0.508194678603794,1.2755979440315457,0.17972350230414746,0.41562291230133785,1.0,5/13,12.48%,RORA;OSBPL7;INSIG1;SMO;RORC
prerank,regulation of cilium assembly (GO:1902017),-0.35942264559494047,-1.275128869931269,0.10361842105263158,0.3204917512985756,1.0,19/62,17.15%,TBC1D15;IFT20;ATG5;TBC1D2B;TBC1D5;TBC1D1;TBC1D22A;SDCCAG8;TBC1D16;TBC1D22B;TBC1D8;TBC1D17;CCDC88A;TBC1D10B;TBC1D30;TBC1D24;DYNLT2B;TBC1D7;TBC1D9B
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.4690162906842823,-1.2742735391800313,0.15905245346869712,0.32169727552982874,1.0,5/19,9.25%,RBPJ;RUNX1;PIM1;TGFBR1;MEF2C
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.379783198359231,-1.2740058099586242,0.128500823723229,0.3218601542692208,1.0,26/48,36.01%,P2RX4;ANXA1;MAPK14;VEGFA;HIF1A;CIB1;CD40;TMSB4X;PIK3C2A;MAP2K3;HSPB1;HMGB1;KDR;FGF18;TGFB1;HMOX1;MAP3K3;ATP5F1B;NUS1;ETS1;ATP5F1A;FGF2;PLCG1;GATA2;SRPX2;PDGFB
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4461414682966976,-1.2738834737128186,0.1597222222222222,0.32176648788881906,1.0,9/24,22.94%,NIBAN2;BLM;RTEL1;DFFA;ERCC4;KMT2A;RPS3;BMPR2;ZRANB3
prerank,DNA duplex unwinding (GO:0032508),-0.37576748262421905,-1.2737991223918435,0.11686143572621036,0.32163744618309686,1.0,22/50,26.01%,DDB2;DHX9;ANXA1;BLM;RTEL1;MCM6;RAD51;UBC;RPS27A;MCM9;SSBP1;WRN;CUL4B;DDX1;MCM2;NBN;CETN2;TWNK;ASCC3;DDB1;RECQL5;MRE11
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5216369675765989,-1.2736305051080519,0.18900343642611683,0.32164541659887314,1.0,6/13,24.02%,CYB5R3;CYB5B;GCH1;ARG2;CYP1B1;NQO1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.471255299414829,-1.2735028997058833,0.1717687074829932,0.32158451266475435,1.0,7/18,12.02%,ABL2;TNFAIP1;RIPOR2;KCTD10;CCDC125;FLCN;ITGA3
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3591240249808941,1.2734969570955792,0.10941475826972011,0.4186669916022076,1.0,5/47,4.76%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,cellular response to retinoic acid (GO:0071300),0.3713718297607313,1.2733754787633855,0.12224938875305623,0.417781511617924,1.0,17/42,20.48%,BRINP3;BRINP1;RORB;TESC;WNT9A;SOX9;LTK;TBX1;RET;EPHA3;BRINP2;FZD4;SNW1;ADNP2;WNT5A;WNT5B;FZD10
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.5472261963204701,-1.2732065891947772,0.1799660441426146,0.321821856884329,1.0,7/11,23.38%,RIPK1;PF4;ID2;IL34;CASP8;CSF1;TGFB1
prerank,response to organophosphorus (GO:0046683),-0.4882632918545453,-1.2727672713187819,0.19081272084805653,0.32224941134115803,1.0,5/16,20.94%,P2RX7;P2RX4;TRIM16;RFC3;STAT1
prerank,regulation of stem cell differentiation (GO:2000736),-0.3390232255023783,-1.2722168679760575,0.0723905723905724,0.3229301786012868,1.0,28/89,20.83%,RUNX1;NELFB;PSME4;PSMB7;PSME3;PSMB9;JAG1;PUS7;EIF2AK2;CBFB;PSMA8;PSMC3;NUDT21;PSMD8;PSMC4;PSMB10;PSMA1;TCF3;PSMB8;KMT2A;GATA3;MYB;TCF12;LMO2;PSMA5;PSMD4;PSMB3;PSMD3
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.28639176973810926,-1.271604709024488,0.030303030303030304,0.32371586283729775,1.0,59/308,14.38%,DAB2;APOE;PRKCH;ABCA1;B4GALT5;FGR;RREB1;CCR2;SDCBP;SYK;LRP1;CD36;ROCK1;NIBAN2;OGT;AGO2;GAPDH;IGF1R;FABP5;KDM3A;HTR2B;IL15;SLC27A1;IL18;STAT6;ADIPOR1;DYNC1H1;PTGER4;BATF;UCP2;PIK3CG;GCNT2;CTNNB1;GAS6;EZH2;KMT5B;PLAC8;VEGFA;EIF2AK2;MDK;TGFBR1;RBM19;CD28;TGFB1I1;KMT5C;CLEC9A;FABP4;AGT;ITGAX;XBP1;IL4R;FOXJ1;CLEC6A;ITK;SERPINE1;PIK3CD;TGFBR2;NFAM1;AGPAT1
prerank,neurotransmitter uptake (GO:0001504),0.517764147460829,1.2715490854236216,0.20506912442396313,0.4203165619717063,1.0,3/12,7.03%,SNAP25;SLC1A6;GLUL
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.33754740227062546,-1.2712898575174592,0.07032590051457976,0.32401814838557397,1.0,30/88,19.26%,MYO5A;VPS13C;FTL;DNM2;VPS13A;KIF16B;AP1G1;ARRB1;EXOC4;EPS15;OSBPL5;VPS35L;SYS1;AP1S3;CORO7;APP;TXNDC5;RABEP1;ARFGEF2;CLINT1;RAB10;ARL3;CHMP2A;RP2;DTNBP1;STX4;EXOC2;AP1S2;DOP1B;EXOC6
prerank,RNA catabolic process (GO:0006401),-0.38591575610896867,-1.2712443201858221,0.11917098445595854,0.32381230174349335,1.0,27/46,41.89%,ERN1;DCP2;RNASE6;FEN1;NCBP1;HSPA1A;LSM6;DNA2;LSM5;XRN2;MTREX;SND1;NUDT16;ZC3H12D;RNASEH2B;METTL3;ISG20;NUDT12;HSPA1B;SLFN14;AGO3;ZFP36;RNASE3;DXO;YTHDF2;RNASEH2A;METTL16
prerank,myotube differentiation (GO:0014902),0.47501254561219514,1.271198977626678,0.1687041564792176,0.4198098931257725,1.0,3/17,2.80%,ADGRB3;ADAM12;KCNH1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.5275160229681529,-1.2706477933744205,0.18545454545454546,0.32458074526431296,1.0,6/12,39.23%,FDXR;TSPOAP1;FDX1;FDX2;STARD3;TSPO
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.5105191509581097,-1.2704713028094625,0.17077464788732394,0.32459033166787965,1.0,7/12,31.47%,MCM6;MCM3;MCM2;GINS4;CDC45;MCM5;MCM7
prerank,positive regulation of growth (GO:0045927),-0.3553244439521129,-1.2703536699086484,0.10774410774410774,0.3245149929890249,1.0,16/64,15.13%,RFTN1;SDCBP;INSR;CSNK2A1;CDC42;BCL2;DDX49;KLHL22;WFS1;TGFBR1;MTPN;CXCL16;CIB1;NCBP1;INO80;EIF4G1
prerank,ceramide metabolic process (GO:0006672),-0.3796536412062569,-1.26988786491549,0.12020905923344948,0.3250295073593662,1.0,26/49,42.80%,SGMS1;SPTLC2;ACER3;SPTSSA;CLN6;SPTLC3;ASAH1;SAMD8;PLPP3;DEGS2;ABCA2;CERS3;ORMDL2;PLA2G15;CERK;ORMDL3;ACER2;CERS2;PNPLA1;FUT7;PLPP2;PPP2CA;PLPP1;ORMDL1;SMPD1;PPP2R1A
prerank,pore complex assembly (GO:0046931),-0.4698303514818345,-1.2698369512431191,0.17162872154115585,0.32484641801495756,1.0,7/19,20.68%,P2RX7;ANO6;PDZD11;NUP205;TPR;NUP153;NUP107
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.49499329948370135,-1.269195760090547,0.1486013986013986,0.3257130392952177,1.0,4/14,7.30%,PTPRC;IGF1;TNFRSF1B;GRN
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.40891146964219266,-1.269060670209384,0.15097402597402598,0.32564423854874336,1.0,8/32,4.20%,CORO1C;RREB1;ARPC2;RAC1;ACTR2;WASF2;CDC42;ACTR3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4359557979576742,-1.269052153076101,0.17277486910994763,0.32538891377622975,1.0,8/24,21.80%,CD44;CD74;BCL2;TPT1;TMEM161A;TAF9;KDM1A;SNAI2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.37401958858380324,-1.2688810667264754,0.10951526032315978,0.3254451637033666,1.0,12/48,8.06%,NEDD9;NRP1;RREB1;RAC1;FBXW8;FLNA;CDC42;CUX1;TRIOBP;DOCK5;MYADM;MDK
prerank,sensory perception of light stimulus (GO:0050953),0.32087948990646087,1.267838323951016,0.08157894736842106,0.4253835818255996,1.0,20/87,13.83%,PCDH15;GRM8;SLC4A10;CRYZ;POU6F2;COL11A1;RPGR;IMPG2;ABLIM1;ADGRV1;TRPM1;PDE6C;GPR143;CRYBB3;WHRN;EML2;PRPH2;ZIC2;CLRN1;USH2A
prerank,activation of protein kinase activity (GO:0032147),-0.3274906274331203,-1.2675425717172413,0.08862876254180602,0.3276013682450989,1.0,27/106,14.10%,OSBPL8;TAOK3;IGF1;PAK2;PRKCD;ADCY7;INSR;MALT1;MINK1;PRRC1;PIBF1;IL18;PTK2B;STK3;AXIN1;GAS6;VEGFA;ITGB1BP1;TPX2;TAOK1;KIF14;CCDC88A;STK11;TRAF2;TGFBR2;MARK2;CALCA
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3373062225051282,-1.267229996324871,0.08374384236453201,0.32786654087996364,1.0,24/87,18.75%,ZMIZ1;CBL;JUN;NRROS;RHOA;LPXN;ARRB2;ITGB1;ADAM9;GCNT2;ARHGEF18;USP9X;SKI;TGFBR1;UBC;RPS27A;ITGB5;ZYX;TGFBR2;ZMIZ2;APPL2;FMOD;SMAD7;ID1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3122066335272981,1.2669376735051245,0.085,0.4261376420066763,1.0,30/110,17.09%,ADGRB3;ADGRL3;ADCY2;ADCY8;LGR5;ADCY5;RAMP3;ADRA1B;ADCY3;GPR101;PTH1R;ADGRL2;ADCY1;GPR3;ADRA2C;GHRH;CALCB;LPAR2;LGR4;ADRA1D;ADRA1A;ADRB1;ADGRG1;GPR26;GNAL;ADGRB2;IAPP;RAMP2;ADGRL4;CRHR1
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.3877709370663112,-1.2668306227586934,0.12824675324675325,0.3282967356346882,1.0,9/42,7.99%,CORO1C;RSU1;RAC1;RHOA;MINK1;PIK3CB;MYADM;GCNT2;ATXN3
prerank,endodermal cell differentiation (GO:0035987),-0.41237042863892015,-1.2668152599634417,0.135,0.32805464331663786,1.0,7/31,9.97%,ITGA4;ITGB2;ITGA5;CTR9;ITGAV;FN1;ITGB5
prerank,keratan sulfate metabolic process (GO:0042339),-0.41130757861365685,-1.2667434327896179,0.15097690941385436,0.327894008363584,1.0,11/31,19.30%,B4GALT5;HEXA;ST3GAL1;GNS;GALNS;SLC35D2;B3GNT2;PRELP;B4GALT3;FMOD;B4GALT1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.5396401785663207,-1.2663537521544743,0.18425460636515914,0.3283036311842612,1.0,6/11,17.10%,ITGB2;SPI1;STAP1;TICAM1;MAVS;STX4
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4777554026735683,-1.2660101403461061,0.17627677100494235,0.32863370252622653,1.0,10/17,36.85%,RAET1E;AP1G1;LAMP1;CD226;SLAMF6;CRTAM;KLRC2;KLRD1;IL12A;IL12B
prerank,neuron fate commitment (GO:0048663),0.490760601997168,1.265855475961276,0.15421686746987953,0.4272101505683915,1.0,2/14,4.44%,MYT1L;POU3F2
prerank,RNA splicing (GO:0008380),-0.336622434312889,-1.2656060200233223,0.10033444816053512,0.32908092544446355,1.0,31/95,24.20%,MBNL1;TRA2B;SRRM1;MPHOSPH10;SMU1;SNRNP35;FUS;SNRPG;SNRPF;SF3B3;PRPF8;NCBP1;ZRSR2;PDCD7;PPIG;PPP1R9B;SRSF10;PRPF18;LSM6;RNPS1;TXNL4A;SCNM1;MAGOH;SLU7;SF3B1;SRPK1;SRSF11;NONO;TARDBP;PRPF6;DDX39B
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.42317953304136546,-1.265526797848109,0.1495798319327731,0.32895678707262543,1.0,6/26,6.87%,LYN;USP50;STAT3;PSME3;AIM2;PICALM
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.4074145454138616,-1.265452201111893,0.13245033112582782,0.3288052662089969,1.0,10/33,12.79%,LYN;SYK;PLAU;DPP4;ADAM9;PIK3CG;ITGB1BP1;NCKAP1L;CIB1;SERPINE1
prerank,digestive tract development (GO:0048565),0.3931485798185811,1.265369943224851,0.15763546798029557,0.42701923411301446,1.0,13/33,20.37%,PCSK5;CLMP;RARB;COBL;SALL1;TGFB2;SMO;PKD1;GLI3;EPHB3;BBS7;GLI2;KIT
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5441046592476102,-1.2652645740398127,0.18388791593695272,0.32884388835301487,1.0,4/11,10.53%,DAB2;MSN;RAB21;EIPR1
prerank,positive regulation of lipid localization (GO:1905954),-0.530580648946027,-1.265152300254872,0.16728624535315986,0.3287671771408005,1.0,4/11,9.75%,LRP1;NFKB1;C3;LPL
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.5456432215849536,-1.265123942857771,0.19827586206896552,0.3285489177318573,1.0,5/10,22.06%,MTHFS;MTHFD1L;MTHFD2L;MTHFR;SHMT1
prerank,regulation of mitochondrial translation (GO:0070129),-0.44778174569596024,-1.2650337443893727,0.16906474820143885,0.32843489527319125,1.0,7/21,19.87%,NSUN3;ALKBH1;FASTKD2;NGRN;FASTKD3;RMND1;C1QBP
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4809997933721648,-1.2648398871776891,0.1684981684981685,0.3285042221613441,1.0,3/17,5.78%,RBPJ;NOTCH2;JAG1
prerank,negative regulation of blood coagulation (GO:0030195),-0.38837330175546947,-1.264713002275565,0.14846416382252559,0.3284697288390898,1.0,13/38,28.13%,APOE;PLAU;TFPI;PLAUR;F7;SERPINE1;F10;PDGFA;APOH;ADTRP;A2M;SERPINB2;F11
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.4729059091859387,-1.2646760554247987,0.166383701188455,0.3282697021353951,1.0,6/17,12.70%,SYK;PIEZO1;ADAM9;NCKAP1L;CCL5;CIB1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5022503305255096,-1.2646323291219592,0.18938053097345134,0.3280791396523358,1.0,2/13,0.66%,CD44;CD74
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5577770698443266,-1.2640460652477614,0.17789291882556132,0.3287824197856892,1.0,4/10,14.84%,SSBP1;DBF4;E2F8;INO80
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.496808943606009,-1.2639856758163297,0.17531305903398928,0.328599856472322,1.0,5/15,8.91%,RBPJ;PTPN12;RHBDF1;RHBDF2;MVB12B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.43684175193526,-1.263894473886508,0.14235500878734622,0.32848442136884903,1.0,8/25,24.20%,ERCC6;ALYREF;KAT7;ZNF326;HMGN1;HTATSF1;CCNK;DDX39B
prerank,cell projection assembly (GO:0030031),-0.44724244970791666,-1.2637385805028492,0.16724137931034483,0.32845517241478694,1.0,6/22,9.89%,RAC1;PARVB;CDC42;RHOQ;CAPG;NCKAP1L
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.5531591249360919,-1.2632625753786737,0.19931856899488926,0.3290031965244383,1.0,6/10,26.42%,BRCA1;HDAC5;SPHK2;KMT2A;CHEK1;SMAD4
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.518827367668499,1.2629318777915721,0.19014084507042253,0.4308819801200998,1.0,2/11,4.22%,DDX11;NOL11
prerank,response to acidic pH (GO:0010447),-0.5135489451471453,-1.262888726998908,0.1891891891891892,0.32935436975405474,1.0,5/13,17.84%,RAB11FIP5;SLC9A1;RAB11B;CTSS;GPR65
prerank,neutrophil chemotaxis (GO:0030593),-0.36922514684659974,-1.262591908114333,0.11694915254237288,0.3296020256239263,1.0,11/53,13.40%,SYK;ITGB2;CKLF;PF4;PIK3CG;JAML;NCKAP1L;CCL5;CXADR;FCER1G;PIK3CD
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.389974054777733,-1.2623607525556004,0.12563667232597622,0.32973229967375633,1.0,11/39,21.23%,ITGA4;ANO6;NFE2L2;GAS6;MAPK7;TNIP2;SERPINE1;CD40;GATA3;NDNF;KDR
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.45231776631137255,-1.2620666733767818,0.17666666666666667,0.32998428129499596,1.0,3/20,6.76%,BRD7;BRCA1;ARRB1
prerank,cardiocyte differentiation (GO:0035051),0.5349697821567477,1.2616881939459554,0.19626168224299065,0.43225296647329375,1.0,5/10,11.34%,NRG1;CBY1;MYOCD;TGFB2;EEF1AKMT4-ECE2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5236030811633349,1.2612818613913732,0.2036613272311213,0.43192744995961085,1.0,5/10,16.81%,PRKCE;PTH1R;IRS1;SNCA;AKT2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4306464245285066,-1.2608523149151756,0.18197278911564627,0.3317822706588502,1.0,4/23,9.94%,PLEK;NUPR1;CBFA2T3;SIK1
prerank,T cell differentiation (GO:0030217),-0.3896874022643527,-1.26060477426282,0.15257048092868988,0.33190944504275854,1.0,11/40,17.97%,PTPRC;SPI1;PTPN22;ANXA1;CD28;LCK;TCF7;FCER1G;PIK3CD;ZAP70;GATA3
prerank,lipid translocation (GO:0034204),-0.4543314991758134,-1.2601222087324548,0.14726027397260275,0.33247465546457694,1.0,4/21,9.21%,ABCA1;ATP8B4;ATP11C;ABCC1
prerank,regulation of insulin secretion (GO:0050796),0.32229150311302124,1.2598613951512756,0.09510869565217392,0.433779100611145,1.0,25/101,16.69%,CACNA1C;CACNA1E;EFNA5;KCNC2;SNAP25;EPHA5;ADCY5;CCN3;NR1D1;ADRA2C;NEUROD1;RAPGEF4;CAPN10;FFAR1;PER2;REST;SYT7;PRKN;KCNS3;INHBB;NLGN2;IRS1;RFX3;PRKCA;MYRIP
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.4107022204575928,-1.2596731033235944,0.1541038525963149,0.3330088170263435,1.0,8/32,19.20%,GAPDH;PF4;RNASE7;RNASE6;CAMP;DEFA6;ANG;CXCL14
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5370381585452041,-1.2595438259742626,0.19223985890652556,0.3329841583845655,1.0,5/11,12.64%,LYN;SYK;PLAUR;JAK1;CCL5
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3883938967571158,-1.2595001002066832,0.1518324607329843,0.3327940947863533,1.0,14/40,26.75%,CSNK2A1;GNA12;PTK2B;AXIN1;RPL11;NUB1;LAPTM5;UBE3A;UBQLN4;TRIM39;SGTA;RPL5;SMURF1;PML
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.470312191334327,-1.2593008272483734,0.17883211678832117,0.33284378968026596,1.0,5/18,17.08%,APOE;ABCG1;PSENEN;CLN3;ADAM19
prerank,nucleus organization (GO:0006997),-0.37956414546548767,-1.259297752457184,0.11166666666666666,0.3325780664230448,1.0,18/47,22.39%,PDCD6IP;ATXN7;CHMP5;USP36;SUN2;NUP205;CHMP7;WDR73;CHMP1A;TPR;LEMD2;CHMP2A;CEP55;NUP35;VPS4A;REEP3;CHMP4B;CHMP4A
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3946586769729009,-1.2587208696439698,0.13752122241086587,0.33333704094353067,1.0,18/39,27.19%,APOE;MSN;CD36;ROCK1;RAP1B;RAP1A;AGT;SPTY2D1;TRAF2;ANKRA2;PARP10;PTPN11;GFAP;VPS11;HJURP;RAPGEF2;HSPA8;BBS10
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3559092003289832,-1.2581046259356712,0.13242784380305603,0.33407579776351454,1.0,13/59,13.28%,MITF;JUN;NFKB1;RUNX2;MED24;CTNNB1;CBFB;RELA;MOV10;CDK1;MED4;MED31;TNRC6C
prerank,positive regulation of translation (GO:0045727),-0.3303537869772842,-1.2569641633659745,0.10472972972972973,0.33577405563130674,1.0,27/94,20.12%,VIM;NIBAN1;YTHDF3;AGO2;DHX9;CNBP;LARP4B;PCIF1;CD28;LARP4;RPS4X;FASTKD2;EEF2;EIF3E;CCL5;PKM;BOLL;METTL14;DHX36;NGRN;FASTKD3;POLR2G;RPS9;RMND1;DDX3X;C1QBP;RBM3
prerank,negative regulation of phosphorylation (GO:0042326),-0.33639090220456386,-1.25547874143009,0.11129848229342328,0.33806428097437974,1.0,28/85,23.38%,PID1;LYN;CORO1C;XDH;NIBAN1;ROCK1;NUPR1;IBTK;STAP1;PPP1R15B;CBFA2T3;LRP6;MYADM;SIRPA;PAQR3;IGFBP3;CIB1;CRKL;ANKLE2;IRS2;CDKN2C;PTPN13;ZC3H12A;INHA;PLPP3;PRKDC;TARDBP;TGFB1
prerank,carbohydrate derivative transport (GO:1901264),-0.46797887987101766,-1.2550132478051357,0.18074324324324326,0.338601018378499,1.0,7/18,17.26%,ABCG1;PLTP;SLC10A7;SLC15A3;NPC2;CLN3;SLC29A1
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.47779479590889296,-1.2544411817532906,0.18858131487889274,0.339334143196751,1.0,8/16,25.43%,BLM;MCM6;RAD51;SSBP1;WRN;MCM2;TWNK;RECQL5
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3389955557392143,-1.2543085006859032,0.12248322147651007,0.3392916457692132,1.0,28/80,25.25%,KLC1;KIF3B;UVRAG;KIF11;RAB1A;COG7;TMED10;KIF23;KIF15;TAPBP;GOLPH3L;KIF4A;RINT1;CENPE;TMED3;COPA;RER1;RACGAP1;KIF2C;TMED2;KIF22;PLPP3;COG4;ARCN1;COPB2;RAB1B;ERGIC1;KIF26A
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.46213765284640296,-1.2539249268636479,0.17264957264957265,0.3396918242976498,1.0,8/20,16.05%,PLEK;ROCK1;RHOQ;LCP1;NCKAP1L;FMNL2;IKBKB;RAB13
prerank,energy reserve metabolic process (GO:0006112),-0.46443823071709067,-1.2537618778283481,0.2013888888888889,0.33969681101893456,1.0,9/19,25.75%,PID1;PRKAG2;PHKG2;GBE1;GSK3B;GFPT1;PYGL;MYC;MT3
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.3134367706880996,-1.2528792371115551,0.07528641571194762,0.3409986798137726,1.0,50/132,26.74%,DHX9;RPL11;CRNKL1;ERAL1;EIF3A;SNRPG;GCFC2;RPS14;EIF5;COIL;SNRPF;RPS28;SART1;NUDT21;CELF1;HSP90AB1;SMN1;MRPS11;YTHDC1;RPL6;NCBP1;SART3;ZRSR2;GEMIN7;SNUPN;DDX1;SRSF10;SHQ1;PRPF18;RPS27;TXNL4A;RPL23A;WDR77;TGS1;SF3B1;GEMIN6;XAB2;SRPK1;RPLP0;BRIX1;PRKDC;RPS15;EIF2S2;PRPF6;DDX39B;MRPS7;RPL5;EIF6;RAMAC;ISY1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4860774203783498,1.252653762652344,0.1939252336448598,0.44750347187832207,1.0,3/13,8.65%,NR3C2;PGR;BMP7
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4356843044067338,1.2525797765288749,0.16159250585480095,0.44648538078487393,1.0,2/21,1.49%,ANK2;CACNA2D1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.3973877727890363,-1.2522762713943256,0.13660245183887915,0.34179341372960304,1.0,10/36,12.80%,MSR1;ARHGAP25;MYH9;CD36;RAC1;ITGB2;CDC42;SH3BP1;ARHGAP12;FCGR2B
prerank,actin filament bundle assembly (GO:0051017),-0.4062320129112959,-1.2518896946864049,0.15331010452961671,0.3421902997363108,1.0,8/33,11.84%,NEDD9;EPS8;BAIAP2;LIMA1;LCP1;MICAL1;HSP90B1;BAIAP2L2
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3407536156161013,-1.251786941510188,0.10774410774410774,0.34210113776386164,1.0,16/76,11.84%,NRP1;P2RX7;PLEK;SNX9;FES;CDC42;PTK2B;STAP1;DYNC1H1;BAIAP2;KATNBL1;NES;NCKAP1L;WDR1;CDC42EP2;BAIAP2L2
prerank,regulation of neuron projection arborization (GO:0150011),0.4809571407492673,1.2517649432763462,0.19714964370546317,0.4469833503454308,1.0,8/15,22.34%,GRIP1;NTNG2;NTNG1;MFSD2A;MAP3K13;FZD4;WNT5A;DVL3
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.336528765926465,-1.2499740088472289,0.10561056105610561,0.3450905266795253,1.0,16/80,11.10%,ABCG1;GSAP;VIM;NIBAN1;PRKCD;YTHDF3;PICALM;LARP4B;PCIF1;CD28;LARP4;SIRT3;RPS4X;RELA;EEF2;EIF3E
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.2693583890610641,-1.2498080791800668,0.01862464183381089,0.34513468519444757,1.0,130/497,22.98%,RBPJ;MDFIC;FOXP1;CD38;RCOR1;DAPK1;BCL6;WWP1;MIDEAS;RB1;JUN;PEX14;NIBAN2;ZNF568;PPARD;GAPDH;ARID5B;BRD7;ZNF148;SBNO2;PPARG;ELK3;GATAD2A;SPI1;BRCA1;WWP2;S100A11;CNOT1;IKZF1;NIPBL;SNX6;HHEX;ZBTB21;RUNX2;FBXW11;PRMT2;CENPF;DAPK3;SMARCC2;NR1H2;CIITA;PUS7;CBFA2T3;AHR;CTNNB1;GAS6;GCFC2;EZH2;PBXIP1;JARID2;DPF2;EIF2AK1;EIF2AK2;BHLHE40;EED;E2F1;SPEN;PCIF1;SELENOS;FOXN3;SUDS3;HDAC10;CIART;RELA;TIMELESS;XRCC6;CHMP1A;KLF10;CHD8;KAT7;CCDC85B;HMGB2;MTA3;HDAC5;DHX36;TFAP4;SIN3A;CALCA;EPC1;PSPC1;ID2;PRMT6;MAP3K10;NCL;BTAF1;PHC3;KMT5A;IKZF4;UBE2I;ATXN1;TOB1;RARA;ATF5;LIMS1;NR3C1;GATA3;MYB;SAMD1;ARID5A;RPS3;ID1;RSF1;DDX3X;ENPP1;CNOT8;BMPR2;DDX6;GSK3B;CIC;BAP1;CBFA2T2;SIRT2;SFRP1;LSM14A;CDK5;KDM1A;RACK1;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SHMT1;SET;RPS6KA5;SCMH1;EID2;CRYAB;NONO;SOX7
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5445526198231067,-1.249746801717984,0.1954225352112676,0.34496530931610986,1.0,5/10,19.32%,PID1;PRKCB;SELENOS;APPL2;ENPP1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.35886652183884693,-1.2495207859435145,0.14285714285714285,0.34505590832743377,1.0,22/61,19.74%,CDK6;RB1;GSPT1;GPR132;CRLF3;PLK2;E2F1;E2F3;EIF4EBP1;DBF4;CDKN3;CDC25A;CUL4B;CACUL1;PLK3;CUL2;CCNE1;CDC34;LATS2;CDKN2C;RCC1;MAX
prerank,negative regulation of growth (GO:0045926),-0.3157986001490944,-1.2490366079441826,0.09120521172638436,0.3456436490128115,1.0,38/121,23.38%,NOTCH2;BCL6;RB1;PTPRJ;SIPA1;APBB2;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;CRLF3;BST2;FLCN;OSGIN1;STK11;ADAM15;CCDC85B;MT2A;BTG1;EI24;PPP1R9B;SPHK2;HSPA1A;CDKN2C;DDX3X;ENPP1;BMPR2;NME6;SFRP1;PPT1;RACK1;CGRRF1;ESR2;TGFB1
prerank,peptidyl-serine modification (GO:0018209),-0.30557195158273254,-1.2488531611563616,0.0660377358490566,0.3456813097689173,1.0,51/166,23.06%,PRKCH;PRKCB;MAPKAPK3;PAK2;PRKCD;ROCK1;CAMK1D;CSNK2A1;VRK2;TLK1;MAPKAPK2;SGK1;DYRK2;MAPK14;ULK2;CAB39;GALNT3;GAS6;PLK2;VRK3;STK38;TGFBR1;GALNT1;NEK6;MASTL;MORC3;CDK1;DYRK1A;MKNK1;TGFBR2;MAST2;MARK2;IKBKB;MAP3K10;TTK;MKNK2;LATS2;PNCK;AURKA;PKN3;ATM;NDNF;WNK1;GSK3B;CDK5;CSNK1G3;MAST3;MAPK1;RPS6KA5;PRKDC;SMG1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.3153950031106741,-1.2487177317596208,0.09359605911330049,0.34561842967703216,1.0,43/129,23.41%,DNM2;BACH1;OPTN;CENPJ;FBXL17;CNTRL;DYNC1H1;FBXW11;CCNY;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;CDK14;YWHAE;MASTL;NES;CEP70;HAUS4;CDC25A;DCTN1;CDK1;HAUS7;PLK3;PPP1R12A;ODF2;NINL;PCNT;FBXL8;SKP2;AURKA;WEE1;PHLDA1;FBXL6;PAFAH1B1;CEP192;CDC25C;CETN2;TUBA4A;CEP41;CCNB1;PPP1CB
prerank,mitochondrial translation (GO:0032543),-0.32417195325042314,-1.248324736761838,0.11461794019933555,0.3460852143671482,1.0,43/104,34.45%,NOA1;MRPS10;ERAL1;MRPL42;TUFM;FASTKD2;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPL54;MRPS25;EARS2;MRPL39;MRPL53;MRPL11;MRPL33;MTRF1;GATB;MRPL28;MRPL30;MRPL43;MRPS17;MTIF3;MRPS5;MRPL1;MRPS28;MRPS35;RARS2;MRPS21
prerank,multivesicular body organization (GO:0036257),-0.40250064240950034,-1.2482638245970112,0.17073170731707318,0.34591195667020225,1.0,17/31,34.65%,PDCD6IP;CHMP5;TSG101;CHMP7;CHMP1A;STAM2;CHMP2A;RAB11A;VPS4A;CHMP4B;CHMP4A;CHMP2B;MVB12A;VPS4B;IST1;VTA1;HGS
prerank,axon extension (GO:0048675),0.42545782375488517,1.2482593608249053,0.15671641791044777,0.4531886059168497,1.0,6/23,4.04%,AUTS2;MAP1B;SLIT3;SLIT2;SEMA5A;SLIT1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.4756494947740348,1.2481332483784462,0.19148936170212766,0.45105367331915464,1.0,4/16,5.44%,ARHGAP6;CLASP2;DLC1;APOD
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.4756494947740348,1.2481332483784462,0.19148936170212766,0.45105367331915464,1.0,4/16,5.44%,ARHGAP6;CLASP2;DLC1;APOD
prerank,muscle tissue morphogenesis (GO:0060415),0.47364553801773074,1.247788729038397,0.22327790973871733,0.45059729671105897,1.0,5/16,20.43%,TBX1;TTN;MYLK;TGFBR3;EFEMP2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3763126855305983,-1.2472248377758486,0.11986863711001643,0.3474607607500021,1.0,15/46,18.75%,RBPJ;RB1;IL15;TLR4;LNPEP;NR1H2;PLCL2;TLE3;ACOT13;FLCN;STK11;IL18R1;TFE3;RHEB;ID1
prerank,regulation of primary metabolic process (GO:0080090),-0.314115140940493,-1.247015837652556,0.08240887480190175,0.34756654748922655,1.0,36/126,20.83%,APOE;PSAP;CREBBP;PPARD;NFYA;PSME4;PPARG;PSMB7;PSME3;ADIPOR1;SMARCD3;PSMB9;TBL1XR1;EDF1;AZIN1;HELZ2;PSMA8;PSMC3;PSMD8;PSMC4;IDI1;PSMB10;RXRA;PSMA1;SIN3A;ID2;ACACB;PSMB8;IRS2;NCOA6;LDLR;PSMA5;PSMD4;TGS1;PSMB3;PSMD3
prerank,positive regulation of reproductive process (GO:2000243),0.39213168080148736,1.2467551175476994,0.1596244131455399,0.45155141073672506,1.0,10/31,16.91%,PLCB1;GLRA1;CFAP69;PLA2G10;HYAL3;TACR3;INHBB;SYDE1;INHBA;PDE3A
prerank,response to peptide hormone (GO:0043434),-0.3787032635184451,-1.246352615322119,0.15077989601386482,0.3484777260110608,1.0,19/43,28.48%,ROCK1;OGT;STAT3;SLC27A1;STAT6;ANXA1;EIF2B3;STAT5B;STAT4;XBP1;TRIM16;EIF2B1;STAT1;STAT2;EIF6;ZFP36L1;ZBTB7B;EIF2B2;EIF2B4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.4034342838192416,-1.2461668689044723,0.16366612111292964,0.3485393994711563,1.0,12/33,21.23%,NUPR1;NFE2L2;GAS6;WFS1;MDK;CAST;MAPK7;TNIP2;SERPINE1;GATA3;NDNF;KDR
prerank,RNA methylation (GO:0001510),-0.3561303152419159,-1.2460658409080727,0.1113013698630137,0.348440314606142,1.0,20/60,25.44%,NSUN3;METTL1;CBLL1;NSUN4;DIMT1;PCIF1;TRMT44;METTL14;METTL6;VIRMA;TRMT6;WTAP;TGS1;BCDIN3D;METTL2B;METTL2A;THADA;RBM15B;BUD23;MRM2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2795769338169556,-1.2460139282909921,0.03129657228017884,0.3482728665002532,1.0,91/327,22.98%,MITF;ZMIZ1;TFEB;RREB1;RB1;DNM2;CREBBP;RUNX3;BACH1;INSR;IRF2;APBB2;SBNO2;NFX1;NFYA;NSD3;SPI1;FOXN2;JMJD1C;CTR9;STAT3;LYL1;ZSCAN26;RYBP;CHD3;RNF20;SAP30;DAPK3;GPBP1L1;GON4L;SRRT;FUS;AHR;GCFC2;EZH2;REXO4;POFUT1;EDF1;BHLHE40;E2F1;CNBP;TGFBR1;THAP1;RALY;HIF1A;MEF2C;FOXN3;UBE2L3;HDAC10;HP1BP3;RELA;PRDM2;KMT2D;SPIN1;MLLT6;KAT7;TCF7;SPTY2D1;POLR2A;RPL6;PSPC1;BTG1;TCF3;ZNF628;NSD1;SRSF10;HCLS1;ATXN1;VHL;ATF5;NR3C1;MYB;PPARGC1B;PLAG1;CXXC1;CASZ1;NUP35;PAK6;SUFU;NUP107;ATF7;ZFPL1;GTF2IRD1;ZSCAN21;SNAI2;CEBPB;RPS6KA5;CHD7;NONO;ESR2;SOX7
prerank,androgen metabolic process (GO:0008209),-0.4667873472979964,-1.2456952995041728,0.18021201413427562,0.3485702743846234,1.0,10/18,37.82%,HSD17B7;SPP1;SRD5A1;SRD5A2;HSD17B10;HSD3B2;SRD5A3;HSD17B3;AKR1D1;CYP19A1
prerank,establishment of endothelial barrier (GO:0061028),-0.4115524941507574,-1.245648516253799,0.1696113074204947,0.3483648732378384,1.0,6/29,6.88%,MSN;RAP1B;RAP2B;RAP1A;RAB1A;MYADM
prerank,dendritic cell chemotaxis (GO:0002407),-0.49168400644024596,-1.2454514763888895,0.19652173913043477,0.3484654537241523,1.0,6/14,19.37%,CCR2;CCR1;PIK3CG;CCL5;CXCR4;HMGB1
prerank,Rho protein signal transduction (GO:0007266),-0.36544177504095665,-1.2452445365552867,0.11054421768707483,0.3485229415138348,1.0,11/53,11.45%,MYO9B;ROCK1;ARHGEF3;RHOA;EPS8;GNA12;CDC42;CDC42EP2;PLEKHG5;GNA13;ARHGEF11
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.511231519082651,1.2450163760406785,0.20046620046620048,0.45407873383897146,1.0,5/11,20.38%,FYN;REST;PRKN;LANCL1;UBQLN1
prerank,regulation of histone acetylation (GO:0035065),-0.39890010367832707,-1.244599962407288,0.156794425087108,0.3493671620077493,1.0,10/33,22.18%,BRD7;SPI1;BRCA1;ARRB1;FLCN;HDAC5;KMT2A;CHEK1;SET;RPS6KA5
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.49873195319537567,1.2443323557997752,0.22325581395348837,0.4544287130728209,1.0,4/12,10.97%,PLCB1;SLIT2;CCN3;NBL1
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.46454644239034,-1.243866260538383,0.1916376306620209,0.3504253555666432,1.0,5/19,17.48%,PRKCD;ABCD2;DAGLB;ABHD5;IRS2
prerank,P-body assembly (GO:0033962),-0.5149219098936604,-1.2438660496259621,0.19965576592082615,0.3501492126544552,1.0,5/12,21.20%,RC3H1;DYNC1H1;PATL1;DDX6;LSM14A
prerank,telomere organization (GO:0032200),-0.37197162592661126,-1.24359579048677,0.14655172413793102,0.3503510978260365,1.0,17/43,26.18%,SP100;BLM;RTEL1;XRCC6;WRN;PCNA;RPA3;POLD2;ERCC4;DOT1L;DNA2;ATM;NBN;PRKDC;POLD4;MRE11;DCLRE1B
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.48222825610879394,-1.2435746647610295,0.20431893687707642,0.35010849347470957,1.0,9/16,35.74%,RAET1E;AP1G1;LAMP1;CD226;SLAMF6;CRTAM;KLRC2;KLRD1;IL12A
prerank,cholesterol biosynthetic process (GO:0006695),0.39069844106599505,1.2430800971705906,0.14320388349514562,0.45589803760504394,1.0,10/31,14.49%,HMGCS1;DHCR24;CYP51A1;INSIG1;SQLE;DHCR7;SC5D;EBP;MVK;LSS
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4433011150673927,-1.2423330562094002,0.18739352640545145,0.35198632495137055,1.0,13/21,33.28%,IGF1;JUN;ERN1;MEF2D;FOXJ2;ADAMTS1;MMP2;P2RY6;FGF9;LDLRAP1;FGF2;GJA1;MMP9
prerank,positive regulation of double-strand break repair (GO:2000781),-0.38287248912190897,-1.241845666455839,0.15017064846416384,0.35255601462440045,1.0,16/39,20.74%,ARID2;ACTR2;SPIDR;ERCC6;FUS;WDR48;KMT5B;PARP9;KMT5C;MGMT;TIMELESS;RAD51AP1;WRAP53;SHLD2;MMS19;DTX3L
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.33433469849272024,-1.2417559303896475,0.10314685314685315,0.35244800058365655,1.0,26/84,20.83%,RB1;PSME4;PSMB7;ANAPC1;PSME3;PSMB9;PSMA8;UBC;RPS27A;PSMC3;CDK1;PSMD8;BUB1B;PSMC4;PSMB10;PSMA1;UBE2C;PSMB8;SKP2;AURKA;ANAPC7;FBXO31;PSMA5;PSMD4;PSMB3;PSMD3
prerank,regulation of biomineral tissue development (GO:0070167),-0.4211319307820284,-1.2417358898269888,0.15736040609137056,0.35219869943173643,1.0,11/26,35.00%,ROCK1;GAS6;ANKH;ENPP1;CEBPB;TGFB1;NOTUM;HEY2;ROCK2;BMP2K;HEY1
prerank,stress granule assembly (GO:0034063),-0.455206465104429,-1.2415956468636813,0.19434628975265017,0.352177297500528,1.0,10/20,23.33%,YTHDF3;DYNC1H1;RPS23;CSDE1;G3BP1;DDX3X;DDX6;LSM14A;ATXN2L;PRRC2C
prerank,positive regulation of gene expression (GO:0010628),-0.2694021758901927,-1.241452416959079,0.02359882005899705,0.35217334162262776,1.0,87/442,14.39%,PID1;RBPJ;MITF;IGF1;MSN;CD74;FGR;LILRB1;P2RX7;VIM;PLCG2;NIBAN1;CD36;ROCK1;YTHDF3;DEK;ERN1;AGO2;GAPDH;NFE2L2;SMARCA5;RIPK1;BRCA1;HTR2B;STAT3;ERCC6;IL15;TLR4;STAP1;ACTB;PTGER4;PTPN22;MAPK14;BATF;PF4;RPL11;PIK3CB;FN1;PIK3CG;GAS6;POLR2H;VEGFA;EIF2AK2;E2F1;MYD88;LARP4B;POLR2F;TGFBR1;WBP2;PCIF1;CD28;DDX5;HIF1A;LARP4;MEF2C;POLR2L;CTSH;SERPINB9;RPS4X;CLEC9A;EGR1;SPRY2;AGT;ITGAX;MOV10;EEF2;APP;EIF3E;MYOM1;OSR1;DYRK1A;MAP2K1;TICAM1;CELF1;CD46;HNRNPLL;CLEC6A;ITK;METTL14;TNRC6C;PIK3CD;DHX36;CALCOCO1;POLR2A;NFAM1;AGPAT1;ID2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.43947678134704415,-1.2414229269916401,0.1733800350262697,0.35195287217404836,1.0,5/22,10.48%,LYN;ABCG1;GSAP;PICALM;RELA
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.5206279882674693,-1.2410883066412848,0.19073083778966132,0.3523016333205113,1.0,4/11,21.48%,CIITA;PF4;XBP1;TMEM106A
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4706052539345363,-1.2410543213804808,0.17894736842105263,0.35207947793604494,1.0,7/16,8.31%,ARHGAP24;OGT;ARHGAP17;PIK3CB;PIK3CG;ALS2;SH3BP1
prerank,negative regulation of cell migration (GO:0030336),0.2988268641382531,1.240731051323157,0.0925,0.45956663010670656,1.0,18/137,5.36%,ROBO1;MAGI2;NAV3;PTPRG;TMEFF2;SLIT2;PTPRR;PTPRT;LIMCH1;IGFBP5;TCAF1;ADORA3;AFDN;CLASP2;ACVR1C;DLC1;PTPRK;PODN
prerank,regulation of mononuclear cell migration (GO:0071675),-0.43458719011031344,-1.2407147010159154,0.1765704584040747,0.3523745569051008,1.0,9/23,22.16%,LYN;MSN;MDK;CCL5;IL34;CMKLR1;STK10;CSF1;MAPK1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.3335458066851146,-1.2403968210737475,0.11221122112211221,0.35269230169605825,1.0,25/87,20.83%,CDK6;RB1;BRD7;PSME4;PSMB7;PSME3;GPR132;PRMT2;PSMB9;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;AVEN;PSMA1;PSMB8;AURKA;WEE1;CDKN2C;CDK2AP2;PSMA5;PSMD4;PSMB3;PSMD3
prerank,renal filtration (GO:0097205),-0.546018619455724,-1.2400896201177247,0.21465076660988075,0.35295274366468155,1.0,5/10,18.61%,SULF2;TBC1D8B;MYO1E;ITGA3;XPNPEP3
prerank,protein-containing complex assembly (GO:0065003),-0.2829967459278807,-1.2400589563878448,0.051908396946564885,0.35272692490087276,1.0,62/259,17.40%,MITF;SKAP2;SH3PXD2B;CD74;WIPF1;CTSZ;P2RX7;PEX14;SNX9;CREBBP;ANO6;LPXN;RIPK1;SLC2A1;DHX9;RAB1A;PTK2B;TMED10;AIM2;BLM;AXIN1;TAPBP;TFG;FN1;WASL;PREB;CAPG;PICALM;CTNNB1;DET1;CTSC;TUBGCP4;SLC9A1;ITGB1BP1;TLE3;REPS2;DARS1;NCKAP1L;PDZD11;DNAJB14;TRAF1;SEC24A;PPP6R3;SEC24D;KMT2D;STX5;TCF7;CAPZA1;TRAF2;KPNA3;SEC31A;TFAP4;NIFK;CD40;ST13;TRAPPC5;TLE4;IL2RB;KMT2A;TMED2;CASP8;CLDN1
prerank,positive regulation of developmental process (GO:0051094),0.2888861471156919,1.2399233936104521,0.05511811023622047,0.460224550642877,1.0,34/164,14.11%,NLGN1;NRXN1;GRIP1;PLCB1;ENPP2;BMPR1B;ARHGEF7;SOX5;SOX6;PTN;CLASP2;GDNF;ACVR1;SHANK3;ANAPC2;SPIRE1;WT1;MIEF1;ALK;SOX9;FMR1;BMP7;COBL;POU4F2;NEUROD1;CPEB3;RELN;BMP1;TAPT1;VLDLR;REST;PRKN;SYDE1;PACSIN1
prerank,regulation of microtubule polymerization (GO:0031113),0.3709829100794814,1.23981103897017,0.18004866180048662,0.45924847801177265,1.0,12/40,17.08%,NAV3;MAP2;MAPRE3;TUBB4A;OCLN;EML2;CDK5R1;CDK5RAP2;CDH5;ARL2;SNCA;PRUNE1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.5093307551650575,-1.239679794657448,0.21195652173913043,0.3531426717323494,1.0,6/12,21.12%,TMEM199;GRN;CLN6;CLN3;VPS33A;PPT1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.48739939776748353,1.2395146769688792,0.21666666666666667,0.45865940512165526,1.0,4/13,15.66%,SYT1;SYT10;HYAL3;CACNA1G
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5092249482977165,-1.2386631160789765,0.20738137082601055,0.3546768628074384,1.0,2/12,1.91%,IREB2;IDH1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.39517537388044516,-1.23860385556549,0.17435897435897435,0.3544972632689196,1.0,11/34,16.15%,MFHAS1;SPI1;RIPOR2;PICALM;SNX33;DNAJA1;NEDD4L;FLCN;SIN3A;LEPROTL1;LATS2
prerank,artery morphogenesis (GO:0048844),-0.40604559864230955,-1.2384823972971282,0.17825311942959002,0.35440713903928234,1.0,14/30,31.99%,NRP1;LRP1;JAG1;VEGFA;TGFBR1;SMAD7;PDGFRB;BMPR2;TBX2;LRP2;ENG;GJA5;ADAMTS9;HEY2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4025384138053908,1.238432969739719,0.17002237136465326,0.45978521431901676,1.0,10/26,20.38%,GNB5;CASQ2;FMR1;CALM1;CALM3;CALM2;CBARP;CRHR1;GPR35;UBQLN1
prerank,regulation of multicellular organismal development (GO:2000026),-0.41883780932654724,-1.2381431901255393,0.1916376306620209,0.35477524943776506,1.0,11/25,21.59%,HPSE;INSR;NIPBL;DUSP6;CDK1;DHX36;RACGAP1;GATA3;TRIP12;OAS2;BAG6
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.42571927554787736,1.2381088969779543,0.1938534278959811,0.45928891959885276,1.0,5/23,7.51%,ANK2;CACNA2D1;CASQ2;PRNP;FYN
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.47330143452675044,-1.237416920345961,0.19725557461406518,0.3558131191977512,1.0,7/16,21.30%,NRP1;PTPRJ;RGS14;PIK3C2A;PDGFRB;PTPN1;PDGFA
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4164896907295645,-1.2370651596924203,0.18134715025906736,0.3561977508416437,1.0,9/25,12.75%,ITGA4;ITGB2;ITGA5;ITGB1;ITGAV;ITGB7;ITGAX;CD2;CXADR
prerank,limb development (GO:0060173),0.4071087786001128,1.2369222911330606,0.17865429234338748,0.46061145741166787,1.0,13/28,21.21%,PCSK5;BMPR1B;LNPK;KREMEN2;FGF10;IQCE;SALL1;KDF1;GLI3;KAT2A;SMOC1;LRP4;INTU
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4344103289168789,1.2367208385702042,0.20608899297423888,0.4598538457202231,1.0,7/20,14.89%,SEMA6D;SEMA6A;SEMA3E;SEMA5A;SEMA3F;SEMA5B;SEMA4G
prerank,cholesterol homeostasis (GO:0042632),-0.34784155321376636,-1.2366391109776642,0.1541038525963149,0.3566907861305739,1.0,15/64,15.20%,APOE;ABCA1;ABCG1;IL18;GRAMD1B;NR1H2;CNBP;RALY;LIMA1;LPL;NPC2;XBP1;TTC39B;EHD1;NPC1
prerank,cellular component assembly (GO:0022607),-0.2829634504717009,-1.235759442421293,0.04468412942989214,0.35802475963392527,1.0,57/253,17.14%,MITF;NEDD9;SKAP2;CD74;WIPF1;FBLIM1;RAC1;YTHDF3;PEX14;SNX9;CREBBP;RHOA;EPS8;FLNA;STX7;LPXN;PARVB;CDC42;SLC2A1;PTK2B;ACTB;TAPBP;WASL;RHOQ;CAPG;PICALM;GAS6;DET1;BAIAP2;SH3BP1;TUBGCP4;CCDC40;LIMA1;REPS2;DARS1;LCP1;NCKAP1L;TLCD2;SPAG16;TRAF1;MICAL1;BAIAP2L2;FOXJ1;CAPZA1;TRAF2;KPNA3;SPEF1;TFAP4;NIFK;CD40;ST13;CHAF1A;DNAJB13;ESPN;IL2RB;RBBP4;KMT2A
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.40361130956142155,1.2352693723476547,0.18491484184914841,0.4617432638341566,1.0,6/24,8.14%,ANK3;TCAF1;MIEF1;PRNP;FYN;MTCL1
prerank,potassium ion homeostasis (GO:0055075),0.43243707756349453,1.2350260177101084,0.19058823529411764,0.46102066615645954,1.0,7/23,12.53%,SLC12A2;SLC12A8;SLC12A1;ATP1A3;ATP1B1;SLC12A5;KCNMA1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.328948049940788,-1.2348929310079806,0.12191103789126853,0.3593776737473807,1.0,27/88,20.83%,PSME4;FBXL17;PSMB7;PSME3;FBXW11;PSMB9;FBXL20;FBXO38;PSMA8;PSMC3;KIF14;CUL4B;PSMD8;PSMC4;PSMB10;CUL2;PSMA1;PSMB8;FBXL8;SKP2;FBXL6;FBXO31;PSMA5;PSMD4;PSMB3;FBXW4;PSMD3
prerank,stem cell differentiation (GO:0048863),-0.38373438527869796,-1.2347808418073059,0.1454849498327759,0.3592880836871631,1.0,9/39,11.44%,PTPRC;NELFB;HTR2B;FBXL17;BATF;LRP6;JARID2;MEF2C;OSR1
prerank,T cell migration (GO:0072678),-0.4956797545702538,-1.2347587866121046,0.2097902097902098,0.3590499356482539,1.0,6/13,17.49%,MSN;MYO1G;PIK3CG;CXCL16;PIK3CD;ZAP70
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.47930478162980017,-1.234727057271042,0.1934931506849315,0.35882453663745045,1.0,2/15,1.09%,CCR2;SYK
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.4900249862123801,-1.2342793348138945,0.19270833333333334,0.35939226127581025,1.0,3/15,5.73%,PPARD;PPARG;NR1H2
prerank,cell cycle G2/M phase transition (GO:0044839),-0.31117551587822856,-1.2342357854938437,0.11237785016286644,0.3591821614439687,1.0,46/130,25.40%,DNM2;OPTN;CENPJ;FBXL17;CNTRL;AKAP8;DYNC1H1;FBXW11;CCNY;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;CDK14;YWHAE;MASTL;NES;CEP70;HAUS4;CDC25A;DCTN1;CDK1;HAUS7;PLK3;PPP1R12A;ODF2;NINL;PCNT;FBXL8;SKP2;AURKA;WEE1;PHLDA1;FBXL6;PAFAH1B1;CEP192;CDC25C;CETN2;TUBA4A;CEP41;CCNB1;PPP1CB;AKAP8L;CCNB2;CEP72
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5159206742218825,-1.2340583179673619,0.2128060263653484,0.359216598611719,1.0,3/12,13.97%,APOBEC1;RESF1;SETDB1
prerank,protein targeting to peroxisome (GO:0006625),-0.41396903344549363,-1.233685017868481,0.16611295681063123,0.3596203452370857,1.0,8/29,16.74%,RAB8B;PEX14;ABCD2;PEX26;ZFAND6;FIS1;PEX7;ABCD3
prerank,ncRNA export from nucleus (GO:0097064),-0.3839851292489698,-1.233429875955351,0.15371621621621623,0.3597967112273952,1.0,14/36,21.45%,NUP50;XPOT;NUP42;NUP88;RAE1;NOL6;NUP205;TPR;NUP188;NUP153;PHAX;NUP35;NUP107;NUP62
prerank,response to fatty acid (GO:0070542),-0.4678164308116123,-1.232984030998157,0.21492007104795738,0.36030652373475935,1.0,4/17,9.75%,PID1;CD36;FOXO3;LPL
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.3486576290032142,-1.2328955250014897,0.1349911190053286,0.36018368303857373,1.0,27/68,26.72%,MTHFS;PANK2;SLC2A1;MTHFD1L;TPK1;CYB5R3;ABCC1;PDZD11;MTR;MTHFD2L;PDXK;ACP5;SLC23A1;SLC23A2;MMUT;ENPP1;LMBRD1;PNPO;MTHFR;SLC52A2;SHMT1;GSTO1;AASDHPPT;HLCS;FPGS;CYB5A;SLC52A1
prerank,regulation of microtubule-based movement (GO:0060632),0.5013753645241771,1.2326806651010296,0.2191780821917808,0.4648601449815393,1.0,5/11,18.37%,MAP2;NEFH;CFAP298;HAP1;TTC21B
prerank,receptor catabolic process (GO:0032801),-0.425936299408564,-1.2322074107404724,0.17413793103448275,0.3610975656317575,1.0,13/24,26.88%,ZNRF3;MYLIP;UVRAG;KIF16B;AP2A2;SNX25;SH3GLB1;RNF43;BECN1;TGFB1;AP2S1;SMURF1;AP2A1
prerank,retina homeostasis (GO:0001895),-0.4268638139572686,-1.2319550681359257,0.19546247818499127,0.36128077329032887,1.0,5/23,11.57%,ACTB;POTEF;B2M;SLC28A2;PRDX1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4631868460767215,-1.2309276331690444,0.1875,0.3628927807243383,1.0,4/18,6.51%,PRKCB;PRKAG2;SLC2A1;C3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5104793204971214,1.2307280082467795,0.21788990825688073,0.4677860922023435,1.0,5/12,19.00%,PDE4D;CALM1;CALM3;CALM2;GJD3
prerank,peptide metabolic process (GO:0006518),0.3198208052874767,1.2304700171540166,0.13493975903614458,0.4671905574659874,1.0,17/75,16.45%,DMD;PCSK5;MME;TRHDE;MGAT3;IDE;SEC11C;ABCB9;GSTZ1;GSTP1;PCSK1;CPE;GGT1;GSTK1;LTA4H;GSTM5;DNPEP
prerank,base-excision repair (GO:0006284),-0.3626111411563945,-1.2303938431848462,0.14886164623467601,0.3636022756036529,1.0,21/48,25.67%,ERCC6;RFC1;NEIL3;LIG1;WRN;PCNA;FEN1;RPA3;RFC2;POLD2;PRMT6;LIG3;NEIL2;DNA2;HUWE1;ADPRS;RFC3;POLB;POLD4;MPG;XRCC1
prerank,purine-containing compound catabolic process (GO:0072523),-0.5026887435640301,-1.2302915093132205,0.22980251346499103,0.3634990917987283,1.0,3/13,9.96%,GDA;XDH;NT5C2
prerank,peptidyl-lysine modification (GO:0018205),-0.3250945102387511,-1.2300819402898218,0.12479201331114809,0.36357994941994176,1.0,36/99,30.34%,NSMCE2;NUP50;PIAS1;ATP7A;NUP42;NUP88;RAE1;SENP3;SIRT3;NUP205;HDAC10;TPR;NUP188;USPL1;UBA2;UBE2I;EYA1;NUP153;NUP35;SIRT2;NUP107;NUP62;EGR2;TOPORS;SUMO3;PLOD3;METTL21A;SAE1;RANBP2;TRIM28;NUP37;EP300;PLOD1;PIAS2;AAAS;NUP133
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.47795419674750433,-1.2297835173010774,0.20825852782764812,0.36384254276980027,1.0,7/16,23.12%,ADCY7;ABCD2;SIRPA;NLRC3;APPL2;ZC3H12A;MEFV
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.33515228349480686,-1.2296570000174023,0.13486842105263158,0.36380532075143235,1.0,36/78,34.60%,DAB2;HECTD1;RNF19A;NFE2L2;PIAS1;CBFA2T3;NUB1;DET1;TRIB1;TRIB2;RNF180;PLK3;ARIH1;GABARAP;HSPA1A;SMAD7;FBXO22;GSK3B;SIRT2;SGTA;RACK1;SOCS5;RNF19B;VCP;COP1;CDC20;KEAP1;USP5;CAV1;HSPBP1;HSPA1B;STUB1;CSNK1D;UBQLN2;NOP53;RAD23A
prerank,protein modification process (GO:0036211),-0.3362171497872589,-1.2296354080825813,0.16243654822335024,0.3635724607665987,1.0,30/76,23.54%,ST3GAL1;PPP4R2;ST8SIA4;ABL2;WWP2;MSRA;PARP4;STK38;UBA7;UBE2L3;UBL5;SEPHS1;B4GALT7;SERP1;PADI4;FBXW2;PIGH;CDC34;RABGGTA;UBE2I;MAN2B1;GNMT;UBE2M;RABGGTB;FBXO22;BAP1;CSNK1G3;MANBA;PRKDC;ERO1A
prerank,positive regulation of DNA replication (GO:0045740),-0.47491758779790394,-1.2293513621732783,0.2111692844677138,0.36383634053482744,1.0,6/16,17.64%,BCAR3;DHX9;PCNA;KAT7;FAF1;DNA2
prerank,Notch signaling pathway (GO:0007219),-0.3495406982796442,-1.2287962438593794,0.14659685863874344,0.3645751598160116,1.0,19/59,21.80%,RBPJ;NOTCH2;CREBBP;PLXND1;MAML1;MAML2;DLGAP5;JAG1;POFUT1;MDK;PSENEN;MIB1;DTX1;DTX3;MAML3;DTX3L;STAT1;HEYL;SNAI2
prerank,regulation of cell aging (GO:0090342),-0.5118421896805592,-1.2285016361814802,0.20781527531083482,0.3648144092477894,1.0,4/11,35.15%,NEK6;LMNA;NEK4;ING2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.38918667804188983,-1.2279004852247537,0.1889483065953654,0.3656461001098587,1.0,8/39,5.78%,RBPJ;ZMIZ1;TSPAN14;CREBBP;MAML1;STAT3;MAML2;JAG1
prerank,RNA 3'-end processing (GO:0031123),-0.34355022460393425,-1.2274953982249677,0.13666666666666666,0.36610630706007485,1.0,29/69,32.70%,SRRM1;TUT7;CHTOP;CDC40;ALYREF;MTPAP;RPRD2;NUDT21;WDR33;NCBP1;THOC2;RNPS1;TENT4B;THOC6;PAPOLA;MAGOH;SLU7;CPSF3;SRSF11;DDX39B;DHX38;CPSF1;U2AF2;SRSF7;EIF4A3;SRSF5;TUT1;SARNP;U2AF1L4
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.34098063518215144,-1.2274891844998248,0.15033783783783783,0.365836236001302,1.0,23/66,25.68%,PRKCD;IPO5;FLNA;CCT7;PARP9;CDK1;TPR;KAT7;MAVS;BAG3;HCLS1;CCT4;CHP2;DTX3L;ZC3H12A;JUP;GTSE1;TGFB1;RBM22;CARD10;TRIM28;ECT2;LARP7
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.4326246525772463,-1.2274205742788602,0.19630872483221476,0.3656770044918196,1.0,12/22,34.12%,ROCK1;MGAT5;MASTL;NCKAP1L;STYXL1;IKBKB;GSK3B;FKBP1B;BOD1L1;PTPA;ROCK2;TNF
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5470070025990952,-1.227243671042439,0.21016949152542372,0.3657190695871794,1.0,4/10,16.54%,TUT7;UBC;RPS27A;ISG15
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5202909077733875,-1.2267296851271603,0.2099827882960413,0.3663880766738349,1.0,5/11,25.96%,MALT1;NFKBIZ;CLEC6A;NFKBID;IL12RB1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.35986379851056105,-1.2267273730107018,0.16279069767441862,0.3661139405370459,1.0,11/46,10.62%,ITGA4;NRP1;RAC1;RHOA;PEAK1;LPXN;PARVB;ITGAV;FN1;ITGB7;KIF14
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.4407310806011088,-1.2267051566269644,0.19458544839255498,0.36587474035740575,1.0,6/20,16.15%,IPO5;HHEX;INCA1;CDK5RAP1;TFAP4;LATS2
prerank,cellular response to interleukin-15 (GO:0071350),-0.50142564113054,-1.2259149164334846,0.21693121693121692,0.3667398807376514,1.0,6/13,10.81%,GRB2;STAT3;IL15;STAT5B;JAK1;IL2RG
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.50142564113054,-1.2259149164334846,0.21693121693121692,0.3667398807376514,1.0,6/13,10.81%,GRB2;STAT3;IL15;STAT5B;JAK1;IL2RG
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3037071191729289,-1.2257174989161903,0.11129568106312292,0.3668349476733183,1.0,41/137,21.97%,BCAR3;PSAP;RSU1;SNX9;RHOA;DOCK10;DOCK11;SGSM2;RGS1;RAP1A;ITGB1;DOCK8;ARAP1;RAB3GAP1;PICALM;EZH2;ALS2;SH3BP1;RCN3;CTSH;TGM2;PIN1;SNX13;FLCN;WRN;SNX18;CCL5;HMGB2;CD40;TBC1D30;TBC1D7;AGRN;LIMS1;RPS3;MMUT;CHP2;GSK3B;SFRP1;RACK1;MAP4K4;RAP1GDS1
prerank,protein kinase B signaling (GO:0043491),-0.43083712973935395,-1.2255211119605853,0.20203735144312393,0.36688801186094194,1.0,12/23,29.85%,IGF1;GAS6;CCL5;PLK3;SIRT2;KDR;TGFB1;ADTRP;MT3;ZFP36L1;TSC2;PAX2
prerank,cGMP metabolic process (GO:0046068),0.5090568291205273,1.2254919113082983,0.22823529411764706,0.4768474916738986,1.0,2/12,3.86%,GUCY1B1;PDE9A
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.434833961800992,-1.2251227212521498,0.20559210526315788,0.3673843738185015,1.0,9/20,23.38%,LYN;TLR4;IL18;PTPN22;TICAM1;CCL5;HCK;MTDH;TGFB1
prerank,regulation of T cell migration (GO:2000404),-0.4588939048916139,-1.2250986189047643,0.19270833333333334,0.367155514477987,1.0,7/18,15.91%,RHOA;LRCH1;DOCK8;RIPOR2;APP;CCL5;SPN
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.31019334816975375,-1.2250868128821022,0.09404388714733543,0.36690193989281655,1.0,45/119,26.23%,INPP4A;PLCG2;PI4K2A;PIK3R5;MTM1;ITPKB;PIP4K2A;SLC27A1;SYNJ1;MTMR3;MTMR14;PITPNM1;PI4K2B;PIK3CB;DPM3;TMEM150A;PIK3CG;PI4KB;TTC7A;RAB5A;IMPA1;MTMR6;PIK3CA;SOCS6;PIK3CD;PIK3C2A;PIGH;PLEKHA2;PGAP3;SOCS3;PTPN13;PLEKHA4;IP6K3;PIP5K1A;MPPE1;SOCS5;VAC14;PIP5K1C;SMG1;RAB4A;ITPKC;PIK3C2G;INPP5K;PIGZ;IP6K1
prerank,positive regulation of macrophage activation (GO:0043032),-0.4666807558052428,-1.2243336265309157,0.21465968586387435,0.36799257668095126,1.0,5/17,18.51%,TLR4;STAP1;TNIP2;KARS1;MMP8
prerank,membrane organization (GO:0061024),-0.28443309268025463,-1.224195084895982,0.07704160246533127,0.3679491208577861,1.0,63/227,16.37%,DAB2;MYOF;TMCC1;GRB2;CORO1C;ARPC2;ITSN1;CBL;SNX3;DNM2;SNX9;ACTR2;PDCD6IP;NEMP1;SH3KBP1;ARRB2;ACTR3;SYNJ1;SYNGR1;CHMP5;ACTB;ARPC3;GLTP;WASL;FCHO2;ARRB1;PICALM;MYADM;EPS15;HIP1;SUN2;AP2A2;RAB5A;AGFG1;FNBP1;IGF2R;REPS2;UBC;RPS27A;TLCD2;PACSIN2;IL7R;CHMP7;TRIP10;RABEP1;CHMP1A;SAR1A;STAM2;CCDC88A;BAIAP2L2;ARPC1A;SERP1;SH3GLB1;LEMD2;CHMP2A;TOR1AIP1;PIK3C2A;NPC1;ARPC5;VAMP4;CLN3;KIF20A;VAPB
prerank,N-terminal protein amino acid modification (GO:0031365),0.4720206355782662,1.2237551300404519,0.23294117647058823,0.47930625924961867,1.0,5/14,15.43%,METAP2;NAA10;NAA60;METAP1;PDF
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5322324383513333,-1.2233399923551136,0.22602739726027396,0.36919291037213636,1.0,5/10,24.50%,BCL2;MLLT11;KDR;RACK1;DCN
prerank,lysosome organization (GO:0007040),-0.38326558784974213,-1.2231274809508297,0.16843971631205673,0.3693262848942026,1.0,17/36,31.13%,ABCA1;TFEB;GRN;GNPTAB;CLN6;MYO7A;CLN3;TPP1;VPS33A;VPS18;HPS4;TPCN2;LAMTOR1;ACP4;SNAPIN;ACP3;ARSB
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3469503029940575,-1.2231129423834257,0.15344827586206897,0.36907573305811825,1.0,22/65,21.64%,PSME4;PSMB7;PSME3;GPR132;NABP1;PSMB9;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;AVEN;PSMA1;PSMB8;AURKA;PSMA5;PSMD4;CHEK1;PSMB3;VPS4A;PSMD3;ZFYVE19
prerank,positive regulation of signal transduction (GO:0009967),-0.2822908224989195,-1.2230336318203996,0.06549520766773163,0.36893365829312635,1.0,45/238,12.30%,RBPJ;SASH1;PTPRC;NRP1;ZMIZ1;PRKCB;IGF1;CD74;TSPAN14;CRADD;AXL;ITGA5;CREBBP;ERN1;MGAT5;FLNA;CSNK2A1;UCHL5;MAML1;STAT3;MAML2;PTK2B;HHEX;ITGAV;SNX5;MACF1;JAG1;C3;GAS6;SKI;SULF2;WLS;TGFBR1;ITGB1BP1;HIF1A;CD63;LY96;ASXL1;ARNT;IL7R;XBP1;ENHO;F7;SPIN1;CLEC6A
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.43717978923196227,-1.222861267710581,0.19736842105263158,0.3686833579498595,1.0,9/21,17.89%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;HSPA1A;EYA3
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.43717978923196227,-1.222861267710581,0.19736842105263158,0.3686833579498595,1.0,9/21,17.89%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;HSPA1A;EYA3
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.28961359743247606,-1.2226617317380764,0.07814992025518341,0.3687723647081793,1.0,45/190,17.36%,LYN;BANK1;ARHGAP25;P2RX7;XDH;MCL1;PLEK;PTPRJ;ITPR1;RIPK1;SPI1;ARRB2;RIOK3;CD22;ADIPOR1;BCL2;MAPK14;DUSP3;PIK3CB;CYRIB;MYADM;IFI35;MGRN1;UBR2;DGKD;PPM1B;SH3BP1;FNIP1;PLAUR;ARHGAP12;SPRED1;RELA;FLCN;CIB1;NLRC3;RNF34;TMSB4X;CDC34;DGKG;NLRX1;TBC1D7;TNIP3;DEPTOR;CASP8;MAP2K3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.32626226992753876,-1.2224464844253782,0.13658536585365855,0.36890545608224523,1.0,28/83,23.03%,CENPJ;CNTRL;DYNC1H1;CENPF;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;YWHAE;TPX2;KIF14;CEP70;HAUS4;DCTN1;CDK1;HAUS7;ODF2;NINL;PCNT;AURKA;ATF5;PAFAH1B1;CEP192;CETN2;TUBA4A;CEP41;GTSE1
prerank,regulation of cell migration (GO:0030334),-0.26838234693288787,-1.2222155365499785,0.038748137108792845,0.3690530772464224,1.0,77/382,13.40%,DAB2;SASH1;MITF;NEDD9;PLXNC1;IGF1;MCTP1;CD74;FGR;CORO1C;CLIC4;SDCBP;ARID2;RAC1;ROCK1;YTHDF3;PTPRJ;MGAT5;RHOA;RAP2B;PLXNA1;INSR;DOCK10;FLNA;IGF1R;PLAU;PLXND1;RAP2A;MINK1;GNA12;SGK1;RNF41;STAT3;FOXO3;CCR1;FLT1;ITGB1;RNF20;PTK2B;RUFY3;ANXA1;ADAM9;MACF1;ELP5;JAG1;SEMA4A;DUSP3;HGF;CYRIB;MYADM;GCNT2;GRN;SUN2;NF2;VEGFA;CBLL1;MDK;BST2;TGFBR1;CTSH;SPRY2;KIF14;ITGAX;XBP1;FLCN;OSGIN1;ARHGEF39;F7;ADAM15;CXCL16;CCL5;CIB1;CPNE3;SERPINE1;STK24;SEMA4B;PIK3CD
prerank,regulation of macrophage migration (GO:1905521),0.5316997949135972,1.2220934693745293,0.25365853658536586,0.48189188357119295,1.0,4/10,8.43%,CD200R1;P2RY12;CD200;CX3CR1
prerank,response to chemokine (GO:1990868),-0.4968572992026017,-1.2216488604577407,0.2181500872600349,0.36980940153587805,1.0,4/13,5.46%,RHOA;LRCH1;DOCK8;RIPOR2
prerank,eye morphogenesis (GO:0048592),-0.45508220933498295,-1.2212463513344862,0.2031523642732049,0.3702833438653753,1.0,6/19,9.63%,STAT3;NIPBL;RARG;SKI;VEGFA;MFAP5
prerank,lytic vacuole organization (GO:0080171),-0.39217590815489883,-1.2211907988435247,0.18197879858657243,0.370089782798184,1.0,16/32,31.13%,ABCA1;TFEB;GRN;GNPTAB;CLN6;MYO7A;CLN3;TPP1;VPS18;HPS4;TPCN2;LAMTOR1;ACP4;SNAPIN;ACP3;ARSB
prerank,cellular lipid catabolic process (GO:0044242),-0.41046397949663793,-1.2209102517157882,0.1935483870967742,0.3702636185727976,1.0,5/27,7.31%,AOAH;PPARD;PLBD1;ABHD12;PLBD2
prerank,carnitine shuttle (GO:0006853),-0.5201039753668649,-1.2207045801819547,0.2396551724137931,0.37035740925839294,1.0,3/11,14.94%,PRKAG2;CPT1A;ACACB
prerank,T cell mediated immunity (GO:0002456),-0.49943998648325005,-1.2206202427653923,0.21635434412265758,0.3702531159262464,1.0,4/13,12.13%,MYO1G;JAG1;CTSH;CD46
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4856961944415086,-1.2203417798623013,0.21280276816608998,0.37045208453364986,1.0,7/15,15.67%,CD84;CD300A;CD300LF;MILR1;GRN;FCGR2B;IL31RA
prerank,triglyceride metabolic process (GO:0006641),-0.3605714218017091,-1.2201518297822378,0.18363636363636363,0.3705354615997945,1.0,21/48,39.51%,APOE;FABP5;AGMO;LPL;FABP4;SEL1L;DGAT1;PLAAT3;APOBR;APOH;LMF1;LIPH;GK5;GPAT2;LPIN3;CAV1;PNPLA1;APOA2;SLC27A5;LIPG;FABP7
prerank,protein K63-linked ubiquitination (GO:0070534),-0.3769159986793915,-1.2199760903052956,0.1733102253032929,0.37057482516677975,1.0,12/41,15.18%,HECTD1;BFAR;TRAF5;WWP2;PELI1;TRAF3;RNF4;RNF8;TRAF1;TRAF2;UBE2G1;UBE2T
prerank,muscle cell development (GO:0055001),0.3953546895974985,1.2199337090830296,0.17718446601941748,0.48549978565904023,1.0,9/30,13.98%,SGCZ;ANK2;DMD;SDC1;NEBL;TTN;DYSF;ALPK2;HES1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.39248046886700627,-1.219911681206256,0.18600682593856654,0.37040489317529285,1.0,8/33,10.48%,JUN;PPARG;SPI1;STAT3;FOXO3;HIF1A;EGR1;RELA
prerank,positive regulation of cell division (GO:0051781),-0.3796353690648673,-1.2196040848756795,0.1705150976909414,0.37072002855057556,1.0,6/38,5.28%,RHOA;SVIL;HTR2B;CDC42;KIF20B;KIF23
prerank,axoneme assembly (GO:0035082),0.39376326209201296,1.2194033054568714,0.18807339449541285,0.4854230954983569,1.0,4/31,3.47%,DNAAF3;CFAP74;DNAI4;RSPH1
prerank,sulfur compound transport (GO:0072348),-0.4098988536065017,-1.218879874576969,0.19405594405594406,0.37180380990334344,1.0,4/27,4.06%,LRRC8D;SLC6A6;SLC26A11;SLC27A1
prerank,positive regulation of cell death (GO:0010942),-0.3499119370881931,-1.2185570862265611,0.15824915824915825,0.3720782456049183,1.0,19/59,21.79%,MAP3K5;LRP1;CD36;ITGB2;C1QA;SLC6A6;RIPK1;RARG;PICALM;EGR1;CELF1;HTATIP2;FCGR2B;EIF4G1;FAF1;GSK3B;ZC3H12A;HPR;HP
prerank,endothelial cell migration (GO:0043542),-0.3799645995176801,-1.218528011622813,0.17391304347826086,0.37185668989938786,1.0,12/37,16.25%,NRP1;MYH9;RHOA;PLXND1;LPXN;DPP4;VEGFA;PLEKHG5;PIK3CA;FAP;RAB13;NR4A1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.3726903014764258,-1.2185274317014863,0.19791666666666666,0.37158630272206283,1.0,11/42,14.55%,HEXA;PSAP;CTSA;GLTP;ARSA;ESYT1;ESYT2;SUMF2;CLN6;NEU1;LARGE1
prerank,plasma membrane organization (GO:0007009),-0.3448704297729056,-1.2183962675343385,0.14871794871794872,0.37154554887413677,1.0,18/61,17.10%,MYOF;P2RX7;MYH9;ARL8B;SNX9;ANO6;ABCD2;AHNAK2;SNX33;TLCD2;PACSIN2;SERP1;BIN3;ANXA6;CXCR4;CLN3;PLSCR4;STX4
prerank,negative regulation of secretion (GO:0051048),0.5168167712785598,1.2177732879884906,0.22863741339491916,0.4877596335098671,1.0,5/10,15.90%,NRG1;EGF;SPX;VAMP8;ERBB3
prerank,histone deubiquitination (GO:0016578),-0.453752148580877,-1.2175689674367072,0.21489001692047377,0.3727865362533202,1.0,10/18,28.84%,ATXN7;USP36;USP3;USP7;BRCC3;USP16;ENY2;UIMC1;EPOP;USP51
prerank,chromatin remodeling (GO:0006338),-0.3150459256487469,-1.217297057901706,0.11703958691910499,0.3730183657634333,1.0,23/100,19.83%,RB1;BPTF;ARID1B;SMARCA5;ERCC6;CHD3;ACTB;SMARCD3;SMARCC2;JARID2;ARID1A;BAZ2B;CHD8;BAZ1A;HDAC5;PADI4;DR1;INO80;RBBP4;INO80C;MYB;RSF1;KDM5B
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.26647939803870857,-1.2169571114780013,0.040229885057471264,0.3733596812189009,1.0,135/417,28.61%,RBPJ;MDFIC;FOXP1;CD38;RCOR1;BCL6;WWP1;MIDEAS;RB1;JUN;PEX14;NIBAN2;ZNF568;PPARD;ARID5B;BRD7;ZNF148;SBNO2;PPARG;ELK3;GATAD2A;SPI1;BRCA1;WWP2;IKZF1;NIPBL;SNX6;HHEX;ZBTB21;RUNX2;FBXW11;PRMT2;CENPF;SMARCC2;NR1H2;CIITA;CBFA2T3;EIF4A2;AHR;CTNNB1;GAS6;GCFC2;EZH2;PBXIP1;JARID2;DPF2;BHLHE40;EED;E2F1;SPEN;FOXN3;SUDS3;HDAC10;CIART;RELA;TIMELESS;XRCC6;CHMP1A;KLF10;CHD8;KAT7;CCDC85B;HMGB2;MTA3;HDAC5;TFAP4;SIN3A;CALCA;EPC1;PSPC1;ID2;PRMT6;MAP3K10;BTAF1;PHC3;KMT5A;IKZF4;UBE2I;ATXN1;RARA;ATF5;LIMS1;NR3C1;GATA3;MYB;SAMD1;ARID5A;ID1;RSF1;CIC;BAP1;CBFA2T2;SIRT2;SFRP1;CDK5;KDM1A;ID3;SMURF2;ZBTB7A;TBX2;HEYL;SET;RPS6KA5;SCMH1;EID2;CRYAB;NONO;SOX7;TGFB1;DEAF1;SHC1;TSC22D4;GZF1;TRIM28;NCOR1;RBM15B;ZBTB16;DEDD2;MT3;INPP5K;CLOCK;ERN2;SMAD4;BMP2;PML;HSPA8;UIMC1;DEPDC1;TBX21;TLE2;MYBBP1A;CREBZF;CITED2;LEF1;DKK3
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.5237538429875378,-1.2161376020059627,0.23958333333333334,0.37462109195699467,1.0,5/10,18.85%,IL18;SPHK2;RARA;GATA3;LGALS9
prerank,cellular response to interleukin-4 (GO:0071353),-0.5191689110264274,-1.2159719933198265,0.22804054054054054,0.3746625493920965,1.0,4/10,17.97%,STAT6;XBP1;TCF7;GATA3
prerank,cellular response to fatty acid (GO:0071398),-0.505631487520247,-1.215790333732732,0.21746880570409982,0.3746930780986953,1.0,5/12,26.41%,PID1;LPL;ZC3H12A;NR1H4;KCNK4
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5249373352168976,1.215779320372278,0.24705882352941178,0.49112039078625275,1.0,7/10,27.60%,SARDH;BHMT;SMOX;ALDH7A1;HNMT;LRTOMT;SLC44A1
prerank,cellular response to unfolded protein (GO:0034620),-0.42027006318508187,-1.2155164840566102,0.19516407599309155,0.3749226616825109,1.0,9/26,21.32%,ERN1;OPTN;HSPA9;TMBIM6;BAG3;HSPA1A;HSPA2;PTPN1;HSPA13
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5327656312798751,-1.2153972520704905,0.2281639928698752,0.37486433037351474,1.0,5/10,24.08%,LILRB1;FN1;HSP90AB1;LAPTM4B;FURIN
prerank,cellular response to nutrient levels (GO:0031669),-0.34271443668972307,-1.2152875726544055,0.16891891891891891,0.374776263159541,1.0,17/62,21.83%,TFEB;LAMP2;ATG7;FNIP1;LPL;XBP1;RRAGD;FLCN;WRN;KLF10;STK24;EIF4G1;RALB;BMPR2;SFRP1;GAS2L1;KCNB1
prerank,lipid modification (GO:0030258),0.36752615294102603,1.214615663496571,0.16414141414141414,0.4925852012911799,1.0,4/37,2.69%,DGKB;PLPP4;PLPPR1;PLPPR4
prerank,regulation of lymphocyte activation (GO:0051249),-0.4990215297666719,-1.2145598884912847,0.21477663230240548,0.37589294480467283,1.0,8/12,31.27%,THEMIS2;LCK;IKZF3;CCL5;CRTAM;CD19;LAT;CD4
prerank,protein heterotetramerization (GO:0051290),0.4806314980488331,1.2144707117453288,0.23950617283950618,0.4916593394869374,1.0,7/13,26.00%,GRIN2B;PKD1;HSD17B8;CPSF6;CPSF7;GRIN1;PKD2
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.4162908117283133,-1.2143956001512612,0.19899665551839466,0.37591614677868074,1.0,5/25,4.20%,PLCG2;PLEK;ITPR1;P2RX4;CD22
prerank,actomyosin structure organization (GO:0031032),0.3190306118989048,1.214295141416832,0.14841849148418493,0.4908517172010789,1.0,16/75,12.80%,SORBS1;TJP1;FRMD5;CDC42BPA;EPB41L4B;EPB41L3;EPB41L4A;PHACTR1;FRMD3;CSRP1;TNNT2;TTN;CAPN3;PGM5;MYH10;FHOD3
prerank,maintenance of blood-brain barrier (GO:0035633),0.39263520540621555,1.2141782096225888,0.19395465994962216,0.4898902643838039,1.0,11/30,18.10%,DMD;TJP1;SLC12A2;SLC1A1;OCLN;MFSD2A;CLDN5;CDH5;WNK3;MBP;LAMA2
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.43600600472700934,-1.2131475210571585,0.20654044750430292,0.3779230445513708,1.0,10/21,33.37%,MYH9;ADAM9;PSENEN;HM13;ADAM19;PSEN2;PRTN3;BACE1;DAG1;ERAP1
prerank,mRNA transport (GO:0051028),-0.31797788410633654,-1.2130150293193183,0.1256198347107438,0.37789697694130603,1.0,46/101,32.70%,NUP50;SRRM1;HHEX;NUP42;CHTOP;NUP88;RAE1;CDC40;AGFG1;NUP205;UPF2;ALYREF;TPR;NUP188;WDR33;YTHDC1;NCBP1;THOC2;RNPS1;NUP153;THOC6;NUP35;MAGOH;SLU7;CPSF3;NUP107;NUP62;SRSF11;SMG1;DDX39B;DHX38;RANBP2;RBM15B;CPSF1;NUP37;U2AF2;ZFP36L1;SRSF7;AAAS;NUP133;EIF4A3;EIF4E;SRSF5;SARNP;ALKBH5;U2AF1L4
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.36292994684512014,-1.2129837529798149,0.17192982456140352,0.3776881700120361,1.0,12/46,11.47%,LYN;PTPRC;TLR4;DUSP3;SIRPA;ITGB1BP1;SPRED1;SPRY2;PIN1;DUSP6;FLCN;SPRED2
prerank,sterol homeostasis (GO:0055092),-0.34082373084136647,-1.2126945145481713,0.17755443886097153,0.3779655188003342,1.0,15/65,15.20%,APOE;ABCA1;ABCG1;IL18;GRAMD1B;NR1H2;CNBP;RALY;LIMA1;LPL;NPC2;XBP1;TTC39B;EHD1;NPC1
prerank,regulation of defense response to virus (GO:0050688),-0.48867026848797185,-1.2125455008822612,0.22486288848263253,0.3779592567398055,1.0,8/14,27.84%,DHX9;TRAF3;PPM1B;PCBP2;RNF216;C1QBP;ZMPSTE24;RNF26
prerank,peroxisomal membrane transport (GO:0015919),-0.41267155462654015,-1.2121330035180804,0.2037037037037037,0.3784597106444401,1.0,7/27,16.74%,RAB8B;PEX14;ABCD2;PEX26;FIS1;PEX7;ABCD3
prerank,positive regulation of TOR signaling (GO:0032008),-0.3747835651059369,-1.2119941963868597,0.16666666666666666,0.3784234723394019,1.0,16/40,25.86%,GPR137B;KLHL22;GAS6;FNIP1;PIP4P1;NCKAP1L;RRAGD;FLCN;PIK3CA;RHEB;HTR6;WDR24;LAMTOR1;LAMTOR3;SIK3;MIOS
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3141763909977416,-1.2118318604747285,0.10526315789473684,0.378458158478394,1.0,21/108,12.25%,MDFIC;RUNX1;LRP1;SNX3;CSNK2A1;HHEX;CCNY;MACF1;AXIN1;MDFI;CTNNB1;SKI;PPP1CA;SULF2;WLS;CDK14;CBFB;OTULIN;APP;ITGA3;SPIN1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5123645003415598,-1.2117748490424936,0.22597864768683273,0.3782866083599364,1.0,5/12,22.80%,RFWD3;PLK3;WAC;FBXO31;PRKDC
prerank,cellular calcium ion homeostasis (GO:0006874),0.28965307416969277,1.2116847072435104,0.10852713178294573,0.4941261945647437,1.0,29/133,16.13%,HTR2C;ANK2;TRPC5;RYR2;ADCY8;SLC24A4;SLC24A2;SLC8A3;HCRTR2;TRPC1;SLC24A3;TMEM203;PTH1R;LETM1;CCDC47;SLC8A2;RYR1;EDN1;CALCB;ATP1B1;MICU3;ATP2B4;CDH5;ATP2B2;ATP2A1;CHRNA7;SELENOK;ATP13A5;PDZD8
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5307041333165075,-1.2113987696041288,0.24050632911392406,0.3786698136942843,1.0,3/10,4.13%,CD36;SLC27A1;SLC2A1
prerank,positive regulation of lyase activity (GO:0051349),0.45691078481598063,1.2112809023277693,0.2112676056338028,0.4938238723413917,1.0,5/14,23.56%,CACNA1C;GUCA1A;FXN;NOS1;NF1
prerank,apoptotic process (GO:0006915),-0.2846711725158892,-1.2111978510113843,0.08253968253968254,0.3787883910807821,1.0,52/203,19.13%,APAF1;NOTCH2;PAEP;DAPK1;PRKCD;ITGB2;BCL2L11;PPARD;OGT;GAPDH;RIPK1;CFLAR;TNFAIP1;NUDT2;PTK2B;BCL2;DAPK3;STK3;TNFRSF21;AHR;DPF2;HIP1;MYD88;CASP4;FASTKD2;APP;PIK3CA;FAP;GADD45A;STK11;CD2;ADAM15;CASP7;CIB1;IFIT2;PLK3;CASP1;TGFBR2;BBC3;MAP3K10;CXCR4;MCM2;BID;BNIP2;CASP8;TNFRSF25;CSRNP1;IFT57;TRADD;TAOK2;CASP2;PAK6
prerank,translational termination (GO:0006415),-0.32010442548583107,-1.210844819286416,0.1440677966101695,0.37913131952421597,1.0,38/95,34.45%,GSPT1;ABCE1;MRPS10;ERAL1;MRPL42;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPL54;MRPS25;MRPL39;MRPL53;MRPL11;MRPL33;MTRF1;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPL1;MRPS28;MRPS35;MRPS21
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.4133601496920109,-1.2107930385361205,0.2018348623853211,0.3789320690004332,1.0,11/26,28.49%,B4GALT5;GBGT1;TPI1;GCNT1;TKT;LARGE1;ALG6;GAL3ST4;ALG11;GK5;ST3GAL4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.34701863492193324,-1.210466546485707,0.16112084063047286,0.37925117392864127,1.0,19/56,27.20%,DAB2;SDCBP;PMEPA1;RBPMS;TGFBR1;SNX25;PIN1;ACVR2A;GREM1;LDLRAD4;TTK;SMAD7;GDF3;BMPR2;INHA;TGFB1;SMAD4;BMP2;ENG
prerank,regulation of macrophage activation (GO:0043030),-0.3978704446589869,-1.210147282485708,0.19744058500914077,0.3795965949458404,1.0,11/30,22.61%,CD74;MFHAS1;GPR137B;TLR4;TNIP2;FCGR2B;KARS1;IL31RA;MMP8;ZC3H12A;IL6
prerank,negative regulation of T cell proliferation (GO:0042130),-0.4113036403351293,-1.2099698536273045,0.1929530201342282,0.37962666599314465,1.0,11/28,21.89%,LILRB1;RC3H1;TNFRSF21;SCRIB;SDC4;IL4I1;VSIG4;SPN;LGALS9;CD274;CEBPB
prerank,positive regulation of axonogenesis (GO:0050772),0.35080108172657665,1.2096962647932774,0.18854415274463007,0.4962592863786163,1.0,9/43,10.11%,ROBO1;ROBO2;SLIT2;NTRK2;CDKL5;SLITRK1;BDNF;PLXNA4;POU4F2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3105678994954368,-1.2092578598717467,0.11661341853035144,0.3806700859704403,1.0,32/112,20.98%,ZMIZ1;CBL;JUN;NRROS;RHOA;LPXN;ARRB2;ITGB1;ADAM9;GCNT2;ARHGEF18;USP9X;SKI;TGFBR1;MEF2C;MAPK7;UBC;RPS27A;ITGB5;ZYX;TGFBR2;ZMIZ2;CRKL;APPL2;LIMS1;SMAD7;NR3C1;ID1;PDCD5;APPL1;SFRP1;USP9Y
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4678067374209973,-1.2089719870649567,0.23415492957746478,0.3809041877007787,1.0,10/15,43.13%,SELENOS;DERL1;SEL1L;HSP90B1;FAF2;VCP;AUP1;OS9;HERPUD1;SYVN1
prerank,cellular potassium ion homeostasis (GO:0030007),0.4900936460670289,1.2086674865332985,0.2517321016166282,0.49736933817583817,1.0,5/13,17.14%,SLC12A2;ATP1A3;ATP1B1;KCNMA1;ATP1B2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5071291844949652,1.2084762393645334,0.22926829268292684,0.4965547520143328,1.0,2/11,2.57%,NECAB1;ITM2A
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.43066547566891694,-1.2084272209762301,0.23024054982817868,0.38161054309091225,1.0,4/21,5.20%,ABCB7;ABCD2;BRCA1;COA8
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.48484256878590254,-1.2080917067657355,0.22797927461139897,0.38165512898213494,1.0,7/14,31.51%,BLVRB;HMOX2;ABCC1;HMOX1;SLCO1B1;UGT1A4;UGT1A1
prerank,heme catabolic process (GO:0042167),-0.48484256878590254,-1.2080917067657355,0.22797927461139897,0.38165512898213494,1.0,7/14,31.51%,BLVRB;HMOX2;ABCC1;HMOX1;SLCO1B1;UGT1A4;UGT1A1
prerank,negative regulation of metabolic process (GO:0009892),-0.3511957404917777,-1.2080589890752225,0.14285714285714285,0.3814269346216169,1.0,17/54,18.75%,RBPJ;RB1;IL15;TLR4;LNPEP;NR1H2;PLCL2;ZDHHC7;TLE3;FIS1;ACOT13;FLCN;STK11;IL18R1;TFE3;RHEB;ID1
prerank,cellular metal ion homeostasis (GO:0006875),0.3020366455223023,1.2080414612128447,0.11678832116788321,0.49634343422181826,1.0,22/102,14.82%,HTR2C;ANK2;RYR2;SLC24A4;SLC24A2;SLC8A3;SLC12A2;SLC24A3;ATP1A3;TMEM203;PTH1R;LETM1;SLC8A2;EDN1;CALCB;ATP1B1;KCNMA1;ATP2B4;CDH5;ATP2B2;ATP2A1;CHRNA7
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.4184616056511936,-1.2079398516336777,0.21392190152801357,0.38139341844426555,1.0,11/24,25.98%,PID1;COX10;LYRM7;SDHAF4;GFPT1;SLC25A13;ACADVL;CYCS;MYC;MT3;COQ10B
prerank,regulation of activated T cell proliferation (GO:0046006),-0.39966790026469573,-1.2076533744724147,0.21516754850088182,0.38162155854094093,1.0,16/30,29.60%,IGF1;IL18;RC3H1;SCRIB;IL27RA;RPS3;LGALS9;HMGB1;AGER;CD274;TNFSF9;IL12RB1;CRTAM;RIPK3;IL2;IGFBP2
prerank,dendritic spine morphogenesis (GO:0060997),0.45778935562203,1.2076342803806472,0.22921914357682618,0.49620746697348267,1.0,4/15,5.24%,CTNND2;PAK3;EPHB1;SHANK3
prerank,negative regulation of histone acetylation (GO:0035067),-0.5091218505400524,-1.2075768237553723,0.2649122807017544,0.38149578903606607,1.0,7/11,34.05%,SPI1;BRCA1;SIN3A;SET;NOC2L;CTBP1;THAP7
prerank,positive regulation of heart contraction (GO:0045823),0.4303089466366974,1.2072431204182172,0.2278177458033573,0.4958899938220684,1.0,5/19,12.77%,RYR2;APLN;EDN1;TGFB2;ADRA1A
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.29488809152651607,-1.2065362973145213,0.1048252911813644,0.3831333018040076,1.0,48/152,22.43%,ZEB2;DKK2;CSNK2A1;PSME4;PSMB7;PSME3;NFKB1;HHEX;USP8;DAPK3;MACF1;PSMB9;AXIN1;TBL1XR1;PPM1B;LRRK1;SKI;SULF2;WLS;PSMA8;PIN1;PSMC3;PSMD8;SPIN1;PSMC4;PSMB10;TNKS2;PSMA1;RSPO3;PSMB8;GPRC5B;JRK;PLEKHA4;DDX3X;RSPO1;PSMA5;PSMD4;TMEM198;PSMB3;WNK1;PSMD3;SFRP1;JUP;DISC1;CSNK1G3;SMURF2;ZRANB1;ILK
prerank,protein stabilization (GO:0050821),-0.2899376600476212,-1.206130591313041,0.10197368421052631,0.38358800989403785,1.0,53/168,26.24%,IGF1;PRKCD;GAPDH;FLNA;LAMP2;COG7;ATP1B3;COA8;STK3;RPL11;GRN;CCT7;USP36;USP9X;WFS1;HIP1;MFSD1;MORC3;RAB21;TNIP2;PIN1;SEL1L;LAMP1;HSP90AB1;FLOT2;CRTAP;BAG3;USP7;TAF9;VHL;HSPA1A;SMAD7;CCT4;TRIM39;PPIB;MDM4;NAA16;GLMP;GOLGA7;BAG6;HYPK;HPS4;CRYAB;PLPP3;GTSE1;PIM2;RABL3;P3H1;AFM;MT3;RPL5;PFN1;RASSF2
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3749238159319345,-1.2059386066886393,0.2062937062937063,0.3836848226845803,1.0,21/39,29.37%,ABCA1;RAB8B;CANX;STEAP3;PREB;RCN3;SEL1L;RAB3D;RAB10;MIA2;MIA3;RAB13;PDIA4;RAB12;TVP23A;TANGO6;MON1A;AFM;PPY;COPG1;LTBP2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3299382229497531,-1.2053172791013675,0.16808149405772496,0.38453965631717896,1.0,23/66,24.32%,SASH1;MAP3K5;TAOK3;PIK3R5;HTR2B;FLT1;PIK3CG;EZH2;VEGFA;ADAM8;TRAF2;CD40;IL34;MAP3K10;ARHGEF5;RPS3;PDGFRB;NOD2;PDGFA;FGF18;TGFB1;DVL2;FLT3
prerank,glycoprotein catabolic process (GO:0006516),0.43975671845354913,1.2050835748872022,0.22863741339491916,0.4994481152223306,1.0,5/17,12.65%,MMP12;FBXO44;FBXO2;FBXO27;ADAMTS12
prerank,acylglycerol catabolic process (GO:0046464),-0.39525021526573423,-1.2050243858632317,0.18706293706293706,0.3848096022555136,1.0,4/30,10.36%,FABP5;ABHD12;LPL;FABP4
prerank,regulation of lipid catabolic process (GO:0050994),0.4262960343167089,1.2048208936089362,0.23227383863080683,0.49887413461468627,1.0,5/19,14.91%,ALK;APOC1;ANGPTL3;ABCB11;ABCD1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4106724431851857,-1.2041985952156016,0.21828358208955223,0.3860233019475443,1.0,9/26,20.38%,TET3;OGT;CTR9;KMT5B;KMT5C;KMT2D;TET2;KMT2A;EEF2KMT
prerank,protein localization to plasma membrane (GO:0072659),0.2860084982859659,1.2041047193805605,0.09798994974874371,0.49928239352392556,1.0,16/129,5.82%,DPP10;KCNIP4;DPP6;KCNB2;ANK3;ANK2;RAB3C;MAP7;CACNB2;TESC;RAB15;EPB41L3;AFDN;CLASP2;NECTIN3;RAMP3
prerank,cholesterol metabolic process (GO:0008203),-0.3378395646895578,-1.2040545217436678,0.1574539363484087,0.3860263987564887,1.0,15/68,14.91%,APOE;ABCA1;ABCG1;PPARD;CYP27A1;NSDHL;OSBPL5;PIP4P1;CLN6;CH25H;IDI1;RXRA;HSD17B7;ACAT2;CYP46A1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.41530037396918607,-1.202997209337073,0.2084063047285464,0.3876824620010305,1.0,5/26,8.64%,PRKAG2;BRCA1;ADIPOR1;NR1H2;ERLIN1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.44653423389356134,-1.2028149376939044,0.23661485319516407,0.38772311322144426,1.0,10/18,29.60%,IGF1;IL18;IL27RA;RPS3;HMGB1;AGER;TNFSF9;IL12RB1;IL2;IGFBP2
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.331117409994248,-1.2024985970710242,0.1470113085621971,0.3880558198477806,1.0,15/70,10.62%,ITGA4;NRP1;RB1;RAC1;RHOA;PEAK1;LPXN;SPI1;PARVB;ITGAV;FN1;SIPA1L3;ITGB7;MEF2C;KIF14
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4717267583887531,1.2023899398116957,0.22566371681415928,0.5019112856530011,1.0,5/14,14.70%,CORIN;OXTR;AGTR1;EDN1;ECE1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4604816484485392,-1.2020465485698852,0.23478260869565218,0.38858324262834915,1.0,9/17,26.70%,CTR9;RNF20;ZC3H14;NUDT21;VIRMA;NCBP1;RNF40;ZC3H3;NELFE
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.47237744452076363,-1.2018364577091085,0.2301038062283737,0.38868554759555696,1.0,5/14,11.47%,XDH;SPRED1;SPRY2;OSR1;SPRED2
prerank,positive regulation of protein depolymerization (GO:1901881),-0.5201555363704404,-1.2017301579638338,0.2314487632508834,0.3886244022376338,1.0,4/11,15.02%,PLEK;NES;WDR1;STMN2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.2650992480762684,-1.201527181700795,0.04817518248175182,0.3887063533777163,1.0,103/366,22.98%,MITF;TFEB;RREB1;RB1;DNM2;CREBBP;RUNX3;BACH1;INSR;IRF2;APBB2;SBNO2;NFX1;NFYA;NSD3;SPI1;FOXN2;JMJD1C;CTR9;STAT3;FOXO3;LYL1;ZSCAN26;RYBP;CHD3;RNF20;SAP30;DAPK3;GPBP1L1;GON4L;PUM3;SRRT;FUS;AHR;GCFC2;EZH2;REXO4;POFUT1;EDF1;BHLHE40;E2F1;CNBP;TGFBR1;THAP1;PCIF1;HIF1A;MEF2C;FOXN3;UBE2L3;NUCKS1;HDAC10;HP1BP3;RELA;MTPN;APP;CCDC88A;PRDM2;KMT2D;ORC5;SPIN1;MLLT6;KAT7;TCF7;SPTY2D1;POLR2A;RPL6;NOLC1;PSPC1;BTG1;TCF3;ZNF628;NSD1;SRSF10;HCLS1;EIF2A;ATXN1;RBM4B;VHL;ATF5;NR3C1;MYB;PPARGC1B;PLAG1;CXXC1;CASZ1;NUP35;PAK6;SUFU;RBM3;ESCO2;NUP107;ATF7;ZFPL1;GTF2IRD1;PDGFA;ZSCAN21;SNAI2;CEBPB;RPS6KA5;CHD7;NONO;ESR2;SOX7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.4681320086555369,-1.2006871190516764,0.24468085106382978,0.389729376034986,1.0,5/15,17.43%,AGO2;CNOT1;TNRC6C;DHX36;TOB1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.4681320086555369,-1.2006871190516764,0.24468085106382978,0.389729376034986,1.0,5/15,17.43%,AGO2;CNOT1;TNRC6C;DHX36;TOB1
prerank,macroautophagy (GO:0016236),-0.3051106987632733,-1.2006334493125819,0.11717495987158909,0.38955647645093977,1.0,35/118,23.00%,PLEKHM1;ARL8B;CSNK2A1;PIP4K2A;TECPR1;PRKAG2;ATG5;UVRAG;LAMP2;ATG7;TCIRG1;MTMR3;MTMR14;ATG10;TBC1D5;TSG101;EPG5;LIX1;HDAC10;STAM2;UBXN6;RB1CC1;CHMP2A;GABARAP;EI24;CLN3;VPS33A;TOMM22;VPS4A;PRKAG1;VPS16;CHMP4B;CHMP4A;BECN1;TOMM70
prerank,intracellular lipid transport (GO:0032365),-0.43354065704052297,-1.2003177866788481,0.20898100172711573,0.3899043719991414,1.0,6/21,16.74%,ABCD2;PRKAG2;CPT1A;NPC2;ACACB;ABCD3
prerank,cation transmembrane transport (GO:0098655),0.3498256968576127,1.2001922409115224,0.1925925925925926,0.5056506739764284,1.0,10/44,17.38%,ASIC2;TRPM3;SLC25A19;TRPM1;ATP1B1;SFXN3;SLC25A38;SLC22A5;SLC6A5;TRPM2
prerank,cell-matrix adhesion (GO:0007160),-0.3158103637959022,-1.1998322312007634,0.15384615384615385,0.39057962081815356,1.0,20/95,12.32%,ITGA4;CD44;LYVE1;RAC1;ITGB2;SIGLEC1;HPSE;PEAK1;ITGAL;ITGB1;ITGAV;ADAM9;FN1;ITGB7;ITGB1BP1;CD63;ITGB5;ZYX;ITGA3;ADAM15
prerank,fatty acid biosynthetic process (GO:0006633),0.3312458718508313,1.1993668367248695,0.1558139534883721,0.5063101214444071,1.0,19/63,20.95%,ELOVL7;ABHD3;ACSM5;OLAH;HACD1;NDUFAB1;CYP1A1;ACACA;ABCD1;LTA4H;DECR2;TECRL;HSD17B8;MLYCD;ACSM3;ASAH2;ELOVL6;ACOT7;ELOVL2
prerank,cardiac cell development (GO:0055006),-0.5052900417843301,-1.1993038397591393,0.24869565217391304,0.3912600300051526,1.0,4/11,12.75%,JAG1;VEGFA;SLC8A1;CXADR
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.38058206733282973,1.1991472696227738,0.17899761336515513,0.5056046308950604,1.0,8/31,15.62%,HOXC4;SOX11;DSCAML1;HOXD3;TFAP2A;TBX1;HOXC9;FUZ
prerank,primary neural tube formation (GO:0014020),-0.39946865853367397,-1.1991028851546395,0.18416523235800344,0.39135018933255655,1.0,19/30,31.13%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;PHACTR4;TGFB1;DVL2;DEAF1;LRP2;TSC2;GRHL3;CELSR1;GRHL2;IFT122;PAX2;BCL10
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.37883190743375106,-1.1989545116725535,0.19686411149825783,0.39134600179843,1.0,19/36,29.30%,MAP3K20;ERCC6;RAD1;E2F1;TIMELESS;RHNO1;DOT1L;BRIP1;RAD9A;DNA2;ATM;CHEK1;TIPIN;NBN;CDC45;CLOCK;USP28;CEP63;DONSON
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.4351032311319843,1.1987753644885424,0.22985781990521326,0.5052535869036433,1.0,3/19,8.95%,TJP1;AFDN;NEXMIF
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.452931003328762,1.1983466541350056,0.24480369515011546,0.5050351601392286,1.0,6/16,19.74%,RORA;PDK3;RORC;PRKN;MLYCD;SIRT1
prerank,positive regulation of cilium assembly (GO:0045724),0.434272946838556,1.1980293979999639,0.20293398533007334,0.5045281077704289,1.0,7/18,22.13%,SEPTIN9;TAPT1;ARHGAP35;FUZ;HAP1;BBS4;HTT
prerank,acylglycerol metabolic process (GO:0006639),-0.37336500070690076,-1.1977007096235526,0.19473684210526315,0.3934288789088161,1.0,18/37,35.13%,APOE;DGKZ;ABHD12;DGKD;LPL;SEL1L;DGAT1;PLAAT3;DGKG;APOBR;APOH;LMF1;DGKA;GK5;AWAT2;CAV1;PGS1;DGKQ
prerank,regulation of dephosphorylation (GO:0035303),0.45251738394859814,1.1975147752042148,0.24065420560747663,0.5044490369475748,1.0,8/15,22.74%,MTMR2;SMG5;CDK5RAP3;PPP1R16B;MTMR9;MTMR4;PPP1R17;SMG7
prerank,prostaglandin metabolic process (GO:0006693),-0.40176459119383756,-1.197212668227939,0.2041522491349481,0.3940853224301681,1.0,9/26,30.14%,TBXAS1;CD74;DAGLB;PLA2G4A;ACOX1;PNPLA8;CYP2S1;PTGES;PTGR1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3364171275988873,-1.1969287679619665,0.17355371900826447,0.3943865234061014,1.0,28/71,22.42%,CTSB;CTSZ;PDCD6IP;MALT1;FBXL17;RNF41;DDI2;USP9X;ATXN3;CTSC;RNF123;CTSH;ATE1;PSMA8;UBC;RPS27A;CUL4B;FAP;CTSS;SOCS6;HM13;ISG15;CASP8;VPS4A;BAG6;ZRANB1;CHMP4B;RSPRY1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.44017686662699895,1.1964752237989662,0.20601851851851852,0.5055830656202808,1.0,4/17,7.47%,CTNNA2;WASF1;ABI2;NCKAP1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.29969832432384164,-1.196421139086832,0.12202852614896989,0.3950413679615802,1.0,35/128,21.71%,ZMIZ1;CBL;JUN;NRROS;RHOA;RNF111;LPXN;ARRB2;ITGB1;RUNX2;ADAM9;SLC33A1;GCNT2;ARHGEF18;USP9X;SKI;TGFBR1;DDX5;TGFB1I1;UBC;RPS27A;ITGB5;ZYX;ACVR2A;TGFBR2;ZMIZ2;APPL2;SMAD7;ID1;GDF3;BMPR2;APPL1;USP9Y;SMURF2;MEGF8
prerank,cell-cell junction maintenance (GO:0045217),0.4832456558025533,1.1963157499520845,0.25740318906605925,0.5047109340539643,1.0,5/11,18.57%,TJP1;CSF1R;FERMT2;NLGN2;PARD6A
prerank,dendritic spine organization (GO:0097061),0.39120952537832265,1.196130719537762,0.21256038647342995,0.5039457890175036,1.0,11/26,15.52%,CTNND2;MTMR2;PAK3;EPHB1;SHANK3;PRNP;FYN;ARC;LGMN;CHRNA7;EPHB3
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.5001713813820396,-1.1961039206456572,0.2482638888888889,0.39534234154489145,1.0,6/12,21.01%,BLM;METTL4;KAT7;TICRR;TIPIN;NBN
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.4971262487565943,-1.1959499971381853,0.24061433447098976,0.3953579510288684,1.0,5/12,17.36%,PARP11;TIPARP;PARP8;TNKS2;PARP10
prerank,cellular response to pH (GO:0071467),-0.45462548140909365,-1.195878882621749,0.22182468694096602,0.3952016525105257,1.0,6/17,26.41%,RAB11FIP5;SLC9A1;RAB11B;ASIC1;GPLD1;KCNK4
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3412639785268833,-1.1957080857094455,0.15897435897435896,0.3952398939164249,1.0,23/57,24.60%,MAP3K5;CTSD;DAPK1;SYK;USP50;MALT1;NLRC4;AIM2;ASPH;NOD1;GRAMD4;FIS1;CASP1;TNFSF10;CASP8;PDCD5;DDX3X;HMGB1;NLRP3;SOX7;MEFV;CYCS;MYC
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.45083113192824675,-1.195493559664963,0.23049001814882034,0.3953439655204333,1.0,6/17,21.80%,CD44;CD74;DYRK1A;RNF34;KDM1A;SNAI2
prerank,response to thyroid hormone (GO:0097066),-0.4768743174862775,-1.1953687915384568,0.25754884547069273,0.39528589584583024,1.0,5/13,21.25%,CTSB;CTSH;CTSS;LMO2;GAS2L1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.40520329812881445,1.1948976968319542,0.21621621621621623,0.5055585415682334,1.0,3/22,6.09%,DDX11;NOL11;UTP15
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3376745561207238,-1.1946122763760287,0.18811881188118812,0.39639051317002444,1.0,17/56,21.07%,NSMCE2;RB1;RAD51B;BRD4;CCND3;DLGAP5;ANXA1;KLHL18;CDC25A;CDK1;EIF4G1;UBE2C;ANAPC7;DDX3X;RAB11A;ADAMTS1;CDC25C
prerank,regulation of tissue remodeling (GO:0034103),-0.44595841700974187,-1.1945889012809716,0.2356902356902357,0.39616310294294843,1.0,4/18,8.06%,RUNX1;IL15;IL18;MDK
prerank,positive regulation of cellular process (GO:0048522),-0.25389030014006375,-1.1937642573004368,0.03770949720670391,0.3974868638189221,1.0,173/565,27.29%,DOCK2;LYN;IGF1;NAMPT;GAB2;SDCBP;P2RX7;LRP1;CYBA;PRKCD;CD36;RAC1;SLC6A6;PTPRJ;CAMK1D;ACER3;NUPR1;TNFRSF1B;INSR;IGF1R;P2RX4;CSNK2A1;CDK13;IL6R;HTR2B;IL15;EAPP;CDC42;TLR4;FLT1;TCIRG1;DPP4;PTK2B;DYNC1H1;ITGAV;BCL2;KIF20B;RPS6;STX3;FN1;DDX49;SLC35F6;LRP6;CHTOP;KLHL22;GCNT2;GAS6;EZH2;GRN;GRK5;VEGFA;SIRPA;MDK;CNBP;RPS15A;PRMT1;TGFBR1;ITGB1BP1;PTPN6;TBC1D8;CTSH;ADAM8;RPS4X;TGM2;RELA;KIF14;ITGAX;MTPN;IL2RG;IL7R;XBP1;FLCN;CELF1;KMT2D;CXCL16;CCL5;HSP90AB1;CACUL1;CIB1;FCGR2B;FCER1G;GLP2R;DHX36;TGFBR2;CST7;GREM1;NCBP1;AGPAT1;CAPNS1;DOT1L;IL34;INO80;ACACB;EIF4G1;CRKL;TTK;IL31RA;BST1;HCLS1;FAF1;IL2RB;CNOT6L;VHL;STX4;RPS9;IRS2;RARA;LILRA5;KRAS;TFE3;SERTAD1;HCK;PDGFRB;DDX3X;MEIS3;PLA2G5;IL7;WDR77;ATM;CSF1;CHP2;CNOT8;C1QBP;CHEK1;PRC1;CSPP1;MAZ;SIRT2;SFRP1;TIPIN;ZC3H12A;KDR;PDGFA;EXOSC4;TBX2;SMC6;HPR;HP;EGR2;FGF18;S1PR2;IL6;P4HB;KITLG;TGFB1;CD47;DVL2;LMNA;SMC5;ECHDC3;FGF9;FLT3;SHC1;MYC;PKHD1;RNF187;FGFR4;FKBP1B;PRTN3;MT3;CCN2;CDCA7L;VIP;FZD7;ZFP36L1;ASH2L;RPS6KA3;CUL3;TBRG4;RTKN2;PDPN;TSPAN31;STAMBP
prerank,response to interferon-beta (GO:0035456),-0.42664122524688464,-1.1937569726164563,0.2147887323943662,0.3972253143538595,1.0,16/22,45.63%,IFNAR2;AIM2;BST2;IFITM2;CDC34;STAT1;IFITM1;IRGC;PLSCR1;IKBKE;TRIM6;XAF1;IFITM3;SHFL;HTRA2;UBE2K
prerank,renal water homeostasis (GO:0003091),0.40712826181226347,1.1937176618981948,0.20185614849187936,0.5069045890788925,1.0,7/23,14.85%,ADCY2;ADCY8;ADCY5;ADCY3;ADCY1;PRKACB;PRKAR1A
prerank,supramolecular fiber organization (GO:0097435),-0.2652090029987801,-1.1934493959613683,0.06466165413533835,0.39752956459567057,1.0,66/334,16.16%,MYO5A;CORO1C;ARHGAP25;VIM;TSPAN14;CD36;RAC1;KLHL24;MYO1F;RHOA;ARHGAP17;MTM1;ARHGEF2;CENPJ;RIPK1;GGA3;CDC42;ATP7A;DYNC1H1;RUFY3;TGFBI;MYO1G;TRIOBP;TPM3;TPM4;P4HA1;USP9X;HIP1;MARCKSL1;SH3BP1;B2M;CKAP5;TGFBR1;TUBGCP4;UBC;RPS27A;CORO7;MYO1E;ARHGAP12;CDC42EP2;PIN1;KIF14;APP;B4GALT7;DCTN1;PSENEN;WDR73;MYO7A;P4HA3;CCDC88A;HSP90AB1;CIB1;PLK3;BIN3;SLAIN2;GREM1;CALCA;COL9A1;COL4A5;KIF2C;MFGE8;STMN2;CRTAP;CST3;PPP1R9B;RND2
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3210457757753081,-1.1931116979755998,0.17028380634390652,0.3978894625095441,1.0,20/82,12.01%,LYN;VAV3;SDCBP;ARPC2;ITSN1;RAC1;ROCK1;ACTR2;RHOA;CDC42;ACTR3;ACTB;ARPC3;WASL;AP2A2;VAV2;PSENEN;CRK;ARPC1B;ARPC1A
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4865099293463856,-1.1929980806600637,0.2555366269165247,0.3978247278351706,1.0,2/13,2.23%,CCR2;GNAI3
prerank,nuclear membrane disassembly (GO:0051081),-0.47385522304229555,-1.192238543686167,0.24912280701754386,0.3989721468020752,1.0,7/14,24.92%,PRKCB;NEK6;DCTN1;CDK1;CCNB1;AKAP8L;CCNB2
prerank,peptide cross-linking (GO:0018149),-0.4135797512380276,-1.192127543717832,0.21006944444444445,0.3989084695703435,1.0,4/25,10.16%,F13A1;ANXA1;FN1;TGM2
prerank,early endosome to Golgi transport (GO:0034498),-0.5025679954846974,-1.1921000542842697,0.24662162162162163,0.39868831507343633,1.0,4/11,18.19%,SNX2;SNX8;STX5;SNX1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5147119821981723,-1.1919969971492141,0.2579505300353357,0.39833568932460284,1.0,7/10,25.92%,ALKBH1;MGMT;FTO;ALKBH3;ASCC3;MPG;ASCC2
prerank,DNA dealkylation (GO:0035510),-0.5147119821981723,-1.1919969971492141,0.2579505300353357,0.39833568932460284,1.0,7/10,25.92%,ALKBH1;MGMT;FTO;ALKBH3;ASCC3;MPG;ASCC2
prerank,toxin transport (GO:1901998),-0.5284204018927413,-1.1916993290661093,0.25357142857142856,0.3986168734659822,1.0,7/10,41.57%,ANTXR2;RAB29;SLC22A3;SLC22A2;ANTXRL;SLC29A4;ADAM10
prerank,cellular response to cAMP (GO:0071320),0.3754080263163833,1.1915138695669596,0.18906605922551253,0.5107022726024296,1.0,6/30,10.58%,AKAP6;IGFBP5;SLC26A3;WT1;HCN2;HCN1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3944413570299942,-1.1910126112056594,0.21079258010118043,0.3996808958960396,1.0,19/32,38.86%,RHOA;ANXA1;VEGFA;MAP2K5;ITGB1BP1;CIB1;HDAC5;PIK3C2A;KDR;HMOX1;CARD10;MAP3K3;TBXA2R;FGF2;KLF4;GATA2;SRPX2;HDAC7;HDAC9
prerank,icosanoid metabolic process (GO:0006690),-0.37199631344500816,-1.1909457408781825,0.22401433691756273,0.39953297973488205,1.0,14/40,30.14%,TBXAS1;MAPKAPK2;ALOX5AP;ABCC1;DAGLB;GPX4;PLA2G4A;PON2;CYP1B1;PNPLA8;PON3;ALOX15;CYP2S1;PTGR1
prerank,negative regulation of cell cycle process (GO:0010948),-0.3413032868895552,-1.1908517786809933,0.18571428571428572,0.3994298157275552,1.0,19/61,21.64%,APAF1;BRCA1;RYBP;EZH2;EED;E2F1;RAD51;E2F8;EPC1;CHMP2A;PHC3;RBBP4;UXT;RBBP8;MAX;CHEK1;NME6;VPS4A;ZFYVE19
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.4377588288264806,-1.190715086215382,0.22614840989399293,0.3994218195185576,1.0,2/17,1.10%,RUNX1;VIM
prerank,steroid biosynthetic process (GO:0006694),0.3288686856421944,1.190576434051567,0.18072289156626506,0.5116377911899346,1.0,18/56,15.12%,OSBPL6;SLC27A2;OSBPL7;CYP51A1;INSIG1;SQLE;DHCR7;ACOX2;SC5D;EBP;HSD3B7;HSD11B1;OSBPL2;ABCB11;ACOT8;LSS;HSD17B4;CYP39A1
prerank,sensory perception of taste (GO:0050909),0.5069577551904234,1.190552086898698,0.2611607142857143,0.5105386934197058,1.0,3/10,10.44%,ASIC2;PKD1L3;TAS1R1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.3978987845679357,-1.1904732565187337,0.21612349914236706,0.39958493169313725,1.0,11/28,28.76%,ARHGAP18;SH3BP1;WDR1;RASA1;BRK1;COTL1;HCLS1;HAX1;PFN1;DBNL;PLEKHG2
prerank,regulation of protein phosphorylation (GO:0001932),-0.27108973697533,-1.1904434020286785,0.0892018779342723,0.39936653515534193,1.0,87/256,27.20%,PID1;LYN;DAB2;FNIP2;CD74;FGR;CORO1C;XDH;NIBAN1;RAC1;ITGB2;INSR;BRD4;IBTK;ATF3;RAP2A;RIPK1;AKAP8;CCND3;PPP1R15B;AXIN1;FN1;HGF;C3;LRP6;ARRB1;MYADM;GAS6;CAMKK2;VEGFA;SIRPA;SMG8;FNIP1;PLAUR;PIN1;PAQR3;APP;FLCN;WDFY2;CCDC88A;IGFBP3;CIB1;ACVR2A;RB1CC1;CD40;PPIL4;IL34;NSD1;CRKL;MAVS;BST1;RALB;KRAS;PTPN13;HSPB1;RSPO1;AGER;ZC3H12A;MOB1B;KDR;PDGFA;RACK1;CEBPB;FGF18;ILK;PLPP3;PRKDC;TARDBP;TGFB1;ADTRP;DVL2;FGF9;PPP2R5B;AKAP8L;STAT2;ECT2;CDK2AP1;PPP2R5A;MT3;INPP5K;CCDC88C;PECAM1;BMP2;PDE8A;PML;PPP2R5E;ENG
prerank,Golgi ribbon formation (GO:0090161),-0.4864177098948315,-1.1904130585379142,0.2530755711775044,0.39913818904788384,1.0,6/13,24.20%,VTI1A;OPTN;STX16;VAMP4;TMED5;TRIP11
prerank,regulation of gluconeogenesis (GO:0006111),-0.39594823815843516,-1.1903792167245895,0.2117437722419929,0.39891442711807024,1.0,8/27,27.60%,OGT;SELENOS;SIK1;USP7;GNMT;DDB1;ZNF692;EP300
prerank,mitochondrial gene expression (GO:0140053),-0.36015554722725746,-1.1900152107541855,0.2109777015437393,0.399333376111644,1.0,17/42,34.45%,FOXO3;NOA1;FASTKD2;MRPS6;MRPS11;TFAM;MRPS16;MRPS15;MRPL51;MRPL47;TWNK;MRPS7;GATB;MRPS17;MRPS28;RARS2;MRPS21
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4225873755521542,-1.1898360348378605,0.21608040201005024,0.3993877145915943,1.0,3/21,8.63%,DAB2;RBPMS;TGFBR1
prerank,steroid hormone biosynthetic process (GO:0120178),-0.3904421721816588,-1.1898068652129172,0.22522522522522523,0.399160835744523,1.0,14/29,39.23%,HSD17B7;FDXR;SRD5A1;SRD5A2;TSPOAP1;FDX1;HSD3B2;HSD17B14;FDX2;SRD5A3;STARD3;HSD17B3;CYP19A1;TSPO
prerank,snRNA processing (GO:0016180),-0.4579522586599494,-1.1893876423288685,0.24259259259259258,0.3996468574808809,1.0,6/16,20.44%,INTS8;INTS11;INTS6;INTS14;INTS1;INTS5
prerank,cytosolic calcium ion transport (GO:0060401),0.3819456661416164,1.1892509451248885,0.2131979695431472,0.5122639478718369,1.0,10/28,15.15%,CACNA1C;RYR2;CACNA2D1;SLC25A23;TRPM1;JPH4;SLC8A2;ADRA1A;MICU3;JPH3
prerank,regulation of inclusion body assembly (GO:0090083),0.4916288082030858,1.189156309072777,0.2645161290322581,0.5112988855313503,1.0,4/11,13.04%,SNCAIP;SACS;DNAJA4;DNAJB2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.49935834467429235,-1.1889736866633476,0.25,0.4001364636314013,1.0,4/11,10.33%,STAT3;DHX9;PUM2;XPO5
prerank,embryonic digestive tract development (GO:0048566),0.4242069740575733,1.1872666504797953,0.24817518248175183,0.5142745906623756,1.0,6/18,14.07%,PCSK5;SOX11;RARB;SALL1;TGFB2;GLI3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.39323458812080203,-1.1868912580468127,0.23426573426573427,0.40372943074616713,1.0,7/26,17.76%,NSMCE2;RB1;DLGAP5;CENPE;NEK6;UBE2C;ANAPC7
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.3947124046207297,-1.1863568108472786,0.2382608695652174,0.40444919640181237,1.0,8/27,16.73%,CREBBP;PHF20;MORF4L1;TAF6;NAA50;KAT7;MRGBP;PHF20L1
prerank,cellular response to organonitrogen compound (GO:0071417),0.2913970120604796,1.1861539276893067,0.1362530413625304,0.5156083445911773,1.0,20/99,12.36%,GABRB3;AKAP6;GABRB1;RYR3;SLIT2;GLRA1;IGFBP5;P2RY12;SLC26A3;WT1;HCN2;RRAGB;GABRB2;GABRG2;SOX9;GLRA2;HCN1;CPEB3;RPTOR;HTR1B
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.36025801794262563,1.1860905035303153,0.20095693779904306,0.5145889177222903,1.0,14/37,20.96%,IFT81;DYNLL1;IFT22;TRAF3IP1;KIFAP3;DYNLL2;CEP131;DYNC2H1;DYNC2LI1;KIF3A;KIF3C;TTC21B;PCM1;DYNC2I1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5147987843512426,-1.1859446265427995,0.2617801047120419,0.404971000293242,1.0,3/10,13.83%,LYN;MAP2K1;GREM1
prerank,regulation of microglial cell activation (GO:1903978),-0.4580632125047412,-1.1856738195391336,0.24957264957264957,0.40521295203327273,1.0,7/15,22.61%,PTPRC;STAP1;GRN;CST7;MMP8;LDLR;IL6
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3939825566446405,-1.1851679129096964,0.23130434782608697,0.4059022383045829,1.0,11/30,24.54%,PTPRC;PLEK;FLT1;BATF;ARMC6;SFRP1;KDR;PRRC2C;TGFB1;FLT3;TNFRSF13B
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.48776253872447317,-1.1849995891806402,0.2638655462184874,0.40592801235353326,1.0,4/13,14.50%,CBL;SNX6;TSG101;CBLB
prerank,extracellular transport (GO:0006858),-0.48382259641981457,-1.1848698931896184,0.2669039145907473,0.4058741620917039,1.0,5/13,21.22%,WWP2;TSG101;CCDC40;ARRDC1;ADCY10
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.4014120940981892,-1.1847715845303406,0.2381786339754816,0.40578484892076183,1.0,13/26,28.61%,DHX58;IRAK3;PPM1B;TRIB1;PCBP2;NLRC3;NFKBIL1;C1QBP;SIRT2;MAPKBP1;CARD16;RNF26;SIGIRR
prerank,mitochondrial translational termination (GO:0070126),-0.31327971663554754,-1.1846247095601827,0.17362270450751252,0.4057692193156653,1.0,36/88,34.45%,MRPS10;ERAL1;MRPL42;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPL54;MRPS25;MRPL39;MRPL53;MRPL11;MRPL33;MTRF1;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPL1;MRPS28;MRPS35;MRPS21
prerank,cellular senescence (GO:0090398),-0.3945435627632381,-1.1845872801725696,0.23268206039076378,0.40555420197686043,1.0,10/27,26.75%,NSMCE2;PRKCD;SPI1;MAPK14;MAP2K1;ID2;TBX2;SMC6;SMC5;PML
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3466686888253916,1.1845846159888003,0.1964735516372796,0.5168404633530199,1.0,17/44,15.12%,OSBPL6;SLC27A2;OSBPL7;INSIG1;SQLE;DHCR7;ACOX2;SC5D;EBP;PER2;HSD3B7;OSBPL2;ABCB11;ACOT8;PSAT1;HSD17B4;CYP39A1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.5318904128991877,-1.1844920939306545,0.26258992805755393,0.4054517806299445,1.0,1/10,0.16%,APOE
prerank,response to cAMP (GO:0051591),0.3599636019893688,1.184224041576164,0.18561484918793503,0.5165147077886051,1.0,7/37,10.58%,AKAP6;IGFBP5;SLC26A3;WT1;HCN2;CITED1;HCN1
prerank,positive regulation of cell motility (GO:2000147),-0.27907992848580476,-1.1840620300559834,0.1136,0.4060051314671237,1.0,58/205,21.91%,DAB2;NEDD9;IGF1;FGR;SDCBP;MGAT5;INSR;IGF1R;PLAU;STAT3;CCR1;FLT1;ITGB1;PTK2B;RUFY3;ADAM9;ELP5;SEMA4A;HGF;MYADM;GCNT2;GRN;SUN2;VEGFA;CBLL1;MDK;TGFBR1;CTSH;SPRY2;ITGAX;XBP1;ARHGEF39;F7;CXCL16;CCL5;CIB1;CPNE3;SEMA4B;PIK3CD;CFAP20;SEMA3D;STX4;CLDN1;SPAG9;PDGFRB;TRADD;F10;ATM;CSF1;MAZ;FERMT3;KDR;PDGFA;RACK1;SEMA3B;CCDC25;SNAI2;MAP4K4
prerank,liver development (GO:0001889),-0.38121017177369176,-1.1839988982100262,0.22146507666098808,0.4058494190563588,1.0,15/32,30.39%,ARID5B;ANXA1;CEBPG;CCDC40;XBP1;GFER;E2F8;AURKA;CEBPB;IL6;LSR;DNAAF1;NKX2-8;CITED2;MET
prerank,positive regulation of sodium ion transport (GO:0010765),0.4727752441818839,1.1838410567138005,0.27380952380952384,0.5162418914763445,1.0,4/12,15.28%,ANK3;AHCYL1;CNKSR3;WNK3
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.474439366753747,-1.1832747056828297,0.25259515570934254,0.40693766812868526,1.0,6/14,13.88%,RAB1A;SEC24A;SAR1A;SEC24D;SEC31A;MIA3
prerank,maintenance of protein location in nucleus (GO:0051457),-0.43359688355985504,-1.1829461201201867,0.24620573355817876,0.40724804132832604,1.0,7/20,26.75%,SP100;SUN2;MORC3;TAF8;TAF3;TOPORS;PML
prerank,nerve growth factor signaling pathway (GO:0038180),0.5072070860777229,1.182766389804431,0.2718676122931442,0.517427813165514,1.0,2/10,7.07%,MAGI2;BDNF
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4215235942399247,-1.18272745882821,0.22241379310344828,0.4073863255973563,1.0,7/21,20.02%,OSBPL8;OSBPL5;PLA2G4A;PLAAT3;PLA2G5;PLA2G12A;LPCAT3
prerank,amino acid transport (GO:0006865),-0.34739166489168616,-1.182582931748579,0.19528619528619529,0.4073814639133672,1.0,11/49,14.69%,SLC38A6;SLC6A6;SLC43A2;SLC38A10;SLC16A10;SLC7A7;SLC38A7;SLC36A4;SLC25A45;SLC7A5;SLC25A44
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.3083701664882479,-1.1821048668389489,0.15619967793880837,0.4080379686129582,1.0,34/101,26.05%,MSN;VIM;NIBAN1;YTHDF3;OGT;ATG7;ATG10;FBXW11;NR1H2;ASPH;LARP4B;PCIF1;CD28;LARP4;RPS4X;AGT;EEF2;EIF3E;CLN6;UHRF1;METTL14;EIF4G1;FAF1;CASP8;DDX3X;CSF1;RBM3;IL6;PRKDC;TGFB1;FGFR4;VPS11;RPL5;EIF6
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5153632417682436,-1.181908963068991,0.2413793103448276,0.4081309252979228,1.0,4/10,10.11%,PRKCB;ITGA5;HIF1A;ARNT
prerank,organelle assembly (GO:0070925),-0.2599864029606972,-1.1818440019398733,0.06083086053412463,0.40797954449615836,1.0,99/385,22.53%,RAB8B;SH3PXD2B;SNX10;ASAP1;RAB7A;YTHDF3;GOLGA8B;ACTR2;PDCD6IP;FLNA;STX7;EHD4;CENPJ;IFT20;ATG5;KIF3B;PIBF1;PACS2;ACTR3;ATG7;CHMP5;RAB1A;RC3H1;DYNC1H1;CENPF;DLGAP5;HAUS5;CENPA;TSG101;RAB32;ULK2;PATL1;HAUS6;CFAP44;STARD9;EXOC4;CENPE;TUBGCP4;NEK6;CEP162;DHX37;SPAG16;RPS23;CSDE1;CHMP7;HAUS4;CHMP1A;STAM2;FOXJ1;RBM14;HAUS7;CFAP70;ABCC4;ARL3;RB1CC1;CFAP20;EHD1;CHMP2A;GABARAP;INO80;POGZ;RP2;CFAP43;EIF2A;DYNLT2B;NUDCD3;PCNT;G3BP1;EXOC2;PDE6D;BBIP1;RILP;RPS3;MRPL22;RCC1;ATG16L2;MAK;DDX3X;EXOC6;EMC6;SYNPO;DDX6;TMEM17;RAB11A;ATP6V0D1;VPS4A;RILPL1;LSM14A;ATXN2L;DISC1;NUP62;HYLS1;FLII;HPS4;CHMP4B;CHMP4A;CEP41;BECN1;TTLL3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4535683765215422,1.181799506624161,0.2431818181818182,0.5185044233855776,1.0,6/12,21.70%,SORBS1;PRKCZ;IGF2;IRS1;SIRT1;SORL1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.41502681908307915,-1.1814572478875336,0.23743500866551126,0.4084145813700032,1.0,2/22,0.73%,MDFIC;SP100
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.48180507448757837,-1.1812568211149292,0.2620320855614973,0.4084911699331284,1.0,5/12,21.25%,CTSB;CTSH;CTSS;LMO2;GAS2L1
prerank,exit from mitosis (GO:0010458),-0.4852441002981577,-1.1810837431554944,0.272419627749577,0.4085576045654506,1.0,6/12,22.38%,EPS8;PPP2R2D;CHMP7;CHMP2A;UBE2C;CHMP4B
prerank,response to growth factor (GO:0070848),-0.367006341624748,-1.180560997203375,0.21525423728813559,0.40927592497737403,1.0,18/41,24.60%,CTNNB1;STAT5B;MAP2K5;TGFBR1;MAPK7;CIB1;CPNE3;ACVR2A;TGFBR2;TBC1D7;TWF2;BMPR2;SFRP1;RACK1;URI1;LRP2;SHC1;MYC
prerank,regulation of oxidoreductase activity (GO:0051341),-0.47299720944693713,-1.1804046852366759,0.24820143884892087,0.4092965742048587,1.0,5/13,25.75%,ABL2;ATP7A;NOD2;HP;MT3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.28485274540016814,1.1801785284827957,0.15968586387434555,0.5210076321519949,1.0,19/124,8.49%,CNTNAP2;NLGN1;MAP2;CNTN4;GPM6A;RASGRF1;SH3GL2;CSF1R;PLP1;TMEM108;CARMIL1;BICDL1;GDNF;GPM6B;KIFAP3;FLRT3;TOR1A;FAM161A;NEDD4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4965796146642365,-1.1799386679354793,0.2657580919931857,0.4099231554775833,1.0,3/11,6.76%,ARRB2;GRK3;ARRB1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.42148341528406424,-1.1798134688751098,0.256993006993007,0.409872343618402,1.0,9/21,28.51%,BCL2L11;TXNDC12;SELENOS;XBP1;TMBIM6;HSPA1A;NCK1;EIF2AK3;BCL2L1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.37062198319296735,-1.1797610091761852,0.19931271477663232,0.40970057219939265,1.0,10/37,14.34%,DDB2;RFC1;UBC;RPS27A;PCNA;CUL4B;RPA3;RFC2;POLD2;ERCC4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4415936158936684,-1.1797330828809225,0.2429078014184397,0.40946981066597216,1.0,2/16,1.10%,RUNX1;VIM
prerank,somite development (GO:0061053),0.5004961592232102,1.179700364735835,0.2654462242562929,0.5209072341118209,1.0,3/11,19.06%,SOX11;SMO;MEOX2
prerank,regulation of nuclear division (GO:0051783),-0.42660163221499325,-1.1796406208437196,0.2602040816326531,0.4093660603021212,1.0,7/20,21.07%,CDK13;KIF20B;DAPK3;PIN1;MKI67;RCC1;CDC25C
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4302789182461222,-1.1792757945860308,0.2667844522968198,0.40977557103213924,1.0,13/20,36.57%,APOE;MBTPS2;TTC39B;FMO5;LPCAT3;NR1H4;ACADVL;ABCA2;LDLRAP1;SREBF1;ARV1;DGKQ;GNB3
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.419957945340534,-1.1788809637462543,0.24064171122994651,0.4102286485240231,1.0,8/21,22.16%,PTK2B;STAP1;MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,regulation of centrosome cycle (GO:0046605),-0.42226010829704924,-1.1788580501996972,0.25,0.4099956573623918,1.0,12/21,27.62%,PDCD6IP;CHMP5;GEN1;CHMP1A;CHMP2A;AURKA;XRCC3;ATF5;CHMP4B;PKHD1;CHMP2B;MARK4
prerank,adrenergic receptor signaling pathway (GO:0071875),0.4177994762508971,1.1787449386485145,0.23222748815165878,0.5219568932305697,1.0,8/20,14.36%,PDE4D;ADRA1B;GPR101;ADRA2C;ADRA1D;ADRA1A;ADRB1;ZDHHC21
prerank,photoperiodism (GO:0009648),-0.3994582910996276,-1.178725510878039,0.234006734006734,0.4099633248286553,1.0,13/28,28.28%,FBXL17;PPP1CA;BHLHE40;SIK1;ID2;FBXL8;RBM4B;FBXL6;PPP1CC;PPP1CB;CLOCK;PML;FBXL3
prerank,histone H2A ubiquitination (GO:0033522),-0.44168141216492857,-1.178014886258804,0.2534722222222222,0.41101017768835457,1.0,9/17,27.68%,DDB2;RYBP;UBR2;RNF8;CUL4B;DTX3L;DDB1;KDM2B;RNF2
prerank,response to ketone (GO:1901654),0.39308529703713696,1.178013005521567,0.23414634146341465,0.5223999750151774,1.0,5/24,10.93%,SLIT3;SLIT2;YAP1;CATSPERD;TGFB2
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.42949560985729346,-1.1777806691958814,0.2491638795986622,0.4111905656146633,1.0,3/19,1.57%,PRKCH;RUNX1;ROCK1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.49503563633380854,-1.1775659732825505,0.24954792043399637,0.41130931845310387,1.0,9/11,45.08%,UQCRC1;UQCRC2;CYCS;UQCRQ;UQCRB;UQCC3;UQCRFS1;UQCR10;UQCR11
prerank,negative regulation of cell adhesion (GO:0007162),-0.32356173076568184,-1.1768141498295361,0.17195325542570952,0.4124145117945343,1.0,15/72,8.99%,PTPRC;PLXNC1;RHOA;PLXNA1;SIPA1;PLXND1;LPXN;TGFBI;RIPOR2;JAG1;GCNT2;NF2;CBLL1;MDK;ITGB1BP1
prerank,DNA strand elongation (GO:0022616),-0.43085193328360144,-1.1763803425748753,0.23743500866551126,0.4129299738083373,1.0,8/18,26.18%,GINS3;MCM3;POLD2;RFC3;NBN;GINS4;MRE11;DCLRE1B
prerank,carboxylic acid transport (GO:0046942),-0.3427066897679296,-1.1761558327652057,0.2231686541737649,0.4130754728267916,1.0,15/55,20.26%,SLC16A7;PSAP;SLC38A6;SLC6A6;SLC36A4;SLC66A1;SLC7A5;SLC16A6;CLN3;SLC23A1;SLC23A2;SLC6A9;SLC38A2;SLC25A10;SLC16A1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.5208705689562109,-1.1760631260399528,0.2786885245901639,0.4127077093123539,1.0,3/10,39.39%,REEP6;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.5208705689562109,-1.1760631260399528,0.2786885245901639,0.4127077093123539,1.0,3/10,39.39%,REEP6;CNGB1;CACNA2D4
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.46262997757369206,1.1760455021812788,0.2579185520361991,0.5258290063734791,1.0,7/13,22.09%,CIAO1;ISCA2;NFU1;CIAO2B;LTO1;CIAO2A;BOLA2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.49564990616630256,-1.1759706798976717,0.26737967914438504,0.412596911188043,1.0,3/12,4.68%,NUPR1;IL18;STAP1
prerank,cellular response to radiation (GO:0071478),-0.365321968543689,-1.1755445404048077,0.21694915254237288,0.41312539198309567,1.0,12/40,17.62%,GRB2;SPIDR;BLM;MAPK14;RAD1;RAD51;GADD45A;RHNO1;RAD51AP1;INO80;NSMCE3;RAD9A
prerank,regulation of cell motility (GO:2000145),-0.2981470528895295,-1.175522743708578,0.15079365079365079,0.4128906830561643,1.0,23/121,11.57%,DIAPH1;PLXNC1;CDK6;RAC1;ROCK1;RHOA;PLXNA1;DOCK10;FLNA;PLXND1;FES;MINK1;ABL2;SGK1;DAPK3;ARHGAP18;MACF1;CYRIB;PIN1;KIF14;CCDC125;OSGIN1;CRK
prerank,histone monoubiquitination (GO:0010390),-0.4068094566692573,-1.1747209501630032,0.2224168126094571,0.4141142649949918,1.0,13/24,30.26%,DDB2;CTR9;RYBP;RNF20;CUL4B;UHRF1;WAC;DTX3L;DDB1;RNF40;KDM2B;RNF2;UBE2E1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.28503912852372865,-1.174384821390667,0.1377049180327869,0.4144931623772723,1.0,18/151,7.18%,PTPRC;APOE;NRP1;CD44;NOTCH2;CD74;MFHAS1;CD36;C5AR1;ARRB2;HTR2B;RAP1A;CCR1;PTK2B;PTPN22;ARRB1;GCNT2;GAS6
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.31574743045386117,-1.1741021634107665,0.17003367003367004,0.4147587284352261,1.0,35/85,28.30%,RAC1;RHOA;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;AP2A2;VANGL1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;VANGL2;PSMB8;RYK;PSMA5;PSMD4;PSMB3;PSMD3;SMURF2;DVL2;PSMB1;AP2S1;PFN1;FZD1;FZD7;SMURF1;AP2A1;DAAM1;CELSR1;PSMA7
prerank,regulation of mitotic cell cycle (GO:0007346),-0.27930226816264314,-1.1737110035821756,0.1407035175879397,0.41519347858162486,1.0,44/171,21.07%,IQGAP1;SDCBP;RB1;PSME4;CDK13;PSMB7;ANAPC1;PSME3;RNF20;KIF20B;DLGAP5;DAPK3;PSMB9;DUSP3;THAP1;NEK6;PSMA8;SIK1;SCRIB;AFAP1L2;PIN1;PSMC3;EIF4EBP1;APP;CDK1;PSMD8;MAEA;BUB1B;PSMC4;MKI67;PSMB10;TFAP4;PSMA1;BTG1;UBE2C;PSMB8;ANAPC7;DYNLT3;RCC1;PSMA5;PSMD4;PSMB3;PSMD3;CDC25C
prerank,negative regulation of histone modification (GO:0031057),-0.4761242696212786,-1.1736489574054911,0.25689655172413794,0.4150338396508528,1.0,8/14,34.05%,BRCA1;JARID2;PRMT6;SPHK2;SET;NOC2L;CTBP1;THAP7
prerank,positive regulation of leukocyte migration (GO:0002687),-0.4017097818485085,-1.1723551937171077,0.2597173144876325,0.41721930688273917,1.0,15/27,36.42%,IL6R;VEGFA;MDK;ADAM8;NCKAP1L;F7;MIA3;CSF1;IL6;PLVAP;TNF;EDN3;TNFRSF18;PRSS56;EDN2
prerank,response to hydroxyurea (GO:0072710),-0.4947480242124592,-1.1722817972371355,0.2577854671280277,0.4171086361209618,1.0,6/11,15.34%,SPIDR;BLM;DDI2;TIMELESS;KAT7;NSMCE3
prerank,regulation of plasminogen activation (GO:0010755),-0.4832560851888401,-1.1719550734413584,0.26444833625218916,0.4174692587114604,1.0,2/12,0.93%,RUNX1;CTSZ
prerank,keratan sulfate catabolic process (GO:0042340),-0.4914751443090014,-1.1716959873526847,0.2655367231638418,0.41769733935074893,1.0,5/11,17.32%,HEXA;GNS;GALNS;PRELP;FMOD
prerank,negative regulation of leukocyte migration (GO:0002686),0.4897471903481562,1.171365964055743,0.2616822429906542,0.5351652717444872,1.0,3/10,7.78%,SLIT2;CD200R1;CD200
prerank,nuclear migration (GO:0007097),-0.47863511121386954,-1.1712120581384147,0.25249169435215946,0.418316944891105,1.0,7/13,23.92%,DYNC1H1;FBXW11;SUN2;SYNE3;DCTN1;PAFAH1B1;SYNE2
prerank,sphingolipid metabolic process (GO:0006665),-0.3008442600974184,-1.170122075198606,0.17609046849757673,0.42007684560733677,1.0,36/108,29.05%,SGMS1;HEXA;PSAP;TEX2;SPTLC2;ACER3;CTSA;GLTP;ARSA;ESYT1;SPTSSA;ESYT2;SUMF2;PRKD3;NEU1;KDSR;VAPB;SPHK2;SPTLC3;PPT1;ASAH1;SAMD8;PLPP3;ELOVL5;DEGS2;ABCA2;B4GALNT1;CERS3;HACD4;ORMDL2;PLA2G15;VAPA;CPTP;HACD3;B3GALNT1;CERK
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.39940528354308347,-1.169942527092401,0.23793103448275862,0.4201463852001208,1.0,6/25,11.05%,SDCBP;RIN3;RAC1;ITGAV;PICALM;APP
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.5128480119424094,-1.1699062492726362,0.26825127334465193,0.4199368624918138,1.0,4/10,17.14%,DCLRE1C;RTEL1;DCLRE1A;TFIP11
prerank,secondary alcohol biosynthetic process (GO:1902653),0.36678942404874504,1.1694137922305683,0.22037914691943128,0.5384129100825077,1.0,9/30,14.49%,HMGCS1;DHCR24;CYP51A1;INSIG1;SQLE;DHCR7;EBP;MVK;LSS
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.44042159318667073,-1.16934893450492,0.26360544217687076,0.4207111333598956,1.0,9/17,27.90%,COX4I1;COX10;AFG1L;COX8A;COX6C;NDUFA4;CYCS;COX5A;COX6A2
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4502498198704811,-1.169097180703242,0.2687074829931973,0.4209214585992528,1.0,5/16,16.94%,PID1;DNAJC30;FLCN;TMSB4X;SPHK2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4703693384039816,-1.1683117948660866,0.29338103756708406,0.4221439314480084,1.0,5/13,21.23%,NAMPT;TLR4;SELENOS;NOD2;KDR
prerank,positive regulation of histone acetylation (GO:0035066),-0.40694591130443114,-1.1681270507670092,0.2542955326460481,0.4221898458802094,1.0,6/23,16.94%,BRD7;BRCA1;ARRB1;WBP2;KAT7;SPHK2
prerank,positive regulation of RNA splicing (GO:0033120),-0.3895014594473656,-1.1681027110155138,0.24744027303754265,0.42195275783074015,1.0,11/29,20.12%,ERN1;TRA2B;DYRK1A;HNRNPLL;POLR2A;NCBP1;NCL;DAZAP1;HSPA1A;SLC38A2;RBM3
prerank,phosphate ion homeostasis (GO:0055062),-0.5136173468403449,-1.1680533031018292,0.2822429906542056,0.42175754024765155,1.0,4/10,36.77%,XPR1;ENPP1;FGFR4;FGF23
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3695853227023814,-1.1673682618396308,0.24064171122994651,0.4228223321878573,1.0,5/35,9.25%,APOE;XDH;PPARG;FLT1;MEF2C
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3302041698449073,-1.1671238944305617,0.2153846153846154,0.42301822858085464,1.0,30/60,34.58%,HGF;CTNNB1;CCT7;PKIB;NVL;PCNA;HSP90AB1;RFC2;TNKS2;GREM1;CHTF18;CCT4;PDGFRB;HNRNPA1;WRAP53;ATM;RFC3;MAPK1;POLG2;MYC;FGFR4;GRHL2;MAPK15;MAP3K4;NEK7;FGF2;TNKS;KLF4;CCT8;CCT5
prerank,reticulophagy (GO:0061709),-0.4841124133509648,-1.166915493067887,0.25357142857142856,0.4231154641289317,1.0,5/12,22.14%,ULK2;TEX264;RETREG1;RB1CC1;UFM1
prerank,regulation of proteolysis (GO:0030162),-0.346404414888001,-1.1666344378923805,0.20954003407155025,0.4233921811350914,1.0,16/48,25.14%,GSAP;OGT;DNAJC1;FBXW11;ASPH;TRAF3;PLAUR;CLN6;LTBP4;CST3;CLN3;CASP8;CDK5;BAG6;FGFR4;SPOP
prerank,mRNA catabolic process (GO:0006402),-0.35479721709396805,-1.1665177640285596,0.2332155477031802,0.4233217343212211,1.0,26/44,43.66%,ERN1;TUT7;RC3H1;DCP2;DDX5;HSPA1A;LSM6;EXOSC10;LSM5;EXOSC4;XRN2;NUDT16;ZC3H12D;METTL3;NBDY;DHX34;NUDT12;HSPA1B;SLFN14;AGO3;ZFP36;DXO;YTHDF2;METTL16;XRN1;RNH1
prerank,rRNA modification (GO:0000154),-0.41785903093002497,-1.1663236473208394,0.2610294117647059,0.4234234486623464,1.0,8/21,25.44%,NSUN3;NSUN4;DIMT1;GAR1;THUMPD1;NHP2;BUD23;MRM2
prerank,protein localization to cell-cell junction (GO:0150105),-0.4521343496017404,-1.1658482733434632,0.2699822380106572,0.42407577403074687,1.0,6/15,13.80%,PAK2;ACTB;ARHGEF18;JAK1;SCRIB;TJP2
prerank,negative regulation of cyclase activity (GO:0031280),-0.46460562398862304,-1.165828748233111,0.2864493996569468,0.4238299322516542,1.0,2/14,2.23%,CCR2;GNAI3
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4355060472795322,-1.1657794357568358,0.2659758203799655,0.42365731717067207,1.0,5/19,18.76%,CENPJ;CEP295;CCT7;CCT4;WRAP53
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.3682858187439903,-1.1657017730490908,0.2206405693950178,0.4235383564275708,1.0,14/35,25.67%,RFC1;LIG1;PCNA;FEN1;RPA3;RFC2;POLD2;LIG3;ADPRS;RFC3;POLB;POLD4;MPG;XRCC1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2950853969165669,-1.1655089703995563,0.18699186991869918,0.4236226071356077,1.0,46/124,28.56%,GNB1;RAC1;RHOA;AGO2;PSME4;ARRB2;PSMB7;CDC42;PSME3;PSMB9;GNG2;CTNNB1;AP2A2;VANGL1;PSMA8;PSMC3;MOV10;PSMD8;PSMC4;PSMB10;PLCB3;TNRC6C;PSMA1;VANGL2;PSMB8;NFATC1;RYK;PSMA5;PSMD4;PSMB3;PSMD3;SFRP1;SMURF2;DVL2;PSMB1;AP2S1;PFN1;CCDC88C;FZD1;FZD7;SMURF1;AP2A1;DAAM1;CELSR1;PSMA7;LEF1
prerank,isotype switching (GO:0045190),-0.5039219405476221,-1.165217756587935,0.27843803056027167,0.42390724494788784,1.0,2/10,10.13%,BATF;RNF8
prerank,cellular response to lipid (GO:0071396),-0.2760300545336326,-1.1645167030735248,0.13249211356466878,0.42492268566913854,1.0,54/191,20.90%,PID1;LYN;MSN;LILRB1;VIM;AXL;RHOA;TNFRSF1B;SBNO2;FES;ABL2;CTR9;TLR4;TFPI;CHMP5;PTK2B;STAP1;NFKB1;ADAM9;MAPK14;PF4;AHR;SIRPA;MYD88;MEF2C;LY96;SELENOS;LPL;UBE2L3;TNIP2;RELA;XBP1;TICAM1;ADAM15;HMGB2;SERPINE1;CASP1;DEFA6;NFKBIL1;SPP1;NFKBIB;NRIP1;TNIP3;SPHK2;TWF2;NR3C1;NOD2;HMGB1;ATM;WNT3;TICAM2;CD274;SFRP1;ZC3H12A
prerank,cellular response to UV (GO:0034644),-0.31462020336606317,-1.1644536517935271,0.21147540983606558,0.42476445367848287,1.0,34/76,33.64%,PRKCD;DDB2;CREBBP;CRIP1;CDC25A;PCNA;CUL4B;STK11;DHX36;ERCC4;RHNO1;TMEM161A;YY1;INO80;NSMCE3;CHEK1;MMP2;MMP1;KDM1A;MYC;DDB1;NOC2L;USP28;METTL3;CARD16;EP300;AQP1;ZBTB1;PPID;COPS9;ATF4;RHBDD1;MMP9;EIF2S1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.3631015340195335,-1.164369149262331,0.22772277227722773,0.4246483857880773,1.0,15/40,24.79%,FGR;RNASE7;MYD88;GBP2;CHGA;RNASE6;CAMP;HMGB2;DEFA6;ANG;GBP7;GBP6;IL6;RPL39;GBP4
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3418412050863224,-1.163953510137323,0.19055944055944055,0.42519609244643125,1.0,19/53,24.19%,PSME4;PSMB7;PSME3;PSMB9;AZIN1;PSMA8;PSMC3;PSMD8;PSMC4;PSMB10;PSMA1;PSMB8;PSMA5;PSMD4;PSMB3;PSMD3;OAZ3;NQO1;PSMB1
prerank,cellular response to glucose starvation (GO:0042149),-0.36159000251373774,-1.1630132070544528,0.24504504504504504,0.42665043824210125,1.0,14/41,23.57%,PRKAG2;FOXO3;MTMR3;SIK1;XBP1;SESN1;SH3GLB1;HNRNPA1;ZC3H12A;CPEB4;PRKAG1;BECN1;RRP8;KPTN
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2678750302833234,-1.1629725255850514,0.11235955056179775,0.42645364367955824,1.0,69/260,22.85%,NRP1;RAB8B;MTSS1;SNX10;SDCBP;ASAP1;P2RX7;FGD6;RAC1;RAP1B;ACTR2;ANO6;RAP2B;FLNA;EMP1;EHD4;CENPJ;RAP2A;FXYD5;MINK1;IFT20;KIF3B;RAP1A;PARVB;PIBF1;ACTR3;FGD4;RAB1A;ITGB1;FGD3;CFAP44;EXOC4;PMP22;CEP162;SPAG16;CCDC88A;FOXJ1;CFAP70;ABCC4;SPEF1;ARL3;CFAP20;EHD1;RP2;PPP1R9B;CFAP43;DYNLT2B;NUDCD3;PCNT;EXOC2;PDE6D;PTPRO;BBIP1;RILP;ARFIP2;MAK;EXOC6;PIP5K1A;TMEM17;RAB11A;ATP6V0D1;RILPL1;DISC1;MAP4K4;HYLS1;CEP41;S1PR2;TTLL3;EMP3
prerank,divalent inorganic cation homeostasis (GO:0072507),0.38251468224848156,1.1628166046608155,0.22632794457274827,0.5524055009209651,1.0,6/25,16.07%,ANK3;TMTC2;KCNA1;PRKN;FAM20A;SNCA
prerank,response to reactive oxygen species (GO:0000302),-0.3391930760541676,-1.162646973876508,0.22972972972972974,0.4267834253698907,1.0,17/54,23.44%,APOE;JUN;COA8;ADAM9;CAMKK2;HIF1A;PRDX5;APTX;NCF1;PLK3;STK24;MPV17;RPS3;CAT;HP;MAPK1;HMOX1
prerank,positive chemotaxis (GO:0050918),-0.4378480984347022,-1.1624768856915095,0.2913793103448276,0.42683289988781814,1.0,4/17,10.26%,NRP1;PTPRJ;VEGFA;SCRIB
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3662313017565452,-1.162181973299349,0.2336283185840708,0.4271692392121891,1.0,10/39,11.64%,MYO5A;TRAK1;MYO1F;RAB1A;FBXW11;MYO1G;WASL;SYT4;MYO1E;MYO7A
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4492018909369424,1.161853801443896,0.26277372262773724,0.5534176986749242,1.0,6/14,16.87%,NME2;AK4;AK5;NMNAT2;ME1;AK3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3141777978604522,-1.161637553996417,0.20330578512396694,0.42792039588939795,1.0,25/85,21.86%,DAB2;HECTD1;NUPR1;RNF19A;PIAS1;CBFA2T3;NUB1;DET1;ATXN3;TRIB1;TRIB2;PSMC3;RNF180;RNF185;ARIH1;GABARAP;TMEM259;HSPA1A;SMAD7;FBXO22;GSK3B;SIRT2;RACK1;BAG6;SOCS5
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.4373107890847982,-1.1616104970247234,0.2705061082024433,0.42768809763757787,1.0,12/18,38.86%,ANXA1;VEGFA;CIB1;PIK3C2A;KDR;HMOX1;MAP3K3;FGF2;GATA2;SRPX2;HDAC7;HDAC9
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.425012722563039,-1.1615087280090572,0.2552083333333333,0.4270579011356689,1.0,8/20,19.63%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.425012722563039,-1.1615087280090572,0.2552083333333333,0.4270579011356689,1.0,8/20,19.63%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.425012722563039,-1.1615087280090572,0.2552083333333333,0.4270579011356689,1.0,8/20,19.63%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,lipoxygenase pathway (GO:0019372),-0.4671631162095411,-1.161192914964716,0.2626970227670753,0.4274192065051001,1.0,10/14,48.10%,ALOX5AP;GPX4;PON2;PON3;ALOX15;ALOX12;PON1;LTC4S;ALOXE3;GPX1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.37356805543135835,-1.1611526962622927,0.25249169435215946,0.42721198750047135,1.0,17/31,31.30%,USP50;OTUD5;USP8;ABRAXAS1;BABAM2;ATXN3;BABAM1;OTUD4;USP7;STAMBPL1;BRCC3;ZRANB1;USP16;STAMBP;UIMC1;ABRAXAS2;OTUD1
prerank,negative regulation of reproductive process (GO:2000242),-0.4448796854377046,-1.1611183171181998,0.26277372262773724,0.426993043317525,1.0,2/17,0.72%,IGF1;PAEP
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.3468527082547006,-1.1609553035847902,0.22857142857142856,0.4270284784779028,1.0,17/45,17.48%,FOXO3;RC3H1;ZC3H7B;PUM3;GCNT2;PUM2;PCIF1;PARP9;LARP4;MTPN;APP;NUDT21;YTHDC1;NOLC1;EIF2A;RBM4B;TDRD7
prerank,regulation of fibroblast migration (GO:0010762),-0.4154755947977458,-1.1607753495815432,0.23674911660777384,0.42710938391366365,1.0,9/20,23.38%,CORO1C;RAC1;GNA12;ITGB1;ITGB1BP1;CLN3;APPL2;APPL1;TGFB1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.35488351767006754,1.160721693008274,0.23271889400921658,0.5548499182061601,1.0,6/37,8.29%,EFNA5;BICD1;MAPRE3;CLASP2;TRAF3IP1;MAP6D1
prerank,epidermal cell differentiation (GO:0009913),-0.35236570834053493,-1.1605511170370684,0.23022847100175747,0.42724764168403484,1.0,17/41,38.05%,CLIC4;ANXA1;ADAM9;JAG1;CTNNB1;PIP5K1A;TXNIP;ASAH1;DSP;CERS3;SPINK5;ERCC2;OVOL2;OVOL1;PITX2;GLI1;SPRR1A
prerank,mitochondrial translational elongation (GO:0070125),-0.30717336964041464,-1.1604169191978557,0.19796954314720813,0.4272126641331323,1.0,36/88,34.45%,MRPS10;ERAL1;MRPL42;TUFM;CHCHD1;MRPS6;MRPS11;MRPS16;GADD45GIP1;MRPL34;DAP3;MRPS15;MRPL21;MRPL45;MRPL22;MRPL17;MRPL15;MRPL51;MRPL47;MRPL18;MRPS7;MRPL54;MRPS25;MRPL39;MRPL53;MRPL11;MRPL33;MRPL28;MRPL30;MRPL43;MRPS17;MRPS5;MRPL1;MRPS28;MRPS35;MRPS21
prerank,mRNA methylation (GO:0080009),-0.45540820015812644,-1.160267708262389,0.27303754266211605,0.42723750538716654,1.0,6/15,15.81%,CBLL1;PCIF1;METTL14;VIRMA;TRMT6;WTAP
prerank,cellular response to alcohol (GO:0097306),-0.35600530729461427,-1.1602256499688797,0.24734982332155478,0.42704886106379625,1.0,12/42,8.96%,GNB1;ADCY7;SPIDR;BRCA1;GRAMD1B;PTGER4;BLM;LRP6;GNG2;AHR;CTNNB1;RAD51
prerank,regulation of protein targeting to membrane (GO:0090313),0.3732468724871315,1.1600096621657645,0.23880597014925373,0.555290536995413,1.0,6/28,8.14%,ANK3;TCAF1;MIEF1;PRNP;FYN;MTCL1
prerank,sphingoid metabolic process (GO:0046519),-0.4822351832016361,-1.1596933396445805,0.2690972222222222,0.42779570727217103,1.0,9/12,40.34%,KDSR;SPHK2;SPTLC3;PLPP3;DEGS2;SPHK1;PLPP2;PLPP1;SGPP1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3813513046455479,-1.1591583313053528,0.25121555915721233,0.4285447734405282,1.0,15/28,29.30%,MAP3K20;ERCC6;RAD1;E2F1;RHNO1;DOT1L;BRIP1;RAD9A;ATM;CHEK1;NBN;CLOCK;USP28;CEP63;DONSON
prerank,positive regulation of cell adhesion (GO:0045785),-0.3196084172783567,-1.1589979618066235,0.2090032154340836,0.42858777188072245,1.0,22/74,20.08%,SYK;RSU1;RAC1;PTPRJ;ITGAV;ADAM9;STX3;VEGFA;MDK;ADAM8;NCKAP1L;TGM2;FLCN;CCL5;CIB1;STX4;LIMS1;SMAD7;TFE3;ATM;C1QBP;NDNF
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.2709687066670765,-1.1589837280434239,0.11916264090177134,0.4283471071997464,1.0,36/214,12.70%,LYN;PTPRC;APOE;NRP1;CD44;NOTCH2;CD74;MFHAS1;SYK;CD36;C5AR1;ARRB2;HTR2B;RAP1A;CCR1;TLR4;PTK2B;PTPN22;DUSP3;FN1;ARRB1;GCNT2;GAS6;SIRPA;ITGB1BP1;PTPN6;SPRED1;SPRY2;PIN1;APP;DUSP6;FLCN;SPRED2;MAP2K1;CCL5;CIB1
prerank,activation of protein kinase B activity (GO:0032148),-0.3798706023257586,-1.1587745662658047,0.2508250825082508,0.4284902099541083,1.0,7/29,11.72%,OSBPL8;IGF1;INSR;IL18;GAS6;ITGB1BP1;CCDC88A
prerank,actin filament bundle organization (GO:0061572),-0.3734273946233954,-1.1580304609159626,0.2391681109185442,0.4296137703113736,1.0,9/33,18.99%,NEDD9;EPS8;BAIAP2;LIMA1;LCP1;MICAL1;BAIAP2L2;ESPN;RFLNB
prerank,response to UV (GO:0009411),-0.30478687568384283,-1.1578536008800904,0.2026359143327842,0.42968055181251513,1.0,20/95,15.34%,PRKCD;MAP4K3;DDB2;CREBBP;ERCC6;PRIMPOL;PCLAF;RELA;UBE4B;CDC25A;WRN;PCNA;FEN1;DHX36;ERCC4;RHNO1;TMEM161A;YY1;INO80;NSMCE3
prerank,acute inflammatory response (GO:0002526),-0.40209361282726686,-1.15757029184407,0.2525597269624573,0.4299722839526057,1.0,12/23,41.92%,ANO6;IL6R;HPR;HP;CEBPB;IL6;SIGIRR;PLSCR1;VNN1;CD6;CTNNBIP1;F3
prerank,mismatch repair (GO:0006298),-0.38478366730271485,-1.1570374877169203,0.22905982905982905,0.43072688803988374,1.0,7/27,13.96%,MCM9;LIG1;PCNA;EXO1;MLH3;RPA3;POLD2
prerank,regulation of interleukin-2 production (GO:0032663),-0.35300739167169165,-1.1568204469777579,0.23339011925042588,0.4308964970836833,1.0,11/43,13.11%,PTPRC;RUNX1;CCR2;PLCG2;MALT1;CARD11;ANXA1;LAPTM5;CD28;TRAF2;VSIG4
prerank,macrophage differentiation (GO:0030225),-0.4688244583989035,-1.156794213138365,0.2720970537261698,0.43067836779452323,1.0,6/13,19.75%,IL15;CDC42;VEGFA;IL31RA;CASP8;CSF1
prerank,UV-damage excision repair (GO:0070914),-0.4843724231570308,-1.1564681123754246,0.28825622775800713,0.43100902297133287,1.0,3/12,14.84%,DDB2;CUL4B;INO80
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.45741180214452304,1.1556756502525027,0.2772511848341232,0.5643986709242185,1.0,5/13,20.95%,ELOVL7;HACD1;TECRL;ELOVL6;ELOVL2
prerank,nucleic acid-templated transcription (GO:0097659),-0.34974006261851237,-1.1556706269046948,0.24408014571949,0.4322617979999946,1.0,18/42,22.24%,MEF2A;POLR2H;E2F1;POLR2F;THAP1;POLR2L;POLR2A;EPC1;NFKBIB;POLR2G;RNPS1;DTX1;POLR3A;MED20;MMS19;POLR2I;XAB2;TOPORS
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3584041515353463,-1.155572688501565,0.24744027303754265,0.4321616159773213,1.0,14/38,23.94%,SNRPG;COIL;SNRPF;PRPF8;SART1;SMN1;SART3;GEMIN7;SNUPN;SRSF10;WDR77;TGS1;GEMIN6;PRPF6
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.4450816702176706,-1.1542097086447527,0.2750865051903114,0.4344793547930485,1.0,6/16,23.60%,SLC27A1;NR1H2;DAGLB;ABHD5;LDLR;GPLD1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.3051640153404684,-1.1541781686614239,0.2103448275862069,0.43427146010966144,1.0,22/84,22.06%,APOE;IGF1;DAPK1;ROCK1;GAPDH;GGA3;CNOT1;DAPK3;PUS7;EIF2AK2;PCIF1;PIN1;DHX36;NCL;TOB1;RPS3;DDX3X;CNOT8;DDX6;LSM14A;RACK1;SHMT1
prerank,response to glucose (GO:0009749),-0.34718168688355944,-1.1541227910885599,0.26194398682042835,0.4341047979281038,1.0,18/46,29.85%,ERN1;IGF1R;TRA2B;EIF2B3;GAS6;SELENOS;LPL;ZBTB20;XBP1;IRS2;EIF2B1;RACK1;KCNB1;GPLD1;EIF2B2;EIF2B4;VAMP2;PAX2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.37491604530274925,1.1539730578933654,0.25,0.5672470946906896,1.0,8/31,10.51%,DLG2;LRRC7;DLG3;PARD3;PRKCI;MTCL1;ANK1;CRB1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4262183694361491,-1.1536191301925156,0.25517241379310346,0.43481386042420234,1.0,6/20,17.40%,ZMIZ1;TGFBR1;HIF1A;EGR1;HSP90AB1;HSPA1A
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.418384849652783,-1.1532083512206406,0.2517361111111111,0.43529147856538236,1.0,3/19,5.77%,RUNX1;VIM;CIITA
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.31493278557553855,-1.1531934013700809,0.20593080724876442,0.43503720286575626,1.0,31/76,32.68%,BIRC3;MALT1;PIAS1;BRCA1;AXIN1;WDR48;WFS1;LAPTM5;UBE2L3;DERL1;DCUN1D4;UBE3A;NSMCE3;UBA2;TBC1D7;SMAD7;HUWE1;NDFIP2;ZC3H12A;SAE1;CUL3;PTTG1IP;RIPK2;TRAF6;XIAP;BCL10;DCUN1D5;CAV1;HSPBP1;FANCI;STUB1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4012157280877117,-1.1531542545319644,0.25906735751295334,0.43483590118865617,1.0,5/24,2.55%,CD44;ITGA5;ARHGAP24;RHOA;FLNA
prerank,regulation of spindle assembly (GO:0090169),-0.4027774095517419,-1.1531003845600412,0.25666666666666665,0.4346599859867684,1.0,14/25,34.01%,PDCD6IP;CHMP5;DYNC1H1;RNF4;CHMP1A;TPR;CHMP2A;HSPA1A;CHMP4B;CHMP2B;VPS4B;HSPA1B;DRG1;NUMA1
prerank,regulation of centriole replication (GO:0046599),-0.4322944670380082,-1.1529219842841072,0.282312925170068,0.43473151579067165,1.0,10/18,27.54%,CENPJ;BRCA1;CEP295;PLK2;CEP295NL;RBM14;STIL;NUP62;ALMS1;MDM1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4219454540408677,-1.1527141352061334,0.2698706099815157,0.434890799923422,1.0,2/20,1.96%,ITGA4;ANO6
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.4216923033587509,-1.1524565348174762,0.26851851851851855,0.4348429437477412,1.0,6/19,21.09%,POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;POLR2I
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.4216923033587509,-1.1524565348174762,0.26851851851851855,0.4348429437477412,1.0,6/19,21.09%,POLR2H;POLR2F;POLR2L;POLR2A;POLR2G;POLR2I
prerank,regulation of viral entry into host cell (GO:0046596),-0.37985681418043155,-1.1521214424465371,0.2603978300180832,0.43520695869943127,1.0,12/30,23.31%,CD74;SNX3;CIITA;IFITM2;TRIM68;LGALS1;TRIM11;TRIM14;LGALS9;TRIM25;IFITM1;P4HB
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.35703137905643795,-1.1519122605491963,0.25585284280936454,0.43533502677165853,1.0,10/40,18.86%,IGF1;BCL2L11;HGF;PLAUR;MLLT11;BBC3;GHITM;BID;TNFSF10;PDCD5
prerank,regulation of bone mineralization (GO:0030500),-0.3306519478616266,-1.151881580742785,0.2370242214532872,0.43512204625179485,1.0,16/55,19.98%,ATP2B1;P2RX7;ANO6;CCR1;SRGN;PTK2B;PKDCC;MEF2C;SLC8A1;OSR1;ACVR2A;GREM1;ISG15;ANKH;ENPP1;BMPR2
prerank,regulation of calcium ion transport (GO:0051924),-0.3336448173125174,-1.151641747158924,0.25301204819277107,0.43531798392532606,1.0,10/54,7.60%,CD84;ATP2B1;LILRB1;SARAF;CRACR2A;P2RX4;CCR1;BCL2;CTNNB1;WFS1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4523264338932039,-1.1513105625130253,0.2760416666666667,0.43565579064557547,1.0,5/15,16.60%,NIPBL;MTHFD1L;TGFBR1;TGFBR2;IRX5
prerank,cellular protein localization (GO:0034613),-0.26125161108363926,-1.151276397040739,0.13282442748091602,0.4354500344344874,1.0,80/285,20.02%,SH3PXD2B;CD74;ITSN1;SNX9;SNX27;SNX8;FLNA;STX7;ARHGEF2;TBC1D15;RAP2A;UNC93B1;RAB31;SGSM2;TLK1;TBC1D2B;RAB20;TBC1D9;GGA3;PACS2;RAB1A;NIPBL;COG7;SNX6;HHEX;TMED10;STX8;CTSA;TBC1D5;TBC1D1;ARL11;STX3;TBC1D22A;RAB32;CTNNB1;TBC1D16;TBC1D22B;SIL1;LAPTM5;WLS;TBC1D8B;RAB5A;TMED3;CD63;TBC1D8;RAB21;TBC1D17;VPS26B;SNX13;RAB24;RRAGD;SAR1A;MYO7A;RAB29;VPS26A;FOXJ1;STX5;TBC1D10B;ARL5A;SEC31A;COPA;EHD1;TBC1D30;STX16;ARFIP1;AP3B1;STX4;AP3D1;TBC1D9B;TMED2;VPS33A;ARL1;SNX1;TBC1D25;ARFIP2;ID1;SLU7;TMED4;GRIN3B;TICAM2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.32631303708047993,1.1510786795728931,0.22141119221411193,0.5730518865730962,1.0,10/52,8.11%,RBFOX1;KHDRBS3;KHDRBS2;SRRM4;CELF4;CELF5;RBFOX2;NOVA1;RBFOX3;FMR1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.45534409226678635,-1.1507318299587503,0.2838709677419355,0.4362373193475425,1.0,6/14,16.94%,MYADM;DGKD;VEGFA;CD40;DGKG;SPHK2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3186276945618161,-1.1506416944504634,0.22602739726027396,0.4361351138526538,1.0,21/76,21.86%,DAB2;HECTD1;RNF19A;PIAS1;AXIN1;CBFA2T3;NUB1;DET1;LAPTM5;TRIB1;TRIB2;RNF180;ARIH1;GABARAP;HSPA1A;SMAD7;FBXO22;GSK3B;SIRT2;RACK1;SOCS5
prerank,arachidonic acid secretion (GO:0050482),-0.5115953628593759,-1.1501887532880242,0.2849557522123894,0.43644405560695004,1.0,5/10,39.07%,ANXA1;PLA2G5;PNPLA8;ACE;NMUR2
prerank,arachidonate transport (GO:1903963),-0.5115953628593759,-1.1501887532880242,0.2849557522123894,0.43644405560695004,1.0,5/10,39.07%,ANXA1;PLA2G5;PNPLA8;ACE;NMUR2
prerank,L-glutamate transmembrane transport (GO:0015813),0.5013423706499385,1.1501486583250367,0.30201342281879195,0.5739345642659824,1.0,3/10,7.87%,SLC1A2;SLC1A6;SLC1A1
prerank,positive regulation of metabolic process (GO:0009893),-0.2962569854405401,-1.150124276911103,0.18833333333333332,0.4362851255105561,1.0,16/103,7.83%,CCR2;SYK;CD36;CAMK1D;OGT;INSR;IGF1R;FABP5;KDM3A;IL18;STAT6;ADIPOR1;DYNC1H1;UCP2;PLAC8;VEGFA
prerank,positive regulation of protein binding (GO:0032092),-0.3295048082831384,-1.1500849796567119,0.229706390328152,0.4360960760183575,1.0,10/56,11.05%,APOE;LRP1;AMFR;STK3;RPL11;NVL;B2M;PIN1;DERL1;APP
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.455340117468503,-1.149176972633317,0.27521367521367524,0.437631277391509,1.0,6/14,28.39%,SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7
prerank,fatty acid elongation (GO:0030497),0.4583153655237492,1.1489677188135956,0.29850746268656714,0.5756425773636739,1.0,5/13,20.95%,ELOVL7;HACD1;ABCD1;ELOVL6;ELOVL2
prerank,regulation of metal ion transport (GO:0010959),0.4236457861506644,1.1489043913366586,0.26884422110552764,0.574550459563358,1.0,2/16,1.49%,ANK2;CACNA2D1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.44467856886266016,-1.1482331687789,0.2910958904109589,0.4391979360039121,1.0,4/15,17.88%,BCL2L11;ANXA1;UBE2L3;NR3C1
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3991255950634393,-1.1479996640223031,0.25925925925925924,0.43937599238952046,1.0,6/24,4.20%,ARPC2;RAC1;ACTR2;WASF2;CDC42;ACTR3
prerank,negative regulation of response to external stimulus (GO:0032102),-0.29635479390984976,-1.1479176583938309,0.19633943427620631,0.4392622487763278,1.0,24/105,13.47%,APOE;AOAH;MFHAS1;PRKCD;RB1;PPARD;METRNL;PPARG;DHX58;TNFAIP8L2;PTGER4;DUSP3;IRAK3;PPM1B;SIRPA;TRIB1;MAPK7;OTULIN;SELENOS;PCBP2;CRK;NLRC3;SERPINE1;NFKBIL1
prerank,negative regulation of vascular permeability (GO:0043116),0.46171684764240467,1.147812623589277,0.28705882352941176,0.5760093314332331,1.0,6/12,16.91%,SLIT2;SH3GL2;FERMT2;CLDN5;RAMP2;PDE3A
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.37048746913930203,1.1477950795584815,0.25,0.5748185164577267,1.0,9/32,9.64%,ARHGAP6;SEMA3E;MMP12;CLASP2;DLC1;APOD;NEXMIF;CDKN2A;PLET1
prerank,photoreceptor cell development (GO:0042461),0.45600588502685846,1.1476697894597827,0.31662870159453305,0.5738693377972562,1.0,5/14,10.94%,RORB;AHI1;CDHR1;CEP290;MFSD2A
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.378604509797749,-1.1475708806607816,0.25263157894736843,0.43964153693230273,1.0,12/30,21.24%,OPTN;GOLGA4;RAB31;GGA3;MACF1;GOLPH3L;SYS1;RAB10;VAMP4;RAB34;GOLGA7;BLZF1
prerank,regulation of calcium ion import (GO:0090279),0.3881919967426248,1.147540264436142,0.2962962962962963,0.5729832346120135,1.0,7/21,19.72%,PLPP4;EGF;PRNP;FYN;WNK3;TRIM27;CCL2
prerank,embryonic heart tube development (GO:0035050),0.43580746913594326,1.1474286625606025,0.2638190954773869,0.5720147671719568,1.0,2/14,5.01%,RYR2;ACVR1
prerank,neural tube closure (GO:0001843),-0.3710875126475144,-1.1473782580875604,0.2339688041594454,0.4397198446917641,1.0,20/34,31.13%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;PHACTR4;TGFB1;DVL2;DEAF1;LRP2;TSC2;KDM2B;GRHL3;CELSR1;GRHL2;IFT122;PAX2;BCL10
prerank,positive regulation of response to stimulus (GO:0048584),-0.34830692005476316,-1.1473328880271725,0.23842195540308747,0.4395364383890207,1.0,15/40,24.60%,PRKCD;CGAS;IL15;DHX9;RSAD2;B2M;EEF1E1;FCGR2B;MAVS;ARG2;TAF9;GATA3;ILK;ECHDC3;MYC
prerank,negative regulation of hormone secretion (GO:0046888),-0.49310469594855705,-1.1473120648802444,0.3176043557168784,0.4392929266713449,1.0,6/10,44.74%,RAB11FIP5;RAB11FIP1;GJA1;FGF23;IL1B;OSM
prerank,ERBB signaling pathway (GO:0038127),0.31152347554174953,1.1473076955060066,0.23273657289002558,0.5710719322387854,1.0,19/64,16.07%,NRG1;ERBB4;PTPRR;SHC3;TGFA;EGF;GAB1;SOS1;PLCE1;FAM83B;NRG2;SOX9;AREG;GAREM1;HSP90AA1;BRAF;ADAM17;ERBB3;PRKCA
prerank,protein heterooligomerization (GO:0051291),0.4257293631228986,1.1470960551252944,0.3094059405940594,0.5703976423718953,1.0,9/17,26.00%,GRIN2B;KCNC2;PKD1;HSD17B8;TMEM120A;CPSF6;CPSF7;GRIN1;PKD2
prerank,cytoskeleton organization (GO:0007010),-0.2953522961702491,-1.146912668652616,0.19896193771626297,0.43980652873142817,1.0,23/114,12.08%,DIAPH1;APOE;NEDD9;ARHGAP10;FGD6;RAC1;RHOA;CAPZB;SIPA1;SH3KBP1;FGD4;FGD3;PLD2;SIPA1L3;MDK;LARP4;DIAPH3;PACSIN2;SYNE3;SPRYD3;MICAL1;FMNL2;MICAL2
prerank,response to interleukin-6 (GO:0070741),-0.5069572239911658,-1.1468914698344312,0.30472854640980734,0.43957783131135864,1.0,4/10,10.48%,PID1;SBNO2;NFKB1;RELA
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.2768260237134031,-1.146240951393784,0.19166666666666668,0.4405592638024505,1.0,52/170,25.13%,PTPRC;APOE;FOXP1;IGF1;TFEB;AFF4;CDK6;AFF1;MTMR3;KIF16B;CIAO3;TAPBP;CRIP1;AHR;HNRNPDL;TBC1D16;SIRPA;HIF1A;SLC8A1;NFKBIZ;PIN1;APP;PCBP2;PRDM2;TRIM68;TRIM11;ANKRA2;SART3;TXK;RASA1;POGZ;NKAPL;TRIM14;TOB1;TOB2;MARF1;TRIM39;RSPO1;LDLR;NFKBID;UBAP2;C1D;ZC3H12A;HNRNPK;MEGF8;APLNR;MEFV;TARDBP;PCBP4;MYC;RNF187;LAMTOR1
prerank,cGMP-mediated signaling (GO:0019934),0.45132635894991996,1.1456601964783597,0.2764423076923077,0.5726825920824381,1.0,4/13,3.86%,HTR2C;KCNC2;GUCY1B1;PDE9A
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.4867236641901503,-1.1454578030074214,0.29739776951672864,0.44181338626632355,1.0,4/11,25.01%,RESF1;TPR;SETDB1;TRIM28
prerank,T cell differentiation in thymus (GO:0033077),-0.45769145821890966,-1.1454554449790875,0.29094076655052264,0.44153991097383644,1.0,1/14,0.14%,PTPRC
prerank,ganglioside biosynthetic process (GO:0001574),-0.4491137037111206,-1.145322870422178,0.30071174377224197,0.4415002782817787,1.0,3/15,2.02%,B4GALT5;ST3GAL1;ST8SIA4
prerank,vesicle transport along microtubule (GO:0047496),-0.40244209314588997,-1.144938147960056,0.28471001757469244,0.44198285753862315,1.0,5/23,4.94%,TRAK1;KIF3B;RAB1A;DYNC1H1;FBXW11
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.46017024802241613,1.1448541024320429,0.2938388625592417,0.5734044840488081,1.0,3/12,10.85%,TMEFF2;EDN1;GSTP1
prerank,nuclear membrane organization (GO:0071763),-0.42676431447542873,-1.1448145421274476,0.28650646950092423,0.44194915562498166,1.0,9/19,24.73%,NEMP1;CHMP7;DCTN1;CHMP2A;TOR1AIP1;VPS4A;CHMP4B;TARDBP;AKAP8L
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.49006584729468916,-1.1447970580165643,0.28822495606326887,0.44171089057367857,1.0,6/11,29.30%,BLM;TIMELESS;LIG3;TIPIN;ZRANB3;DONSON
prerank,tube closure (GO:0060606),-0.37668425691189544,-1.144574279092632,0.25510204081632654,0.4418911021911584,1.0,19/31,31.13%,MTHFD1L;LRP6;SKI;SCRIB;VANGL2;STIL;MTHFR;PHACTR4;TGFB1;DVL2;DEAF1;LRP2;TSC2;GRHL3;CELSR1;GRHL2;IFT122;PAX2;BCL10
prerank,regulation of protein polymerization (GO:0032271),0.35222089542102564,1.1444305939794912,0.24647887323943662,0.5731998141957747,1.0,4/35,4.42%,MAP2;MAPRE3;PAK3;TTBK1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.451367272492189,-1.1443128108668617,0.2918149466192171,0.4421087332007805,1.0,8/14,35.15%,AKAP8;NIPBL;DYRK1A;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,regulation of kinase activity (GO:0043549),0.2935091928924459,1.144209725585771,0.21558441558441557,0.5725295634154727,1.0,25/89,17.03%,ERBB4;NTRK3;EPHA6;LDB2;NTRK2;EPHA7;EPHA5;CSF1R;EPHB1;TIE1;PLCE1;ALK;EPHA10;ROS1;LTK;EMP2;TTN;TYRO3;RET;EPHB4;EPHB3;ERBB3;EPHA3;CDKN1C;ROR1
prerank,neurotrophin signaling pathway (GO:0038179),0.40380672626639,1.1441609137585604,0.3037383177570093,0.5714391217911639,1.0,4/21,7.07%,MAGI2;NTRK2;SOS1;BDNF
prerank,negative regulation of peptidase activity (GO:0010466),0.32300088558961637,1.144061923090445,0.23095823095823095,0.5704817453426956,1.0,5/47,4.76%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4543149075797826,-1.1433748405293553,0.29557522123893804,0.44364970842672996,1.0,5/13,17.43%,AGO2;CNOT1;TNRC6C;POLR2G;TOB1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.48084805631320193,-1.1431214484734344,0.3088480801335559,0.44389206434258477,1.0,4/11,19.28%,ABCG1;AGT;PLA2G7;PLA2G5
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.4373851829133678,-1.1429316289484523,0.30442477876106194,0.4439769243936747,1.0,6/16,10.78%,IGF1;ROCK1;MEF2A;SLC9A1;AGT;MTPN
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.4741619795965306,-1.1427498656579427,0.30297723292469353,0.44407317409638253,1.0,2/12,4.21%,CCR2;IL18
prerank,protein import into nucleus (GO:0006606),-0.31808364571509545,-1.1425157040877782,0.22697368421052633,0.44425737767127793,1.0,21/66,22.37%,SYK;KPNA4;IPO5;NUP50;STAT3;NUP88;E2F3;TPR;KPNA3;NUP188;CBLB;APPL2;NUP153;NUP35;FAM53A;TNPO3;APPL1;NUP107;NXT2;NUP62;SPRN
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4845144474487607,-1.1423481669016364,0.30874785591766724,0.44429899239569337,1.0,2/11,2.65%,PLCG2;P2RX4
prerank,cardiac muscle cell differentiation (GO:0055007),0.39800851811621524,1.1416633046082607,0.2930232558139535,0.5748354710522472,1.0,7/21,12.16%,NRG1;CBY1;ACVR1;WT1;MYOCD;TTN;ALPK2
prerank,circulatory system development (GO:0072359),0.2776987957937731,1.1416392547824454,0.19607843137254902,0.5737048769343365,1.0,34/118,18.88%,FGF12;CACNA1C;PCSK5;ERBB4;NTRK3;ZFPM2;PRICKLE4;ACVR1;WT1;PLCE1;FLRT3;CACYBP;SOX9;SALL1;DNAAF4;POU4F2;POPDC2;TBX1;FBXW7;TGFB2;PKD1;EEF1AKMT4-ECE2;PDLIM4;CDH5;MKKS;ECE1;ERBB3;RAMP2;PDLIM7;KAT2A;ZDHHC16;RBM20;TEK;FOXC2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.48896496794861977,-1.1414790460729078,0.29845626072041165,0.4456906139943515,1.0,5/11,26.43%,EGR1;ASAH1;NR1H4;FGFR4;BMP2
prerank,hippo signaling (GO:0035329),0.3773556878735498,1.1406113101649937,0.2559241706161137,0.5749499815921217,1.0,8/26,12.96%,TJP1;TEAD4;DCHS1;FAT4;YAP1;TEAD1;WWC1;AMOTL1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.4489624165963606,-1.1406106922958223,0.31216931216931215,0.4470996240960952,1.0,5/14,17.40%,TXNDC12;SELENOS;XBP1;TMBIM6;HSPA1A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.45562958225922034,-1.1401903971911975,0.3082191780821918,0.44765507657088466,1.0,5/14,24.17%,CCR2;PTK2B;CCL5;WNK1;CCL7
prerank,response to axon injury (GO:0048678),0.4182301796709114,1.1401541052408217,0.2780487804878049,0.5748682771901009,1.0,7/18,14.87%,P2RY12;APOD;FLRT3;DPYSL3;RTN4RL1;DHFR;FOLR1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.33391301980032384,-1.1399808899231294,0.24247491638795987,0.44781206553360214,1.0,18/52,25.39%,BCL2;RNF31;USP36;E2F1;YWHAE;UBE2L3;UBL5;SH3GLB1;BBC3;BID;CASP8;HUWE1;BAP1;SFN;HPS4;NMT1;SAE1;VPS11
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.38778684087324833,-1.1398940087680924,0.2916666666666667,0.44771706535169525,1.0,12/27,28.28%,FBXL17;PPP1CA;BHLHE40;SIK1;ID2;FBXL8;RBM4B;FBXL6;PPP1CC;PPP1CB;PML;FBXL3
prerank,regulation of cellular respiration (GO:0043457),-0.4387565389090624,-1.1395081990525369,0.30338983050847457,0.44815062599665795,1.0,4/17,11.52%,IL10RB;NOA1;CBFA2T3;IFNAR1
prerank,negative regulation of axonogenesis (GO:0050771),0.37328987216952786,1.1394326119544234,0.2739018087855297,0.5753485450971909,1.0,3/27,2.17%,MAP2;DCC;LINGO1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.30539899135857196,-1.1392717131454924,0.23604465709728867,0.4483207360512312,1.0,24/78,21.35%,PID1;DAB2;PRKCH;LRP1;STX7;ITGB1;ACTB;STX8;STX3;RHOQ;PICALM;ZDHHC7;ZDHHC8;ZDHHC2;ITGA3;CIB1;PPFIA1;CLN3;STX4;TMEM59;ZDHHC5;VPS4A;APPL1;CDK5
prerank,brain morphogenesis (GO:0048854),0.4507073381069042,1.1381482400791512,0.2882205513784461,0.577202881235254,1.0,2/12,5.24%,CTNNA2;SHANK3
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.44162467679640516,-1.1374385709489743,0.3018867924528302,0.45156294907530553,1.0,5/14,19.87%,FASTKD2;NGRN;FASTKD3;RMND1;C1QBP
prerank,RNA destabilization (GO:0050779),-0.42408944948116284,-1.1371347873976976,0.28378378378378377,0.4518685125134279,1.0,5/18,13.10%,ROCK1;YTHDF3;FTO;CELF1;METTL14
prerank,histone acetylation (GO:0016573),-0.3134265219403809,-1.1371264042581037,0.24752475247524752,0.45160776368740296,1.0,16/69,18.54%,CREBBP;PHF20;SPI1;MORF4L1;TAF6;ZZZ3;WDR5;JADE2;NAA50;KAT7;EPC1;DR1;MRGBP;PHF20L1;TAF9;TRIM16
prerank,regulation of gastrulation (GO:0010470),0.43899925698154085,1.1366357471099402,0.30296127562642367,0.5797799540324426,1.0,2/14,4.30%,TENM4;CLASP2
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3391894052968627,-1.1364319249349075,0.2612312811980033,0.45262370906950833,1.0,18/47,20.12%,APOE;FOXO3;NFKB1;NR1H2;PUM3;PCIF1;AGT;MTPN;APP;WDR91;UHRF1;NOLC1;EIF4G1;SSH1;EIF2A;RBM4B;CSF1;RBM3
prerank,stress fiber assembly (GO:0043149),-0.44160210742092837,-1.1362330473543456,0.31099656357388317,0.4524515061198672,1.0,6/15,11.39%,RHOA;TNFAIP1;ITGB1;ARRB1;ITGB5;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),-0.44160210742092837,-1.1362330473543456,0.31099656357388317,0.4524515061198672,1.0,6/15,11.39%,RHOA;TNFAIP1;ITGB1;ARRB1;ITGB5;ZYX
prerank,negative regulation of DNA recombination (GO:0045910),-0.3410178156507352,-1.1361655114175344,0.23909249563699825,0.4523177590570135,1.0,13/43,22.94%,CGAS;BLM;RTEL1;POLR2H;POLR2F;POLR2L;RADX;POLR2A;UBQLN4;POLR2G;SHLD2;POLR2I;ZRANB3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.46089054268179874,1.136111094827523,0.2921615201900237,0.5786339333772951,1.0,4/12,8.21%,EFNA5;MELTF;SPRY4;KANK1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.46089054268179874,1.136111094827523,0.2921615201900237,0.5786339333772951,1.0,4/12,8.21%,EFNA5;MELTF;SPRY4;KANK1
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.40585534000341783,-1.1355131957697286,0.28130360205831906,0.4533254656209056,1.0,6/21,16.45%,PGD;DERA;RPE;HK3;TKT;PGLS
prerank,selective autophagy (GO:0061912),-0.32389337580346517,-1.13538660514656,0.2348111658456486,0.45329290061857214,1.0,14/56,16.91%,VIM;RAB7A;ATG5;WDFY3;DYNC1H1;ULK2;TEX264;UBC;RPS27A;RETREG1;RB1CC1;DYNC1LI2;USP30;PCNT
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.2563495709629962,-1.1353600794043193,0.13423831070889894,0.4530664806516564,1.0,55/291,13.47%,PID1;LYN;LILRB1;DAPK1;P2RX7;VIM;GNB1;PRKCD;AXL;JUN;RAP1B;RHOA;TNFRSF1B;IPO5;P2RX4;SBNO2;FES;ABL2;RAP1A;CTR9;TLR4;CHMP5;PTK2B;STAP1;NFKB1;ACTB;ADAM9;MAPK14;PF4;GNG2;AHR;CAMKK2;SIRPA;MYD88;MEF2C;LY96;SELENOS;LPL;PRDX5;EGR1;TGM2;TNIP2;RELA;NCF1;XBP1;RRAGD;HSP90B1;TICAM1;MTR;HMGB2;SERPINE1;CASP1;DEFA6;DHX36;NFKBIL1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3568700289613852,1.1349811284909386,0.2850574712643678,0.5800569254353917,1.0,6/31,10.93%,NRG1;RYR2;ZFPM2;TNNT2;MYH7;TGFB2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3066304318936098,-1.1341637021070647,0.22240527182866557,0.4551807899850726,1.0,15/80,6.47%,NRP1;PLEKHM1;ARPC2;P2RX7;RAC1;ACTR2;EPS8;WASF2;DOCK11;CDC42;ACTR3;ARAP1;RIPOR2;WASL;RHOQ
prerank,ribosomal small subunit assembly (GO:0000028),-0.42844496335019666,-1.1340493402546123,0.31095406360424027,0.45511462026764243,1.0,8/16,25.15%,ERAL1;RPS14;RPS28;MRPS11;RPS27;PRKDC;RPS15;MRPS7
prerank,copper ion transport (GO:0006825),-0.47962554272996294,-1.1336137142792855,0.3215547703180212,0.45567299692723556,1.0,3/11,9.42%,ATP7A;STEAP3;SLC31A1
prerank,negative regulation of nuclear division (GO:0051784),0.4738425579926466,1.1335414509923456,0.3047404063205418,0.5823047289338475,1.0,4/11,20.56%,AURKAIP1;BMP7;TOM1L1;FBXO5
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4322787734651924,-1.1333005301174304,0.30244755244755245,0.45598740378866237,1.0,6/15,17.98%,AGO2;CNOT1;TNRC6C;POLR2G;TOB1;TENT4B
prerank,lymphocyte chemotaxis (GO:0048247),-0.3592993412337437,-1.1331764254371468,0.261986301369863,0.45595559637773986,1.0,8/34,13.40%,CKLF;PIK3CG;GAS6;ADAM8;CH25H;CXCL16;CCL5;PIK3CD
prerank,phosphatidylserine metabolic process (GO:0006658),-0.36725220292099914,-1.1325052103528233,0.27287853577371046,0.4570157714773606,1.0,17/32,35.48%,OSBPL8;SLC27A1;ABHD12;OSBPL5;PLA2G4A;PLAAT3;PLA2G5;PLA2G12A;LPCAT3;PLA2G15;LPCAT4;SERINC1;PLSCR1;SERINC5;PLA2G3;PTDSS2;PLA2G4B
prerank,positive regulation of receptor internalization (GO:0002092),0.3843165686910767,1.1321697383779596,0.28378378378378377,0.5844193700564316,1.0,5/22,8.11%,MAGI2;AHI1;EGF;APLN;FMR1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4818279268756863,-1.131714810067175,0.33793103448275863,0.4582737517098128,1.0,5/10,34.58%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.4145507714375793,-1.1317125172029536,0.3075601374570447,0.4580001756444247,1.0,9/19,33.43%,MTHFS;MTHFD1L;MTHFD2L;GGH;MTHFR;SHMT1;FPGS;SLC19A1;MTHFD1
prerank,cellular response to UV-A (GO:0071492),0.45746505513081004,1.131372310965124,0.302540415704388,0.5851676438790561,1.0,3/11,9.75%,MME;OPN3;OPN5
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.44733908998304617,1.131264826529017,0.3036144578313253,0.5842521150994993,1.0,3/13,7.38%,CHST5;MGAT3;CHST7
prerank,response to insulin (GO:0032868),-0.3034833931336941,-1.130989677221051,0.2483221476510067,0.4590918139961991,1.0,14/80,13.39%,MYO5A;RAB8B;DENND4C;OGT;INSR;PPARG;RAB31;SLC27A1;RHOQ;SELENOS;XBP1;PKM;RAB10;HDAC5
prerank,heterochromatin assembly (GO:0031507),0.3987280846032316,1.1307651788508373,0.2698072805139186,0.58426685324525,1.0,7/20,19.74%,SUV39H1;HMGA2;CDKN2A;BAHD1;HELLS;HMGA1;SIRT1
prerank,protein targeting to membrane (GO:0006612),-0.3022550008086584,-1.1299877198489474,0.22824302134646962,0.46083930446533017,1.0,26/83,25.23%,RAB8B;SDCBP;PEX14;ABCD2;SEC63;PEX26;SRP14;NACA;ZDHHC7;SIL1;FIS1;ZDHHC2;NCF1;ZDHHC12;GET3;ABCD3;TAOK2;ZDHHC1;NACAD;SGTA;GOLGA7;CHMP4B;CHMP4A;MICALL1;ZDHHC6;YIF1B
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.40537017365335376,-1.1298364077225773,0.29326047358834245,0.4608543120563766,1.0,10/21,31.85%,RAD51B;BRD4;CDC25A;CDK1;RAB11A;CDC25C;CCNB1;RAD51C;RCC2;VPS4B
prerank,cellular response to nitrogen compound (GO:1901699),-0.4141056670670075,-1.1293683232870366,0.3057553956834532,0.46144598574235063,1.0,7/20,15.34%,SPIDR;RIOK3;BLM;DDI2;EPG5;TIMELESS;NSMCE3
prerank,positive regulation of cytokinesis (GO:0032467),-0.36601299595353326,-1.12878739803156,0.2765957446808511,0.4622841544266714,1.0,7/32,14.67%,RHOA;SVIL;CDC42;KIF20B;KIF23;KIF14;RACGAP1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3932011776126738,-1.1284735573900269,0.26573426573426573,0.4626497037130246,1.0,9/22,27.04%,ERI3;RPS21;NOP14;ERI2;EXOSC10;NOL9;WDR12;RPP40;EXOSC8
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4178651071234426,-1.128244862453021,0.32263513513513514,0.4628136749030114,1.0,10/19,24.40%,ITGB2;PIK3AP1;TLR4;LY96;TNIP3;LGALS9;TICAM2;NR1H4;TRIL;ITGAM
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.27928563112572385,-1.1280672347201488,0.21333333333333335,0.46288294142641373,1.0,41/138,22.95%,RBPJ;NOTCH2;CREBBP;PPARD;PPARG;MAML1;GTF2A1;MAML2;E2F2;RARG;NR1H2;TAF6;TBL1XR1;NR2F1;POLR2H;POLR2F;E2F3;POLR2L;NRBF2;HDAC10;HDAC5;GTF2E2;RXRA;POLR2A;DR1;TAF4B;TAF8;NR4A1;POLR2G;TAF9;TAF3;RARA;NR3C1;TAF4;MAML3;MAZ;POLR2I;GTF2F2;GTF2A2;NR1H4;ESR2
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.4165084051678969,-1.127475181011537,0.31413612565445026,0.4638186486990851,1.0,5/18,10.65%,POR;ABL2;ATP7A;SIRT3;AGT
prerank,regulation of stress fiber assembly (GO:0051492),-0.3077524986773513,-1.1274300290986548,0.23883161512027493,0.4636355126212332,1.0,15/74,8.99%,NRP1;PAK2;RAC1;ROCK1;RHOA;WASF2;CDC42;ARAP1;PTGER4;ARHGEF10;ARHGEF18;NF2;TGFBR1;SLC9A1;ITGB1BP1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.47995672551862745,1.1272109185477983,0.3106796116504854,0.5915803385079017,1.0,3/10,7.32%,YOD1;UBE2J1;INSIG1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3823433602781839,-1.1270679370625403,0.2827586206896552,0.46408149001533233,1.0,5/26,6.51%,OSBPL8;IGF1;INSR;RHOQ;C3
prerank,cell proliferation in forebrain (GO:0021846),0.4696657913286344,1.124938599034215,0.2897196261682243,0.5958204732968598,1.0,4/10,19.13%,HOOK3;NUMB;DOCK7;PCM1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4080694160687231,-1.1248678491447293,0.3152542372881356,0.46818051897909924,1.0,9/19,21.48%,NFKB1;WFS1;MAP2K5;MAPK7;MTPN;APP;KLF2;GATA3;TMEM106A
prerank,organonitrogen compound catabolic process (GO:1901565),-0.3226944948089927,-1.1242760129565856,0.2562396006655574,0.4690232642983676,1.0,22/57,26.95%,NPL;ANPEP;GNPDA1;LNPEP;CLN6;TRIM24;CPQ;IL4I1;MPST;PLA2G7;PLA2G4A;TPP1;PLA2G6;PLA2G5;GGACT;GNPDA2;PPT1;AMDHD2;PNPLA8;RENBP;LRSAM1;PLA2G15
prerank,response to interleukin-1 (GO:0070555),-0.3079414777177138,-1.1242679334952976,0.25549915397631134,0.46875820670604157,1.0,19/73,20.90%,IRAK2;RC3H1;NFKB1;ANXA1;YTHDC2;IRAK3;SIRPA;MYD88;HIF1A;GBP2;RELA;APP;CCL5;CD40;TAF9;LGALS9;GBP3;SFRP1;ZC3H12A
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.43660067376486866,-1.1242260683686318,0.3107638888888889,0.4685577004172075,1.0,5/16,11.34%,RREB1;METRNL;PIM1;FTO;FLCN
prerank,negative regulation of cell development (GO:0010721),-0.3844396133423405,-1.124066047285858,0.2762237762237762,0.46861121871174033,1.0,8/25,23.91%,IGF1;LILRB1;B2M;APPL2;RFLNB;GSK3B;IL6;PAX6
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.47860552291997405,-1.1239219388349742,0.3204903677758319,0.4686258820484891,1.0,2/10,0.40%,DSE;XYLT1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.4654912770198506,1.123429037520848,0.3377777777777778,0.5971861684152465,1.0,4/11,13.07%,CASQ2;CALM1;CALM3;CALM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.4654912770198506,1.123429037520848,0.3377777777777778,0.5971861684152465,1.0,4/11,13.07%,CASQ2;CALM1;CALM3;CALM2
prerank,cellular response to virus (GO:0098586),-0.3748374866799427,-1.1229414599487457,0.2983050847457627,0.47032539733183387,1.0,11/30,23.00%,RIOK3;MAPK14;GSDME;HIF1A;CCL5;POU2AF1;LGALS9;DDX3X;ZC3H12A;IL6;TOMM70
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.3577177611377917,-1.1229124292683945,0.29591836734693877,0.47009313669239755,1.0,11/33,25.36%,SNRPG;SNRPF;SSU72;NUDT21;WDR33;NCBP1;PAPOLA;CPSF3;MAZ;MED18;CPSF1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.2709066022972032,1.1223696510548948,0.20215633423180593,0.5985917051852667,1.0,23/138,8.53%,PTPRD;PTPRG;ERBB4;PTPRT;NTRK3;EPHA6;NTRK2;SHC3;AHI1;EPHA7;EPHA5;CSF1R;PTN;SHC4;EPHB1;TIE1;MPZL1;ALK;BDNF;FYN;GFRA2;SHC2;EPHA10
prerank,positive regulation of cell differentiation (GO:0045597),-0.25771201019302087,-1.1218333420676967,0.1838351822503962,0.47192747318716294,1.0,49/237,14.63%,DAB2;PRKCH;MSR1;IGF1;TCF4;SDCBP;CD36;SLC6A6;MEF2A;RHOA;PPARD;ARHGEF2;FES;PPARG;IL6R;RAP1A;CDC42;IL18;RIN2;NFKB1;RUNX2;MEDAG;PKDCC;RIPOR2;MAPK14;PF4;HGF;GCNT2;CTNNB1;EZH2;MDK;TGFBR1;TGFB1I1;MEF2C;LPL;AGT;XBP1;WDFY2;NUDT21;IGFBP3;HSP90AB1;ACVR2A;DHX36;SMYD1;TGFBR2;SIN3A;BTG1;ID2;TCF3
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.31613889856134547,-1.1216283751749658,0.26812816188870153,0.47203982225656277,1.0,12/63,8.19%,MCL1;ROCK1;NUPR1;HTR2B;STAT3;TAB2;BCL2;PTPN22;EIF4G3;HGF;KLHL22;TIMP2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.48977396971671794,-1.1215324910115843,0.36493738819320215,0.4719608994427931,1.0,1/10,0.19%,PRKCH
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3500615602513216,-1.1213945866498922,0.2815699658703072,0.4719526826997363,1.0,15/36,32.10%,APOE;SP100;PPARG;MEF2C;ANGPT2;GADD45A;HMGB1;JUP;APOH;TGFB1;DCN;ADAMTS9;AGTR2;CSNK2B;FGF2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4105024579613759,1.1212330251589187,0.319047619047619,0.6001578737473544,1.0,3/17,7.01%,PRKG1;TAFA5;APLN
prerank,regulation of histone methylation (GO:0031060),-0.45586920114129525,-1.121101156498475,0.3250883392226148,0.47224829239295546,1.0,7/13,29.97%,CTR9;CHTOP;JARID2;NSD1;MTHFR;FAM47E;TTLL12
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.39619618824856573,1.120953884894081,0.30402010050251255,0.5996573491256328,1.0,6/19,12.12%,GRM5;RYR2;VCAM1;PRNP;GPR143;BCAP31
prerank,regulation of actin filament polymerization (GO:0030833),-0.3120020105464111,-1.1203423325963522,0.260797342192691,0.4734366315507906,1.0,31/69,30.24%,PRKCD;SNX9;PTK2B;ARFGEF1;ARHGAP18;CYRIB;MYADM;BAIAP2;NCKAP1L;CDC42EP2;MTPN;BAIAP2L2;SSH3;RASA1;COTL1;SSH1;CDC42EP3;HCLS1;TWF2;HCK;HAX1;SSH2;NCK1;PFN1;DBNL;ALOX15;CCL24;PLEKHG2;CDC42EP5;NCK2;TWF1
prerank,negative regulation of nervous system development (GO:0051961),0.4140966221347957,1.1199498240960566,0.31100478468899523,0.600897291154292,1.0,4/17,12.75%,ROBO2;SLIT1;HOOK3;REST
prerank,response to peptide (GO:1901652),-0.3643227015623778,-1.1196659049390683,0.2991596638655462,0.47440244650239,1.0,18/33,28.48%,STAT3;STAT6;IRF5;ANXA1;EIF2B3;STAT5B;STAT4;ERBIN;KAT7;NOD2;AGER;EIF2B1;MMP2;STAT1;CACNA1A;STAT2;EIF2B2;EIF2B4
prerank,positive regulation of calcium ion transport (GO:0051928),-0.35782482744322874,-1.119560435695333,0.28695652173913044,0.47434903605491513,1.0,10/36,18.61%,ATP2B1;P2RX7;CRACR2A;P2RX4;CCR1;WFS1;CCL5;SPHK2;LILRA5;PDGFRB
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.33277887904442865,1.1194762046727003,0.2823529411764706,0.6008273382823407,1.0,9/39,9.64%,SPOCK1;EFNA5;SEMA3E;MELTF;SPRY4;KANK1;NEXMIF;CDKN2A;PLET1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.4884369266128405,-1.1186069540885688,0.33511586452762926,0.47598601408793956,1.0,4/10,21.39%,BRCA1;JARID2;MYB;KDM1A
prerank,placenta development (GO:0001890),-0.46508981688037454,-1.118473542306601,0.3127147766323024,0.4759494927261514,1.0,4/12,17.08%,PPARG;E2F8;ANG;ADAM19
prerank,regulation of blood circulation (GO:1903522),0.35007668405388426,1.1183172933300511,0.2847222222222222,0.602490509117615,1.0,12/34,21.59%,KCNMB2;ADORA3;KCNIP2;TNNT2;AGTR1;PER2;KCNJ12;ECE1;TPM1;CELF2;KCNMB4;DMPK
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.28004727279385055,-1.1181796564109743,0.2179930795847751,0.4762505268667178,1.0,39/129,21.63%,ZEB2;DKK2;PSME4;PSMB7;PSME3;NFKB1;HHEX;USP8;DAPK3;PSMB9;AXIN1;TBL1XR1;PPM1B;LRRK1;WLS;PSMA8;PIN1;PSMC3;PSMD8;PSMC4;PSMB10;TNKS2;PSMA1;PSMB8;GPRC5B;JRK;PLEKHA4;DDX3X;RSPO1;PSMA5;PSMD4;TMEM198;PSMB3;WNK1;PSMD3;SFRP1;JUP;CSNK1G3;SMURF2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2889899503806785,-1.11811479981499,0.2585616438356164,0.47612142658817974,1.0,28/104,19.06%,RB1;RHOA;UVRAG;SLC27A1;CCND3;ACTB;INCENP;BLM;TSG101;LRP6;CAB39;EZH2;TRIB1;SLC8A1;TRIB2;CDKN3;CDC25A;MAP2K1;GADD45A;CIB1;KSR1;CCNE1;RALB;CDKN2C;SERTAD1;CNPPD1;ADRB2;DDX3X
prerank,epithelial to mesenchymal transition (GO:0001837),-0.32961607247576147,-1.118062978924354,0.2824302134646962,0.47595699579936346,1.0,19/47,29.33%,RBPJ;ROCK1;HGF;CTNNB1;TGFBR1;DDX5;HIF1A;LIMS1;FAM83D;GSK3B;S100A4;HEYL;SNAI2;TGFB1;TRIM28;BMP2;ENG;LEF1;DDX17
prerank,protein localization to cell periphery (GO:1990778),0.264975695435211,1.1180202427611905,0.2275,0.6019986944752873,1.0,13/133,4.30%,DPP10;KCNIP4;DPP6;KCNB2;ANK3;ANK2;RAB3C;MAP7;CACNB2;TESC;RAB15;EPB41L3;CLASP2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4290800147377156,-1.117971090045695,0.31141868512110726,0.47585260687031505,1.0,5/16,11.34%,GPR137B;KLHL22;PIP4P1;RRAGD;FLCN
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4558167464918514,-1.1176945508795615,0.3339382940108893,0.4761241820564088,1.0,3/12,8.64%,BRCA1;PIBF1;ERLIN1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.40466916510624235,-1.1176479759022806,0.31478260869565217,0.4759401197428494,1.0,8/21,19.63%,CENPF;KLHL22;BUB1;TPR;BUB1B;TTK;MAD1L1;ATM
prerank,regulation of embryonic development (GO:0045995),-0.35866830750409023,-1.1174333198221806,0.2807017543859649,0.4761080675721241,1.0,11/34,21.59%,B4GALT5;NIBAN2;INSR;NIPBL;RBM19;CDK1;DHX36;RACGAP1;CFL1;TRIP12;BAG6
prerank,positive regulation by host of viral transcription (GO:0043923),-0.44522511897603606,-1.1174074064308215,0.31686541737649065,0.47587779936200686,1.0,5/15,28.56%,JUN;NUCKS1;TFAP4;EP300;LEF1
prerank,positive regulation of viral genome replication (GO:0045070),-0.3711842945858144,-1.1170222396813503,0.300509337860781,0.4763240288580531,1.0,15/29,41.53%,TOP2A;CD28;IFIT1;CCL5;VAPB;DDX3X;SRPK1;DDB1;HACD3;PPID;ADARB1;RAD23A;TMEM39A;TARBP2;PKN2
prerank,regulation of lamellipodium assembly (GO:0010591),-0.36165036017379926,-1.1165137573100157,0.27768595041322314,0.47707082716878874,1.0,7/34,4.20%,ARPC2;RAC1;ACTR2;CAPZB;WASF2;CDC42;ACTR3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3272721222396374,-1.1156760302411233,0.2763385146804836,0.47851275445634406,1.0,9/51,8.99%,NRP1;PLEK;RAC1;RHOA;CDC42;ARHGEF10;NF2;TGFBR1;ITGB1BP1
prerank,negative regulation of transport (GO:0051051),-0.3264086454271338,-1.115444395669852,0.28524590163934427,0.4786654355117664,1.0,10/51,8.44%,MCTP1;LILRB1;RAB7A;SNX3;WWP2;ITGAV;NR1H2;SNX33;SIRPA;BST2
prerank,anterograde axonal transport (GO:0008089),0.33929198193361887,1.1146036213323829,0.28883495145631066,0.6093717522846267,1.0,12/37,17.67%,DLG2;KIF5C;KIF1B;RAB27B;KIF5A;AP3M2;NEFL;AP3S2;KIF3A;MAP1A;HAP1;BLOC1S6
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4839048899613113,-1.114559538185683,0.35611510791366907,0.48016863263896487,1.0,2/10,12.31%,DNMT3A;ZFP57
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3284756936423538,1.1140152422935712,0.25471698113207547,0.6095934796449345,1.0,10/39,11.28%,SLIT2;SEMA3E;PAX8;GDNF;TIE1;WT1;FGF10;SALL1;CITED1;PKD1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3499213712326519,-1.1137297554076,0.2782462057335582,0.4816201006764883,1.0,14/36,21.24%,RAB7A;OPTN;GOLGA4;RAB31;GGA3;MACF1;GOLPH3L;SYS1;RAB10;VAMP4;RAB34;GOLGA7;RILPL1;BLZF1
prerank,embryonic eye morphogenesis (GO:0048048),-0.4802174300827577,-1.113625212086542,0.3482142857142857,0.4815504631581806,1.0,5/11,27.45%,RARG;LRP6;MFAP5;TBX2;KDM2B
prerank,negative regulation of lyase activity (GO:0051350),-0.4265601369870835,-1.1134524469850215,0.33962264150943394,0.48162028559404796,1.0,2/16,2.23%,CCR2;GNAI3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.399774251842119,-1.1132243373897575,0.3099315068493151,0.4817977951352725,1.0,9/21,27.85%,SMARCD3;CTNNB1;VEGFA;MDK;NES;DISC1;KDM1A;LRP2;DCT
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.32866864539620305,-1.1131839269207016,0.29246935201401053,0.4815948257728607,1.0,8/47,10.40%,PLEK;BRCA1;SLC27A1;NFKB1;SIRPA;ERLIN1;SIK1;PRMT3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3184665858028434,1.112800428377042,0.2871287128712871,0.6114083451048539,1.0,13/51,11.96%,CNTNAP2;DCLK1;NYAP2;MYO16;GPM6A;WASF1;EPB41L3;BDNF;NCKAP1;BMP7;SRGAP2;NBL1;TNIK
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.3465748775588561,-1.1126798641472064,0.2789473684210526,0.48234183821753956,1.0,14/39,24.96%,DDB2;RFC1;UBC;RPS27A;PCNA;CUL4B;RPA3;RFC2;POLD2;ERCC4;RFC3;FAN1;POLD4;DDB1
prerank,negative regulation of protein modification process (GO:0031400),-0.2995463695724211,-1.1123857904098582,0.2482758620689655,0.4826613109219061,1.0,27/79,25.93%,PID1;LYN;CORO1C;MFHAS1;XDH;NIBAN1;IBTK;PPP1R15B;LRP6;MYADM;SIRPA;PAQR3;IGFBP3;CIB1;CRTAP;CRKL;PTPN13;GSK3B;ZC3H12A;PLPP3;PRKDC;TARDBP;TGFB1;CDYL;P3H1;XRCC1;INPP5K
prerank,smooth muscle contraction (GO:0006939),-0.4509118918316817,-1.1120686901709103,0.3197879858657244,0.4830067354717525,1.0,7/14,23.90%,ROCK1;SLC8A1;EDNRA;PIK3C2A;CHRNB2;TPCN2;SMTN
prerank,ceramide transport (GO:0035627),-0.4571833821626284,-1.112040483075555,0.33218588640275387,0.4827786785175205,1.0,3/12,5.92%,PSAP;PLTP;GLTP
prerank,regulation of protein processing (GO:0070613),-0.3982776592121157,-1.111807493431671,0.3010204081632653,0.4829132330992482,1.0,5/21,18.18%,RUNX1;NLRC4;ADAM8;CLN3;TMEM59
prerank,positive regulation of secretion by cell (GO:1903532),0.2969381715615636,1.1116404141326894,0.24940047961630696,0.6130553433115461,1.0,23/70,20.71%,CADPS;FRMD4A;SOX11;SLC12A2;CADPS2;CLASP2;RAB27B;PLA2G10;EDN1;TGFB2;TTN;MYH10;ARF6;UNC13B;RAB27A;SNCA;RAB3A;IL1A;STX1B;GRK2;CD33;TREM2;DNM1L
prerank,negative regulation of telomere maintenance (GO:0032205),-0.435842840280976,-1.1115018916668011,0.32160804020100503,0.4832389138059635,1.0,6/15,21.01%,RTEL1;TNKS2;ERCC4;SLX4;ATM;NBN
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3848604912154123,-1.110772821828518,0.2912280701754386,0.48442083629214777,1.0,9/24,14.75%,CANX;TAPBP;B2M;TAP2;SEC24A;SEC24D;FCER1G;SEC31A;TAPBPL
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.44938862106110067,-1.110349312884239,0.3185689948892675,0.48500120369102917,1.0,4/13,5.50%,IGF1;INSR;DYRK2;PHKG2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.426996590716593,-1.1102472353493853,0.3048780487804878,0.48492058998029064,1.0,5/16,19.48%,CDK13;DHX9;DDX5;SCNM1;SLU7
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.49417146565329817,-1.1100991076977325,0.345679012345679,0.484942043714628,1.0,5/10,25.16%,YWHAE;SESTD1;PLN;VDAC1;FKBP1B
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3964103238587315,-1.1089623944121896,0.3290909090909091,0.48696386486651105,1.0,6/21,10.86%,ARHGAP25;CYRIB;SH3BP1;ARHGAP12;SPRY2;RASAL3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2897875734454714,-1.1088437803950628,0.27107438016528923,0.48689824307358065,1.0,14/90,7.83%,CCR2;SYK;CD36;OGT;IGF1R;FABP5;KDM3A;IL18;STAT6;ADIPOR1;DYNC1H1;UCP2;PLAC8;VEGFA
prerank,megakaryocyte differentiation (GO:0030219),0.45681489046158685,1.1085892036689384,0.3340857787810384,0.619382116362978,1.0,4/11,23.37%,KIT;THPO;TAL1;UBA5
prerank,negative regulation of catabolic process (GO:0009895),-0.3312734108060913,-1.1083692547470467,0.29264214046822745,0.48756851161716086,1.0,13/47,20.66%,SNX3;NUPR1;FLNA;CBFA2T3;IRAK3;ZDHHC7;AZIN1;SF3B3;PIN1;CST3;RILP;MDM4;SIRT2
prerank,epidermis development (GO:0008544),-0.3206828291898861,-1.1083380303551382,0.2962328767123288,0.4873456527196952,1.0,29/56,42.95%,EMP1;FABP5;FLOT2;DSP;CERS3;CCN2;ATP2C1;FOXN1;DCT;GRHL3;PLOD1;SPINK5;GRHL2;LAMC2;LAMB3;YBX1;GRHL1;OVOL2;EDAR;OVOL1;EDA2R;GLI1;SPRR1A;NTF4;SVEP1;LAMA3;FGF7;ATP2A2;UGCG
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3540338237299605,-1.108176103290081,0.3048128342245989,0.48740120314679475,1.0,10/31,21.33%,DCP1A;PATL1;EXOSC5;DCP2;POLR2G;LSM6;CNOT8;DDX6;LSM5;EXOSC4
prerank,histone H2B ubiquitination (GO:0033523),-0.47804152146966034,-1.1078701450420674,0.35121107266435986,0.48773757539099505,1.0,7/10,30.26%,CTR9;RNF20;RNF8;WAC;DTX3L;RNF40;UBE2E1
prerank,wound healing (GO:0042060),-0.314905693763804,-1.1077254779784615,0.28711256117455136,0.48774060306508593,1.0,12/62,9.08%,MYOF;IGF1;MYH9;ARL8B;HPSE;CFLAR;MACF1;FUT10;AHNAK2;PRCP;TGFBR1;JAML
prerank,proteoglycan biosynthetic process (GO:0030166),-0.36133670603649715,-1.1073614386822959,0.2964912280701754,0.48815540137468116,1.0,7/31,12.23%,EXT1;XYLT1;IGF1;CHST12;CHST11;B4GALT7;XYLT2
prerank,regulation of protein transport (GO:0051223),-0.37842490939463835,-1.1072195845366628,0.3242784380305603,0.4881516596737351,1.0,16/27,34.12%,SNX3;DNAJC1;WWP2;RHBDF1;RHBDF2;DNAJA1;LCP1;ARFIP1;NDFIP2;PTPN1;P3H1;HSPA8;ATP13A2;LLGL2;GAPVD1;TNF
prerank,regulation of vasculogenesis (GO:2001212),-0.4398292544210738,-1.1066799877969233,0.3472222222222222,0.48897991862535223,1.0,3/14,4.26%,XDH;RAP1A;RIN2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.424285102387685,-1.1065856902636233,0.3263525305410122,0.48888523822799973,1.0,6/15,17.76%,ANAPC1;CENPE;NEK6;TPR;UBE2C;ANAPC7
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.385234628537166,-1.1064539058096763,0.3228621291448517,0.4888731199696817,1.0,6/24,10.11%,PRKCB;ITGA5;NIBAN2;HHEX;HIF1A;ARNT
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4030801865439255,-1.1060636147234368,0.3191489361702128,0.4893568797205564,1.0,5/18,12.13%,LILRB1;ITGAV;FN1;HIF1A;CD46
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.45243949155514473,-1.1057299129078766,0.3281786941580756,0.48969414667721833,1.0,4/13,13.58%,NRP1;CTNNB1;VEGFA;TGFBR2
prerank,protein tetramerization (GO:0051262),0.29205773667373613,1.1052841657869108,0.26405867970660146,0.6264206715899556,1.0,18/67,17.38%,RYR3;GRIN2B;CRYZ;CBY1;HOMER1;RYR1;HCN1;PKD1;ACACA;KCNJ12;GOLGA2;OSBPL2;CTH;GLS;HSD17B8;SNCA;ALDH1A3;TRPM2
prerank,peptidyl-methionine modification (GO:0018206),0.43767332429665257,1.1050756177354395,0.33109619686800895,0.6257472777767291,1.0,5/12,19.36%,METAP2;NAA60;METAP1;PDF;NAA30
prerank,signal peptide processing (GO:0006465),0.4574163286416951,1.104939057983017,0.35194174757281554,0.624886810555923,1.0,2/11,7.25%,PCSK5;SEC11C
prerank,histone deacetylation (GO:0016575),-0.3371994588267884,-1.1040772373486019,0.3132328308207705,0.49274353073006616,1.0,10/43,14.02%,RCOR1;MIDEAS;MORF4L1;TBL1XR1;SUDS3;HDAC10;RBM14;MTA3;HDAC5;SIN3A
prerank,regulation of cell population proliferation (GO:0042127),-0.23302276292602664,-1.1036283059895053,0.14184397163120568,0.49338292673958645,1.0,191/691,24.84%,LYN;RUNX1;IGF1;NAMPT;ABI1;GAB2;SDCBP;ARID2;BCL6;CDK6;JUN;NIBAN2;PTPRJ;BIRC6;ACER3;NUPR1;RHOA;BRD7;INSR;IGF1R;CSNK2A1;ARHGEF2;FES;CDK13;PIAS1;IL6R;HTR2B;S100A11;SGK1;RNF41;STAT3;IL15;EAPP;FLT1;STAT6;TCIRG1;DPP4;PTK2B;HHEX;ITGAV;RARG;BCL2;KIF20B;RPS6;JAG1;STX3;CBFA2T3;PF4;SMYD2;FN1;SLC35F6;CHTOP;GCNT2;IFI35;CTNNB1;EZH2;GRK5;STAT5B;STAT4;SKI;NF2;VEGFA;NME1;EIF2AK2;CNBP;RPS15A;PRMT1;TGFBR1;GSDME;ITGB1BP1;TGFB1I1;PTPN6;TBC1D8;CTSH;RPS4X;INCA1;HP1BP3;RELA;KIF14;AGT;ITGAX;CDKN3;IL7R;APP;TIMELESS;XBP1;STRN;XRCC6;OSGIN1;MAP2K1;CCDC88A;KLF10;CELF1;KMT2D;STK11;IGFBP3;EEF1E1;CACUL1;CIB1;HMGB2;UHRF1;SHCBP1;FRK;GLP2R;KSR1;TGFBR2;TFAP4;GREM1;BTG1;ID2;CAPNS1;DOT1L;IL34;CRKL;TTK;IL31RA;PPP1R9B;BST1;HCLS1;KLF11;RBBP4;CNOT6L;VHL;STX4;RPS9;HSPA1A;TOB1;IRS2;RARA;KRAS;ATF5;LIMS1;CDKN2C;GATA3;SERTAD1;HCK;PDGFRB;PDCD5;COL18A1;MEIS3;MDM4;IL7;WDR77;CSF1;CHP2;CNOT8;BMPR2;PRC1;ADAMTS1;BAP1;MAZ;SIRT2;PDS5B;SFRP1;TIPIN;COPS8;STAT1;GNRH1;JUP;KDR;PDGFA;NUP62;TBX2;IFITM1;CGRRF1;INHA;FGF18;S1PR2;IL6;EID2;PRKDC;BNIPL;SOX7;KITLG;TGFB1;PIM2;GPLD1;CD47;CYP1B1;TES;LMNA;FGF9;FLT3;SHC1;FTH1;MYC;NUDT6;PKHD1;RNF187;STAT2;FGFR4
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.45767641825126637,-1.1034968564633352,0.3378607809847199,0.4933804777086035,1.0,1/12,0.16%,APOE
prerank,aorta development (GO:0035904),0.42643908942610115,1.103330819373932,0.31797235023041476,0.6277837920519025,1.0,2/14,0.73%,ROBO1;ROBO2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.30116230083978457,-1.1033234524430076,0.2866779089376054,0.4934472211306697,1.0,12/75,10.38%,CCR2;STAB1;ROCK1;NIBAN2;PPARG;HHEX;SARS1;PF4;CTNNB1;KLK3;SPRED1;SPRY2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.4574230643973602,-1.1029011571735357,0.3415929203539823,0.4939691192907611,1.0,8/12,41.49%,PPARG;ZC3H12A;TGFB1;NCOR1;ESR1;TNF;ZC3H10;ELAVL1
prerank,chromatin assembly (GO:0031497),-0.3428377220941988,-1.1027177866665034,0.31010452961672474,0.49405127936087806,1.0,11/38,18.84%,SMARCA5;ANP32B;ASF1A;HMGB2;SPTY2D1;PADI4;SART3;CHAF1A;RBBP4;BRD2;RSF1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3149792511601236,-1.1021494668936573,0.26359143327841844,0.4949017330720996,1.0,21/54,33.33%,OGT;ARRB2;RPL11;ARRB1;CTNNB1;DNAJA1;SPRY2;PRMT3;ISG15;HSPA1A;SMAD7;RPS3;UBXN1;HDAC8;RPL5;U2AF2;COPS9;SQSTM1;CAV1;HSPA1B;PRR7
prerank,negative regulation of receptor internalization (GO:0002091),-0.4510527353319148,-1.101775371474347,0.3381294964028777,0.4953593161741118,1.0,2/12,1.02%,SDCBP;RIN3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.42928479024085797,-1.1012886918844493,0.34348561759729274,0.49607866633306075,1.0,5/15,12.82%,ITGA5;VEGFA;JAK1;JMJD8;PKM
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.282863276627193,-1.1012203374423535,0.24567474048442905,0.4959461002463045,1.0,23/107,14.15%,ATP2B1;CCR2;SLC30A5;SLC10A7;HTR2B;CCR1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SLC8A1;ATP2A3;ATP13A1;TPT1;LCK;SLC24A5;CCL5;MT2A;CD40
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4239937782399913,1.101142023192735,0.33710407239819007,0.6321011969042271,1.0,3/14,10.56%,ANK2;KCNIP2;ATP1B1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.3727659222213469,-1.100565908647571,0.3396880415944541,0.4969736424692467,1.0,8/26,19.30%,B4GALT5;ST3GAL1;SLC35D2;B3GNT2;PRELP;B4GALT3;FMOD;B4GALT1
prerank,regulation of viral release from host cell (GO:1902186),-0.39810658513036856,-1.100343737881991,0.3228621291448517,0.4971699864954086,1.0,9/21,26.75%,TSG101;TRIM11;CHMP2A;VPS4A;TRIM25;DDB1;CHMP2B;TRIM28;PML
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.38445646445084203,-1.1000726101444847,0.33115823817292006,0.4971628759780319,1.0,8/23,22.72%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;SFN;NMT1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.38445646445084203,-1.1000726101444847,0.33115823817292006,0.4971628759780319,1.0,8/23,22.72%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;SFN;NMT1
prerank,mitochondrion organization (GO:0007005),-0.26553708572952955,-1.0992829925470569,0.23217247097844113,0.49849526559768814,1.0,48/165,24.52%,PID1;VPS13C;TRAK1;DNM2;MEF2A;IMMP2L;MTM1;PYROXD2;ATP7A;NRF1;PITRM1;RAB32;HIGD2A;BCS1L;ATAD3A;SIRT3;FIS1;SSBP1;TIMM44;TMEM11;RAB29;TIMM22;IFIT2;CXADR;MPV17;AFG1L;TFAM;SLC25A4;USP30;NIPSNAP2;BID;BNIP3L;MIGA2;FBXO7;COX7A2;TOMM22;MTFR1L;MTX1;TOMM34;HAX1;POLG2;TWNK;TOMM70;MTFP1;BIK;ATP5F1B;CYCS;PTCD2
prerank,ceramide catabolic process (GO:0046514),-0.43852810839418893,-1.0992702108848236,0.34440559440559443,0.4982343631147962,1.0,2/14,1.92%,HEXA;ACER3
prerank,response to nitric oxide (GO:0071731),0.43323571445410347,1.0989870868938656,0.32941176470588235,0.6362380149156225,1.0,2/13,2.89%,KCNC2;GUCY1B1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.37175502258090976,-1.0980293089463127,0.32867132867132864,0.5004751657986358,1.0,4/25,4.68%,PRKCD;ARHGAP24;CAPZB;STAP1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.2700457579677055,-1.0978363049241935,0.2540192926045016,0.5005687177258895,1.0,49/144,25.39%,PRKCD;ITGB2;IPO5;FLNA;RUFY3;BCL2;ANP32B;KIF20B;RNF31;GAS6;USP36;E2F1;ITGB1BP1;YWHAE;UBE2L3;FIS1;UBL5;ZDHHC2;TPR;SAR1A;RAB29;CIB1;PLK3;SH3GLB1;BBC3;MAVS;BAG3;HCLS1;BID;PCNT;CASP8;HUWE1;CHP2;GSK3B;BAP1;ZC3H12A;JUP;SFN;KCNB1;HPS4;NMT1;GTSE1;TGFB1;RBM22;SAE1;ITGAM;TRIM28;ECT2;VPS11
prerank,cellular response to glucose stimulus (GO:0071333),-0.357663570407468,-1.097446812150529,0.3147208121827411,0.5010358304390674,1.0,8/30,11.54%,ERN1;IGF1R;TRA2B;RAB11FIP5;GAS6;ZBTB20;XBP1;RAB11B
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.38061565182611123,1.0973446837357628,0.33254716981132076,0.6392514873914588,1.0,6/21,15.16%,DMD;PDE4D;MLXIPL;INPP5J;NLRP2B;CNKSR3
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.46268875017770095,1.0969851912567734,0.35697399527186763,0.6389184736913207,1.0,3/10,5.46%,SEMA5A;CARMIL1;CARMIL2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3997437660624577,-1.0967781318408143,0.32857142857142857,0.5021407721405536,1.0,11/21,36.56%,AXIN1;LRP6;CTNNB1;PPP1CA;GSK3B;DVL2;FZD1;FRAT1;CAV1;APC;FRAT2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.4479901846208606,-1.0962573141528302,0.3488773747841105,0.5029068822662147,1.0,3/13,4.60%,RREB1;METRNL;PIM1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4138990721450542,1.0961750125411802,0.3318077803203661,0.6397495696831602,1.0,6/13,21.70%,SORBS1;PRKCZ;IGF2;IRS1;SIRT1;SORL1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3972828448725816,-1.0961581263249363,0.33638025594149906,0.5028205054602056,1.0,5/20,10.40%,BRCA1;SLC27A1;ERLIN1;SIK1;PRMT3
prerank,negative regulation of synaptic transmission (GO:0050805),0.36829860202017106,1.0959907284575423,0.29603729603729606,0.6389724105545493,1.0,6/23,19.02%,SLC24A2;MTMR2;SYT11;GRIK3;SHANK2;SLC24A1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3499443699266073,1.0959384572003361,0.32036613272311215,0.6378999228321497,1.0,5/32,5.53%,NAV3;MAP2;TUBB4A;CLASP2;APC2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.41276860840881624,1.0957426797207328,0.3402777777777778,0.6371746462284549,1.0,8/16,19.84%,ST8SIA2;ST8SIA3;ST6GALNAC3;ST8SIA1;ST8SIA5;B3GALT4;B4GALT6;ST6GALNAC5
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3871777488305901,-1.0955419238763882,0.36695652173913046,0.5037728117091435,1.0,8/22,17.60%,PRKCD;ARFGEF1;CYRIB;MYADM;SSH3;TMSB4X;SSH1;TWF2
prerank,positive regulation of hormone secretion (GO:0046887),0.40302159378617064,1.0955215279163897,0.30403800475059384,0.6365090173762261,1.0,5/17,16.00%,SOX11;EDN1;VAMP7;VAMP8;GRP
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3231436750382086,1.0953940692039712,0.302540415704388,0.6355970509272714,1.0,10/43,12.31%,NELL1;SOX11;BMPR1B;ACVR1;YAP1;PRKD1;SUCO;BMP7;FERMT2;ATRAID
prerank,GTP metabolic process (GO:0046039),-0.4304004328085272,-1.094885935617063,0.35241502683363146,0.5047924111264588,1.0,5/15,11.02%,GNAI3;IMPDH2;RHOQ;EFL1;GTPBP1
prerank,homeostasis of number of cells (GO:0048872),0.43774247258992777,1.0945223700854985,0.34579439252336447,0.6366450535216317,1.0,3/12,8.43%,OCIAD1;CCN3;CX3CR1
prerank,positive regulation of catabolic process (GO:0009896),-0.30369482402980397,-1.094099705980507,0.30112721417069244,0.5061112998374812,1.0,13/65,12.52%,WWP1;RAB7A;CSNK2A1;WWP2;RNF41;AREL1;ATG7;TIPARP;AXIN1;PLK2;NEDD4L;ASB5;STX5
prerank,membrane repolarization (GO:0086009),0.4124190360116055,1.093747538373778,0.34811529933481156,0.6373049201642514,1.0,5/15,17.14%,KCND3;KCNIP2;ATP1B1;KCNE4;ATP1B2
prerank,protein localization to cilium (GO:0061512),-0.351960725040704,-1.0937042314671714,0.3185840707964602,0.5066274172419113,1.0,15/32,36.09%,SNX10;IFT20;RABEP1;RAB29;ARL3;EHD1;IFT140;IFT122;ODAD4;TULP2;MAPK15;INVS;CSNK1D;WDR19;ROPN1
prerank,camera-type eye development (GO:0043010),0.3636230271932337,1.0921576366597172,0.33737864077669905,0.6399689501728569,1.0,6/25,11.93%,CACNA1C;TENM3;WT1;TSKU;CEP290;HES5
prerank,response to sterol (GO:0036314),0.4386236133696881,1.0918655176048624,0.334070796460177,0.6395219028629837,1.0,3/11,12.48%,RORA;INSIG1;RORC
prerank,positive regulation of histone deacetylation (GO:0031065),-0.45610440485182535,-1.091857968450889,0.3666061705989111,0.5100360274322486,1.0,8/12,35.15%,AKAP8;NIPBL;VEGFA;APLNR;AKAP8L;ZBTB7B;CTBP1;ING2
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.4108100417709645,-1.0915624849835042,0.34452296819787986,0.5103431687107112,1.0,3/18,4.99%,AOAH;SAMHD1;DERA
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3658622236758815,-1.0905618986515473,0.3481848184818482,0.5120593184371559,1.0,7/26,7.99%,ITSN1;SIGLEC1;CANX;ITSN2;FCHO2;PICALM;AP2A2
prerank,piRNA metabolic process (GO:0034587),0.39211897437348286,1.0903431389226197,0.33035714285714285,0.6421345184064894,1.0,3/19,9.54%,TDRD12;TDRD9;PIWIL4
prerank,cellular response to amyloid-beta (GO:1904646),-0.34396114504618513,-1.0899424464875869,0.3152542372881356,0.5130173929718378,1.0,11/35,12.80%,ITGA4;IGF1;LRP1;CD36;IGF1R;TLR4;SNX6;CASP4;ABCC1;APP;FCGR2B
prerank,endoderm formation (GO:0001706),-0.34657211541775335,-1.0898966937251175,0.31802721088435376,0.5128036131784458,1.0,6/35,9.97%,ITGA4;ITGB2;ITGA5;ITGAV;FN1;ITGB5
prerank,cardiac conduction system development (GO:0003161),-0.3807154266200784,-1.0897474308764932,0.32620320855614976,0.5128347322629634,1.0,12/24,39.60%,NOTCH2;MAML1;GJB6;SMAD4;GJA5;HEY2;GJA1;SMAD1;HEY1;NPPA;TBX18;SMAD5
prerank,muscle tissue development (GO:0060537),0.4373436784861492,1.089192294034754,0.3356009070294785,0.6438740826820699,1.0,6/13,28.54%,CSRP1;SMO;PGM5;NF1;CSRP2;PTCH1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.47410192367598114,-1.0891070077257048,0.362453531598513,0.5139168674858587,1.0,2/10,3.37%,NFE2L2;RIPK1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.43055686429477713,-1.089025675485648,0.38578680203045684,0.5137971471915046,1.0,5/14,13.46%,DHX9;CNBP;PKM;UNK;DHX36
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.44092367179721165,-1.0889476928220287,0.3339191564147627,0.5136768561911457,1.0,6/13,35.63%,BCL2L11;VDAC2;BNIP3L;BNIP3;BLOC1S2;RTL10
prerank,regulation of protein neddylation (GO:2000434),-0.4874113496167553,-1.0883944509247128,0.3645833333333333,0.5145118492961168,1.0,7/10,34.94%,RPL11;HIF1A;DCUN1D4;RPL5;COPS9;DCUN1D5;DCUN1D1
prerank,mRNA 3'-end processing (GO:0031124),-0.29539258425258547,-1.0883903461197038,0.27666666666666667,0.5142279443099771,1.0,32/78,32.70%,SRRM1;CHTOP;SSU72;CDC40;APP;ALYREF;MTPAP;RPRD2;NUDT21;WDR33;NCBP1;THOC2;RNPS1;TENT4B;THOC6;PAPOLA;MAGOH;SLU7;CPSF3;GRSF1;SRSF11;DDX39B;DHX38;CPSF1;U2AF2;SRSF7;EIF4A3;SRSF5;TUT1;POLR2D;SARNP;U2AF1L4
prerank,regulation of cell cycle phase transition (GO:1901987),-0.285231582898133,-1.088252812598593,0.28321678321678323,0.514201605241734,1.0,28/91,24.96%,PSME4;PSMB7;ANAPC1;PSME3;PSMB9;PSMA8;PSMC3;DBF4;CDK1;PSMD8;BUB1B;PSMC4;PSMB10;TFAP4;PSMA1;UBE2C;PSMB8;ANAPC7;TRIM39;PSMA5;PSMD4;PSMB3;PSMD3;TCIM;GTSE1;CCNB1;PSMB1;DDB1
prerank,female gamete generation (GO:0007292),-0.36183721452759726,-1.0880194706652542,0.33391003460207613,0.5143843617470005,1.0,9/29,20.98%,DIAPH2;USP9X;MDK;MCM9;KMT2D;TOB2;MARF1;HORMAD1;DMC1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.30741455809915963,-1.0872122757569693,0.3172302737520129,0.5157104651357393,1.0,20/66,20.56%,CDK6;RB1;BRD7;PSME3;CCND3;PRMT2;ANXA1;E2F1;PTPN6;KIF14;ID2;INO80;EIF4G1;APPL2;WEE1;CDKN2C;CDK2AP2;DDX3X;ADAMTS1;APPL1
prerank,limb morphogenesis (GO:0035108),-0.39048365692744136,-1.0871618934248082,0.3513986013986014,0.5155104781333906,1.0,4/20,7.78%,MBNL1;NIPBL;LRP6;SKI
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.2891470840319307,-1.0871039604063475,0.3,0.5153396282310794,1.0,24/85,24.63%,MTSS1;IGF1;CDK6;NUPR1;RUNX3;C5AR1;GRN;VEGFA;NME1;B2M;OSR1;NLRC3;UHRF1;NR4A1;LIMS1;NOD2;SFRP1;FGF18;PRKDC;TGFB1;DEAF1;FGF9;MYC;PKHD1
prerank,regulation of transmembrane transport (GO:0034762),-0.35355296788680796,-1.086938590780059,0.34290540540540543,0.5153733335166361,1.0,6/31,5.01%,PRKCB;WWP2;SLC2A1;PIM1;ACTB;BCL2
prerank,phosphate ion transport (GO:0006817),-0.4212338923492369,-1.08671062181844,0.3516295025728988,0.5155387023766062,1.0,6/16,30.89%,SLC37A1;XPR1;SLC20A2;SLC25A10;SLC37A2;SLC20A1
prerank,second-messenger-mediated signaling (GO:0019932),-0.28935284332768824,-1.086445392908789,0.30363036303630364,0.5157791987448299,1.0,13/82,10.65%,APOE;MCTP1;CCR2;PLCG2;CD36;P2RX4;HTR2B;CCR1;DGKD;CAMKK2;HRH1;INPP5A;AGT
prerank,proteoglycan metabolic process (GO:0006029),-0.37224117716194605,-1.086423642479694,0.3303411131059246,0.5155452711932803,1.0,7/26,11.06%,XYLT1;IGF1;HPSE;CHST12;SULF2;CHST11;B4GALT7
prerank,gland development (GO:0048732),0.2977767618383864,1.0863588491263776,0.286783042394015,0.649695573812173,1.0,16/59,16.76%,NRG1;PAX8;PRKCSH;WT1;FGF10;SOX9;HOXD3;COBL;CDK5RAP3;SALL1;TBX1;ARHGAP35;HES1;EPHB3;IGSF3;TGFBR3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.44440686770302273,-1.0859251970802368,0.36379928315412186,0.5162354652743912,1.0,5/12,22.39%,SEC63;GET3;SGTA;CHMP4B;CHMP4A
prerank,carbohydrate homeostasis (GO:0033500),-0.29975480661518394,-1.0857053047599792,0.2878289473684211,0.5164013728362595,1.0,19/67,25.93%,INSR;IGF1R;PPARG;STAT3;ADIPOR1;RPS6;WFS1;STK11;APPL2;TENT4B;CYB5R4;SLC8B1;KCNB1;PYGL;IL6;PAX6;RBP4;FGFR4;INPP5K
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.37414733352181007,-1.0856375225404093,0.34102141680395387,0.516234910080064,1.0,8/24,21.23%,NFE2L2;GAS6;MAPK7;TNIP2;SERPINE1;GATA3;NDNF;KDR
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.290780881796537,-1.085577485468784,0.30282861896838603,0.5160545987296442,1.0,13/86,13.27%,RBPJ;DAB2;ZEB2;SDCBP;CREBBP;RNF111;RBPMS;TGFBR1;TGFB1I1;FLCN;STK11;HSP90AB1;ACVR2A
prerank,regulation of cellular protein localization (GO:1903827),0.31719664952980464,1.0851938568686923,0.32075471698113206,0.6514154987340907,1.0,7/45,8.44%,MAP2;GPC6;GPC5;EGF;BDNF;TOR1A;TRIM46
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.489164412931125,-1.0848447775240668,0.36650082918739635,0.5172837840632006,1.0,4/10,27.09%,NCKAP1L;TGFBR2;LGALS9;ZBTB7B
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3734697473438159,-1.0844212205988848,0.337228714524207,0.5178623637962908,1.0,8/24,20.29%,IGF1;INSR;DYRK2;SELENOS;PPP1R3E;IRS2;ENPP1;GSK3B
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4295542344076613,-1.0844170726384021,0.3188405797101449,0.5175763321368718,1.0,7/13,32.17%,ENTPD6;ENTPD3;ENPP1;NUDT15;SMPDL3A;DCTPP1;ENTPD7
prerank,positive regulation of histone methylation (GO:0031062),-0.37601315376155225,-1.0842868829642052,0.356140350877193,0.517539229941582,1.0,7/24,8.54%,OGT;BRCA1;CTR9;CHTOP;CTNNB1;JARID2;WDR5
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.36249549052248364,1.084165076682983,0.35799522673031026,0.6527828431726991,1.0,5/24,3.44%,DSCAM;SEMA6D;SEMA6A;SEMA3E;SEMA5A
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4138341989000021,1.0841237850315222,0.35731414868105515,0.6516511355678485,1.0,4/15,11.17%,PAX8;GDNF;SOX9;SMO
prerank,autophagy of nucleus (GO:0044804),-0.4164048901599245,-1.0839514547850881,0.35344827586206895,0.5179774015296422,1.0,4/16,13.61%,ATG5;ATG7;ULK2;RB1CC1
prerank,glial cell development (GO:0021782),-0.36627178110978625,-1.0838910587515573,0.3395585738539898,0.5177869230561818,1.0,10/25,28.48%,CDK6;NRROS;EIF2B3;MDK;APP;SOX10;EIF2B1;MT3;EIF2B2;EIF2B4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.44393751902494877,-1.0835600046334795,0.3591549295774648,0.5181664326129009,1.0,5/12,34.58%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,regulation of filopodium assembly (GO:0051489),0.33176783232110807,1.0833201360744313,0.3258145363408521,0.6525115108931498,1.0,4/38,1.83%,NLGN1;TENM2;TENM1;GPM6A
prerank,protein localization to organelle (GO:0033365),-0.2678161250237627,-1.0831852279592757,0.2796610169491525,0.5186279608595703,1.0,46/133,26.97%,SNX10;DCP1A;OPTN;IFT20;LAMP2;DHX9;COG7;HHEX;RPL11;LAMP5;GBP5;DNAJA1;SYS1;YWHAE;TRAM2;GBP2;PACSIN2;PAQR3;APP;LAMP1;TSPAN17;SERP1;STX5;ARL3;EHD1;UBAC2;TOR1AIP1;DDX1;ISG15;ARL1;DDX3X;RAB11A;LMBRD1;SGTA;ZBTB7A;TOPORS;TRAM1L1;HMOX1;MICALL1;IFT140;LMNA;RAB35;CYB5A;ARFRP1;OTOF;VAPA
prerank,positive regulation of isotype switching (GO:0045830),-0.4228217263193035,-1.0830918320666136,0.3624382207578254,0.5185498666763485,1.0,5/15,23.38%,KMT5B;KMT5C;CD40;SHLD2;TGFB1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3852845227034556,-1.0828996816903431,0.348294434470377,0.5186561122367105,1.0,3/22,3.16%,APOE;PPARD;PPARG
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.43891421065929087,-1.0824319786150551,0.3524305555555556,0.519282593903291,1.0,1/13,0.03%,PID1
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.3012734468643683,-1.0823739636650818,0.31141868512110726,0.5191038751149954,1.0,31/64,35.21%,AFF4;NELFB;CDK13;CTR9;POLR2H;POLR2F;POLR2L;ELOF1;POLR2A;NCBP1;POLR2G;ELP4;ELOC;RTF1;POLR2I;CCNK;GTF2F2;GTF2F1;SSRP1;NELFE;POLR1E;ELOA;MNAT1;SETD2;POLR2D;NELFA;CDK12;GTF2H1;ERCC2;POLR2B;CDK7
prerank,positive regulation of actin nucleation (GO:0051127),0.44024226031507496,1.0822177567247429,0.3578199052132701,0.6541312760852721,1.0,4/11,10.85%,WASF1;ABI2;NCKAP1;GSN
prerank,positive regulation of angiogenesis (GO:0045766),-0.28000421241485113,-1.0820963680719344,0.3160453808752026,0.5193810268267649,1.0,22/108,14.29%,SASH1;RUNX1;PRKCB;ITGA5;AGO2;BRCA1;FLT1;ITGB1;GRN;VEGFA;MDK;JAK1;HIF1A;CTSH;ITGAX;XBP1;JMJD8;SERPINE1;PKM;PIK3CD;CD40;BTG1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3623302529482743,-1.081852451335359,0.3360927152317881,0.5195812677235226,1.0,7/28,10.48%,IRAK2;TAB2;NOD1;OTULIN;UBC;RPS27A;RELA
prerank,respiratory system development (GO:0060541),-0.34617529497652,-1.0818111928010739,0.3380281690140845,0.519360229389276,1.0,18/32,42.78%,VEGFA;CCDC40;ITGA3;BAG6;CHD7;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2;SMCHD1;STRA6;DISP1;LOXL3;FGF7;BASP1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.4203066259781595,-1.0815033651278605,0.3777403035413153,0.5197334520624476,1.0,3/14,7.83%,YTHDF3;AGO2;VEGFA
prerank,regulation of cartilage development (GO:0061035),0.39026562188979214,1.081147920587514,0.34134615384615385,0.6555927246501069,1.0,7/18,12.14%,BMPR1B;SOX5;SOX6;SOX9;MBOAT2;BMP1;TAPT1
prerank,negative regulation of mRNA processing (GO:0050686),-0.417872224900753,-1.080614114060606,0.3486394557823129,0.5212359109351563,1.0,7/15,33.98%,SRSF10;RNPS1;C1QBP;PCBP4;U2AF2;SRSF7;BARD1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.381715909717896,-1.0802009785111721,0.32562277580071175,0.5218035873974713,1.0,6/22,13.88%,MAN1C1;AMFR;UBC;RPS27A;SEL1L;RNF185
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.40757921777380457,-1.080039615866873,0.3274647887323944,0.5218345553859757,1.0,6/17,15.45%,RB1;KNL1;CENPA;ZWILCH;CDK1;TTK
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4718557099587263,-1.0798796267166983,0.3730834752981261,0.5218717345919682,1.0,3/10,20.25%,CCR2;CCL5;WNK1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4548590642389715,1.0798126300834874,0.3548387096774194,0.6577707932636037,1.0,3/10,12.07%,GALNT13;GALNT16;POGLUT3
prerank,necroptotic process (GO:0070266),-0.42016052255387165,-1.0795696667389345,0.3602150537634409,0.522200188991599,1.0,8/16,28.86%,RIPK1;TLR4;LY96;TICAM1;MLKL;TICAM2;ITPK1;RIPK3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.2398366433890521,-1.0778263635774439,0.22620904836193448,0.5254911078940366,1.0,66/348,14.39%,PID1;RBPJ;MITF;IGF1;MSN;CD74;LILRB1;P2RX7;PLCG2;CD36;ROCK1;AGO2;NFE2L2;INSR;ANXA2;BRCA1;ARRB2;STAT3;TLR4;STAP1;PTPN22;TBC1D5;MAPK14;PF4;RPL11;PIK3CB;FN1;ARRB1;GAS6;WFS1;VEGFA;MAP2K5;E2F1;LAPTM5;MYD88;TGFBR1;CD28;HIF1A;CD63;MEF2C;CTSH;SERPINB9;MAPK7;EGR1;SCRIB;SPRY2;ITGAX;MOV10;MTPN;APP;MYOM1;RESF1;OSR1;MAP2K1;TICAM1;CELF1;RAB29;CD46;TNRC6C;PIK3CD;DHX36;CALCOCO1;GREM1;SETDB1;KLF2;ID2
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.259183306069877,-1.0775323184667296,0.2892561983471074,0.5258109284264734,1.0,46/166,22.95%,RBPJ;NOTCH2;CREBBP;PPARD;PPARG;SMARCA5;MAML1;GTF2A1;MAML2;E2F2;RARG;NR1H2;TAF6;TBL1XR1;NR2F1;POLR2H;POLR2F;E2F3;POLR2L;NRBF2;HDAC10;HDAC5;GTF2E2;RXRA;POLR2A;TFAM;TAF4B;TAF8;NR4A1;POLR2G;TAF9;TAF3;RARA;TAF1A;POLR1F;NR3C1;NCOA6;TAF4;RSF1;MAML3;MAZ;POLR2I;GTF2F2;GTF2A2;NR1H4;ESR2
prerank,regulation of axon guidance (GO:1902667),-0.47019533568654265,-1.0775283333685586,0.36185383244206776,0.5255231158128225,1.0,4/10,15.65%,NRP1;ZSWIM8;VEGFA;ZSWIM6
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.398964050192293,-1.0767157153868652,0.3424657534246575,0.5269124809055505,1.0,10/18,45.93%,HHEX;THOC2;ENY2;NUP133;SARNP;ZC3H11A;PABPN1;PCID2;POLDIP3;DDX25
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4376611787243827,-1.0765221664157,0.3923611111111111,0.5270200090428881,1.0,5/13,19.63%,DDX5;SPRED1;SPRED2;EEF1E1;ATM
prerank,regulation of angiogenesis (GO:0045765),-0.2577097754249611,-1.0763844624755265,0.27035330261136714,0.5270257982470006,1.0,51/192,23.76%,SASH1;RUNX1;PRKCB;SP100;CCR2;STAB1;ROCK1;NIBAN2;AGO2;PLXND1;PPARG;BRCA1;FLT1;ITGB1;HHEX;SARS1;PF4;CTNNB1;GRN;VEGFA;EGLN1;HIF1A;CTSH;KLK3;SPRED1;SPRY2;ITGAX;XBP1;HTATIP2;SERPINE1;PIK3CD;CD40;BTG1;FOXJ2;PGK1;HSPB1;AGGF1;ADAMTS1;SFRP1;ZC3H12A;STAT1;JUP;KDR;APOH;FGF18;IL6;APLNR;SERPINF1;MTDH;HMOX1;CYP1B1
prerank,positive regulation of glucose import (GO:0046326),-0.382347321405481,-1.0762502729012804,0.3670668953687822,0.5270039451238749,1.0,4/21,6.47%,OSBPL8;IGF1;INSR;RHOQ
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.4123677645669133,-1.0755626579248792,0.36589698046181174,0.528100052281781,1.0,4/16,17.87%,NUDT2;IMPDH2;ADSS1;PFAS
prerank,fluid transport (GO:0042044),0.4357578113158659,1.0754670882986406,0.37610619469026546,0.6678989860310922,1.0,3/12,19.87%,SLC4A11;AQP11;AQP4
prerank,melanosome organization (GO:0032438),-0.36049900721655864,-1.0754365173650897,0.33676975945017185,0.528080383930991,1.0,7/26,17.11%,LYST;AP1G1;RAB32;RAB29;DTNBP1;AP3B1;AP3D1
prerank,negative regulation of cellular process (GO:0048523),-0.2307192065147018,-1.0753129019039638,0.19804741980474197,0.5280490119805678,1.0,155/521,26.75%,LYN;PLXNC1;VPS13C;SP100;ABI1;LILRB1;ARID2;BCL6;CDK6;MYH9;RB1;SNX3;NIBAN2;PTPRJ;NUPR1;RUNX3;TNFRSF1B;BRD7;PLXNA1;SIPA1;APBB2;PLXND1;LPXN;CD9;ATG5;HTR2B;S100A11;RNF41;PTK2B;RARG;BCL2;ANP32B;CRLF3;TGFBI;RIPOR2;BLM;NR1H2;TXNDC12;CBFA2T3;SMYD2;TNFRSF21;TAF6;IFI35;UBR2;CTNNB1;WFS1;SKI;NF2;CBLL1;NME1;EIF2AK2;SIRPA;MDK;BST2;GSDME;ITGB1BP1;TGFB1I1;PTPN6;INCA1;CDKN3;APP;STRN;FLCN;OSGIN1;CHMP1A;MAP2K1;KLF10;CELF1;STK11;IGFBP3;ADAM15;EEF1E1;TMBIM6;CCDC85B;CIB1;FCGR2B;FRK;SPEF1;TFAP4;MIA3;ANXA6;BTG1;CHMP2A;RASA1;EI24;PPP1R9B;SPN;TMEM109;NR4A1;APPL2;KLF11;RBBP4;SPHK2;VHL;BNIP3L;HSPA1A;TOB1;ATF5;CDKN2C;GATA3;PDCD5;COL18A1;DDX3X;MDM4;ENPP1;BMPR2;LPCAT3;TXNIP;NME6;ADAMTS1;BAP1;SIRT2;PDS5B;SFRP1;COPS8;GNRH1;PPT1;RACK1;NUP62;IFITM1;CGRRF1;INHA;CHMP4B;BECN1;IL6;CRYAB;BNIPL;ESR2;SOX7;TGFB1;PIM2;GPLD1;CYP1B1;TES;LMNA;RND1;FTH1;MYC;NUDT6;PKHD1;SMYD5;ACTN1;CCN4;PRTN3;P3H1;TPTE;MT3;NCK1;CCN2;SMAD4;BMP2;PDE8A;CASK;RAPGEF2;PML
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4155868117137051,-1.0752592740495823,0.37055837563451777,0.5278756680965672,1.0,7/16,22.80%,KMT5B;PARP9;KMT5C;WRAP53;SHLD2;DTX3L;PRKDC
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3398249442883597,1.0745874615395195,0.33007334963325186,0.6689387187848991,1.0,5/32,11.21%,AKAP6;TRPC1;RAMP3;NPSR1;CAPN3
prerank,cellular response to organic substance (GO:0071310),0.26139675328685946,1.0745533693822755,0.31794871794871793,0.6677729460017984,1.0,13/116,5.82%,IL1RAPL1;AKAP6;ROBO2;NCOA2;SLIT3;SLIT2;BMPR1B;IGFBP5;CSF1R;MME;ACVR1C;ACVR1;RAMP3
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.3451270238534372,-1.0744388004340508,0.3544973544973545,0.5293339976800643,1.0,11/33,26.18%,RFC1;RTEL1;RAD51;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53;NHP2;MRE11;DCLRE1B
prerank,positive regulation of ossification (GO:0045778),0.32171583772705264,1.0743215613517187,0.3474178403755869,0.6671612037927214,1.0,11/39,12.31%,NELL1;SOX11;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;TFAP2A;TGFB2;ATRAID
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3925873201402523,-1.0740464917794201,0.36115843270868825,0.5298556022325628,1.0,10/20,33.09%,AGO2;ZC3H7B;PUM2;TSNAX;PUM1;TSN;ZC3H7A;SNIP1;DROSHA;SPOUT1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.2761307719316162,-1.0738661012277995,0.30201342281879195,0.5299279179143042,1.0,14/117,8.22%,LYN;FGR;CD163;SYK;PLCG2;GNB1;MYH9;ADCY7;PTGER4;MAPK14;GNG2;PLK2;CYSLTR1;RHBDF2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.30140011618351675,1.0734208364779863,0.35279805352798055,0.6682823657568264,1.0,9/54,7.02%,HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;PXYLP1;HS3ST1;SDC1;B3GAT2
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2596818644853753,-1.0733489407643622,0.3032258064516129,0.5307519390162775,1.0,36/172,16.22%,INPP4A;PLCG2;PI4K2A;DDHD1;PIK3R5;MTM1;DGKZ;CSNK2A1;PIP4K2A;SLC27A1;TAMM41;SYNJ1;MTMR3;MTMR14;PITPNM1;CEPT1;PI4K2B;PLD2;PIK3CB;GPD1;PIK3CG;DGKD;PI4KB;RAB5A;IMPA1;MTMR6;PIK3CA;ABHD5;CPNE3;PIK3CD;AGPAT1;PLA2G4A;PIK3C2A;PLEKHA2;DGKG;CLN3
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4384706339872908,-1.0733352618429821,0.3546099290780142,0.5304847694482443,1.0,5/12,17.52%,CENPE;KIF2C;MAD1L1;NUF2;NDC80
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3308196984572311,1.0732737491363453,0.34068627450980393,0.6674173642773558,1.0,5/33,7.01%,PRKG1;IGFBP5;TAFA5;APOD;APLN
prerank,regulation of osteoclast differentiation (GO:0045670),-0.34937918041277793,-1.0724204023584623,0.3247232472324723,0.5321182876223647,1.0,5/33,8.36%,LILRB3;GPR137B;CCR1;TLR4;PRXL2A
prerank,sensory perception of pain (GO:0019233),-0.3817026946181829,-1.0722125875908954,0.37919463087248323,0.5322228316852528,1.0,3/21,2.65%,CCR2;P2RX7;P2RX4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3805268502843169,-1.0721750104407246,0.35144312393887944,0.5319964676561505,1.0,5/22,13.46%,MED24;PSMC3;MED4;PSMC4;DHX36
prerank,rRNA 3'-end processing (GO:0031125),-0.47205007066777926,-1.072143524941895,0.4049733570159858,0.5317614381826743,1.0,3/10,8.01%,ERI3;RPS21;ERI2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.4046545112636475,-1.071461864066327,0.3586206896551724,0.5328319160494633,1.0,6/18,25.74%,SLC35F6;BID;HSPA1A;ACAA2;GSK3B;TMEM14A
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2743395018113226,-1.0712858112576917,0.30845771144278605,0.5328899274353185,1.0,19/116,14.30%,LYN;FGR;CD163;SYK;PLCG2;GNB1;MYH9;ADCY7;PTGER4;MAPK14;GNG2;PLK2;CYSLTR1;RHBDF2;SELENOS;FCGR2B;GLP2R;CALCA;ADCYAP1R1
prerank,neuron projection extension (GO:1990138),-0.3445360267660338,-1.0712610380609715,0.3474576271186441,0.5326417829395929,1.0,9/32,12.65%,IQGAP1;NRP1;ALCAM;ULK2;NRP2;CTNNB1;USP9X;LLPH;HSP90AB1
prerank,blood circulation (GO:0008015),0.3121639126826905,1.070841193893576,0.36561743341404357,0.6724782070816913,1.0,7/49,10.08%,SGCZ;SGCD;SERPING1;GUCY1B1;COL4A3;SGCG;AGTR1
prerank,regulation of spindle organization (GO:0090224),-0.3986747509692429,-1.0708059931867313,0.37542087542087543,0.5333130481374551,1.0,5/18,11.24%,DYNC1H1;RAE1;RNF4;TPX2;DCTN1
prerank,hemidesmosome assembly (GO:0031581),0.4356802216806069,1.0706222104725986,0.36470588235294116,0.6718103325633863,1.0,2/11,8.51%,DST;CD151
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4287384866709713,-1.0705629125958962,0.3738819320214669,0.5335533274963077,1.0,8/13,40.62%,RPS21;NOP14;NOL9;RPP40;RCL1;TBL3;BMS1;KRI1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3704487840177684,-1.070525446147778,0.3701188455008489,0.5333250531654293,1.0,5/24,7.30%,MCL1;NUPR1;FOXO3;CTNNB1;GRN
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2947775047007035,1.070442491300783,0.33578431372549017,0.67103747295236,1.0,18/59,17.23%,OSBPL6;SLC27A2;OSBPL7;ACSM5;ACOX2;NDUFAB1;PER2;ACACA;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1;HSD17B8;MLYCD;ACSM3;ALDH1A3
prerank,body fluid secretion (GO:0007589),0.3993470343220048,1.0702137170674206,0.34953703703703703,0.6703833313747272,1.0,3/15,9.28%,ERBB4;APLN;OXTR
prerank,amyloid-beta metabolic process (GO:0050435),0.4039015967765438,1.0697008659095544,0.3543123543123543,0.6704415705250134,1.0,3/16,5.37%,MME;MGAT3;IDE
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.31248149388237884,-1.0685889741977754,0.32892561983471075,0.5367479969461617,1.0,21/51,26.25%,NUP205;CHMP7;CDK1;NUP188;LEMD2;CHMP2A;ANKLE2;UBE2I;RCC1;NUP35;VPS4A;SIRT2;NUP107;REEP3;CHMP4B;CHMP4A;CCNB1;LMNA;CCNB2;CHMP2B;NUP37
prerank,mitotic nuclear membrane organization (GO:0101024),-0.31248149388237884,-1.0685889741977754,0.32892561983471075,0.5367479969461617,1.0,21/51,26.25%,NUP205;CHMP7;CDK1;NUP188;LEMD2;CHMP2A;ANKLE2;UBE2I;RCC1;NUP35;VPS4A;SIRT2;NUP107;REEP3;CHMP4B;CHMP4A;CCNB1;LMNA;CCNB2;CHMP2B;NUP37
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4328406555949467,-1.0685405093607816,0.3954248366013072,0.5365599683777974,1.0,6/14,22.60%,FLNA;ITGB1BP1;CD63;BST1;LIMS1;PHACTR4
prerank,tRNA metabolic process (GO:0006399),-0.3884250902162859,-1.0682813589821063,0.3803786574870912,0.5367957450946087,1.0,6/17,20.70%,FARS2;ADAT1;SARS1;KARS1;AARS1;DARS2
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.3464186377312141,-1.0682527338922216,0.35106382978723405,0.5365751739356021,1.0,15/32,22.48%,PRKCD;ROCK1;FOXO3;TMED10;PUM3;PICALM;PCIF1;MTPN;APP;NOLC1;EIF2A;RBM4B;RBM3;SAMD8;NR1H4
prerank,mitochondrion localization (GO:0051646),-0.3926628284246728,-1.0676331395613534,0.3865979381443299,0.5375724530634958,1.0,3/19,2.65%,TRAK1;MEF2A;MTM1
prerank,cellular response to alkaloid (GO:0071312),0.39663517735407994,1.0674335695218449,0.38028169014084506,0.6750267957063848,1.0,6/17,12.36%,RYR3;RYR2;CASQ2;RYR1;CASP6;HTR1B
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.28060942308388787,-1.0670259682000356,0.32764505119453924,0.5385121101785201,1.0,19/91,11.58%,PTPRC;NRP1;RAB8B;FGR;SYK;FES;ABL2;CD22;DNAJC13;ITGAV;PICALM;HIP1;RINT1;RAB5A;RAB21;PACSIN2;RAB3D;RAB11B;MAP2K1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42968230990391976,-1.0670037049417311,0.3950617283950617,0.5382603301119998,1.0,4/13,10.48%,PPARD;PPARG;NFATC3;RELA
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.4322829179335025,-1.0669908402396953,0.3921232876712329,0.5379938619748033,1.0,4/14,13.39%,RHOA;MAP2K5;ITGB1BP1;HDAC5
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.33947927789316035,1.0669042411596208,0.34467120181405897,0.67519034809815,1.0,7/29,9.24%,GRIK2;SHISA6;SLC4A10;SHISA9;NETO1;SLC8A2;CAMK2A
prerank,sodium-independent organic anion transport (GO:0043252),0.44881307722805597,1.0666854877410583,0.391304347826087,0.6745750099306272,1.0,4/10,15.06%,SLCO4A1;SLCO2B1;SLC16A2;SLCO3A1
prerank,peptidyl-amino acid modification (GO:0018193),0.44808882348468615,1.0663543275022567,0.3752913752913753,0.6741695689656771,1.0,3/10,15.43%,METAP2;METAP1;PDF
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.3689160854815084,-1.0663498027174574,0.380327868852459,0.5390377953365245,1.0,4/25,5.85%,CBL;PPARG;SNX6;TSG101
prerank,axonal transport (GO:0098930),-0.3368433015460378,-1.0662898392850944,0.358974358974359,0.5388758349806368,1.0,14/36,20.75%,KIF3B;DYNC1H1;FBXW11;AP3S1;KIF4A;HIF1A;RAB21;AP3M1;DCTN1;DTNBP1;AP3B1;AP3D1;PAFAH1B1;AP3B2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.37271350155812655,-1.0662113168989866,0.3584905660377358,0.5387520835222109,1.0,10/23,21.64%,NABP1;PLK2;ZWILCH;BUB1;PLK3;BUB1B;WEE1;CHEK1;VPS4A;ZFYVE19
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4334389469251404,-1.065946997038817,0.41127694859038144,0.5390255360224715,1.0,9/13,33.76%,NFE2L2;ATXN3;RNF185;TMEM259;SGTA;BAG6;CAV1;RNFT1;UBQLN2
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.3934017297487823,-1.0656609424863532,0.38023450586264657,0.5393339637388226,1.0,11/19,33.61%,PDCD6IP;CHMP5;CHMP1A;TPR;CHMP2A;HSPA1A;CHMP4B;CHMP2B;VPS4B;HSPA1B;DRG1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3901079568005387,1.064902147306394,0.3375,0.6767162653118673,1.0,4/17,11.99%,PCSK5;PCSK6;APOC1;ANGPTL3
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3951101447180333,-1.0648488975453572,0.3693379790940767,0.5406841444357253,1.0,4/18,10.48%,ABCG1;GSAP;PICALM;RELA
prerank,peptide hormone secretion (GO:0030072),0.35495915114399623,1.064677235807177,0.3409090909090909,0.6760796008345047,1.0,5/26,10.49%,RIMS2;MAFA;EDN1;GHRH;NEUROD1
prerank,mesonephros development (GO:0001823),0.4425982648262044,1.0645839426651735,0.39631336405529954,0.6750905026685453,1.0,3/11,8.65%,PAX8;FGF10;BMP7
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.41512802722552344,1.0642721011625895,0.3761904761904762,0.6747052522089552,1.0,3/14,3.06%,SLIT2;PRKG1;IGFBP5
prerank,negative regulation of secretion by cell (GO:1903531),-0.32679864951196386,-1.0642527491497191,0.36155202821869487,0.5416703109061227,1.0,9/38,10.44%,APOE;LILRB1;TNFRSF1B;ANXA1;RSAD2;RHBDF1;RHBDF2;SYT4;CHGA
prerank,cellular response to hydroxyurea (GO:0072711),-0.46225449563429444,-1.0638802188396697,0.3968253968253968,0.5420966564055802,1.0,5/10,15.34%,SPIDR;BLM;DDI2;TIMELESS;NSMCE3
prerank,glucose homeostasis (GO:0042593),-0.2829057622388637,-1.0635958628270588,0.32676518883415434,0.5423763266362465,1.0,22/83,25.93%,LRRC8D;INSR;IGF1R;PPARG;STAT3;ADIPOR1;RPS6;WFS1;HIF1A;NUCKS1;HK3;STK11;APPL2;CYB5R4;SLC8B1;KCNB1;PYGL;IL6;PAX6;RBP4;FGFR4;INPP5K
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.38335286113186207,-1.0629912470751062,0.3844856661045531,0.5433342384849733,1.0,5/20,10.16%,PACS2;BCL2;WFS1;FIS1;TGM2
prerank,negative regulation of signal transduction (GO:0009968),-0.2436892898435479,-1.062594826572368,0.2857142857142857,0.5438678330097532,1.0,57/249,21.86%,PID1;LYN;PTPRC;PRKCB;LRP1;XDH;PLEK;PRKCD;RB1;NIBAN2;PTPRJ;CSNK2A1;PIP4K2A;WWP2;HERC4;CNOT1;PTPN12;PTPRE;HHEX;BCL2;MDFI;PIK3CB;ARRB1;MGRN1;IRAK3;EZH2;SULF2;TRIB1;ASXL1;SPRY2;AGT;IGFBP3;TMBIM6;CCL5;NFKBIL1;ARRDC1;RGS14;RNF43;OTUD4;BRAP;GPR108;TMEM25;NFATC1;GATA3;ENPP1;SUFU;UBASH3B;CYP26C1;APPL1;MAZ;PTPN1;SFRP1;RACK1;MEGF8;ZBTB7A;SNAI2;SOCS5
prerank,cognition (GO:0050890),0.3155416427609363,1.062591434484779,0.3333333333333333,0.6778995677052168,1.0,13/42,17.93%,GRM5;SHROOM4;MGAT3;CUX2;HRH3;TTC8;SOBP;SLC8A2;MFSD2A;LINS1;CHRNA7;TUSC3;FAM107A
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4491355552247773,-1.062533483565845,0.3835616438356164,0.5436885735000564,1.0,5/12,22.16%,LYN;BST2;IL34;CSF1;MAPK1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3674718486018931,-1.0624035755822177,0.37894736842105264,0.543675660557109,1.0,6/26,9.70%,ALPK1;IRAK2;TAB2;NOD1;UBC;RPS27A
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3774651771930991,-1.0621859049167366,0.38205980066445183,0.5435507003513119,1.0,7/22,24.43%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3774651771930991,-1.0621859049167366,0.38205980066445183,0.5435507003513119,1.0,7/22,24.43%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3604435865903205,-1.0616728929262738,0.39750445632798576,0.5443247950765198,1.0,7/24,16.92%,DNMT3A;SPI1;EZH2;JARID2;EED;EPC1;RBBP4
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3386397573170503,-1.0613148681412592,0.3689839572192513,0.5447967963063373,1.0,4/33,4.75%,APOE;SP100;CORO1C;ADIPOR1
prerank,autophagosome assembly (GO:0000045),-0.3109037557422834,-1.061113915183899,0.3563025210084034,0.5449389083660962,1.0,22/52,34.97%,RAB7A;ATG5;PACS2;ATG7;RAB1A;ULK2;RB1CC1;GABARAP;ATG16L2;EMC6;BECN1;VMP1;RAB19;RAB1B;SMURF1;TRAPPC8;ATG101;STX17;GABARAPL1;TP53INP2;UBQLN2;ATG9A
prerank,membrane repolarization during action potential (GO:0086011),0.41461459733457934,1.0609279918496963,0.3755656108597285,0.6808914611182418,1.0,4/13,16.71%,KCND3;KCNIP2;ATP1B1;KCNE4
prerank,muscle contraction (GO:0006936),0.2582249184152926,1.0608544827836361,0.30637254901960786,0.6798598161084057,1.0,21/126,13.04%,SORBS1;DMD;DTNA;GLRA1;GNAO1;CASQ2;TNNI1;ACTA1;KCNIP2;MYL12B;OXTR;TNNT2;RYR1;MYH7;TTN;CALD1;MYLK;DYSF;CALM1;ADRA1A;KCNJ12
prerank,negative regulation by host of viral transcription (GO:0043922),-0.4367204229095475,-1.0606904332286695,0.37305699481865284,0.5455332561430928,1.0,6/12,25.93%,JUN;PSMC3;CCL5;TFAP4;TARDBP;INPP5K
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4129170155869436,1.0603723562449168,0.3938679245283019,0.6798600564671484,1.0,8/14,21.17%,ACOX2;EHHADH;ACOT8;ABCD1;DECR2;HSD17B4;CROT;ACOX3
prerank,regulation of mitotic spindle organization (GO:0060236),-0.3373131136148356,-1.060245378157341,0.3652597402597403,0.5461572339963292,1.0,12/35,22.38%,PDCD6IP;CHMP5;DYNC1H1;RAE1;TPX2;DCTN1;CHMP1A;TPR;CHMP2A;HSPA1A;NUP62;CHMP4B
prerank,negative regulation of neuron projection development (GO:0010977),0.29323729311506436,1.0597598789013287,0.32360742705570295,0.6802100201934893,1.0,4/56,2.17%,NLGN1;SPOCK1;DCC;LINGO1
prerank,regulation of DNA replication (GO:0006275),-0.31502538993606516,-1.0597000369960412,0.37264957264957266,0.5470374150422802,1.0,11/49,17.64%,BCAR3;S100A11;DHX9;BLM;NUCKS1;PCNA;CCDC88A;ORC5;KAT7;FAF1;DNA2
prerank,TOR signaling (GO:0031929),-0.3629080903672947,-1.059382529429615,0.37251655629139074,0.5473977759663179,1.0,7/26,11.72%,CARD11;RPS6;FNIP1;EIF4EBP1;EIF4EBP2;FLCN;CCDC88A
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2970525959001983,-1.059127028420012,0.38209982788296043,0.5475918261801976,1.0,30/62,35.21%,AFF4;NELFB;CDK13;CTR9;POLR2H;POLR2F;POLR2L;ELOF1;POLR2A;NCBP1;POLR2G;ELP4;ELOC;RTF1;POLR2I;CCNK;GTF2F2;GTF2F1;SSRP1;NELFE;ELOA;MNAT1;SETD2;POLR2D;NELFA;CDK12;GTF2H1;ERCC2;POLR2B;CDK7
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3612827893054869,1.059126152730271,0.36446469248291574,0.6806187143915438,1.0,8/23,20.95%,ELOVL7;FAR2;HACD1;ACSL3;ACSL6;ELOVL6;ACOT7;ELOVL2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.2948850534297056,-1.0578917393431881,0.35813148788927335,0.5498904134311293,1.0,6/66,1.97%,APOE;MTSS1;XDH;CDK6;NUPR1;RUNX3
prerank,negative regulation of cell cycle (GO:0045786),-0.2909739323230997,-1.0573281351659791,0.3622448979591837,0.550789468493197,1.0,17/73,16.25%,LILRB1;CDK6;RB1;NUPR1;RUNX3;IPO5;SIPA1;HHEX;TAF6;INCA1;SCRIB;CDK5RAP1;CHMP1A;TFAP4;BTG1;LATS2;NR4A1
prerank,negative regulation of insulin secretion (GO:0046676),0.38577933646451973,1.0568834164106062,0.3811881188118812,0.685201663988773,1.0,6/17,14.92%,CCN3;REST;PRKN;INHBB;KLF7;IRS1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.37218896221370124,-1.0568459237868792,0.3815789473684211,0.5514783070779935,1.0,6/23,9.62%,MTM1;MTMR10;SYNJ1;MTMR3;PIP4P1;MTMR6
prerank,establishment of protein localization to organelle (GO:0072594),-0.2820826358872551,-1.0566046377032776,0.3300653594771242,0.5516496137167308,1.0,23/72,22.37%,SYK;IPO5;NUP50;STAT3;LAMP2;NUP88;LAMP5;E2F3;TPR;LAMP1;TSPAN17;NUP188;APPL2;NUP153;FAM53A;RAB11A;TNPO3;APPL1;NUP107;NXT2;NUP62;NEURL1B;SPRN
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3580675637574683,-1.056498852124829,0.36644951140065146,0.5515688466577479,1.0,10/28,22.80%,ACTR2;ERCC6;KMT5B;PARP9;KMT5C;TFIP11;WRAP53;SHLD2;DTX3L;PRKDC
prerank,negative regulation of kinase activity (GO:0033673),-0.3013534900090348,-1.0562426351992902,0.3783783783783784,0.5518249515692195,1.0,10/62,10.21%,PTPRC;PAK2;RB1;PRKAG2;CEP85;LRP6;TRIB1;ITGB1BP1;TRIB2;SPRED1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2698416446635672,1.0553764545087696,0.3349397590361446,0.6880349817281286,1.0,19/95,11.27%,HS3ST6;HS3ST5;GPC6;GPC5;HS6ST2;CHSY3;PXYLP1;VCAN;HS3ST1;B4GALT4;DSEL;CHST5;SDC1;GLCE;CHST7;OMD;HAS2;CHST9;CHST14
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4302967236238566,-1.0553016497287813,0.3904923599320883,0.5535074895813091,1.0,7/12,41.36%,CCR2;CLEC6A;IL12RB1;ZBTB1;SLC11A1;IL12B;IL1B
prerank,dicarboxylic acid transport (GO:0006835),0.3528579403844383,1.0550131322283607,0.3632286995515695,0.6877247479540065,1.0,7/28,14.88%,SLC1A2;SLC1A6;SLC1A1;SLC13A5;SLC26A8;FOLR1;FOLR2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.44734186441748325,-1.0548727356803844,0.40341880341880343,0.5541000249441932,1.0,5/11,21.23%,HPSE;PRCP;VEGFA;NDNF;KDR
prerank,cellular glucan metabolic process (GO:0006073),-0.44240812561838133,-1.05478798700389,0.4,0.5539906996772815,1.0,5/11,21.92%,PRKAG2;PHKG2;GBE1;GSK3B;PYGL
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.36600473757799085,-1.0546224369228787,0.3944153577661431,0.5540612123882754,1.0,9/23,31.54%,PREB;SELENOS;DERL1;SEL1L;HSP90B1;FAF2;VCP;RANGRF;AUP1
prerank,sprouting angiogenesis (GO:0002040),0.29505490286008695,1.054312179687114,0.33569739952718675,0.6883184914914958,1.0,8/51,7.80%,ROBO1;SLIT2;CDH13;SEMA3E;SEMA5A;VEGFD;PGF;ADGRA2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3973169782809932,-1.0542722176203534,0.3944153577661431,0.5545443133809951,1.0,5/17,19.55%,PLBD1;PLA2G4A;PLAAT3;PLA2G5;PLA2G12A
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3794388824621644,1.0538914618767956,0.3811881188118812,0.6881134885992745,1.0,3/17,10.94%,ALK;APOC1;MFSD2A
prerank,regulation of ruffle assembly (GO:1900027),0.3549978318688604,1.0529926101245892,0.3878504672897196,0.6892041322625732,1.0,5/23,8.21%,NLGN1;FAM98A;P2RY12;CARMIL2;KANK1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3513763333224218,-1.0528278700870461,0.39436619718309857,0.5572646214867875,1.0,5/29,7.95%,AGO2;TUT7;ZC3H7B;SRRT;PUM2
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3206494178052918,-1.0523868011805448,0.3861209964412811,0.5578682029013788,1.0,9/44,11.72%,NRP1;RAC1;RHOA;CDC42;ARHGEF10;NF2;TGFBR1;ITGB1BP1;CCDC88A
prerank,neutral amino acid transport (GO:0015804),-0.35868731002279186,-1.0522577872842183,0.38054607508532423,0.557856471542136,1.0,8/28,19.25%,SLC38A6;SLC6A6;SLC43A2;SLC36A4;CTNS;SLC7A5;SLC6A9;SLC38A2
prerank,negative regulation of developmental process (GO:0051093),0.28133815075920193,1.0518930649519418,0.3545232273838631,0.6908620028341178,1.0,16/69,15.62%,OMA1;DCC;GRIN3A;NFIB;RPS6KA6;ARHGEF15;SOX9;KANK1;POU4F2;TBX1;ALPK2;HYAL3;PRKN;PTPRS;KLF7;FUZ
prerank,ear morphogenesis (GO:0042471),0.3744300884696897,1.0512766955962418,0.39285714285714285,0.6912934530686576,1.0,5/20,12.82%,PAX8;MYO6;TFAP2A;TBX1;TMIE
prerank,motile cilium assembly (GO:0044458),0.4328363540298089,1.0509966645531954,0.4,0.6907564374969485,1.0,1/12,0.58%,DNAAF3
prerank,muscle organ development (GO:0007517),0.2918893665469471,1.0506316668303468,0.3594132029339853,0.6904440588641747,1.0,11/54,13.88%,SGCD;DMD;MKX;SOX6;TEAD4;SGCG;TBX1;SGCE;CAPN3;ITGA11;FKTN
prerank,mitochondrial transport (GO:0006839),-0.3089158999684603,-1.0498369212563632,0.3773913043478261,0.5627047543516521,1.0,21/53,29.09%,SLC25A24;BCL2;TMEM14C;PITRM1;BCS1L;FLVCR1;FIS1;TIMM44;TIMM22;SLC25A4;MAIP1;FBXO7;TOMM22;TOMM34;SLC25A13;TOMM70;TMEM14A;TOMM40;SLC25A31;BCL2L1;BNIP3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3695368192580449,-1.0498021405322187,0.3875838926174497,0.5624726652736756,1.0,6/22,16.15%,IPO5;HHEX;INCA1;CDK5RAP1;TFAP4;LATS2
prerank,folic acid metabolic process (GO:0046655),-0.38835650884867046,-1.0494560035238023,0.39965397923875434,0.5629290394030174,1.0,8/18,33.43%,MTHFS;MTHFD1L;MTHFD2L;MTHFR;SHMT1;FPGS;SLC19A1;MTHFD1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.3639254568670791,-1.0492877158013056,0.39078498293515357,0.5629931045714435,1.0,8/23,20.48%,USP50;OTUD5;USP8;MINDY2;ATXN3;OTUD4;MINDY1;BAP1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4214038587753035,1.04921600813245,0.37209302325581395,0.6929269647251488,1.0,3/12,5.77%,ANK2;RYR2;CASQ2
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.34011122340964794,-1.048967329383028,0.3866432337434095,0.5633436583815197,1.0,5/32,10.88%,APOE;PRKAG2;ADIPOR1;C3;ZBTB20
prerank,MAPK cascade (GO:0000165),-0.23774678183984627,-1.048687560192211,0.32404692082111436,0.5636220680577105,1.0,98/295,24.84%,MAP3K8;MAP3K5;TAOK3;IGF1;GRB2;RASA3;MEF2A;CSF2RA;MAP3K20;PSME4;MINK1;ABHD17C;MAPKAPK2;HTR2B;RASGRP4;PSMB7;IL18;PSME3;NFKB1;ITGAV;FBXW11;RGL2;PTGER4;PSMB9;PIK3CB;HGF;CAMKK2;FRS2;JAK1;YWHAE;MEF2C;CTSH;PSMA8;UBC;RPS27A;SPRED1;TNIP2;TAOK1;PSMC3;PAQR3;IL2RG;RASAL3;DUSP6;CDK1;MAP2K1;PIK3CA;CSF2RB;PSMD8;CCL5;KSR1;PSMC4;PSMB10;PSMA1;IKBKB;RASA1;KARS1;IL31RA;BRAP;PSMB8;IL2RB;IRS2;KRAS;NRAS;PDE6D;RASA4;IL17RD;PDGFRB;TAOK2;DUSP5;LGALS9;PSMA5;PSMD4;PSMB3;RGL3;PSMD3;GOLGA7;KDR;PDGFA;MAP4K4;LYPLA1;MAPK1;FGF18;PTPN7;PPP1CC;SPTAN1;KITLG;TGFB1;PPP1CB;IL2RA;MAP3K3;PSMB1;FGF9;FLT3;SHC1;RASA2;MYC;RCE1;FGFR4
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.3722204826739397,-1.0486511704602268,0.3801369863013699,0.5633881172399393,1.0,5/22,10.51%,ABCB7;HSCB;HSPA9;CIAO3;IBA57
prerank,regulation of cytoplasmic transport (GO:1903649),-0.4437925334519451,-1.0484848065420544,0.4321608040201005,0.5634471514591542,1.0,4/11,22.16%,DNAJC13;MAP2K1;USP7;MAPK1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3596953673066163,-1.0484703898643875,0.39028475711892796,0.5631710858046077,1.0,7/25,18.86%,BCL2L11;PLAUR;MLLT11;BBC3;BID;TNFSF10;PDCD5
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3444679075477355,-1.048388273269715,0.3884430176565008,0.5630299222501571,1.0,5/26,3.59%,PTPRC;PLCG2;ITPR1;IBTK;HTR2B
prerank,regulation of neuron death (GO:1901214),0.27057305376960616,1.0471244210664015,0.3439153439153439,0.6970559598106688,1.0,25/82,19.50%,GRID2;TRIM2;GRIN2B;DCC;CD200R1;EPHB1;TSC1;DHCR24;PRNP;FYN;CD200;REST;PRKN;PPARGC1A;CHRNA7;SNCA;LANCL1;UBB;IKBKG;GRM4;FOS;EFNB2;NSMF;NAE1;WNT5A
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4449570954085355,-1.046763896457894,0.4204152249134948,0.5661322946247082,1.0,5/11,31.33%,DHX9;TPR;NUP153;AKAP8L;SETD2
prerank,positive regulation of phosphorylation (GO:0042327),-0.23984483713841823,-1.045851623778369,0.3405238828967643,0.567724445237628,1.0,44/240,15.46%,LYN;DAB2;NRP1;IGF1;CD74;SDCBP;P2RX7;NIBAN1;AXL;RAC1;INSR;IGF1R;RAP2A;RIPK1;FLT1;CCND3;PFKFB3;AXIN1;HGF;C3;ARRB1;GAS6;CAMKK2;VEGFA;FNIP1;PLAUR;HIF1A;NCKAP1L;ARNT;PIN1;ZBTB20;PFKFB4;APP;FLCN;WDFY2;CCL5;CIB1;ACVR2A;RB1CC1;CD40;IL34;CRKL;ANG;MAVS
prerank,negative regulation of angiogenesis (GO:0016525),-0.2821461246589663,-1.0458187239107324,0.36317567567567566,0.5674870621369118,1.0,14/84,10.38%,CCR2;STAB1;ROCK1;NIBAN2;PPARG;E2F2;HHEX;SARS1;PF4;PIK3CB;CTNNB1;KLK3;SPRED1;SPRY2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.41127150242266725,-1.0453665123733606,0.40241796200345425,0.5681411917648539,1.0,5/15,20.83%,RNF213;ZNRF3;SPEF1;RSPO3;SFRP1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.456293608044835,-1.045316231796239,0.42439862542955326,0.5679441794865584,1.0,5/10,26.67%,RAP1A;RIN2;ASB4;KDR;RAPGEF2
prerank,regulation of transposition (GO:0010528),0.4169034822827137,1.0447958001878757,0.4,0.7020685661033571,1.0,3/13,9.54%,TDRD9;AICDA;PIWIL4
prerank,organelle disassembly (GO:1903008),-0.33170089634213884,-1.044658010194862,0.3940972222222222,0.5690448302495899,1.0,8/33,13.61%,KLC1;ULK2;TEX264;CDK1;STX5;PLK3;RETREG1;RB1CC1
prerank,protein monoubiquitination (GO:0006513),-0.33613960301743473,-1.0444112931899232,0.4115586690017513,0.5692505116355444,1.0,14/36,27.06%,CTR9;RNF20;UBE2R2;KLHL22;MGRN1;UHRF1;WAC;UBE2T;HUWE1;DTX3L;TRIM25;TOPORS;RNF40;CUL3
prerank,thymus development (GO:0048538),0.41814638898138007,1.044261278423495,0.37317073170731707,0.702244213373163,1.0,5/13,19.15%,FGF10;TBX1;HES1;EPHB3;FADD
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.35499567417731337,-1.0440946166411864,0.3993174061433447,0.5696223554609416,1.0,5/24,3.59%,PTPRC;PLCG2;ITPR1;IBTK;HTR2B
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.3970639458254654,-1.0437082679792984,0.37606837606837606,0.5701343595530013,1.0,5/16,10.72%,TNFRSF1B;CD22;PTPN22;AHR;IKZF3
prerank,regulation of T cell chemotaxis (GO:0010819),-0.4405049447900701,-1.0434264773194954,0.41367521367521365,0.5703965099671977,1.0,3/11,20.25%,CCR2;CCL5;WNK1
prerank,visual perception (GO:0007601),0.2637503815413876,1.042931956886751,0.3256997455470738,0.704531538253245,1.0,16/84,11.96%,GRM8;SLC4A10;CRYZ;POU6F2;COL11A1;RPGR;IMPG2;ABLIM1;ADGRV1;TRPM1;PDE6C;GPR143;CRYBB3;EML2;PRPH2;ZIC2
prerank,response to UV-A (GO:0070141),0.3916599541057789,1.0426739083942391,0.4066193853427896,0.7040141918741001,1.0,3/14,9.75%,MME;OPN3;OPN5
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.26762166021103656,-1.0425202671513456,0.3504132231404959,0.5720387250319687,1.0,39/117,31.69%,AOAH;IGF1;CD36;MTHFS;PPARD;PANK2;PPARG;KYNU;CPT1A;MTHFD1L;ME2;LPL;PDZD11;AGXT;BCO2;NPC1;SLC6A8;DLD;AMACR;ACOT2;SLC16A1;ACOT4;PDHB;AASDHPPT;ECHDC3;VDAC1;HLCS;PNPLA8;HOGA1;ACOT11;ALDH8A1;GPAT2;CYP2S1;SCP2;PTGR1;UGT1A7;UGT1A8;UGT1A1;SCPEP1
prerank,proteolysis (GO:0006508),-0.23986205486167808,-1.0422763085461193,0.3209302325581395,0.5722409435129384,1.0,51/252,18.91%,CTSB;FAM111A;ADAM33;CTSD;CTSZ;ANPEP;OGT;PLAU;MALT1;SRGN;DPP4;CTSA;LNPEP;DDI2;HGF;PITRM1;PCSK7;PRCP;ATG4C;CTSC;RNF123;CASP4;RNPEPL1;CNDP2;CTSH;KLK3;PSENEN;CAPN15;F7;FAP;UBE3A;CPQ;CTSS;HTRA3;CASP7;CASP1;DPP7;PSMC4;FBXW2;CTSE;LAP3;HM13;CLN3;TPP1;ADAM19;VHL;CASP8;MMP8;XPNPEP3;MMP17;CASP2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.39613404708923394,1.042095938757302,0.41834451901565994,0.7042565654477447,1.0,5/14,16.87%,NME2;ENPP3;AK4;AK5;AK3
prerank,regulation of phospholipase C activity (GO:1900274),0.3848125063277378,1.0418608157691416,0.38672768878718533,0.7036368883849101,1.0,2/15,1.52%,NTRK3;BICD1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.4530851635186046,-1.0417998046655976,0.42538593481989706,0.5729005952280966,1.0,4/10,20.02%,PTPN22;IFI35;WDFY1;TICAM2
prerank,autonomic nervous system development (GO:0048483),0.38260801011542406,1.0415457290539145,0.44075829383886256,0.7033117301287768,1.0,3/17,4.57%,PHOX2A;SOX11;GDNF
prerank,macrophage chemotaxis (GO:0048246),-0.4510646502014465,-1.041307257240156,0.4188034188034188,0.5735977159925222,1.0,7/10,44.64%,CKLF;CCL5;EDNRB;EDN2;TAFA4;CXCL17;CCL3
prerank,membrane lipid biosynthetic process (GO:0046467),-0.29554508199296514,-1.04118903438345,0.39625850340136054,0.5735646094040691,1.0,29/58,40.34%,SGMS1;SPTLC2;ACER3;SPTSSA;GBGT1;PRKD3;KDSR;VAPB;SPHK2;SPTLC3;SAMD8;PLPP3;ELOVL5;DEGS2;CERS3;HACD4;VAPA;ST3GAL4;HACD3;ST8SIA6;ACER2;ALDH3B1;CERT1;CERS2;SPHK1;ELOVL1;PLPP2;PLPP1;SGPP1
prerank,regulation of protein acetylation (GO:1901983),-0.42619987987626884,-1.0410947635616719,0.40425531914893614,0.5734749985433362,1.0,4/12,20.29%,CEP295;TAOK1;DDX3X;GSK3B
prerank,triglyceride homeostasis (GO:0070328),-0.3500517093496315,-1.040731905527621,0.4027538726333907,0.5739104951044245,1.0,5/26,11.08%,APOE;IL18;LPL;APOC4;XBP1
prerank,regulation of cellular senescence (GO:2000772),-0.3454119089124,-1.0407119640751392,0.4024390243902439,0.5736428198738205,1.0,6/28,15.88%,CDK6;CGAS;B2M;NEK6;EEF1E1;ARG2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.40214184246181145,-1.040499872046604,0.38841567291311757,0.5737732003426148,1.0,4/15,23.38%,LILRB1;IRAK3;SMAD7;TGFB1
prerank,ATP transport (GO:0015867),-0.4576558419497023,-1.0397235609254134,0.41695501730103807,0.5750646324222696,1.0,5/10,25.46%,SLC25A24;SLC25A42;SLC25A4;CD47;SLC17A9
prerank,relaxation of cardiac muscle (GO:0055119),-0.41678105511678587,-1.039721006358223,0.40202702702702703,0.5747652976402546,1.0,5/13,19.57%,P2RX4;SLC8A1;CHGA;PIK3CA;PLN
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3356942720346049,-1.0397107068501108,0.398576512455516,0.5744833193867885,1.0,7/33,12.72%,RUNX1;PRMT2;AXIN1;CBFB;DDX5;KLK3;TRIM68
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.4473191631660307,-1.0397084255357385,0.4277673545966229,0.5741826452701487,1.0,5/11,25.68%,EXOSC5;TENT4B;EXOSC10;EXOSC4;LARP7
prerank,ethanol metabolic process (GO:0006067),0.42250142820111813,1.0395372235420182,0.4049382716049383,0.7074688204452849,1.0,4/12,25.40%,ACSS2;ALDH1A1;ACSS1;ALDH2
prerank,regulation of nervous system development (GO:0051960),0.3155885509438973,1.0388771164744353,0.38642297650130547,0.7080157445142616,1.0,13/37,17.50%,TENM4;PTN;YAP1;CX3CR1;PTPRZ1;GBX2;PER2;HES5;HES1;NPHP3;PRUNE1;HES3;DOCK7
prerank,aminoglycan metabolic process (GO:0006022),-0.45296277955655423,-1.0386978354569372,0.425,0.5760020431308658,1.0,4/10,12.23%,XYLT1;B4GALT7;CLN6;XYLT2
prerank,regulation of cellular localization (GO:0060341),0.3020934985390983,1.0385681344632889,0.40703517587939697,0.7076120122299049,1.0,17/46,20.91%,MAP2;EFNA5;EPHA5;ADCY5;TRIM46;NR1D1;GSN;BRSK1;WWC1;PRKN;CSNK1E;HSP90AA1;REEP5;GOSR1;PARD6A;FER;TTL
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3925275933850373,-1.0377617024754122,0.409683426443203,0.577680801595398,1.0,5/16,23.55%,PRPF39;SART1;CWC15;WBP11;RBM22
prerank,autophagosome maturation (GO:0097352),-0.336987561857485,-1.037598807021807,0.3946037099494098,0.5777078520904639,1.0,11/32,23.78%,TECPR1;UVRAG;LAMP2;TSG101;EPG5;LIX1;GABARAP;CLN3;VPS33A;VPS16;VMP1
prerank,modulation by host of symbiont process (GO:0051851),-0.335409311342683,-1.03746122550355,0.4088669950738916,0.577693042931932,1.0,11/31,28.56%,JUN;SAP30;NUCKS1;CCL5;TFAP4;TARDBP;LRRC19;INPP5K;EP300;AQP1;LEF1
prerank,positive regulation of transferase activity (GO:0051347),0.24670676448999562,1.037391948469613,0.3296398891966759,0.7095049347022555,1.0,34/142,16.23%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;CSF1R;MAGEC2;EPHB1;TIE1;MAP2K7;ALK;XRCC5;CD200;EPHA10;ROS1;CHTF8;LTK;FBXW7;TYRO3;RET;EPHB4;NAF1;DCUN1D2;BMI1;RPS2;IGF2;MAPKAPK5;HSP90AA1;CHRNA7;EPHB3;ERBB3;EPHA3;PNKP
prerank,arachidonic acid metabolic process (GO:0019369),-0.3275436693086109,-1.0368081071155684,0.38235294117647056,0.5787188992774117,1.0,10/35,29.82%,TBXAS1;DAGLB;CBR1;GPX4;PLA2G4A;CYP1B1;PNPLA8;ALOX15;CYP2S1;PTGES
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.46253729861794357,-1.0366439126299762,0.44858156028368795,0.5787427465275322,1.0,2/10,9.89%,TLR4;NCKAP1L
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.35615719772057175,-1.0365235862065618,0.41367521367521365,0.5786954380173042,1.0,9/26,17.89%,MCL1;BCL2;EYA4;PF4;MAP2K5;MAPK7;EYA1;HSPA1A;EYA3
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.4518821875099149,-1.0360211712582497,0.42418772563176893,0.5794699885629714,1.0,6/10,34.05%,BRCA1;SET;NOC2L;KLF15;CTBP1;THAP7
prerank,phospholipid dephosphorylation (GO:0046839),0.3200132919047677,1.035878376987317,0.37468354430379747,0.7121827466228869,1.0,5/37,3.12%,PLPP4;MTMR2;PLPPR1;PLPPR4;SYNJ2
prerank,ncRNA 3'-end processing (GO:0043628),-0.41181107650725945,-1.0349984349871488,0.4336917562724014,0.581304990844013,1.0,5/14,21.70%,INTS8;INTS6;INTS14;INTS5;ELAC2
prerank,cellular response to hormone stimulus (GO:0032870),0.28028932606779694,1.0344048020069618,0.39675174013921116,0.7148238288360036,1.0,9/69,7.67%,ROBO2;NCOA2;SLIT3;SLIT2;THRB;PAX8;WT1;RAMP3;ATP1A3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4293557250387241,-1.0341998100709584,0.42473118279569894,0.5827165101579503,1.0,7/12,23.67%,MDK;LCK;MIA3;ASS1;WNK1;FUT4;ADTRP
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.43465815371241384,1.0339874112546599,0.43301435406698563,0.7147264611347034,1.0,3/10,12.31%,NELL1;CDK5RAP3;ATRAID
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4168511337084738,1.0338986553682719,0.4095238095238095,0.7137391000410097,1.0,4/12,11.17%,PAX8;GDNF;SOX9;SMO
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3919823681738069,-1.0328776781457147,0.40106951871657753,0.5848764215181596,1.0,9/15,34.53%,AP3S1;AP3M1;DTNBP1;AP3B1;AP3D1;AP3B2;BLOC1S4;SNAPIN;BLOC1S2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3919823681738069,-1.0328776781457147,0.40106951871657753,0.5848764215181596,1.0,9/15,34.53%,AP3S1;AP3M1;DTNBP1;AP3B1;AP3D1;AP3B2;BLOC1S4;SNAPIN;BLOC1S2
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3016660689866373,-1.032769269219026,0.41480206540447506,0.584801963582486,1.0,14/50,15.01%,IGF1;GAB2;RHOA;OGT;IGF1R;PLCL2;PIK3CB;PIK3CG;PI4KB;PIK3CA;PLCB3;PIK3CD;PLCD1;PIK3C2A
prerank,protein lipidation (GO:0006497),-0.2979284590802799,-1.0327669254091845,0.39347079037800686,0.5844974239241987,1.0,19/59,27.21%,ATG5;ATG7;ATG10;DPM3;ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;PIGH;PGAP3;ZDHHC1;ZDHHC5;MPPE1;HHAT;ZDHHC13;GPLD1;ZDHHC6;PIGZ;PGAP2
prerank,regulation of peptidase activity (GO:0052547),-0.37766578277504176,-1.0326955970444707,0.4199655765920826,0.5843329176332414,1.0,11/19,42.04%,RCN3;CTSH;CST7;CST3;PSMB8;FURIN;ATP13A2;CAV1;ECM1;PSMA3;PINK1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.288386998043029,1.0324024283381894,0.3772609819121447,0.7165011243779417,1.0,12/52,16.11%,DPP10;SORBS1;PRKCE;RAMP3;GNAI1;PRKCI;NKD2;ARF6;STAC;ATP2B4;WNK3;EPHA3
prerank,transepithelial transport (GO:0070633),0.39331214147726395,1.0320385925240971,0.4017857142857143,0.7162166423253947,1.0,3/15,7.87%,SLC12A2;SLC1A2;SLC1A1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3956416388175691,-1.0315793464994385,0.4446397188049209,0.5864567238645302,1.0,6/16,22.39%,CHMP5;TMEM50A;CHMP7;LEPROTL1;CHMP4B;CHMP4A
prerank,cellular response to organic cyclic compound (GO:0071407),-0.25575315406044624,-1.0313707108089532,0.39057239057239057,0.5865743880160326,1.0,26/141,10.16%,DIAPH1;MSN;P2RX7;GNB1;RAP1B;SPIDR;P2RX4;FES;BRCA1;RAP1A;RIOK3;IL18;TFPI;ACTB;TIPARP;BLM;GNG2;AHR;CTNNB1;HRH1;EPG5;RAD51;MEF2C;UBE2L3;EGR1;TGM2
prerank,protein glycosylation (GO:0006486),-0.25939693967798916,-1.0312041568254544,0.3832528180354267,0.5866238041644501,1.0,42/125,23.91%,B4GALT5;TRAK1;TET3;ST3GAL1;ST8SIA4;MGAT5;OGT;GALNT7;MAN1C1;GALNT10;ALG5;COG7;FUT10;DPM3;GCNT2;POFUT1;GALNT1;ALG12;MPI;MAGT1;POMK;B3GNT2;B4GALT7;SERP1;POMGNT1;TET2;LARGE1;NPC1;PMM2;MGAT2;POMT1;ALG6;B4GALT1;MGAT4B;STT3B;GFPT1;GCNT4;GALNT6;FUT4;PLOD3;DDOST;B3GNT9
prerank,long-term memory (GO:0007616),0.3601443882736949,1.0310273872633493,0.4053398058252427,0.717679660062141,1.0,9/19,17.75%,RASGRF1;CAMK4;PRNP;NFATC4;CPEB3;PJA2;ARC;KAT2A;CALB1
prerank,sterol biosynthetic process (GO:0016126),0.3198084977895966,1.030843222355255,0.3976190476190476,0.7169872352276541,1.0,10/33,14.49%,HMGCS1;DHCR24;CYP51A1;INSIG1;SQLE;DHCR7;SC5D;EBP;MVK;LSS
prerank,snRNA metabolic process (GO:0016073),-0.3929091749476986,-1.0306843588850454,0.42363636363636364,0.5875025529802315,1.0,6/17,23.10%,INTS8;INTS11;INTS6;INTS1;INTS5;MTREX
prerank,glycerophospholipid catabolic process (GO:0046475),0.3391921076151601,1.0296366763830227,0.41346153846153844,0.7189818439072694,1.0,6/27,10.60%,ENPP2;ABHD16A;GDPD1;PLA2G4E;PLA2G10;ENPP6
prerank,cellular response to hexose stimulus (GO:0071331),-0.3578375785945823,-1.0290429690068092,0.39864864864864863,0.590740843922252,1.0,6/23,11.08%,ERN1;IGF1R;TRA2B;GAS6;ZBTB20;XBP1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.26905930983727055,1.0288923704688673,0.3870967741935484,0.7197100636930966,1.0,16/69,12.05%,PLCB1;PLCL1;NYAP2;MYO16;PIK3C2B;KCNH1;CSF1R;PLCH2;PLCE1;PLCZ1;PIRT;GPR143;EDN1;LTK;PLCD3;TYRO3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2764932254185849,-1.0288019567258924,0.40365448504983387,0.5909680812397143,1.0,19/86,18.25%,APOE;PLEK;RB1;RAC1;SNX9;FES;PTK2B;BAIAP2;NCKAP1L;WDR1;CDC42EP2;APP;DCTN1;BAIAP2L2;SLAIN2;STMN2;CDC42EP3;RPS3;HCK
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.37612898412717766,-1.0287186095100551,0.42226148409893993,0.5908111462526346,1.0,5/20,13.28%,AGO2;CNOT1;MOV10;CELF1;TNRC6C
prerank,primary alcohol metabolic process (GO:0034308),-0.3537926657129111,-1.0286622979940097,0.41872791519434627,0.5906161965135912,1.0,2/25,0.78%,IGF1;DHRS3
prerank,fat cell differentiation (GO:0045444),-0.29357885885189144,-1.028486131987342,0.40619621342512907,0.5906930925220661,1.0,4/57,3.16%,PID1;OSBPL8;METRNL;PPARG
prerank,histone H4 acetylation (GO:0043967),-0.30790090899497546,-1.028032099994774,0.4263959390862944,0.5914072853695665,1.0,11/47,18.54%,OGT;PHF20;KANSL2;MORF4L1;ZZZ3;WDR5;JADE2;KAT7;EPC1;KMT2A;TRIM16
prerank,chromatin organization (GO:0006325),-0.2553651644228973,-1.027660099314838,0.3827993254637437,0.5918700485403818,1.0,29/132,19.83%,RB1;BPTF;SMARCA5;SPI1;SMARCD3;SMARCC2;EZH2;JARID2;PWWP3A;ARID1A;HIRIP3;NUCKS1;HDAC10;BAZ2B;HP1BP3;BAZ1A;HMGB2;HDAC5;PADI4;SETDB1;DR1;INO80;HMGN1;RBBP4;LRWD1;INO80C;MYB;RSF1;KDM5B
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3813326147542292,-1.0276368390959494,0.4221824686940966,0.5916168352705533,1.0,5/19,18.95%,DCP2;TEN1;TENT4B;HNRNPA1;EXOSC10
prerank,negative regulation of locomotion (GO:0040013),0.417690104515118,1.0275949309689487,0.42660550458715596,0.7219591077547278,1.0,2/12,1.70%,SPOCK3;FRMD5
prerank,sympathetic nervous system development (GO:0048485),-0.39583009546859715,-1.0274309179635084,0.42434782608695654,0.591762107084626,1.0,3/15,7.15%,NRP1;NRP2;CTNNB1
prerank,chromatin assembly or disassembly (GO:0006333),-0.4320375211233116,-1.0269924176360594,0.4293286219081272,0.5923510401951478,1.0,5/11,27.38%,HIRIP3;CHAF1A;RBBP4;HDAC8;NOC2L
prerank,regulation of microtubule depolymerization (GO:0031114),0.34060046161789537,1.0269318874231599,0.38631346578366443,0.7224811655495896,1.0,4/25,5.53%,NAV3;MAP1B;CLASP2;APC2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4148123670643064,1.026864425505434,0.4412470023980815,0.7214472423060599,1.0,7/13,23.08%,SAR1B;BCAP31;TMEM30A;TM9SF4;CD81;SORL1;SEC16A
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.4006453350159343,-1.0264065450229074,0.421875,0.5932333601660481,1.0,4/15,9.94%,SLC27A1;NR1H2;C3;SIK1
prerank,cell junction organization (GO:0034330),0.2737351697467887,1.0259913765397548,0.3700234192037471,0.7224938645118455,1.0,12/71,8.85%,GRM5;CTNND2;PPFIA2;TJP1;SLC8A3;PAK3;SEMA3E;SDK1;PRKCI;SLC6A1;OCLN;SLC8A2
prerank,Wnt signaling pathway (GO:0016055),-0.270551183142615,-1.0258674002888177,0.3865546218487395,0.5940754509681692,1.0,30/92,28.56%,PLCG2;SNX3;RARG;AXIN1;LRP6;CTNNB1;WLS;UBC;RPS27A;STRN;VPS26A;TCF7;RYK;DDX3X;WNT3;GSK3B;SFRP1;CSNK1G3;ZRANB1;PLPP3;DVL2;USP34;CCDC88C;WNT7B;FZD1;FZD7;BCL9;WNT6;FRAT1;LEF1
prerank,positive regulation of transporter activity (GO:0032411),-0.41231263646005817,-1.0254370365231604,0.4317032040472175,0.5946371381332577,1.0,3/13,17.14%,SGK1;RXRA;KMT2A
prerank,positive regulation of myelination (GO:0031643),0.41897275600990835,1.0254090740222863,0.43478260869565216,0.7228225668413868,1.0,2/11,1.83%,TENM4;PARD3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.267608052823433,-1.0252350890643671,0.37603993344425957,0.5947778826142389,1.0,24/88,22.06%,APOE;DAPK1;GAPDH;DNAJC1;CNOT1;NFKB1;DAPK3;PUS7;EIF2AK2;PCIF1;DHX36;NCL;CST3;CLN3;TOB1;RPS3;DDX3X;CNOT8;DDX6;LSM14A;CDK5;RACK1;BAG6;SHMT1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3151887817563397,-1.0249115059609681,0.4013605442176871,0.5951803431347746,1.0,14/41,23.75%,CD44;PIEZO1;GCNT2;MDK;PLAUR;JAK1;LCK;CCL5;ADAM19;SMAD7;AGER;CD3E;PLPP3;CD47
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.35642546282095844,-1.024524291274503,0.41637010676156583,0.5957335042707623,1.0,8/23,13.83%,IGF1;NIBAN2;PIEZO1;MAML1;MAPK14;MEF2C;SMYD1;GREM1
prerank,mRNA metabolic process (GO:0016071),-0.27290041474577265,-1.0240305338382392,0.4033333333333333,0.5964975471977916,1.0,37/90,35.73%,ERN1;SON;RNASE4;SNRPG;SNRPF;DCP2;DDX5;PRPF8;PCBP2;NUDT21;CELF1;NCBP1;SF3A1;PRPF18;HSPA1A;LSM6;CPSF3;LSM5;SRSF11;NONO;AKAP8L;NUDT16;ZC3H12D;U2AF2;HIPK3;TBRG4;METTL3;SRSF7;SRSF5;HNRNPR;NUDT12;HSPA1B;ALKBH5;SF3B4;SNRPD3;KIN;SLFN14
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.33318203757340104,-1.0235797219416969,0.4088495575221239,0.5971798539161165,1.0,9/29,21.33%,DCP1A;PATL1;EXOSC5;DCP2;LSM6;CNOT8;DDX6;LSM5;EXOSC4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.42558341285486784,-1.0234347309024547,0.46619217081850534,0.5968706444290134,1.0,6/11,40.89%,CCT7;CCT4;LARP7;CCT8;CCT5;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.42558341285486784,-1.0234347309024547,0.46619217081850534,0.5968706444290134,1.0,6/11,40.89%,CCT7;CCT4;LARP7;CCT8;CCT5;MEPCE
prerank,hepaticobiliary system development (GO:0061008),-0.3717288004385589,-1.0233434168678992,0.4413309982486865,0.596767912624663,1.0,5/20,11.35%,ARID5B;NIPBL;CEBPG;XBP1;GFER
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3354224319556273,-1.023185735210774,0.4231433506044905,0.5967710623393677,1.0,9/29,20.02%,PLBD1;NR1H2;TMEM86B;PLA2G4A;PLAAT3;PLA2G6;PLA2G5;PLA2G12A;LPCAT3
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.3617044940193931,-1.023180971725693,0.43409490333919154,0.596469863237208,1.0,7/23,24.84%,REXO4;DNASE1L1;HMGB2;DFFA;ENDOG;HMGB1;DNASE2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.33437080067119784,-1.0230862706333526,0.4131944444444444,0.5963796664797131,1.0,11/30,25.39%,RNF31;USP36;UBE2L3;UBL5;SH3GLB1;HUWE1;PDCD5;BAP1;HPS4;SAE1;VPS11
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3509341977401489,-1.0229749966561186,0.4265232974910394,0.5962844426823094,1.0,9/25,23.38%,IGF1;RB1;NIBAN2;SIN3A;DOT1L;NSD1;GATA3;ZBTB7A;TGFB1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.4142234540607088,-1.0223908658046441,0.43716814159292033,0.5972180066300502,1.0,2/13,8.06%,ITGA4;MDK
prerank,striated muscle cell differentiation (GO:0051146),0.38034142686717676,1.0222851499334122,0.4072398190045249,0.7299369638260776,1.0,5/16,10.28%,NRG1;CBY1;SDC1;MYOCD;POPDC2
prerank,regulation of feeding behavior (GO:0060259),0.41121524049134717,1.0221106451367372,0.4246575342465753,0.7291482750810567,1.0,2/11,8.34%,SGIP1;LEPR
prerank,regulation of mitotic nuclear division (GO:0007088),-0.29127093052064074,-1.0218794685536654,0.4058219178082192,0.5980105753551499,1.0,16/55,21.45%,IGF1;INSR;CDK13;KIF20B;DAPK3;CD28;PIN1;MKI67;NUSAP1;AURKA;PDGFRB;RCC1;CHEK1;NME6;CDC25C;NUP62
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.33098077165023576,-1.0218644624325721,0.4339622641509434,0.597732520637325,1.0,16/33,26.84%,IGF1;PIK3R5;IGF1R;HTR2B;PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;GATA3;C1QBP;SIRT2;NYAP1;PIK3C2G;TPTE;ZFP36L1
prerank,negative regulation of JNK cascade (GO:0046329),-0.3353501473383362,-1.0218538281231453,0.4166666666666667,0.5974521985043844,1.0,6/31,11.64%,TAOK3;PTPN22;DUSP3;SIRPA;DNAJA1;AIDA
prerank,cellular response to inorganic substance (GO:0071241),0.3550184340134222,1.0215938018591637,0.4236111111111111,0.7293044156365655,1.0,4/21,8.11%,DDX11;KCNC2;GUCY1B1;FMR1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2967320395374061,-1.0208820490076718,0.4003322259136213,0.5991908172511271,1.0,13/50,23.02%,OGT;ARRB2;ARRB1;DNAJA1;SPRY2;PRMT3;ISG15;HSPA1A;SMAD7;RPS3;UBXN1;DTX3L;HDAC8
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.4368204265176579,-1.0198311816124332,0.4542372881355932,0.6011726625621077,1.0,7/10,43.29%,ACADM;ACAD11;ACADVL;ACADS;GCDH;IVD;ACADL
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.278253116415814,-1.0197424547415135,0.41233766233766234,0.6010517116792669,1.0,36/80,35.95%,BIRC3;MALT1;BRCA1;AXIN1;WFS1;LAPTM5;UBE2L3;PIN1;DERL1;DCUN1D4;ARRDC4;UBE3A;NSMCE3;TBC1D7;SMAD7;HUWE1;NDFIP2;KDM1A;TOPORS;UBE2N;CUL3;PTTG1IP;RIPK2;TRAF6;XIAP;BCL10;DCUN1D5;CAV1;HSPBP1;FANCI;STUB1;TSPYL5;MTA1;DCUN1D1;PEF1;KLHL40
prerank,neuron remodeling (GO:0016322),0.431029390524259,1.018907768029837,0.43902439024390244,0.7353415010311989,1.0,1/10,0.11%,ADGRB3
prerank,iron-sulfur cluster assembly (GO:0016226),-0.34957239012842534,-1.0188498925961533,0.4151260504201681,0.602604116648349,1.0,5/24,10.51%,ABCB7;HSCB;HSPA9;CIAO3;IBA57
prerank,aspartate family amino acid catabolic process (GO:0009068),0.37314141723221017,1.0187407190129065,0.42990654205607476,0.7345566766895208,1.0,10/19,28.02%,ASPA;GOT1;AASS;SDSL;ALDH7A1;SLC25A21;SDS;HYKK;DDO;GOT2
prerank,protein deneddylation (GO:0000338),-0.44967853737582697,-1.0186586146200678,0.4589041095890411,0.6026934299312988,1.0,5/10,20.89%,GPS1;COPS6;COPS5;COPS4;COPS8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.4030029251814684,1.0182559666273339,0.4330357142857143,0.7346307838076207,1.0,2/13,11.88%,SOX11;PER2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4512873424468558,-1.0181120943491053,0.45051194539249145,0.603537216727511,1.0,2/10,5.73%,ABCD2;NR1H2
prerank,activin receptor signaling pathway (GO:0032924),0.3817210381469762,1.0180301996914196,0.4256926952141058,0.7340051732028635,1.0,6/15,19.57%,ACVR1C;ACVR1;INHBB;INHBA;ACVR2B;AMHR2
prerank,protein insertion into membrane (GO:0051205),0.32040868329773176,1.017982849813724,0.39819004524886875,0.7329293878713353,1.0,8/32,9.60%,GET4;PRNP;RTP4;COX18;REEP1;CCDC47;UBE2J2;RTP2
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.42453741978154663,-1.01790359330019,0.45811051693404636,0.6036571426220809,1.0,5/12,24.92%,PRKCB;NEK6;CDK1;CCNB1;CCNB2
prerank,anion transmembrane transport (GO:0098656),-0.28425525723994743,-1.01738956602908,0.4231433506044905,0.6044327727983891,1.0,16/67,17.77%,LRRC8D;SLC16A7;MFSD12;SLC27A1;LRRC8C;SLC36A4;SFXN2;ABCC1;SLC25A42;SLC7A5;SFXN1;SLC25A4;SLC23A1;SLC23A2;SLC6A9;SLC6A8
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2703716511223086,-1.0169748990913696,0.40558292282430214,0.6050238638690292,1.0,14/88,10.21%,PTPRC;CORO1C;PAK2;RB1;PRKAG2;CEP85;DUSP3;LRP6;MVP;TRIB1;ITGB1BP1;SLC8A1;TRIB2;SPRED1
prerank,regulation of receptor internalization (GO:0002090),-0.3204311153672852,-1.0162310674671502,0.42151675485008816,0.6062961889585026,1.0,8/35,9.20%,SDCBP;RIN3;INSR;ARRB2;TBC1D5;ARRB1;VEGFA;CD63
prerank,positive regulation of exocytosis (GO:0045921),0.30475358067251646,1.0161922432256958,0.42206235011990406,0.7364429418368079,1.0,6/35,6.30%,CADPS;CADPS2;RAB15;CLASP2;RAB27B;SDC1
prerank,regulation of tube diameter (GO:0035296),-0.4160495335182509,-1.0160743197218396,0.4337979094076655,0.6059860253653785,1.0,6/13,34.06%,ROCK1;ITGB1BP1;ACE2;SCPEP1;ACE;ROCK2
prerank,vascular process in circulatory system (GO:0003018),-0.4160495335182509,-1.0160743197218396,0.4337979094076655,0.6059860253653785,1.0,6/13,34.06%,ROCK1;ITGB1BP1;ACE2;SCPEP1;ACE;ROCK2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.41317539142039456,-1.0157476897641249,0.45454545454545453,0.6063720723485004,1.0,4/13,10.48%,ITGB2;RHOA;MDK;RELA
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.37612115930604306,1.015697809493378,0.4428904428904429,0.7365333392356176,1.0,3/16,1.86%,AKAP6;ERBB4;ZFPM2
prerank,sodium ion import across plasma membrane (GO:0098719),0.38057752960166885,1.015518589031413,0.44341801385681295,0.7357895946225178,1.0,4/17,8.36%,SLC12A2;SLC9A2;HCN2;SLC6A1
prerank,collagen fibril organization (GO:0030199),0.2600330239449891,1.0154274246935981,0.4153846153846154,0.734844578290217,1.0,15/88,11.62%,P3H2;COL27A1;TLL1;DST;COL11A1;COLGALT2;COL25A1;PLOD2;COL4A3;COL23A1;COL19A1;CD151;TGFB2;BMP1;COL7A1
prerank,organic substance transport (GO:0071702),-0.25591989424886136,-1.015372817938193,0.41390205371248023,0.606840162370528,1.0,36/121,25.33%,ABCA1;ABCG1;PLTP;MYH9;RAB7A;MFSD12;ABCD2;TOM1;CENPF;RCN3;FLVCR1;TAP2;CHMP1A;HSP90B1;ARRDC4;MIA3;ABCA9;ARRDC1;CHMP2A;ABCA13;LMAN2L;SLC50A1;ABCD3;SLC23A1;RILP;SNX4;ABCA4;TXNIP;PPT1;SLC22A18;LRP2;ARRDC2;ATP8A1;CHMP2B;ABCA2;SLC22A3
prerank,negative regulation of protein depolymerization (GO:1901880),-0.35410030402711057,-1.0150297615364843,0.42778793418647165,0.6072621367409943,1.0,9/24,15.02%,ATXN7;ARHGEF2;LIMA1;TPX2;TAOK1;PIK3CA;CIB1;SPEF1;STMN2
prerank,dephosphorylation (GO:0016311),0.23979163693350733,1.014350546560452,0.3908355795148248,0.736552100678627,1.0,33/147,17.13%,PTPRD;PTPRG;PTPRN2;PLPP4;PTPRR;PTPRT;PPM1E;MTMR2;PLPPR1;PLPPR4;PXYLP1;PTPRK;PTPN3;ACP6;PPP2R1B;PTPRB;PTPRZ1;PPP2R2A;THTPA;CTDNEP1;MTMR7;DUSP4;DUSP10;DUSP18;PTPRS;PTPN4;PHPT1;PLPPR2;PNKP;DUSP8;THNSL2;PPM1G;CTDSP1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3857877365750091,-1.013546347293138,0.4471830985915493,0.6102582172473168,1.0,7/16,22.64%,TIMELESS;TICRR;TOPBP1;RAD9A;DNA2;TIPIN;CDC45
prerank,acylglycerol homeostasis (GO:0055090),-0.3659741043657472,-1.0133424560675646,0.43456375838926176,0.6104158730393642,1.0,4/20,10.56%,APOE;IL18;LPL;APOC4
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.346272385307818,-1.0130666893966236,0.43791946308724833,0.6106809517437392,1.0,6/24,10.11%,HPSE;BRCA1;C3;SULF2;HIF1A;ARNT
prerank,establishment of protein localization to membrane (GO:0090150),-0.28058746748322594,-1.0129149404288469,0.41989881956155145,0.6106845259024309,1.0,20/66,21.03%,RFTN1;SDCBP;SEC63;RAB3GAP1;NACA;ZDHHC7;ZDHHC2;NCF1;SYNE3;RAB11B;RAB10;ZDHHC12;NPC1;BID;TAOK2;ZDHHC1;GRIN3B;NACAD;RAB11A;GOLGA7
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.372908050965852,-1.0129115091055085,0.4411764705882353,0.6103751564484566,1.0,5/18,13.88%,AMFR;UBC;RPS27A;SEL1L;RNF185
prerank,skeletal system development (GO:0001501),-0.2475055997447938,-1.0123317613413372,0.4250814332247557,0.6112862609670844,1.0,19/148,11.57%,EXT1;CD44;AKAP13;XYLT1;SH3PXD2B;TRPS1;IGF1;ANKRD11;SLC10A7;ATP7A;PTGER4;PKDCC;DYM;CREB3L2;SULF2;TGFBR1;TGM2;PRELP;PRDX1
prerank,regulation of intracellular pH (GO:0051453),0.31134691631154016,1.0122650616170659,0.43317972350230416,0.7410132834358822,1.0,5/34,5.65%,SLC4A10;SLC4A4;SLC9A2;SLC26A3;CA2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4127527535560809,1.0122182154308292,0.4506024096385542,0.7387126768974952,1.0,4/12,13.71%,FHL2;PRNP;HOMER3;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4127527535560809,1.0122182154308292,0.4506024096385542,0.7387126768974952,1.0,4/12,13.71%,FHL2;PRNP;HOMER3;ATP2B4
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4142351190936534,-1.0119100296627077,0.4629948364888124,0.6118932872437084,1.0,7/13,28.57%,STX3;SNX33;HSP90AB1;STX4;GPD1L;TMEM35A;RANGRF
prerank,protein methylation (GO:0006479),-0.31348635943554226,-1.0116181828328346,0.4409171075837742,0.6121916515553788,1.0,9/40,15.15%,NSD3;GSPT1;PRMT2;EZH2;PRMT1;METTL22;PRMT3;PRMT6;NSD1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.4213114263593109,-1.0113882549608195,0.47442680776014107,0.6123591126494485,1.0,6/12,30.89%,SLC37A1;XPR1;SLC20A2;SLC25A10;SLC37A2;SLC20A1
prerank,lamellipodium organization (GO:0097581),0.32613417954185026,1.01095273644398,0.4405594405594406,0.7408145315022538,1.0,6/29,5.06%,ARHGEF7;CDH13;WASF1;P2RY12;CARMIL1;ABLIM1
prerank,negative regulation of cellular component movement (GO:0051271),-0.4000713925411409,-1.0109196540913439,0.44680851063829785,0.6130428546319621,1.0,9/15,25.27%,SP100;CD9;PIN1;CCDC125;CRK;GATA3;PKHD1;ACTN1;SPINT2
prerank,negative regulation of potassium ion transport (GO:0043267),-0.40809449719266233,-1.0108125668961045,0.4547069271758437,0.6129582341803009,1.0,3/13,10.66%,PTK2B;CAB39;NEDD4L
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.34961302307528286,-1.0107406226234792,0.44020797227036396,0.6127987365513783,1.0,7/24,13.84%,CENPJ;IL10RB;PIBF1;PTK2B;CRLF3;CCL5;OCIAD2
prerank,cartilage development (GO:0051216),-0.29612318216768385,-1.0107194676695417,0.4397283531409168,0.6125311061567451,1.0,9/49,11.44%,CD44;RUNX1;RUNX3;ATP7A;RUNX2;CREB3L2;SULF2;MEF2C;OSR1
prerank,negative regulation of immune system process (GO:0002683),-0.3900598523722739,-1.010563702965471,0.4631578947368421,0.6125771415284509,1.0,6/16,28.75%,LYN;FCGR2B;HMOX1;ADTRP;FCRLB;SPINK5
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4383748875351007,-1.0105083949403872,0.4740740740740741,0.6123753107279191,1.0,3/10,11.88%,PRKCD;CD9;ADAMTS18
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.4328188985703154,-1.0105074035746593,0.4494949494949495,0.6120668126628345,1.0,3/10,10.38%,XDH;PIK3CB;SPRY2
prerank,regulation of signal transduction (GO:0009966),-0.24207877511562526,-1.0103511613743072,0.4186046511627907,0.612092278625922,1.0,33/190,12.21%,MDFIC;RUNX1;SP100;DHRS3;CD36;SNX3;CREBBP;OGT;ELF1;IRAK2;RASGRP4;FBXL17;GRK3;AMFR;CDC42SE2;RGS3;AXIN1;RIC8B;GRK5;POFUT1;ZDHHC7;RGS11;CBFB;ITGB1BP1;CD63;NUCKS1;APP;CRK;RGS12;RFNG;ITGA3;CD46;IGFBP3
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3211667714354729,-1.0101182426341389,0.44966442953020136,0.6122810048511252,1.0,9/35,12.79%,CBL;RAC1;PIK3CB;C3;PICALM;HIP1;B2M;RAB21;SERPINE1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.39814266779445645,1.0096208579456216,0.4361948955916473,0.7431330858817543,1.0,6/13,19.15%,GRIN2A;TBC1D10A;LGMN;CIDEB;PERP;FADD
prerank,positive regulation of nuclear division (GO:0051785),-0.34458704994896344,-1.0081699407849074,0.4427767354596623,0.616090139163703,1.0,8/25,21.45%,IGF1;INSR;CD28;NUSAP1;AURKA;PDGFRB;SIRT2;NUP62
prerank,positive regulation of cellular component movement (GO:0051272),-0.3544043651566263,-1.007952608125321,0.4597902097902098,0.6162182964139187,1.0,5/24,13.93%,LYN;VEGFA;TGFBR1;STK11;CFAP20
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4150826624951174,-1.0079032493661846,0.4610169491525424,0.6160008094767722,1.0,3/12,3.82%,IGF1;INSR;DYRK2
prerank,glycoprotein biosynthetic process (GO:0009101),-0.27107097154627285,-1.0071429079967615,0.4536256323777403,0.6173385078584683,1.0,18/79,15.20%,B4GALT5;XYLT1;IGF1;ST8SIA4;ALG5;COG7;ATP7A;FUT10;CHST12;GCNT2;CHST11;MPI;B3GNT2;B4GALT7;SERP1;GCNT1;LARGE1;NPC1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.43267331820949617,-1.0066585040319194,0.443859649122807,0.6180672111655798,1.0,4/10,27.60%,CREBBP;KAT7;BAG6;EP300
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3574983297029438,-1.0063744912681287,0.4379310344827586,0.6183750534238837,1.0,7/23,13.84%,MGAT5;CENPJ;IL10RB;CRLF3;IL7R;CCL5;OCIAD2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2306093426486577,-1.0061065758231802,0.4317817014446228,0.61864065541039,1.0,83/248,28.61%,DAB2;APOE;ZEB2;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;NFKB1;HHEX;CCNY;USP8;DAPK3;PSMB9;STK3;BICC1;AXIN1;LRP6;CTNNB1;TBL1XR1;PPM1B;LRRK1;PPP1CA;SDHAF2;MDK;WLS;CDK14;TLE3;PSMA8;OTULIN;PIN1;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;TNKS2;GREM1;PSMA1;UBAC2;LATS2;TLE4;PSMB8;GPRC5B;JRK;PTPRO;PLEKHA4;DDX3X;RSPO1;PSMA5;PSMD4;TMEM198;PSMB3;WNK1;GSK3B;PSMD3;SFRP1;JUP;CSNK1G3;SMURF2;SNAI2;ILK;SOX7;TGFB1;DVL2;PSMB1;TMEM170B;USP34;CCDC88C;SIAH2;BMP2;FZD7;VCP;CUL3;TMEM131L;FRMD8;TLE2;FRAT1;PSMA7;NOTUM;DKK3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3275976632990554,-1.005637259426994,0.43471074380165287,0.6193381949614822,1.0,9/31,22.72%,BCL2;E2F1;YWHAE;BBC3;BID;CASP8;GSK3B;SFN;NMT1
prerank,negative regulation of catalytic activity (GO:0043086),-0.35273674361440266,-1.0055724876219296,0.44082332761578047,0.619172303226123,1.0,9/24,25.75%,PARP9;NES;IFIT1;PPP1R12A;CLN3;APBA3;PLN;HP;MT3
prerank,regulation of lipid kinase activity (GO:0043550),-0.42697532295854423,-1.005435412211104,0.4625,0.6191584171393899,1.0,4/11,25.80%,RB1;WDR91;PPP2R5A;RBL2
prerank,regulation of steroid metabolic process (GO:0019218),-0.3507096886516525,-1.0053413064104577,0.4395017793594306,0.6190677277646845,1.0,16/23,36.57%,APOE;ABCG1;PANK2;TTC39B;FMO5;ASAH1;NR1H4;ACADVL;ABCA2;LAMTOR1;UGT1A8;UGT1A1;STUB1;ARV1;DGKQ;GNB3
prerank,snRNA 3'-end processing (GO:0034472),-0.3639824935266822,-1.0048150753996465,0.44765342960288806,0.6199028416977665,1.0,11/19,33.87%,INTS8;EXOSC5;INTS6;INTS14;INTS1;INTS5;EXOSC4;EXOSC8;TUT1;USB1;EXOSC3
prerank,negative regulation of cell division (GO:0051782),-0.43360320983929207,-1.0044704189304137,0.4680483592400691,0.6203378158980393,1.0,9/11,40.18%,BLM;E2F8;TXNIP;VPS4A;ZFYVE19;MYC;ORC6;SUSD2;AURKB
prerank,positive regulation of dephosphorylation (GO:0035306),0.3309927518422706,1.0044560071202522,0.44549763033175355,0.755593548351331,1.0,13/27,21.40%,CAMTA1;DLC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;MTMR9;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.330584300073388,-1.004427727235296,0.448566610455312,0.6201169627552164,1.0,4/30,6.76%,AKAP13;RAC1;ARHGEF3;ARRB1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.37453657139034147,-1.0043568520785329,0.4479338842975207,0.6199511802946395,1.0,3/18,10.66%,SLC43A2;CAB39;NEDD4L
prerank,negative regulation of ion transport (GO:0043271),0.3404481337778789,1.0039804682368814,0.44567627494456763,0.7556470948564715,1.0,11/24,20.44%,GPM6B;HRH3;CASQ2;NEDD4;SYT11;HTR1B;WNK4;WNK3;SNCA;WNK2;CD33
prerank,protein maturation (GO:0051604),0.25754047091456533,1.003978909303177,0.44235924932975873,0.7544308756598379,1.0,20/95,15.81%,METAP2;PCSK5;MMP16;PCSK2;TESC;MME;ECE2;PCSK6;CIAO1;NAA10;MMEL1;PCSK1;EEF1AKMT4-ECE2;NDUFAB1;CPE;NAA60;LIPT2;ECE1;TASP1;ADAM17
prerank,bile acid biosynthetic process (GO:0006699),0.3379346647486506,1.0037740979083456,0.4182692307692308,0.7537884380231246,1.0,10/24,15.12%,OSBPL6;SLC27A2;OSBPL7;ACOX2;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1
prerank,glucose metabolic process (GO:0006006),0.28299760607468033,1.0037356976928802,0.45742092457420924,0.7526624247900116,1.0,13/58,14.31%,OMA1;PFKFB1;GOT1;APOD;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;HECTD4;PPARGC1A
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.28816099104976073,-1.0034925217178932,0.43617021276595747,0.6215279741254213,1.0,20/54,27.38%,RPL7;RPL11;RPL10A;NVL;RPL14;RPL6;PAK1IP1;SURF6;RPL23A;GTF3A;NIP7;RPLP0;BRIX1;SNU13;RPL7A;WDR12;NHP2;RPL5;EIF6;NOC2L
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.36960546443407116,1.0034569561697113,0.4492099322799097,0.7521912053987987,1.0,6/18,20.95%,ELOVL7;HACD1;ACSL3;ACSL6;ELOVL6;ELOVL2
prerank,smoothened signaling pathway (GO:0007224),0.31495023289601437,1.003444061894965,0.4410377358490566,0.7510131609390923,1.0,15/32,28.54%,PTCH2;TMEM231;EVC2;ARL13B;SMO;HES5;GLI3;GLI2;ULK3;DISP3;CC2D2A;DISP2;B9D1;HIPK2;PTCH1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4392971861444292,-1.0030263600507971,0.4484536082474227,0.6219155229989438,1.0,4/10,26.88%,MYLIP;AP2A2;AP2S1;AP2A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4392971861444292,-1.0030263600507971,0.4484536082474227,0.6219155229989438,1.0,4/10,26.88%,MYLIP;AP2A2;AP2S1;AP2A1
prerank,telomere maintenance via telomerase (GO:0007004),-0.3340954854433102,-1.0030206708780225,0.4497354497354497,0.6216123254350356,1.0,9/28,26.01%,RFC1;RTEL1;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53;NHP2;MRE11
prerank,lipid droplet formation (GO:0140042),0.4286004420941608,1.002831624822673,0.42369020501138954,0.7513878564545725,1.0,3/10,19.25%,SQLE;ZFYVE1;CDS1
prerank,positive regulation of protein maturation (GO:1903319),-0.4188046819339537,-1.0026870331629583,0.4740484429065744,0.6219727894586852,1.0,5/11,33.96%,NLRC4;ADAM8;CCBE1;RHBDD1;TFR2
prerank,cilium movement (GO:0003341),0.292124063283833,1.0016187766946503,0.43935926773455375,0.7534099221956259,1.0,20/48,27.63%,DNAI4;ODAD3;CFAP91;DNAH17;DNAAF4;CFAP73;GAS8;ZBBX;DNAH5;DNHD1;CFAP53;DNAAF5;DNAH1;SPEF2;CAMSAP3;CFAP206;CABYR;DNAH9;RSPH4A;CFAP100
prerank,endocrine system development (GO:0035270),0.349527628063676,1.001365108262046,0.48711943793911006,0.7528675607644262,1.0,5/21,10.61%,PAX8;WT1;HOXD3;SALL1;TBX1
prerank,smooth muscle tissue development (GO:0048745),0.4224165428581319,1.0009743384252916,0.46187363834422657,0.7527318662614758,1.0,5/10,28.54%,SMO;MYLK;EFEMP2;NF1;PTCH1
prerank,purine-containing compound salvage (GO:0043101),-0.4181016589147599,-1.0005797847913815,0.47368421052631576,0.6262234112620397,1.0,6/12,30.35%,HPRT1;DCK;DGUOK;PNP;ADA;GMPR2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3784581768160845,-1.0003829261944925,0.43316412859560066,0.626334005805712,1.0,5/17,21.76%,BCL2;FIS1;BBC3;BID;SFN
prerank,pre-miRNA processing (GO:0031054),-0.4028638491441655,-1.0003284886751214,0.4963898916967509,0.6261508673024304,1.0,2/14,3.76%,AGO2;TUT7
prerank,regulation of fibrinolysis (GO:0051917),-0.40926701352405187,-1.0001701927288318,0.48771929824561405,0.6261583919358538,1.0,6/13,35.96%,FAP;SERPINE1;APOH;F11;F12;HRG
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.32876237468322106,-1.0000919036334008,0.4584717607973422,0.6260090131261027,1.0,8/33,18.14%,CDK6;RB1;BRD7;PRMT2;PLK3;WEE1;CDKN2C;CDK2AP2
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.31533015433679834,-0.9999173549596827,0.4629948364888124,0.626068047332029,1.0,7/38,12.70%,BANK1;XDH;PTPRJ;ARRB2;PIK3CB;FLCN;CIB1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3924309406322565,-0.9993693965471869,0.4648370497427101,0.626954700836627,1.0,4/15,22.73%,APOE;APP;LDLR;CRYAB
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.3048769700280626,-0.9992006834207269,0.44851657940663175,0.6269810029475037,1.0,16/42,33.98%,RARS1;FARS2;SARS1;CARS2;DARS1;EEF1E1;KARS1;TARS2;AARS1;DARS2;IARS1;EARS2;TARS3;WARS2;VARS2;RARS2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2414781489369306,-0.9990291063846812,0.4645161290322581,0.6270536961346973,1.0,51/161,28.61%,DAB2;APOE;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;PSMB9;STK3;BICC1;AXIN1;LRP6;SDHAF2;MDK;TLE3;PSMA8;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;GREM1;PSMA1;UBAC2;LATS2;TLE4;PSMB8;PTPRO;PSMA5;PSMD4;PSMB3;GSK3B;PSMD3;SFRP1;SNAI2;TNN;DVL2;PSMB1;TMEM170B;CCDC88C;SIAH2;BMP2;CUL3;TMEM131L;FRMD8;TLE2;PSMA7;NOTUM;DKK3
prerank,regulation of response to stress (GO:0080134),0.427294618624539,0.9988230554952279,0.4412470023980815,0.757309023434285,1.0,4/10,20.27%,ADCY8;DYRK3;OPRM1;STOX1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.40150336397980546,0.9984850996951699,0.47045951859956237,0.7557539616399741,1.0,2/12,2.18%,AKAP6;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.40150336397980546,0.9984850996951699,0.47045951859956237,0.7557539616399741,1.0,2/12,2.18%,AKAP6;CAMTA1
prerank,positive regulation of protein modification process (GO:0031401),-0.23278093785188028,-0.9984246495490411,0.4478330658105939,0.6280071874939062,1.0,37/203,16.02%,LYN;DAB2;CD74;NIBAN1;PRKCD;RAC1;INSR;RAP2A;RIPK1;CEP295;ATG7;CCND3;ATG10;RAB3GAP1;AXIN1;HGF;C3;ARRB1;GAS6;CAMKK2;VEGFA;FNIP1;PLAUR;TAOK1;PIN1;APP;FLCN;DYRK1A;WDFY2;CIB1;ACVR2A;RB1CC1;CD40;IL34;CRKL;MAVS;ANKLE2
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.43839615106305335,-0.9983508664627382,0.47755834829443444,0.6278567136665041,1.0,5/10,33.64%,NFE2L2;QRICH1;EIF2AK3;ATF4;EIF2S1
prerank,positive regulation of vasculature development (GO:1904018),-0.26412498473057255,-0.9981930512222621,0.4916387959866221,0.6278794220634688,1.0,27/94,23.76%,SASH1;RUNX1;PRKCB;AGO2;BRCA1;FLT1;ITGB1;GRN;VEGFA;HIF1A;CTSH;ITGAX;XBP1;SERPINE1;PIK3CD;CD40;BTG1;HSPB1;AGGF1;ZC3H12A;JUP;KDR;FGF18;APLNR;MTDH;HMOX1;CYP1B1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.30525581576132294,-0.9979959259821373,0.4743362831858407,0.6279990805735726,1.0,9/45,11.79%,IQGAP1;GRB2;CBL;PTK2B;KIF16B;DGKD;ERBIN;REPS2;PIK3CA
prerank,C4-dicarboxylate transport (GO:0015740),0.3885006520864789,0.9979825246425271,0.45794392523364486,0.7558859825480594,1.0,5/14,11.27%,SLC1A2;SLC1A6;SLC1A1;SLC13A5;SLC25A11
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.39530498615314397,0.9978763509013457,0.47619047619047616,0.7549643840938316,1.0,6/12,19.25%,HUS1B;CLSPN;STK33;SETMAR;CHEK2;NAE1
prerank,ameboidal-type cell migration (GO:0001667),0.28109741207591754,0.9975260537939648,0.4515366430260047,0.75472691815535,1.0,15/51,16.05%,ERBB4;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;CCN3;SRGAP2;SEMA3F;TBX1;SEMA5B;AMOTL1;SEMA4G;RADIL;NRTN
prerank,regulation of neuroblast proliferation (GO:1902692),0.37768658449772635,0.9975019132116764,0.4363207547169811,0.7536002998388552,1.0,3/15,8.43%,TAFA1;PTN;CX3CR1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3918335611011915,-0.9974386178982271,0.44727272727272727,0.6288736417237731,1.0,8/15,26.84%,ATF3;DHX36;MKNK2;HNRNPA1;DDX3X;ZC3H12A;GSTO1;VCP
prerank,negative regulation of neuron death (GO:1901215),-0.2638573966329406,-0.9973871698399696,0.4619124797406807,0.6286539267942421,1.0,28/93,22.39%,APOE;TNFRSF1B;SNX6;PTK2B;BCL2;GRN;WFS1;MDK;MEF2C;ADAM8;INPP5A;CHGA;KIF14;RETREG1;TRAF2;RASA1;EIF4G1;CLN3;FBXO7;CSF1;NDNF;GSK3B;CPEB4;PPT1;CDK5;SET;CHMP4B;CHMP4A
prerank,neuron projection regeneration (GO:0031102),0.41838513407617,0.9973403589536692,0.4547677261613692,0.7528072494500406,1.0,4/10,14.87%,PTN;RTN4RL1;DHFR;FOLR1
prerank,calcium-mediated signaling (GO:0019722),0.2542762979305683,0.9969084461682539,0.4336734693877551,0.7528161427690118,1.0,15/93,10.56%,GRM5;ANK2;CACNA1C;RYR2;CHRM3;RCAN2;P2RY12;VCAM1;PRNP;PLCE1;CX3CR1;GPR143;AGTR1;EDN1;ATP1B1
prerank,establishment of vesicle localization (GO:0051650),0.3599537200440381,0.9968968414357903,0.4569377990430622,0.7516630474996603,1.0,5/18,9.01%,KIF5C;KIF5A;TOR1A;SYT11;F8A1
prerank,aggrephagy (GO:0035973),-0.33877975383094244,-0.9965745998291303,0.4702886247877759,0.6300854340028149,1.0,8/27,16.91%,VIM;ATG5;WDFY3;DYNC1H1;UBC;RPS27A;DYNC1LI2;PCNT
prerank,response to organonitrogen compound (GO:0010243),-0.3146042993242059,-0.9964491343518301,0.4723127035830619,0.6300397829076833,1.0,14/38,26.84%,KYNU;IRF5;IRAK3;RCN3;DERL1;SEL1L;UBXN6;KAT7;RNF185;ERLEC1;NR1H4;IL6;HLCS;VCP
prerank,protein O-linked glycosylation (GO:0006493),-0.26091378751334404,-0.9962602431864148,0.4551386623164764,0.6301340368125398,1.0,22/96,14.55%,B4GALT5;TRAK1;TET3;ST3GAL1;OGT;GALNT7;GALNT10;DPM3;GALNT3;POFUT1;GALNT1;XXYLT1;ST6GAL1;C1GALT1;POMK;B3GNT2;GXYLT1;GALNT12;POMGNT1;GCNT1;TET2;LARGE1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3220875530195359,0.996034127601684,0.4576659038901602,0.7527422559151201,1.0,11/28,17.93%,ADCY8;PTN;SHANK3;NSG1;ADCY1;RELN;ARC;LGMN;CHRNA7;CALB1;FAM107A
prerank,lamellipodium assembly (GO:0030032),0.3244959029758116,0.9958332707167719,0.4250559284116331,0.752053275324425,1.0,6/26,8.93%,ARHGEF7;CDH13;P2RY12;CARMIL1;ABLIM1;SRGAP2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.34714214342233346,-0.9952153604508337,0.4603448275862069,0.6320817964102559,1.0,8/24,19.35%,IRAK2;TAB2;NOD1;UBC;RPS27A;RNF34;CASP8;NOD2
prerank,positive regulation of axon extension (GO:0045773),-0.35556116114540154,-0.9949266269079031,0.4810126582278481,0.6323565135119495,1.0,5/22,7.83%,NRP1;GOLGA4;RUFY3;MACF1;VEGFA
prerank,autophagosome organization (GO:1905037),-0.2949942656437836,-0.994892429147799,0.4571917808219178,0.6321141885863688,1.0,14/50,24.94%,RAB7A;ATG5;PACS2;ATG7;RAB1A;ULK2;RB1CC1;GABARAP;ATG16L2;EMC6;BECN1;VMP1;RAB19;RAB1B
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2833415356929631,-0.994874378942798,0.4704918032786885,0.631835826138826,1.0,17/57,24.50%,BCL2L11;DDHD1;CAMKK2;PLAUR;FIS1;MLLT11;BBC3;BID;TNFSF10;AURKA;FBXO7;PDCD5;GSK3B;KDR;BIK;ZDHHC6;DCN
prerank,endoderm development (GO:0007492),-0.40218825562923466,-0.9947472913841033,0.4794520547945205,0.6317802216486322,1.0,7/13,38.50%,KIF16B;DUSP5;SOX7;DUSP2;DUSP1;EOMES;SOX17
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3557665838320565,-0.9946603371098455,0.4702886247877759,0.631636830028578,1.0,8/22,27.74%,RPS20;DDX5;SPRED1;SPRED2;EEF1E1;ATM;RPS15;PLA2R1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.32982119249670827,-0.994639255724082,0.45183887915936954,0.6313787671675438,1.0,9/29,26.01%,RFC1;RTEL1;PPP6R3;HSP90AB1;GAR1;SHQ1;WRAP53;NHP2;MRE11
prerank,amino acid import across plasma membrane (GO:0089718),0.3373010012638861,0.9943694778305132,0.4423529411764706,0.7547750986850043,1.0,7/24,16.73%,SLC1A2;SLC1A6;SLC47A1;SLC1A1;SLC6A13;SLC16A2;SLC6A5
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3383515460278564,0.994112298788539,0.4551569506726457,0.7542716069194209,1.0,5/23,13.02%,SLC12A2;SLC12A8;SLC12A1;SLC12A5;CLCN3
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.3523135230754273,-0.9941116939126743,0.4875886524822695,0.6321899780462136,1.0,9/21,37.34%,PPARD;AGXT;ACOX1;CYP26C1;PLA2G15;HOGA1;LPIN3;FAH;HAO1
prerank,regulation of epithelial cell migration (GO:0010632),-0.2898514192183753,-0.9939343468212168,0.4543859649122807,0.6322710891461735,1.0,9/51,9.44%,SASH1;CORO1C;RREB1;PLCG2;ADIPOR1;MACF1;DOCK5;HIF1A;CTSH
prerank,eye photoreceptor cell differentiation (GO:0001754),0.39788434782550197,0.9935347575388151,0.4557823129251701,0.7546401128588422,1.0,2/12,2.34%,DSCAM;RORB
prerank,cellular protein-containing complex assembly (GO:0034622),-0.24011396086710599,-0.9934486799477484,0.4881889763779528,0.6329890925167357,1.0,53/160,27.25%,TCF4;CYBA;SNX9;IMMP2L;UVRAG;DHX9;CENPF;DLGAP5;CENPA;AXIN1;FCHO2;PICALM;HIGD2A;EPS15;HIP1;CENPE;CCDC40;NUP205;DNAJB14;TPR;TBCE;HSP90AB1;TRAF2;GPX4;CHMP2A;HSPA4;PIK3C2A;POGZ;VAMP4;SHQ1;TESPA1;FMOD;HSPA1A;POMP;NUP153;COX7A2;ADRB2;VAMP1;PSMD4;NUP107;CD3E;CHMP4B;CHMP4A;EID2;TGFB1;COG4;TMEM35A;AP2S1;DNAAF1;NCK1;SMAD4;BBS10;HIGD1A
prerank,macromolecule catabolic process (GO:0009057),-0.33466394034423713,-0.9933340020060248,0.4664371772805508,0.6329134731646413,1.0,12/26,26.69%,UVRAG;KIF16B;SNX25;CLN6;TRIM24;SH3GLB1;TPP1;PPT1;BECN1;TGFB1;LRSAM1;SMURF1
prerank,neural crest cell migration (GO:0001755),0.30243894419420647,0.9932580926215272,0.4497716894977169,0.7542470337295976,1.0,13/36,16.05%,ERBB4;SEMA6D;SEMA6A;SEMA3E;SEMA5A;GDNF;SEMA3F;TBX1;SEMA5B;FOLR1;SEMA4G;RADIL;NRTN
prerank,positive regulation of kinase activity (GO:0033674),-0.2523224549551063,-0.9929313113665327,0.45454545454545453,0.6334387475543726,1.0,15/107,8.35%,IQGAP1;PTPRC;CD74;AXL;SNX9;INSR;IGF1R;PRKAG2;RAP1A;TAB2;FLT1;PTK2B;GAS6;ALS2;CENPE
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.35780370849002224,0.9927895169543858,0.4572127139364303,0.7542932086467574,1.0,4/19,10.73%,ROBO1;SEMA6A;TSPAN12;SMOC2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.30428595121321583,-0.992521504314658,0.4957698815566836,0.6340308380658222,1.0,17/40,33.14%,MCL1;PRKCD;ARMT1;SMYD2;RFWD3;WDR76;RADX;KMT5A;FEM1B;SMG1;UBE2V2;MYC;UBE2N;USP51;PARG;ANKLE1;NEK4
prerank,sarcomere organization (GO:0045214),0.3255680301527874,0.9921292778478419,0.45045045045045046,0.7548432353931178,1.0,6/27,17.04%,CSRP1;TNNT2;TTN;CAPN3;FHOD3;TPM1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3938649752469798,-0.9918578133515097,0.4822934232715008,0.6351956443100961,1.0,4/14,19.20%,KMT5B;KMT5C;CD226;SHLD2
prerank,carnitine metabolic process (GO:0009437),-0.4123326591939791,-0.9912523345161247,0.4956217162872154,0.636198460728777,1.0,4/12,22.06%,CPT1A;ACADM;TMLHE;SHMT1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.306997075985478,-0.9906942197165274,0.46928327645051193,0.6370535863760582,1.0,14/40,20.66%,ROCK1;SNX3;FLNA;CTSA;IRAK3;AZIN1;TIMP2;SF3B3;PIN1;CST3;SNRNP70;RILP;MDM4;SIRT2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.23439041446686348,-0.9902737555212925,0.495114006514658,0.637643328777567,1.0,58/186,28.61%,DAB2;APOE;RNF213;LRP1;ZNRF3;DKK2;PSME4;AMFR;PSMB7;PSME3;PSMB9;STK3;BICC1;AXIN1;MDFI;LRP6;SDHAF2;MDK;TLE3;PSMA8;PSMC3;PSMD8;STK11;CHD8;PSMC4;PSMB10;GREM1;PSMA1;UBAC2;RNF43;LATS2;TLE4;PSMB8;NFATC1;PTPRO;PSMA5;PSMD4;PSMB3;GSK3B;PSMD3;SFRP1;RACK1;SNAI2;DVL2;PSMB1;TMEM170B;CCDC88C;SIAH2;BMP2;CUL3;TMEM131L;TSC2;FRMD8;TLE2;PSMA7;NOTUM;SHISA2;DKK3
prerank,tRNA aminoacylation (GO:0043039),-0.3077418360801352,-0.989984846646607,0.47750865051903113,0.6379467091196014,1.0,9/37,23.67%,RARS1;FARS2;SARS1;DARS1;EEF1E1;KARS1;AARS1;DARS2;IARS1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3241111598275055,-0.9895902003662469,0.46397188049209137,0.6384780558052623,1.0,13/29,28.56%,CREBBP;CTNNB1;TLE3;KMT2D;TCF7;TLE4;MYC;RBBP5;ASH2L;BCL9;EP300;TLE2;LEF1
prerank,cellular response to drug (GO:0035690),0.32598832204546635,0.9892356283593945,0.4580498866213152,0.7611410866800048,1.0,2/25,1.60%,PDE4B;PPM1E
prerank,central nervous system neuron development (GO:0021954),0.36800898330333354,0.9890032664161221,0.4563106796116505,0.7606189216864059,1.0,2/15,1.99%,MAP2;NTRK2
prerank,regulation of neuron apoptotic process (GO:0043523),0.24753055066348303,0.9887632056355795,0.4794871794871795,0.7600113061383578,1.0,21/96,14.45%,GRID2;TRIM2;NTRK2;EPHA7;GDNF;PRKCI;PRNP;BDNF;PTPRZ1;TFAP2A;NFATC4;FOXQ1;CITED1;TOX3;TGFB2;CDK5R1;TYRO3;VSTM2L;PRKN;PPARGC1A;LGMN
prerank,organelle transport along microtubule (GO:0072384),-0.31798771484588534,-0.9884341999096343,0.4694915254237288,0.6406944067181739,1.0,11/31,21.15%,TRAK1;PEX14;CDC42;RAB1A;FBXW11;LRPPRC;MAP1S;CLN3;UXT;PAFAH1B1;BORCS5
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.36561889797755875,-0.9873462103801793,0.47920133111480867,0.6427165032823504,1.0,7/18,32.98%,BCL2L11;ANXA1;UBE2L3;NR3C1;ZFP36L1;AQP1;PCK2
prerank,negative regulation of cell projection organization (GO:0031345),0.28337556905156974,0.9864699263670339,0.46634615384615385,0.7648790706127346,1.0,10/48,13.71%,SPOCK1;GRIN2B;DCC;PRNP;FYN;KANK1;TSKU;DPYSL3;RTN4RL1;PTPRS
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.3305297011714267,-0.9862057205400739,0.4625,0.6448487405269717,1.0,13/27,30.07%,ERN1;RNASE4;KHNYN;RNASE6;NYNRIN;CPSF3;ZC3H12A;NHP2;NUDT16;ZC3H12D;LACTB2;ZC3H12C;POP1
prerank,regulation of microtubule-based process (GO:0032886),-0.3058033847283776,-0.9861738958794188,0.48217317487266553,0.644592899383649,1.0,11/36,20.29%,DIAPH1;ROCK1;MACF1;TAOK1;MARK2;KLHL42;AURKA;MEMO1;ATF5;CDK2AP2;GSK3B
prerank,carbohydrate catabolic process (GO:0016052),-0.3108727764119723,-0.9857341845388276,0.4742268041237113,0.6452115949032062,1.0,15/38,29.80%,GAPDH;DERA;HK3;TPI1;PKM;NEU1;MAN2C1;MAN2B1;PGK1;MANBA;PGM1;PGAM2;PGAM4;PGAM1;ALDOA
prerank,negative regulation of GTPase activity (GO:0034260),-0.35056276099971173,-0.9857234365903139,0.4982517482517482,0.6449162724106389,1.0,5/22,20.25%,LRCH1;ARFGEF1;TMED2;RASA4;WNK1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.40063125935121574,-0.9854985859589241,0.5025553662691652,0.6450616019041561,1.0,2/13,2.65%,NUPR1;MTM1
prerank,actin-myosin filament sliding (GO:0033275),0.3027893915104744,0.9854246940853824,0.49295774647887325,0.7651853200330047,1.0,6/38,11.10%,DMD;TNNI1;ACTA1;TNNT2;MYH7;TTN
prerank,muscle filament sliding (GO:0030049),0.3027893915104744,0.9854246940853824,0.49295774647887325,0.7651853200330047,1.0,6/38,11.10%,DMD;TNNI1;ACTA1;TNNT2;MYH7;TTN
prerank,RNA interference (GO:0016246),-0.3750512100775464,-0.9850753633614339,0.48947368421052634,0.6456432852088746,1.0,5/17,25.03%,AGO2;DHX9;CELF1;TSNAX;TSN
prerank,cellular response to catecholamine stimulus (GO:0071870),0.339621620995822,0.985031111328569,0.47438752783964366,0.7650616681320135,1.0,2/23,1.17%,PDE4B;RYR2
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.3549897435437187,-0.9845715888365567,0.4708994708994709,0.6464030410508227,1.0,7/21,26.84%,RUNX1;ROCK1;CBFB;GDF3;SFN;MAFF;ZFP36L1
prerank,steroid metabolic process (GO:0008202),-0.2675864097567501,-0.9840848541497477,0.48056537102473496,0.6471365417012704,1.0,35/72,39.23%,LIPA;CYP27A1;HSD17B7;CYP46A1;FDXR;NPC1;CYP2R1;SRD5A1;AMACR;CYP26C1;CYP1B1;SRD5A2;LRP2;DHRS4;FDX1;HSD17B10;HSD3B2;HSD17B14;SCP2;FDX2;UGT1A7;UGT1A8;UGT1A1;ARV1;STARD3;DHRS11;BAAT;AKR1C1;NR1I2;HSD17B3;AKR1D1;CYP19A1;SULT2A1;VDR;TSPO
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.4182893993329697,-0.9838546621136047,0.4790528233151184,0.6473424123813251,1.0,4/11,15.17%,PICALM;SNX33;NEDD4L;LEPROTL1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4175919291897817,-0.9835724360108962,0.49081803005008345,0.6476421255253173,1.0,4/11,20.83%,DAB2;RSPO3;PLEKHA4;SFRP1
prerank,rRNA transcription (GO:0009303),-0.370110872408492,-0.9829856187971755,0.4704861111111111,0.6486098435995591,1.0,7/17,27.73%,SPIN1;NIFK;ANG;GTF3A;GTF3C5;BRF1;POLR1E
prerank,anterior/posterior pattern specification (GO:0009952),0.2770664078458454,0.9829551250194986,0.4605911330049261,0.7692747016959972,1.0,15/53,19.48%,PCSK5;HOXC4;WT1;HOXD3;TBX1;HES5;HOXC5;HOXC9;HES1;ATP6AP2;HOXB6;HOXC6;HES3;CELSR2;ACVR2B
prerank,replicative senescence (GO:0090399),0.3970863877213031,0.9828256862181959,0.4964871194379391,0.7684026736021242,1.0,5/12,19.24%,MME;ROMO1;CDKN2A;TERT;CHEK2
prerank,protein processing (GO:0016485),0.24674991147724265,0.9824887138077341,0.46055979643765904,0.768054210507295,1.0,19/102,14.70%,OMA1;METAP2;PCSK5;MMP16;PCSK2;MME;ECE2;ATP23;PCSK6;PRSS12;SEC11C;MMEL1;PCSK1;EEF1AKMT4-ECE2;CPE;GGT1;F9;LGMN;ECE1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.3827681792464027,-0.9824011477883137,0.47619047619047616,0.649501450076893,1.0,4/15,19.24%,PAOX;SAT1;MOXD1;SAT2
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.36953779833206524,-0.9823424120061761,0.48771929824561405,0.6493216498894694,1.0,2/16,5.50%,AOAH;PHKG2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.22861038787908747,0.9815833344620961,0.5,0.7693336689777068,1.0,28/140,16.92%,HTR2C;CACNA1C;RYR2;CACNA2D1;ADCY8;GRM1;ADCY5;PLCE1;ADRA1B;TRPM1;CX3CR1;JPH4;CCKBR;PLCZ1;AGTR1;EDN1;LPAR2;FFAR1;BCAP31;F2RL2;ADRA1D;ADRA1A;TAC1;JPH3;OPRL1;CXCR3;IAPP;GPR157
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.30806201956402013,-0.9811845482340878,0.47627118644067795,0.651467339044669,1.0,6/37,9.25%,IGF1;JUN;ERN1;PPARG;MEF2D;MEF2C
prerank,negative regulation of cell activation (GO:0050866),-0.3862523515946677,-0.9799868518802842,0.4743362831858407,0.6537598179956818,1.0,1/14,0.16%,APOE
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2518034450433973,-0.9794471687544086,0.4872665534804754,0.654625982411232,1.0,23/104,20.35%,DSE;B4GALT5;ST3GAL1;CDO1;SLC10A7;SLC35D2;TPK1;CHST12;CHST11;CNDP2;B3GNT2;PRELP;CHST3;MPST;B4GALT3;CSPG4;AKR1A1;PAPSS1;FMOD;CHAC2;MAT2A;B4GALT1;BGN
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.32675222935474324,-0.9792120447440309,0.4774624373956594,0.6548261717152293,1.0,4/31,5.00%,CDK6;RB1;BRD7;PRMT2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.297265825941361,0.9784033792262322,0.48598130841121495,0.7764729333034388,1.0,8/35,16.32%,PAM;FAR2;HMGCLL1;GGT1;ACACA;ACAT1;HSD17B8;GGT5
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3403398394909098,0.9782471899792311,0.4668192219679634,0.7757157017043291,1.0,6/20,15.81%,MAPRE3;TTBK1;CCNYL1;PKD1;SPDYA;ADAM17
prerank,negative regulation of protein secretion (GO:0050709),-0.3021688423347409,-0.9776035885764112,0.4878048780487805,0.6579887635859981,1.0,6/38,10.44%,APOE;RAB11FIP5;RSAD2;RHBDF1;RHBDF2;CHGA
prerank,negative regulation of cell differentiation (GO:0045596),-0.23454202111205605,-0.9774815365883285,0.521669341894061,0.6579201138999974,1.0,44/181,21.80%,ABCA1;ABCG1;XDH;CDK6;RB1;NELFB;PPARG;CTR9;PTK2B;ADIPOR1;ITGAV;ANP32B;NR1H2;JAG1;SKI;SDHAF2;E2F1;TGFBR1;ASXL1;TRIB2;SPRED1;SPRY2;OSR1;SPRED2;CHADL;CCDC85B;METTL14;GREM1;TRIO;ID2;LDLRAD4;VASN;SMAD7;GATA3;MYB;DTX1;IL17RD;PTPN11;ENPP1;SUFU;SIRT2;SFRP1;ANKRD26;SNAI2
prerank,regulation of osteoblast differentiation (GO:0045667),0.2527905983014803,0.9768910433977837,0.4964705882352941,0.7780355680085815,1.0,25/82,20.56%,NELL1;SOX11;RORB;BMPR1B;ACVR1;YAP1;PRKD1;SUCO;SOX9;BMP7;CITED1;FERMT2;MEN1;ATRAID;REST;NOCT;RIOX1;TMEM64;PTK2;SMOC1;RANBP3L;ACVR2B;WWTR1;LRP3;FBXO5
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3568550413578567,0.9768384490926457,0.47072072072072074,0.7769882443609023,1.0,6/17,18.29%,AHI1;SOX9;TMEM100;KDF1;RFX3;SULT2B1
prerank,nuclear membrane reassembly (GO:0031468),-0.284115084800372,-0.9765905305921819,0.4991652754590985,0.6595463262598855,1.0,21/54,26.25%,NUP205;CHMP7;CDK1;NUP188;LEMD2;CHMP2A;ANKLE2;UBE2I;RCC1;NUP35;VPS4A;SIRT2;NUP107;REEP3;CHMP4B;CHMP4A;CCNB1;LMNA;CCNB2;CHMP2B;NUP37
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.25315940508838,-0.9764954328284792,0.5101694915254237,0.6594281009064415,1.0,16/102,13.39%,MYO5A;RAB8B;DENND4C;PRKCD;ADCY7;INSR;PPARG;RAB31;NFKB1;RHOQ;SELENOS;RELA;XBP1;PKM;RAB10;HDAC5
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3928227429959083,-0.9761341667878506,0.4972677595628415,0.6598884452760365,1.0,5/14,19.94%,MDFI;TMSB4X;NFKBIB;FAF1;SUFU
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3987080231734431,-0.9757040314494826,0.5034129692832765,0.6604870051174462,1.0,2/13,6.62%,STX7;CYRIB
prerank,protein localization to cell surface (GO:0034394),0.32295055509686776,0.9755277912374737,0.47890818858560796,0.7792767991649019,1.0,7/26,14.37%,ANK2;PIGU;PTPRK;FGF10;EMP2;ARF6;RIC3
prerank,cellular response to amino acid stimulus (GO:0071230),0.30625950156707477,0.9755079599896836,0.491725768321513,0.7781587348898696,1.0,9/33,11.46%,GLRA1;SESN3;RRAGB;UBR1;FYN;GLRA2;CASTOR2;CPEB3;RPTOR
prerank,regulation of supramolecular fiber organization (GO:1902903),0.33422171737181505,0.9748068867805113,0.45278450363196127,0.7788228743909735,1.0,3/22,2.21%,MAP2;MAP1B;MAPRE3
prerank,heterochromatin organization (GO:0070828),0.38072097870666544,0.9742813161897879,0.4720357941834452,0.7790551353118423,1.0,6/14,19.74%,HMGA2;SNAI1;BAHD1;MECOM;PRDM16;SIRT1
prerank,protein depolymerization (GO:0051261),-0.3299884583523105,-0.974145688259607,0.4946808510638298,0.6635188677538774,1.0,10/27,18.37%,CKAP5;WDR1;KIF14;MICAL1;MICAL2;KIF2C;STMN2;TWF2;KIF18B;CFL1
prerank,protein localization to nucleus (GO:0034504),-0.2522151241417978,-0.973334325934825,0.5245098039215687,0.6649595020454316,1.0,28/102,22.37%,SYK;IPO5;NUP50;STAT3;HHEX;RPL11;NUP88;E2F3;YWHAE;MORC3;GBP2;WRN;TPR;NUP188;TOR1AIP1;TAF8;APPL2;TAF3;NUP153;FAM53A;TNPO3;APPL1;NUP107;NXT2;NUP62;ZBTB7A;TOPORS;SPRN
prerank,polyamine metabolic process (GO:0006595),-0.39826799352614123,-0.9730723694097377,0.49029982363315694,0.6652380587646615,1.0,5/13,21.13%,PAOX;SAT1;HDAC10;SAT2;SMS
prerank,positive regulation of biomineral tissue development (GO:0070169),0.289799145345437,0.9724970349056098,0.5092592592592593,0.7826599217181621,1.0,9/40,9.33%,NELL1;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;AMELX;TFAP2A
prerank,artery development (GO:0060840),0.32508668656412243,0.9716688158905384,0.49759615384615385,0.7836712802321122,1.0,2/23,0.73%,ROBO1;ROBO2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.4257367866309999,-0.9716596076911973,0.503448275862069,0.6680591951507837,1.0,4/10,17.55%,PPARG;RARG;RXRA;RARA
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.3715417821594824,0.9713076906148397,0.4961439588688946,0.7834149167087113,1.0,6/16,21.08%,HFM1;SHOC1;CORT;MEIOB;MSH4;RMI1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2652440689039711,-0.9712497056890851,0.5033670033670034,0.6686469071576326,1.0,18/72,15.57%,APOE;PRKCD;ATXN7;ARHGEF2;ARFGEF1;CYRIB;MYADM;LIMA1;TPX2;TAOK1;DYRK1A;PIK3CA;CHADL;SSH3;CIB1;SPEF1;STMN2;SSH1
prerank,epithelial tube morphogenesis (GO:0060562),0.30739304874549306,0.9710501709906765,0.4889975550122249,0.7829371273574335,1.0,8/32,15.22%,RYR2;SLIT2;CSF1R;ACVR1;FGF10;PKD1;HES1;PODXL
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.403169867446154,-0.9706492842266929,0.5026269702276708,0.6696181693817638,1.0,5/12,27.43%,BRCA1;YTHDC1;CDYL;RBM15B;METTL3
prerank,histone lysine methylation (GO:0034968),-0.3138689749764454,-0.970494260450585,0.5173611111111112,0.6696337554950255,1.0,15/33,28.47%,SMYD2;SMYD3;EZH2;WDR5;KMT2D;SMYD1;SETDB1;DOT1L;KMT2A;CXXC1;SETD6;RBBP5;ASH2L;KDM6A;WDR5B
prerank,gene silencing by miRNA (GO:0035195),-0.31470673289555595,-0.970208178028927,0.4991243432574431,0.6699159687583461,1.0,7/32,13.28%,AGO2;CNOT1;ZC3H7B;PUM2;XPO5;MOV10;TNRC6C
prerank,negative regulation of dephosphorylation (GO:0035305),-0.35969046314752423,-0.9699247985187179,0.4908485856905158,0.670187703445296,1.0,3/18,8.85%,MFHAS1;ZCCHC9;GPATCH2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.37904873142473755,0.9691924260667415,0.4961439588688946,0.7866259497548624,1.0,3/14,8.98%,PPP2R2B;PPTC7;PPP2R2A
prerank,positive regulation of cyclase activity (GO:0031281),0.3710926553612845,0.9684520906158989,0.5023255813953489,0.787417836305862,1.0,1/14,0.82%,CACNA1C
prerank,mitochondrial fission (GO:0000266),0.3653382031025786,0.9684438593362124,0.48267898383371827,0.7862596011603126,1.0,3/16,6.08%,DNM3;MIEF1;DNM1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.37118992121248456,-0.9680246774988555,0.4991181657848324,0.6738675605390797,1.0,7/16,26.84%,RC3H1;MOV10;DHX36;ZC3H12A;TARDBP;ZC3H12D;ZFP36L1
prerank,positive regulation of protein transport (GO:0051222),-0.2678198198535443,-0.9678313676050829,0.535234899328859,0.6739823980010159,1.0,16/67,16.91%,IGF1;ABCG1;RUFY3;TMED10;KIF20B;ADAM9;GOLPH3L;ADAM8;MYOM1;TPR;RAB29;PLK3;ANG;ARHGEF5;CLN3;PCNT
prerank,positive regulation of protein localization to membrane (GO:1905477),0.23980488927951607,0.9677900980657604,0.5295774647887324,0.7868098145697598,1.0,17/98,13.71%,DPP10;ANK3;SORBS1;PRKCE;TCAF1;RAMP3;TFDP2;MIEF1;PRKCI;PRNP;FYN;MTCL1;NKD2;ARF6;STAC;PRKN;ATP2B4
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.27769319794210523,-0.96767427662643,0.5098039215686274,0.6740114126574922,1.0,18/59,22.80%,PRKCD;ROCK1;CSNK2A1;DYRK2;TGFBR1;CDK1;DYRK1A;MAP2K1;TGFBR2;MARK2;MAP3K10;CHEK1;CDC42BPG;WNK1;GSK3B;CDK5;MAPK1;PRKDC
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.386668327523797,-0.9675082759128867,0.5365853658536586,0.674038002813686,1.0,6/14,22.16%,MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,regulation of chemotaxis (GO:0050920),-0.31658813291473786,-0.9673227600027166,0.5168918918918919,0.6741076807277742,1.0,11/30,24.71%,P2RX4;DUSP3;STX3;CYRIB;ZSWIM8;ZSWIM6;CXCR4;STX4;PDGFRB;TGFB1;ZSWIM4
prerank,pharyngeal system development (GO:0060037),0.36435312856124136,0.9671977809026941,0.48654708520179374,0.7872406353555311,1.0,5/15,14.87%,BMP7;TBX1;TGFB2;HES1;FOLR1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.42197401561131753,-0.9670693725454759,0.5,0.6743167437205259,1.0,3/10,11.05%,SYNGR1;RAB5A;APP
prerank,response to leucine (GO:0043201),-0.4229905636866032,-0.9668000971943536,0.5357766143106457,0.6742487437124983,1.0,4/10,11.77%,KLHL22;UBR2;RRAGD;SESN1
prerank,cellular response to leucine (GO:0071233),-0.4229905636866032,-0.9668000971943536,0.5357766143106457,0.6742487437124983,1.0,4/10,11.77%,KLHL22;UBR2;RRAGD;SESN1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3321887248342008,-0.966664173325935,0.48939929328621906,0.6742165859763674,1.0,6/26,14.34%,DDB2;RNF111;UBC;RPS27A;CUL4B;ERCC4
prerank,transcription preinitiation complex assembly (GO:0070897),-0.3988777222898099,-0.9665158411574332,0.5336700336700336,0.6742406103663499,1.0,3/12,27.73%,DR1;GTF2A2;POLR1E
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3063015188041486,-0.9664409369732538,0.5321739130434783,0.6740753426815975,1.0,7/35,8.31%,NRP1;RAC1;FLNA;PLXND1;SEMA4A;NRP2;SH3BP1
prerank,gluconeogenesis (GO:0006094),0.2942429451963993,0.9662565308143084,0.5059952038369304,0.788541065833967,1.0,10/39,14.31%,PFKFB1;GOT1;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;PPARGC1A
prerank,protein localization to chromosome (GO:0034502),-0.3078103033756183,-0.9661980417989501,0.5050505050505051,0.6743124604778863,1.0,8/34,16.40%,RB1;CENPA;MCM9;CHMP7;XRCC4;TNKS2;LEMD2;TPP1
prerank,organic cation transport (GO:0015695),0.33194985986030245,0.9660403526592369,0.5216400911161732,0.7879442224252191,1.0,3/20,5.80%,SLC25A19;SLC47A1;SLC5A7
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3534504376863161,-0.9658335799103193,0.5081081081081081,0.6747557334517251,1.0,7/20,21.85%,MCL1;ITGAV;BCL2;CASP2;GSK3B;APPL1;BCL2L2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3705616358787604,-0.965546894452168,0.4925373134328358,0.6750495290183333,1.0,5/15,27.65%,ERN1;TSEN54;DDX1;CPSF1;ZBTB8OS
prerank,regulation of cell differentiation (GO:0045595),-0.23626707206624292,-0.9640214589932021,0.5336617405582923,0.6780538382210657,1.0,29/148,17.97%,RUNX1;PRKCB;TRPS1;BCL6;CDK6;ROCK1;SLC6A6;CREBBP;RUNX3;FES;RUNX2;ANP32B;EIF2AK2;MDK;TGFBR1;CBFB;DDX5;SIK1;CDK5RAP1;LTBP4;HSP90AB1;GREM1;ID2;FLOT2;TAF8;VHL;PLEKHB1;SMAD7;GATA3
prerank,RNA transport (GO:0050658),-0.2653794668220436,-0.9637298016047186,0.5375626043405676,0.6783517164924814,1.0,31/71,32.70%,RFTN1;SRRM1;CHTOP;RAE1;CDC40;CKAP5;XPO5;ALYREF;TPR;NUP188;TGFBR2;NCBP1;THOC2;RNPS1;NUP153;THOC6;HNRNPA1;MAGOH;SLU7;NUP62;SRSF11;DDX39B;DHX38;U2AF2;ZFP36L1;SRSF7;EIF4A3;EIF4E;SRSF5;SARNP;U2AF1L4
prerank,mucosal immune response (GO:0002385),-0.37990131687737616,-0.9628349340019969,0.5093696763202725,0.6799382104755805,1.0,7/15,44.28%,CAMP;DEFA6;RPL39;LTF;NOS2;RNASE3;IFNLR1
prerank,mitochondrion disassembly (GO:0061726),-0.31338654782975767,-0.9626254067195512,0.4927797833935018,0.6800706604438254,1.0,9/34,17.82%,ATG5;ATG7;ULK2;FIS1;RB1CC1;MARK2;GABARAP;USP30;FBXO7
prerank,positive regulation of wound healing (GO:0090303),-0.3055929164515748,-0.96254328146517,0.508833922261484,0.6799192809635596,1.0,7/36,12.79%,RREB1;HPSE;ITGB1;ARFGEF1;ANXA1;XBP1;SERPINE1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3354917384744996,-0.9624240979515916,0.5207612456747405,0.6798483015340884,1.0,7/23,20.02%,PLBD1;PLA2G4A;PLAAT3;PLA2G6;PLA2G5;PLA2G12A;LPCAT3
prerank,microtubule anchoring (GO:0034453),0.3969346763780133,0.9624158520852892,0.5317647058823529,0.7963163811318625,1.0,2/12,4.30%,BICD1;CLASP2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3559048151354358,0.962156076447275,0.5059101654846335,0.7958050354641046,1.0,2/17,1.35%,ROBO1;SLIT2
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.33368850496986086,-0.9618937497022225,0.5227272727272727,0.6806651113660225,1.0,6/25,15.42%,NRP1;SDCBP;NCKAP1L;APP;CCL5;ANG
prerank,ganglion development (GO:0061548),-0.40305115554648874,-0.9607021039367876,0.5072992700729927,0.6828863152242338,1.0,3/11,7.15%,NRP1;NRP2;CTNNB1
prerank,regulation of neurogenesis (GO:0050767),0.2689393092047151,0.9605840457950613,0.5201005025125628,0.7987294519807091,1.0,17/55,19.13%,SOX11;MME;YAP1;HOOK3;NUMB;CX3CR1;RASSF10;PER2;HES5;REST;HES1;OPRM1;PRUNE1;HES3;DOCK7;SNW1;PCM1
prerank,tRNA 5'-leader removal (GO:0001682),0.38264583047196493,0.9603239381529173,0.5011764705882353,0.7982200119787003,1.0,6/13,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,dicarboxylic acid catabolic process (GO:0043649),0.3794206412969409,0.960289475446414,0.5238095238095238,0.7971264040575139,1.0,4/13,14.45%,ASPA;GOT1;GLUL;ACOT8
prerank,organophosphate catabolic process (GO:0046434),-0.41071839740548943,-0.9597549618791614,0.5151006711409396,0.6846518588954378,1.0,3/11,7.31%,PLBD1;ABHD12;PLBD2
prerank,cellular response to interferon-beta (GO:0035458),-0.3902787315215928,-0.9594552598161448,0.518850987432675,0.6849733102282459,1.0,5/14,28.53%,AIM2;IFITM2;CDC34;STAT1;IRGC
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.40195150701684573,-0.95916653857358,0.5243055555555556,0.6852404853938466,1.0,2/11,13.66%,SP100;TFAP4
prerank,mitochondrial membrane organization (GO:0007006),-0.31002131901847996,-0.9591143894798205,0.5178571428571429,0.6850183729066714,1.0,15/32,34.08%,HSPA9;BCL2;MICOS13;TMEM11;GHITM;SLC25A4;MAIP1;MTX1;DNAJC11;SLC25A31;BCL2L1;BNIP3;CHCHD6;SAMM50;MICOS10
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3043760098604992,-0.9589977359448153,0.5394045534150613,0.6849451861697965,1.0,16/35,34.58%,RTEL1;CTNNB1;CCT7;PKIB;DHX36;TNKS2;CCT4;HNRNPA1;ATM;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;CCT8;CCT5
prerank,alpha-amino acid metabolic process (GO:1901605),0.2783051190401274,0.9589208512687244,0.4853932584269663,0.799445251240875,1.0,12/45,17.58%,ASPA;GOT1;GLUL;ALDH18A1;GPT;FOLH1;ASNS;RIMKLB;GLS2;GLS;GPT2;CBS
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4275620062013794,-0.9585285436954883,0.5362563237774031,0.6856437020593428,1.0,4/10,25.93%,PRKCB;IRS2;OAZ3;INPP5K
prerank,cellular response to light stimulus (GO:0071482),-0.2686579019875811,-0.9585220392829361,0.5343383584589615,0.6853299691231302,1.0,34/66,40.18%,GNB1;PRKCD;CREBBP;CDC25A;PCNA;DHX36;ERCC4;RHNO1;TMEM161A;YY1;INO80;NSMCE3;KDM1A;MYC;NOC2L;USP28;METTL3;EP300;GPR52;AQP1;ZBTB1;COPS9;CNGB1;ATF4;RHBDD1;EIF2S1;RRH;SAG;MAPK13;USP47;SDE2;TRIAP1;RUVBL2;AURKB
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2978237843597727,-0.9582736614111969,0.5213523131672598,0.685527113026709,1.0,20/37,41.98%,ENTPD6;DNASE1L1;RNASE6;NCBP1;ENTPD3;XRN2;MTREX;NUDT15;SND1;NUDT16;RNASEH2B;ISG20;ENTPD7;NUDT1;DNASE1;NUDT5;RNASE3;DNASE1L2;RNASEH2A;ENTPD1
prerank,lipid oxidation (GO:0034440),-0.4010373028994467,-0.9580313828721044,0.5273037542662116,0.685699231637978,1.0,4/12,26.75%,ADIPOR1;PLA2G7;ACOX1;ALOX15
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.30609149129394647,0.9575229753503882,0.5035460992907801,0.8007636001448056,1.0,12/29,22.83%,GLYAT;ACSM5;ACOT8;ACAT1;MLYCD;ACSM3;ACSL6;ACOT12;ACOT7;CROT;GPAT4;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.30609149129394647,0.9575229753503882,0.5035460992907801,0.8007636001448056,1.0,12/29,22.83%,GLYAT;ACSM5;ACOT8;ACAT1;MLYCD;ACSM3;ACSL6;ACOT12;ACOT7;CROT;GPAT4;OXSM
prerank,regulation of isotype switching (GO:0045191),-0.37608907967568206,-0.9572438221879045,0.499151103565365,0.6870515392108503,1.0,4/14,22.75%,KMT5B;KMT5C;SHLD2;SLC15A4
prerank,positive regulation of cellular senescence (GO:2000774),-0.41683986226685404,-0.9571577554340428,0.533213644524237,0.6869066964462549,1.0,4/10,15.88%,CGAS;B2M;EEF1E1;ARG2
prerank,vitamin D metabolic process (GO:0042359),0.37379396470156245,0.9569438452029444,0.540045766590389,0.8011209051770037,1.0,4/13,15.10%,CUBN;CYP1A1;LGMN;GC
prerank,chondrocyte differentiation (GO:0002062),0.2921231207827669,0.9566083329245338,0.5,0.800792834396943,1.0,9/32,11.93%,NFIB;BMPR1B;SOX5;SOX6;CCN3;HMGA2;SOX9;AMELX;HES5
prerank,myotube cell development (GO:0014904),-0.41981811065441244,-0.9561945781770388,0.5191256830601093,0.6886633968711224,1.0,2/10,7.78%,IGF1;SKI
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.28657951259927794,-0.9561652079888332,0.5246179966044142,0.6883744998513937,1.0,13/45,27.20%,DAB2;SDCBP;RBPMS;TGFBR1;ACVR2A;TTK;GDF3;BMPR2;INHA;TGFB1;SMAD4;BMP2;ENG
prerank,protein complex oligomerization (GO:0051259),-0.25417773780947983,-0.9560443443427468,0.5529411764705883,0.6883436800790222,1.0,28/85,25.50%,LRRC8D;RNF213;PDCD6IP;EHD4;CARD11;NLRC4;LRRC8C;BLM;FUS;ALS2;TMEM120B;PRMT1;SLC9A1;NUDT21;EHD1;CHMP2A;IKZF4;CLDN1;MAT2A;HGSNAT;ZC3H12A;RNF135;TWNK;TRIM72;UPB1;PRF1;ECT2;MS4A1
prerank,regulation of cell death (GO:0010941),-0.25092945695447183,-0.956003339996367,0.5447154471544715,0.6880947182014622,1.0,32/94,26.55%,CTSZ;LRP1;CD36;ACER3;TNFRSF1B;ATG5;HTR2B;SLC25A24;NOA1;TXNDC12;CELF1;RAB29;CCL5;SPEF1;CHMP2A;EIF4G1;TMEM109;FAF1;BNIP3L;HSPA1A;ZC3H12A;RILPL1;HPR;HP;CHMP4B;BECN1;CRYAB;CCN4;MT3;NCK1;CCN2;PDE8A
prerank,neuron maturation (GO:0042551),0.34741664124840205,0.9553076767618374,0.524822695035461,0.8031217097643863,1.0,2/18,2.37%,ADGRB3;SRRM4
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3590488413806983,0.9552696613601478,0.526829268292683,0.8020389586860895,1.0,6/17,13.09%,ADRA1B;GPR101;ADRA2C;ADRA1D;ADRA1A;ADRB1
prerank,regulation of monooxygenase activity (GO:0032768),-0.33740295999438175,-0.955172568926093,0.5195246179966044,0.6895634222995589,1.0,3/23,6.31%,DNM2;POR;WASL
prerank,protein localization to chromatin (GO:0071168),-0.36143578642719704,-0.9546665223821705,0.5244755244755245,0.6903538607619537,1.0,11/18,39.67%,NIPBL;MCM9;CHMP7;LEMD2;LRWD1;ESR1;FAM47E;RAD21;WAPL;MRNIP;RUVBL2
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3686563534554985,-0.9546142278226473,0.5176678445229682,0.6901319707936474,1.0,5/16,24.84%,HMGB2;DFFA;ENDOG;HMGB1;DNASE2
prerank,Golgi localization (GO:0051645),-0.3975633548435874,-0.9543440955425438,0.5424610051993067,0.6903764072918815,1.0,2/11,4.09%,UVRAG;CDC42
prerank,blood vessel morphogenesis (GO:0048514),-0.2753497999702901,-0.9538915997002367,0.5488,0.6909765015426119,1.0,19/54,28.52%,RBPJ;NRP1;SYK;FLT1;VEGFA;TGFBR1;TGFBR2;RASA1;SMAD7;ID1;AGGF1;KDR;APLNR;TGFB1;CYP1B1;ADM;ENG;GJA5;CCBE1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.2710567593039704,-0.9535089480132886,0.5430016863406408,0.6914696021840187,1.0,18/60,25.01%,NFKB1;RUNX2;MED24;CTNNB1;CBFB;RELA;MOV10;CDK1;MED4;MED31;TNRC6C;DHX36;MED6;MED20;CEBPB;IL6;CCNB1;TRIM28
prerank,cellular component maintenance (GO:0043954),0.3856807182813311,0.9529600755267887,0.5,0.8068923124788091,1.0,4/12,7.51%,MTMR2;LNPK;PRNP;FYN
prerank,negative regulation of protein processing (GO:0010955),-0.3968097649155817,-0.9521763456511785,0.5111492281303602,0.6940120933647168,1.0,3/12,18.18%,CTSZ;SERPINE1;TMEM59
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.32934202246354494,-0.9520228239838208,0.549469964664311,0.6940163189697811,1.0,7/25,17.99%,CENPJ;CKAP5;PIN1;KIF14;KIF2C;STMN2;KIF18B
prerank,regulation of vasculature development (GO:1901342),-0.3283686741221591,-0.951476508704633,0.5269168026101142,0.6948918422168222,1.0,9/26,26.25%,SP100;PLXND1;CTNNB1;EGLN1;HTATIP2;SFRP1;IL6;HMOX1;VASH2
prerank,regulation of ERAD pathway (GO:1904292),-0.41141138904201985,-0.9512565737987045,0.55668358714044,0.6950711144953173,1.0,5/11,21.59%,ATXN3;RNF185;TMEM259;UBXN1;BAG6
prerank,response to amyloid-beta (GO:1904645),-0.28607471516980787,-0.9511562621863993,0.5468227424749164,0.6949674883777947,1.0,11/44,12.80%,ITGA4;IGF1;LRP1;CD36;IGF1R;TLR4;SNX6;CASP4;ABCC1;APP;FCGR2B
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.2857293109585146,0.9504304171891498,0.5138888888888888,0.8122900704649644,1.0,12/38,20.53%,RORA;OTUD7A;NLRP12;NR1D1;GSTP1;OTUD7B;TNIP1;TRIM59;CCDC22;SIRT1;PER1;TREM2
prerank,regulation of endopeptidase activity (GO:0052548),0.2553948815364786,0.9500442958622092,0.553921568627451,0.8121399103053765,1.0,5/59,4.76%,SPOCK1;SPOCK3;SERPINI1;SERPING1;TIMP3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4082721931531045,-0.9496249038137778,0.5307167235494881,0.6979255906413216,1.0,2/10,13.66%,SP100;TFAP4
prerank,regulation of protein localization to centrosome (GO:1904779),0.3951526848532241,0.9495275784050573,0.4930875576036866,0.8123458977282046,1.0,4/10,18.57%,BICD1;NSFL1C;UBXN2B;PARD6A
prerank,myelin assembly (GO:0032288),0.40251050900065727,0.9494654267027022,0.5058823529411764,0.8113304186602384,1.0,2/10,3.91%,TENM4;EPB41L3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.22448340704354447,0.9492771849486733,0.5978260869565217,0.810622166468136,1.0,25/142,14.42%,CACNA1C;TRPC5;RYR2;ADCY8;HCRTR2;TRPC1;ADCY5;PLCE1;ADRA1B;CX3CR1;CCKBR;SLC8A2;PLCZ1;RYR1;AGTR1;EDN1;CALCB;LPAR2;FFAR1;BCAP31;ADRA1D;ADRA1A;TAC1;ATP2B4;ATP2B2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2448720670693385,0.9492092084326681,0.5292553191489362,0.8096092023694734,1.0,22/93,16.07%,DMD;NTRK3;TENM1;PDE4D;MLXIPL;OPRD1;RAMP3;PRKD1;BDNF;INPP5J;CREBL2;SPTBN4;CAPRIN2;SH2D3C;RPTOR;NLRP2B;CNOT9;ATP2B4;HSP90AA1;CNKSR3;BRAF;SNCA
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3431420555930397,0.9491418885583194,0.5011990407673861,0.8086126855349559,1.0,5/17,15.81%,MAPRE3;CCNYL1;PKD1;SPDYA;ADAM17
prerank,negative regulation of cell communication (GO:0010648),0.33034474445977513,0.9489819900843413,0.533816425120773,0.8078544718774664,1.0,5/21,15.90%,GLRA1;ACVR1;NLRP12;OPRM1;ERBB3
prerank,regulation of lipid metabolic process (GO:0019216),-0.2519796700590592,-0.9489313249119381,0.5539452495974235,0.699107600735356,1.0,18/88,14.94%,PSAP;CREBBP;PPARD;PANK2;NFYA;PRKAG2;PPARG;ADIPOR1;SMARCD3;TBL1XR1;EDF1;HELZ2;NPC2;IDI1;RXRA;SIN3A;ID2;ACACB
prerank,icosanoid biosynthetic process (GO:0046456),-0.4134015204650451,-0.9487895545435044,0.5414364640883977,0.6991088125027872,1.0,3/10,19.28%,ALOX5AP;PLA2G4A;PLA2G5
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.27387020467909995,-0.9487776904729511,0.5502645502645502,0.6987979724446611,1.0,10/55,10.67%,CD44;HEXA;LYVE1;HPSE;GNS;GALNS;SLC9A1;GUSB;SDC4;PRELP
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3834741890423575,0.9487614619174752,0.5276381909547738,0.8072680153270592,1.0,3/12,9.57%,SNAP25;STX2;PRRT2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.33740024522863427,0.9484458119923901,0.5092592592592593,0.8068910618487142,1.0,3/18,7.07%,SOX6;CCN3;BDNF
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.2415780863623993,-0.9484228354607093,0.5608974358974359,0.6992095434373219,1.0,28/113,21.23%,NRP1;IGF1;NOTCH2;RREB1;C5AR1;HTR2B;NRP2;GRN;VEGFA;NME1;MDK;TGFBR1;JAML;HIF1A;ARNT;XBP1;OSR1;HMGB2;PIK3CD;ANG;NR4A1;CLDN1;NRAS;AGGF1;NOD2;BMPR2;SFRP1;KDR
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3355352930887947,0.9481804289447773,0.5350467289719626,0.8063662718337238,1.0,5/20,13.69%,SLC8A3;SLC25A23;LETM1;PMPCB;MICU3
prerank,apoptotic nuclear changes (GO:0030262),-0.3249319618875368,-0.9480341628566107,0.5388513513513513,0.6996868191213291,1.0,9/24,26.18%,TOP2A;ACIN1;HMGB2;DFFA;ENDOG;HMGB1;DNASE2;DEDD2;ERN2
prerank,regulation of axon extension (GO:0030516),-0.29897524109734064,-0.9479520454994781,0.5635062611806798,0.6995345814907016,1.0,5/37,5.63%,APOE;DNM2;GOLGA4;RUFY3;MACF1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.32995020441134704,-0.9476825843258182,0.5454545454545454,0.6997780949732949,1.0,11/24,35.48%,SLC27A1;PLA2G4A;PLA2G5;PLA2G12A;PNPLA8;PLA2G15;LPCAT4;ABCA3;PGS1;PLA2G3;PLA2G4B
prerank,negative regulation of macrophage activation (GO:0043031),0.34651690478068364,0.94749691027869,0.5359628770301624,0.8070047901232417,1.0,4/16,9.98%,LRFN5;CD200;SYT11;NR1D1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3648015927535436,-0.947475539800887,0.5472370766488414,0.69987185450591,1.0,1/15,0.19%,PRKCH
prerank,negative regulation of fat cell differentiation (GO:0045599),0.28850585611907775,0.947456393800937,0.5237020316027088,0.8059506009058502,1.0,3/34,2.59%,RORA;ZFPM2;RUNX1T1
prerank,programmed necrotic cell death (GO:0097300),-0.3528992707560385,-0.9468040046143542,0.5543859649122806,0.700952732631296,1.0,8/18,28.86%,RIPK1;TLR4;LY96;TICAM1;MLKL;TICAM2;ITPK1;RIPK3
prerank,positive regulation of cell development (GO:0010720),0.29984746249903965,0.9465433109918501,0.5454545454545454,0.8071293491389611,1.0,9/31,18.95%,SOX11;MME;NUMB;CX3CR1;RASSF10;RFX3;OPRM1;PDE3A;SNW1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.40003718483182765,-0.9463013067913326,0.5440414507772021,0.7017005638520687,1.0,2/12,5.78%,NELFB;JAG1
prerank,female gonad development (GO:0008585),-0.34778651239125385,-0.9462169335761177,0.5397923875432526,0.7015599830757077,1.0,10/19,38.04%,VEGFA;ANG;NUP107;CEBPB;INHA;EIF2B2;EIF2B4;CYP19A1;FSHR;LHCGR
prerank,embryonic digit morphogenesis (GO:0042733),-0.35032747652546675,-0.945707557460838,0.5432098765432098,0.7022881667103357,1.0,3/18,11.44%,CREBBP;MAP3K20;OSR1
prerank,inositol phosphate metabolic process (GO:0043647),0.2743515297398601,0.9456090672752938,0.5683962264150944,0.8084031327587998,1.0,12/46,12.62%,PLCB1;NUDT11;PLCH2;PLCE1;IP6K2;INPP5J;ITPKA;INPP4B;PLCZ1;PLCD3;CALM1;PPIP5K2
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.40702698565432716,-0.9447486142293495,0.5340136054421769,0.7037296607130715,1.0,2/10,6.03%,NUPR1;CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),-0.40702698565432716,-0.9447486142293495,0.5340136054421769,0.7037296607130715,1.0,2/10,6.03%,NUPR1;CBFA2T3
prerank,zymogen activation (GO:0031638),0.2830610188114295,0.944560107728812,0.5407239819004525,0.8099117723366223,1.0,15/39,22.82%,GRIN2A;OMA1;PRSS12;TBC1D10A;GGT1;F9;LGMN;CIDEB;PERP;KLK1;FADD;KLKB1;MMP14;KLK2;C1RL
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2324483981377314,0.9444403389237997,0.565947242206235,0.8090566243916422,1.0,29/101,20.77%,ROBO1;TENM1;MAPRE3;ETAA1;PDGFD;CSF1R;EGF;CCNYL1;HMGA2;SLC8A2;EDN1;PKD1;RPTOR;FERMT2;SPDYA;CALM1;CALM3;CALM2;ATP2B4;ADAM17;SNCA;PIH1D1;TELO2;IRAK1;WNT5A;SIRT1;TPD52L1;KIT;HRAS
prerank,meiosis I (GO:0007127),0.320095279429391,0.9444330845803002,0.5081967213114754,0.8079204408998438,1.0,6/23,14.25%,ZCWPW1;TDRD9;PTTG1;MEIKIN;BRDT;MEIOB
prerank,response to iron ion (GO:0010039),-0.3840321194582127,-0.9443110159698982,0.5246179966044142,0.7043498410791807,1.0,3/12,9.13%,BCL2;B2M;HIF1A
prerank,epiboly involved in wound healing (GO:0090505),0.35540854278748385,0.9441782348992706,0.5544794188861986,0.8074181869192756,1.0,6/16,12.27%,TMEFF2;MRTFA;CARMIL2;TOR1A;CD151;ARHGAP35
prerank,dorsal/ventral pattern formation (GO:0009953),0.33308928855503417,0.9441214507895006,0.532258064516129,0.8064411955781857,1.0,4/20,10.97%,BMPR1B;ACVR1;DSCAML1;NBL1
prerank,negative regulation of histone methylation (GO:0031061),-0.4080427880153115,-0.9439497845594919,0.5479204339963833,0.7047378505821094,1.0,3/10,8.54%,BRCA1;JARID2;WDR5
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3458445310760945,-0.9438734579351208,0.5373665480427047,0.7045741360676925,1.0,4/20,9.96%,IMPDH2;HPRT1;ADSS1;NT5C2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3583987981289805,-0.9435732440074505,0.5451388888888888,0.7048802888772463,1.0,6/16,14.29%,RIPOR2;MAPK14;MEF2C;IGFBP3;SMYD1;BTG1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.38744659846324514,0.9416379521238926,0.5277108433734939,0.8116473300301879,1.0,4/11,14.75%,PTS;CALM1;DHFR;HSP90AA1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3311441488277675,-0.9408562321256477,0.5684931506849316,0.7103999586628589,1.0,7/22,19.28%,ABL2;FLT1;GNA13;CCL5;ARL1;PDGFRB;PLA2G5
prerank,substantia nigra development (GO:0021762),-0.3005730631549697,-0.9406948048892059,0.5531914893617021,0.7104179208241864,1.0,7/37,10.09%,RHOA;ZNF148;CDC42;ACTB;RAD1;YWHAE;SUDS3
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3369064404652743,-0.9403979805070329,0.5451388888888888,0.710726700975135,1.0,4/21,10.69%,MFHAS1;YWHAE;MASTL;STYXL1
prerank,base conversion or substitution editing (GO:0016553),-0.4084629034171352,-0.9402220400770637,0.571912013536379,0.7107549370395049,1.0,1/11,0.05%,APOBEC1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3843806233790348,-0.9398771343595053,0.5561497326203209,0.7112094198714167,1.0,7/12,27.33%,STAT3;BCDIN3D;ZC3H12A;IL6;TGFB1;NCOR1;ESR1
prerank,mammary gland epithelium development (GO:0061180),0.3579880499471558,0.9392898626431142,0.5364705882352941,0.8164878695505032,1.0,2/14,3.22%,ERBB4;CSF1R
prerank,bone morphogenesis (GO:0060349),0.3515088562668802,0.9384521976375994,0.5446428571428571,0.8175131032949794,1.0,3/14,10.24%,BMPR1B;TFAP2A;MMP13
prerank,import into cell (GO:0098657),-0.2820525120555837,-0.9384192274324822,0.5701906412478336,0.7139509387826578,1.0,13/41,25.71%,LRRC8D;SLC6A6;SLC27A1;LRRC8C;SLC12A7;SLC12A6;SLC7A5;SLC5A3;SLC29A1;SLC11A2;NEURL1B;LRP2;LRSAM1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.37952614510871996,-0.9374508506212653,0.535234899328859,0.715682854663948,1.0,3/13,9.25%,RBPJ;PIM1;MEF2C
prerank,skeletal system morphogenesis (GO:0048705),0.2809066355523064,0.9371496470567023,0.5583126550868487,0.8196191737954587,1.0,8/42,15.62%,HOXC4;SOX11;DSCAML1;HOXD3;TFAP2A;MMP13;HOXC9;FUZ
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2980867844083772,-0.936947638380881,0.5342465753424658,0.7164100623790913,1.0,10/33,17.10%,RAB11FIP5;STX3;PICALM;SNX33;CTNNB1;NEDD4L;RAB11B;HSP90AB1;LEPROTL1;STX4
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2780895361293713,-0.9366628699660221,0.571900826446281,0.7166746450594803,1.0,19/48,29.95%,DDHD1;DGKZ;SLC27A1;PLD2;GPD1;DGKD;ABHD5;AGPAT1;PLA2G4A;DGKG;PLA2G6;PLA2G5;PLA2G12A;GPD1L;LCLAT1;DGKA;LIPH;GPAT2;LPCAT4
prerank,protein secretion (GO:0009306),0.2601710247531975,0.9364645428206785,0.5960099750623441,0.8202114084775142,1.0,6/56,5.60%,RIMS2;OLFM2;PCSK5;RAB3C;RAB15;MAFA
prerank,secretion (GO:0046903),0.3615161168837013,0.9360183119622538,0.5430622009569378,0.8201793442439127,1.0,4/14,18.27%,RIMS1;PRKCI;ABCB11;FBLN5
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.22144930360163906,-0.9356688084437653,0.6270928462709284,0.7184809633260959,1.0,43/199,20.29%,RBPJ;ATP2B1;PAEP;CORO1C;RB1;ROCK1;SPI1;RAB11FIP5;IL15;TLR4;SRGN;ADIPOR1;PTGER4;LNPEP;NR1H2;PLCL2;GAS6;GRN;SDHAF2;MDK;TLE3;MEF2C;SPRED1;SPRY2;ACOT13;FLCN;SPRED2;STK11;FCGR2B;LDLRAD4;IL18R1;VASN;SMAD7;PTPRO;TFE3;GATA3;IL17RD;RHEB;ID1;WDR77;AGER;BMPR2;GSK3B
prerank,atrial septum morphogenesis (GO:0060413),-0.4037663517792063,-0.9356648907081759,0.5640569395017794,0.718153270851931,1.0,1/10,0.56%,NOTCH2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.29511434130558184,0.9356627576549581,0.5492957746478874,0.819881569716771,1.0,13/32,21.40%,MAGI2;CAMTA1;DLC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.27348024417275113,0.9354844432736144,0.5565819861431871,0.8191850787198918,1.0,7/48,8.71%,ADCY2;ADCY8;PANK3;GUCY1B1;ADCY5;ADCY3;ADCY1
prerank,regulation of fat cell differentiation (GO:0045598),-0.2535033661756549,-0.9339495082448466,0.6111111111111112,0.7215220256779558,1.0,30/74,26.84%,PPARD;PPARG;MEDAG;E2F1;LPL;ASXL1;TRIB2;FTO;XBP1;WDFY2;CCDC85B;TRIO;ID2;TAF8;CMKLR1;GATA3;ENPP1;GDF3;SIRT2;SFRP1;ZC3H12A;ANKRD26;CEBPB;IL6;ADIG;TGFB1;ZBTB16;GPS2;BMP2;ZFP36L1
prerank,apoptotic cell clearance (GO:0043277),0.2954008809089438,0.9338522013974011,0.5616113744075829,0.8222416141187427,1.0,5/30,6.42%,XKR4;XKR6;RHOBTB2;ITGB3;XKR8
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2743805854160923,-0.9335117757151248,0.6,0.7221309762577598,1.0,8/53,12.65%,APOE;NUPR1;UCHL5;GNA12;PSME3;RHBDF1;PSMC3;HSP90AB1
prerank,visual system development (GO:0150063),-0.29466942764237264,-0.933459143733103,0.5637931034482758,0.7219007934720035,1.0,6/37,7.50%,SH3PXD2B;C1QA;C3;SMG9;ATF6;SIPA1L3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3566793842129866,-0.9328900844284089,0.5793918918918919,0.7227601032330404,1.0,6/16,19.63%,RTEL1;DHX36;TNKS2;ERCC4;SLX4;ATM
prerank,tRNA wobble base modification (GO:0002097),-0.3748824236171717,-0.932195004445317,0.5687285223367697,0.7239117181060274,1.0,4/14,16.97%,ALKBH1;MOCS3;ADAT2;ELP4
prerank,positive regulation of protein secretion (GO:0050714),-0.2557391805897253,-0.9321044112245624,0.5747126436781609,0.7237634965404569,1.0,9/69,11.16%,IGF1;ABCG1;TLR4;TMED10;ADAM9;GOLPH3L;WLS;ADAM8;MYOM1
prerank,cellular response to gamma radiation (GO:0071480),-0.3557647624929028,-0.9320179117276868,0.5415959252971138,0.7236159897512273,1.0,7/17,22.73%,MAP3K20;XRCC6;WRN;TMEM109;ATM;KDM1A;CRYAB
prerank,polyol metabolic process (GO:0019751),0.26941396096564274,0.9318418127402703,0.5697674418604651,0.8262473638514272,1.0,12/46,12.62%,PLCB1;NUDT11;PLCH2;PLCE1;IP6K2;INPP5J;ITPKA;INPP4B;PLCZ1;PLCD3;CALM1;PPIP5K2
prerank,leukotriene metabolic process (GO:0006691),-0.3401237566347475,-0.9313213389878621,0.5537918871252204,0.7248203307962106,1.0,12/19,43.06%,MAPKAPK2;ALOX5AP;ABCC1;PLA2G4A;PLA2G5;ALOX15;PTGR1;ALOX12;MGST2;MGST3;LTC4S;DPEP2
prerank,dopamine metabolic process (GO:0042417),0.3372668308317384,0.9313016398336845,0.5496535796766744,0.8264807755176544,1.0,6/18,16.07%,SNCAIP;MAOA;MAOB;TGFB2;PRKN;SNCA
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.38339178367827986,0.9309382718673269,0.5447941888619855,0.8261902979581123,1.0,2/11,10.93%,ZFPM2;TGFB2
prerank,spliceosomal complex assembly (GO:0000245),-0.2804565470799625,-0.9305916177931247,0.5635451505016722,0.7260321875318326,1.0,16/46,24.20%,CRNKL1;SNRPG;GCFC2;CELF1;SMN1;YTHDC1;NCBP1;ZRSR2;SF3A1;DDX1;SRSF10;TXNL4A;SF3B1;SRPK1;PRPF6;DDX39B
prerank,positive regulation of bone mineralization (GO:0030501),0.28717595390206424,0.9305348604645,0.5269607843137255,0.8260403367020983,1.0,8/35,9.33%,NELL1;BMPR1B;PTN;ACVR1;GPM6B;ADGRV1;BMP7;TFAP2A
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3467188901404389,-0.9302929622588558,0.5505415162454874,0.7263092274372157,1.0,2/18,1.41%,RUNX1;RB1
prerank,cellular response to hypoxia (GO:0071456),-0.23339140210305515,-0.9300924187311824,0.6134868421052632,0.7263915337107539,1.0,50/126,29.09%,CREBBP;BACH1;PSME4;PSMB7;PSME3;PSMB9;VEGFA;EGLN1;HIF1A;PSMA8;ADAM8;UBC;RPS27A;ARNT;HP1BP3;PSMC3;PSMD8;PLK3;PSMC4;PSMB10;CUL2;PSMA1;PSMB8;VHL;BNIP3L;PGK1;ACAA2;HYOU1;MDM4;ELOC;PSMA5;PSMD4;NDNF;PSMB3;SIRT2;PSMD3;SFRP1;P4HB;HMOX1;LMNA;PSMB1;MYC;MT3;ZFP36L1;HIGD1A;CARD16;EP300;PSMA7;AQP1;BNIP3
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3867102779888788,-0.9298656360548867,0.5578947368421052,0.726545651301038,1.0,5/11,34.58%,CCT7;CCT4;WRAP53;CCT8;CCT5
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3600278040572091,-0.9294418951106976,0.5528169014084507,0.7271250041005586,1.0,4/15,18.45%,PLCG2;EZH2;KLHL18;FAM83D
prerank,response to cholesterol (GO:0070723),-0.3520364162581919,-0.9292254433906574,0.5711743772241993,0.7272458867643736,1.0,7/17,25.05%,GRAMD1B;LRP6;TGFBR1;TGFBR2;TGFB1;GPLD1;ABCA2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.30199150531279795,0.9292181612018959,0.5848623853211009,0.8281890792298189,1.0,9/29,20.95%,ELOVL7;HACD1;ACACA;HSD17B8;ACSL3;ACSL6;ELOVL6;FASN;ELOVL2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.3019481330391947,0.9288583465370489,0.5770171149144254,0.8279438833740259,1.0,4/27,8.69%,FGF12;SCN2B;PTPN3;FXYD6
prerank,positive regulation of ion transport (GO:0043270),-0.27675327412091905,-0.9280720065119162,0.5921985815602837,0.7294427570226087,1.0,13/48,18.23%,ATP2B1;P2RX7;ANO6;CRACR2A;P2RX4;CCR1;WFS1;CCL5;SCN4B;SCN3B;CHRNB2;LILRA5;SNX4
prerank,protein palmitoylation (GO:0018345),-0.30874908834241155,-0.9279718181848491,0.5570934256055363,0.7293219298007528,1.0,10/30,24.43%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;GOLGA7;HHAT;ZDHHC13;ZDHHC6
prerank,positive regulation of chemotaxis (GO:0050921),-0.2797775787087215,-0.9271899095055672,0.5895652173913043,0.7306568643103315,1.0,16/43,23.38%,NRP1;CCR2;P2RX4;IL6R;STX3;VEGFA;MDK;F7;TMSB4X;STX4;PDGFRB;HSPB1;KDR;MEGF8;IL6;TGFB1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.31015920480425174,-0.927073133421906,0.5716814159292035,0.7305745837373774,1.0,4/29,4.65%,FGR;DGKZ;FLT1;PTK2B
prerank,negative regulation of DNA binding (GO:0043392),-0.3102532330124325,-0.926926836666958,0.5691202872531418,0.7305244807165888,1.0,9/28,22.71%,SP100;JUN;MDFI;E2F1;TFAP4;SIN3A;RSF1;KDM1A;SUMO3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.29710034967608234,-0.9265822729561166,0.5932773109243697,0.7309299350460207,1.0,11/36,18.28%,PTPRC;CENPJ;IL10RB;ADIPOR1;CRLF3;NF2;CCL5;OCIAD2;DOT1L;VHL;SOCS3
prerank,glycoprotein metabolic process (GO:0009100),-0.2673512920207571,-0.9263010044073843,0.5783132530120482,0.7312118820687135,1.0,26/53,34.01%,B4GALT5;ST8SIA4;HPSE;MAN1C1;MAN2A1;HIF1A;B4GALT7;GCNT1;LARGE1;GANC;MAN2B1;ERP44;MGAT4B;STT3B;MANBA;MAN1B1;GANAB;AGA;GAL3ST4;ST3GAL4;ADAMTS9;ST8SIA6;CNMD;OGA;FBXO6;MAN2A2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.32089959032987025,0.9259850749894779,0.5613636363636364,0.8341123180883729,1.0,5/22,13.81%,TAFA1;TOX;PTPRZ1;RASSF10;SLC16A2
prerank,organelle fission (GO:0048285),-0.3195851797604904,-0.9257770100560357,0.5692307692307692,0.7320007484151388,1.0,3/24,1.72%,TMCC1;CORO1C;DNM2
prerank,regulation of TORC1 signaling (GO:1903432),-0.29646564216814963,-0.9254565483928407,0.5623931623931624,0.7323980894970048,1.0,7/33,12.09%,GPR137B;KLHL22;PIP4P1;RRAGD;FLCN;SESN1;STK11
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.36442321185498905,-0.9253151959892607,0.5758620689655173,0.7323546930515495,1.0,8/15,27.14%,LRP1;DPP4;FAP;CST3;IL6;TGFB1;FGFR4;PDPN
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.27430616097433813,-0.924941100206556,0.589041095890411,0.7328155267297789,1.0,15/49,23.12%,PMEPA1;RIOK3;CDC42;PTGER4;KIF14;AIDA;NLRC3;LDLRAD4;TFIP11;DDX3X;HMGB1;TMC8;GSK3B;CRYAB;MEFV
prerank,extracellular matrix assembly (GO:0085029),0.3085444586480211,0.9243486521477956,0.5827338129496403,0.837012574347627,1.0,9/23,22.01%,NTNG2;NTNG1;GPM6B;HAS2;RAMP2;FBLN5;EFEMP2;TNXB;NTN4
prerank,protein dephosphorylation (GO:0006470),0.2200768247904682,0.9242318204268808,0.6585365853658537,0.8361771898338634,1.0,18/135,8.98%,PTPRD;PTPRG;PPP2R2B;PTPRN2;PTPRR;PTPRT;PPM1E;MTMR2;EYA2;PTPRK;TNS2;PTPN3;PPTC7;RPRD1A;PPP2R1B;PTPRB;PTPRZ1;PPP2R2A
prerank,heart morphogenesis (GO:0003007),0.26234659690156825,0.9235708877756346,0.5930521091811415,0.8367250361425882,1.0,11/50,13.98%,RYR2;DLC1;ACVR1;SOX9;TBX1;TGFB2;TTN;ALPK2;EPHB4;FLRT2;HES1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.37533213747013205,-0.9235175233965728,0.5701754385964912,0.7355180274232148,1.0,4/13,11.02%,GNAI3;RHOQ;EFL1;GTPBP1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.32144935627732163,-0.9227000698812189,0.5754884547069272,0.736935875243299,1.0,7/23,23.00%,BCL2L11;TIMM22;HSPA4;TIMM29;MAIP1;TOMM22;TOMM70
prerank,bicarbonate transport (GO:0015701),0.3093339117768278,0.9214618249896931,0.5596330275229358,0.8408891382852036,1.0,4/25,10.07%,SLC4A10;SLC4A4;CA2;SLC4A11
prerank,in utero embryonic development (GO:0001701),-0.31396779664146324,-0.9214370801960301,0.5663865546218487,0.7393514027293722,1.0,5/25,11.34%,MBNL1;ZNF568;VEGFA;TGFBR1;FLCN
prerank,endothelial cell proliferation (GO:0001935),-0.34832084698474236,-0.9212197226098688,0.599647266313933,0.7394555299914328,1.0,3/17,8.99%,ERN1;THAP1;ITGB1BP1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3813262169752166,-0.9209705160080016,0.5724381625441696,0.7396325626247285,1.0,4/12,12.54%,RB1;CTNNB1;BUB1;FEN1
prerank,peptidyl-arginine modification (GO:0018195),-0.35728591169960466,-0.9205023872555089,0.583904109589041,0.740270611359413,1.0,7/15,39.14%,PRMT1;PADI4;ART4;PRMT5;PADI1;KRTCAP2;PRMT8
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3914665967357212,-0.920354160014704,0.5696864111498258,0.7402505243283332,1.0,2/11,2.64%,IGF1;IGF1R
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3944877704953247,0.9202556967080842,0.5388235294117647,0.8427739021546867,1.0,2/10,3.70%,PDE4D;PDE11A
prerank,skin development (GO:0043588),-0.2580799379368314,-0.91973743570679,0.6095551894563427,0.7412345469608211,1.0,16/65,25.78%,CLIC4;ATP7A;ANXA1;ADAM9;JAG1;ITGA3;CLDN1;PIP5K1A;TXNIP;PDGFA;ASAH1;SFN;LSR;DSP;COL5A2;CERS3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2457243378695574,-0.9196268855094586,0.6151368760064412,0.7411434443721887,1.0,27/84,21.84%,MBNL1;RBM39;MBNL2;SON;TRA2B;SMU1;MBNL3;HNRNPL;CWC22;DDX5;CELF1;YTHDC1;NCBP1;NCL;DAZAP1;WTAP;SRSF10;RNPS1;NSRP1;HNRNPA1;MAGOH;C1QBP;RBM3;RBM11;HNRNPK;ZBTB7A;SRPK1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.30983292240489935,-0.9189448736712558,0.5759162303664922,0.742264418832661,1.0,9/27,24.84%,NIBAN2;PARP4;HGF;PDGFRB;ATM;BMPR2;PDGFA;MYC;FGFR4
prerank,regulation of mRNA processing (GO:0050684),-0.2979442478252664,-0.9187497903708415,0.579225352112676,0.7423407068935084,1.0,13/32,26.84%,RBM39;SON;DHX9;CWC22;YTHDC1;NCBP1;SRSF10;PAPOLA;HNRNPK;SRPK1;PTCD2;LARP7;ZFP36L1
prerank,histone H4 deacetylation (GO:0070933),-0.39274307248888046,-0.918546917832122,0.5559440559440559,0.7424061234840839,1.0,1/10,0.80%,RCOR1
prerank,mRNA stabilization (GO:0048255),-0.2835326451309643,-0.9173947822100804,0.5792079207920792,0.744565959646888,1.0,8/40,13.09%,MAPKAPK2;DHX9;MAPK14;FUS;E2F1;MYD88;TENT5A;BOLL
prerank,positive regulation of macrophage migration (GO:1905523),-0.3382516850077896,-0.916833960833947,0.5891608391608392,0.745416923671867,1.0,7/19,22.16%,P2RX4;MDK;CCL5;IL34;CMKLR1;CSF1;MAPK1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3128917881164958,0.9165926712558414,0.5788235294117647,0.8508609630279755,1.0,8/21,16.13%,SLC8A3;SLC25A23;LETM1;FATE1;BCAP31;MICU3;ATP2A1;PDZD8
prerank,positive regulation of signaling receptor activity (GO:2000273),0.28378117514685375,0.9165135972105602,0.6052009456264775,0.8498975002690577,1.0,16/36,22.43%,TGFA;EGF;SHANK3;AREG;ADRA2C;EDN1;FBXW7;RELN;ARC;JAK2;ADAM17;CCL2;NCOA3;HDAC2;NLGN3;HDAC6
prerank,negative regulation of inclusion body assembly (GO:0090084),0.3854279330425303,0.9161776072607061,0.5450643776824035,0.8496036092235458,1.0,3/10,13.04%,SACS;DNAJA4;DNAJB2
prerank,bile acid metabolic process (GO:0008206),0.2984779411871147,0.915887826579644,0.5697115384615384,0.8491556956362802,1.0,10/27,15.12%,OSBPL6;SLC27A2;OSBPL7;ACOX2;HSD3B7;OSBPL2;ABCB11;ACOT8;HSD17B4;CYP39A1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2753136840936242,-0.9158238981849968,0.6059602649006622,0.7472622895959696,1.0,18/46,29.95%,DDHD1;DGKZ;SLC27A1;PLD2;GPD1;DGKD;ABHD5;AGPAT1;PLA2G4A;DGKG;PLA2G5;PLA2G12A;GPD1L;LCLAT1;DGKA;LIPH;GPAT2;LPCAT4
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.33572444887518565,-0.9156817256236175,0.5960854092526691,0.7471857343902061,1.0,9/19,30.08%,IGF1;ZC3H12A;NLRP3;MEFV;CARD16;CPTP;FFAR4;GHRL;PYDC1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3678731124572804,0.9151001423721946,0.5818181818181818,0.8499468334728002,1.0,2/12,3.06%,PRKG1;IGFBP5
prerank,polyol biosynthetic process (GO:0046173),-0.3501455095549606,-0.914411217510642,0.569023569023569,0.7495521026958909,1.0,7/16,26.23%,ACER3;ITPKB;CYP27A1;CYP2R1;IP6K3;ITPKC;IP6K1
prerank,xenobiotic transport (GO:0042908),-0.3447259890818663,-0.9141998319865845,0.5582608695652174,0.7496491788109404,1.0,10/17,38.50%,ABCC1;SLC7A5;SLC22A18;SLC22A3;ABCC3;ABCA3;GJA1;NR1I2;SLC22A2;SLC29A4
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.35234418524395505,-0.9140328215043345,0.5778546712802768,0.7496577666357445,1.0,9/16,29.33%,ARID1A;DDX5;PPARGC1B;DDX54;ESR2;TADA3;ESR1;SAFB;DDX17
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3241700214220049,0.9134277630079117,0.591743119266055,0.8530034479950671,1.0,5/20,13.39%,SPRY4;APLN;SMOC2;CREB3L1;SPRY1
prerank,epithelium development (GO:0060429),-0.23541382334723443,-0.9133570641556309,0.6334459459459459,0.7507362797948225,1.0,38/107,33.43%,CTSB;ANXA4;TAGLN2;PPARG;CPT1A;VEGFA;RCN3;TIMELESS;CDK1;OSR1;PCNA;FOXJ1;CBR1;TPP1;SOX10;STIL;PGK1;WNT3;EHF;STAT1;KDR;TBX2;SNAI2;ANXA7;TGFB1;ACADVL;VDAC1;WNT7B;BMP2;SPINK5;GRHL2;IFT122;PAX2;DAG1;VCL;SOX8;PPP2R3A;MTHFD1
prerank,fatty acid metabolic process (GO:0006631),-0.23292017867550005,-0.9133282431486924,0.637987012987013,0.7504550628036124,1.0,28/115,27.27%,AOAH;CD36;PPARD;ABCD2;PPARG;CPT1A;ADIPOR1;ALOX5AP;ACADM;LPL;XBP1;ACSL5;GPX4;PON2;ABCD3;MCAT;ACOX1;ACSBG1;ACOT2;ACOT4;ACAD9;ECHDC3;PNPLA8;PON3;SLC27A3;ALOX15;PLA2G15;LIPH
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.34037380266840955,-0.9133221604212838,0.5792988313856428,0.7501243057519611,1.0,7/18,32.44%,FLNA;POLR2L;MAF1;RASL11A;UBTF;EIF2AK3;ATF4
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.2922819871677403,-0.9128663736466579,0.5863247863247864,0.7507259997557473,1.0,16/35,29.33%,ZMIZ1;KDM3A;PMEPA1;ARID1A;WBP2;DDX5;UBE3A;CALCOCO1;NR3C1;PPARGC1B;DDX54;ESR2;TADA3;ESR1;SAFB;DDX17
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3521864561073812,-0.9127228048765585,0.5887850467289719,0.7506877151729586,1.0,3/15,15.10%,COQ8A;NDUFA9;FDXR
prerank,tRNA methylation (GO:0030488),-0.28803303339079267,-0.9126195192546069,0.6031746031746031,0.7505494417863029,1.0,13/34,34.55%,METTL1;PRORP;DALRD3;TRMT44;METTL6;BCDIN3D;METTL2B;METTL2A;THADA;HSD17B10;FTSJ1;TRMT61A;TRMT61B
prerank,cardiac myofibril assembly (GO:0055003),-0.35803768266886177,-0.9120615530315476,0.5688405797101449,0.7513958249070284,1.0,2/15,7.52%,MEF2A;NRAP
prerank,cellular copper ion homeostasis (GO:0006878),-0.3606597410644233,-0.9120287733960944,0.5773195876288659,0.751130321565797,1.0,4/14,13.43%,ATP7A;SLC31A1;APP;MT2A
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3085059855757639,0.9118264160256025,0.5771971496437055,0.8557378837068707,1.0,3/22,7.27%,APOD;ALK;APOC1
prerank,positive regulation of response to wounding (GO:1903036),-0.3182849490819007,-0.9115246084327621,0.5859106529209622,0.7518520773277887,1.0,5/24,8.06%,ITGB1;ARFGEF1;ANXA1;GRN;MDK
prerank,cardiac atrium morphogenesis (GO:0003209),-0.35100329413808207,-0.9113803137558102,0.6096654275092936,0.7517964437351012,1.0,1/16,0.56%,NOTCH2
prerank,extracellular matrix organization (GO:0030198),0.19732579826314797,0.9113527467786383,0.7838616714697406,0.8557560446919972,1.0,71/276,20.57%,ADAM12;MMP16;TNR;P3H2;ADAMTS17;COL27A1;LAMC3;TLL1;MMP12;VCAN;DST;ADAMTS16;SCUBE1;COL11A1;ITGB8;ADAMTSL1;GFOD2;GPM6B;VCAM1;MMP15;ITGB3;ITGA9;VIT;COLGALT2;COL25A1;THSD4;PLOD2;COL4A3;COL23A1;COL19A1;CD151;MMP13;HAS2;SMOC2;CTSK;GSN;TGFB2;HTRA1;TTR;BMP1;COL7A1;ADAMTS5;ITGA11;ADAMTS12;CREB3L1;ADAMTS6;FLRT2;CDH1;CAPNS2;COL24A1;NID2;SPARC;CAPN2;ST7;ADAMTSL2;LAMA2;COL1A1;FBLN5;LOXL1;LAMA5;COL26A1;SMOC1;TNC;SH3PXD2A;KLKB1;LOX;JAM3;COL4A4;NID1;MMP14;ITGA2B
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.29795385247629785,0.9110451723143032,0.5950617283950618,0.8553464977033243,1.0,4/26,11.46%,PLCB1;UBE2E2;FGF10;RPTOR
prerank,negative regulation of calcium ion transport (GO:0051926),-0.35669576198131814,-0.9101999520545836,0.5914742451154529,0.7539262147696095,1.0,6/15,32.12%,LILRB1;TMBIM6;PLN;INPP5K;PACSIN3;SLC30A1
prerank,amino acid import (GO:0043090),0.318268678509702,0.9101536279397998,0.5849056603773585,0.8564600981972826,1.0,7/21,13.81%,SLC47A1;SLC1A1;SLC6A1;SLC6A13;SFXN3;SLC25A38;SLC16A2
prerank,ovarian follicle development (GO:0001541),-0.37078293899965786,-0.9099123208778612,0.5945485519591142,0.7541830248252721,1.0,6/13,28.48%,VEGFA;ANG;CEBPB;INHA;EIF2B2;EIF2B4
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3605412782441205,-0.9095202970509428,0.5911413969335605,0.7546345033662003,1.0,6/14,18.01%,BRCA1;CTR9;CTNNB1;WDR5;KMT2A;MYB
prerank,establishment of spindle localization (GO:0051293),-0.36333766114562915,-0.9087771383212594,0.591304347826087,0.7558772127970987,1.0,4/14,18.37%,DYNC1H1;MAP4;NUSAP1;CFL1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.2820612075757882,-0.907699492368536,0.6125211505922166,0.7577254768105613,1.0,10/38,17.56%,PTPRC;NEDD9;RAP2B;MVP;GAS6;AGT;APP;IL34;GPRC5B;LILRA5
prerank,regulation of DNA metabolic process (GO:0051052),-0.2749958314857815,-0.9075231628608813,0.5989761092150171,0.7577218863376849,1.0,15/44,25.66%,NUCKS1;IL7R;ALYREF;KAT7;TICRR;RADX;MPV17;NBN;PDGFA;WDR70;HDAC8;SMG1;UBE2V2;MYC;UBE2N
prerank,negative regulation of chemokine production (GO:0032682),-0.35686245915839016,-0.9073555739354201,0.579225352112676,0.7577520357532864,1.0,7/14,28.61%,SIRPA;MAP2K5;OAS3;LGALS9;IL6;MEFV;SIGIRR
prerank,regulation of phospholipase activity (GO:0010517),-0.40158611439067826,-0.9070027530472949,0.5877192982456141,0.7581890610742206,1.0,1/10,1.17%,LRP1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.31704003871750497,-0.906415691005715,0.6,0.7590672366849617,1.0,10/23,30.08%,IGF1;GAS6;ZC3H12A;NLRP3;MEFV;CARD16;CPTP;FFAR4;GHRL;PYDC1
prerank,cellular response to ATP (GO:0071318),-0.3544406175021851,-0.9061781221896972,0.591304347826087,0.759189382657389,1.0,4/14,15.57%,P2RX7;P2RX4;HSP90B1;SSH1
prerank,striated muscle cell development (GO:0055002),0.34094381449725286,0.9054264251503431,0.5853131749460043,0.8670562551094169,1.0,3/14,11.24%,SDC1;CAPN3;PGM5
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2892025354942993,-0.9053556303178056,0.6075731497418244,0.7605579653086495,1.0,12/34,20.80%,PTPRJ;PTPN12;PTPN22;DUSP3;PTPN6;DUSP6;PTPRO;PTPN13;PTPN11;DUSP5;UBASH3B;PTPN1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.30219258171901653,0.9050301117431607,0.5779816513761468,0.8668650910499164,1.0,6/26,11.04%,ANK2;CASQ2;NETO1;NEDD4;ATP1B1;KCNG1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3530129798998439,-0.9050003761080188,0.6178010471204188,0.7609463594743029,1.0,2/15,3.85%,SNX10;PIBF1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.31321259784043604,0.904854947243451,0.600451467268623,0.8661558777804964,1.0,6/22,12.99%,EPB41L4B;PTPRK;FGF10;PRKD1;AREG;KLF9
prerank,cellular amino acid catabolic process (GO:0009063),0.23089431707898944,0.9039378979769377,0.6790123456790124,0.8672615600683448,1.0,28/87,24.10%,GLDC;ASPA;GOT1;SARDH;GLUL;HMGCLL1;MCCC2;GSTZ1;MCCC1;BCAT1;AASS;ABAT;SDSL;DBT;GLS2;GLS;ACAT1;ALDH5A1;CBS;BCAT2;ALDH7A1;CARNS1;SLC25A21;BCKDHB;NOS1;SHMT2;HNMT;ACADSB
prerank,regulation of chondrocyte differentiation (GO:0032330),0.29643848938870043,0.9034096777536816,0.6112412177985949,0.867373250567203,1.0,7/24,12.65%,BMPR1B;SOX5;WNT9A;SOX6;SOX9;MBOAT2;ADAMTS12
prerank,rRNA methylation (GO:0031167),-0.3188514694901086,-0.902504854268351,0.6010733452593918,0.765842234952029,1.0,6/22,25.44%,NSUN3;NSUN4;DIMT1;EMG1;BUD23;MRM2
prerank,regulation of hippo signaling (GO:0035330),0.3275165557608899,0.9024320505273622,0.5785876993166287,0.8686266526739925,1.0,8/17,17.63%,SOX11;WWC1;WTIP;MARK3;SCHIP1;SHANK2;CIT;DLG5
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3414386279717138,-0.9021249758543286,0.6192893401015228,0.7662783232978484,1.0,4/17,14.72%,ROCK1;VEGFA;PPP1R12A;IKBKB
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.24426963869854337,-0.9019816325730622,0.6365131578947368,0.7662389351294755,1.0,21/78,23.29%,IPO5;CCND3;HHEX;ACTB;CCNY;BLM;INCA1;CDK5RAP1;CDKN3;CDC25A;GADD45A;TFAP4;CCNE1;LATS2;CDKN2C;SERTAD1;CNPPD1;CDC25C;CCNK;CCNF;CCNB1
prerank,response to light stimulus (GO:0009416),0.2511370599990085,0.9019405681153158,0.6343825665859564,0.8686678002593785,1.0,11/55,12.03%,MAPK10;MAP2K7;GTF2H2;TRPM1;OPN3;OPN1MW;OPN1MW3;OPN5;OPN4;BRSK1;MEN1
prerank,positive regulation of translational initiation (GO:0045948),-0.33515911374597984,-0.9016253134985769,0.5693430656934306,0.7666481290793139,1.0,5/18,19.06%,YTHDF3;CCL5;BOLL;POLR2G;DDX3X
prerank,regulation of cholesterol transport (GO:0032374),-0.32535163220277286,-0.9015692255562605,0.6163194444444444,0.7664283762094787,1.0,5/20,15.21%,LRP1;NFKB1;NR1H2;TTC39B;ABCA13
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2931817864928007,-0.9008006622811834,0.6135957066189625,0.7677104554394958,1.0,10/30,24.97%,MGAT5;ALG5;DPM3;ST6GAL1;MAGT1;NUDT14;MGAT2;STT3B;DDOST;MCFD2
prerank,response to organic cyclic compound (GO:0014070),-0.26298509556207617,-0.9003621458962349,0.627318718381113,0.7683186291887673,1.0,18/52,28.06%,KYNU;STAT3;IL18;ANXA1;TIPARP;CTNNB1;STAT5B;CCL5;SPP1;CHRNB2;SFRP1;TGFB1;CYP1B1;FGFR4;ABCA2;HLCS;ESR1;ALPL
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.34211164962836815,-0.9002570410391646,0.6061643835616438,0.7681805872582526,1.0,5/18,22.93%,NFE2L2;HIF1A;MAPK7;HSPB1;NONO
prerank,negative regulation of hydrolase activity (GO:0051346),-0.26638601658127453,-0.9002114332289338,0.6252129471890971,0.7679303681444843,1.0,13/49,23.53%,ZCCHC9;LRCH1;ARFGEF1;EGLN1;GPATCH2;MAPK7;CST7;CST3;TMED2;RASA4;WNK1;SH2D4A;URI1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.2958177347759295,-0.9000224672159401,0.6254180602006689,0.7679942320872584,1.0,9/33,18.37%,IGF1;SLC35F6;HGF;VAT1;FLCN;GHITM;HSPA1A;ACAA2;HUWE1
prerank,positive regulation of cell aging (GO:0090343),-0.3776777940023476,-0.8993713629854029,0.5960854092526691,0.7690036489903506,1.0,4/11,15.88%,CGAS;B2M;EEF1E1;ARG2
prerank,vasoconstriction (GO:0042310),-0.37797840438049113,-0.8993222559110858,0.5905096660808435,0.7687517232947879,1.0,4/11,15.01%,HTR2B;SLC8A1;EDNRA;PIK3C2A
prerank,purine ribonucleotide catabolic process (GO:0009154),0.31694788212844227,0.8992953597386159,0.6017897091722595,0.8739801901120294,1.0,7/21,17.45%,PDE4D;PDE9A;NUDT11;NUDT7;ACAT1;MLYCD;NUDT3
prerank,Golgi inheritance (GO:0048313),-0.37807383717230403,-0.8987912694121353,0.6092362344582594,0.7694776866791052,1.0,3/11,12.93%,CDK1;STX5;PLK3
prerank,fatty acid beta-oxidation (GO:0006635),-0.2594532341161672,-0.8983255760248837,0.6389830508474577,0.7700770097985367,1.0,20/51,33.45%,PPARD;ABCD2;ACADM;ACAD11;ACAT2;ABCD3;MCAT;ACOX1;ACAA2;AMACR;ACADVL;ACOXL;HSD17B10;ACADS;ECHDC2;ACAD10;SCP2;ECHS1;HADH;SLC25A17
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.37403962623869974,-0.8980662291489966,0.6075268817204301,0.7702255709510546,1.0,4/12,25.18%,IMPDH2;ADSS1;PFAS;ATIC
prerank,protein localization to condensed chromosome (GO:1903083),-0.37041548720576273,-0.8972012803011324,0.6303236797274276,0.7717023319235883,1.0,4/12,15.45%,KNL1;ZWILCH;CDK1;TTK
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3403800324650241,-0.8969719540945625,0.6123893805309735,0.77182831532732,1.0,3/16,11.25%,CREBBP;NAA25;NAA50
prerank,lipid biosynthetic process (GO:0008610),0.23720905371438233,0.8968834256788869,0.6552567237163814,0.8786670017365171,1.0,24/77,26.19%,PAM;CYP51A1;GPAM;AGPAT3;ACSM5;OLAH;NDUFAB1;ACSS2;ACACA;MVK;LSS;HSD17B8;MLYCD;ACSM3;CLN8;ACSL6;GPAT4;PDSS1;MVD;OXSM;PRKAA2;PRLR;MBOAT1;FDFT1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3140453046655145,0.896635046367981,0.6264236902050114,0.8768991472244496,1.0,6/20,20.24%,GSTZ1;GSTP1;GSTK1;GSTM5;GSTA4;GSTT1
prerank,glutathione derivative metabolic process (GO:1901685),0.3140453046655145,0.896635046367981,0.6264236902050114,0.8768991472244496,1.0,6/20,20.24%,GSTZ1;GSTP1;GSTK1;GSTM5;GSTA4;GSTT1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.39373502764211654,-0.8964746236643656,0.599647266313933,0.7724828142590531,1.0,4/10,27.33%,PSMC3;PSMC4;HMGB1;ESR1
prerank,hexose biosynthetic process (GO:0019319),0.26797072200218236,0.8964293163284105,0.6294536817102138,0.8762172548233913,1.0,10/42,14.31%,PFKFB1;GOT1;ENO1;GAPDHS;G6PC3;G6PC1;ALDOB;SLC25A11;PER2;PPARGC1A
prerank,response to retinoic acid (GO:0032526),0.2445235901333531,0.8962976248347211,0.6518518518518519,0.8753898416807068,1.0,17/59,20.48%,BRINP3;BRINP1;RORB;TESC;WNT9A;SOX9;LTK;TBX1;RET;EPHA3;BRINP2;FZD4;SNW1;ADNP2;WNT5A;WNT5B;FZD10
prerank,sulfur compound catabolic process (GO:0044273),0.2692120515548971,0.8962249293067852,0.6306695464362851,0.8743934107501314,1.0,13/38,16.69%,HEXB;VCAN;NUDT7;OMD;GLB1;GGT1;CTH;ACAT1;MLYCD;IDUA;GGT5;ADO;IDS
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3199442205336108,0.8961305134676374,0.5780487804878048,0.8734708726212638,1.0,6/18,13.98%,TENM4;PTN;PTPRZ1;DAAM2;HES5;HES1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2363340009891553,-0.8960292490034361,0.6751700680272109,0.773029377011876,1.0,32/88,32.38%,APOE;NRP1;XDH;HTR2B;NRP2;VEGFA;TGFBR1;HIF1A;ARNT;HMGB2;PIK3CD;ANG;NR4A1;NRAS;AGGF1;BMPR2;STAT1;KDR;APOH;FGF18;VASH2;BMP2;VIP;CCL24;GHRL;NRARP;FGF16;TNMD;ATP5F1A;FGF2;CAV1;CNMD
prerank,B cell activation involved in immune response (GO:0002312),-0.36033358899247103,-0.8953557566268368,0.612565445026178,0.7741564163431699,1.0,6/13,33.87%,BATF;RNF8;FCGR2B;GAPT;CD19;EXOSC3
prerank,positive regulation of telomere maintenance (GO:0032206),-0.29395495123510945,-0.8951699230448132,0.615257048092869,0.7741660390678762,1.0,14/31,33.91%,RTEL1;PKIB;DHX36;TNKS2;SLX4;ATM;NBN;MAPK1;MRE11;PML;MAPK15;MAP3K4;NEK7;TNKS
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.313841941465443,-0.8951168589491584,0.6260720411663808,0.7739456965100615,1.0,13/23,31.15%,LTBP4;ITGA3;LATS2;SMAD7;SMURF2;EID2;TGFB1;SMAD4;ENG;BCL9;NREP;DKK3;SMAD2
prerank,atrioventricular valve development (GO:0003171),0.3452690651535619,0.8947262845322531,0.5956416464891041,0.8756805690485255,1.0,3/14,10.93%,SLIT3;ACVR1;TGFB2
prerank,response to glucocorticoid (GO:0051384),0.2931183440770369,0.8946126310667608,0.6262626262626263,0.8748156158894845,1.0,3/26,4.76%,SLIT3;SLIT2;GOT1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.32842771034640317,-0.8942695932446314,0.6319444444444444,0.775325641738396,1.0,6/18,25.17%,CCT7;DCP2;SHQ1;CCT4;EXOSC10;NHP2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.33403666307278557,0.8938122528420491,0.6109839816933639,0.8756081749686435,1.0,7/14,22.52%,PKIA;ATP2B4;PRKAR1A;SIRT1;PRKAR2B;HTT;PRKAR1B
prerank,modulation by symbiont of entry into host (GO:0052372),0.3424992141088011,0.8936221056478549,0.6303317535545023,0.8748944291779377,1.0,1/16,0.53%,HS3ST5
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2923242307091675,0.8930423595258821,0.625,0.8751221216962085,1.0,6/27,16.92%,HTR2C;GRM1;AGTR1;F2RL2;OPRL1;GPR157
prerank,regulation of lipase activity (GO:0060191),0.34406540949683284,0.8929566651911542,0.5898058252427184,0.874162622911095,1.0,4/13,16.07%,PCSK5;PCSK6;ANGPTL3;SNCA
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.24966027069107943,0.8928396853328412,0.6477832512315271,0.8733062399062059,1.0,11/52,16.11%,DPP10;SORBS1;PRKCE;RAMP3;PRKCI;NKD2;ARF6;STAC;ATP2B4;WNK3;EPHA3
prerank,negative regulation of myotube differentiation (GO:0010832),0.35750668624587545,0.8926360354721673,0.6101694915254238,0.8725957457545724,1.0,2/12,7.07%,CCN3;BDNF
prerank,oligodendrocyte development (GO:0014003),-0.3438801993956415,-0.8924147101774997,0.6230899830220713,0.7788520103472967,1.0,6/15,28.48%,B4GALT5;EIF2B3;SOX10;EIF2B1;EIF2B2;EIF2B4
prerank,regulation of multicellular organism growth (GO:0040014),-0.3494668705098349,-0.8923287165374129,0.6355785837651122,0.778694205945838,1.0,3/15,11.05%,IGF1;STAT5B;APP
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2627175070919156,0.8921833848658534,0.6572769953051644,0.8725603618178366,1.0,8/44,11.69%,TENM1;PRKCE;CARMIL1;CARMIL2;SPIRE1;NCKAP1;GSN;ARF6
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.2596986236677517,-0.8908498646992614,0.6581196581196581,0.781240058836633,1.0,16/52,26.98%,MTHFS;IDH1;MTHFD1L;ME2;DGLUCY;MTHFD2L;OGDH;ASS1;ACOT4;MTHFR;SHMT1;MDH1;D2HGDH;MDH2;FPGS;HOGA1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.29927854546477,-0.8908334298433942,0.6175438596491228,0.7809233762963778,1.0,13/29,34.12%,PAK2;RIPK1;AGT;TRAF2;BID;TNFSF10;SFRP1;DEDD2;PML;AGTR2;BCL10;CAV1;TNF
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.29249323156451057,-0.8905784957592929,0.6446700507614214,0.7811083082352799,1.0,9/29,17.60%,PRKCD;ARFGEF1;CYRIB;MYADM;LIMA1;PIK3CA;SSH3;SSH1;TWF2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.34425985474530535,-0.890566708643175,0.5996563573883161,0.7807797870662485,1.0,5/15,16.88%,RAB3GAP1;SRP14;ZFAND2A;RAB10;SRPRB
prerank,skeletal muscle organ development (GO:0060538),-0.30142262194510516,-0.890349910611872,0.6427320490367776,0.7808428564426676,1.0,4/26,14.55%,SVIL;CFLAR;MEF2C;LARGE1
prerank,glutamate metabolic process (GO:0006536),0.32743924251395984,0.8903311522642612,0.6278538812785388,0.8758165733297143,1.0,7/19,17.21%,GOT1;GLUL;ALDH18A1;GGT1;GLS2;GLS;ALDH5A1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.347571979853142,-0.890213862107621,0.601123595505618,0.7807880351582737,1.0,8/14,41.98%,ENTPD6;ENTPD3;NUDT15;NUDT16;ENTPD7;NUDT1;NUDT5;ENTPD1
prerank,microtubule depolymerization (GO:0007019),-0.33754219051291073,-0.8902108057563918,0.5842293906810035,0.7804468273710541,1.0,11/17,40.27%,CKAP5;KIF14;KIF2C;STMN2;KIF18B;KIF19;NCKAP5L;KIF18A;KATNB1;CCSAP;KIF24
prerank,negative regulation of hippo signaling (GO:0035331),0.3543046270477525,0.889920593129774,0.6179245283018868,0.875689290725462,1.0,7/12,21.87%,WWC1;WTIP;MARK3;SHANK2;CIT;DLG5;AJUBA
prerank,protein homotetramerization (GO:0051289),0.2511786948544024,0.8897225816418034,0.6641025641025641,0.8750425122624946,1.0,13/49,17.38%,RYR3;CRYZ;CBY1;RYR1;HCN1;ACACA;KCNJ12;GOLGA2;OSBPL2;CTH;GLS;ALDH1A3;TRPM2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.321124416639752,0.8891150100095535,0.5918367346938775,0.87533854603379,1.0,5/18,14.16%,ASPA;GOT1;ADI1;FOLH1;ASNS
prerank,response to ATP (GO:0033198),-0.33196944834489306,-0.8889155318498462,0.6175942549371634,0.7828004204479713,1.0,4/18,15.57%,P2RX7;P2RX4;HSP90B1;SSH1
prerank,regulation of receptor binding (GO:1900120),-0.3839040038079575,-0.8882828073175634,0.6126279863481229,0.7837663139788078,1.0,3/10,12.32%,B2M;ATP2A3;ADAM15
prerank,protein destabilization (GO:0031648),-0.2859094900559896,-0.8882443510371606,0.6230899830220713,0.7834844247004757,1.0,6/32,10.59%,CREBBP;GGA3;FBXW11;SERF2;CTSH;DERL1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3539656019612643,-0.8881576801763559,0.6108108108108108,0.7833170463917573,1.0,5/13,26.43%,NRROS;CD46;GREM1;GREM2;BMP2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3514782114144718,-0.8879945506782572,0.6215277777777778,0.7833015432338363,1.0,3/15,15.12%,IGF1;HGF;GHITM
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.3792585621030603,0.887575880397305,0.5953488372093023,0.8779017999881666,1.0,2/10,8.65%,SOX11;BMP7
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.2291060557942041,-0.887251795301375,0.717607973421927,0.7845120012694453,1.0,35/104,26.69%,PPARG;PMEPA1;SNX6;SKI;TGFBR1;TGFB1I1;SNX25;UBC;RPS27A;SPRED1;SPRY2;PIN1;SPRED2;HTRA3;ACVR2A;TGFBR2;GREM1;LEMD2;LDLRAD4;VASN;HSPA1A;SMAD7;IL17RD;RBPMS2;GDF3;BMPR2;SMURF2;ZBTB7A;EID2;TGFB1;LRP2;SKIL;SMAD4;BMP2;SMURF1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.24463747939828878,-0.8871812848759787,0.6885813148788927,0.7843024944659654,1.0,31/69,33.76%,AMFR;RHBDD2;WFS1;ERLIN1;DNAJB9;SELENOS;DNAJB14;DERL1;UBE4B;SEL1L;HSP90B1;RNF185;RNF121;STT3B;FOXRED2;SGTA;TRIM25;FAF2;BAG6;MAN1B1;EDEM1;VCP;UBE4A;AUP1;STUB1;UBXN4;DNAJC18;SEL1L2;FBXO6;DNAJB12;UBQLN2
prerank,protein targeting to mitochondrion (GO:0006626),-0.26010059445550565,-0.8870618609922605,0.6655112651646448,0.7841884960557758,1.0,15/52,23.00%,IMMP2L;PITRM1;TOMM40L;FIS1;TIMM21;TIMM44;TIMM22;HSPA4;TIMM29;GRPEL2;FBXO7;TOMM22;TOMM34;TOMM20L;TOMM70
prerank,acidic amino acid transport (GO:0015800),0.32774485643630213,0.8864992017258665,0.6056034482758621,0.8794210363480048,1.0,5/17,9.46%,SLC1A2;SLC1A6;SLC1A1;SLC6A1;SLC6A13
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.34274320469137565,-0.8862714466811834,0.6318493150684932,0.7853974904247056,1.0,2/16,1.52%,APOE;CD36
prerank,autophagy of mitochondrion (GO:0000422),-0.2780389025072247,-0.8860227830259755,0.6187943262411347,0.7855567042769172,1.0,9/38,17.82%,ATG5;ATG7;ULK2;FIS1;RB1CC1;MARK2;GABARAP;USP30;FBXO7
prerank,membrane fusion (GO:0061025),0.2713672160691236,0.885966266626749,0.6467661691542289,0.8795767980458422,1.0,5/33,11.82%,DNM3;RIMS1;DNM1;DYSF;NSFL1C
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.35981489933493477,-0.8857811053595169,0.6197916666666666,0.7856811102229162,1.0,4/14,13.40%,NRP1;VEGFA;PIK3CA;PIK3CD
prerank,regulation of cellular pH (GO:0030641),0.28547398864094164,0.8855329459784803,0.657074340527578,0.8794212382009026,1.0,4/29,5.65%,SLC4A10;SLC4A4;SLC9A2;CA2
prerank,positive regulation of protein acetylation (GO:1901985),-0.3662128060172438,-0.8854133486724692,0.6072607260726073,0.7861117609855294,1.0,3/12,19.06%,CEP295;TAOK1;DDX3X
prerank,negative regulation of protein polymerization (GO:0032272),0.28707838135198105,0.8850711295192585,0.6255813953488372,0.879344362648755,1.0,8/27,16.96%,MAP2;SLIT2;TUBB4A;KANK1;EML2;CDH5;SNCA;KANK4
prerank,Rac protein signal transduction (GO:0016601),0.32056836926943705,0.8845670043191007,0.6146572104018913,0.8793484716002674,1.0,5/18,11.54%,CDH13;WASF1;ABI2;NCKAP1;FARP2
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3812524613930732,0.8844092212851717,0.6241299303944315,0.8785691850354804,1.0,4/10,18.53%,MTMR2;MFSD2A;MTMR9;MTMR4
prerank,protein export from nucleus (GO:0006611),-0.29639210219477485,-0.884245320537829,0.6233108108108109,0.7881088594630455,1.0,13/27,32.74%,NUP42;XPO6;XPO5;TPR;STRADA;CCHCR1;EGR2;TGFB1;SMURF1;CSE1L;STYX;XPO7;ANKLE1
prerank,negative regulation of ATPase activity (GO:0032780),0.33288299398213694,0.8841063362614281,0.6313253012048192,0.8781116192721742,1.0,5/16,19.74%,TSC1;TNNT2;PPIF;VCPKMT;SIRT1
prerank,carbohydrate transport (GO:0008643),0.3621201020298168,0.8829620159537097,0.6027397260273972,0.8796826253392777,1.0,1/11,1.11%,SLC2A5
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3672529524453859,-0.8825276929622745,0.6363636363636364,0.7912383919183329,1.0,6/11,26.53%,FRS2;MEF2C;GREM1;TGFB1;BMP2;FZD7
prerank,outer dynein arm assembly (GO:0036158),0.3374603483943255,0.882228105279324,0.6100917431192661,0.8802592298632458,1.0,5/15,17.67%,ODAD3;DNAH17;DNAAF4;LRRC49;DNAH5
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3001125456677703,0.8816668434960685,0.6542056074766355,0.8804779023845524,1.0,4/24,6.15%,PEX5L;PDE4D;PDE11A;GNAI1
prerank,protein oxidation (GO:0018158),0.37005649717514144,0.8814672638440979,0.6013986013986014,0.8798262946811075,1.0,11/11,63.02%,LOXL1;LOX;TMX3;SUMF1;APOA1;LOXL4;LOXL2;PRDX3;CHCHD4;LOXL3;APOA2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3105897059868168,-0.8813706460572904,0.6417657045840407,0.7932188015354948,1.0,4/21,5.68%,BIRC3;USP50;AIM2;PSMB9
prerank,canonical Wnt signaling pathway (GO:0060070),-0.24593152369323848,-0.880991742932489,0.6805555555555556,0.7936425914504637,1.0,21/68,28.56%,RARG;AXIN1;LRP6;CTNNB1;PPP1CA;RAB5A;TCF7;GATA3;RYK;WNT3;GSK3B;SFRP1;PLPP3;DVL2;WNT7B;FZD1;FZD7;BCL9;WNT6;FRAT1;LEF1
prerank,autophagy of peroxisome (GO:0030242),-0.3626337039244827,-0.8804457787598317,0.6140939597315436,0.7943837532830952,1.0,7/12,36.11%,RB1CC1;USP30;ATM;TRAPPC8;SQSTM1;PEX5;PJVK
prerank,detection of mechanical stimulus (GO:0050982),0.309102714468316,0.8800987444079243,0.6181818181818182,0.8819276491182322,1.0,4/19,11.28%,CDH2;PKD1L3;TTN;PKD1
prerank,positive regulation of cell growth (GO:0030307),-0.22949369240999676,-0.8800320478888365,0.7166947723440135,0.7948653438122414,1.0,20/96,15.13%,IGF1;SDCBP;CSNK2A1;GOLGA4;ITSN2;CDC42;RUFY3;BCL2;MACF1;DDX49;KLHL22;TGFBR1;SYT4;NEDD4L;MTPN;CXCL16;CIB1;NCBP1;INO80;EIF4G1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.35234201255792863,-0.8795912677082057,0.6282722513089005,0.7953980471422184,1.0,3/14,14.15%,ERN1;NUDT21;NCBP1
prerank,regulation of protein dephosphorylation (GO:0035304),0.26938619761151095,0.879464833221655,0.6633663366336634,0.8821957863597599,1.0,16/37,23.09%,CAMTA1;DLC1;TSC1;PPP1R16B;CALM1;CALM3;CALM2;CDH5;TIPRL;CNEP1R1;PPP1R7;NSMF;CDCA2;SYMPK;HTT;ENSA
prerank,regulation of cell development (GO:0060284),-0.2774783624787261,-0.8789829225196558,0.655448717948718,0.7962782945820442,1.0,12/36,25.98%,NOTCH2;CTNNB1;GRN;BHLHE40;HMGB2;RHEB;WNT3;FBXO22;HEYL;HES7;HES6;CLOCK
prerank,regulation of protein secretion (GO:0050708),-0.2228679126565345,-0.8788758392401284,0.752442996742671,0.7961382778122491,1.0,19/119,12.73%,APOE;IGF1;ABCG1;ITPR1;DNAJC1;RAP1A;SLC2A1;DPP4;TMED10;ADAM9;RSAD2;GOLPH3L;RHBDF1;RHBDF2;ADAM8;EIPR1;MYOM1;CCL5;ITPR3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.29984939778864267,-0.8770037304968713,0.6520210896309314,0.7995712928622315,1.0,13/25,43.10%,CSNK2A1;RPL11;HSP90AB1;TRIM39;SGTA;RPL5;PML;PSMF1;PSME3IP1;LAMP3;HFE;OPHN1;RPS7
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3394478068070503,-0.8769956521201532,0.6387434554973822,0.7992301659011122,1.0,5/17,14.12%,PTPRC;CD300A;PPP1R15B;HSP90AB1;PPP1R12A
prerank,negative regulation of transposition (GO:0010529),-0.33333268558878537,-0.8769895892933294,0.6341030195381883,0.7988871527414335,1.0,3/16,10.75%,TUT7;UBR2;MOV10
prerank,organelle fusion (GO:0048284),-0.310040067600374,-0.8765919489950601,0.6448275862068965,0.7993154945380477,1.0,9/22,28.64%,EEA1;FIS1;USP30;STX4;MIGA2;VPS18;CYP26C1;VPS11;THG1L
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.36483406696607856,0.8765432576697187,0.6241457858769932,0.8879465723572078,1.0,3/11,15.23%,PCBP3;NOVA1;NOVA2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.34958872692612253,-0.8765146993958303,0.6460176991150443,0.7991143173264322,1.0,3/16,17.40%,CLDN10;CLDN18;CLDN1
prerank,regulation of cellular component organization (GO:0051128),0.21089622707891797,0.8764709926316716,0.7751937984496124,0.8869783133368631,1.0,18/135,10.08%,NRG3;SPOCK1;RIT2;TJP1;PAK5;SNCAIP;CDH13;MELTF;PTCH2;MLLT3;STON1;PLCE1;ANGPTL7;CHPT1;NEDD4;TMEM97;ROS1;AGTR1
prerank,peptidyl-asparagine modification (GO:0018196),-0.2835265779115894,-0.8763617750986074,0.6546762589928058,0.799088153638024,1.0,10/31,24.97%,MGAT5;ALG5;DPM3;ST6GAL1;MAGT1;NUDT14;MGAT2;STT3B;DDOST;MCFD2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2514393363504811,0.8762725691121146,0.6643518518518519,0.8862968709857563,1.0,11/45,17.19%,BRINP3;BRINP1;AURKAIP1;PTPN3;ZW10;BMP7;TOM1L1;TRIM35;NABP2;CDKN1C;BRINP2
prerank,fatty acid oxidation (GO:0019395),-0.24874074662762075,-0.8758340456383286,0.6869009584664537,0.7997998206816448,1.0,21/57,33.45%,PPARD;ABCD2;ADIPOR1;ACADM;ACAD11;ACAT2;ABCD3;MCAT;ACOX1;ACAA2;ACADVL;ALOX15;HSD17B10;ACADS;ECHDC2;ACAD10;SCP2;ECHS1;HADH;ADH5;SLC25A17
prerank,chordate embryonic development (GO:0043009),-0.2520417145409691,-0.8755914919319593,0.7070707070707071,0.7999491500072464,1.0,7/55,8.63%,MBNL1;XYLT1;ZNF568;BRCA1;VEGFA;SULF2;TGFBR1
prerank,negative regulation of cellular component organization (GO:0051129),-0.23990781720248652,-0.8754958623470088,0.696969696969697,0.7997698738362982,1.0,22/74,22.73%,MCTP1;LILRB1;DNM2;RIOK3;CDC42;WASL;RTEL1;SNX33;IRAK3;VEGFA;SPRY2;AIDA;FAP;TFIP11;HSPA1A;DDX3X;HSPA2;TMC8;GSK3B;DNAJB6;NR1H4;CRYAB
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.27785515857803544,-0.8754951660384845,0.6694352159468439,0.7994173199505283,1.0,8/33,14.33%,ITGA5;E2F2;PIK3CB;VEGFA;JAK1;JMJD8;PKM;KLF2
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.24479803020134572,-0.8751772894964961,0.6918032786885245,0.799744341098595,1.0,19/69,22.93%,APOE;SNX6;PTK2B;BCL2;GRN;WFS1;MDK;HIF1A;MEF2C;ADAM8;KIF14;RETREG1;RASA1;CLN3;NDNF;CPEB4;PPT1;SET;NONO
prerank,ether lipid biosynthetic process (GO:0008611),0.3641838194755683,0.874163557769424,0.6217494089834515,0.8900009065065844,1.0,2/10,7.13%,LPCAT2;CHPT1
prerank,protein localization to centrosome (GO:0071539),-0.328601081896265,-0.8736878041835872,0.6426056338028169,0.8023379206224133,1.0,5/17,20.88%,SNX10;PIBF1;NUDCD3;STIL;CEP192
prerank,regulation of myelination (GO:0031641),0.2937184499636003,0.8736121598610307,0.6388206388206388,0.8900776538877478,1.0,5/25,11.93%,TENM4;PARD3;PTN;PTPRZ1;HES5
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.28923264056482795,-0.8727530491943916,0.6354166666666666,0.803816442313728,1.0,9/31,23.00%,PEX14;PEX26;TOMM40L;TIMM21;TIMM44;PEX7;GRPEL2;TOMM20L;TOMM70
prerank,aminoglycan catabolic process (GO:0006026),0.2846651650045397,0.8723478673104376,0.6610978520286396,0.8917974447350276,1.0,7/28,16.69%,GPC6;GPC5;SDC1;GLB1;SDC2;IDUA;IDS
prerank,membrane lipid catabolic process (GO:0046466),0.36082333685144774,0.8720964872564929,0.6144578313253012,0.891231784803205,1.0,1/10,2.27%,ENPP2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.23944212484520672,-0.8714562224360032,0.7043189368770764,0.806056413927236,1.0,12/73,16.21%,FNIP2;CD44;BCAR3;AXIN1;GAS6;VEGFA;FNIP1;SPRY2;APP;HSP90AB1;EIF4G1;HCLS1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.334480399946134,-0.8714027647896324,0.6462093862815884,0.8058047200390717,1.0,7/16,21.39%,BRCA1;CTR9;CTNNB1;WDR5;KMT2A;MYB;KDM1A
prerank,neurotransmitter biosynthetic process (GO:0042136),0.3238379519663009,0.8708582099487618,0.6338672768878718,0.89282064585307,1.0,5/14,23.56%,SLC5A7;CHAT;SLC6A4;NOS1;ALDH9A1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.299452306167348,-0.8707882026953412,0.6564625850340136,0.8066650925161273,1.0,7/24,21.20%,CDO1;MSRA;MTR;MPST;MMUT;SMS;MTHFR
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.21043734665092517,-0.8707664763666789,0.8009554140127388,0.8063513686704413,1.0,56/173,25.74%,CTSZ;VTI1A;CAPZB;RAB1A;COG7;DYNC1H1;TMED10;TRAPPC11;TFG;PREB;PROS1;GAS6;CTSC;TMED3;SEC24A;DCTN1;SAR1A;F7;SEC24D;RAB29;STX5;CAPZA1;MIA2;COG2;COG5;SEC31A;MIA3;COPA;TRAPPC5;DYNC1LI2;VAMP4;LMAN2L;VAPB;TMED2;HYOU1;F10;TMED4;TICAM2;F5;MPPE1;DCTN4;BET1L;TMED5;SPTAN1;COG4;PGAP1;TRIP11;ARCN1;DCTN5;TRAPPC3;COPB2;RAB1B;MCFD2;ERGIC1;YIF1B;TRAPPC2L
prerank,protein homooligomerization (GO:0051260),0.21297927287725144,0.8706973263112557,0.7913486005089059,0.8920519865175646,1.0,26/114,18.38%,MPP2;RYR3;KCNC2;ADCY8;CRYZ;SLC1A2;CBY1;LETM1;RYR1;HCN1;GSDMD;SCARA5;ACACA;KCNJ12;GOLGA2;OSBPL2;ARC;CTH;GLRA3;RS1;GLS;AQP11;ALDH1A3;TRPM2;TMEM120A;RBMX
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.20755450312699958,-0.8706814198394781,0.8006482982171799,0.8061650944193213,1.0,35/198,15.28%,PTPRC;INPP4A;PLCG2;PAK2;PLBD1;ITPKB;PIP4K2A;PANK2;NADK;HTR2B;STAT3;SYNJ1;PFKFB3;DUSP3;PIK3CB;PIK3CG;LGALS13;PPP1CA;COQ8A;IMPA1;PIP4P1;LPL;HK3;INPP5A;TAOK1;PFKFB4;PIK3CA;PLCB3;PIK3CD;GPX4;PLCD1;AGPAT1;PLA2G4A;PLAAT3;NUDT14
prerank,transport along microtubule (GO:0010970),-0.3518011085078101,-0.8704388200504636,0.6487455197132617,0.8063081860540011,1.0,7/13,30.07%,CDC42;APP;BAG3;APBA1;BORCS5;COPG1;SPG11
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2502363635797379,0.8699365219285707,0.6746411483253588,0.8926757179081753,1.0,9/44,18.47%,RYR2;AHI1;ACVR1;SMO;HES1;MKKS;FOLR1;NPHP3;BBS7
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.28498563777857333,-0.8693249548186018,0.6818181818181818,0.8078048904560156,1.0,17/31,35.21%,POLR2H;POLR2F;POLR2L;CMTR2;POLR2A;NCBP1;POLR2G;POLR2I;GTF2F2;GTF2F1;RAMAC;MNAT1;POLR2D;GTF2H1;ERCC2;POLR2B;CDK7
prerank,7-methylguanosine RNA capping (GO:0009452),-0.28498563777857333,-0.8693249548186018,0.6818181818181818,0.8078048904560156,1.0,17/31,35.21%,POLR2H;POLR2F;POLR2L;CMTR2;POLR2A;NCBP1;POLR2G;POLR2I;GTF2F2;GTF2F1;RAMAC;MNAT1;POLR2D;GTF2H1;ERCC2;POLR2B;CDK7
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.3232568838353661,-0.8690356361732202,0.6666666666666666,0.8080479824976272,1.0,1/19,0.16%,APOE
prerank,protein alkylation (GO:0008213),-0.3136641153889582,-0.8683961820534095,0.6706896551724137,0.8089594970771864,1.0,5/22,10.40%,GSPT1;PRMT2;PRMT1;METTL22;PRMT3
prerank,regulation of endocytic recycling (GO:2001135),-0.36795894230768267,-0.867887661711183,0.6474820143884892,0.8096376740479052,1.0,3/11,14.42%,EIPR1;RAB11B;EHD1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3504205657816881,0.8676998682534283,0.6119733924611973,0.8966347902522551,1.0,3/11,9.23%,POMT2;TOR1A;UGGT2
prerank,positive regulation of protein polymerization (GO:0032273),0.2355424934759545,0.8676994526585229,0.7377450980392157,0.8955035223418644,1.0,12/65,14.79%,NAV3;TENM1;PRKCE;CARMIL1;TTBK1;NCKAP1;OCLN;CDK5R1;ARF6;CDK5RAP2;HSP90AA1;ARL2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.2393412086607936,-0.8673058618578502,0.7277310924369748,0.8104599189008775,1.0,29/68,35.21%,SNRPG;SNRPF;POLR2H;SSU72;POLR2F;POLR2L;NUDT21;SMN1;WDR33;POLR2A;NCBP1;TTF1;TAF1A;POLR1F;PAPOLA;CPSF3;MAZ;MED18;CPSF1;POLR1C;UBTF;POLR1E;MNAT1;TAF1D;SNRPD3;GTF2H1;ERCC2;PRMT5;CDK7
prerank,pseudouridine synthesis (GO:0001522),-0.3511237894766517,-0.8665927748238719,0.6948275862068966,0.8114942800533929,1.0,3/13,14.10%,PUS7;PUS1;GAR1
prerank,positive regulation of embryonic development (GO:0040019),-0.3212056531504394,-0.8664083444346062,0.6731107205623902,0.8114840440840274,1.0,4/19,11.44%,B4GALT5;NIBAN2;RBM19;OSR1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.2874976980951457,0.8660900293506409,0.6334106728538283,0.8978871170117328,1.0,4/26,6.34%,AKAP6;CAMTA1;FHL2;PRNP
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3465620353803318,-0.8655612653544389,0.6309090909090909,0.812783269825085,1.0,7/13,33.79%,GEN1;TPR;XRCC3;NDC80;CCNB1;ANAPC15;DUSP1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.36436869452531273,-0.8643369391396744,0.6288848263254113,0.8148369382872845,1.0,4/11,15.09%,P4HA1;EGLN1;P4HA3;CRTAP
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3316528416328689,0.8639544668777841,0.6287015945330297,0.9015087901499358,1.0,6/14,23.98%,XRCC5;NABP2;PINX1;TERT;BRCA2;TINF2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2899657989877835,-0.8636434256913035,0.6912751677852349,0.8158059422246257,1.0,8/30,19.65%,CGAS;ERCC6;RNF169;RADX;UBQLN4;TFIP11;SHLD2;TRIP12
prerank,sodium ion export across plasma membrane (GO:0036376),0.3377118450094739,0.8636024056501497,0.6306306306306306,0.9011609854675556,1.0,4/13,17.14%,SLC4A4;ATP1A3;ATP1B1;ATP1B2
prerank,negative regulation of cell population proliferation (GO:0008285),-0.19197103595232376,-0.8634576344516437,0.8692421991084696,0.8157797880115837,1.0,92/351,24.63%,LYN;MTSS1;ABI1;ARID2;CD300A;CDK6;NIBAN2;PTPRJ;NUPR1;RUNX3;BRD7;PPARG;S100A11;RNF41;PTK2B;RARG;CBFA2T3;SMYD2;IFI35;CTNNB1;SKI;NF2;NME1;EIF2AK2;E2F1;B2M;E2F3;TRIB1;GSDME;ITGB1BP1;TGFB1I1;PTPN6;MORC3;INCA1;CDKN3;APP;B4GALT7;STRN;FLCN;MAP2K1;KLF10;FAP;CELF1;STK11;IGFBP3;EEF1E1;CIB1;NLRC3;FRK;TFAP4;GREM1;BTG1;ANG;APPL2;KLF11;RBBP4;VHL;PARP10;HSPA1A;TOB1;ATF5;CDKN2C;GATA3;PDCD5;COL18A1;MDM4;BMPR2;ADAMTS1;BAP1;SIRT2;PDS5B;SFRP1;COPS8;GNRH1;NUP62;IFITM1;CGRRF1;IL6;BNIPL;SOX7;TGFB1;HMOX1;PIM2;GPLD1;TNN;CYP1B1;TES;LMNA;FTH1;MYC;RBP4;NUDT6
prerank,cGMP biosynthetic process (GO:0006182),0.37667476820998835,0.8633719118479385,0.6370023419203747,0.9005225604362722,1.0,1/10,2.89%,GUCY1B1
prerank,histone H3-K36 demethylation (GO:0070544),-0.37920986896280534,-0.8631545460152598,0.6637478108581436,0.8160026657233205,1.0,2/10,7.77%,KDM7A;KDM2A
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3084441129707472,-0.8629138184225281,0.6907216494845361,0.8160990088038592,1.0,3/22,6.22%,CCR2;GNAI3;CAP1
prerank,muscle cell migration (GO:0014812),-0.3772867998676274,-0.8627517979799203,0.6480836236933798,0.8160457769445495,1.0,2/10,8.99%,ROCK1;ITGB1BP1
prerank,central nervous system myelination (GO:0022010),0.35017684744350047,0.8618742057690495,0.6335877862595419,0.9027297094365523,1.0,2/11,3.30%,TENM4;PLP1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3470557459103516,-0.8612330009068134,0.6488413547237076,0.8186898024216619,1.0,2/13,6.32%,NFE2L2;HGF
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3377014921627319,0.860811352702961,0.6451612903225806,0.9039136538969551,1.0,4/13,20.17%,CAMK4;TOX;ZC3H8;GLI2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2671328794511638,-0.8605959983958898,0.708904109589041,0.8195365005842299,1.0,15/36,27.20%,RAP2A;MVP;VEGFA;TAOK2;DDX3X;ENPP1;NBN;MOB1B;PDGFA;PPP2R5B;PPP2R5A;MRE11;RASSF2;PPP2R5E;ENG
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3323335180270098,0.8604165516495127,0.6524822695035462,0.903724048648012,1.0,4/14,7.89%,ELAVL4;DAZL;TIRAP;YBX3
prerank,negative regulation of cell growth (GO:0030308),0.2110496283675216,0.8602495013172337,0.8068783068783069,0.9029758003076745,1.0,15/121,9.16%,MAP2;SLIT3;SLIT2;DCC;RERG;CDA;CCN3;MSX1;WT1;RBBP7;IP6K2;ENO1;TRIM46;CAPRIN2;CDKN2A
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3337067835979294,-0.858908009836849,0.6495726495726496,0.8224995397800339,1.0,4/15,25.76%,RPL11;SMAD7;DTX3L;RPL5
prerank,glutamine family amino acid metabolic process (GO:0009064),0.27371139339187145,0.858500918755049,0.6946386946386947,0.9057297953296891,1.0,9/33,17.21%,GOT1;GLUL;ALDH18A1;GGT1;RIMKLB;GLS2;GLS;CAD;ALDH5A1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3775350108686395,-0.8584510190275374,0.6601769911504425,0.8230275997041759,1.0,3/10,11.64%,PTPN22;DNAJA1;AIDA
prerank,COPII-coated vesicle budding (GO:0090114),-0.2368796139614204,-0.8583752598333895,0.7352445193929174,0.8228244526345404,1.0,24/68,27.06%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;SEC24A;SAR1A;PPP6R3;SEC24D;STX5;SEC31A;MIA3;TRAPPC5;VAPB;TMED2;TRAPPC9;F5;TRAPPC3;RAB1B;MCFD2;TRAPPC2L;VAPA;CUL3
prerank,axonal transport of mitochondrion (GO:0019896),-0.364703372837878,-0.8581588579805909,0.6743801652892562,0.8228895395224969,1.0,2/11,9.13%,TRAK1;HIF1A
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.3094301719918375,-0.8578612532318923,0.6815068493150684,0.8231267401072184,1.0,3/22,4.68%,PLEK;ROCK1;STAP1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.30810164760914327,-0.856863094301224,0.6690140845070423,0.8247700765702236,1.0,6/20,27.20%,RBPJ;TGFBR1;HEYL;SNAI2;BMP2;ENG
prerank,glycine metabolic process (GO:0006544),0.3438645600991803,0.8567051790714286,0.6309523809523809,0.9084811033642598,1.0,6/12,26.59%,GLDC;GLYAT;SDSL;RIDA;SHMT2;SDS
prerank,cobalamin metabolic process (GO:0009235),-0.3219169495341456,-0.856550677412166,0.6654478976234004,0.8250202290472574,1.0,4/17,20.45%,ABCC1;MTR;MMUT;LMBRD1
prerank,peptide catabolic process (GO:0043171),-0.2978670282558359,-0.8563871725525192,0.6555944055944056,0.824969258887204,1.0,6/23,18.22%,ANPEP;LNPEP;CTSH;CPQ;TPP1;CHAC2
prerank,peroxisome organization (GO:0007031),-0.2971240368868306,-0.8553048949586803,0.6852173913043478,0.8266982717395317,1.0,6/25,16.74%,PEX14;ABCD2;FIS1;PLAAT3;PEX7;ABCD3
prerank,positive regulation of vascular permeability (GO:0043117),0.3369165934449883,0.8550110398867214,0.6568181818181819,0.9110660499870925,1.0,2/12,8.71%,TJP1;OCLN
prerank,regulation of muscle cell differentiation (GO:0051147),0.2683403548614028,0.8538494236126605,0.7113163972286374,0.9123784236976499,1.0,2/31,1.32%,CTNNA2;CDH2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.3302612591765207,-0.8537247867807093,0.647912885662432,0.8293250278663428,1.0,4/15,10.66%,ATP1B3;SLC9A1;SLC8A1;NEDD4L
prerank,sodium ion homeostasis (GO:0055078),0.30419754610763583,0.8536273994949904,0.6620370370370371,0.9117390329814113,1.0,4/21,10.56%,SLC12A2;SLC12A1;ATP1A3;ATP1B1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.3634573685755646,-0.8535273877387732,0.6700680272108843,0.8293312834204807,1.0,6/12,46.11%,PPP1R3E;INPP5K;PPP1R3A;AKT1;PPP1R3D;PPP1R3B
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3482182549127363,-0.853418788268999,0.6495575221238938,0.8291787599945749,1.0,5/12,15.01%,ACTB;ZDHHC7;SCRIB;RAB10;VANGL2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3539251070760965,-0.8534108961947299,0.660377358490566,0.8288387114594173,1.0,3/12,10.38%,XDH;PIK3CB;SPRY2
prerank,positive regulation of ATPase activity (GO:0032781),0.25402866511673255,0.8533508107977007,0.6853932584269663,0.9111827664503683,1.0,13/41,17.85%,RYR2;DYNLL1;FGF10;DYNLL2;TNNT2;ALDOB;ATP1B1;DNAJB2;ATP2A1;TPM1;GABARAPL2;ATP1B2;SETMAR
prerank,tRNA 5'-end processing (GO:0099116),0.3295095476103538,0.8532382436001811,0.6581395348837209,0.910274709725234,1.0,6/15,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,histone H3 acetylation (GO:0043966),-0.2604432824889015,-0.8527700219038931,0.7239057239057239,0.8297176666618719,1.0,15/40,35.40%,SPI1;WDR5;JADE2;KAT7;DR1;TAF9;TRIM16;TADA1;TADA3;LEF1;TAF5;TAF5L;JADE3;KAT6A;YEATS2
prerank,negative regulation of coagulation (GO:0050819),-0.34331241087860437,-0.8526702320454802,0.6863799283154122,0.8295351749459685,1.0,2/14,4.37%,APOE;TFPI
prerank,copper ion homeostasis (GO:0055070),-0.3226075840207349,-0.8524684951961414,0.6598984771573604,0.8295664928043174,1.0,4/17,13.43%,ATP7A;SLC31A1;APP;MT2A
prerank,regulation of cell growth (GO:0001558),0.19340044574012819,0.8524154671686216,0.8757062146892656,0.9109001712544719,1.0,30/204,13.04%,NRG3;AKAP6;SPOCK1;SLIT3;SLIT2;PAK5;RERG;CDA;CCN3;MELTF;PTCH2;MSX1;WT1;PLCE1;RBBP7;IP6K2;ENO1;CHPT1;TMEM97;CAPRIN2;CDKN2A;ROS1;EIF4G2;AGTR1;TGFB2;MFSD2A;RPTOR;SMARCA2;TAF9B;DNAJB2
prerank,skeletal muscle tissue development (GO:0007519),-0.2777760020634498,-0.8520370621419706,0.71280276816609,0.8300216897084264,1.0,15/32,40.93%,SVIL;CFLAR;SKI;MEF2C;LEMD2;EGR2;IGSF8;CAV1;CAV2;KLHL40;SIX4;MYORG;MYOZ2;SELENON;KLHL41
prerank,defense response to tumor cell (GO:0002357),-0.380082253778186,-0.8519857249829553,0.6696269982238011,0.8297440728453229,1.0,4/10,14.89%,DAPK1;SPI1;LAPTM5;PRDX2
prerank,microtubule polymerization (GO:0046785),-0.2825223133947361,-0.8518331008837928,0.6920353982300885,0.8296736529810446,1.0,6/29,13.77%,CENPJ;CKAP5;TUBGCP4;TPX2;PIN1;SLAIN2
prerank,regulation of keratinocyte migration (GO:0051547),0.3440614114593697,0.8518219652706324,0.665083135391924,0.9110325304101816,1.0,3/12,11.69%,EPB41L4B;FGF10;ARF6
prerank,endoplasmic reticulum organization (GO:0007029),-0.23301908430982327,-0.8509604132805205,0.7423423423423423,0.8309326957150773,1.0,32/72,37.26%,TMCC1;TRAM2;APP;SERP1;STX5;RAB10;SEC31A;MIA3;LMAN2L;VAPB;DOP1B;LPCAT3;REEP3;SGTA;TRAM1L1;HMOX1;CYB5A;OTOF;VAPA;EIF2AK3;VAMP2;MAPK15;REEP6;GAK;MOSPD3;LMAN2;TOR1AIP2;CAV2;SEC31B;TLE6;LMAN1L;SEC16B
prerank,regulation of response to oxidative stress (GO:1902882),-0.3605365065266943,-0.8509137522222373,0.6804835924006909,0.8306480990298318,1.0,1/11,0.63%,MCTP1
prerank,cellular component disassembly (GO:0022411),0.23572577755819016,0.8505858418767018,0.7493917274939172,0.9125744895364246,1.0,14/53,16.37%,MMP16;TLL1;MMP12;SCUBE1;MMP15;MMP13;CTSK;GSN;HTRA1;BMP1;ADAMTS5;DYRK3;CAPNS2;CAPN2
prerank,protein localization to kinetochore (GO:0034501),-0.3354841029733356,-0.8500949262167946,0.694300518134715,0.8318564966243438,1.0,4/14,15.45%,KNL1;ZWILCH;CDK1;TTK
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.36185308229808344,-0.8494385993354155,0.667779632721202,0.8324265143378952,1.0,3/11,10.21%,SYNJ1;IMPA1;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.36185308229808344,-0.8494385993354155,0.667779632721202,0.8324265143378952,1.0,3/11,10.21%,SYNJ1;IMPA1;INPP5A
prerank,negative regulation of macroautophagy (GO:0016242),-0.2882219725333145,-0.8492083594140534,0.6945898778359512,0.8324735304354658,1.0,10/26,27.40%,NUPR1;MTM1;USP36;PIK3CA;UBQLN4;CHMP4B;CHMP4A;SMG1;QSOX1;TSC2
prerank,determination of bilateral symmetry (GO:0009855),0.27719939370696867,0.8489052968070359,0.6966824644549763,0.9150900262891871,1.0,8/25,20.14%,ODAD3;DNAAF4;TBX1;MKKS;NPHP3;DNAH5;BBS7;CFAP53
prerank,SNARE complex assembly (GO:0035493),-0.359697636014585,-0.8486029242716553,0.6654611211573237,0.8332546618299844,1.0,7/10,40.51%,UVRAG;VAMP4;VAMP1;VAMP2;VAMP3;CLTRN;STXBP1
prerank,regulation of histone modification (GO:0031056),-0.3417717404027468,-0.8471422736310901,0.6742556917688266,0.8357010460643255,1.0,6/13,31.10%,AKAP8;FLCN;MTHFR;AKAP8L;UBE2N;PARG
prerank,regulation of telomere capping (GO:1904353),-0.29889500037740796,-0.8470486501909912,0.6822107081174439,0.8355319127118501,1.0,14/23,41.27%,RTEL1;PKIB;TNKS2;USP7;ATM;NBN;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;NEK2;AURKB;TERF2
prerank,response to metal ion (GO:0010038),-0.23944929579447902,-0.8468548960490314,0.7833622183708839,0.8355173404849063,1.0,13/67,13.59%,SLC30A5;ANXA11;MT1X;MT1A;BCL2;ADAM9;CRIP1;PPP1CA;HIF1A;NEDD4L;ITPR3;MT2A;SEC31A
prerank,negative regulation of heart contraction (GO:0045822),0.3438935488830984,0.8464782773333187,0.658256880733945,0.9191156617064464,1.0,3/11,8.28%,PDE4D;SPX;SPTBN4
prerank,acyl-CoA metabolic process (GO:0006637),0.25667318198998307,0.845867905080619,0.7132530120481928,0.9192669591905034,1.0,13/35,22.83%,HMGCS1;GLYAT;ACSM5;ACACA;MCEE;ACOT8;MLYCD;ACSM3;ACSL6;ACOT12;ACOT7;GPAT4;OXSM
prerank,cardiac muscle cell development (GO:0055013),0.29488664000874454,0.8453498967248924,0.64,0.9192078059045551,1.0,4/20,12.80%,SORBS2;TTN;ALPK2;FHOD3
prerank,nitrogen compound transport (GO:0071705),-0.21135946592797467,-0.845298285544507,0.8095238095238095,0.8380495358707003,1.0,40/141,27.52%,LRRC8D;MYH9;RAB7A;SLC6A6;SLC43A2;SLC15A3;TOM1;CENPF;SLC16A10;SLC7A7;RCN3;FLVCR1;ABCC1;CHMP1A;HSP90B1;SLC25A45;ARRDC4;SEC14L1;SLC7A5;MIA3;ARRDC1;CHMP2A;LMAN2L;SLC23A1;SLC6A8;RILP;SNX4;SLC38A2;TXNIP;PPT1;SLC52A2;SLC15A4;LRP2;ARRDC2;CHMP2B;SLC22A3;SLC52A1;PDPN;SLC7A2;SLC7A4
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.22872340152507062,-0.845044149086445,0.7474916387959866,0.8381684899705572,1.0,23/75,26.48%,ITGA4;NRP1;HTR2B;NRP2;VEGFA;MDK;TGFBR1;HIF1A;ARNT;HMGB2;PIK3CD;ANG;NR4A1;NRAS;AGGF1;HMGB1;BMPR2;KDR;APLNR;HMOX1;VASH2;BMP2;VIP
prerank,cellular modified amino acid catabolic process (GO:0042219),0.32144571097527364,0.844946949316147,0.6466512702078522,0.9189035948887601,1.0,4/15,16.32%,ABHD16A;SARDH;GGT1;GGT5
prerank,regulation of telomere maintenance (GO:0032204),-0.289134696306193,-0.8446691774269749,0.6751269035532995,0.8385261104176095,1.0,10/26,26.75%,RTEL1;DHX36;ERCC4;USP7;NBN;HDAC8;SMG1;MYC;MRE11;PML
prerank,central nervous system neuron axonogenesis (GO:0021955),0.3405219898706337,0.8445281398257823,0.6690821256038647,0.9186453295951292,1.0,6/12,18.96%,MYCBP2;EPHB1;SPTBN4;ARHGAP35;HSP90AA1;B4GALT6
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.35159572229790326,0.8443735265846642,0.6824644549763034,0.9178385718125488,1.0,3/11,10.36%,SLC25A19;ENPP3;THTPA
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3344785133184465,-0.8439022880011833,0.6998223801065719,0.8396174938700831,1.0,4/14,25.18%,IMPDH2;ADSS1;PFAS;ATIC
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2823292530275595,0.8434590201599388,0.7031630170316302,0.918648813790969,1.0,5/25,13.20%,OMA1;POMT2;TOR1A;UGGT2;KLHL15
prerank,gliogenesis (GO:0042063),-0.32710047001038867,-0.8433359637895681,0.6932203389830508,0.8403423892824564,1.0,5/15,15.66%,CDK6;CD9;ANXA1;METTL14;METRN
prerank,RNA polyadenylation (GO:0043631),-0.28557430286395613,-0.8433209633700597,0.7053726169844021,0.8396461477814829,1.0,8/26,20.54%,SSU72;APP;MTPAP;WDR33;TENT4B;PAPOLA;CPSF3;GRSF1
prerank,mRNA polyadenylation (GO:0006378),-0.28557430286395613,-0.8433209633700597,0.7053726169844021,0.8396461477814829,1.0,8/26,20.54%,SSU72;APP;MTPAP;WDR33;TENT4B;PAPOLA;CPSF3;GRSF1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.2868570505862063,0.8431769722385244,0.7213114754098361,0.918125692428432,1.0,5/23,11.17%,EGF;PAX8;GDNF;SOX9;SMO
prerank,extracellular matrix disassembly (GO:0022617),0.23207865355473556,0.8426345934117658,0.7614457831325301,0.91818449295726,1.0,11/53,12.14%,MMP16;TLL1;MMP12;SCUBE1;MMP15;MMP13;CTSK;GSN;HTRA1;BMP1;ADAMTS5
prerank,cellular response to ketone (GO:1901655),-0.2701318678477055,-0.8425336771205278,0.715,0.8406900707574113,1.0,9/35,17.88%,MSN;GNB1;PTGER4;GNG2;AHR;ADAM15;SPP1;SPHK2;NR3C1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.24529315824962117,-0.8422665039286042,0.7669565217391304,0.8408239762467066,1.0,17/51,26.69%,PPARG;SKI;HTRA3;ACVR2A;GREM1;LEMD2;SMAD7;RBPMS2;GDF3;BMPR2;SMURF2;GREM2;LRP2;SKIL;SMAD4;BMP2;SMURF1
prerank,neuron projection organization (GO:0106027),-0.331183843268791,-0.8422279242712788,0.689419795221843,0.8405320311640916,1.0,4/15,11.24%,INSR;ABCD2;APP;DCTN1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.36068765029234645,-0.8421321908705864,0.6666666666666666,0.8403479172146104,1.0,4/11,23.60%,SLC27A1;NR1H2;LDLR;GPLD1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.30739128585567593,0.8412917953062042,0.6768867924528302,0.9197338378594965,1.0,6/18,18.75%,CCN3;REST;PRKN;INHBB;IRS1;CRH
prerank,synaptic vesicle membrane organization (GO:0048499),0.3046882568912285,0.8401018430986985,0.6926605504587156,0.9210974848852234,1.0,4/17,9.57%,SNAP25;STX2;TOR1A;PRRT2
prerank,external encapsulating structure organization (GO:0045229),0.1886826500467646,0.8392194919187701,0.9080779944289693,0.9218075835976418,1.0,51/205,20.67%,ADAM12;MMP16;TNR;ADAMTS17;COL27A1;LAMC3;MMP12;VCAN;ADAMTS16;COL11A1;ITGB8;ADAMTSL1;GFOD2;VCAM1;MMP15;ITGB3;ITGA9;VIT;THSD4;COL4A3;COL23A1;COL19A1;MMP13;SMOC2;TTR;COL7A1;ADAMTS5;ITGA11;ADAMTS12;ADAMTS6;CDH1;COL24A1;NID2;SPARC;ST7;ADAMTSL2;LAMA2;COL1A1;FBLN5;LOXL1;LAMA5;SMOC1;TNC;SH3PXD2A;LOX;JAM3;COL4A4;NID1;MMP14;ITGA2B;TGM1
prerank,establishment of spindle orientation (GO:0051294),-0.28088925481444255,-0.838955232015765,0.7045454545454546,0.8457658205796637,1.0,12/28,34.01%,ITGB1;FBXW11;CENPA;DCTN1;MAP4;NDC80;PAFAH1B1;PKHD1;SPDL1;GJA1;LLGL2;NUMA1
prerank,regulation of lipid storage (GO:0010883),-0.29394143611693047,-0.8389409447577819,0.7170474516695958,0.8454393036975374,1.0,5/22,10.93%,NFKB1;ITGAV;C3;LPL;FTO
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.29895991411716155,-0.83882860410673,0.6879562043795621,0.8452781997009181,1.0,7/21,15.02%,ATXN7;ARHGEF2;TPX2;TAOK1;CIB1;SPEF1;STMN2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.2855770454805416,0.8386754292913515,0.7105882352941176,0.9218152414189642,1.0,5/22,15.10%,CUBN;RBP2;CYP1A1;LGMN;GC
prerank,ceramide biosynthetic process (GO:0046513),-0.25936393786551554,-0.8385104142668607,0.7376760563380281,0.8455235410746238,1.0,3/40,2.02%,SGMS1;SPTLC2;ST8SIA4
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.3137016344312028,-0.8382088988004559,0.6875,0.8456909359157326,1.0,6/17,26.68%,TFPI;UBE2L3;NR3C1;URI1;ADTRP;ATP1A1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3395326168590454,-0.8377073189126929,0.700507614213198,0.8462731332496433,1.0,1/13,0.06%,RBPJ
prerank,positive regulation of chromosome organization (GO:2001252),-0.32538664106555487,-0.8372837810657323,0.6949152542372882,0.8466461275002494,1.0,7/15,26.75%,RTEL1;FEN1;DHX36;SHCBP1L;NBN;MRE11;PML
prerank,synaptic vesicle transport (GO:0048489),0.34990222163498075,0.8370596335405518,0.6713947990543735,0.923972881662937,1.0,3/11,8.20%,KIF5C;KIF5A;TOR1A
prerank,atrioventricular valve morphogenesis (GO:0003181),0.29245027466864837,0.8361577152085186,0.6910377358490566,0.9246817914388202,1.0,3/19,10.93%,SLIT3;ACVR1;TGFB2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3070339899063828,0.8359179758963036,0.6935866983372921,0.9240421001329174,1.0,2/16,5.95%,SLC2A5;SPX
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.3295448907632803,-0.8358735938188169,0.6948590381426202,0.8488123707676051,1.0,6/14,21.80%,TGFBR1;CHADL;GREM1;PTPN11;RFLNB;SNAI2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.32638254840338965,0.8350510481762338,0.6705336426914154,0.9247629824338803,1.0,7/14,22.15%,SPRY4;APLN;CREB3L1;SPRY1;FUZ;SULF1;GPC1
prerank,intestinal absorption (GO:0050892),0.33191816640446453,0.8344076173913384,0.6590389016018307,0.9249231530658893,1.0,1/13,1.11%,SLC2A5
prerank,modulation by host of viral genome replication (GO:0044827),-0.3367981224280358,-0.8338830275787026,0.6957295373665481,0.8520621570742392,1.0,6/13,26.97%,YTHDC2;NUCKS1;PPIB;ZC3H12A;CCNK;VAPA
prerank,positive regulation of cellular protein localization (GO:1903829),-0.23069581271248596,-0.8334535217018536,0.7835218093699515,0.8524591126423837,1.0,28/69,34.51%,GPR137B;STX3;SNX33;PARP9;CDK1;CCDC88A;KAT7;HSP90AB1;SLC5A3;STX4;NDC80;GSK3B;DTX3L;NUP62;GTSE1;TGFB1;GPD1L;CARD10;TMEM35A;MARK4;EIF2AK3;RANGRF;NGFR;CENPQ;ORMDL3;NUMA1;TNF;APC
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.2563258884430205,-0.8325691419155008,0.7380952380952381,0.8536769919194133,1.0,10/40,15.42%,C5AR1;ABL2;HTR2B;RASGRP4;FLT1;GNA15;ITK;EDNRA;TXK;ANG
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2605951405644356,-0.8323037702338314,0.7300509337860781,0.8537687021323145,1.0,13/37,23.38%,PRKAG2;AXIN1;CAB39;SPRED1;SPRY2;APP;SPRED2;EIF4G1;SMAD7;SIRT2;MAPK1;S1PR2;TGFB1
prerank,regulation of cell projection organization (GO:0031344),0.32597503688770985,0.8322434670862259,0.6904176904176904,0.9280990453310081,1.0,3/13,10.94%,NTNG2;NTNG1;MFSD2A
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.3490940091247239,-0.8320890822334708,0.6953405017921147,0.8538049975457292,1.0,5/12,24.50%,DSE;CHST12;CSPG4;BGN;DCN
prerank,sulfate transport (GO:0008272),-0.3304420273579487,-0.8318976587109802,0.7045454545454546,0.853796484852939,1.0,6/14,33.77%,SLC26A11;RACGAP1;SLC25A10;SLC26A4;SLC13A4;SLC26A7
prerank,cellular response to osmotic stress (GO:0071470),-0.2981532612814789,-0.8315377733366051,0.7164685908319185,0.8540954936455329,1.0,4/21,9.69%,LRRC8D;ARHGEF2;CAB39;RCSD1
prerank,protein kinase A signaling (GO:0010737),-0.3443075865098751,-0.8314069708911945,0.6672384219554031,0.8539826488952025,1.0,6/12,36.42%,LCP1;MYOM1;RAB13;GAL;EZR;TCP11
prerank,regulation of cell morphogenesis (GO:0022604),0.262979675583898,0.8312420844783911,0.723744292237443,0.9289972429194827,1.0,10/30,16.13%,EFNA5;NTNG2;NTNG1;MFSD2A;SH3D19;FERMT2;WTIP;ARC;SPARC;PDZD8
prerank,amino sugar metabolic process (GO:0006040),-0.3698975365150396,-0.830606286190215,0.6996402877697842,0.8550741819328349,1.0,2/10,9.46%,ST3GAL1;ST6GAL1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.2614070541165987,-0.8304001614643043,0.7363796133567663,0.8550730318219494,1.0,5/36,11.64%,TAOK3;PTPN22;DUSP3;SIRPA;AIDA
prerank,integrated stress response signaling (GO:0140467),0.32260258496534794,0.8303398091618717,0.6829268292682927,0.9296708209927264,1.0,1/14,0.59%,OMA1
prerank,myelination (GO:0042552),0.23813334474172174,0.8302219544177247,0.7577197149643705,0.9288003093144118,1.0,6/46,5.17%,SLC8A3;PARD3;SCN2A;PLP1;EPB41L3;MAL
prerank,embryonic hemopoiesis (GO:0035162),-0.3459644291371306,-0.8301648963719538,0.6991452991452991,0.8551365399987253,1.0,8/12,41.23%,TGFBR2;KMT2A;KDR;KITLG;TPO;ATF4;SH2B3;ZFPM1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3398820711322806,0.8298665554725055,0.64,0.9283878002556286,1.0,4/10,16.16%,CDC73;CPEB3;HSF1;LEO1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.30795512029372907,-0.8297920886527141,0.6631016042780749,0.8554343428793205,1.0,8/17,26.05%,EXOSC10;C1D;NOL9;EXOSC4;PRKDC;MTREX;WDR12;EIF6
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.2742703504729798,0.8291754556935884,0.7373271889400922,0.9286645531059048,1.0,7/27,18.00%,SLC1A2;SLC1A6;SLC47A1;SLC1A1;SLC25A38;SLC6A5;SLC38A1
prerank,heart trabecula morphogenesis (GO:0061384),0.3030763534512896,0.8284215960393453,0.7062937062937062,0.9290746044807129,1.0,3/18,10.93%,NRG1;BMP7;TGFB2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.30217045868004616,-0.8277439100552799,0.7097345132743362,0.8587666262821588,1.0,3/20,9.40%,MTHFS;SLC27A1;CNDP2
prerank,amide transport (GO:0042886),-0.27953754549915893,-0.8276114114071067,0.7455516014234875,0.8586258341486999,1.0,5/26,15.21%,PLTP;SLC27A1;GLTP;TAP2;ABCA13
prerank,DNA catabolic process (GO:0006308),-0.3519809303926813,-0.8272430615200256,0.7032590051457976,0.8589532617749401,1.0,6/11,40.42%,REXO4;DNASE1L1;XRN2;ISG20;DNASE1;DNASE1L2
prerank,C-terminal protein amino acid modification (GO:0018410),0.3493992762684732,0.827241945467487,0.7051886792452831,0.9302856782274229,1.0,5/11,20.91%,AGBL4;AGBL1;FOLH1;LCMT1;TTL
prerank,glycolipid biosynthetic process (GO:0009247),0.2505505341502168,0.8268230756807121,0.7343358395989975,0.9300198104849834,1.0,19/38,29.33%,ST8SIA3;PIGU;B3GNT5;PIGA;PGAP4;DPM2;ST8SIA1;ST8SIA5;B4GALT6;ST6GALNAC5;PIGO;PIGL;PIGN;DPM1;PIGB;PIGW;PIGQ;PIGF;PIGP
prerank,regulation of protein localization to membrane (GO:1905475),0.26275903235096165,0.8267410261512405,0.745958429561201,0.9290663868887259,1.0,6/28,14.32%,GPC6;GPC5;FYN;GSN;PRKN;VAMP8
prerank,response to estradiol (GO:0032355),-0.2676079066780986,-0.8260737307635482,0.7636054421768708,0.8606804435739921,1.0,4/31,7.44%,STAT3;ANXA1;CTNNB1;STAT5B
prerank,respiratory tube development (GO:0030323),-0.2718984695813081,-0.8258641147607539,0.7435008665511266,0.8606832092780231,1.0,15/28,41.73%,VEGFA;CCDC40;ITGA3;BAG6;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2;HECA;STRA6;LOXL3;FGF7
prerank,response to purine-containing compound (GO:0014074),-0.3147688682635534,-0.8258145187648647,0.7119856887298748,0.8603998096646276,1.0,2/17,2.65%,P2RX7;P2RX4
prerank,microtubule-based transport (GO:0099111),0.32429179268428654,0.8248357121253781,0.7084282460136674,0.9317093580070844,1.0,6/13,25.58%,DYNC1I1;DNAAF4;DYNC1I2;HTT;SPEF2;CABYR
prerank,ruffle organization (GO:0031529),-0.32154843969935976,-0.8248107511903521,0.7108433734939759,0.8618234701545453,1.0,5/16,19.99%,PLEK;RAC1;LIMA1;ARFIP2;PIP5K1A
prerank,tyrosine metabolic process (GO:0006570),-0.3468399283723729,-0.8245744743337334,0.7150170648464164,0.8618870164506433,1.0,7/11,43.31%,IL4I1;DCT;HGD;FAH;TAT;TH;THAP4
prerank,vascular transport (GO:0010232),0.21327203389430746,0.8244605840920143,0.8465346534653465,0.9313215424995804,1.0,18/81,15.06%,SLC12A2;SLC2A13;SLC4A4;SLC1A2;SLC24A3;SLC6A17;SLC1A1;LEPR;SLC6A1;SLC8A2;SLC6A13;SLC38A3;MFSD2A;SLCO2B1;ATP2B4;SLC16A2;SLC22A5;SLCO3A1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.31448245189912766,0.8240460514258999,0.7159353348729792,0.9309824347645035,1.0,4/15,10.61%,EDA;MSX1;AMELX;TBX1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.33244181144337837,0.8239965026343593,0.7063106796116505,0.9299846633114691,1.0,5/12,16.81%,PPARGC1A;ABCD1;IRS1;MLYCD;AKT2
prerank,protein N-linked glycosylation (GO:0006487),-0.22928608741519066,-0.8236428620115431,0.7753743760399334,0.8632198551760638,1.0,17/66,20.85%,ST3GAL1;MGAT5;MAN1C1;ALG5;DPM3;ALG12;ST6GAL1;MAGT1;B4GALT7;NUDT14;PMM2;MGAT2;ALG6;B4GALT1;MGAT4B;STT3B;GFPT1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.28363859965949456,0.8233043160633922,0.7299771167048055,0.9301683772773376,1.0,6/23,19.43%,GSTP1;CYP1A1;LTA4H;ASAH2;ELOVL6;ACOT7
prerank,eye development (GO:0001654),0.23268811457582858,0.8231420092648368,0.8043478260869565,0.9293675730133664,1.0,10/54,12.13%,CACNA1C;MEIS1;BMPR1B;SALL2;WT1;TSKU;CEP290;TGFB2;HES5;PBX1
prerank,blood vessel endothelial cell migration (GO:0043534),0.2858885572697297,0.8230841993127104,0.739454094292804,0.9283800046424207,1.0,2/22,1.35%,ROBO1;SLIT2
prerank,protein targeting (GO:0006605),-0.2098054261507517,-0.8224782980166113,0.85,0.8648471841908087,1.0,38/118,27.10%,SDCBP;TRAK1;KIF13B;SEC63;LAMP2;FUT10;RPL11;PITRM1;SRP14;NACA;ZFAND2A;ZDHHC7;ZFAND6;AP1S3;FIS1;ZDHHC2;NCF1;TIMM44;TIMM22;ZDHHC12;GABARAP;SRPRB;FBXO7;TAOK2;ZDHHC1;TOMM22;NACAD;GOLGA7;TOMM34;HPS4;TOMM70;MICALL1;EDEM1;ZDHHC6;YIF1B;AP4E1;LONP2;TOMM40
prerank,cortical cytoskeleton organization (GO:0030865),-0.2518177988376216,-0.82180429238829,0.7610169491525424,0.8656415675916265,1.0,11/41,16.16%,PLEK;RAC1;ROCK1;RHOA;RHOQ;LCP1;NCKAP1L;FMNL2;IKBKB;RAB13;RND2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3500354671919338,0.8210967939581684,0.710955710955711,0.9311151624565046,1.0,3/10,11.69%,EPB41L4B;FGF10;ARF6
prerank,stabilization of membrane potential (GO:0030322),0.2993115711154002,0.820752209690036,0.7149643705463183,0.9307146419895952,1.0,2/16,6.15%,KCNK10;KCNK2
prerank,cochlea morphogenesis (GO:0090103),0.3471812297725777,0.8205652189131821,0.6919315403422983,0.9299619901991738,1.0,2/10,10.61%,SOX9;TBX1
prerank,protein acylation (GO:0043543),-0.25759331468718816,-0.8201845692725419,0.774597495527728,0.8680276580484361,1.0,12/38,27.60%,CREBBP;ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;HHAT;ZDHHC13;ZDHHC6;CLOCK;EP300
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3121888957696476,-0.8196116480510506,0.7012089810017271,0.8686590767320796,1.0,9/15,30.07%,KHNYN;NYNRIN;ZC3H12A;RPP40;NUDT16;ZC3H12D;LACTB2;ZC3H12C;POP1
prerank,regulation of chromatin binding (GO:0035561),0.3526680209756939,0.8193795488501974,0.7037914691943128,0.9311061608190669,1.0,1/10,1.15%,DDX11
prerank,glycine transport (GO:0015816),0.35252048213272447,0.8190499730075422,0.7042606516290727,0.9306731780001685,1.0,3/10,16.73%,SLC6A17;SLC25A38;SLC6A5
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.2377572588959822,-0.818686377923126,0.8178752107925801,0.8698974371951933,1.0,16/50,24.92%,CCND3;ACTB;BLM;CDKN3;CDC25A;GADD45A;HSP90AB1;CCNE1;CDKN2C;SERTAD1;CNPPD1;CDC25C;CCNK;CCNF;CCNB1;CCNB2
prerank,negative regulation of organelle assembly (GO:1902116),-0.2561598014208134,-0.8183803820471923,0.7482758620689656,0.8700680712314274,1.0,12/35,27.67%,NUPR1;MTM1;BRCA1;STYXL1;RBM14;TBC1D30;TBC1D7;CHMP4B;CHMP4A;SMAD4;MDM1;NBDY
prerank,neurogenesis (GO:0022008),0.23845707886343845,0.8181204014532555,0.7795454545454545,0.931331338607594,1.0,11/43,17.62%,SPOCK1;EPHB1;DCHS1;FAT4;NEUROD1;TGFB2;CDK5RAP2;BTBD3;CIT;BTBD6;HAP1
prerank,activation of phospholipase C activity (GO:0007202),-0.27117218389136344,-0.8179895763562723,0.7517482517482518,0.870396694904261,1.0,8/29,15.42%,C5AR1;HTR2B;RASGRP4;GNA15;ITK;EDNRA;TXK;ANG
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.26567554511987573,-0.8164013311820973,0.7367491166077739,0.8728007794082138,1.0,17/32,40.73%,CTNNB1;CCT7;PKIB;TNKS2;CCT4;HNRNPA1;ATM;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;CCT8;CCT5;NEK2;AURKB;HMBOX1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.2816529748431819,-0.816098485537215,0.7349397590361446,0.8729694503516285,1.0,6/26,14.50%,CBL;SNX6;TSG101;NCF1;APP;CBLB
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.19901506937599828,-0.8156205454160861,0.8915857605177994,0.8733980742989313,1.0,43/151,28.79%,APOE;B4GALT5;SGMS1;SPTLC2;ACER3;CDO1;CSNK2A1;SLC27A1;MOCS1;CEPT1;SPTSSA;PRKD3;GCNT1;MOCS3;GCH1;PLA2G4A;LARGE1;AKR1A1;ARG2;KDSR;VAPB;ASS1;SPHK2;TYW5;LPCAT3;SPTLC3;SAMD8;INHA;GSTO1;PLPP3;ELOVL5;FURIN;DEGS2;TYW1;CERS3;HACD4;GAL3ST4;ESD;VAPA;LCAT;ST3GAL4;HACD3;PCYT1A
prerank,cardiac ventricle development (GO:0003231),-0.29949705031968554,-0.815558480716555,0.7710843373493976,0.8731198426371222,1.0,9/20,35.00%,HECTD1;TMEM65;GATA3;MDM4;HEYL;ENG;GJA5;HEY2;HEY1
prerank,extracellular structure organization (GO:0043062),0.1831295827106308,0.8148396162304179,0.947075208913649,0.936340207529503,1.0,50/204,20.57%,ADAM12;MMP16;TNR;ADAMTS17;COL27A1;LAMC3;MMP12;VCAN;ADAMTS16;COL11A1;ITGB8;ADAMTSL1;GFOD2;VCAM1;MMP15;ITGB3;ITGA9;VIT;THSD4;COL4A3;COL23A1;COL19A1;MMP13;SMOC2;TTR;COL7A1;ADAMTS5;ITGA11;ADAMTS12;ADAMTS6;CDH1;COL24A1;NID2;SPARC;ST7;ADAMTSL2;LAMA2;COL1A1;FBLN5;LOXL1;LAMA5;SMOC1;TNC;SH3PXD2A;LOX;JAM3;COL4A4;NID1;MMP14;ITGA2B
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.3028188644699876,-0.8143093342129157,0.7177700348432056,0.8749276241901153,1.0,4/18,17.14%,ASH1L;SMYD2;KMT2D;KMT2A
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.2699666352953306,-0.8140034471932298,0.7773913043478261,0.8750701269869695,1.0,4/29,10.88%,APOE;SLC27A1;NR1H2;ZBTB20
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.26797513706202525,0.8136614549199049,0.744920993227991,0.9373820316678855,1.0,6/27,10.76%,CHSY3;PXYLP1;VCAN;B3GAT2;CHST7;CHST9
prerank,negative regulation of T cell differentiation (GO:0045581),-0.35740036135926084,-0.8136246090192497,0.7175438596491228,0.8753347931358588,1.0,2/10,12.26%,MDK;FOXJ1
prerank,acute-phase response (GO:0006953),-0.3396608496282523,-0.8135648757457644,0.7221269296740995,0.8750785804543467,1.0,5/12,33.67%,IL6R;CEBPB;IL6;SIGIRR;PLSCR1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3178659716212533,0.8134401903056387,0.6738609112709832,0.9366801982122187,1.0,3/15,7.07%,NTRK2;SOS1;BDNF
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.2657162015223187,0.812660397796324,0.740909090909091,0.9370650375375116,1.0,8/25,20.86%,SOX11;BMPR1B;HES5;CDH5;ZNF423;UBE2O;ACVR2B;SULF1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.346769623433847,-0.8125930613883945,0.7046263345195729,0.8763079860389318,1.0,3/10,12.70%,HTR2B;DGKD;PRKD3
prerank,positive regulation of intracellular transport (GO:0032388),0.24860200615569922,0.8115710139049864,0.788235294117647,0.937997513481869,1.0,10/38,14.48%,TENM1;PLA2G4E;ZFAND1;PRR5L;NEDD4;CEP131;CEP290;CAPN10;ICE1;ATP2A1
prerank,relaxation of muscle (GO:0090075),-0.3242007855450012,-0.8104382280831829,0.7321739130434782,0.8795345966972418,1.0,4/13,19.57%,P2RX4;SLC8A1;PIK3CA;PLN
prerank,determination of heart left/right asymmetry (GO:0061371),-0.24681924691923512,-0.8100443359207421,0.7916666666666666,0.8797995376478681,1.0,12/43,27.63%,MEF2C;CCDC40;MICAL2;TGFBR2;VANGL2;STIL;MEGF8;TBX2;APLNR;DNAAF1;ENG;TBX21
prerank,ncRNA metabolic process (GO:0034660),-0.25358042185624413,-0.8096206780414651,0.765017667844523,0.8801359139210633,1.0,8/37,20.44%,AGO2;TUT7;EXD1;XPO5;NIFK;TDRKH;TENT4B;BCDIN3D
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.32623500335730216,-0.8091527432506508,0.7450628366247756,0.880594501695664,1.0,2/14,5.66%,SLC27A1;CEPT1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.3403453335309464,-0.8090378228130372,0.7217235188509874,0.8804244070659829,1.0,4/11,23.38%,MEF2C;DHX36;GREM1;TGFB1
prerank,peptidyl-threonine modification (GO:0018210),-0.23030638194718472,-0.8089935946938082,0.8282828282828283,0.8801227290010187,1.0,20/66,22.80%,PRKCD;ROCK1;CSNK2A1;DYRK2;GALNT3;TGFBR1;GALNT1;CDK1;DYRK1A;MAP2K1;TGFBR2;MARK2;MAP3K10;CHEK1;CDC42BPG;WNK1;GSK3B;CDK5;MAPK1;PRKDC
prerank,alanine transport (GO:0032328),-0.35938318069537156,-0.808319973194688,0.7209705372616985,0.8809202902138076,1.0,2/10,8.64%,SLC6A6;SLC36A4
prerank,ganglioside metabolic process (GO:0001573),0.28845460745366613,0.807588914292865,0.7009132420091324,0.944190269161987,1.0,3/20,3.49%,ST8SIA2;ST8SIA3;HEXB
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.27445515861199704,0.8075687147137763,0.745049504950495,0.9431231033237719,1.0,6/22,16.88%,PPM1E;DUSP4;DUSP10;DUSP18;DUSP8;PPM1G
prerank,regulation of chromatin organization (GO:1902275),-0.324008878139987,-0.8072147230823651,0.7345132743362832,0.8824462506421243,1.0,3/14,13.22%,TLK1;METTL4;MKI67
prerank,intracellular protein transmembrane transport (GO:0065002),-0.24773333011881385,-0.8068627271854054,0.7832167832167832,0.8826656849528112,1.0,10/42,23.00%,PEX14;SEC63;PEX26;TOMM40L;TIMM21;TIMM44;PEX7;GRPEL2;TOMM20L;TOMM70
prerank,vasculogenesis (GO:0001570),-0.2637700628834653,-0.8068011402178473,0.7724137931034483,0.8823951552998255,1.0,15/32,32.34%,VEGFA;SPRED1;TGFBR2;RASA1;PDGFRB;AGGF1;KDR;APLNR;TGFB1;ADM;WNT7B;ENG;RASIP1;HEY2;CAV1
prerank,transport across blood-brain barrier (GO:0150104),-0.21470023664674276,-0.8062587039652884,0.855,0.8829197645336166,1.0,19/83,20.26%,SLC16A7;LRP1;CD36;SLC6A6;INSR;FABP5;SLC27A1;SLC2A1;ABCC1;ATP2A3;SLC28A2;ABCC4;SLC7A5;SLC5A3;SLC29A1;SLC6A9;SLC38A2;AGER;SLC16A1
prerank,cilium assembly (GO:0060271),-0.18241010140862274,-0.8061050006620556,0.9633587786259542,0.8828050636379565,1.0,66/297,22.53%,RAB8B;SNX10;ASAP1;ACTR2;FLNA;EHD4;CENPJ;IFT20;KIF3B;PIBF1;CNTRL;ACTR3;RAB1A;DYNC1H1;HAUS5;SDCCAG8;HAUS6;CFAP44;EXOC4;CEP57;CKAP5;YWHAE;CEP162;CCDC40;SPAG16;CEP70;HAUS4;DCTN1;CDK1;SPATA6;FOXJ1;HAUS7;CFAP70;ABCC4;ARL3;TMEM80;GORAB;CFAP20;EHD1;VANGL2;RP2;CFAP43;ODF2;NINL;DYNLT2B;NUDCD3;PCNT;EXOC2;PDE6D;BBIP1;RILP;IFT57;MAK;EXOC6;PAFAH1B1;TMEM17;RAB11A;ATP6V0D1;CEP192;RILPL1;CETN2;DISC1;HYLS1;TUBA4A;CEP41;TTLL3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.2696500223651992,-0.8058269536783976,0.76,0.8828972938552,1.0,10/29,25.66%,AXIN1;UBE2L3;PIN1;DCUN1D4;ARRDC4;SMAD7;DTX3L;TOPORS;FEM1B;UBE2N
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2735931643035683,-0.8053911551300361,0.7563451776649747,0.8832210052648002,1.0,5/28,10.61%,NUPR1;AXIN1;LAPTM5;CTSC;PSMC3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.2821517033210144,0.8044826414465377,0.7511737089201878,0.9475994898634118,1.0,6/20,20.34%,FAR2;ACACA;HSD17B4;HSD17B8;ACSL3;FASN
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.32066958299814996,-0.8044131152861717,0.7347972972972973,0.8845038745935668,1.0,8/14,40.41%,MALT1;TRAF2;COPS8;CARD10;TRAF6;CARD14;TNFSF15;TLR3
prerank,protein K11-linked ubiquitination (GO:0070979),-0.26872780080509007,-0.804311778537031,0.7719928186714542,0.8843040072231907,1.0,7/27,17.76%,ANAPC1;RNF4;UBE2L3;UBE2H;UBE2T;UBE2C;ANAPC7
prerank,serine family amino acid metabolic process (GO:0009069),-0.30386620434323136,-0.8042567946681325,0.7201309328968903,0.8840170651436049,1.0,2/16,5.16%,CDO1;SARS1
prerank,regulation of pH (GO:0006885),-0.33553193733324815,-0.804218373300288,0.7335640138408305,0.8837153985567952,1.0,7/11,40.39%,SLC9A1;SLC26A4;ATP6AP1;ATP6V0A4;ATP6V1B1;ATP1A4;LACC1
prerank,hexose metabolic process (GO:0019318),-0.2523806717649627,-0.8021075769090493,0.798951048951049,0.8867841707959385,1.0,16/39,32.88%,PPARD;GALT;SORD;AKR1A1;FUOM;GALM;IRS2;GALK2;PMM2;PGM1;PMM1;GALK1;GHRL;ALDOA;SLC35A2;GDPGP1
prerank,clathrin coat assembly (GO:0048268),-0.31368820991581936,-0.8016543684559964,0.7455830388692579,0.8871884572422428,1.0,4/15,7.64%,FCHO2;PICALM;EPS15;HIP1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.32326606697352706,0.8009596959926883,0.7155963302752294,0.9527867099259805,1.0,6/12,21.95%,BICD1;HOOK3;CCDC68;KIF3A;PCM1;BBS4
prerank,determination of left/right symmetry (GO:0007368),0.2405718215228006,0.8008693888295186,0.8188405797101449,0.9518494292046354,1.0,11/37,20.14%,ODAD3;DNAAF4;TBX1;SMO;ENKUR;MKKS;RFX3;NPHP3;DNAH5;BBS7;CFAP53
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.31834927374063265,-0.8007193860240921,0.7417677642980935,0.8883664799936153,1.0,2/13,2.05%,PTPRC;MGAT5
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.2955576164205921,-0.7998802066462886,0.7456445993031359,0.8893220070196093,1.0,6/19,30.12%,TPST1;SULT6B1;PAPSS1;ENPP1;SLC35B3;TPST2
prerank,zinc ion transport (GO:0006829),-0.28244041685739574,-0.7995243835239959,0.7408056042031523,0.8895532575715884,1.0,9/21,37.96%,SLC30A5;SLC30A6;SLC39A3;MT3;SLC30A10;SLC30A1;SLC39A11;SLC30A8;SLC39A4
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.32927436733729243,-0.7993791773628333,0.7347670250896058,0.8894070273139999,1.0,3/12,9.99%,IQGAP1;JAG1;MYO1E
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2671825676307656,-0.7987281721062816,0.7832167832167832,0.8901381470929903,1.0,5/29,13.91%,VTI1A;GOLGA5;COG2;COG5;COPA
prerank,nuclear envelope organization (GO:0006998),-0.29193047941591205,-0.7986846032626664,0.7647058823529411,0.889841622656106,1.0,6/20,20.93%,NEMP1;SUN2;LEMD2;TOR1AIP1;VPS4A;REEP3
prerank,regulation of hormone secretion (GO:0046883),0.3005089977048121,0.7985188457183339,0.7444933920704846,0.9548245007922318,1.0,3/15,14.26%,SOX11;EDN1;SCG5
prerank,cell junction maintenance (GO:0034331),-0.31792660395953953,-0.7984137550192564,0.7408695652173913,0.8899273028452747,1.0,7/14,30.62%,MYADM;DCTN1;CBLN2;CLDN1;PRTN3;CD177;F2R
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3172465770393854,0.798280454614467,0.7142857142857143,0.9541346272892347,1.0,3/13,12.12%,YOD1;UBE2J1;BCAP31
prerank,positive regulation of phosphatase activity (GO:0010922),-0.28416280477506145,-0.7981835319087949,0.7594501718213058,0.8899312078062466,1.0,12/21,31.16%,CD300A;PLEK;PPP1R15B;MEF2C;HSP90AB1;PDGFRB;CHP2;GPLD1;BMP2;RIPK3;AGTR2;PTPA
prerank,cellular response to BMP stimulus (GO:0071773),0.20993436408816513,0.7979636052507535,0.8645320197044335,0.9535866720432714,1.0,17/66,21.46%,BMPR1B;ACVR1;VSTM2A;SOX9;TMEM100;BMP7;BMP15;TGFB2;ADAMTS12;RGMA;GDF15;TGFBR3;ACVR2B;AMHR2;RGMB;SMAD9;SCX
prerank,branched-chain amino acid catabolic process (GO:0009083),0.27589424463116646,0.7978687194028633,0.7534883720930232,0.9515694742214679,1.0,9/20,25.20%,MCCC2;MCCC1;BCAT1;DBT;ACAT1;BCAT2;BCKDHB;ACADSB;AUH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.27589424463116646,0.7978687194028633,0.7534883720930232,0.9515694742214679,1.0,9/20,25.20%,MCCC2;MCCC1;BCAT1;DBT;ACAT1;BCAT2;BCKDHB;ACADSB;AUH
prerank,regulation of mitochondrial fission (GO:0090140),-0.275005669167099,-0.797749962175968,0.7671232876712328,0.890251516464332,1.0,8/24,24.81%,DDHD1;CYRIB;FIS1;INF2;AURKA;KDR;DCN;STAT2
prerank,amide biosynthetic process (GO:0043604),0.22796119527067218,0.7974762445608327,0.8143564356435643,0.9511777950613067,1.0,3/47,3.43%,DMD;PCSK5;PAM
prerank,glycerolipid metabolic process (GO:0046486),0.33670203845896524,0.7969973318766128,0.7223529411764706,0.9509220644308486,1.0,1/11,0.91%,DGKB
prerank,coenzyme A metabolic process (GO:0015936),0.3116972943941615,0.796680794493335,0.7354368932038835,0.9503747844691448,1.0,6/14,19.47%,PANK3;NUDT7;ACAT1;COASY;ACOT7;CROT
prerank,regulation of myoblast differentiation (GO:0045661),-0.25415804977067763,-0.7966694229240717,0.7829716193656093,0.8916061286784728,1.0,7/32,14.66%,RIPOR2;MAPK14;MEF2C;IGFBP3;SMYD1;BTG1;FLOT2
prerank,regulation of ossification (GO:0030278),-0.25104899874274933,-0.7963932812167095,0.8075601374570447,0.8916570608343123,1.0,9/36,20.83%,RBPJ;LRP6;MDK;MEF2C;PTPN11;ANKH;ENPP1;BMPR2;SFRP1
prerank,ERAD pathway (GO:0036503),-0.21290149102543685,-0.7960167693304996,0.8500823723228995,0.8918987895560729,1.0,24/83,22.14%,AMFR;RHBDD2;WFS1;ATXN3;ERLIN1;RCN3;DNAJB9;SELENOS;DNAJB14;DERL1;UBE4B;SEL1L;HSP90B1;UBXN6;RNF185;RNF121;ERLEC1;STT3B;FOXRED2;SGTA;TRIM25;FAF2;BAG6;MAN1B1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.27787108022828655,0.7956105694666745,0.754257907542579,0.9511353249701618,1.0,3/18,11.25%,NAV3;PRNP;HOMER3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2905674234916994,-0.7949422296691679,0.7604166666666666,0.8932643636950858,1.0,5/19,13.46%,POLR3G;PRDX5;MAF1;CHD8;DHX36
prerank,retinoid metabolic process (GO:0001523),0.2125486025631518,0.79403251666238,0.8610421836228288,0.952668547097746,1.0,13/71,17.23%,GPC6;GPC5;DHRS13;RETSAT;SDC1;OPN1MW;RBP2;TTR;CYP1A1;SDC2;ALDH1A1;RDH11;ALDH1A3
prerank,anion transport (GO:0006820),-0.2548302021691869,-0.7939446351039334,0.7974910394265233,0.8944622154346533,1.0,3/33,4.97%,LRRC8D;LRRC8C;VDAC2
prerank,proton transmembrane transport (GO:1902600),-0.24773465661117783,-0.7936240402595593,0.8057921635434412,0.894603592602593,1.0,15/36,40.71%,ATP6V1A;UCP2;SLC9A1;ATP6V0E1;NNT;ATP5MF;ATP6V0D1;ATP5F1B;ATP1A1;SLC36A3;ATP6V0A4;ATP6V1B1;ATP1A4;ATP6V1F;ATP5PO
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.24338647207642644,0.7931272507668019,0.8063725490196079,0.9532011827150654,1.0,7/35,13.27%,MAGI2;TSC1;BOD1;CALM1;CALM3;CALM2;PPP4R4
prerank,inner mitochondrial membrane organization (GO:0007007),-0.23443599004370397,-0.7926802447916621,0.8404074702886248,0.8956841483916611,1.0,21/47,34.15%,HSPA9;ATP5MC1;MICOS13;TMEM11;TIMM22;GHITM;TIMM29;MAIP1;ATP5MC2;ATP5MF;MTX1;TOMM70;ATP5F1B;ATP5F1D;DNAJC11;CHCHD6;ATP5F1C;ATP5F1A;SAMM50;MICOS10;UQCC3
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2542747542847149,0.7924972633806685,0.7883211678832117,0.9531556027731323,1.0,9/30,20.95%,ELOVL7;SLC27A2;ACOX2;HACD1;ABCD1;TECRL;ACSL6;ELOVL6;ELOVL2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3198210014053002,0.7922187786407761,0.7378190255220418,0.9525506506566089,1.0,3/11,10.97%,SLIT2;CCN3;NBL1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.24216950566658216,-0.7913742683283319,0.8089700996677741,0.8973986200000084,1.0,2/40,5.01%,PID1;BCL2
prerank,vasculature development (GO:0001944),-0.30352050326005636,-0.7902995844436915,0.7698961937716263,0.8987386180810955,1.0,9/16,40.05%,PIK3CA;STK11;PDGFRB;BMPR2;APLNR;FLT4;STRA6;PDGFRA;NOTCH4
prerank,positive regulation of telomerase activity (GO:0051973),-0.2552034448912271,-0.7898140480825145,0.7884940778341794,0.8991240317888164,1.0,15/33,34.29%,CTNNB1;PKIB;NVL;HSP90AB1;GREM1;CCT4;WRAP53;MAPK1;MYC;GRHL2;MAPK15;MAP3K4;NEK7;TNKS;KLF4
prerank,regulation of mitochondrial fusion (GO:0010635),-0.34113676860134573,-0.7897467814743586,0.7482517482517482,0.8988705014923898,1.0,2/11,8.39%,PID1;VAT1
prerank,inositol phosphate catabolic process (GO:0071545),-0.33195457383016314,-0.7894495879874219,0.7448630136986302,0.8989821045735686,1.0,3/12,10.21%,SYNJ1;IMPA1;INPP5A
prerank,endochondral bone morphogenesis (GO:0060350),0.319814701082593,0.7888035416375365,0.7228637413394919,0.9572866589662543,1.0,1/11,2.92%,BMPR1B
prerank,response to UV-B (GO:0010224),-0.32322298691409956,-0.7887436835379374,0.7474226804123711,0.8996995262480889,1.0,3/12,12.09%,CRIP1;RELA;STK11
prerank,proteasome assembly (GO:0043248),0.32153563280321185,0.7885179013671573,0.7522935779816514,0.9566799053200679,1.0,6/11,26.91%,PSMG2;PSMD5;PSMG1;ADRM1;PSMD11;PSMD13
prerank,regulation of protein localization (GO:0032880),-0.22524791376882486,-0.7883781019079807,0.8573853989813243,0.8998796354539772,1.0,15/58,22.79%,CTSD;PLEKHM2;USP8;PICALM;ZDHHC7;TPR;HSP90AB1;TRIM68;TRIM14;VPS4A;DNAJB6;TRIM25;KDM1A;RACK1;TRIM67
prerank,regulation of smoothened signaling pathway (GO:0008589),0.22578120262036255,0.7874204770045555,0.8345498783454988,0.9574837213132601,1.0,5/50,6.17%,RORA;IFT81;PTCH2;DCDC2;MOSMO
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.32872070294818845,-0.7873690791079515,0.736283185840708,0.9010636782431471,1.0,4/11,42.98%,SIK1;EP300;C1QTNF12;CLK2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.2068622961427835,0.7871768570489385,0.8671679197994987,0.956810224299742,1.0,17/79,15.61%,SLIT2;BMPR1B;VWC2;PDCD6;SPRY4;VWC2L;APLN;NEDD4;EPN2;NBL1;ADAMTS12;CREB3L1;SPRY1;ATP2B4;TRIM33;BMPER;SPART
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.30423056678361704,-0.7857585834750994,0.7808695652173913,0.9031723418714628,1.0,9/15,32.10%,P2RX4;VEGFA;TMSB4X;HSPB1;KDR;FGF18;MET;FGF16;FGF2
prerank,cilium-dependent cell motility (GO:0060285),-0.2775213679582654,-0.785645331400349,0.7843478260869565,0.9029759129971554,1.0,7/22,31.54%,EFHC2;CFAP44;DNAH8;DNAH3;TEKT5;DRC1;CFAP54
prerank,glycerolipid catabolic process (GO:0046503),0.2818300852393932,0.7844887104748706,0.7603686635944701,0.9601573169897697,1.0,5/19,18.44%,GDPD1;PLA2G4E;ENPP6;PNPLA6;GDE1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3460367030825884,-0.7840939251954081,0.756140350877193,0.9049601970730138,1.0,4/10,31.75%,AGO2;TSNAX;TSN;DROSHA
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.32548101486704273,0.7840684017891997,0.7385321100917431,0.9597403563767993,1.0,2/11,4.11%,TJP1;AFDN
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.2771569729140685,0.7828083701078379,0.7897091722595079,0.9607507079171342,1.0,4/21,10.76%,CHSY3;VCAN;CHST7;CHST9
prerank,retinol metabolic process (GO:0042572),-0.31135991771861066,-0.7827678380246582,0.7652027027027027,0.9065779549416255,1.0,5/14,29.02%,DHRS3;CYP1B1;RBP4;RDH12;RDH10
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.33921676188231653,-0.7823976014567341,0.7772020725388601,0.906741027944113,1.0,4/10,13.88%,LRCH1;RIPOR2;WASL;MIA3
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.27564114327331246,-0.7821608795917688,0.7699115044247787,0.9067206540091536,1.0,6/23,19.92%,ITGB1;FBXW11;CENPA;DCTN1;NDC80;PAFAH1B1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2392542483544105,0.7817939775035316,0.8349514563106796,0.9613258774868216,1.0,4/33,6.83%,PLCB1;UBE2E2;FGF10;CDC73
prerank,urogenital system development (GO:0001655),0.3111465598076802,0.781035113362624,0.7666666666666667,0.9615045135042208,1.0,4/11,21.58%,PAX8;SOX9;EPHB3;LHX1
prerank,oogenesis (GO:0048477),0.2970478173417111,0.7809836246109773,0.7745535714285714,0.9605135437240737,1.0,6/15,23.35%,PTN;FMN2;IHO1;NANOS3;MEI4;NANOS1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.311095753365968,0.7809197664867681,0.7622377622377622,0.9595248108960261,1.0,1/12,1.61%,ADCY8
prerank,tetrapyrrole metabolic process (GO:0033013),-0.2899650973774404,-0.7808850424166239,0.7618181818181818,0.9083188900915008,1.0,4/18,20.45%,ABCC1;MTR;MMUT;LMBRD1
prerank,protein insertion into ER membrane (GO:0045048),-0.24556330406779042,-0.7806041176923464,0.8262411347517731,0.9083630071673905,1.0,16/37,31.27%,TRAM2;APP;SERP1;STX5;GET3;EMC6;EMC9;SGTA;BAG6;TRAM1L1;HMOX1;CYB5A;OTOF;VAPA;VAMP2;UBL4A
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.3389197405028313,-0.7801376232654064,0.7672849915682968,0.9086822256326492,1.0,4/10,32.34%,MVP;ENPP1;ENG;CAV1
prerank,protein prenylation (GO:0018342),0.3320329731539372,0.7800387065340046,0.7272727272727273,0.9598409599896871,1.0,3/10,11.86%,FNTB;AIPL1;FNTA
prerank,transition metal ion transport (GO:0000041),-0.24612513359614752,-0.7796672108536075,0.8321678321678322,0.9090504925967152,1.0,5/35,10.18%,IREB2;SLC30A5;ATP7A;SLC31A1;CP
prerank,cellular response to misfolded protein (GO:0071218),-0.2805110921417113,-0.7794694720155783,0.8052631578947368,0.9089651831461398,1.0,11/20,33.35%,ATXN3;DNAJB14;DERL1;RNF185;BAG6;VCP;CUL3;AUP1;STUB1;DNAJC18;DNAJB12
prerank,response to amino acid (GO:0043200),0.2430671687380131,0.7794363436502436,0.8029197080291971,0.9597115924454859,1.0,9/31,19.90%,GLRA1;RRAGB;GLRA2;CPEB3;RPTOR;GLRA3;CAPN2;NSMF;RRAGA
prerank,glutathione metabolic process (GO:0006749),0.23808966000131168,0.7790516102452033,0.8089622641509434,0.9592536251914352,1.0,12/38,24.03%,GSS;GSTZ1;GSTP1;GGT1;GSTK1;GSTM5;GGT5;GSTA4;GSTT1;GSTT2;HAGH;GCLC
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.20511209678350018,-0.7788417774596987,0.9052287581699346,0.9095194467758189,1.0,24/95,22.45%,CENPJ;CNTRL;DYNC1H1;HAUS5;SDCCAG8;HAUS6;CEP57;CKAP5;YWHAE;CEP162;CEP70;HAUS4;DCTN1;CDK1;HAUS7;ODF2;NINL;PCNT;PAFAH1B1;RAB11A;CEP192;CETN2;TUBA4A;CEP41
prerank,melanosome transport (GO:0032402),-0.28673101227359193,-0.7786725560073176,0.773356401384083,0.9090476888713459,1.0,1/18,0.09%,MYO5A
prerank,pigment granule transport (GO:0051904),-0.28673101227359193,-0.7786725560073176,0.773356401384083,0.9090476888713459,1.0,1/18,0.09%,MYO5A
prerank,mesenchyme morphogenesis (GO:0072132),0.28555265462289386,0.7784390656474597,0.7962962962962963,0.9591410315568584,1.0,3/17,10.93%,ACVR1;SOX9;TGFB2
prerank,regulation of acute inflammatory response (GO:0002673),-0.2892666848204864,-0.7781771944464164,0.7754010695187166,0.909424688620102,1.0,8/18,44.74%,ADAM8;NLRP3;IL6;PTGES;F12;DNASE1;IL6ST;OSM
prerank,filopodium assembly (GO:0046847),-0.3002958668195413,-0.7773322804929106,0.7950530035335689,0.910298854805254,1.0,5/16,15.90%,FGD6;FGD4;FGD3;SPEF1;PPP1R9B
prerank,response to gamma radiation (GO:0010332),-0.273137035372012,-0.7773318146206047,0.8140703517587939,0.9099258291457389,1.0,9/24,24.60%,MAP3K20;XRCC6;WRN;TMEM109;ATM;KDM1A;FANCD2;CRYAB;MYC
prerank,acylglycerol biosynthetic process (GO:0046463),0.26546854076573684,0.7770623153435571,0.8194130925507901,0.9603059264187749,1.0,5/23,14.12%,MOGAT3;PLCE1;GPAM;DGAT2L6;GPAT3
prerank,histone H2A monoubiquitination (GO:0035518),-0.2928171964014944,-0.7769038822957488,0.7689594356261023,0.9101925586672327,1.0,3/17,11.66%,DDB2;RYBP;CUL4B
prerank,aerobic electron transport chain (GO:0019646),-0.21580839924911296,-0.7768866445873808,0.8954468802698144,0.9098386225044167,1.0,26/68,34.15%,SDHAF2;NDUFA9;COX4I1;NDUFB2;COX10;AFG1L;NDUFS5;UQCRC1;COX8A;NDUFA1;UQCRC2;COX6C;NDUFA3;NDUFA4;CYCS;COX5A;NDUFB8;NDUFC2;COX6A2;NDUFC1;UQCRQ;NDUFS6;UQCRB;NDUFS3;NDUFB11;UQCC3
prerank,cellular response to leucine starvation (GO:1990253),0.32824436413037694,0.7768387551615366,0.7816377171215881,0.9595571348837141,1.0,2/10,6.68%,SESN3;RRAGB
prerank,glycerophospholipid metabolic process (GO:0006650),-0.21104417665806527,-0.7765819023102875,0.8964346349745331,0.9099375905414061,1.0,18/75,19.99%,PLEK;SYNJ1;ABHD12;CPNE3;PLCB3;PLCD1;PLA2G7;PLA2G4A;PIGH;PIGX;CLN3;PLAAT1;PDGFRB;GPCPD1;IP6K3;PLA2G6;PAFAH1B1;PIP5K1A
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2653801761554271,-0.7756452199772143,0.8141135972461274,0.9109489259085208,1.0,12/25,40.34%,HPRT1;DCK;DGUOK;SHMT1;PRPSAP1;PNP;ADA;GMPR2;MTHFD1;AMPD3;PRPS1L1;PRPS1
prerank,regulation of cell communication (GO:0010646),0.23945191958471,0.775338064693591,0.836027713625866,0.960890924149855,1.0,4/35,7.50%,ANK2;RYR2;CASQ2;GRK4
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.25135029374178214,-0.7751353567901222,0.8065068493150684,0.9113164784526132,1.0,7/36,13.28%,GNB1;AGO2;GNG2;CTNNB1;MOV10;PLCB3;TNRC6C
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3046447613805584,-0.7750997745528064,0.7721518987341772,0.9109924955670542,1.0,2/15,6.04%,DSE;CHST12
prerank,aerobic respiration (GO:0009060),-0.2789852533532678,-0.7748307061612705,0.7885304659498208,0.9110185499901566,1.0,7/20,30.58%,SIRT3;UQCRC1;MTFR1L;MDH2;UQCRC2;ATP5F1D;UQCRB
prerank,positive regulation of secretion (GO:0051047),-0.3349713970256639,-0.7746631461794952,0.77737881508079,0.9108768419587796,1.0,6/11,39.78%,XBP1;GPLD1;AQP1;SCIN;TRH;NPR1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.31820729800128794,-0.7742598309487569,0.7867383512544803,0.9110695848495777,1.0,5/13,24.50%,DSE;CHST12;CSPG4;BGN;DCN
prerank,nucleotide metabolic process (GO:0009117),0.26275088290873916,0.774192953249808,0.8086560364464692,0.9616606415086212,1.0,6/23,16.71%,NME2;ENPP3;AK4;AK5;NMNAT2;ME1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.214290154572766,-0.7737201120751592,0.9078726968174204,0.9114691511023809,1.0,26/69,34.15%,SDHAF2;NDUFA9;COX4I1;NDUFB2;COX10;AFG1L;NDUFS5;UQCRC1;COX8A;NDUFA1;UQCRC2;COX6C;NDUFA3;NDUFA4;CYCS;COX5A;NDUFB8;NDUFC2;COX6A2;NDUFC1;UQCRQ;NDUFS6;UQCRB;NDUFS3;NDUFB11;UQCC3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.22695705169741195,-0.7734589665891093,0.8812392426850258,0.9114626722258357,1.0,12/51,22.16%,CTNNB1;CCT7;PKIB;DCP2;TNKS2;TEN1;TENT4B;CCT4;HNRNPA1;EXOSC10;ATM;MAPK1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3143252147127215,-0.7734554147973367,0.7824561403508772,0.9110925124128686,1.0,2/13,4.78%,NIBAN2;HHEX
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.21886604626381206,-0.7733695623617751,0.8780487804878049,0.9108406406816905,1.0,17/64,26.75%,CPT1A;DAGLB;ACSL5;AIG1;GPX4;PLA2G4A;ACOX1;ACSBG1;ACOT2;ACOT4;ACAD9;ELOVL5;ADTRP;CYP1B1;PNPLA8;SLC27A3;ALOX15
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.2707373074072832,-0.7726682989266082,0.8057040998217468,0.911481067884682,1.0,9/22,26.24%,RAP2A;VEGFA;GREM1;TAOK2;DDX3X;NBN;PDGFA;MRE11;RASSF2
prerank,renal absorption (GO:0070293),0.32664395396942325,0.7726470537943481,0.7614879649890591,0.963007082663243,1.0,6/10,27.48%,HAS2;GSN;WNK4;KCNQ1;SLC15A2;HYAL2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2942267730098296,0.7722867372994915,0.7672209026128266,0.9624958757995283,1.0,5/14,16.81%,MFSD2A;ABCB11;ABCD1;IRS1;AKT2
prerank,diterpenoid metabolic process (GO:0016101),-0.22447079981471485,-0.7719752446125947,0.8674496644295302,0.9120857065745742,1.0,3/55,1.17%,APOE;DHRS3;LRP1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2567506780076914,-0.7716841336640151,0.8170289855072463,0.9121565434396842,1.0,5/28,13.22%,APOE;PANK2;ADIPOR1;TTC39B;FMO5
prerank,regulation of glucose metabolic process (GO:0010906),0.2363345360606979,0.7702704866622129,0.8309859154929577,0.964461889573127,1.0,7/34,16.81%,RORA;PDK3;RORC;PRKN;IRS1;MLYCD;AKT2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.33505447858801485,-0.7699771383156502,0.7604690117252931,0.9142504527271252,1.0,6/10,26.95%,PLA2G7;PLA2G4A;PLA2G6;PLA2G5;PNPLA8;PLA2G15
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2500852201365912,-0.7699147997196053,0.8055555555555556,0.9139610750370574,1.0,6/31,12.04%,RAB1A;AXIN1;UBE2L3;PIN1;DCUN1D4;ARRDC4
prerank,lipid phosphorylation (GO:0046834),0.3257270870882406,0.7698722429458736,0.7555555555555555,0.9640218917385964,1.0,1/10,0.91%,DGKB
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.25990631391087476,-0.7693708546973885,0.8106194690265487,0.9143424073378859,1.0,14/27,36.08%,FGR;FLT1;PTK2B;PDGFRB;NOD2;TGFB1;FLT3;FPR2;CD19;CCL19;FGF2;EPHA8;PDGFB;CCR7
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.27881797016708665,-0.7692947723703917,0.7955706984667802,0.914074344401012,1.0,5/20,14.89%,PLEK;GRK3;MGRN1;CCL5;RGS14
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.23896314389701662,-0.7688987896077605,0.8402777777777778,0.9142613274565362,1.0,11/38,25.39%,RNF31;USP36;UBE2L3;UBL5;SH3GLB1;HUWE1;BAP1;HAX1;HPS4;SAE1;VPS11
prerank,nucleoside salvage (GO:0043174),0.32604916124043626,0.7687424115127817,0.7464454976303317,0.9646294346418519,1.0,2/10,4.16%,UPP2;CDA
prerank,establishment of melanosome localization (GO:0032401),-0.28047821235202175,-0.7684016159191419,0.7888307155322862,0.9145556651534996,1.0,1/19,0.09%,MYO5A
prerank,negative regulation of wound healing (GO:0061045),-0.25676644948913496,-0.7683802256931059,0.8259325044404974,0.9142215568313032,1.0,4/28,12.79%,APOE;TFPI;CRK;SERPINE1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.29814157027574917,-0.7683720337894705,0.7822299651567944,0.9138641279304718,1.0,2/16,4.56%,NUPR1;ATP7A
prerank,microtubule nucleation (GO:0007020),-0.2773256650169912,-0.7673399848636437,0.781305114638448,0.9149279615676186,1.0,4/20,13.77%,CENPJ;TUBGCP4;TPX2;SLAIN2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.27131204015304927,-0.7670576657210016,0.8070175438596491,0.9149712761439972,1.0,4/22,11.66%,DDB2;UBC;RPS27A;CUL4B
prerank,actin filament depolymerization (GO:0030042),-0.3306048739165329,-0.7662840927704679,0.7836363636363637,0.9156948854016764,1.0,5/11,18.37%,WDR1;MICAL1;MICAL2;TWF2;CFL1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.27954211213602803,0.765854621682415,0.8,0.9678912241320894,1.0,4/18,14.75%,NELL1;CDK5RAP3;ATRAID;HSP90AA1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3022126003976903,0.7654018168420667,0.7772727272727272,0.967468981014496,1.0,4/13,20.36%,UPP2;OGG1;UNG;NT5M
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.269465831130597,-0.7651566192188461,0.8056951423785594,0.9168909884869625,1.0,8/23,29.14%,HERC4;MGRN1;ENPP1;SUFU;RACK1;MEGF8;VCP;IFT122
prerank,endothelial cell differentiation (GO:0045446),-0.3150430147051741,-0.7648661976439234,0.7975133214920072,0.9169089081823808,1.0,4/12,21.23%,JAG1;EDF1;BMPR2;KDR
prerank,atrial septum development (GO:0003283),0.2980828340281283,0.7648045731763943,0.7825112107623319,0.9672826090018282,1.0,1/13,0.68%,ANK2
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.3006515386278886,-0.7637624422451682,0.7950963222416813,0.9180229305371066,1.0,6/15,25.49%,GNPDA1;CHST3;LARGE1;GNPDA2;AMDHD2;RENBP
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.30735527660124007,-0.7630074550867434,0.7676950998185118,0.9187105946151117,1.0,2/13,6.91%,ABCE1;NUP88
prerank,glutamine family amino acid catabolic process (GO:0009065),0.2992616160807854,0.7629708876601377,0.7657266811279827,0.9689792458306281,1.0,3/13,15.36%,GLUL;GLS2;GLS
prerank,skeletal muscle contraction (GO:0003009),0.27038879721324616,0.7621785400278199,0.7980295566502463,0.9690631215953465,1.0,3/19,11.89%,TNNI1;MYH7;STAC
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.2880857840931419,0.7618525926137434,0.7524509803921569,0.9684584227705414,1.0,4/15,14.45%,SEMA5A;PRKD1;SMOC2;LGMN
prerank,negative regulation of cell aging (GO:0090344),-0.29187345231564177,-0.7616908432253773,0.7783595113438045,0.9200941654106454,1.0,1/16,1.33%,CDK6
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3066789169896077,0.7615369421181457,0.7737226277372263,0.9678076871503607,1.0,4/12,17.16%,UPP2;CDA;DHODH;CAD
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.255398323229859,-0.7608671109030498,0.8529411764705882,0.9208729582789047,1.0,7/28,18.15%,RAC1;FES;CKAP5;DCTN1;SLAIN2;HSPA1A;RPS3
prerank,phospholipid catabolic process (GO:0009395),0.25329590951465913,0.7605950588638382,0.8142201834862385,0.9681106902272232,1.0,7/24,18.44%,ENPP2;GDPD1;PLA2G4E;ENPP6;ANGPTL3;PNPLA6;GDE1
prerank,lung development (GO:0030324),-0.24093440106093264,-0.7605212621631348,0.8362369337979094,0.9210022140050593,1.0,13/33,32.10%,VEGFA;RCN3;CCDC40;ITGA3;FOXJ1;BAG6;FGF9;RBP4;DNAAF1;WNT7B;PDPN;ABCA3;FGF2
prerank,negative regulation of TOR signaling (GO:0032007),0.23189810290484994,0.7604805416624636,0.8613636363636363,0.967229127028407,1.0,6/36,9.00%,PDCD6;TSC1;SESN3;UBR1;NPRL3;CASTOR2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.29158140192745285,-0.7599566958816162,0.7804878048780488,0.92139921826869,1.0,6/16,33.76%,TPT1;TMEM161A;RPS3;SNAI2;BCL2L1;ACKR3
prerank,negative regulation of signaling (GO:0023057),0.2493415676818438,0.7598106431682238,0.822429906542056,0.9671115883857616,1.0,6/25,17.97%,GLRA1;ACVR1;NLRP12;OPRM1;ERBB3;AP1AR
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.2486160740502153,-0.7596413292442205,0.8558394160583942,0.9214162633088252,1.0,8/30,20.35%,DSE;HEXA;CHST12;CHST11;CHST3;CSPG4;NDNF;BGN
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.24840108282870482,-0.7595939074389912,0.8350694444444444,0.9211027434218556,1.0,10/32,28.21%,DYRK2;DDX5;STK11;TMEM109;BAG6;RRP8;PML;USP28;EP300;MYBBP1A
prerank,regulation of membrane depolarization (GO:0003254),0.26923860131427113,0.7586341883834439,0.78239608801956,0.9677798741879505,1.0,4/18,15.85%,SCN2B;PTPN3;ABCD1;SCN10A
prerank,peptidyl-lysine methylation (GO:0018022),-0.2567622491806714,-0.7585980721539156,0.8096085409252669,0.9220422686596501,1.0,12/26,35.12%,SMYD2;SMYD3;SMYD1;KMT5A;EEF2KMT;SETD6;METTL21A;SETD7;SETD2;ETFBKMT;ANTKMT;SETD4
prerank,organic anion transport (GO:0015711),-0.20681621784842366,-0.7582842271701209,0.9120135363790186,0.9221039360122043,1.0,34/76,38.08%,LRRC8D;CYB5R1;SLC25A24;LRRC8C;SLC25A42;ABCC4;SLC25A4;SLC23A1;SLCO5A1;CYB5R4;SLC52A2;CYB5R2;CA4;SLC22A3;SLC17A9;SLC52A1;SLC4A1;SLC4A5;CPTP;SLC35B1;AQP1;SLC2A2;SLCO1B1;SLC4A8;SLC35A2;SLC19A1;RHAG;SLC25A17;SLC26A7;SLC2A6;SLC52A3;CA1;SLC22A6;CA3
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3059649564221839,0.7582496932471535,0.7906976744186046,0.9672725816125497,1.0,3/13,15.41%,PLCB1;GOLGA2;SOAT1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.284587784416016,-0.7572895246628634,0.8123924268502581,0.9231081291288128,1.0,7/17,40.59%,PLA2G4A;PLA2G5;PLA2G12A;LPCAT4;PLA2G3;PLA2G4B;SERAC1
prerank,N-glycan processing (GO:0006491),-0.27592984359564554,-0.7567363584366699,0.8258620689655173,0.923456461777417,1.0,3/18,2.55%,ST8SIA4;MAN1C1;MAN2A1
prerank,heart looping (GO:0001947),-0.23344650597209565,-0.7565897044501921,0.8706896551724138,0.9232887575069041,1.0,11/40,27.63%,MEF2C;CCDC40;MICAL2;TGFBR2;VANGL2;STIL;TBX2;APLNR;DNAAF1;ENG;TBX21
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.32505239323284196,-0.7564414735664423,0.789103690685413,0.923104750721802,1.0,4/10,24.60%,TGFBR2;STAT1;PDGFA;MYC
prerank,miRNA metabolic process (GO:0010586),-0.27492639052518175,-0.7560434881445973,0.8173758865248227,0.9232629586151889,1.0,8/20,31.75%,AGO2;TUT7;XPO5;TENT4B;BCDIN3D;SND1;DDX17;DROSHA
prerank,negative regulation of viral transcription (GO:0032897),-0.3058164363660285,-0.7550881585809914,0.7885304659498208,0.9241621330222658,1.0,3/13,15.94%,UBP1;TRIM11;TRIM14
prerank,glycerol metabolic process (GO:0006071),0.32440017031626606,0.7545957859836315,0.7708333333333334,0.9713466646051603,1.0,4/10,23.83%,GOT1;ANGPTL3;COQ3;PDXP
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.3097330606053438,-0.7544004359864708,0.8078231292517006,0.9247108321519959,1.0,4/13,16.61%,ATG7;ATG10;UBA7;UBA2
prerank,sensory organ development (GO:0007423),0.21238663109582054,0.7538837408347324,0.8925233644859814,0.9712523077919101,1.0,12/51,19.31%,AHI1;MEIS1;BMPR1B;PAX8;SALL2;TGFB2;PBX1;ECE1;MAB21L1;RAB18;ZDHHC16;SMOC1
prerank,blood vessel diameter maintenance (GO:0097746),-0.23572119269854055,-0.7524698099035098,0.8672566371681416,0.9268534711982416,1.0,6/34,14.33%,ROCK1;HTR2B;ITGB1BP1;AGT;EDNRA;KLF2
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2529330260402765,-0.7523023311333404,0.863716814159292,0.9266892788469674,1.0,7/28,19.92%,ITGB1;FBXW11;CENPA;DCTN1;NUSAP1;NDC80;PAFAH1B1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.2869942949741176,-0.7521776400488064,0.8342151675485009,0.926473539769104,1.0,5/16,25.17%,BRCA1;ERLIN1;APPL2;ACADVL;NCOR1
prerank,odontogenesis (GO:0042476),0.2322217545511879,0.7520071223777015,0.8544152744630071,0.9728941005090666,1.0,6/35,14.63%,EDA;MSX1;AMELX;TBX1;TGFB2;INHBA
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3065036761879487,-0.7516675539618418,0.788034188034188,0.926774554590793,1.0,3/12,24.62%,TLR4;NOD2;RBP4
prerank,negative regulation of proteolysis (GO:0045861),-0.24349145854318158,-0.7512630470412776,0.8399339933993399,0.9269119748970892,1.0,9/34,21.59%,ROCK1;DNAJC1;TIMP2;CST7;CST3;CLN3;TMEM59;CDK5;BAG6
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.33406526819945104,-0.7510198056635783,0.774597495527728,0.9268626711672538,1.0,6/10,35.12%,SMYD2;KMT5A;SETD6;SETD7;SETD2;SETD4
prerank,glycogen metabolic process (GO:0005977),-0.2511862913748411,-0.750258359699395,0.8354661791590493,0.9274806796705626,1.0,4/27,10.24%,PRKAG2;GYG1;PHKG2;GBE1
prerank,positive regulation of protein processing (GO:0010954),-0.27478375142448375,-0.7499515541784072,0.8163265306122449,0.9275030947985956,1.0,3/19,9.64%,MYH9;NLRC4;ADAM8
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.28978033674512305,-0.7498888778919102,0.8286189683860233,0.9272102169960175,1.0,5/16,20.12%,TRA2B;NCBP1;NCL;DAZAP1;RBM3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3190360965409757,-0.7498553682852909,0.7913043478260869,0.9268784283521981,1.0,7/11,42.04%,HIF1A;FBXO7;RACK1;NONO;ATF4;NR4A3;PINK1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.3236030624214651,-0.7495882947033431,0.8032786885245902,0.9268401339093216,1.0,5/11,28.51%,FAP;DFFA;SIRT2;ZC3H12A;BCL2L1
prerank,regulation of wound healing (GO:0061041),-0.23319932957037665,-0.7495647648406558,0.8596802841918295,0.9264963815766009,1.0,6/42,12.79%,PLAU;ITGB1;ARFGEF1;ANXA1;CRK;SERPINE1
prerank,COPII vesicle coating (GO:0048208),-0.21087478213273214,-0.7494420756662553,0.9075342465753424,0.9255528231992188,1.0,20/61,27.06%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;SEC24A;PPP6R3;SEC24D;STX5;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;TRAPPC3;RAB1B;MCFD2;TRAPPC2L;CUL3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.21087478213273214,-0.7494420756662553,0.9075342465753424,0.9255528231992188,1.0,20/61,27.06%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;SEC24A;PPP6R3;SEC24D;STX5;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;TRAPPC3;RAB1B;MCFD2;TRAPPC2L;CUL3
prerank,vesicle coating (GO:0006901),-0.21087478213273214,-0.7494420756662553,0.9075342465753424,0.9255528231992188,1.0,20/61,27.06%,CTSZ;RAB1A;TMED10;TFG;PREB;CTSC;SEC24A;PPP6R3;SEC24D;STX5;SEC31A;TRAPPC5;TMED2;TRAPPC9;F5;TRAPPC3;RAB1B;MCFD2;TRAPPC2L;CUL3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.24545902359184826,0.7492103732912637,0.831353919239905,0.9756448496664301,1.0,5/26,14.79%,NAV3;OCLN;CDK5R1;CDK5RAP2;ARL2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2896501045784574,-0.7489087253674493,0.8165784832451499,0.9258532553323431,1.0,4/17,23.31%,NFE2L2;MAPK7;HSPB1;P4HB
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.32397548928474973,-0.7480609958049396,0.8026070763500931,0.9265314558253663,1.0,2/10,20.85%,HK3;GFPT1
prerank,protein autoprocessing (GO:0016540),-0.2864492022637769,-0.7476789406807423,0.8115183246073299,0.9266331898991566,1.0,3/17,13.02%,FAM111A;CASP4;CASP1
prerank,negative regulation of centrosome duplication (GO:0010826),0.304343383658222,0.74764686611484,0.7792792792792793,0.9766098534144456,1.0,5/11,20.01%,TRIM37;TMEM67;CDK5RAP2;KAT2A;NPM1
prerank,regulation of telomerase activity (GO:0051972),-0.22742872489715799,-0.7476196277038848,0.8864406779661017,0.9263289932701095,1.0,18/45,34.29%,PARP4;CTNNB1;PKIB;NVL;HSP90AB1;GREM1;ERCC4;CCT4;WRAP53;ATM;MAPK1;MYC;GRHL2;MAPK15;MAP3K4;NEK7;TNKS;KLF4
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2265281815763773,-0.7471873650926171,0.8822525597269625,0.9265082122170438,1.0,12/46,23.00%,PITRM1;TOMM40L;FIS1;TIMM21;TIMM44;TIMM22;GRPEL2;FBXO7;TOMM22;TOMM34;TOMM20L;TOMM70
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.20762987781262582,-0.7471033262387939,0.9169381107491856,0.9262506823980087,1.0,10/68,11.17%,GNAI3;TPST1;RHOQ;HPRT1;ADSS1;NT5C2;ACOT9;EFL1;GTPBP1;ACOT13
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3025843978134782,-0.746732526161351,0.8114901256732495,0.9263370786823956,1.0,7/14,38.76%,CCR1;CSF1;TRAF6;ATP6AP1;TNF;IL12B;POU4F1
prerank,response to interleukin-4 (GO:0070670),-0.32096334717756936,-0.7465279683643743,0.7777777777777778,0.9262242558487566,1.0,3/10,17.97%,XBP1;TCF7;GATA3
prerank,glucan catabolic process (GO:0009251),0.2860683820166594,0.7461211790305958,0.804147465437788,0.9775391125084314,1.0,3/15,12.82%,PHKG1;CALM1;PHKA1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.20880165454583843,-0.7459135837689734,0.9089376053962901,0.9266303880646084,1.0,30/70,37.41%,PLBD1;CSNK2A1;SLC27A1;CEPT1;NR1H2;TMEM86B;PLA2G7;PLA2G4A;PLAAT3;PLAAT1;PLA2G6;PLA2G5;PLA2G12A;LPCAT3;GPLD1;PNPLA8;PLA2G15;LCAT;PCYT1A;LPCAT4;LPIN3;CSNK2B;ABCA3;DBI;PCTP;PLA2G3;PLA2G4B;PLB1;APOA2;PON1
prerank,phospholipid metabolic process (GO:0006644),-0.20774702704788106,-0.745499272580892,0.9187817258883249,0.926800756145046,1.0,12/71,14.79%,PLBD1;PIP4K2A;ABHD12;PLBD2;LGALS13;PIP4P1;LPL;GPX4;PLCD1;AGPAT1;PLA2G4A;PLAAT3
prerank,digestive tract morphogenesis (GO:0048546),0.28712943136396957,0.7440314680591532,0.7985257985257985,0.9792165775344833,1.0,1/14,1.31%,SOX11
prerank,hexose transmembrane transport (GO:0008645),0.2625050632504255,0.7432682868107056,0.819047619047619,0.9791478399466946,1.0,6/21,18.09%,SLC2A5;SLC2A9;SLC5A10;SLC2A12;SLC2A8;SLC45A1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.25851085848612276,-0.7432221037087828,0.8475177304964538,0.9292722629036722,1.0,8/24,25.16%,FLVCR1;RSAD1;HMBS;COX10;PGRMC1;PPOX;UROD;SUCLA2
prerank,diacylglycerol metabolic process (GO:0046339),0.2565306973638285,0.7421604826299854,0.8104265402843602,0.9795545067941744,1.0,3/23,8.21%,DGKB;PLCE1;GPAM
prerank,embryonic organ development (GO:0048568),0.20350038337811555,0.742035653262763,0.9436274509803921,0.978663495861505,1.0,12/61,14.07%,PCSK5;GDNF;TEAD4;RARB;COBL;SALL1;NEUROD1;TGFB2;MFSD2A;PBX1;TEAD1;GLI3
prerank,epithelial structure maintenance (GO:0010669),0.30827873668787403,0.742022601032889,0.7954545454545454,0.9776165854586794,1.0,2/11,9.54%,STRAP;PIWIL4
prerank,regulation of rRNA processing (GO:2000232),-0.2843100107390383,-0.7418970310822078,0.8194444444444444,0.9305798096642898,1.0,5/16,26.03%,USP36;DIMT1;SHQ1;BUD23;NUDT16
prerank,monocarboxylic acid transport (GO:0015718),-0.21573550741810077,-0.7418885379659322,0.8987783595113438,0.9302215074956396,1.0,11/51,22.48%,SLC16A7;CD36;SLC27A1;STARD5;ABCC4;RXRA;SLC16A6;SLC6A8;SLC10A6;SLC16A1;NR1H4
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.251398043880474,-0.7418719691396014,0.8618968386023295,0.929878735424093,1.0,14/29,41.49%,FUS;E2F1;TENT5A;TENT5C;TENT5D;VIP;DHX34;SLC11A1;YBX1;PKP3;RBM24;PKP1;TAF15;ELAVL1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.24421216113268296,-0.7418252277394342,0.8586387434554974,0.9295642558039916,1.0,15/29,41.44%,KYNU;KMO;KYAT1;IL4I1;IDO2;HOGA1;HSD17B10;HGD;DAO;FAH;HAAO;TAT;OTC;BLMH;ALDH4A1
prerank,iron ion transmembrane transport (GO:0034755),-0.3245143338629055,-0.7416137924717889,0.7904085257548845,0.9294736030444227,1.0,1/10,2.53%,ABCB7
prerank,negative regulation of phosphatase activity (GO:0010923),-0.25355924347176617,-0.7405682489198449,0.8406779661016949,0.9303683333367816,1.0,9/25,27.53%,ZCCHC9;GPATCH2;MASTL;STYXL1;GSK3B;SH2D4A;URI1;FKBP1B;BOD1L1
prerank,melanosome localization (GO:0032400),-0.26163260233903773,-0.7396284750013756,0.845360824742268,0.9311484434796147,1.0,1/21,0.09%,MYO5A
prerank,sulfur amino acid catabolic process (GO:0000098),0.3087343695202039,0.7390767274452796,0.7955665024630542,0.9803129471176606,1.0,4/10,24.30%,CTH;ADO;CBS;TST
prerank,primary miRNA processing (GO:0031053),-0.32729805770153597,-0.7385827027053765,0.8072727272727273,0.9320044972458958,1.0,5/10,33.27%,SRRT;METTL3;SMAD2;DROSHA;SMAD1
prerank,protein hydroxylation (GO:0018126),0.2799569470420371,0.7383745849543228,0.8258706467661692,0.9801700928533049,1.0,2/15,7.62%,P3H2;PLOD2
prerank,serine family amino acid catabolic process (GO:0009071),0.31361011355716945,0.7379374029101706,0.7722095671981777,0.979662158238931,1.0,5/10,26.59%,GLDC;THNSL2;CBS;SHMT2;SDS
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.2929236047534689,0.7372100369080964,0.8270142180094787,0.9795427653777229,1.0,5/12,22.77%,ACOT8;ABCD1;HSD17B4;ELOVL2;FADS2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.28476617781093727,-0.7357342049282211,0.8519134775374376,0.9350548008369332,1.0,4/16,19.20%,CGAS;RADX;UBQLN4;SHLD2
prerank,negative regulation of blood pressure (GO:0045776),-0.2941715331961535,-0.7356564425041677,0.8156996587030717,0.9347748148094174,1.0,5/13,37.12%,PRCP;BMPR2;SCPEP1;NOS2;NPPA
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.2792941388425623,0.7352017724480093,0.8317757009345794,0.9809977800144157,1.0,5/15,24.61%,LNPK;REEP1;RAB18;ATL2;TMEM170A
prerank,glucose transmembrane transport (GO:1904659),0.26276349513072533,0.7341856803459573,0.8387096774193549,0.9812529753857587,1.0,5/18,18.09%,SLC2A5;SLC2A9;RAB4B;SLC2A8;SLC45A1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.26914735489472763,-0.7339612727481101,0.8353140916808149,0.936351466295617,1.0,6/19,27.60%,DYRK2;TMEM109;BAG6;PML;USP28;EP300
prerank,DNA modification (GO:0006304),-0.2537110399609005,-0.7337221293639449,0.8480565371024735,0.9362524928252259,1.0,10/22,41.27%,EXOSC5;NEIL3;NEIL2;EXOSC4;MPG;MUTYH;EXOSC3;PARP2;SMUG1;TERF2
prerank,protein import into peroxisome matrix (GO:0016558),-0.3076561453911811,-0.7336930622722414,0.8153310104529616,0.9359135867176204,1.0,2/12,4.86%,PEX14;PEX26
prerank,inner dynein arm assembly (GO:0036159),0.3028451582609804,0.7335343922040454,0.8096385542168675,0.9809655066956678,1.0,5/11,27.63%,DNAAF4;CFAP73;DNAAF5;DNAH1;CFAP100
prerank,steroid catabolic process (GO:0006706),-0.31752492667249743,-0.7333827105841779,0.819672131147541,0.9358741098216117,1.0,4/10,37.82%,SPP1;HSD17B14;FGF23;CYP19A1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.2916233466184195,0.7331005455085813,0.7839643652561247,0.9804205092610764,1.0,5/12,25.74%,GSS;GGT1;HAGH;GCLC;GGCT
prerank,dopaminergic neuron differentiation (GO:0071542),-0.26864166919445104,-0.73298322050267,0.8172231985940246,0.9359770884806295,1.0,5/19,18.20%,LRP6;CTNNB1;VEGFA;MANF;RYK
prerank,catecholamine metabolic process (GO:0006584),0.28562524978223436,0.7327497357867834,0.8385650224215246,0.979817617483412,1.0,3/14,13.51%,SNCAIP;DDC;PRKN
prerank,endocardial cushion morphogenesis (GO:0003203),0.2626575298064623,0.7326148655404702,0.8398169336384439,0.9789346818660878,1.0,3/18,10.93%,ACVR1;SOX9;TGFB2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.29284505356145896,-0.7326107520384543,0.8297872340425532,0.9360418251128869,1.0,2/15,3.16%,PPARD;PPARG
prerank,vitamin transport (GO:0051180),0.2366894179880429,0.7313544012049622,0.8744588744588745,0.9794063495719798,1.0,7/29,17.24%,CUBN;SLC35F3;FOLR1;FOLR2;AMN;GC;SLC2A8
prerank,regulation of osteoblast proliferation (GO:0033688),-0.2803357391010618,-0.7313163933305309,0.8489583333333334,0.9371506172510831,1.0,10/17,34.56%,HPSE;RHOA;EIF2AK2;GREM1;SFRP1;TNN;BMP2;SOX8;MN1;LTF
prerank,positive regulation of cell cycle (GO:0045787),-0.2074557842195423,-0.7311243196284303,0.9192982456140351,0.9370026775888175,1.0,8/62,11.05%,NUPR1;CCND3;CCNY;DUSP3;LRP6;RPS15A;EIF4EBP1;APP
prerank,magnesium ion transport (GO:0015693),0.2980772191073662,0.7306212549782505,0.8064516129032258,0.9792595335230245,1.0,6/12,20.04%,NIPA1;MMGT1;NIPAL4;TUSC3;NIPAL2;MRS2
prerank,monoacylglycerol metabolic process (GO:0046462),0.28109560495836305,0.730003820356411,0.8278481012658228,0.9789638487529502,1.0,3/13,13.73%,ABHD16A;MOGAT3;DGAT2L6
prerank,cellular response to heat (GO:0034605),-0.23221044333260027,-0.7292533294669511,0.8821490467937608,0.9387415560878711,1.0,14/35,32.68%,ATXN3;YWHAE;TPR;HSP90AB1;DHX36;BAG3;HSPA1A;SLU7;TCIM;HMOX1;VCP;POLR2D;HSPA1B;STUB1
prerank,regulation of stem cell proliferation (GO:0072091),-0.27020999888167585,-0.7291290037480043,0.8236331569664903,0.938529115707601,1.0,3/17,12.73%,PTPRC;EIF2AK2;HMGB2
prerank,camera-type eye morphogenesis (GO:0048593),-0.3188911686041447,-0.7291204395176468,0.8016528925619835,0.9381649913598679,1.0,3/10,7.83%,LRP6;SKI;VEGFA
prerank,mesoderm development (GO:0007498),-0.27211982536705587,-0.7290759802624921,0.8411053540587219,0.9378460578161214,1.0,6/18,27.56%,IKZF1;VEGFA;IKZF3;HCK;HES7;MESD
prerank,endocardial cushion development (GO:0003197),0.25128355907067745,0.728773959269569,0.852112676056338,0.9793795226907461,1.0,3/21,10.93%,ACVR1;SOX9;TGFB2
prerank,response to steroid hormone (GO:0048545),-0.2348121011511402,-0.7282296351448768,0.8671209540034072,0.9384241071893791,1.0,12/31,28.58%,TFPI;WBP2;UBE2L3;UBE3A;NR3C1;TGFB1;URI1;ADTRP;ABCA2;CATSPER2;ATP1A1;CATSPERB
prerank,regulation of BMP signaling pathway (GO:0030510),0.19397765991507657,0.7280821647899883,0.9506172839506173,0.9791838224525211,1.0,19/73,21.70%,SOX11;TWSG1;BMPR1B;VWC2;VWC2L;PCSK6;NBL1;HES5;TRIM33;CDH5;BMPER;SPART;ZNF423;UBE2O;ACVR2B;SKOR2;SMAD9;SULF1;SORL1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.31660930457465153,-0.7278301465265167,0.8084358523725835,0.938492550222705,1.0,3/10,23.79%,PIAS1;UBA2;SAE1
prerank,apical junction assembly (GO:0043297),-0.21229850348403795,-0.7268321139084049,0.9173553719008265,0.9392546503701803,1.0,9/53,17.40%,PAK2;RHOA;PDCD6IP;WDR1;CLDN10;STRN;RAB13;CLDN18;CLDN1
prerank,regulation of transport (GO:0051049),-0.22655073273871662,-0.7254504845414351,0.88107202680067,0.940431821898186,1.0,5/36,10.91%,NRP1;FES;ACTB;DNAJA1;CLDN10
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.23553374971976448,0.7230253653211084,0.9094922737306843,0.9842046756323015,1.0,6/29,19.35%,TNNT2;MYH7;TTN;TGFBR3;TPM1;TNNC1
prerank,negative regulation of cellular senescence (GO:2000773),-0.2967082939028123,-0.7225253679478556,0.8518518518518519,0.9433339120038812,1.0,1/13,1.33%,CDK6
prerank,chemical homeostasis (GO:0048878),0.19767185902013837,0.7218568280631019,0.9585365853658536,0.9845405949572974,1.0,18/61,21.17%,SLC4A10;SLC4A4;SLC4A11;ACOX2;FBXW7;ANGPTL3;WNK4;ABCB11;EIF5A2;TM6SF2;WNK3;AQP11;CLN8;WNK2;AQP4;TREM2;ADCK1;ACOX3
prerank,sphingolipid biosynthetic process (GO:0030148),-0.1977829254871072,-0.7215866000120467,0.9457627118644067,0.944018703513191,1.0,18/71,26.97%,SGMS1;SPTLC2;ACER3;SPTSSA;PRKD3;LARGE1;KDSR;VAPB;SPHK2;SPTLC3;ASAH1;SAMD8;PLPP3;ELOVL5;DEGS2;CERS3;HACD4;VAPA
prerank,cellular respiration (GO:0045333),-0.22228894071803512,-0.7214782397732898,0.9143356643356644,0.9437737864472185,1.0,12/41,25.98%,SIRT3;COX10;LYRM7;SDHAF4;UQCRC1;MTFR1L;SLC25A13;MDH2;UQCRC2;CYCS;ATP5F1D;COQ10B
prerank,synaptonemal complex assembly (GO:0007130),-0.279741708280699,-0.7212396453307366,0.8420138888888888,0.9433005803259499,1.0,7/15,42.34%,HORMAD1;BAG6;TEX12;RAD21;RAD21L1;SYCP1;SYCE2
prerank,synaptonemal complex organization (GO:0070193),-0.279741708280699,-0.7212396453307366,0.8420138888888888,0.9433005803259499,1.0,7/15,42.34%,HORMAD1;BAG6;TEX12;RAD21;RAD21L1;SYCP1;SYCE2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.2527165081139806,-0.7198360711958892,0.8765432098765432,0.9440629554273762,1.0,10/24,34.07%,GAPDH;HK3;TPI1;PKM;PGK1;PGAM2;PGAM1;ALDOA;FOXK2;FOXK1
prerank,canonical glycolysis (GO:0061621),-0.2527165081139806,-0.7198360711958892,0.8765432098765432,0.9440629554273762,1.0,10/24,34.07%,GAPDH;HK3;TPI1;PKM;PGK1;PGAM2;PGAM1;ALDOA;FOXK2;FOXK1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.31825487391993673,-0.7191764117164117,0.8244406196213425,0.9444009452004337,1.0,4/10,20.56%,RC3H1;SCRIB;LGALS9;CD274
prerank,negative regulation of cell death (GO:0060548),0.18765059646775145,0.7189488492935939,0.9772727272727273,0.986845524049873,1.0,21/88,19.69%,SOX11;CD200R1;TIGAR;CCN3;PRKD1;FYN;CD200;BMP7;PACRG;SRGAP2;AGR3;FERMT2;AMIGO2;PRKN;PPARGC1A;MECOM;SNCA;IKBKG;DUS2;ADNP2;RAD18
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.2616248299169679,-0.717579865339921,0.8604651162790697,0.9456991519776767,1.0,4/20,10.66%,ATP1B3;SLC9A1;SLC8A1;NEDD4L
prerank,myelination in peripheral nervous system (GO:0022011),0.27653989525475786,0.7174702956635673,0.8023529411764706,0.9875150072253691,1.0,1/13,1.83%,PARD3
prerank,cilium organization (GO:0044782),-0.1676572706086115,-0.7170426634089339,0.9984177215189873,0.9458872178983693,1.0,43/210,22.53%,RAB8B;SNX10;ASAP1;ACTR2;FLNA;EHD4;CENPJ;IFT20;KIF3B;PIBF1;ACTR3;RAB1A;CFAP44;EXOC4;CEP162;SPAG16;FOXJ1;CFAP70;ABCC4;ARL3;CFAP20;EHD1;RP2;CFAP43;ODF2;DYNLT2B;NUDCD3;PCNT;EXOC2;PDE6D;BBIP1;RILP;MAK;EXOC6;TTC17;TMEM17;RAB11A;ATP6V0D1;RILPL1;DISC1;HYLS1;CEP41;TTLL3
prerank,negative regulation of complement activation (GO:0045916),0.3037575750185217,0.7161307477397523,0.8494117647058823,0.9879894335145014,1.0,1/10,2.29%,SERPING1
prerank,ncRNA catabolic process (GO:0034661),-0.2351374442109913,-0.7160420318166059,0.8747763864042933,0.9465550001926893,1.0,13/28,35.73%,EXOSC5;TENT4B;EXOSC10;EXOSC4;MTREX;SND1;DEDD2;NUDT16;ERN2;EXOSC8;POP1;EXOSC3;SLFN14
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.2287417652092799,-0.7158953512166786,0.9047619047619048,0.9463395384206007,1.0,3/34,4.65%,FGR;FLT1;PTK2B
prerank,embryonic axis specification (GO:0000578),-0.2812398568669232,-0.7157249627772155,0.8381112984822934,0.9461523653582645,1.0,3/15,19.11%,STIL;RIPPLY2;HOXD8
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3053600285832899,-0.7143487625859076,0.8203799654576857,0.9472229547158445,1.0,2/11,10.66%,CAB39;NEDD4L
prerank,organophosphate biosynthetic process (GO:0090407),-0.2251501840628219,-0.7134979241740618,0.8996655518394648,0.9477409269820861,1.0,13/37,29.44%,ITPKB;MOCS1;TPK1;TPI1;MOCS3;TKT;IP6K3;PIP5K1A;PNPO;ITPKC;IP6K1;GK5;GPAT2
prerank,organic acid transport (GO:0015849),-0.1889041254484662,-0.7131594362674509,0.9752475247524752,0.9477311445559078,1.0,38/94,38.28%,LRRC8D;SLC6A6;PPARD;SLC43A2;SLC27A1;SLC16A10;SLC7A7;STARD5;SLC25A45;ABCC4;RXRA;SLC23A1;SLC23A2;SLC10A6;SLC38A2;SLC25A10;SLC16A1;NR1H4;SLC27A3;PDPN;SLC7A2;SLC7A4;ABCC3;SLCO1B1;SLC51A;SLC7A1;SLC19A1;SLC25A17;SLC26A7;SLC7A8;SLC6A12;AKR1C1;SLC38A5;SLC27A5;SLC6A19;SLC6A14;SLC22A6;SLC10A2
prerank,organic hydroxy compound transport (GO:0015850),-0.22481392089438837,-0.7126796799701396,0.9110738255033557,0.9478675560874834,1.0,19/36,39.92%,STARD5;NPC2;ABCC4;RXRA;SLC5A3;SLC10A6;SLC16A1;NR1H4;RBP4;GHRL;ABCC3;SLCO1B1;SLC51A;ABCG8;AKR1C1;SLC27A5;SLC10A2;STRA6;SLCO1C1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.28656081949203066,-0.712490468305257,0.85,0.9477028930166514,1.0,4/13,17.26%,HIF1A;LRPPRC;MAP1S;UXT
prerank,membrane lipid metabolic process (GO:0006643),-0.2551416312739948,-0.712320448920079,0.8737864077669902,0.9475136911342326,1.0,9/22,38.78%,TEX2;AGMO;SPHK2;CYP1B1;CERK;SERINC1;ARV1;MGST2;SPHK1
prerank,bile acid and bile salt transport (GO:0015721),0.23799198787460835,0.7121233005177401,0.8771929824561403,0.9914254637332657,1.0,4/24,14.33%,NCOA2;SLCO2B1;NCOA1;ABCB11
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.2867312892442649,0.7116092102279229,0.8532110091743119,0.990922222798763,1.0,2/11,8.34%,PTPRT;LEPROT
prerank,negative regulation of cholesterol transport (GO:0032375),0.2977588655532255,0.7109947127413303,0.8278301886792453,0.9905421041713419,1.0,2/10,9.63%,APOC1;PLA2G10
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.22467100623377242,0.7097823125591468,0.8948598130841121,0.9907844813342569,1.0,6/30,16.76%,SOX11;TWSG1;PCSK6;TRIM33;FOLR1;TGFBR3
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.2499059503615792,-0.7096726592334672,0.8620689655172413,0.9497599875592283,1.0,7/21,28.45%,UCHL5;TUBD1;RAB34;TTC23;SFRP1;TEDC1;EVC
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.29194234458243074,-0.7089253066958905,0.8442906574394463,0.9501655582559104,1.0,2/13,5.95%,FLNA;MDFI
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2518877730221827,-0.7086711561520599,0.8867595818815331,0.950048565465426,1.0,3/22,8.91%,TSG101;UBAP1;MVB12B
prerank,glutathione biosynthetic process (GO:0006750),0.291639496437668,0.7081974993915728,0.7968036529680366,0.9914823864899525,1.0,5/11,25.74%,GSS;GGT1;HAGH;GCLC;GGCT
prerank,myelin maintenance (GO:0043217),-0.3130303877689792,-0.707760611575508,0.837171052631579,0.9506005154979843,1.0,2/10,15.96%,ABCD2;CXCR4
prerank,bicellular tight junction assembly (GO:0070830),0.20501509817167285,0.7074937691423873,0.946078431372549,0.9911948405114304,1.0,11/46,19.63%,PARD3;AFDN;PRKCI;OCLN;CLDN5;PATJ;CDH5;ARL2;RAMP2;PARD6A;MPP7
prerank,regulation of viral life cycle (GO:1903900),-0.25701885503970195,-0.7074398269143719,0.8791593695271454,0.9505326832898394,1.0,6/21,21.27%,AXL;TSG101;TRIM68;TRIM14;VPS4A;TRIM25
prerank,cellular macromolecule catabolic process (GO:0044265),0.20424053858086127,0.7073192723550619,0.9137529137529138,0.9903376387659434,1.0,7/49,9.94%,EXOSC7;MAGEC2;IDE;FBXO44;FBXO2;RNASEH1;FBXO27
prerank,ribosomal large subunit assembly (GO:0000027),-0.24551390815947632,-0.7072259029160234,0.882960413080895,0.9503770803618355,1.0,7/24,25.76%,RPL11;FASTKD2;RPL6;RPL23A;RPLP0;BRIX1;RPL5
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2550526250824643,-0.7067114390407417,0.8656987295825771,0.9501376002503766,1.0,4/21,14.34%,DDB2;CUL4B;RPA3;ERCC4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2550526250824643,-0.7067114390407417,0.8656987295825771,0.9501376002503766,1.0,4/21,14.34%,DDB2;CUL4B;RPA3;ERCC4
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2626908727613372,0.705582220612889,0.8578313253012049,0.9911255774017088,1.0,6/16,20.34%,ACACA;ACAT1;HSD17B8;MLYCD;ACSS1;FASN
prerank,positive regulation of telomere capping (GO:1904355),-0.266675630893946,-0.7039379732128613,0.8777969018932874,0.9525368437908521,1.0,10/17,40.18%,RTEL1;PKIB;TNKS2;MAPK1;MAPK15;MAP3K4;NEK7;TNKS;NEK2;AURKB
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22433703655835024,0.703000064778673,0.9152941176470588,0.9927249060949158,1.0,4/29,14.25%,ZCWPW1;IHO1;SYCP2;MEIOB
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2891136204095489,-0.7029263379637164,0.8709677419354839,0.9531790363953325,1.0,6/12,40.34%,HPRT1;PRPSAP1;ADA;MTHFD1;PRPS1L1;PRPS1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.2725045115876524,-0.7024827605165667,0.8842676311030742,0.9532259433250093,1.0,1/16,0.53%,IGF1
prerank,regulation of axon regeneration (GO:0048679),0.28618902857490247,0.7018740583852452,0.8512195121951219,0.9928669576481399,1.0,3/12,13.71%,PTN;RTN4RL1;PTPRS
prerank,respiratory chain complex IV assembly (GO:0008535),0.24265590863216807,0.7012867514492962,0.8914141414141414,0.9924063626391072,1.0,5/21,13.87%,COX16;COX18;COX19;COX15;SCO1
prerank,response to hexose (GO:0009746),0.23230614554195667,0.7004010495331823,0.9063291139240506,0.992267977039762,1.0,3/25,10.49%,SLC2A5;MAFA;NEUROD1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.26752661828435054,-0.7000720362576683,0.8564273789649416,0.9551729766613198,1.0,8/17,26.43%,TNFRSF1B;MDK;ID2;IL34;CXCR4;EGR2;TGFB1;BMP2
prerank,protein import into mitochondrial matrix (GO:0030150),-0.2614279535524806,-0.698994425233161,0.8828671328671329,0.9558105044250957,1.0,7/18,27.10%,TOMM40L;TIMM21;TIMM44;GRPEL2;TOMM20L;TOMM70;TOMM40
prerank,glycolytic process (GO:0006096),-0.2365512994457729,-0.6985927904102461,0.9038461538461539,0.9558067842468075,1.0,10/28,29.80%,GAPDH;HK3;TPI1;PKM;PGK1;PGM1;PGAM2;PGAM4;PGAM1;ALDOA
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.2813043112813054,-0.6980578576077324,0.869639794168096,0.9559425156001985,1.0,3/13,19.32%,TPST1;SULT6B1;ENPP1
prerank,regulation of biosynthetic process (GO:0009889),0.2820918932959005,0.6974812487311829,0.8321167883211679,0.9941304616508676,1.0,4/11,27.83%,GSTP1;SNCA;CCN6;ALOX5
prerank,regulation of intracellular transport (GO:0032386),0.20722423235998622,0.6957773874323623,0.907928388746803,0.9947755069265327,1.0,9/38,18.37%,MAP2;NEFH;CAPN10;WWC1;SCFD1;GRIPAP1;REEP5;HAP1;TTC21B
prerank,negative regulation of transferase activity (GO:0051348),-0.23671392587566448,-0.6957063704300358,0.9011925042589438,0.9577431831055548,1.0,6/28,20.74%,EIF4A2;ERCC4;IRS2;SMAD7;GSK3B;DTX3L
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.2882592667487379,0.695358024521447,0.8314087759815243,0.9931187346090297,1.0,4/10,20.72%,NFATC4;ADGRB2;PPP3CB;PPP3R1
prerank,calcineurin-mediated signaling (GO:0097720),0.2882592667487379,0.695358024521447,0.8314087759815243,0.9931187346090297,1.0,4/10,20.72%,NFATC4;ADGRB2;PPP3CB;PPP3R1
prerank,triglyceride biosynthetic process (GO:0019432),0.25123997010395205,0.6945863607775606,0.8876404494382022,0.9928020124343043,1.0,3/18,14.12%,MOGAT3;GPAM;GPAT3
prerank,phospholipid biosynthetic process (GO:0008654),-0.2213842432034977,-0.6942283213940913,0.9285714285714286,0.9586766189495526,1.0,7/36,21.69%,SGMS1;CPNE3;IDI1;CLN3;SPHK2;PIP5K1A;SAMD8
prerank,DNA packaging (GO:0006323),0.259094142681378,0.6941001055308883,0.8765133171912833,0.9922554295521024,1.0,5/16,19.62%,NAA10;H1-0;BANF2;BANF1;CHAF1B
prerank,regulation of astrocyte differentiation (GO:0048710),0.27979228540272083,0.6934144858238167,0.8308457711442786,0.9918802523308056,1.0,5/12,23.28%,HES5;HES1;SERPINE2;BIN1;EPHA4
prerank,pancreas development (GO:0031016),-0.2852238379149262,-0.6929512863301994,0.8925476603119584,0.9594570749624718,1.0,4/12,38.10%,CCDC40;DNAAF1;MET;NKX6-1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2566806293537888,-0.6928009068681698,0.8729582577132486,0.9592224522747262,1.0,2/18,4.77%,CNOT1;CNOT2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.24629235833701155,-0.6925562142010045,0.902946273830156,0.9590763177757009,1.0,2/21,6.07%,RAB1A;RPL11
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2545265118565853,0.6914480182484923,0.8871681415929203,0.9927292565237208,1.0,4/17,11.91%,SOX11;HMGA2;CITED1;FERMT2
prerank,inorganic anion transport (GO:0015698),-0.20095701585590955,-0.6907355150446188,0.9462738301559792,0.960316256739214,1.0,10/53,19.66%,CLIC4;ANO6;SLC26A11;TTYH3;PACC1;XPR1;RACGAP1;CLIC1;ENPP1;SLC25A10
prerank,lysine metabolic process (GO:0006553),-0.28576592961446545,-0.690310278571322,0.8733944954128441,0.959952053761936,1.0,3/12,17.93%,OGDH;PHYKPL;DLD
prerank,lysine catabolic process (GO:0006554),-0.28576592961446545,-0.690310278571322,0.8733944954128441,0.959952053761936,1.0,3/12,17.93%,OGDH;PHYKPL;DLD
prerank,response to nutrient levels (GO:0031667),-0.25625654466358777,-0.6895902307021794,0.864957264957265,0.9602313736369621,1.0,8/17,42.54%,EIF4G1;KCNB1;SCTR;CD68;ATF4;RPS6KB1;MTOR;ULK1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.25719614172371486,-0.6890376189930815,0.8801369863013698,0.9603538462381342,1.0,7/19,32.71%,CAMKK2;USP36;FBXO7;HAX1;VDAC1;ATP13A2;SREBF1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.19755632944354518,-0.6882283400481141,0.9833610648918469,0.9603089406117894,1.0,19/56,33.15%,NDUFA9;BCS1L;TIMM21;NDUFAF2;NDUFB2;NDUFAF8;NDUFS5;NDUFA1;ACAD9;NDUFA3;NDUFAF7;NDUFB8;NDUFC2;NDUFC1;NDUFS6;NDUFS3;DMAC1;NDUFB11;TIMMDC1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.19755632944354518,-0.6882283400481141,0.9833610648918469,0.9603089406117894,1.0,19/56,33.15%,NDUFA9;BCS1L;TIMM21;NDUFAF2;NDUFB2;NDUFAF8;NDUFS5;NDUFA1;ACAD9;NDUFA3;NDUFAF7;NDUFB8;NDUFC2;NDUFC1;NDUFS6;NDUFS3;DMAC1;NDUFB11;TIMMDC1
prerank,regulation of actin nucleation (GO:0051125),-0.2841531322093112,-0.6877505099059563,0.875,0.9603676088418406,1.0,7/12,41.50%,ARFIP1;ARFIP2;ARF1;WHAMM;PICK1;SCIN;CORO1A
prerank,regulation of mitochondrion organization (GO:0010821),-0.20637848689045235,-0.6877003036506083,0.9436860068259386,0.9600374135087073,1.0,7/47,15.14%,PID1;CYRIB;USP36;FIS1;FLCN;INF2;PRMT6
prerank,microtubule anchoring at centrosome (GO:0034454),-0.2962474506193652,-0.6875618461783063,0.8628472222222222,0.9597892230322616,1.0,3/10,16.39%,NIN;DCTN1;NINL
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.23630651958185983,0.6872600094817662,0.9221698113207547,0.9955158905578992,1.0,7/23,15.28%,EGF;BMP7;RPTOR;CALM1;CALM3;CALM2;WNK3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.27413202006052156,0.6866754366896564,0.8863636363636364,0.9950313687996164,1.0,5/12,23.25%,GGT1;CTH;PSAT1;CBS;PHGDH
prerank,neuron apoptotic process (GO:0051402),0.24152186817329613,0.6861333890421317,0.9007444168734491,0.9944915620884519,1.0,2/19,2.71%,TRPC5;SCN2A
prerank,negative regulation by host of viral process (GO:0044793),-0.2987475765778598,-0.6861210947529474,0.8626760563380281,0.9606781036462023,1.0,6/10,36.05%,PSMC3;ZC3H12A;CCNK;VAPA;LTF;CCL8
prerank,epithelial cell development (GO:0002064),0.2453723004583523,0.6860441941851088,0.8918269230769231,0.9935509263808235,1.0,6/20,20.04%,DACT2;ROS1;PDZD7;TMEM79;ACTA2;WNT5B
prerank,receptor recycling (GO:0001881),-0.29935900612586125,-0.6849671106987306,0.8576642335766423,0.961284933698121,1.0,5/10,36.76%,ARFGEF2;RAB11B;PHETA1;REP15;PHETA2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.24464679136032097,0.6849598097781912,0.8726415094339622,0.9935248695197636,1.0,9/18,27.10%,COX16;COX18;COX19;SCO1;COX20;COX14;COA3;COA5;PET100
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.29069013114833575,0.6847683022606227,0.836405529953917,0.99265714609673,1.0,6/10,30.59%,MMGT1;EMC8;EMC2;EMC3;EMC4;EMC7
prerank,mitochondrial transcription (GO:0006390),-0.29674552537833426,-0.6833272522512173,0.8775510204081632,0.962316757467625,1.0,3/10,22.78%,FOXO3;TFAM;TWNK
prerank,regulation of intracellular protein transport (GO:0033157),0.21447998495945877,0.6832952316110393,0.916083916083916,0.9929241143110379,1.0,7/32,15.70%,TENM1;ZFAND1;PRR5L;CEP131;CEP290;ICE1;GCC2
prerank,protein localization to mitochondrion (GO:0070585),-0.2926190598392942,-0.6832281672693836,0.8855098389982111,0.9620117452581811,1.0,3/11,16.67%,DNAJA1;ISG15;MAIP1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.2925999866993915,-0.6831260594015773,0.8519195612431444,0.9617208058099858,1.0,3/11,14.33%,E2F2;PIK3CB;KLF2
prerank,positive regulation of mRNA processing (GO:0050685),-0.24369136242957162,-0.6828985271101317,0.9008547008547009,0.9615421762777056,1.0,6/21,20.12%,TRA2B;DHX36;NCBP1;NCL;DAZAP1;RBM3
prerank,heterocycle biosynthetic process (GO:0018130),0.25549767953252017,0.6828220530052799,0.8823529411764706,0.9923000789548239,1.0,1/14,1.52%,GPHN
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.2791357919062045,0.6815496166868961,0.8587962962962963,0.9923873002821936,1.0,4/12,24.05%,INSIG1;TAPT1;HSPA5;INSIG2
prerank,positive regulation of chromatin organization (GO:1905269),-0.2821403204667706,-0.6809076505445139,0.8952879581151832,0.9628483602281556,1.0,3/12,25.66%,SIN3A;MIER1;UBE2N
prerank,pyruvate metabolic process (GO:0006090),-0.19985882379240774,-0.6799409930884626,0.9489795918367347,0.9632480143769689,1.0,16/52,29.80%,GAPDH;ME2;HK3;TPI1;PKM;PGK1;DLD;SLC16A1;PDHB;VDAC1;PGM1;HOGA1;PGAM2;PGAM4;PGAM1;ALDOA
prerank,protein trimerization (GO:0070206),-0.26980684059048843,-0.6796419064316176,0.8874773139745916,0.9627558338224838,1.0,3/14,17.72%,ALOX5AP;ASIC1;MLKL
prerank,protein homotrimerization (GO:0070207),-0.26980684059048843,-0.6796419064316176,0.8874773139745916,0.9627558338224838,1.0,3/14,17.72%,ALOX5AP;ASIC1;MLKL
prerank,leukotriene biosynthetic process (GO:0019370),-0.27147885995636456,-0.6789211947346014,0.8837209302325582,0.9629517927218582,1.0,3/14,19.28%,ALOX5AP;PLA2G4A;PLA2G5
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.20800686260091777,-0.6783802281535718,0.9539823008849557,0.9630257814767653,1.0,9/41,23.38%,RBPJ;JAG1;MEF2C;TGFBR2;SMAD7;GATA3;MYBPC3;HEYL;TGFB1
prerank,water transport (GO:0006833),0.2715173582773558,0.6782425848819482,0.8577878103837472,0.9942626227359682,1.0,12/12,72.87%,AQP11;AQP4;CFTR;AQP9;MIP;UPK3A;AQP6;AQP5;AQP7;SLC5A1;AQP1;PDPN
prerank,glycogen catabolic process (GO:0005980),0.2563835491979425,0.6778970624877249,0.8645598194130926,0.9935454026802082,1.0,3/15,12.82%,PHKG1;CALM1;PHKA1
prerank,eosinophil migration (GO:0072677),-0.2712648585775508,-0.6766879856802022,0.8864468864468864,0.9636371906919778,1.0,5/14,36.05%,CCL5;CCL7;CCL24;CCL4;CCL8
prerank,eosinophil chemotaxis (GO:0048245),-0.2712648585775508,-0.6766879856802022,0.8864468864468864,0.9636371906919778,1.0,5/14,36.05%,CCL5;CCL7;CCL24;CCL4;CCL8
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.26518720322825606,-0.6763750392492661,0.8846153846153846,0.9635102508252414,1.0,5/14,33.74%,TSEN54;DDX1;CPSF1;ZBTB8OS;RTCB
prerank,covalent chromatin modification (GO:0016569),0.252213222829158,0.6745208439060878,0.9049773755656109,0.9953550967901299,1.0,14/14,74.80%,AURKC;HELLS;SIRT1;SIRT7;UFL1;PARK7;HDAC1;MBD2;AURKB;SETD5;CHD1;PARP2;MT3;HLCS
prerank,negative regulation of cartilage development (GO:0061037),-0.27369190993740516,-0.674472710831798,0.9095477386934674,0.9646771714318104,1.0,5/13,21.80%,TGFBR1;CHADL;GREM1;PTPN11;SNAI2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.2501551453664066,-0.6730234792592913,0.9130434782608695,0.9654442439807951,1.0,6/17,20.66%,SPRED1;SPRY2;SPRED2;EIF4G1;SMAD7;SIRT2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.29597409341682024,-0.6719806750309405,0.8754325259515571,0.9658764966863886,1.0,1/10,7.83%,VEGFA
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.2799405725644208,0.6694691516690658,0.8636363636363636,0.9985291133615354,1.0,5/11,23.06%,ST18;GSN;PIH1D1;FAS;CAAP1
prerank,regulation of aerobic respiration (GO:1903715),-0.26254613024085893,-0.6691445659356077,0.9089316987740805,0.9676377059827242,1.0,2/15,6.03%,ATP7A;CBFA2T3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.23247263866172432,-0.6682245895971396,0.9221238938053097,0.9679791238447542,1.0,10/25,34.07%,GAPDH;HK3;TPI1;PKM;PGK1;PGAM2;PGAM1;ALDOA;FOXK2;FOXK1
prerank,mitochondrial fusion (GO:0008053),0.2406222581847566,0.6681009912965478,0.9127358490566038,0.9986211862747086,1.0,2/18,5.93%,MFN1;MIEF1
prerank,regulation of phosphatase activity (GO:0010921),-0.22979374705969552,-0.6675465188801235,0.9288194444444444,0.9681026162195931,1.0,10/24,31.16%,ZCCHC9;GPATCH2;PPP6R3;HSP90B1;CHP2;SH2D4A;URI1;BMP2;RIPK3;PTPA
prerank,mesoderm formation (GO:0001707),0.2445461361322595,0.6664604693631205,0.8979118329466357,0.9989196747725687,1.0,3/17,10.02%,ITGB3;HMGA2;SNAI1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.21905214782899954,-0.6654712721153603,0.9393414211438474,0.9692356980355985,1.0,5/29,13.33%,DDB2;UBC;RPS27A;CUL4B;RPA3
prerank,homocysteine metabolic process (GO:0050667),-0.27951945087822355,-0.6646760643181574,0.890625,0.9694713895711916,1.0,3/11,21.20%,MPST;MMUT;MTHFR
prerank,GPI anchor biosynthetic process (GO:0006506),-0.22079561168620201,-0.6646212785559533,0.9433962264150944,0.9691385004074456,1.0,9/30,27.21%,DPM3;PIGH;PIGX;PGAP3;MPPE1;PGAP1;PIGS;PIGZ;PGAP2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.2748481148819637,0.6633364481043853,0.9013452914798207,1.0,1.0,3/11,16.23%,ROMO1;TIMM10;AGK
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.21846039681498863,-0.6614786313411058,0.9376053962900506,0.9710284053829906,1.0,3/28,6.76%,NIBAN2;WWP2;ARRB1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.282122762754519,-0.6606108300115051,0.8942807625649913,0.9713104695142847,1.0,5/11,26.43%,TGFBR1;TGFBR2;SMAD7;TGFB1;BMP2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.21538898712963062,0.660193692536426,0.9389671361502347,1.0,1.0,7/27,16.87%,NME2;RRM2B;AK4;GLRX;CTPS1;AK5;AK6
prerank,negative regulation of cilium assembly (GO:1902018),-0.27134415392338196,-0.6595745539013196,0.8869257950530035,0.971670855904451,1.0,3/12,16.65%,MAP4;TBC1D30;TBC1D7
prerank,negative regulation of defense response to virus (GO:0050687),-0.27981603468098604,-0.6595385263795929,0.8688811188811189,0.9713248650488994,1.0,4/10,27.84%,PPM1B;PCBP2;C1QBP;RNF26
prerank,genitalia development (GO:0048806),0.2616367315839973,0.6583879704581787,0.9181818181818182,1.0,1.0,3/12,19.50%,WT1;PKD1;WNT5A
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.2693418218527545,0.6583669593020374,0.9004524886877828,1.0,1.0,2/11,15.01%,CD200;ATP6AP2
prerank,cytoplasmic microtubule organization (GO:0031122),-0.1933178873811397,-0.6581845497098378,0.9747899159663865,0.9719322237063458,1.0,9/54,13.77%,RHOA;DYNC1H1;TUBGCP4;DCTN1;WDR73;CCDC88A;CIB1;PLK3;SLAIN2
prerank,RNA stabilization (GO:0043489),-0.21470107576777064,-0.6581656561200062,0.9470198675496688,0.9715731653611323,1.0,6/33,18.42%,FUS;E2F1;TENT5A;DHX36;TENT5C;PHAX
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.17589782908223245,-0.6580386867858246,0.9867986798679867,0.971302247786173,1.0,14/87,15.07%,IMMP2L;COA8;SDHAF2;NDUFA9;BCS1L;TIMM21;UQCC1;NDUFAF2;NDUFB2;LYRM7;NDUFAF8;NDUFS5;SDHAF4;FASTKD3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.21294933787151946,-0.6575541657348417,0.9258010118043845,0.9712742574416273,1.0,3/32,5.66%,CSNK2A1;SLC27A1;CEPT1
prerank,L-amino acid transport (GO:0015807),0.214068607727359,0.6562978151126659,0.9482352941176471,1.0,1.0,4/28,10.04%,SLC1A2;SLC1A6;SLC1A1;SLC38A3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.19683477884815154,0.6552600282655876,0.961352657004831,1.0,1.0,7/38,15.54%,NDUFB7;NDUFV2;NDUFA2;NDUFAB1;NDUFB9;NDUFA8;NDUFV3
prerank,T cell homeostasis (GO:0043029),0.2791917338984039,0.6536644653279915,0.8918918918918919,1.0,1.0,4/10,20.34%,ZC3H8;JAK3;FADD;FAS
prerank,positive regulation of calcium ion import (GO:0090280),0.2585431265021821,0.6533384261357756,0.910377358490566,1.0,1.0,3/12,19.72%,RAMP3;ATP2A1;CCL2
prerank,glucan biosynthetic process (GO:0009250),-0.2671306678558811,-0.6522546401776899,0.8843416370106761,0.9741589559663307,1.0,5/12,32.15%,GYG1;GBE1;PGM1;PGM2;UGP2
prerank,glycogen biosynthetic process (GO:0005978),-0.2671306678558811,-0.6522546401776899,0.8843416370106761,0.9741589559663307,1.0,5/12,32.15%,GYG1;GBE1;PGM1;PGM2;UGP2
prerank,gas transport (GO:0015669),0.2796902710559237,0.652052366342975,0.8918918918918919,1.0,1.0,1/10,5.65%,CA2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.21547636198015419,-0.6516316215174688,0.9567474048442907,0.9742016018543503,1.0,7/30,23.11%,BATF;DDX5;STK11;GREM1;MDM4;NBN;RRP8
prerank,development of primary male sexual characteristics (GO:0046546),-0.2102154493613746,-0.6512878297282155,0.9673539518900344,0.9740367564364903,1.0,14/34,38.04%,LHFPL2;CSDE1;GATA3;KITLG;BIK;SRD5A2;LRP2;FGF9;SOX8;MEA1;SIX4;ADAM29;FSHR;LHCGR
prerank,microtubule bundle formation (GO:0001578),-0.20019602062795397,-0.6509900770800657,0.9632224168126094,0.9738494135778076,1.0,17/42,34.39%,NAV1;CCDC40;SPAG16;FOXJ1;SPEF1;MAP1S;KIF20A;GAS2L1;TTLL3;RP1;LRGUK;MARK4;AAAS;TPPP3;CFAP46;NUMA1;NCKAP5L
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.21779335603960168,-0.6508870556014774,0.9515570934256056,0.973543015828271,1.0,9/27,30.21%,SLC27A1;CEPT1;PLAAT3;PLAAT1;PLA2G6;PNPLA8;ALOX15;PLA2G15;LPIN3
prerank,oxoacid metabolic process (GO:0043436),-0.2146485621831211,-0.6503630087742731,0.9439728353140917,0.9735330842206917,1.0,5/27,19.32%,TPST1;AGXT;SULT6B1;GNMT;ENPP1
prerank,regulation of cilium movement (GO:0003352),-0.28537118109796233,-0.64917034082907,0.9022556390977443,0.973952510099632,1.0,4/10,29.64%,CCDC40;CFAP43;DNAAF1;DRC1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.21155303635873607,-0.648955576979783,0.9482758620689655,0.9737113659161979,1.0,3/31,7.78%,CDK6;PPARG;SKI
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.26733953958208834,-0.6484809029035147,0.8966131907308378,0.9736656296359671,1.0,3/13,22.51%,IDH1;OGDH;D2HGDH
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.2458087113670771,0.6479479044764024,0.9421296296296297,1.0,1.0,3/15,14.90%,NME2;AK4;AK5
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.26235606543335827,-0.6475078161440693,0.9159212880143113,0.9739603825111658,1.0,4/13,23.57%,SESN1;STK11;ATM;KPTN
prerank,nuclear transport (GO:0051169),0.2413375326544499,0.6466535658904773,0.908883826879271,1.0,1.0,7/16,20.76%,NXT1;CITED1;BANF1;XPO1;HMGA1;NPM1;NUTF2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2477838397836914,-0.6466532059009655,0.9281961471103327,0.974143036346495,1.0,6/15,34.58%,CCT7;SHQ1;CCT4;NHP2;CCT8;CCT5
prerank,positive regulation of glucose metabolic process (GO:0010907),0.24602482240945217,0.6466124755383645,0.9018691588785047,1.0,1.0,4/14,19.74%,PPARGC1A;IRS1;AKT2;SIRT1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2795529302524148,-0.6465770171167697,0.9049295774647887,0.9734482741939879,1.0,7/11,41.95%,AGO2;TNRC6C;EIF6;AGO3;ZFP36;NOTCH4;TRIM71
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2795529302524148,-0.6465770171167697,0.9049295774647887,0.9734482741939879,1.0,7/11,41.95%,AGO2;TNRC6C;EIF6;AGO3;ZFP36;NOTCH4;TRIM71
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24486421358808316,0.6461619090859795,0.9344660194174758,1.0,1.0,4/15,19.24%,ATF2;HUS1B;NEK11;CHEK2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.26957776948527695,-0.6459475688613031,0.9125214408233276,0.9735050814686043,1.0,4/12,23.31%,APOC4;DGAT1;LPCAT3;P4HB
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.2749466713582438,0.6436376166813695,0.893719806763285,1.0,1.0,4/10,19.37%,ZNHIT3;NAF1;PIH1D1;RUVBL1
prerank,cellular response to acid chemical (GO:0071229),0.21101254946855036,0.6424529648412686,0.9358024691358025,1.0,1.0,8/27,19.90%,GLRA1;RRAGB;GLRA2;CPEB3;RPTOR;CAPN2;NSMF;RRAGA
prerank,regulation of fatty acid oxidation (GO:0046320),0.24110240803742222,0.6423716392655586,0.9284009546539379,0.9998750885380412,1.0,5/16,16.06%,SOX9;PPARGC1A;ABCB11;ABCD1;MLYCD
prerank,calcium import into the mitochondrion (GO:0036444),-0.2799687958860103,-0.6422426943546893,0.9052823315118397,0.9754650496079642,1.0,5/10,30.46%,MCUB;MAIP1;MICU2;SMDT1;MCUR1
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.21077993057952352,-0.6407919321844078,0.9626485568760611,0.9760113296106112,1.0,14/31,37.82%,MOCS1;MOCS3;GCH1;FDXR;SRD5A1;SRD5A2;PYCR3;HSD3B2;SCP2;PYCR2;DHRS11;HDC;HSD17B3;CYP19A1
prerank,tight junction assembly (GO:0120192),0.18327078679671746,0.6397243371117971,0.9805825242718447,1.0,1.0,11/49,19.63%,PARD3;AFDN;PRKCI;OCLN;CLDN5;PATJ;CDH5;ARL2;RAMP2;PARD6A;MPP7
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2638332924141883,-0.6383857757175606,0.9095652173913044,0.9770955966091953,1.0,4/13,23.94%,PRPF8;SART3;SRSF10;PRPF6
prerank,catecholamine biosynthetic process (GO:0042423),-0.27113088709627686,-0.6378362482391138,0.8964285714285715,0.9770679535437995,1.0,3/11,17.97%,MOXD1;GCH1;GATA3
prerank,mesenchyme development (GO:0060485),0.23709785946286294,0.6368547032401513,0.9435294117647058,1.0,1.0,2/15,8.65%,HMGA2;BMP7
prerank,linoleic acid metabolic process (GO:0043651),0.23448882190404424,0.6339060926806901,0.9358024691358025,1.0,1.0,17/17,76.58%,GSTP1;ABCD1;ELOVL2;FADS2;ALOX5;FADS1;ALOX12B;GSTA1;ELOVL3;GSTM2;ACSL1;ALOXE3;ELOVL1;ALOX12;ALOX15;PNPLA8;ELOVL5
prerank,fatty acid catabolic process (GO:0009062),-0.174887032176958,-0.6333133990442963,0.9917763157894737,0.9792822825756244,1.0,22/67,31.89%,PPARD;ABCD2;ACADM;AIG1;ACAD11;ACAT2;ABCD3;MCAT;ACOX1;ACAA2;MMUT;ACADVL;ADTRP;PLA2G15;HSD17B10;ACADS;ECHDC2;ACAD10;SCP2;LPIN3;ECHS1;HADH
prerank,regulation of chromosome organization (GO:0033044),0.21652220946929884,0.632435697800026,0.9551886792452831,1.0,1.0,6/22,17.85%,YLPM1;XRCC5;SMG5;CDT1;UPF1;SETMAR
prerank,monosaccharide transmembrane transport (GO:0015749),-0.24538745604492665,-0.632105165216951,0.9492119089316988,0.9795733192944868,1.0,4/16,17.06%,SLC5A3;SLC50A1;SLC23A1;SLC23A2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.23501614608700397,0.6312082581329898,0.9304556354916067,1.0,1.0,9/16,29.33%,PIGA;DPM2;PIGL;PIGN;PIGB;PIGW;PIGQ;PIGF;PIGP
prerank,cristae formation (GO:0042407),0.206165308350157,0.6297816653817682,0.9662650602409638,1.0,1.0,5/27,11.91%,ATP5MG;APOO;LETM1;ATP5MC3;ATP5ME
prerank,peptidyl-proline modification (GO:0018208),0.2086301659390546,0.6296179654625333,0.9630484988452656,1.0,1.0,7/25,22.67%,P3H2;PPIL3;PPIF;PPIH;FKBP4;CWC27;PPIL2
prerank,non-motile cilium assembly (GO:1905515),-0.2072858813274736,-0.6289308858285384,0.9686956521739131,0.9809800465381889,1.0,8/30,21.37%,PIBF1;DCTN1;TMEM80;GORAB;VANGL2;IFT57;TMEM17;DISC1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.25426313790711597,-0.6271303390964902,0.9229508196721311,0.9815871247654587,1.0,4/13,25.41%,MTHFD1L;GCH1;QDPR;FPGS
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.20720253385010734,-0.6268130632071198,0.9511343804537522,0.9813861041640619,1.0,14/30,35.21%,POLR2H;POLR2F;POLR2L;TTF1;TAF1A;POLR1F;POLR1C;UBTF;POLR1E;MNAT1;TAF1D;GTF2H1;ERCC2;CDK7
prerank,regulation of transferase activity (GO:0051338),-0.23972068468896862,-0.6244369176294506,0.93717277486911,0.9822456205946067,1.0,5/17,22.27%,NLRC5;PARP4;JMJD8;ATM;FEM1B
prerank,phasic smooth muscle contraction (GO:0014821),-0.26930317277559146,-0.6230350906080311,0.9327433628318584,0.9826163422510554,1.0,6/10,36.42%,HTR2B;TIFAB;PTGER3;EDNRB;EDN3;EDN2
prerank,eye photoreceptor cell development (GO:0042462),0.23557505878223173,0.6227368897179258,0.9278846153846154,1.0,1.0,2/15,10.89%,RORB;CEP290
prerank,transcription by RNA polymerase III (GO:0006383),-0.2098287167505788,-0.62151250077118,0.9571183533447685,0.9830166965980061,1.0,8/27,25.81%,POLR3G;POLR2L;SNAPC2;SNAPC3;GTF3A;GTF3C5;POLR3GL;BRF1
prerank,morphogenesis of an epithelium (GO:0002009),-0.21002895890972034,-0.6211526029345658,0.9600725952813067,0.9828238493388125,1.0,10/25,32.36%,ACTB;LRP6;ARHGAP12;TIMELESS;SOX10;KDM2B;DAG1;ACTG1;VCL;SOX8
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.22195828792705957,-0.6206210256450628,0.9655172413793104,0.9827133470574526,1.0,3/19,10.21%,NFATC3;HRH1;INPP5A
prerank,regulation of TOR signaling (GO:0032006),-0.17353280814320626,-0.6205336194397574,0.9901477832512315,0.9823811678241189,1.0,18/67,27.40%,GNA12;UBR2;GAS6;FNIP1;RRAGD;FLCN;PIK3CA;TBC1D7;DEPTOR;FAM83D;RHEB;HTR6;WDR24;PKHD1;LAMTOR1;LAMTOR3;MIOS;TSC2
prerank,negative regulation of DNA replication (GO:0008156),-0.24946957016549637,-0.6194955512818829,0.9319371727748691,0.9825812636513184,1.0,1/13,3.61%,S100A11
prerank,quinone biosynthetic process (GO:1901663),-0.242600556863097,-0.6178595927390138,0.9329608938547486,0.9830097990050818,1.0,3/14,25.98%,COQ8A;FDXR;COQ10B
prerank,male meiosis I (GO:0007141),-0.23474510920383146,-0.6176526621958713,0.9585492227979274,0.9827296472880662,1.0,6/16,35.24%,FOXJ3;FOXJ2;ZSCAN21;SLC25A31;ING2;HSF2BP
prerank,regulation of epithelial cell differentiation (GO:0030856),0.22314057541154764,0.6171911695198491,0.9592326139088729,1.0,1.0,4/17,14.78%,APOLD1;SOX9;AJAP1;KLF7
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.20712385988513182,0.6168089143472465,0.9644549763033176,1.0,1.0,5/26,14.02%,GPR37;FYN;REST;PRKN;NOL3
prerank,myofibril assembly (GO:0030239),0.18257916039345123,0.6165449144103585,0.9882903981264637,1.0,1.0,6/42,12.80%,CSRP1;TNNT2;TTN;CAPN3;PGM5;FHOD3
prerank,chondroitin sulfate catabolic process (GO:0030207),0.2516681752731981,0.6165340208812854,0.9375,1.0,1.0,2/13,3.64%,HEXB;VCAN
prerank,rRNA catabolic process (GO:0016075),-0.23390460545186872,-0.6151227573831646,0.9423791821561338,0.9835992562331218,1.0,9/16,38.55%,EXOSC5;EXOSC10;EXOSC4;DEDD2;ERN2;EXOSC8;EXOSC3;SLFN14;PELO
prerank,modified amino acid transport (GO:0072337),0.23420443297269553,0.6150680122065784,0.9422632794457275,1.0,1.0,3/15,14.88%,SLC6A13;FOLR1;FOLR2
prerank,BMP signaling pathway (GO:0030509),0.16410134644996777,0.6146680826115158,0.9925925925925926,1.0,1.0,14/62,21.46%,BMPR1B;ACVR1;TMEM100;BMP7;BMP15;TGFB2;RGMA;GDF15;TGFBR3;ACVR2B;AMHR2;RGMB;SMAD9;SCX
prerank,protein acetylation (GO:0006473),-0.20165230467159656,-0.6141615143482205,0.9766187050359713,0.9836662513131158,1.0,13/30,44.46%,CREBBP;NAA50;NAA16;ESCO2;CLOCK;EP300;KAT6A;NAA11;SPHK1;FOXO1;NAA15;KAT2B;NAA35
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2434574244391033,-0.6141009200598021,0.9430147058823529,0.9833176952165544,1.0,4/14,26.91%,FOXO3;TFAM;TWNK;EARS2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.18258689534161185,0.6132114905594022,0.9786223277909739,1.0,1.0,38/39,75.39%,GHRH;CAPN10;NLGN2;GRP;MYRIP;CRH;LRRC8A;MCU;BAD;TM7SF3;ISL1;SELENOT;RASL10B;AIMP1;AACS;ADCYAP1;GCK;GLUD1;ACSL4;TNFSF11;UCN;FGG;SCT;DRD2;TCF7L2;SOX4;PSMD9;HFE;NNAT;GPER1;TRH;SLC30A8;TFR2;DOC2B;GHRL;FFAR4;BLK;RBP4
prerank,endodermal cell fate commitment (GO:0001711),-0.2639720900959063,-0.6128968207392971,0.9086021505376344,0.9835174511342973,1.0,1/10,3.75%,CTR9
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.23786378620955884,-0.6128828435533173,0.929701230228471,0.9831533882348281,1.0,7/16,31.45%,ATP5MC1;ATP5MC2;ATP5MF;ATP5F1B;ATP5F1D;ATP5F1C;ATP5F1A
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.20700233022168796,-0.6124576516093222,0.9704347826086956,0.9829836219968949,1.0,4/26,11.05%,DUSP3;EIF4EBP1;KLHL18;APP
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.23554862154849554,0.6120108484285635,0.933649289099526,1.0,1.0,4/14,18.69%,GSTP1;NLRP2B;PELI3;CCDC3
prerank,thyroid hormone generation (GO:0006590),-0.26803209551144186,-0.611784967472332,0.9380378657487092,0.9829200278515179,1.0,5/10,35.64%,CPQ;TG;SLC5A5;TPO;DUOX1
prerank,prostanoid metabolic process (GO:0006692),-0.2455816637791869,-0.6112020358922259,0.9301533219761499,0.9828313752829774,1.0,5/13,36.12%,ACOX1;CYP2S1;PTGES;PTGR1;AKR1C1
prerank,GPI anchor metabolic process (GO:0006505),-0.20952813838636902,-0.6104134230277267,0.967409948542024,0.9828631613337285,1.0,8/26,27.21%,DPM3;PIGH;PGAP3;MPPE1;GPLD1;PGAP1;PIGZ;PGAP2
prerank,ubiquinone metabolic process (GO:0006743),-0.23327363943804688,-0.6101823897604444,0.9452554744525548,0.9825938745767564,1.0,4/15,31.11%,COQ8A;FDXR;COQ10B;AIFM2
prerank,cellular amide metabolic process (GO:0043603),-0.15849333084652859,-0.6078531121225195,1.0,0.9832865771470287,1.0,31/102,33.85%,MTHFS;ST3GAL1;PANK2;MTHFD1L;ST6GAL1;PDZD11;ACOT9;ACOT13;MTHFD2L;PLAAT3;PLAAT1;ACOT2;ACOT4;MTHFR;SHMT1;PLPP3;AASDHPPT;ABCA2;HLCS;FPGS;ORMDL2;PLA2G15;ACOT11;CERK;GNE;ORMDL3;ATF4;SLC19A1;DBI;MTHFD1;ACOT6
prerank,mRNA splice site selection (GO:0006376),-0.1980774947251782,-0.6063256637766629,0.9704861111111112,0.983590660750208,1.0,6/30,19.48%,PRPF39;CELF1;YTHDC1;SF3A1;SRSF10;SLU7
prerank,cranial nerve development (GO:0021545),0.24752556068043136,0.6055545827698083,0.9393939393939394,1.0,1.0,3/11,15.90%,SALL1;TFAP2A;ERBB3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.2660320919157341,-0.6028710215610285,0.9375,0.9847497749034987,1.0,6/10,35.96%,SERPINE1;WNK1;SNAI2;CYP1B1;ACER2;HRG
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.2555699738463533,-0.6011497431877013,0.9381625441696113,0.9850980774041879,1.0,4/10,24.20%,RFWD3;WDR76;FEM1B;DDX39B
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2491752245834963,-0.5970499930347176,0.9379194630872483,0.9863990417933444,1.0,1/11,3.89%,PACS2
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.25023189713756744,-0.5968359382940248,0.944153577661431,0.9861225450266686,1.0,3/11,32.14%,VAPB;LPCAT3;MOSPD3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.24914259501471486,-0.5966680085985603,0.9294320137693631,0.9858156738054125,1.0,4/11,24.60%,TGFBR2;STAT1;PDGFA;MYC
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.26717113230366796,-0.5952208723306069,0.9252669039145908,0.9860180763914105,1.0,5/10,31.45%,ATP5MC1;ATP5MC2;ATP5F1D;ATP5F1C;ATP5F1A
prerank,L-serine metabolic process (GO:0006563),0.2479374121969568,0.5944270479110626,0.9439024390243902,1.0,1.0,5/10,26.59%,PSAT1;CBS;PHGDH;SHMT2;SDS
prerank,negative regulation of myoblast differentiation (GO:0045662),0.23386489201406319,0.5941760088094262,0.962877030162413,1.0,1.0,13/13,76.63%,SOX9;SRA1;MSTN;TBX3;SOSTDC1;BMP4;EID2B;DLL1;NOTCH1;PRICKLE1;ANKRD2;SOX8;TGFB1
prerank,retinal metabolic process (GO:0042574),0.23475429658585104,0.5941272367775856,0.9550827423167849,1.0,1.0,3/12,17.23%,DHRS13;RDH11;ALDH1A3
prerank,nuclear body organization (GO:0030575),0.2377477819742133,0.5939534899491972,0.9378109452736318,1.0,1.0,1/12,1.78%,AFF2
prerank,lung epithelium development (GO:0060428),-0.2592238702732693,-0.593802220876156,0.926056338028169,0.9862078258610328,1.0,4/10,28.96%,RCN3;FOXJ1;WNT7B;GRHL2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.25119540252372863,-0.5928865813574132,0.9411764705882353,0.9861942459541095,1.0,6/11,39.40%,P2RX4;LMNA;SMAD4;RGS2;FOXO1;GLRX3
prerank,tRNA wobble uridine modification (GO:0002098),-0.23745150334804288,-0.5918957723373607,0.9602763385146805,0.9861991829245297,1.0,3/14,16.97%,ELP1;MOCS3;ELP4
prerank,spermatid development (GO:0007286),-0.19079874741029856,-0.5905979990395412,0.9832775919732442,0.9863308396663875,1.0,5/32,12.70%,YTHDC2;CEP57;ACRBP;RNF8;CIB1
prerank,positive regulation of locomotion (GO:0040017),0.19033897791637988,0.5898610164000637,0.9762470308788599,1.0,1.0,2/27,3.95%,CSF1R;P2RY12
prerank,estrogen metabolic process (GO:0008210),-0.22634389108833175,-0.5897575566407554,0.9656357388316151,0.986301047722061,1.0,6/15,31.51%,HSD17B7;CYP1B1;HSD17B10;HSD17B14;UGT1A7;UGT1A1
prerank,regulation of phosphate metabolic process (GO:0019220),0.2185487543276007,0.5896558078723674,0.9447004608294931,1.0,1.0,2/16,8.49%,TIGAR;SMG5
prerank,negative regulation of neurogenesis (GO:0050768),0.17742596284116605,0.5894669758542747,0.9822784810126582,1.0,1.0,3/34,7.08%,LINGO1;PTN;HOOK3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.22480358157588914,-0.5888995093120062,0.9504424778761061,0.9862611108048228,1.0,7/17,31.45%,ATP5MC1;ATP5MC2;ATP5MF;ATP5F1B;ATP5F1D;ATP5F1C;ATP5F1A
prerank,heme biosynthetic process (GO:0006783),-0.20946075616063714,-0.5870563452508851,0.9789103690685413,0.9865575219440005,1.0,6/22,23.29%,FLVCR1;HMBS;COX10;PGRMC1;PPOX;UROD
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.242061235658305,-0.5862928755560392,0.9511343804537522,0.9864690297108902,1.0,2/12,16.52%,RAB1A;UBE2C
prerank,regulation of urine volume (GO:0035809),0.24562174377000823,0.5845933876910512,0.9353348729792148,1.0,1.0,10/10,75.45%,HAS2;HYAL2;ADCY6;TRPV5;NPPB;TFAP2B;NPR3;NPR1;INPP5K;ADM
prerank,sphingolipid catabolic process (GO:0030149),-0.22540446799552674,-0.5825035150360466,0.9644670050761421,0.9874622033072785,1.0,11/15,47.33%,ACER3;PPT1;ASAH1;SMPDL3A;ACER2;PDXDC1;SPHK1;SMPD1;GLA;SMPD2;SMPD4
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2247070844205455,0.5812128629518237,0.9518072289156626,1.0,1.0,3/14,11.79%,ZNHIT3;RPF2;DDX18
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2118846722193757,-0.5804160188266249,0.9627749576988156,0.9878247449830061,1.0,6/20,25.16%,PIN1;PPIL6;PPIG;PPIB;PPIL1;FKBP1B
prerank,histone H2A acetylation (GO:0043968),-0.22404210156566134,-0.5796046619044006,0.9765886287625418,0.9877368012557938,1.0,3/16,16.94%,MORF4L1;EPC1;SPHK2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.23666719462126296,0.5775772610561205,0.9393939393939394,1.0,1.0,2/11,6.83%,AHCYL1;CDC73
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2187881858009757,-0.5760156218637856,0.9738675958188153,0.9885254995920243,1.0,2/16,10.44%,C3;CHGA
prerank,erythrocyte development (GO:0048821),-0.24844129342017512,-0.5757969381797873,0.9499105545617174,0.9882299364534477,1.0,2/10,21.71%,NCKAP1L;ZBTB7A
prerank,inositol phosphate biosynthetic process (GO:0032958),0.23437686636680294,0.5753194928412122,0.9496567505720824,1.0,1.0,3/11,12.62%,IP6K2;ITPKA;PPIP5K2
prerank,smooth muscle cell differentiation (GO:0051145),-0.23502746835382277,-0.5742625709244867,0.9717813051146384,0.988342374657046,1.0,7/12,38.60%,MEF2C;MRTFB;APLNR;EDNRB;HEY2;HEY1;TBX18
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.21278316695154206,-0.5742038486362058,0.9665492957746479,0.9879927496945567,1.0,7/19,30.35%,HPRT1;DCK;POLD2;DGUOK;PNP;ADA;GMPR2
prerank,zinc ion transmembrane transport (GO:0071577),-0.1992302926908845,-0.5723553479536204,0.9794168096054888,0.9882055653226915,1.0,3/22,16.34%,SLC30A5;SLC30A6;SLC39A3
prerank,regulation of microtubule nucleation (GO:0010968),0.24489796672228326,0.5719003951874375,0.9537037037037037,1.0,1.0,2/10,10.77%,ARHGEF7;EML2
prerank,transcription by RNA polymerase I (GO:0006360),-0.1853641352023539,-0.5708358359535182,0.9842105263157894,0.9883160459131194,1.0,14/34,35.21%,POLR2H;POLR2F;POLR2L;TTF1;TAF1A;POLR1F;POLR1C;UBTF;POLR1E;MNAT1;TAF1D;GTF2H1;ERCC2;CDK7
prerank,negative regulation of response to wounding (GO:1903035),-0.2117224983881373,-0.5701270170167945,0.9717314487632509,0.9881775393638413,1.0,3/19,12.79%,MDK;CRK;SERPINE1
prerank,ketone body metabolic process (GO:1902224),-0.2474897981119361,-0.567513765801463,0.9612794612794613,0.9886333417386506,1.0,1/10,4.92%,OXCT1
prerank,secondary palate development (GO:0062009),-0.22752575003769934,-0.5671405592991626,0.968595041322314,0.9883752876827723,1.0,6/14,37.17%,TGFBR2;CHD7;SMAD4;LEF1;SMAD2;WNT11
prerank,maintenance of protein localization in organelle (GO:0072595),-0.21059193102314208,-0.5662183908255679,0.9811643835616438,0.9882764366463921,1.0,5/19,26.75%,MORC3;TAF8;TAF3;TOPORS;PML
prerank,response to progesterone (GO:0032570),0.20805607349420344,0.5636200254163307,0.9727047146401985,1.0,1.0,4/18,17.14%,YAP1;CATSPERD;TGFB2;ACOD1
prerank,regulation of exit from mitosis (GO:0007096),-0.17628805630902722,-0.5629118170514189,0.9929203539823008,0.9888460839504911,1.0,8/38,20.66%,ANAPC1;UBC;RPS27A;BUB1B;PPP1R9B;UBE2C;ANAPC7;SIRT2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2047110883183569,-0.5621639755711583,0.9789103690685413,0.9886888094716398,1.0,6/20,29.99%,HSP90AB1;HSPA4;HSPA1A;TMEM35A;BBS10;LONP1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.2338338771008801,0.5611382613272717,0.9680365296803652,1.0,1.0,6/10,30.34%,NAF1;NOP10;RPUSD4;RPUSD3;RPUSD1;TSR3
prerank,respiratory electron transport chain (GO:0022904),0.21516920951842794,0.5591816105537996,0.9659090909090909,1.0,1.0,14/14,78.50%,PPARGC1A;ETFB;ETFRF1;SDHB;SDHA;ETFDH;GPD2;ETFA;SLC25A12;NDUFA5;UQCRFS1;SLC25A18;SLC25A13;SLC25A22
prerank,coenzyme A biosynthetic process (GO:0015937),0.22739546383580003,0.5582297770306626,0.9524886877828054,1.0,1.0,4/11,19.43%,PANK3;ACAT1;COASY;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.22739546383580003,0.5582297770306626,0.9524886877828054,1.0,1.0,4/11,19.43%,PANK3;ACAT1;COASY;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.22739546383580003,0.5582297770306626,0.9524886877828054,1.0,1.0,4/11,19.43%,PANK3;ACAT1;COASY;ACOT7
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.2297321805001173,-0.55744811096733,0.9645390070921985,0.989614567503122,1.0,3/12,30.06%,TPR;TGFB1;AAAS
prerank,positive regulation of insulin secretion (GO:0032024),0.16805118876616454,0.5528200031759226,0.9953379953379954,1.0,1.0,7/36,20.62%,ADCY8;CAPN10;NLGN2;MYRIP;PPP3CB;LRRC8A;ANO1
prerank,nucleotide biosynthetic process (GO:0009165),0.19717096967853703,0.5515195926572876,0.977116704805492,1.0,1.0,5/18,17.92%,RRM2B;NMNAT2;ADSL;ME1;PPAT
prerank,histone H3 deacetylation (GO:0070932),0.20670601532085892,0.5503870465601779,0.9730941704035875,1.0,1.0,15/15,79.35%,PER2;SIRT1;PER1;HDAC2;SIRT7;SFPQ;HDAC1;HDAC4;ELK4;SIRT6;SMARCAD1;HDAC3;HDAC9;HDAC8;SIRT2
prerank,maturation of LSU-rRNA (GO:0000470),-0.18713029396633438,-0.5488764753699648,0.9911504424778761,0.9914693418813215,1.0,11/26,34.20%,RPL7;RPL10A;NIFK;SNU13;RPL7A;WDR12;NHP2;EIF6;RPL7L1;MRPL1;BOP1
prerank,positive regulation of rRNA processing (GO:2000234),0.23014798272485207,0.5474346532760905,0.9694117647058823,1.0,1.0,1/10,6.09%,UTP15
prerank,male gonad development (GO:0008584),-0.1757554938401708,-0.547120296171352,0.9932088285229203,0.9915176907670479,1.0,14/34,38.04%,CSDE1;GATA3;KITLG;BIK;SRD5A2;LRP2;FGF9;SOX8;ING2;MEA1;SIX4;ADAM29;FSHR;LHCGR
prerank,gastrulation (GO:0007369),0.20457114152957417,0.5425653410254098,0.9785714285714285,1.0,1.0,15/15,79.56%,MKKS;NPHP3;LHX1;UGDH;WNT8B;TASOR;LRP5;GPC3;APELA;FGF8;NR4A3;EOMES;SMAD2;MEGF8;LMBRD1
prerank,apoptotic mitochondrial changes (GO:0008637),0.1698216389199574,0.5405355145871373,0.9975369458128078,1.0,1.0,10/32,25.74%,ERBB4;BOK;CAMK2A;ATP2A1;ATG3;DNM1L;HK2;BAK1;CCAR2;GGCT
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.22175128256414178,-0.5401276004218006,0.9689119170984456,0.9927018218730875,1.0,8/13,47.41%,ALG12;ALG6;ALG11;SRD5A3;ALG1;ALG2;ALG9;ALG13
prerank,apical protein localization (GO:0045176),0.22765649990259404,0.5400196917299989,0.9757174392935982,1.0,1.0,5/10,23.59%,MAL;GOPC;JAM3;ATP8B1;INSC
prerank,intraciliary retrograde transport (GO:0035721),0.22243767290394287,0.5372870252245838,0.9784172661870504,1.0,1.0,4/12,20.96%,DYNC2H1;DYNC2LI1;TTC21B;DYNC2I1
prerank,DNA biosynthetic process (GO:0071897),-0.2043847853843438,-0.5353861292476936,0.9892665474060823,0.9933079791852533,1.0,4/16,24.57%,WRN;POLD2;RFC3;POLD4
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.23203239353074756,-0.5347873010667081,0.9817578772802653,0.9930591331952273,1.0,2/10,20.83%,BATF;SFRP1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.20277462213605438,-0.5337203510791649,0.9809688581314879,0.9929075753313621,1.0,8/16,36.85%,VEGFA;APLNR;HMOX1;NGFR;FGF2;GATA2;IL12A;IL12B
prerank,lipid droplet organization (GO:0034389),0.1855580669089304,0.5322470227940435,0.9793577981651376,1.0,1.0,4/22,19.25%,SQLE;ZFYVE1;RAB18;CDS1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.1903829164302488,0.5311194242596393,0.9904761904761905,1.0,1.0,9/19,29.73%,DNAAF4;RFX3;NPHP3;AQP4;CFAP53;SPEF2;CABYR;NEK10;DNAAF2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.19801294286600962,-0.530400677936276,0.9912891986062717,0.9932359734223885,1.0,7/18,37.64%,BCL2;SLC25A4;SLC25A31;BCL2L1;BNIP3;ALKBH7;HEBP2
prerank,gonad development (GO:0008406),0.15778733632675807,0.5286416805038149,0.9975609756097561,1.0,1.0,6/41,14.63%,WT1;SOX9;SALL1;TGFB2;MKKS;INHBA
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.1993021750436933,-0.5248457212961664,0.9751332149200711,0.9938955003546783,1.0,5/18,24.50%,DDHD1;FIS1;AURKA;KDR;DCN
prerank,cellular response to estradiol stimulus (GO:0071392),0.18902358222423082,0.5244689220152771,0.9791666666666666,0.999916879285121,1.0,2/18,10.11%,RAMP3;POU4F2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.19933030594918988,-0.5199383605019151,0.989247311827957,0.994356429610849,1.0,5/17,21.59%,GET3;EMC6;EMC9;SGTA;BAG6
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.18486342216937238,-0.5161127897613808,0.9878260869565217,0.9946089199086151,1.0,8/20,45.86%,SIK1;NCOR1;EP300;UGT1A8;BCKDK;C1QTNF12;CLK2;WNT4
prerank,negative regulation of viral release from host cell (GO:1902187),0.20509875929008442,0.5126290895760575,0.9778270509977827,1.0,1.0,2/13,15.66%,TRIM13;TRIM35
prerank,vasodilation (GO:0042311),0.20494281575691503,0.5113202645078854,0.9829683698296837,1.0,1.0,2/13,13.09%,KCNMA1;ADRB1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.1665895535017165,-0.5100006457005649,0.9947916666666666,0.995182626632822,1.0,13/32,35.21%,POLR2H;POLR2F;POLR2L;TAF1A;POLR1F;POLR1C;UBTF;POLR1E;MNAT1;TAF1D;GTF2H1;ERCC2;CDK7
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.20907394692328002,-0.5022188012291129,0.9893992932862191,0.9959410015872631,1.0,5/12,35.13%,MBTPS2;LPCAT3;ABCA2;SREBF1;DGKQ
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.21787709497206698,0.5013768991117122,0.9824561403508771,1.0,1.0,10/10,78.23%,PRKN;SNCA;HDAC6;DRD5;OXA1L;AOC3;GZMA;ETFBKMT;MT3;HP
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.16850546088234702,0.5011104374627804,0.9977728285077951,0.9998736718921734,1.0,5/23,19.35%,TNNT2;MYH7;TGFBR3;TPM1;TNNC1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.2067618614446999,-0.48672820233418546,0.9914236706689536,0.9973781516555069,1.0,6/11,37.44%,ITGB5;JUP;DSP;VCL;PLEKHA7;THBS4
prerank,nucleotide-sugar metabolic process (GO:0009225),0.20093778730554565,0.4866827956648047,0.9931662870159453,1.0,1.0,6/12,27.63%,FUT8;B4GALNT2;SLC35A3;GMDS;CSGALNACT1;GFPT2
prerank,metanephric mesenchyme development (GO:0072075),-0.21499686236545923,-0.48530816292587964,0.9909420289855072,0.9971697302394181,1.0,6/10,45.86%,OSR1;STAT1;PAX2;SIX4;BASP1;WNT4
prerank,diol metabolic process (GO:0034311),-0.17906012948981095,-0.4833165647970919,0.9949066213921901,0.997002548983674,1.0,10/19,41.40%,GCH1;SPHK2;PLPP3;DEGS2;GCHFR;SPHK1;PLPP2;PLPP1;SGPP1;AKT1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.19567059526692027,0.47961436738853086,0.9844444444444445,1.0,1.0,6/12,24.66%,MAOA;DDC;ODC1;HNMT;AMD1;SRM
prerank,regulation of water loss via skin (GO:0033561),0.17399221398970238,0.4679674287287088,0.9906759906759907,0.999624749592164,1.0,15/15,82.62%,KDF1;TMEM79;STMN1;FA2H;ABCA12;ALOX12B;FLG;HRNR;ALOXE3;UGCG;ALOX12;MET;LSR;SFN;CLDN1
prerank,establishment of skin barrier (GO:0061436),0.17399221398970238,0.4679674287287088,0.9906759906759907,0.999624749592164,1.0,15/15,82.62%,KDF1;TMEM79;STMN1;FA2H;ABCA12;ALOX12B;FLG;HRNR;ALOXE3;UGCG;ALOX12;MET;LSR;SFN;CLDN1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.14489156289594407,-0.46433689579854753,1.0,0.9982068042544764,1.0,10/41,30.14%,DAGLB;GPX4;PLA2G4A;ACOX1;ELOVL5;CYP1B1;PNPLA8;ALOX15;SCP2;PTGR1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.18698032037799092,-0.45853820355794633,0.9911816578483245,0.998222745953151,1.0,4/13,32.07%,NUDT21;NCBP1;CPSF1;TUT1
prerank,UV protection (GO:0009650),-0.19555722089333544,-0.44786984241733696,0.9982300884955753,0.9984484390352063,1.0,2/10,20.39%,FEN1;CAT
prerank,protein neddylation (GO:0045116),0.17461142604182128,0.4459258102710753,1.0,1.0,1.0,3/13,19.25%,UBA3;DCUN1D2;NAE1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.17897384863564106,0.43729368532690943,0.9976470588235294,0.999565186148628,1.0,4/10,28.32%,MYOCD;SIRT1;PRKAA2;DIP2A
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.15197186636523485,-0.41097780417807506,0.9982363315696648,0.9993577234327016,1.0,17/17,84.83%,NEIL3;NEIL2;MPG;MUTYH;SMUG1;TERF2;TDG;NEIL1;MBD4;ACD;TERF2IP;NTHL1;TINF2;ERCC5;UNG;TERF1;OGG1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.13198991390714285,0.3512086604537904,1.0,0.999977029697411,1.0,5/17,22.79%,DPAGT1;DHDDS;DOLK;MPDU1;MVD
